data_3gcc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3gcc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.617 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 19.6 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.264 0.554 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.84 82.24 5.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.561 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.56 -13.48 3.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 33.3 t -102.16 120.87 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 109.395 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -103.9 89.44 3.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.54 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -46.97 149.98 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.426 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 13.1 mmt180 -113.42 161.81 25.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.937 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.29 6.09 4.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.662 2.241 . . . . 0.0 110.584 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -114.18 -15.05 12.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 30.96 2.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 28.6 mmmt -120.35 -175.31 2.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.638 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 156' ' ' LYS . 88.2 m-85 -157.64 117.71 3.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.104 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -89.94 122.46 32.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -98.53 111.95 24.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.58 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 4.4 mt-10 -135.21 150.88 50.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.403 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -127.9 148.29 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 133.0 36.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.746 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 171' ' ' VAL . 43.2 t0 -126.65 94.5 40.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.436 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.83 -24.99 8.09 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.656 2.237 . . . . 0.0 110.575 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.37 -11.91 61.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -100.12 55.61 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 56.3 31.04 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.955 . . . . 0.0 109.592 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.22 67.96 1.85 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -124.69 -180.0 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -1.154 . . . . 0.0 109.375 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -111.32 156.13 22.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.53 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 163' ' ' ASP . 29.5 t -129.15 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 3.2 t-105 -79.58 102.23 8.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.482 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 7.9 mt -56.78 -55.51 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 109.331 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 159.53 153.32 6.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.0 p -65.99 166.68 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 69.2 m-85 -141.39 -177.33 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.466 ' C ' HG21 ' A' ' 178' ' ' THR . 22.9 tt0 -95.84 -30.25 13.77 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.307 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.553 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.6 p -136.68 167.07 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.268 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.512 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -71.45 -26.34 62.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.307 -0.871 . . . . 0.0 108.916 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.93 -35.27 69.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.285 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.428 ' CG ' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.12 -43.56 57.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.075 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.36 -23.78 61.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 108.916 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -76.59 -42.75 41.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.02 -38.81 92.68 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.82 -38.58 83.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 108.982 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.2 t80 -60.61 -39.24 87.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.456 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 1.2 m-20 -56.96 -44.1 82.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -0.815 . . . . 0.0 109.577 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -48.84 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.482 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -72.82 -15.45 61.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 0.0 109.847 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.527 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -91.45 -17.49 25.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.152 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 2.8 t80 -94.34 -31.29 14.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -46.72 26.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.6 ttm -65.54 -33.52 76.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.687 -0.633 . . . . 0.0 109.83 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.473 ' HG2' ' NH1' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -100.14 18.21 19.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 109.646 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 57.43 -99.43 0.1 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.51 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 0.5 OUTLIER -126.13 158.08 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -1.154 . . . . 0.0 109.717 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.57 91.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . -140.19 174.12 10.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.415 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.99 113.58 26.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.16 179.48 5.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.88 -35.16 64.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 4.9 m-85 -120.03 83.35 30.67 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 122.626 2.217 . . . . 0.0 110.465 -179.649 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 27.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.52 31.01 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.034 -1.041 . . . . 0.0 109.774 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.09 20.16 0.35 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' A' ' 182' ' ' ALA . 61.6 t -140.62 107.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -1.061 . . . . 0.0 109.37 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -85.06 110.6 19.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 108.678 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -75.95 156.01 34.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.567 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.425 ' HG3' ' C ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -109.56 158.54 34.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.83 . . . . 0.0 109.19 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.82 13.79 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.514 2.143 . . . . 0.0 111.024 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -120.33 -25.43 5.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.071 -1.018 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.53 33.84 0.59 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.425 ' C ' ' HG3' ' A' ' 152' ' ' ARG . 42.5 mttt -126.44 -169.24 1.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 178' ' ' THR . 58.6 m-85 -156.42 172.19 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.379 -0.825 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.591 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.08 116.99 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.063 -1.023 . . . . 0.0 110.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -87.17 119.77 27.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 108.605 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -144.3 147.01 32.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.515 HD13 ' NH1' ' A' ' 194' ' ' ARG . 8.8 tt -135.94 143.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 108.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -80.81 134.47 35.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.036 -1.04 . . . . 0.0 109.811 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -122.94 103.6 36.62 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.391 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 -29.95 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.448 2.099 . . . . 0.0 110.594 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.66 -26.69 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.641 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -91.4 37.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.24 50.23 18.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.64 80.09 0.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -132.37 95.51 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.3 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -44.28 133.0 5.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 43.7 t -109.92 103.18 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.439 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.591 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.0 t-105 -93.68 97.31 10.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -54.3 -49.0 70.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.061 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.54 159.53 8.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -76.99 144.08 38.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.647 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 61.4 m-85 -118.01 178.26 4.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.456 -0.778 . . . . 0.0 109.21 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.6 mm-40 -88.24 -25.55 22.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 110.012 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.566 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.8 p -141.17 178.17 7.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.514 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -80.38 -23.17 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.385 -0.822 . . . . 0.0 109.19 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 13.6 tt0 -74.93 -36.81 62.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.455 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.84 -43.91 43.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.609 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -67.25 -37.88 84.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.346 -0.846 . . . . 0.0 109.045 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.532 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -61.25 -44.88 96.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.426 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.7 -18.72 62.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 108.894 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 11.6 t80 -76.22 -31.58 58.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.002 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 200' ' ' LEU . 15.2 m-20 -68.38 -51.09 47.95 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.545 -0.722 . . . . 0.0 109.798 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -27.52 69.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.438 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -86.15 -23.03 26.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.302 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.49 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.18 -15.63 35.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.37 -0.831 . . . . 0.0 109.124 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.4 OUTLIER -92.81 -32.13 14.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -78.8 -40.58 32.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.02 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.1 tpp -70.34 -30.93 68.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 0.0 109.581 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.515 ' NH1' HD13 ' A' ' 161' ' ' ILE . 1.5 mpt_? -91.62 -12.67 33.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 196' ' ' SER . . . 62.57 81.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.574 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 3.3 m 61.01 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -1.161 . . . . 0.0 109.69 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 61.76 120.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.922 . . . . 0.0 109.632 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 173.31 153.59 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.04 118.6 35.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.02 -177.41 4.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.499 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -72.8 -34.36 66.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.532 ' CD2' HD21 ' A' ' 184' ' ' LEU . 2.2 m-85 -128.66 76.52 78.62 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.722 2.281 . . . . 0.0 110.66 -179.382 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 18.6 m-85 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.168 0.508 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.09 88.19 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 124.77 26.29 1.43 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.7 t -140.35 109.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -1.106 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -95.46 93.77 7.41 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.224 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 157' ' ' PHE . 44.0 tt0 -52.05 167.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.418 ' N ' ' CG ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -129.69 158.91 72.15 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.335 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.57 4.32 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.625 2.216 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CD1' ' O ' ' A' ' 154' ' ' TRP . 50.0 t-105 -113.25 -7.77 13.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.52 22.6 8.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -115.09 174.08 6.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.596 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 151' ' ' GLN . 79.6 m-85 -146.91 152.98 39.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.032 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -121.85 117.45 26.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.873 -1.142 . . . . 0.0 109.653 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE2' ' A' ' 176' ' ' PHE . . . -91.89 111.07 22.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.435 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -130.22 145.87 51.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.063 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.51 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 14.9 tt -124.15 154.7 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.61 136.32 34.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.418 ' HB2' HG22 ' A' ' 171' ' ' VAL . 44.0 t0 -146.16 93.05 5.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.669 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.16 -23.42 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.635 2.223 . . . . 0.0 110.281 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.48 -11.52 24.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.821 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 13.2 mtpt -100.87 35.67 2.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 1.6 t-20 70.39 47.22 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.66 89.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -163.71 136.1 5.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -71.82 178.68 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.497 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 23.2 t -138.51 81.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.581 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 9.2 t-105 -61.87 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.506 ' CD2' ' CB ' ' A' ' 189' ' ' ALA . 26.6 mt -51.7 -34.87 40.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.127 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 137.33 155.22 6.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 5.8 p -68.24 -177.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.323 -1.104 . . . . 0.0 109.383 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 175' ' ' THR . 74.2 m-85 -157.54 177.94 10.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -88.84 -26.91 21.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.655 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.7 p -140.83 175.59 9.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.545 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -80.44 -21.07 42.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.284 -0.885 . . . . 0.0 109.2 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -76.31 -37.55 57.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.35 -36.06 63.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.167 -0.958 . . . . 0.0 109.027 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . . . -72.72 -39.76 66.67 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.038 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.619 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -66.3 -39.53 89.39 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.0 108.734 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.0 tp -64.56 -42.7 95.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.53 -24.15 67.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.2 t80 -76.04 -28.79 57.81 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.482 -0.761 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.3 m-20 -74.48 -47.55 32.66 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -62.43 -31.61 72.34 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.506 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -88.54 -20.59 24.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.024 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.1 -1.96 58.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -107.97 -35.42 6.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.906 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -76.81 -39.77 50.27 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 27.7 ttm -76.6 -36.94 57.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.64 -0.662 . . . . 0.0 109.978 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -77.73 -18.36 56.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.965 . . . . 0.0 109.18 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.16 -127.79 9.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 197' ' ' ARG . 13.8 m -63.96 -148.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 110.053 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 196' ' ' SER . 1.8 ttm180 -39.99 139.72 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 110.033 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.78 -175.88 4.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.143 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.23 121.36 43.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.497 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -131.69 152.42 50.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -33.04 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.3 m-85 -117.44 94.19 44.85 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.308 -1.558 0 C-N-CA 122.432 2.088 . . . . 0.0 110.374 -179.695 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.577 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 12.7 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.43 81.84 3.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 108.917 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.67 19.79 2.0 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 44.4 t -133.21 129.51 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.259 . . . . 0.0 109.198 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 112.36 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.579 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.1 pt20 -80.17 157.18 26.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -125.75 159.13 62.63 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 109.698 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 3.4 7.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.571 2.181 . . . . 0.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -101.22 -19.21 15.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.51 39.79 1.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 35.1 mttt -145.56 166.1 26.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.427 -1.043 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.611 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 23.8 m-85 -133.65 178.54 6.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.36 112.74 6.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.704 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -88.49 108.17 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -129.4 158.42 39.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.356 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.8 tt -139.72 139.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -80.72 128.72 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.902 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -114.78 95.74 42.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -23.27 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.613 2.208 . . . . 0.0 110.617 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.65 -7.1 30.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.185 -0.947 . . . . 0.0 109.687 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -119.09 57.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.1 m120 49.49 26.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.91 99.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -142.62 105.34 4.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 109.248 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.01 141.94 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 38.2 t -122.81 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.574 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 5.6 t-105 -73.7 96.49 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.786 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 189' ' ' ALA . 30.3 mt -56.04 -46.99 78.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.33 154.53 6.59 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.9 p -70.33 161.25 30.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -1.107 . . . . 0.0 109.356 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 65.2 m-85 -136.16 178.72 6.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.414 ' C ' HG21 ' A' ' 178' ' ' THR . 23.7 mp0 -84.15 -31.25 25.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.459 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.8 p -142.06 170.33 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -70.23 -22.42 62.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.106 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.88 -42.59 63.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -68.29 -43.45 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.862 . . . . 0.0 109.606 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.67 -45.76 85.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . . . -58.8 -38.93 79.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.63 -51.52 68.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 109.125 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.532 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.49 -20.25 65.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 108.815 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -79.27 -28.47 42.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.445 -0.785 . . . . 0.0 109.41 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.485 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 9.4 m-20 -72.34 -35.47 68.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.701 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -76.19 -40.04 53.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.502 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -73.89 -30.02 62.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.467 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.87 -23.62 33.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.837 . . . . 0.0 109.4 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.51 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 28.7 t80 -83.74 -22.34 31.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 108.974 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -78.86 -38.49 37.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.638 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.1 ttm -80.15 -43.12 22.17 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 0.0 110.173 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.519 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 12.2 mtt180 -92.57 -38.34 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.828 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 63.11 161.43 0.28 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 197' ' ' ARG . 22.5 p 50.53 -176.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -1.097 . . . . 0.0 109.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.5 mtm180 -43.7 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.519 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . -119.27 35.99 4.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 198' ' ' ALA . 5.0 mt 39.35 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.485 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -118.18 149.77 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.972 . . . . 0.0 109.353 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -49.18 -37.31 22.17 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.9 m-85 -120.81 83.22 36.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 200' ' ' LEU . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.905 2.403 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 68.6 m-85 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.59 35.02 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.184 -0.948 . . . . 0.0 110.15 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.431 ' O ' HG21 ' A' ' 149' ' ' VAL . . . -171.78 26.24 0.09 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 183' ' ' ALA . 96.7 t -150.27 117.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.417 -1.049 . . . . 0.0 109.185 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.541 ' CG ' ' HB1' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -99.09 137.13 38.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.104 -0.997 . . . . 0.0 109.09 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.6 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -103.11 155.62 18.27 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.265 -0.897 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.69 161.02 55.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.815 . . . . 0.0 109.38 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.85 -8.41 16.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.513 2.142 . . . . 0.0 109.964 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.59 -1.41 57.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.5 56.27 2.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.4 mttt -159.27 171.27 20.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.788 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.6 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 36.2 m-85 -142.17 -177.68 5.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -152.49 116.92 4.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.779 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -89.23 118.35 28.85 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 109.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 5.6 mt-10 -137.82 177.57 7.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 tt -164.72 142.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.909 -1.119 . . . . 0.0 109.939 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -69.5 134.17 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.045 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 171' ' ' VAL . 11.2 t0 -113.14 98.07 44.7 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 0.0 109.62 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.12 -22.07 10.17 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.535 2.157 . . . . 0.0 110.28 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.25 67.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.296 -0.878 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -104.98 32.5 4.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.72 58.52 4.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 82.09 -127.56 8.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 67.18 87.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -53.5 134.83 40.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 163' ' ' ASP . 70.3 t -102.01 105.8 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 108.962 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.578 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 9.4 t-105 -87.49 93.9 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.031 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 189' ' ' ALA . 3.7 mt -53.55 -48.69 68.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.0 108.998 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 153.62 162.23 10.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.29 160.84 30.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -1.141 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -134.75 -176.5 4.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 0.0 109.608 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -90.58 -28.2 18.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.638 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.542 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p -146.5 172.18 13.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -70.61 -24.36 62.72 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.127 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -73.81 -36.37 64.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.2 OUTLIER -72.03 -47.05 54.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -65.65 -32.15 73.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.589 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -70.2 -37.62 75.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.135 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.97 -47.56 77.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 108.86 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.571 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.25 -22.11 66.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 183' ' ' ALA . 28.9 t80 -69.79 -36.28 75.57 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 9.7 m-20 -63.57 -54.33 37.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.395 -0.815 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -55.68 -29.68 59.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.26 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.528 ' HB3' ' CD2' ' A' ' 173' ' ' LEU . . . -85.11 -24.64 27.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.084 . . . . 0.0 110.06 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.94 -14.91 37.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.995 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.548 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.4 t80 -96.25 -25.33 15.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.17 -0.956 . . . . 0.0 108.853 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.34 -38.79 34.31 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.2 tpp -79.59 -42.13 25.63 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.383 0.611 . . . . 0.0 109.749 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 9.7 mtp180 -97.73 -41.27 8.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 109.629 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 43.24 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 197' ' ' ARG . 0.6 OUTLIER 45.87 50.62 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -1.12 . . . . 0.0 109.828 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 70.46 118.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -138.96 174.21 10.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.335 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 108.07 19.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.522 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -122.0 -175.91 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.562 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -84.6 -33.52 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 6.2 m-85 -121.02 77.49 31.5 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HA ' HD13 ' A' ' 200' ' ' LEU . 34.6 Cg_endo . . . . . 0 C--N 1.31 -1.498 0 C-N-CA 122.686 2.257 . . . . 0.0 110.507 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 30.4 m-85 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 83.6 2.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.57 -22.2 3.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.7 t -90.48 116.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -1.15 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -105.48 120.21 41.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.575 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 pp0? -85.54 163.8 18.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.881 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -131.66 165.73 33.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.452 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.0 Cg_endo -78.39 -4.09 13.92 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.683 2.255 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -91.96 -18.03 24.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.007 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.86 35.84 2.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -137.16 -175.59 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 0.0 109.634 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 36.2 m-85 -144.83 -173.37 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.59 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -154.01 108.32 3.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.213 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -82.73 119.41 24.29 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.563 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 10.6 mt-10 -134.89 179.65 6.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.084 -1.01 . . . . 0.0 109.365 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -174.76 141.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.43 136.76 39.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' CA ' ' A' ' 168' ' ' GLY . 10.5 t0 -111.47 101.02 49.8 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -24.02 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 110.308 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.85 -37.0 75.99 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 14.2 mttt -98.33 59.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 8.6 p30 41.36 48.02 3.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.438 -0.789 . . . . 0.0 109.797 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 163' ' ' ASP . . . 75.48 -114.68 4.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 168' ' ' GLY . . . 63.27 95.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 169' ' ' ALA . 7.7 ptt180 -45.28 157.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.675 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 41.1 t -129.29 93.02 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.59 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 13.5 t-105 -79.59 93.19 5.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.12 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -53.47 -40.18 65.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.485 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 148.25 -171.93 28.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -103.39 154.94 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -1.162 . . . . 0.0 109.028 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 67.0 m-85 -130.1 165.28 22.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.464 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.7 OUTLIER -77.71 -17.87 57.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.096 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.517 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.9 p -153.56 162.36 41.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.545 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -66.63 -23.28 66.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.309 -0.869 . . . . 0.0 109.405 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.0 -39.72 65.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.501 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.453 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.8 OUTLIER -72.04 -40.49 68.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.572 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -70.83 -32.13 69.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.592 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -71.47 -41.15 69.73 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.75 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.32 -46.91 88.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.34 -22.88 63.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 108.845 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.0 t80 -72.48 -30.74 64.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 38.5 m-20 -69.34 -50.48 45.97 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.36 -0.837 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -54.95 -38.02 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.918 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.02 -30.15 49.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -82.64 -2.8 55.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.383 -0.823 . . . . 0.0 109.385 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' GLY . 37.3 t80 -99.45 -40.67 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.149 -0.97 . . . . 0.0 108.918 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -64.34 -49.12 72.94 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -40.38 95.22 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 195' ' ' GLY . 60.3 mtt180 -105.31 36.52 2.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 108.962 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -34.69 147.72 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.2 t 80.91 102.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.56 -0.965 . . . . 0.0 109.402 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.496 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 49.8 ttm-85 64.71 -96.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.407 -0.808 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.496 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 63.08 145.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.005 -1.06 . . . . 0.0 109.401 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 122.46 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.23 152.53 38.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -0.919 . . . . 0.0 109.24 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -48.5 -37.16 16.78 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.9 m-85 -120.19 92.31 47.0 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.631 2.221 . . . . 0.0 110.916 -179.202 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.635 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 86.41 3.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.832 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.41 -19.78 5.62 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.494 ' CG2' ' HB2' ' A' ' 146' ' ' TYR . 44.1 t -90.0 114.58 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.667 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -100.08 113.92 26.88 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.459 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 12.0 pt20 -78.62 154.57 30.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.311 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.493 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -118.42 174.43 2.67 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -77.68 -48.07 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.632 2.221 . . . . 0.0 110.507 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -62.51 1.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.65 52.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -141.48 173.44 11.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.674 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.459 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 74.8 m-85 -139.15 175.37 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.64 110.27 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.558 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.56 124.2 28.76 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -146.03 160.29 42.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.788 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.45 HD11 ' HE1' ' A' ' 193' ' ' MET . 3.4 tt -149.47 147.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.859 . . . . 0.0 109.181 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.441 ' NH2' ' HG2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -96.94 137.15 36.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.99 . . . . 0.0 109.614 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.444 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 44.5 t0 -122.23 114.45 30.59 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.361 -0.837 . . . . 0.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.71 -35.05 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.324 2.016 . . . . 0.0 110.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.61 64.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.105 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -93.89 39.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.42 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.36 30.98 13.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.76 62.59 5.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.44 33.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.491 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -84.64 161.93 19.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.632 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.6 t -137.3 94.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.432 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 7.3 t-105 -79.3 100.36 7.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 2.2 mt -59.47 -43.12 93.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 146.26 157.02 7.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -76.26 151.06 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.169 . . . . 0.0 109.432 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.608 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 58.9 m-85 -123.38 -176.25 3.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -87.59 -31.98 19.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.5 p -139.29 176.27 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.193 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.457 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -76.26 -26.06 55.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.3 -37.37 71.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -72.97 -39.57 66.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.552 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -72.97 -26.52 61.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.327 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.635 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -77.21 -39.28 49.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.136 -0.978 . . . . 0.0 109.013 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 1.1 tm? -63.75 -43.07 97.54 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 108.838 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.608 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.72 -29.45 69.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -66.31 -32.18 73.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 0.0 109.14 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 3.6 m-20 -65.93 -49.6 67.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.09 -29.71 67.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.005 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.449 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -85.48 -24.28 27.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.821 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.69 -6.53 58.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.613 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 196' ' ' SER . 2.1 t80 -104.01 -37.47 7.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.44 -40.99 56.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.273 -0.892 . . . . 0.0 109.163 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.45 ' HE1' HD11 ' A' ' 161' ' ' ILE . 2.0 mtm -71.94 -30.79 65.69 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.563 -0.711 . . . . 0.0 110.067 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -92.75 -6.4 49.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.84 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.0 -104.23 3.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.581 ' O ' ' CZ ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -108.02 -78.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.981 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.83 122.79 15.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.881 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -156.54 162.4 39.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.158 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.55 124.77 52.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -123.61 173.19 8.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.222 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.463 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.5 OUTLIER -74.66 -28.73 60.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 4.0 m-85 -125.24 67.25 54.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.545 -0.722 . . . . 0.0 109.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.463 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.8 Cg_endo . . . . . 0 C--N 1.31 -1.471 0 C-N-CA 122.553 2.169 . . . . 0.0 109.876 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.559 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 17.8 m-85 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 87.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 125.8 28.29 1.07 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.8 t -142.41 123.05 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.094 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 85.62 2.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.585 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 1.3 pp0? -59.49 144.39 47.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.511 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 159.79 34.71 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.23 18.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.742 2.295 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.35 -39.99 2.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.44 46.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HD2' ' HB ' ' A' ' 175' ' ' THR . 34.9 ttpt -147.18 147.93 31.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -1.165 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.585 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 16.4 m-85 -133.79 130.46 38.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.581 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -99.32 108.93 21.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.082 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.543 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.11 109.21 18.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.224 -0.923 . . . . 0.0 108.585 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.496 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 1.8 mp0 -132.53 141.54 48.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.12 -0.987 . . . . 0.0 109.668 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.7 131.89 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.798 . . . . 0.0 109.269 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.73 122.98 24.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.683 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -113.87 108.39 51.22 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.858 . . . . 0.0 109.313 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 -27.62 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.387 2.058 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.31 75.29 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -95.9 40.56 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.463 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 4.9 m-20 69.56 46.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.506 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.35 29.79 1.82 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.96 123.05 20.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -1.122 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.04 130.16 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.489 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.75 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.581 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 9.3 t-105 -74.65 94.17 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.372 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 39.4 mt -54.24 -41.63 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 145.15 155.01 6.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 2.3 p -68.04 179.77 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 75.1 m-85 -154.62 -174.23 4.89 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.396 -0.815 . . . . 0.0 109.343 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.38 -25.37 13.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.578 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.8 p -142.7 170.85 14.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.551 ' CA ' ' CD2' ' A' ' 157' ' ' PHE . . . -74.68 -23.9 58.7 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.157 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -34.03 61.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.2 OUTLIER -74.79 -39.97 61.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 109.019 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.468 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -70.48 -35.63 73.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -70.54 -40.64 73.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.996 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.1 -43.66 97.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.48 -24.0 63.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.539 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 7.2 t80 -69.37 -30.08 67.99 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -49.11 50.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.491 -0.756 . . . . 0.0 109.046 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -54.11 -39.27 66.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.687 . . . . 0.0 109.608 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.539 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -79.61 -27.62 41.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.7 -4.1 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.19 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 10.0 t80 -103.79 -23.82 13.37 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -81.55 -36.41 29.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.6 tpp -81.05 -44.07 18.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.785 -0.572 . . . . 0.0 109.91 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.7 mtt180 -85.3 -33.35 22.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.175 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 62.47 127.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 195' ' ' GLY . 69.6 m 61.56 142.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -1.104 . . . . 0.0 110.34 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 2.4 tpp180 43.06 -96.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.49 -0.756 . . . . 0.0 110.376 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 65.29 168.7 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.152 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 200' ' ' LEU . 0.1 OUTLIER -106.0 109.85 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.599 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.439 ' N ' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.75 159.41 32.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.464 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -68.66 -30.55 69.26 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.0 m-85 -122.49 86.36 48.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.309 -1.51 0 C-N-CA 122.707 2.271 . . . . 0.0 110.669 -179.351 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.64 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 28.1 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.259 0.552 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 99.85 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.09 -33.25 4.28 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 146' ' ' TYR . 52.1 t -75.3 134.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -1.19 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.18 106.69 11.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.061 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -77.12 163.21 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -120.8 175.99 2.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.412 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.39 -23.43 8.67 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.744 2.296 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -84.25 -56.03 3.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.62 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.02 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.2 157.88 41.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -1.125 . . . . 0.0 109.138 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 13.7 m-85 -126.1 -178.43 4.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 109.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.615 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.97 108.19 4.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 110.345 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.69 107.57 13.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.42 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -130.29 146.05 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 189' ' ' ALA . 14.5 tt -135.12 156.44 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.291 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.05 132.78 33.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -132.17 102.55 14.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.303 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 -26.67 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.442 2.094 . . . . 0.0 109.961 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.52 64.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 35.9 mttm -90.03 26.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 3.7 t-20 75.11 43.99 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.38 48.48 80.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.02 147.32 42.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -1.153 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -76.81 154.95 33.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 171' ' ' VAL . 9.0 t -122.12 85.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.615 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 6.5 t-105 -73.86 96.46 2.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 108.882 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 189' ' ' ALA . 7.6 mt -52.94 -48.59 67.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.132 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 150.43 152.29 5.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.5 p -65.55 171.14 4.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.173 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 61.6 m-85 -144.95 -176.49 5.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -89.42 -29.58 18.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.5 p -143.06 171.18 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.572 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -71.62 -28.11 63.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -69.46 -33.75 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -76.36 -41.11 49.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 109.031 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.58 -23.12 61.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.852 . . . . 0.0 109.081 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.64 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -80.24 -42.52 23.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 108.86 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -36.22 83.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.14 -29.78 65.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 17.7 t80 -64.83 -37.43 87.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.504 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 14.2 m-20 -63.39 -47.09 83.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.512 -0.742 . . . . 0.0 109.336 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -53.04 -42.37 65.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.52 ' HB3' ' CD2' ' A' ' 173' ' ' LEU . . . -82.02 -17.92 45.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.7 -5.09 56.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.189 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 5.6 t80 -102.8 -33.73 9.26 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -77.23 -41.36 41.47 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.39 -29.27 63.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 109.343 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.6 mtt-85 -104.66 9.79 35.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.67 -162.79 14.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 59.0 p -61.49 161.56 9.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -1.101 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 54.94 104.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.551 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -151.58 172.98 15.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 109.163 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.415 ' C ' ' CD1' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -107.43 112.89 25.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.72 179.44 4.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 109.31 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.464 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -74.53 -30.59 61.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 108.422 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.3 m-85 -126.1 67.0 61.52 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.589 -0.694 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.46 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 122.609 2.206 . . . . 0.0 110.304 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.646 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.364 0.602 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -80.71 99.08 8.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.668 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 160' ' ' GLU . . . 115.92 -9.72 18.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 89.7 t -100.88 112.61 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.034 -1.274 . . . . 0.0 109.79 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.1 ttm-85 -91.83 94.12 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.108 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.564 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -71.57 134.94 46.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.85 160.65 34.31 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.85 -2.55 12.53 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.71 2.273 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -109.73 19.95 18.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.661 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.16 68.03 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.527 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -162.01 133.47 5.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 108.797 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 5.3 m-85 -132.51 137.27 47.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -0.945 . . . . 0.0 109.115 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.637 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -107.26 116.76 32.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.002 -1.061 . . . . 0.0 110.357 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -89.39 114.12 25.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 148' ' ' GLY . 2.5 mp0 -130.61 155.57 46.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.403 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.475 ' CG2' ' HE3' ' A' ' 193' ' ' MET . 8.9 tt -139.06 125.77 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -82.03 117.55 22.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.52 108.94 58.31 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.23 -33.08 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.381 2.054 . . . . 0.0 110.288 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.28 65.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -89.46 39.54 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.428 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.4 m120 46.57 50.17 13.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.594 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.15 88.69 0.03 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -146.85 89.04 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -1.157 . . . . 0.0 109.741 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -49.18 145.23 4.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.326 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.55 86.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.691 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.637 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 5.6 t-105 -67.21 97.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 108.91 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.498 HD13 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -53.98 -42.42 68.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.859 . . . . 0.0 109.606 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.48 155.53 6.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.7 p -67.77 -176.59 0.67 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -1.141 . . . . 0.0 109.302 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 71.0 m-85 -156.75 -168.52 2.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 109.397 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.57 -25.88 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.456 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.57 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.1 p -141.49 174.54 10.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.476 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -79.85 -24.42 41.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -35.08 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.455 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.1 OUTLIER -77.79 -39.32 44.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.91 -41.93 61.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 108.853 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.59 -40.58 95.3 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.67 -25.83 64.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.454 ' HA ' HD12 ' A' ' 173' ' ' LEU . 15.2 t80 -68.15 -41.09 82.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 25.5 m-20 -61.1 -50.1 74.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.224 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -48.27 -39.5 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.557 -0.714 . . . . 0.0 110.128 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 173' ' ' LEU . . . -81.9 -26.16 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.966 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.15 7.36 32.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.041 -1.037 . . . . 0.0 109.143 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 10.0 t80 -111.94 -33.8 6.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -43.06 32.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.475 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -75.62 -29.73 59.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.319 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -95.51 5.41 51.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.907 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 85.37 -89.51 1.61 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 45.0 t -138.76 -80.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -1.208 . . . . 0.0 109.879 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 111.79 1.01 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.408 ' C ' HD22 ' A' ' 200' ' ' LEU . . . -150.49 170.01 20.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.83 107.99 20.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.453 ' HB3' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -115.42 157.87 23.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.189 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.441 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -61.19 -31.72 71.48 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 4.8 m-85 -121.97 83.92 44.42 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.301 -179.71 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 19.2 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.345 0.593 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -82.45 83.32 7.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.878 . . . . 0.0 109.199 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.96 6.15 5.51 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 95.8 t -119.69 118.14 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -1.233 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.2 ttp180 -88.24 115.0 25.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -83.38 152.3 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.751 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.516 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.3 mtm105 -137.5 175.42 3.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -0.819 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 34.9 Cg_endo -77.44 159.13 32.67 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.5 2.134 . . . . 0.0 110.019 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.568 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 8.2 t-105 83.77 -60.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.41 54.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -132.88 154.11 50.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -1.185 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.551 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 74.4 m-85 -142.43 179.17 7.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.45 113.94 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.061 -1.024 . . . . 0.0 110.017 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.536 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -88.31 121.74 31.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.377 -0.827 . . . . 0.0 108.974 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -146.17 151.34 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.148 -0.97 . . . . 0.0 109.313 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.9 tt -129.83 124.3 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 124.28 22.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.43 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.19 96.92 50.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.72 -22.67 10.26 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.611 2.207 . . . . 0.0 110.223 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.29 -3.85 19.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.349 -0.844 . . . . 0.0 109.703 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 1.0 OUTLIER -122.38 27.59 7.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 75.19 58.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.095 -1.003 . . . . 0.0 109.626 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.9 39.69 6.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -84.44 93.32 8.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -1.209 . . . . 0.0 109.285 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -50.01 142.47 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.452 ' HB ' HG21 ' A' ' 161' ' ' ILE . 31.4 t -116.3 86.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 109.194 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.7 t-105 -75.62 96.12 3.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.539 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 4.3 mp -54.45 -42.88 71.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.62 152.42 5.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.6 p -68.35 164.44 20.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.443 -1.033 . . . . 0.0 109.44 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.4 m-85 -138.41 -169.88 2.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.491 ' HG2' ' OD2' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -96.93 -30.87 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p -136.59 -179.62 5.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.85 -1.157 . . . . 0.0 110.247 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -76.49 -32.38 58.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 8.0 tt0 -66.23 -70.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.497 ' OD1' ' OG1' ' A' ' 178' ' ' THR . 0.0 OUTLIER -38.79 -59.97 0.89 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.623 . . . . 0.0 110.166 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -55.6 -38.44 69.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 202' ' ' PHE . . . -64.08 -34.63 78.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.136 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -38.42 80.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.915 -1.115 . . . . 0.0 109.44 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.551 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.06 -32.39 73.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.84 . . . . 0.0 108.911 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.0 t80 -67.17 -33.85 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 109.523 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.465 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 29.4 m-20 -64.25 -44.91 90.33 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -62.66 -32.88 74.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.79 . . . . 0.0 110.408 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.539 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -83.47 -24.65 31.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.101 -1.0 . . . . 0.0 109.853 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.65 -12.64 53.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.8 t80 -99.56 -40.47 7.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.016 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.14 -39.9 96.01 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.9 tpp -74.92 -55.32 5.91 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.558 0.694 . . . . 0.0 109.569 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.7 mtt180 -88.95 -55.74 3.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 0.0 109.685 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 57.28 170.15 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER 56.25 81.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.522 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.42 100.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.896 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -133.56 176.7 8.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 200' ' ' LEU . 8.1 mp -95.85 109.3 21.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -130.49 143.17 50.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.117 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.413 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -51.89 -32.11 31.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 4.9 m-85 -124.13 89.53 51.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.447 ' HA ' ' CD1' ' A' ' 200' ' ' LEU . 34.0 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 C-N-CA 122.462 2.108 . . . . 0.0 110.435 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.589 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 36.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 89.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.66 -28.19 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 50.6 t -85.86 118.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -1.177 . . . . 0.0 109.61 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.53 116.81 33.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 108.994 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.51 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 4.4 pt20 -81.58 157.25 24.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.931 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.489 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.3 mtt-85 -122.46 160.36 48.61 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -76.84 -8.54 17.97 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.514 2.143 . . . . 0.0 110.162 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.89 -27.14 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.3 34.46 0.95 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 11.8 mtpp -132.06 176.97 7.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -1.157 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.58 ' CE2' ' HB1' ' A' ' 179' ' ' ALA . 64.3 m-85 -145.45 177.24 8.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.29 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.13 108.35 3.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.866 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.55 107.21 13.16 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -129.6 151.98 49.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.304 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 162' ' ' ARG . 3.0 tt -141.61 149.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 161' ' ' ILE . 5.6 ttp85 -86.51 144.76 27.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -137.6 99.35 9.52 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.11 -25.63 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.015 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.83 -13.38 32.98 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -104.83 43.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.74 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 23.0 m120 59.38 59.28 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.13 79.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.08 148.91 42.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.384 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.5 mtt-85 -86.15 167.04 15.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.53 100.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.102 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.0 t-105 -85.95 106.3 17.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.4 mt -64.56 -49.61 70.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 153.75 158.13 8.45 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -78.03 155.59 30.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -1.145 . . . . 0.0 109.076 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 66.6 m-85 -130.5 173.8 10.5 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.42 -31.77 42.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.935 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.436 HG22 ' OD2' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -141.03 172.55 12.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.58 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -72.48 -22.54 61.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.474 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -72.76 -38.55 67.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -74.3 -44.92 50.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.589 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -62.72 -44.76 95.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.394 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.589 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -58.43 -43.29 88.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.089 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.36 -51.66 68.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.865 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.95 -23.15 66.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.4 t80 -72.96 -31.88 64.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 109.503 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 26.8 m-20 -70.93 -50.28 36.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -37.45 47.66 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.676 -0.64 . . . . 0.0 109.985 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.1 -23.49 23.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.83 7.69 45.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -118.83 -37.61 3.22 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -81.5 -38.87 25.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -79.07 -32.86 44.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.718 -0.614 . . . . 0.0 109.727 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -91.74 -17.88 24.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.219 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 41.98 -156.94 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.0 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.173 . . . . 0.0 109.545 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -56.05 -58.3 8.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.606 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.29 177.81 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.169 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.403 ' C ' HD21 ' A' ' 200' ' ' LEU . 11.0 mt -140.89 122.5 15.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.541 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -123.32 154.37 38.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 109.377 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.3 OUTLIER -56.06 -33.68 65.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.39 80.27 37.44 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.499 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 17.4 m-85 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 83.68 7.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.27 -3.52 5.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 146' ' ' TYR . 41.9 t -107.62 114.71 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.775 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -94.89 115.93 28.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.852 . . . . 0.0 109.219 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -88.39 155.04 19.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.23 162.28 22.87 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 -7.59 16.59 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.526 2.151 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -99.21 -64.53 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.47 50.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -146.05 156.43 43.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -1.176 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.55 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 28.4 m-85 -130.24 179.99 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.597 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.63 111.8 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.85 125.75 33.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.676 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -147.81 158.63 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 171' ' ' VAL . 7.7 tt -143.54 134.61 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.98 131.18 41.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -111.33 106.32 57.12 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.06 -31.4 4.95 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.279 1.986 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.4 -16.67 64.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.339 -0.85 . . . . 0.0 108.948 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -107.42 53.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.477 -0.764 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.23 21.68 2.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.11 62.41 3.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.87 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -1.182 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.69 155.85 14.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.887 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' A' ' 161' ' ' ILE . 23.7 t -140.98 83.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.597 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 3.9 t-105 -71.49 98.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 108.98 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 186' ' ' TYR . 0.8 OUTLIER -56.32 -51.42 68.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 157.28 157.85 8.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.6 p -72.81 153.12 41.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -1.129 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 72.0 m-85 -129.01 -172.63 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.511 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.32 -28.84 13.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.7 p -140.91 166.06 25.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.487 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -68.03 -21.22 65.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -75.32 -44.25 46.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 109.756 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.408 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -69.81 -38.69 76.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.16 -43.27 74.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -64.16 -35.43 80.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 108.97 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.474 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.5 -48.4 77.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.026 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.13 -25.45 67.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.469 -0.77 . . . . 0.0 109.064 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.9 t80 -68.91 -34.3 75.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 40.1 m-20 -64.05 -48.01 77.93 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.379 -0.825 . . . . 0.0 108.917 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -52.16 -44.58 64.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.711 -0.618 . . . . 0.0 110.295 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -75.42 -27.64 59.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -88.2 6.82 34.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.472 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.0 t80 -115.61 -26.4 7.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 108.938 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -83.32 -37.5 23.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mtp -80.9 -39.27 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.525 ' CB ' ' HB1' ' A' ' 198' ' ' ALA . 73.1 mtt180 -94.0 -34.24 13.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 48.92 -168.72 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.9 m 57.96 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.361 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -124.87 -54.92 1.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.083 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 194' ' ' ARG . . . 61.85 154.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.751 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 108.44 19.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.64 -174.34 2.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.58 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.439 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -80.72 -37.79 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.1 m-85 -116.4 80.58 10.11 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.288 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.513 0 C-N-CA 122.688 2.259 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 40.4 m-85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.281 0.562 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.5 88.31 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.96 -29.85 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 179' ' ' ALA . 48.1 t -86.15 113.25 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.698 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -93.34 105.86 17.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 108.583 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.632 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 13.7 pt20 -103.47 133.85 47.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 110.097 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.553 ' HG3' ' N ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -88.23 -179.26 1.26 Allowed Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.553 ' N ' ' HG3' ' A' ' 152' ' ' ARG . 33.3 Cg_endo -75.22 77.98 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.826 1.684 . . . . 0.0 109.825 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER 70.47 75.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.775 . . . . 0.0 109.272 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.61 -86.35 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.553 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -137.87 178.35 7.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.147 -1.208 . . . . 0.0 110.252 -178.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.632 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 9.5 m-85 -135.93 174.53 10.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.12 104.73 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.504 ' HB1' ' CA ' ' A' ' 182' ' ' ALA . . . -79.93 102.6 9.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.195 -0.941 . . . . 0.0 109.201 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 5.8 tm-20 -125.79 154.27 42.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.792 . . . . 0.0 109.197 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.1 tt -132.71 149.24 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.963 . . . . 0.0 109.694 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.449 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.2 ttm180 -103.46 108.33 19.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.314 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -100.23 118.36 61.48 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.96 -26.46 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.284 1.989 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -14.4 22.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.255 -0.903 . . . . 0.0 109.378 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -102.1 39.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.354 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.67 33.41 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.82 53.66 9.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -108.72 121.97 46.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.53 159.21 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.605 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 26.1 t -138.25 87.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.264 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.577 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 3.1 t-105 -69.71 114.55 8.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 109.394 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.523 HD23 ' CB ' ' A' ' 189' ' ' ALA . 20.2 mt -75.39 -53.9 7.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.85 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.69 156.46 8.75 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -73.67 152.93 40.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.15 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 58.3 m-85 -131.05 173.99 10.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.74 -30.68 32.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.623 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -138.2 -172.77 3.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.593 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 183' ' ' ALA . . . -88.42 -22.24 23.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.955 . . . . 0.0 108.833 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -72.21 -37.43 69.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.011 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -74.2 -46.72 40.19 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.416 -0.802 . . . . 0.0 108.948 179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -70.27 -21.23 62.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.6 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -78.68 -39.11 37.68 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 3.1 tm? -68.24 -45.33 73.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.24 -26.73 68.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -67.84 -33.51 74.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 11.3 m-20 -68.19 -42.36 80.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 188' ' ' ARG . 17.4 tpp180 -61.59 -40.41 94.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.995 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -79.65 -23.96 42.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 109.701 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.92 -3.5 57.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.581 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 187' ' ' ASP . 1.7 t80 -105.53 -27.84 11.15 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.204 -0.935 . . . . 0.0 108.763 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -81.59 -40.97 22.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.77 -33.55 60.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -0.777 . . . . 0.0 109.304 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 8.0 mmm180 -92.63 -16.41 25.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.827 . . . . 0.0 108.929 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . 42.29 -108.72 0.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 197' ' ' ARG . 56.1 p -50.53 111.81 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -1.136 . . . . 0.0 110.097 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.35 160.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 0.0 110.344 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 177.32 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.2 mt -95.54 116.21 28.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.447 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.64 -176.69 4.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.411 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.479 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -80.36 -35.5 35.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 2.3 m-85 -120.03 79.25 25.45 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 122.614 2.209 . . . . 0.0 110.713 -179.428 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.643 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 23.2 m-85 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.185 0.517 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.58 74.91 7.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.381 -0.825 . . . . 0.0 108.898 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 155.3 -16.41 0.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 179' ' ' ALA . 9.2 t -105.26 111.11 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.979 -1.306 . . . . 0.0 109.785 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.94 131.68 54.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.586 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . 2.8 pm0 -122.8 131.76 53.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.991 . . . . 0.0 110.473 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.583 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -71.86 -172.87 0.23 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.13 90.57 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.645 1.563 . . . . 0.0 109.977 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.8 m95 64.49 50.14 2.27 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.02 -123.61 2.04 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.459 -1.353 . . . . 0.0 111.09 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -106.68 151.78 24.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.972 . . . . 0.0 110.434 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 151' ' ' GLN . 2.9 m-30 -100.2 -171.7 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.591 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.79 121.28 2.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.611 -1.306 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -100.11 121.24 41.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 2.0 mt-10 -136.19 158.47 44.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.809 . . . . 0.0 109.672 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.6 tt -141.54 123.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.57 139.2 58.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.417 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 43.7 t0 -128.2 97.8 28.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.284 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.52 -28.18 7.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.307 2.005 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.2 -14.06 52.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -108.8 42.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.736 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.47 30.02 9.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.074 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.47 66.94 1.56 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -116.33 85.92 2.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -1.147 . . . . 0.0 109.338 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.3 ptt85 -42.2 144.95 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.406 -0.808 . . . . 0.0 109.481 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.437 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 45.7 t -120.19 88.58 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.145 -0.972 . . . . 0.0 109.811 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.591 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.0 t-105 -73.66 93.75 2.11 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.137 -0.977 . . . . 0.0 109.025 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 2.2 mt -51.43 -47.38 63.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.763 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.51 165.11 12.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -77.54 148.02 35.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 48.3 m-85 -123.44 -166.4 1.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.35 -0.844 . . . . 0.0 109.397 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -105.01 -26.75 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.541 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.9 p -144.61 -172.27 3.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 109.548 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 183' ' ' ALA . . . -87.11 -22.63 25.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.03 -36.61 56.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.59 -52.2 11.12 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.217 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.574 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -62.43 -34.73 77.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.164 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.643 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -68.64 -44.16 74.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -38.21 77.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.397 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.73 -28.24 63.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.006 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -70.67 -30.16 66.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 96.7 m-20 -71.84 -41.9 67.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.411 -0.806 . . . . 0.0 109.942 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.7 -34.12 73.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 110.082 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.472 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -80.65 -29.08 36.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.764 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.02 -24.93 35.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.377 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -81.33 -26.84 35.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -45.56 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.43 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -71.71 -35.22 70.14 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.585 -0.697 . . . . 0.0 109.965 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 198' ' ' ALA . 3.3 mpt_? -94.66 -7.89 39.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.24 -87.25 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 197' ' ' ARG . 4.4 t -85.25 -146.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.702 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' A' ' 196' ' ' SER . 28.1 mtm180 -38.46 140.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.598 -0.689 . . . . 0.0 110.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 194' ' ' ARG . . . -157.14 32.69 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 198' ' ' ALA . 7.2 mt 41.68 92.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.66 -0.65 . . . . 0.0 109.651 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.536 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -120.51 143.66 48.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.2 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -45.89 -33.96 3.56 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 1.4 m-85 -134.04 88.01 32.92 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 200' ' ' LEU . 34.2 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.572 2.181 . . . . 0.0 110.545 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 15.5 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 98.46 3.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.192 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.0 -31.94 3.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 157' ' ' PHE . 41.0 t -79.55 136.53 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -1.1 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.4 89.91 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 109.228 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.557 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 3.9 pt20 -59.42 131.21 50.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.978 . . . . 0.0 109.462 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -110.66 159.5 32.1 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.75 -1.68 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.708 2.272 . . . . 0.0 110.543 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -25.71 14.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.05 39.87 0.62 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 157' ' ' PHE . 21.6 mttt -130.05 179.96 5.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 151' ' ' GLN . 86.5 m-85 -159.12 109.0 1.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 108.679 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -85.8 127.12 34.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.09 -1.006 . . . . 0.0 111.263 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -99.9 116.92 33.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.45 166.16 25.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.041 -1.037 . . . . 0.0 110.316 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 8.8 tt -152.18 158.63 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.451 -0.78 . . . . 0.0 108.952 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.54 139.7 48.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.95 -1.094 . . . . 0.0 109.858 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.404 ' HB2' ' HE3' ' A' ' 193' ' ' MET . 64.7 t0 -138.11 93.63 11.62 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.36 -22.99 10.51 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.587 2.191 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.89 -13.99 19.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -107.38 51.03 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 167' ' ' ASN . 28.7 t-20 57.03 38.32 29.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.341 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.94 97.91 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.6 100.89 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.127 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -51.99 166.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 67.2 t -147.83 90.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.575 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.1 t-105 -87.06 101.83 13.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 1.2 mt -56.12 -50.79 70.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.42 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 148.63 148.68 4.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -68.32 158.41 33.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.08 -1.247 . . . . 0.0 108.967 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.577 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 85.5 m-85 -131.86 -176.89 4.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.622 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -27.69 14.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.553 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.7 p -133.03 170.41 15.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.515 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.536 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -78.42 -22.61 47.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.377 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -73.09 -33.11 65.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.428 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.454 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -80.54 -34.95 35.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.235 -0.915 . . . . 0.0 109.173 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.577 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -76.48 -27.83 56.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -77.14 -40.56 45.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.203 -0.936 . . . . 0.0 108.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.89 -41.75 97.64 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.513 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.58 -37.76 85.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -62.73 -40.44 97.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.45 -0.781 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.506 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 14.4 m-20 -60.7 -52.2 66.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.498 -0.751 . . . . 0.0 109.833 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -54.16 -31.19 51.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -84.4 -26.95 27.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.25 2.99 54.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.542 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.5 t80 -117.16 -31.24 5.4 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -74.92 -38.49 61.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.404 ' HE3' ' HB2' ' A' ' 163' ' ' ASP . 26.2 ttm -81.53 -46.26 14.74 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.418 0.627 . . . . 0.0 109.735 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.7 mtt85 -93.94 -41.89 9.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.039 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 48.12 -149.79 3.39 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m 50.26 -107.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -1.188 . . . . 0.0 109.601 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.01 56.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.222 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -66.18 169.65 6.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.332 -0.855 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -113.67 116.44 29.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.098 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -125.25 179.28 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.555 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.4 OUTLIER -70.33 -38.25 74.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 7.8 m-85 -112.16 96.11 33.26 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.457 0 C-N-CA 122.578 2.185 . . . . 0.0 110.708 -179.123 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.596 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 18.8 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -77.79 96.98 5.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.637 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.66 -16.72 7.39 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 27.3 t -97.48 117.61 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.811 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 3.4 mmp_? -96.53 117.89 31.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -85.38 160.07 19.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 0.0 110.016 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.536 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 16.4 mtt180 -126.7 158.26 68.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.681 -0.637 . . . . 0.0 109.337 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.2 3.49 7.05 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.577 2.185 . . . . 0.0 110.298 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -9.9 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.485 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.01 33.24 4.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.2 mtmt -127.81 173.09 10.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 59.6 m-85 -144.33 -178.29 5.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.366 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.69 104.1 2.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 109.94 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.513 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.04 123.22 27.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.235 -0.916 . . . . 0.0 108.974 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 1.1 mt-10 -139.12 164.51 29.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.266 -0.896 . . . . 0.0 109.267 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.457 HG21 ' HB ' ' A' ' 171' ' ' VAL . 6.2 tt -146.02 141.84 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -86.8 108.72 18.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.68 113.14 64.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.321 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.36 -27.31 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -9.14 56.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 4.4 mmpt? -117.87 39.35 3.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 1.2 m-20 68.74 29.38 5.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.41 27.1 68.89 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.81 116.53 8.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -1.209 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -59.04 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.457 ' HB ' HG21 ' A' ' 161' ' ' ILE . 37.8 t -68.31 104.99 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 10.4 t-105 -80.51 99.01 7.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 19.7 mt -56.63 -37.67 71.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.027 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 136.3 158.27 8.04 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -78.52 148.87 33.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -1.13 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 69.4 m-85 -120.25 -168.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.695 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.466 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 9.9 pt-20 -99.23 -32.59 11.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.579 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.1 p -133.85 170.1 16.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -77.32 -23.65 50.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.96 . . . . 0.0 109.556 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -73.13 -36.61 66.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -75.32 -45.38 39.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -61.76 -47.2 86.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -58.32 -42.39 86.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.103 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 184' ' ' LEU . 21.3 tp -60.79 -39.83 90.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.564 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.19 -24.34 66.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -0.813 . . . . 0.0 109.046 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -72.35 -29.95 64.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 187' ' ' ASP . 2.0 m-20 -72.18 -50.32 28.58 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -60.91 -28.7 69.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.48 -19.57 23.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.927 . . . . 0.0 109.274 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.72 -8.14 41.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -105.79 -33.67 7.92 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -80.15 -39.77 28.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -30.57 64.12 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.673 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 12.8 mtt180 -96.2 -0.95 49.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.36 -87.17 1.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 197' ' ' ARG . 3.0 m -135.8 164.4 27.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -1.188 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.82 109.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' ' HD3' ' A' ' 194' ' ' ARG . . . -163.31 150.1 12.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.957 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.432 ' C ' HD21 ' A' ' 200' ' ' LEU . 1.1 mp -92.37 118.23 30.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -127.51 174.74 8.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 109.413 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.484 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -70.42 -34.59 72.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 108.613 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.8 m-85 -121.34 84.58 41.34 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.48 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 46.0 m-85 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -82.03 36.18 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.154 -0.966 . . . . 0.0 109.753 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.04 26.59 0.09 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 57.6 t -143.6 113.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -1.154 . . . . 0.0 109.424 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.05 94.79 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.32 134.29 56.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.454 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 7.5 mmt180 -99.17 161.25 25.37 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.668 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.454 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.32 -34.81 1.41 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.678 2.252 . . . . 0.0 110.263 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -47.69 83.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.08 43.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 2.6 mttm -131.94 -168.65 2.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.587 ' CD2' ' HA ' ' A' ' 178' ' ' THR . 63.3 m-85 -159.47 108.29 1.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.096 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.618 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -82.38 139.34 34.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -111.11 113.58 26.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -134.79 164.75 26.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 0.0 109.899 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.3 tt -141.52 143.3 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 108.914 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.405 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 1.2 tmm_? -82.62 119.71 24.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.825 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.407 ' CG ' ' SD ' ' A' ' 193' ' ' MET . 41.5 t0 -111.06 97.74 35.99 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.072 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.426 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 34.7 Cg_endo -76.39 -26.39 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.475 2.117 . . . . 0.0 110.673 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.81 -22.76 67.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 109.578 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -100.4 64.33 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.587 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 48.16 44.22 19.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.602 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 50.92 59.64 7.87 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -107.18 136.71 46.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -1.165 . . . . 0.0 109.44 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 163.24 28.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.87 99.7 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 158' ' ' ALA . 16.0 t-105 -84.09 91.67 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.982 . . . . 0.0 109.599 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 57.6 mt -51.38 -48.45 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.246 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 152.39 158.52 8.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.8 p -73.61 162.71 28.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -1.175 . . . . 0.0 109.477 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 67.0 m-85 -138.83 179.57 6.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -28.46 19.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.587 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 p -142.72 168.51 19.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.5 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -72.09 -24.6 61.52 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.83 -39.79 76.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -74.63 -45.69 43.18 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -64.14 -31.15 72.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -72.69 -47.83 44.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.255 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -35.68 72.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 108.834 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.43 -28.98 65.47 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.278 -0.888 . . . . 0.0 108.696 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -65.88 -28.03 68.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.62 -47.88 51.67 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.303 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -34.74 68.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.501 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -84.2 -39.11 19.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.929 -1.107 . . . . 0.0 109.981 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -69.22 -18.91 63.95 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.572 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.6 t80 -85.55 -40.6 16.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.139 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -40.28 86.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.759 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.407 ' SD ' ' CG ' ' A' ' 163' ' ' ASP . 28.9 ttm -77.86 -43.16 31.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.666 -0.646 . . . . 0.0 109.591 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.506 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 70.4 mtt180 -102.25 34.2 2.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.955 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -41.12 164.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 84.53 -47.71 0.1 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.834 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -171.73 128.81 0.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.208 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.506 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . -159.66 148.77 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.436 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -89.77 122.62 33.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.436 HD22 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.83 157.26 31.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.164 -0.96 . . . . 0.0 109.303 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -53.93 -35.59 61.86 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 4.2 m-85 -124.16 83.53 56.18 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.515 2.143 . . . . 0.0 110.529 -179.78 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.579 ' CG ' ' HB3' ' A' ' 183' ' ' ALA . 21.5 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -72.11 96.75 1.81 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.54 -8.33 7.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 38.5 t -105.01 112.32 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -1.172 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -96.19 117.61 31.11 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.574 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.38 153.76 24.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.84 . . . . 0.0 109.433 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -116.58 155.94 48.18 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.25 -10.52 16.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.661 2.241 . . . . 0.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -36.59 17.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.136 -0.977 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 156' ' ' LYS . . . 133.61 61.81 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 155' ' ' GLY . 19.4 mttp -166.83 -171.64 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 109.514 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 53.8 m-85 -148.88 -175.12 4.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 109.102 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.578 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.31 108.53 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 0.0 110.017 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.562 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.8 134.17 36.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.154 -0.966 . . . . 0.0 108.984 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.24 148.96 29.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.095 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 3.8 tt -141.79 127.71 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.023 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.427 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -69.46 143.63 53.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 109.204 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 168' ' ' GLY . 43.5 t0 -110.52 97.65 33.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.573 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.6 Cg_endo -76.57 -26.9 8.04 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.355 2.037 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.51 68.33 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 3.0 mmmm -101.55 25.31 8.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 67.46 66.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 69.32 -106.64 1.85 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 51.33 80.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.255 . . . . 0.0 109.578 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.9 153.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 171' ' ' VAL . 11.7 t -128.07 81.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.578 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 7.5 t-105 -61.4 97.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 109.168 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 185' ' ' ALA . 0.3 OUTLIER -52.68 -49.14 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.43 154.26 6.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -68.54 153.86 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -1.196 . . . . 0.0 109.214 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 56.7 m-85 -129.4 172.91 11.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.754 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -77.02 -30.11 55.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 109.854 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.519 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.5 p -145.65 -174.07 4.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.501 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -81.81 -28.62 33.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.673 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -70.61 -34.46 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 109.624 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -73.32 -44.42 58.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.133 -0.979 . . . . 0.0 109.452 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -68.96 -30.2 68.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.579 ' HB3' ' CG ' ' A' ' 146' ' ' TYR . . . -71.98 -41.49 67.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.301 -0.875 . . . . 0.0 109.105 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.75 94.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.302 -0.873 . . . . 0.0 109.16 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.18 -22.9 66.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -0.809 . . . . 0.0 108.935 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.3 t80 -69.79 -33.9 73.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 109.081 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.489 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 18.9 m-20 -67.68 -43.85 79.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.429 -0.795 . . . . 0.0 109.472 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -58.9 -40.53 84.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.773 . . . . 0.0 109.84 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 173' ' ' LEU . . . -81.89 -20.75 38.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.89 -8.9 48.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.3 t80 -101.96 -33.95 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.284 -0.885 . . . . 0.0 108.924 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -76.4 -40.95 49.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 108.782 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.01 -31.61 64.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.576 -0.702 . . . . 0.0 109.484 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.7 mtt85 -105.81 1.82 27.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 49.3 -99.07 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER -48.2 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 109.737 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -42.77 160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.778 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -157.72 37.0 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 109.273 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 199' ' ' LEU . 7.8 mp 39.89 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.718 -0.614 . . . . 0.0 109.869 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.489 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -111.91 173.93 6.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.972 . . . . 0.0 109.401 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.419 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -72.0 -34.54 68.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.7 m-85 -122.67 80.42 48.16 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.58 2.186 . . . . 0.0 110.65 -179.421 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.642 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 17.4 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 99.9 4.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.2 -25.21 7.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 52.0 t -86.79 126.14 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -1.191 . . . . 0.0 110.046 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -104.4 110.98 23.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 pm0 -75.88 144.63 41.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 156.62 53.32 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.158 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.03 3.51 6.96 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.552 2.168 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -96.19 -13.84 23.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.79 26.41 6.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.493 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -133.76 -173.78 3.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -1.155 . . . . 0.0 109.527 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.551 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 65.7 m-85 -149.0 -177.59 5.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.351 -0.843 . . . . 0.0 109.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.63 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.77 108.24 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.842 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.94 108.82 13.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 108.993 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER -126.47 155.16 42.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -0.947 . . . . 0.0 109.966 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 193' ' ' MET . 7.5 tt -141.55 117.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.387 -0.82 . . . . 0.0 109.015 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -89.99 126.05 35.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -111.11 103.9 55.48 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 0.0 109.395 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.98 -25.12 9.19 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.307 2.005 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.92 -18.71 64.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 39.16 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.93 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.2 m120 55.53 46.05 23.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.42 121.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.61 128.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -1.137 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -95.26 148.62 22.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 171' ' ' VAL . 41.6 t -133.48 89.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.63 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 3.5 t-105 -75.36 102.9 5.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.063 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.529 HD22 ' CB ' ' A' ' 189' ' ' ALA . 3.6 mt -57.67 -57.8 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.665 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 161.88 157.01 8.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.47 153.21 41.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -1.128 . . . . 0.0 109.227 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 61.8 m-85 -127.06 178.11 6.21 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.913 . . . . 0.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.416 ' C ' HG21 ' A' ' 178' ' ' THR . 4.0 mt-10 -84.51 -30.86 24.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -138.64 176.81 8.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.273 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.542 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -79.86 -23.09 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.439 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -74.45 -35.05 63.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.14 -37.83 53.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -72.57 -32.85 66.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.226 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.642 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -75.84 -37.28 59.15 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -66.34 -39.58 89.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.086 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.88 -23.34 62.28 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -73.14 -29.81 63.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.505 -0.747 . . . . 0.0 109.0 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 39.5 m-20 -69.74 -50.15 46.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.266 -0.897 . . . . 0.0 109.55 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -60.09 -35.84 76.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 109.946 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -80.96 -24.67 37.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.159 -0.963 . . . . 0.0 109.521 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.8 -1.85 57.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -106.51 -27.89 10.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.606 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -40.32 23.72 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.459 ' HE1' HD12 ' A' ' 161' ' ' ILE . 4.6 ttp -74.24 -33.77 63.44 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.5 mtt180 -86.74 -13.02 46.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 53.97 -92.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 195' ' ' GLY . 9.3 p -54.17 -167.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.3 mtm105 -42.77 156.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.454 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 194' ' ' ARG . . . -156.31 155.23 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 118.25 36.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.459 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -129.17 179.94 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -76.53 -31.45 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.14 75.26 30.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.311 -1.434 0 C-N-CA 122.661 2.24 . . . . 0.0 110.638 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.595 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 18.7 m-85 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.458 ' CG ' ' O ' ' A' ' 147' ' ' ARG . 1.7 ptt180 -67.83 125.06 25.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.126 -0.984 . . . . 0.0 108.718 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.04 20.9 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -88.94 106.44 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.772 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -80.16 108.45 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.604 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -72.0 160.17 32.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 110.51 -178.798 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.628 ' HG2' ' CA ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.58 169.15 18.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.851 -0.531 . . . . 0.0 112.334 -178.046 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 152' ' ' ARG . 37.3 Cg_endo -85.17 -16.24 5.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.567 2.178 . . . . 0.0 106.986 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -145.64 -67.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.628 ' CA ' ' HG2' ' A' ' 152' ' ' ARG . . . -147.68 113.22 0.63 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 147.79 148.31 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 117.856 0.828 . . . . 0.0 110.1 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 51.4 m-85 -139.84 170.44 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.449 -1.407 . . . . 0.0 108.645 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.577 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -141.99 113.36 7.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.478 ' HB1' ' CE2' ' A' ' 176' ' ' PHE . . . -81.96 118.46 22.98 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' A' ' 170' ' ' ARG . 1.5 tt0 -141.18 158.36 44.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 109.864 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.446 HG21 ' HB ' ' A' ' 171' ' ' VAL . 6.5 tt -151.85 125.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -88.71 118.94 28.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -99.33 117.38 64.06 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.62 -26.42 7.08 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.355 2.037 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -14.98 62.64 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -103.21 32.62 3.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.679 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.43 54.98 1.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 45.83 65.98 1.8 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.98 98.31 6.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.457 ' HB3' ' OE2' ' A' ' 160' ' ' GLU . 7.5 mtt180 -48.69 166.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 170' ' ' ARG . 7.2 t -143.96 86.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.161 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.577 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.3 t-105 -70.77 96.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.25 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 185' ' ' ALA . 0.8 OUTLIER -56.01 -42.74 76.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 176' ' ' PHE . . . 146.06 152.06 5.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 4.4 p -66.68 179.36 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.223 -1.163 . . . . 0.0 109.464 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 70.4 m-85 -155.56 -173.93 4.75 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 0.0 109.141 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' C ' ' CG2' ' A' ' 178' ' ' THR . 32.9 tt0 -97.37 -17.94 19.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.617 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 7.3 p -152.32 169.45 22.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.786 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.6 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -71.33 -22.79 61.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -73.09 -41.95 63.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -34.79 67.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.431 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -74.66 -31.27 61.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.266 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.595 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -72.8 -40.17 66.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.47 -48.46 81.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.28 -28.56 70.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.552 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.0 t80 -68.34 -28.1 66.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.535 ' CB ' HD11 ' A' ' 200' ' ' LEU . 5.0 m-20 -72.64 -37.02 68.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -64.67 -36.21 83.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 110.196 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -80.25 -41.86 24.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.826 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -71.96 -5.95 38.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.734 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.1 t80 -104.81 -44.03 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.048 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -40.11 94.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.0 mtm -80.44 -43.3 21.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.569 -0.707 . . . . 0.0 109.54 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 196' ' ' SER . 14.1 mtt180 -102.78 33.19 3.31 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.449 -0.782 . . . . 0.0 109.415 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -41.98 94.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 194' ' ' ARG . 12.2 p 170.28 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.268 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 35.5 11.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.449 ' O ' HD22 ' A' ' 200' ' ' LEU . . . -60.19 145.55 46.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.35 135.65 35.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.535 HD11 ' CB ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -138.59 -174.56 3.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.853 . . . . 0.0 109.127 -179.982 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.446 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -68.94 -36.39 77.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 8.3 m-85 -119.15 76.32 15.85 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.3 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 122.631 2.221 . . . . 0.0 110.801 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.579 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 12.9 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.15 84.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.9 -32.62 1.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.3 t -77.21 144.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 158' ' ' ALA . 8.7 ttm-85 -123.83 97.34 5.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.063 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.552 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 5.4 pt20 -87.57 135.62 33.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.329 -0.857 . . . . 0.0 109.345 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.568 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -89.36 -173.99 0.43 Allowed Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -74.37 81.05 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.411 1.408 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.2 m0 63.17 74.85 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.63 -0.669 . . . . 0.0 109.309 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 152' ' ' ARG . . . -170.5 -99.99 0.13 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.156 -1.497 . . . . 0.0 111.003 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.41 -178.23 3.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -1.134 . . . . 0.0 110.755 -178.334 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 8.3 m-85 -132.47 179.76 5.93 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.28 112.61 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.881 -1.137 . . . . 0.0 110.446 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -88.38 119.29 28.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 6.6 mt-10 -137.91 170.42 16.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.872 -179.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.444 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.3 tt -159.22 156.38 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.444 ' N ' HG12 ' A' ' 161' ' ' ILE . 42.0 ttp180 -96.38 129.67 43.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.738 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.471 ' HB2' HG22 ' A' ' 171' ' ' VAL . 10.6 t0 -113.31 106.17 54.74 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.236 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.83 -23.59 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.413 2.075 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.23 -19.61 62.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.282 -0.886 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -100.84 46.97 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.74 38.9 21.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 58.88 53.79 43.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.15 138.5 39.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -1.144 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -67.39 163.24 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 163' ' ' ASP . 40.5 t -139.06 94.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.578 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 9.3 t-105 -82.69 94.13 7.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 109.028 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 189' ' ' ALA . 13.6 mt -51.25 -41.73 60.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 109.134 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.546 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 142.58 152.76 5.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.6 p -67.28 152.61 45.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -1.107 . . . . 0.0 109.444 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 52.3 m-85 -127.06 179.11 5.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.167 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 -25.43 28.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.819 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.581 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.7 p -147.5 -174.15 4.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.486 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -84.51 -23.99 29.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.781 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -34.29 65.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 109.615 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.64 -43.92 36.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.03 -47.1 81.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 109.17 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.579 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -58.53 -38.39 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -52.31 65.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 108.915 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -62.65 -18.55 62.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.559 ' CE1' ' HB3' ' A' ' 190' ' ' ALA . 10.5 t80 -75.65 -34.6 60.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.878 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.448 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 26.7 m-20 -61.67 -47.64 84.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.567 -0.708 . . . . 0.0 109.597 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.37 85.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.532 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -73.25 -17.01 61.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.559 ' HB3' ' CE1' ' A' ' 186' ' ' TYR . . . -87.41 -19.65 27.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.238 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.532 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 5.5 t80 -93.59 -31.49 14.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -38.91 67.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.432 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -74.12 -52.13 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -86.41 -50.23 7.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.463 -0.773 . . . . 0.0 109.241 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 50.79 176.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 197' ' ' ARG . 33.9 t 58.81 71.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.634 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER 50.12 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.967 . . . . 0.0 109.535 179.839 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -125.39 163.36 22.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -92.83 127.54 38.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.448 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -133.23 152.74 51.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.29 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -48.89 -38.99 24.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.145 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.0 m-85 -120.85 89.47 45.56 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 110.88 -179.289 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.64 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 30.8 m-85 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -76.86 85.28 3.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.865 . . . . 0.0 109.352 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.56 -23.27 3.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 94.7 t -88.13 137.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.398 -1.06 . . . . 0.0 109.301 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.456 ' HB3' ' HB1' ' A' ' 158' ' ' ALA . 14.6 tpp180 -124.82 103.64 8.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.84 . . . . 0.0 109.244 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.564 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 60.1 tt0 -61.89 169.27 2.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.44 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -128.57 163.36 45.33 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.341 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 35.1 Cg_endo -76.63 76.08 4.16 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.577 2.185 . . . . 0.0 110.319 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER 168.86 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.535 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 156' ' ' LYS . . . 159.86 41.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.6 mmtt -137.49 179.8 6.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.513 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 151' ' ' GLN . 62.1 m-85 -149.83 -179.99 7.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.63 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.32 113.25 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.574 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.79 119.08 25.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 108.936 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -140.5 152.24 45.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.44 HD12 ' HE3' ' A' ' 193' ' ' MET . 3.5 tt -137.26 132.33 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 99.2 12.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.64 116.13 65.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.619 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.98 -23.6 9.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.39 2.06 . . . . 0.0 110.295 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.24 -22.33 62.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.453 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -96.98 44.79 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.576 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.11 20.53 5.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.3 43.21 7.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.79 109.86 21.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -54.9 150.13 10.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.064 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.9 t -131.19 86.63 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.63 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 4.1 t-105 -74.15 99.7 3.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 2.1 mt -53.54 -54.48 36.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.458 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 156.13 153.09 6.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.8 p -66.72 152.85 44.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -1.069 . . . . 0.0 109.357 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.574 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 63.9 m-85 -126.53 -173.1 2.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.885 . . . . 0.0 109.541 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.51 -28.75 15.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.455 HG21 ' OD2' ' A' ' 181' ' ' ASP . 2.7 p -140.75 171.91 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 109.423 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.56 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -75.97 -25.04 55.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -74.05 -35.94 64.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.455 ' OD2' HG21 ' A' ' 178' ' ' THR . 0.0 OUTLIER -75.13 -40.15 59.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 108.994 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.98 -31.02 67.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.316 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.64 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.89 -38.08 64.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.338 -0.851 . . . . 0.0 108.817 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.406 ' HA ' ' OD2' ' A' ' 187' ' ' ASP . 43.8 tp -64.14 -45.2 89.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.448 -0.783 . . . . 0.0 109.102 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.55 -27.85 68.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 108.888 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -66.86 -30.79 71.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.212 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 184' ' ' LEU . 11.7 m-20 -67.89 -55.0 14.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.296 -0.877 . . . . 0.0 109.423 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -31.59 37.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.531 -0.73 . . . . 0.0 109.919 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.466 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -82.58 -29.47 30.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.834 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -86.75 -1.32 57.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -103.33 -31.14 10.2 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 108.89 179.613 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -77.75 -40.59 40.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.327 -0.858 . . . . 0.0 108.961 179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.44 ' HE3' HD12 ' A' ' 161' ' ' ILE . 1.6 mtp -81.16 -32.07 33.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.606 -0.684 . . . . 0.0 110.378 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -91.18 -1.62 57.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 83.13 -150.05 27.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.57 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 p -63.01 -97.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 109.833 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -48.99 153.14 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.814 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 178.8 160.91 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.38 111.53 23.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.59 172.1 9.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 108.987 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.428 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -72.55 -33.28 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.237 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 6.8 m-85 -121.46 75.36 33.49 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 122.611 2.207 . . . . 0.0 110.417 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 23.2 m-85 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -78.23 83.02 4.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.202 -0.936 . . . . 0.0 109.284 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 144.21 -23.36 2.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 182' ' ' ALA . 6.1 t -102.12 122.93 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.259 . . . . 0.0 109.735 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 9.3 mtt180 -122.03 171.61 8.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 151' ' ' GLN . 9.4 pm0 -138.2 143.54 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 109.597 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.7 mtt85 -104.41 169.59 7.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.726 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.4 Cg_endo -78.18 8.02 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.764 2.31 . . . . 0.0 110.93 -179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -35.28 7.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.456 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 128.31 45.77 0.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 21.7 mttt -149.59 134.86 18.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.165 . . . . 0.0 109.618 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD2' ' C ' ' A' ' 178' ' ' THR . 5.4 m-30 -98.38 -168.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 108.671 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.618 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.91 126.31 2.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 173' ' ' LEU . . . -106.57 113.78 27.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.489 ' OE2' ' HB3' ' A' ' 158' ' ' ALA . 2.7 mp0 -131.04 174.77 9.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.425 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.3 tt -168.6 140.62 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -0.797 . . . . 0.0 109.148 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -73.67 152.76 40.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.0 109.66 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' CG ' ' A' ' 166' ' ' LYS . 58.1 t0 -123.08 95.49 45.91 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.93 -27.86 6.64 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.527 2.151 . . . . 0.0 110.056 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.49 -28.44 69.83 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.446 -0.784 . . . . 0.0 109.099 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' CG ' ' OD2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -95.25 27.37 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 0.0 109.534 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.88 72.54 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.65 106.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -169.07 102.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.9 148.36 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 32.0 t -133.03 94.92 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 109.449 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.4 t-105 -82.77 100.33 10.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.432 HD23 ' HB1' ' A' ' 189' ' ' ALA . 7.5 mt -55.51 -55.37 32.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.15 161.08 10.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -74.59 153.18 39.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.218 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 54.2 m-85 -127.11 -167.59 1.76 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.68 -28.45 11.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.002 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.4 p -147.0 -179.81 7.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 183' ' ' ALA . . . -76.94 -33.41 57.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.79 -37.9 88.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.064 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -70.66 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.483 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.569 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -46.36 -27.59 1.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.256 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.642 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -71.37 -45.65 62.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.44 -39.05 93.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.684 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.36 -28.2 64.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.8 t80 -71.33 -30.84 66.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.447 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 13.0 m-20 -67.85 -45.21 75.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.964 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -37.8 83.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.687 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.432 ' HB1' HD23 ' A' ' 173' ' ' LEU . . . -82.83 -20.35 35.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.52 -0.6 56.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -109.78 -31.38 7.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.145 -0.972 . . . . 0.0 108.599 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.54 -40.39 21.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.2 ttm -75.26 -31.59 60.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.753 -0.592 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.3 mtt180 -95.5 -17.45 21.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' SER . . . 47.68 -106.28 0.16 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 197' ' ' ARG . 83.8 p -40.34 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -1.046 . . . . 0.0 110.165 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER 46.17 -173.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.833 . . . . 0.0 109.649 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 190' ' ' ALA . . . 170.73 152.59 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.8 mt -101.75 108.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.453 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -123.17 -175.64 3.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -78.59 -37.86 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 108.875 179.7 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.615 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 4.5 m-85 -115.6 82.26 9.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.491 -0.756 . . . . 0.0 109.173 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.753 2.302 . . . . 0.0 110.563 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.649 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 27.2 m-85 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.26 0.552 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.81 131.19 45.08 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.287 -0.883 . . . . 0.0 108.963 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.63 -35.93 3.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 182' ' ' ALA . 52.9 t -81.19 113.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.272 . . . . 0.0 109.996 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -95.88 114.44 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 19.8 pt20 -97.43 128.74 44.47 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.866 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.627 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mtp180 -75.62 169.59 19.85 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 29.4 Cg_endo -69.85 83.79 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.18 1.253 . . . . 0.0 109.605 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.448 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 61.6 m95 63.27 63.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -155.06 -106.45 0.26 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.589 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.55 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 5.4 mttp -111.19 -169.67 1.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.335 -1.097 . . . . 0.0 110.514 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.615 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 27.4 m-85 -143.59 173.56 11.54 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.45 109.06 3.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.851 -1.156 . . . . 0.0 110.305 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.87 124.96 29.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.166 -0.959 . . . . 0.0 108.882 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 136.45 31.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.952 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.432 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 2.7 tt -128.78 120.53 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.17 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.29 144.74 29.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 0.0 109.585 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.437 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 32.1 t0 -124.34 116.52 26.92 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.925 . . . . 0.0 109.317 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 36.2 Cg_endo -77.04 -31.03 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.528 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -25.42 67.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -89.03 44.76 1.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.18 53.7 10.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.36 94.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -147.86 111.16 4.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 144.48 54.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.303 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 53.3 t -122.93 94.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.669 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 4.6 t-105 -72.75 98.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.483 ' CD2' ' CB ' ' A' ' 189' ' ' ALA . 1.1 mt -57.91 -45.48 86.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.797 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 149.8 162.96 10.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -79.51 158.14 27.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.23 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 75.1 m-85 -133.84 175.39 9.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.0 tp10 -82.37 -30.7 30.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.683 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -143.31 167.6 21.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.561 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -67.77 -22.47 65.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -38.68 69.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.92 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -75.47 -37.12 60.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.91 -34.74 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.188 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.649 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -72.43 -39.65 67.71 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -42.86 98.12 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.467 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.41 -32.79 73.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.556 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.6 t80 -62.98 -30.49 71.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.148 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 16.0 m-20 -69.7 -41.79 74.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.378 -0.826 . . . . 0.0 109.657 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -63.72 -40.19 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 110.594 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -82.08 -25.95 34.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.987 -1.071 . . . . 0.0 109.94 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.29 -18.19 39.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.437 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.7 t80 -85.39 -36.24 20.84 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.083 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -66.64 -42.18 87.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.437 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 7.2 tpp -80.52 -41.78 23.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.792 . . . . 0.0 109.445 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 18.6 mtt180 -100.71 33.37 2.79 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 108.959 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -39.52 161.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 76.94 85.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 108.983 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 71.83 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 108.999 -179.492 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 67.02 162.47 0.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 110.061 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.434 ' C ' HD22 ' A' ' 200' ' ' LEU . 5.7 mt -116.52 113.25 22.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.442 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.0 159.78 27.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -32.87 70.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 8.3 m-85 -117.35 88.75 29.27 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.698 2.266 . . . . 0.0 110.637 -179.358 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.5 m-85 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.363 0.601 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -79.53 85.84 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.945 . . . . 0.0 109.935 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.35 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.415 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 179' ' ' ALA . 96.8 t -109.18 116.95 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.38 . . . . 0.0 110.325 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.82 146.02 28.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.2 pt20 -142.01 132.58 25.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.554 ' CD ' ' N ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -84.1 178.7 2.25 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.5 Cg_endo -77.09 79.27 3.18 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.179 1.92 . . . . 0.0 109.549 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 23.7 t-105 72.6 60.83 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -153.31 -108.8 0.36 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.704 -179.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.544 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 14.6 mmtt -113.24 -171.7 1.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -1.137 . . . . 0.0 110.694 -178.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 23.5 m-85 -141.81 -170.9 3.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.561 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -161.22 110.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.951 -1.093 . . . . 0.0 110.446 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.552 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -83.68 107.16 15.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.523 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 27.9 mt-10 -132.32 152.11 51.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.13 -0.981 . . . . 0.0 109.739 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.448 HD12 ' CE ' ' A' ' 193' ' ' MET . 1.5 tt -140.41 133.06 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.214 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.62 139.61 33.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.404 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 28.7 t0 -123.87 107.24 31.14 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.169 -0.957 . . . . 0.0 109.291 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.63 -28.28 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.268 1.978 . . . . 0.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -25.91 67.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.404 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 10.4 mmtt -90.86 43.45 1.15 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.88 27.17 15.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.54 58.43 3.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.24 95.35 6.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -1.129 . . . . 0.0 109.545 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.442 ' O ' HG21 ' A' ' 171' ' ' VAL . 1.0 OUTLIER -55.06 162.12 1.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.822 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 170' ' ' ARG . 59.9 t -149.84 95.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.04 -1.038 . . . . 0.0 110.153 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.561 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 2.8 t-105 -79.99 106.54 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 29.0 mt -64.16 -47.01 81.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 109.715 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.62 157.09 7.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -76.49 156.65 32.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 -179.8 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.6 m-85 -133.01 177.36 7.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.466 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 3.2 pt-20 -82.55 -31.63 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.162 -0.961 . . . . 0.0 109.786 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 p -141.26 175.36 9.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 109.777 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.578 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -74.1 -22.53 59.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.656 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.55 -49.13 51.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 1.4 m-20 -64.2 -50.39 68.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -56.19 -52.4 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.615 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -52.39 -42.12 63.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.57 -41.78 90.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.77 -22.29 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.8 . . . . 0.0 109.185 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 21.2 t80 -71.51 -36.59 71.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.476 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 6.3 m-20 -65.52 -50.85 63.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.11 -34.74 58.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.49 -0.756 . . . . 0.0 110.101 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -87.79 -19.85 26.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.054 -1.028 . . . . 0.0 109.679 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 194' ' ' ARG . . . -92.14 -5.43 52.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.444 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.6 t80 -102.76 -34.13 9.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.221 -0.924 . . . . 0.0 108.611 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -79.34 -40.69 29.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.448 ' CE ' HD12 ' A' ' 161' ' ' ILE . 6.2 ttp -83.12 -30.05 28.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.609 -0.682 . . . . 0.0 109.656 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -99.77 -9.23 23.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 -179.727 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 42.19 -163.63 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.6 OUTLIER 48.39 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -1.14 . . . . 0.0 109.562 179.874 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 198' ' ' ALA . 0.7 OUTLIER -57.28 -47.02 82.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 197' ' ' ARG . . . 59.39 149.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.438 -0.789 . . . . 0.0 109.722 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.75 124.04 41.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.62 169.23 14.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.93 . . . . 0.0 109.387 -179.906 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.476 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -63.29 -36.07 82.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.039 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 2.8 m-85 -127.18 81.66 69.56 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.635 2.223 . . . . 0.0 110.775 -179.436 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 19.5 m-85 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.406 0.622 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.28 110.62 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.73 -20.7 14.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.8 t -92.59 110.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -1.12 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 112.39 24.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 108.954 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.567 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -75.63 153.74 37.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 110.02 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.551 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.1 mtp180 -132.52 174.87 4.2 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.3 Cg_endo -77.66 167.53 23.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.11 1.873 . . . . 0.0 110.069 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.489 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 74.92 -80.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.191 -179.47 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 156' ' ' LYS . . . 174.99 67.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 mmtt -146.35 164.05 33.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.051 -1.264 . . . . 0.0 110.069 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.567 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 62.7 m-85 -148.31 179.61 7.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.574 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.51 107.78 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.028 -1.045 . . . . 0.0 109.991 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.85 117.13 21.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.032 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.46 ' OE2' ' HD2' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -141.76 140.45 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.53 -179.771 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.519 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.2 tt -125.38 159.42 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.519 ' N ' HG12 ' A' ' 161' ' ' ILE . 8.7 ttt180 -97.78 115.05 27.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 193' ' ' MET . 19.1 t0 -99.25 110.12 57.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.1 Cg_endo -77.63 -27.72 5.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.3 2.0 . . . . 0.0 110.168 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.71 -21.68 64.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.348 -0.845 . . . . 0.0 109.555 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 2.7 mttt -90.66 23.15 3.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.448 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 76.51 40.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.626 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.42 86.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.35 177.82 8.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -1.081 . . . . 0.0 109.417 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 0.9 OUTLIER -100.99 163.87 12.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.678 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.39 85.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.0 109.045 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.574 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.9 t-105 -73.2 97.12 2.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.395 -0.816 . . . . 0.0 109.883 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' A' ' 189' ' ' ALA . 1.1 mt -59.6 -41.06 89.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.88 . . . . 0.0 109.257 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.428 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 147.52 166.6 12.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -83.72 153.68 24.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -1.194 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 59.2 m-85 -126.72 -177.5 4.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.659 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 -30.97 16.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 181' ' ' ASP . 1.7 p -138.72 167.45 21.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.25 -41.21 67.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.293 -0.879 . . . . 0.0 109.79 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.7 OUTLIER -71.22 -40.74 70.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.56 -30.34 67.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.3 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.593 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -75.15 -34.04 61.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.143 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -66.72 -42.09 86.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 109.044 179.635 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.03 -22.72 64.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.2 t80 -77.32 -32.2 55.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.238 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 97.6 m-20 -67.55 -41.44 84.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -70.05 -35.91 74.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.867 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.487 ' HB3' ' CD2' ' A' ' 173' ' ' LEU . . . -77.51 -24.22 50.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.656 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.95 -26.74 27.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 195' ' ' GLY . 5.7 t80 -83.11 -23.55 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -43.74 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.515 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -75.01 -32.36 61.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.02 -179.658 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.9 mtt-85 -96.69 -13.28 22.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.283 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 191' ' ' PHE . . . 74.86 -125.2 8.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.68 172.37 9.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -1.094 . . . . 0.0 109.97 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.403 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 0.0 OUTLIER 54.04 -117.64 1.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.408 -0.807 . . . . 0.0 109.608 179.743 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 194' ' ' ARG . . . 65.35 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.692 -1.255 . . . . 0.0 109.317 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 200' ' ' LEU . 5.8 mt -85.04 130.13 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.705 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.527 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.66 166.16 18.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.806 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.427 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.3 OUTLIER -63.0 -31.91 73.16 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.327 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 7.2 m-85 -120.06 77.17 23.64 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 122.699 2.266 . . . . 0.0 110.562 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.612 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 20.4 m-85 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -82.35 92.46 6.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 186' ' ' TYR . . . 123.39 -5.58 9.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -108.96 120.72 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -1.159 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -97.07 118.65 33.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.493 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -89.36 149.45 23.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.606 -179.805 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.439 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mmt180 -120.51 158.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.52 8.81 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.616 2.21 . . . . 0.0 110.876 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.29 -13.33 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 105.4 49.21 0.99 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 8.8 mtmm -150.07 -174.74 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -1.165 . . . . 0.0 109.54 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 178' ' ' THR . 76.8 m-85 -153.99 178.35 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.271 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.619 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.12 111.15 4.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.683 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -84.91 118.43 24.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.345 -0.847 . . . . 0.0 108.96 179.46 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 19.2 mt-10 -137.42 179.55 6.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 109.28 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.2 tt -169.63 130.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -63.36 153.05 36.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.857 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.93 103.71 3.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.45 -25.33 9.79 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.42 2.08 . . . . 0.0 110.321 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.6 66.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 109.168 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 44.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 0.0 109.473 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t30 51.08 57.16 6.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.417 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 51.24 79.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -141.31 131.15 24.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -1.203 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -73.28 143.53 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.42 ' HB ' HG21 ' A' ' 161' ' ' ILE . 54.1 t -111.77 105.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.619 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 6.7 t-105 -89.69 95.57 10.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.53 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -53.58 -42.87 68.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.451 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 146.64 158.17 7.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.36 159.36 32.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -1.045 . . . . 0.0 109.516 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 70.9 m-85 -133.45 174.91 9.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.43 -30.42 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.6 p -137.54 -176.98 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.493 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -84.52 -30.15 25.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -68.05 -32.21 72.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.958 . . . . 0.0 109.584 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.1 OUTLIER -75.67 -48.59 21.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.306 -0.871 . . . . 0.0 109.025 179.862 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -66.61 -21.69 66.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 108.912 179.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.612 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -77.59 -45.77 24.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.9 tp -62.56 -40.75 97.86 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.17 -24.71 63.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 108.919 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 160' ' ' GLU . 14.6 t80 -70.77 -32.17 69.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -69.04 -45.61 69.97 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -58.29 -35.22 71.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.509 -0.744 . . . . 0.0 110.176 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.53 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -80.83 -33.63 34.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.516 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -86.95 -2.41 58.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.202 -0.937 . . . . 0.0 109.217 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.489 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 25.4 t80 -103.25 -24.47 13.54 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.295 -0.878 . . . . 0.0 109.113 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -84.48 -40.9 17.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 108.785 179.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -31.33 57.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.621 -0.674 . . . . 0.0 109.868 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 43.8 mtt180 -100.86 -18.82 16.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 47.57 -176.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.41 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.311 -1.111 . . . . 0.0 109.732 179.952 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.3 140.04 48.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.61 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 200' ' ' LEU . . . -144.83 163.58 33.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.412 ' C ' HD21 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -82.45 105.61 13.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.682 -179.773 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -122.86 164.97 17.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 108.998 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -66.4 -33.0 74.73 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.128 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.4 m-85 -124.54 76.06 63.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.683 2.255 . . . . 0.0 110.558 -179.471 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 22.8 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.4 92.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.15 -32.06 3.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.465 HG22 ' CB ' ' A' ' 146' ' ' TYR . 29.5 t -77.8 133.64 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -1.216 . . . . 0.0 109.801 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.502 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -121.41 107.01 11.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.324 179.898 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.575 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.3 pt20 -75.09 164.61 26.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.46 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.9 mtt-85 -127.81 172.11 7.33 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.678 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.02 -30.22 3.72 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.822 2.348 . . . . 0.0 110.704 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -35.36 60.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.657 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.46 34.93 0.43 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -127.23 159.42 34.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -1.165 . . . . 0.0 109.264 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 27.5 m-85 -125.19 -179.12 4.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.566 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.41 108.29 3.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.31 114.8 19.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.718 179.185 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -131.18 157.88 42.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.567 -179.727 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 tt -149.8 128.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.551 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.15 8.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.454 ' HB2' HG22 ' A' ' 171' ' ' VAL . 48.3 t0 -92.8 117.22 67.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 109.557 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 35.6 Cg_endo -78.19 -26.24 6.5 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.286 1.991 . . . . 0.0 109.899 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.73 -14.63 62.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 6.2 mmtp -101.26 30.16 4.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 41.3 t-20 67.51 28.4 7.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.53 62.5 2.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.8 129.26 55.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -1.128 . . . . 0.0 109.469 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.42 122.52 16.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.504 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 21.6 t -101.73 94.69 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.566 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.8 t-105 -69.65 100.73 1.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -59.77 -48.99 79.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.656 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 153.67 152.56 6.09 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.1 p -69.51 163.71 24.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -1.206 . . . . 0.0 109.131 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 60.7 m-85 -140.0 -177.84 5.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -86.85 -30.01 21.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.626 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.579 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -146.71 171.41 15.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.589 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.558 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -69.82 -22.51 63.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.05 -40.54 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.1 m-20 -71.52 -41.84 68.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.27 -30.38 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -74.42 -40.7 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -38.85 89.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.497 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.32 -24.15 63.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.6 t80 -73.93 -29.07 61.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.534 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 43.4 m-20 -70.26 -49.04 53.89 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.218 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -60.97 -38.49 86.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 109.874 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.434 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -80.5 -21.83 41.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.646 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.92 -14.31 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.76 -27.14 14.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 109.101 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -82.56 -40.36 21.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 2.7 tpp -70.9 -30.56 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.666 -0.647 . . . . 0.0 109.357 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 196' ' ' SER . 2.7 mtt180 -101.13 -12.82 18.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.33 -0.856 . . . . 0.0 109.242 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 52.61 -88.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 194' ' ' ARG . 0.3 OUTLIER -46.3 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -1.093 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' SER . 13.4 mtt180 -40.44 157.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 200' ' ' LEU . . . -164.25 156.25 16.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 109.307 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.13 127.85 37.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.534 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.96 162.67 29.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.141 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 0.2 OUTLIER -58.23 -34.69 70.7 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.117 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 8.5 m-85 -116.58 80.95 10.86 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 33.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.561 2.174 . . . . 0.0 110.311 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.634 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 9.2 m-85 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.311 0.577 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.61 87.76 3.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 108.824 179.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.97 2.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 182' ' ' ALA . 45.8 t -137.87 108.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.288 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.81 127.62 33.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.426 -0.796 . . . . 0.0 109.009 179.713 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.1 pp0? -104.48 146.64 28.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.944 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.5 164.03 15.89 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.61 37.0 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.836 2.358 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -146.05 -62.28 0.32 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.02 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.99 36.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.63 168.92 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -1.202 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 178' ' ' THR . 59.3 m-85 -148.36 177.23 9.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.374 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.15 111.84 4.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -82.29 110.4 17.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -131.33 149.52 52.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.281 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 17.4 tt -128.21 146.68 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.094 -1.004 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -87.38 130.59 34.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 109.55 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -119.96 94.39 48.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.468 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 35.9 Cg_endo -78.26 -22.78 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.578 2.186 . . . . 0.0 110.44 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.46 75.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 166' ' ' LYS . 8.4 mmtt -86.25 63.03 7.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.847 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 168' ' ' GLY . 1.8 m-80 52.67 48.55 22.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 43.41 52.63 6.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.52 130.08 35.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 109.319 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 143.94 46.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.416 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 77.1 t -123.19 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.835 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 4.8 t-105 -117.01 97.33 5.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.525 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 2.3 mp -54.83 -50.51 68.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.266 -0.896 . . . . 0.0 109.149 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 155.31 153.56 6.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.4 p -65.36 166.93 9.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -1.046 . . . . 0.0 109.332 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.565 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 65.0 m-85 -144.02 174.51 10.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -25.3 30.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.731 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 2.3 p -149.56 171.06 17.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.47 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -70.56 -25.46 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.46 -42.1 75.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.28 -48.59 56.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.202 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.552 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -65.91 -22.82 66.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.922 . . . . 0.0 109.029 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.634 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -78.22 -36.89 46.55 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 108.873 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -68.05 -45.22 74.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.581 -0.699 . . . . 0.0 109.175 179.491 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.565 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.01 -23.69 65.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.459 -0.775 . . . . 0.0 109.012 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.476 ' O ' ' HB1' ' A' ' 190' ' ' ALA . 12.2 t80 -71.52 -35.38 70.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -0.783 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.6 m-20 -65.64 -41.85 92.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.321 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -41.05 84.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -82.75 -19.65 37.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.33 -9.63 52.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -99.12 -31.22 11.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.821 . . . . 0.0 109.271 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -77.98 -42.78 31.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.896 . . . . 0.0 109.116 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 48.0 ttm -69.65 -31.53 69.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.315 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 22.2 mtt-85 -100.86 11.91 38.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 48.57 -154.54 1.76 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 29.6 m -53.45 143.27 19.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -1.119 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 196' ' ' SER . 6.5 mtp85 68.53 138.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.466 ' O ' HD22 ' A' ' 200' ' ' LEU . . . 176.47 140.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.417 ' C ' HD22 ' A' ' 200' ' ' LEU . 2.2 mt -81.37 109.3 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -116.0 -178.09 3.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.408 179.755 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.458 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -81.38 -28.81 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.155 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 6.6 m-85 -122.68 70.15 36.33 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.483 0 C-N-CA 122.467 2.112 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 12.4 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.36 89.67 3.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 108.848 179.364 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.48 11.0 3.47 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 146' ' ' TYR . 47.3 t -126.3 109.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.289 . . . . 0.0 109.359 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -93.0 111.34 22.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.443 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.5 pt20 -80.87 151.08 28.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 108.975 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.49 163.89 37.72 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.442 -179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.13 -5.56 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.615 2.21 . . . . 0.0 110.121 -179.88 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -98.23 27.89 4.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 109.273 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.53 60.99 7.98 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -156.44 170.52 22.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 179' ' ' ALA . 73.4 m-85 -142.64 172.84 12.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.008 179.917 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.87 105.28 4.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.57 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -81.5 123.09 28.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.051 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.465 ' CD ' ' CE3' ' A' ' 172' ' ' TRP . 4.3 mt-10 -145.28 153.3 41.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 0.0 109.334 -179.543 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.5 tt -141.04 149.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -84.33 117.1 23.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 109.734 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.523 ' HB2' ' CE ' ' A' ' 193' ' ' MET . 67.8 t0 -114.58 102.12 54.66 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -25.53 9.78 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.326 2.017 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.47 -16.12 63.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.863 . . . . 0.0 109.217 179.67 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -93.38 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.7 54.13 9.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.421 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.95 71.26 0.67 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.23 118.55 12.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.494 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.4 ' O ' HG21 ' A' ' 171' ' ' VAL . 13.1 ptp180 -54.21 170.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 163' ' ' ASP . 38.4 t -139.84 90.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.656 -179.694 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 6.0 t-105 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 109.178 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.466 HD12 ' HB1' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -52.62 -43.96 65.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 -179.72 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.38 150.39 5.23 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.8 p -63.18 168.78 3.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -1.157 . . . . 0.0 109.327 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.57 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 63.9 m-85 -141.55 -174.14 3.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.515 -179.767 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.74 -24.97 14.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.698 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.6 p -140.82 174.49 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -77.29 -24.83 50.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.328 -0.857 . . . . 0.0 109.363 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -77.02 -30.27 55.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.631 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -76.08 -40.68 52.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 109.279 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.96 -36.48 69.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.195 -0.941 . . . . 0.0 109.028 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.605 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -69.58 -39.78 77.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.799 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.97 -46.32 88.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 109.004 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.76 -26.87 67.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.475 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 29.8 t80 -68.7 -36.28 78.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.132 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 7.0 m-20 -64.07 -52.15 60.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 109.838 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -56.88 -37.16 70.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.422 -0.799 . . . . 0.0 109.527 -179.76 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 173' ' ' LEU . . . -78.38 -20.65 50.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.212 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.68 -11.88 43.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.3 t80 -101.88 -26.67 13.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.119 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -40.63 29.85 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.315 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 163' ' ' ASP . 13.9 mtp -77.93 -44.49 26.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.242 0.544 . . . . 0.0 110.165 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.0 mtt180 -83.51 -37.74 22.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 108.943 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 58.52 145.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ALA . 2.8 m 63.12 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -1.138 . . . . 0.0 109.987 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 44.26 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.999 179.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 196' ' ' SER . . . 66.95 144.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.988 . . . . 0.0 109.328 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.434 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.12 117.27 34.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.913 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.1 156.06 35.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 179.944 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -32.32 73.5 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.05 97.51 47.95 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.094 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.459 ' HA ' HD13 ' A' ' 200' ' ' LEU . 33.4 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.331 2.02 . . . . 0.0 110.6 -179.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 28.4 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.158 0.504 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.87 37.64 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.129 179.738 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . -169.95 26.77 0.11 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 182' ' ' ALA . 60.9 t -142.67 117.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -1.091 . . . . 0.0 109.681 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 93.08 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.162 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.47 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 9.9 pt20 -60.65 144.67 51.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.75 -179.748 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.482 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -103.88 171.7 4.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.308 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.2 Cg_endo -77.12 -31.81 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -82.6 -74.98 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.73 71.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 56.3 mttt -153.85 168.04 27.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.577 179.925 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 64.0 m-85 -150.68 120.67 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 108.737 179.694 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.608 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -93.76 118.87 31.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.748 -178.823 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.509 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -86.15 122.73 30.57 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.308 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.437 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 11.2 tt0 -137.69 150.6 47.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.02 . . . . 0.0 110.421 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.3 tt -136.23 137.33 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -86.57 127.46 34.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.834 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.418 ' HB2' ' HE3' ' A' ' 193' ' ' MET . 63.3 t0 -125.05 105.55 28.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.413 -0.805 . . . . 0.0 108.984 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.91 -26.08 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.455 2.103 . . . . 0.0 110.58 -179.737 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.88 -12.0 57.83 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 51.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 56.24 25.05 8.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 -179.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.18 40.92 40.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -100.1 142.87 30.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -84.43 155.7 22.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.3 100.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.608 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.4 t-105 -80.16 95.29 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.322 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.486 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -50.55 -49.46 55.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.039 -179.641 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.466 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 151.23 155.25 6.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.6 p -68.18 169.97 9.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -1.095 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.509 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 67.2 m-85 -148.2 -170.46 3.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -23.84 13.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.578 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.574 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.6 p -144.34 160.05 41.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.302 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.56 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -66.26 -24.7 66.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.065 -1.022 . . . . 0.0 109.216 179.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.66 -33.22 68.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -76.78 -47.88 20.32 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.021 179.78 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -66.46 -25.62 66.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.17 -0.956 . . . . 0.0 108.954 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.616 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -74.12 -49.94 21.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.112 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -34.09 74.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.438 -0.789 . . . . 0.0 109.032 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.74 -30.63 68.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.5 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -67.77 -27.89 67.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.712 . . . . 0.0 109.109 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 58.5 m-20 -71.19 -45.27 63.78 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.596 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -65.15 -29.03 69.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 110.368 -179.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.486 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -85.7 -32.65 21.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 110.026 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -80.99 -18.81 45.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.41 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.3 t80 -91.02 -38.73 12.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.326 -0.859 . . . . 0.0 109.353 179.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -41.85 97.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.09 -1.007 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 163' ' ' ASP . 3.6 ttm -79.95 -43.1 22.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 109.271 179.608 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 21.4 mtt180 -101.96 32.96 3.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.515 -0.74 . . . . 0.0 109.162 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -37.94 -32.47 0.12 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -75.74 81.93 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -1.15 . . . . 0.0 109.263 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 61.19 139.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.358 -179.806 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -170.57 144.51 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -98.1 108.99 21.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.454 ' HB3' ' OD1' ' A' ' 187' ' ' ASP . 0.2 OUTLIER -111.1 159.42 17.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.435 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -53.0 -37.81 61.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.094 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.9 m-85 -123.08 86.12 51.15 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.321 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.644 2.229 . . . . 0.0 110.722 -179.02 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 14.8 m-85 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -77.82 94.44 4.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.25 -3.4 11.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 49.0 t -108.69 112.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.27 . . . . 0.0 110.057 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.541 ' HG3' ' CB ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -87.43 111.61 21.31 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.752 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.563 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 8.0 pt20 -90.06 138.62 31.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -178.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.631 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 14.0 mmm-85 -74.86 -166.76 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.1 Cg_endo -76.88 -15.23 16.83 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.313 1.342 . . . . 0.0 110.629 -179.256 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.54 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 158.79 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.496 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.58 -68.93 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.347 179.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mttt -116.7 -168.53 1.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.852 -1.381 . . . . 0.0 111.282 -178.16 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.615 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 50.9 m-85 -154.8 179.46 9.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.2 110.33 4.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 109.993 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 182' ' ' ALA . . . -81.5 134.86 35.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.71 134.68 14.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.8 tt -120.11 141.4 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.411 ' HD2' ' HD3' ' A' ' 164' ' ' PRO . 1.6 tmm_? -85.07 129.54 34.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -116.12 92.47 35.62 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD3' ' HD2' ' A' ' 162' ' ' ARG . 34.8 Cg_endo -76.97 -22.35 11.56 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.676 2.251 . . . . 0.0 110.719 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.12 69.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.407 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 35.4 mmtt -85.38 -55.78 3.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 109.473 179.907 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 12.6 p30 169.14 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.97 4.5 67.5 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.824 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.09 108.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.119 . . . . 0.0 109.446 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 142.86 29.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.265 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 161' ' ' ILE . 47.1 t -115.65 83.18 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.5 t-105 -65.32 100.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 109.164 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 189' ' ' ALA . 4.8 mt -61.61 -41.48 97.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.687 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 144.29 174.0 16.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.846 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -92.06 157.36 16.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.252 . . . . 0.0 109.148 179.753 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 78.7 m-85 -130.53 -176.51 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.815 -179.53 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.408 ' O ' HG21 ' A' ' 178' ' ' THR . 8.8 mm-40 -89.14 -20.12 24.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 4.0 p -147.97 175.41 11.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.95 . . . . 0.0 109.87 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -78.7 -22.21 47.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.45 -0.781 . . . . 0.0 109.45 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.6 tm-20 -76.83 -32.43 57.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -77.78 -36.12 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.927 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.27 -43.92 60.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 108.895 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -63.34 -37.15 86.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.361 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -64.98 -46.71 80.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.521 -0.737 . . . . 0.0 109.11 179.495 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.98 -18.8 64.64 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.5 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -74.14 -38.12 63.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.041 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 25.2 m-20 -62.16 -49.87 74.12 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.449 -0.782 . . . . 0.0 109.37 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -52.11 -44.84 64.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.618 -0.676 . . . . 0.0 109.925 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.449 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -78.32 -19.15 54.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 109.702 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -92.27 -4.55 53.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.883 . . . . 0.0 109.586 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.441 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.1 t80 -108.38 -29.8 8.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -85.04 -37.75 19.98 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.016 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.7 ttm -77.88 -35.61 50.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.737 -0.602 . . . . 0.0 109.562 179.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.5 mtp180 -94.26 -23.57 17.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.139 -0.976 . . . . 0.0 108.886 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 53.2 170.29 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.986 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 43.61 -159.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -1.211 . . . . 0.0 109.664 179.898 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.25 153.84 3.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.579 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -160.86 168.18 25.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 104.83 14.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.519 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -122.75 162.96 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.983 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.471 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -65.7 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.606 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 7.2 m-85 -119.1 80.29 19.04 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 C--N 1.309 -1.524 0 C-N-CA 122.566 2.178 . . . . 0.0 110.285 -179.557 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 65.9 m-85 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -81.01 36.07 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.616 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.415 ' HA3' ' CD2' ' A' ' 186' ' ' TYR . . . -176.8 27.3 0.07 OUTLIER Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.664 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 182' ' ' ALA . 78.6 t -150.67 139.8 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -1.204 . . . . 0.0 109.648 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -110.55 160.1 16.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 108.991 179.489 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.576 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.0 pt20 -131.37 146.15 52.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.043 -1.036 . . . . 0.0 110.115 -179.48 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.8 OUTLIER -121.63 160.55 45.93 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.759 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -77.78 -4.43 14.5 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 110.776 -179.848 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -98.08 -7.35 29.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.504 179.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.28 47.46 1.85 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 9.2 mtpp -146.74 140.72 26.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.161 . . . . 0.0 109.513 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 7.0 m-85 -119.98 -170.28 1.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.917 . . . . 0.0 109.376 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.579 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -156.43 110.51 2.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 179.892 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -81.11 119.78 24.0 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.435 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 12.3 mt-10 -136.94 153.89 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.827 . . . . 0.0 109.603 -179.67 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.457 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 5.8 tt -141.61 138.91 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 108.979 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.47 131.39 35.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.756 -179.664 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -124.73 90.81 50.41 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.51 -23.33 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.549 2.166 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.46 -9.89 29.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 15.0 mmtp -104.37 23.7 12.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 26.8 t-20 64.34 45.14 3.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.06 110.74 0.12 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 170' ' ' ARG . . . -177.11 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -1.179 . . . . 0.0 109.466 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -43.2 163.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.457 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 92.7 t -135.15 91.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.955 . . . . 0.0 109.864 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 10.8 t-105 -75.31 92.38 2.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 108.882 179.464 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -52.31 -46.11 65.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.224 -179.741 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.25 156.37 7.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.678 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 5.6 p -73.21 153.27 40.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -1.082 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.584 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 61.2 m-85 -128.99 -170.97 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 -32.38 14.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.277 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.555 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -141.41 173.89 11.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.226 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.508 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -72.27 -24.58 61.37 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -70.63 -37.7 73.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.867 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.97 -43.81 51.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.072 -1.018 . . . . 0.0 109.205 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.27 -24.81 63.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 108.997 179.717 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.609 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -75.59 -44.9 40.72 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -61.68 -43.52 98.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.573 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.83 -32.23 73.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 108.827 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -64.46 -29.62 70.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.325 -0.859 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 191' ' ' PHE . 38.1 m-20 -72.92 -43.56 62.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.382 -0.824 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.03 -23.94 67.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.772 . . . . 0.0 110.127 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.52 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -92.72 -31.9 14.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.011 -1.056 . . . . 0.0 109.761 -179.708 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.93 -10.83 57.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.235 -0.915 . . . . 0.0 109.099 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -100.38 -41.15 7.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 179.542 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -41.24 94.34 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.32 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 ttp -75.73 -42.75 49.81 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 109.177 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 37.4 mtt180 -104.0 33.95 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.48 -0.763 . . . . 0.0 109.095 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -38.29 109.3 0.09 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 1.4 t 162.87 -71.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -1.071 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 62.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.785 . . . . 0.0 109.214 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.472 ' O ' HD22 ' A' ' 200' ' ' LEU . . . -83.27 160.92 21.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.859 . . . . 0.0 109.627 -179.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.88 124.18 35.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 108.988 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.472 HD22 ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -123.97 177.03 5.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.482 -179.59 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.533 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.5 OUTLIER -63.92 -34.88 78.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.327 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.1 m-85 -122.66 79.66 48.03 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.311 -1.406 0 C-N-CA 122.817 2.344 . . . . 0.0 110.742 -179.364 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.656 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 19.1 m-85 . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' ARG . 3.2 ptt180 -75.13 127.85 34.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.181 179.623 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.28 -21.02 47.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 183' ' ' ALA . 89.3 t -94.3 108.02 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -79.21 147.71 32.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.058 -1.026 . . . . 0.0 108.769 179.339 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.454 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.6 pp0? -120.07 140.36 51.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.897 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.463 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mpp_? -115.87 171.43 4.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -78.04 -35.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.63 2.22 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.63 -21.81 66.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.522 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.24 17.62 8.16 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -102.37 174.33 5.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -1.154 . . . . 0.0 109.449 179.905 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.455 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 55.4 m-85 -147.55 -172.86 4.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.006 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.584 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.05 110.34 2.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.75 121.83 25.84 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.204 -0.935 . . . . 0.0 108.915 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -142.92 151.49 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 -179.552 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 5.4 tt -137.33 128.35 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.854 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 5.2 ptt180 -73.48 117.95 15.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -98.73 109.26 52.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 109.602 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.43 -25.13 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.353 2.036 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.16 -17.54 60.9 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.356 -0.84 . . . . 0.0 109.343 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -94.75 26.93 3.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 63.56 48.2 3.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.503 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.87 69.2 1.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -127.78 103.97 7.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -1.135 . . . . 0.0 109.389 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 149.13 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 29.9 t -127.55 93.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.095 179.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 10.2 t-105 -73.8 97.43 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.817 -179.614 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -58.38 -38.13 76.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.48 157.04 7.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.81 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 4.9 p -73.73 155.63 38.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -1.047 . . . . 0.0 109.784 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 59.8 m-85 -131.24 173.95 10.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' O ' HG21 ' A' ' 178' ' ' THR . 0.5 OUTLIER -85.58 -18.16 34.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 0.0 109.7 -179.854 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 177' ' ' GLU . 3.7 p -151.53 173.31 14.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.953 . . . . 0.0 109.592 -179.758 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.486 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -74.95 -24.98 58.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.54 -34.68 65.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.46 -34.11 54.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.377 -0.827 . . . . 0.0 109.269 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -78.73 -26.98 44.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -0.908 . . . . 0.0 109.319 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -76.7 -37.58 55.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.134 -0.979 . . . . 0.0 108.688 179.382 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -62.65 -44.12 97.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.191 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.35 -33.95 77.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.457 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 190' ' ' ALA . 11.7 t80 -62.73 -35.11 78.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.14 179.624 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 62.7 m-20 -60.41 -53.26 59.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.503 -0.748 . . . . 0.0 109.901 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -26.78 66.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.484 ' HB2' HG23 ' A' ' 161' ' ' ILE . . . -88.57 -16.91 31.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.448 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 186' ' ' TYR . . . -93.48 -11.73 31.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -99.84 -33.85 10.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 108.865 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -79.54 -42.29 25.43 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.425 ' HE2' HG22 ' A' ' 171' ' ' VAL . 3.5 tpp -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.644 -0.66 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.6 mmp_? -102.17 12.59 36.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.03 -156.31 11.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 5.4 p -65.41 154.72 37.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 196' ' ' SER . 10.8 mtt180 62.86 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -161.65 173.66 14.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.46 125.91 51.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.603 -179.8 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.45 -179.76 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.815 -179.63 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.437 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -75.88 -34.6 59.99 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.128 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.3 m-85 -123.84 83.61 54.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.86 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.511 2.141 . . . . 0.0 110.508 -179.452 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.644 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 26.9 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.297 0.57 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -79.15 76.39 5.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.228 179.647 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.98 -21.33 0.44 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.511 HG12 ' CB ' ' A' ' 182' ' ' ALA . 16.8 t -101.11 109.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.283 . . . . 0.0 109.455 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.77 174.7 5.77 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.608 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.584 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -142.53 133.35 25.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 110.282 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.568 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.0 ttm-85 -68.67 -174.95 0.23 Allowed Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.918 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 29.3 Cg_endo -70.75 82.78 0.92 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.17 1.246 . . . . 0.0 110.021 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 7.2 m95 63.7 65.41 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.524 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.62 -132.49 1.35 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.537 -1.315 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -79.23 159.17 27.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.549 -0.971 . . . . 0.0 110.47 -178.756 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 151' ' ' GLN . 8.5 m-30 -101.71 -163.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -158.35 112.3 2.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.896 -1.127 . . . . 0.0 110.779 -179.906 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -84.94 128.01 34.43 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.381 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -143.76 166.85 23.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.108 -178.942 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.424 HG12 ' N ' ' A' ' 162' ' ' ARG . 1.9 tt -161.74 149.05 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 161' ' ' ILE . 12.6 ptm180 -80.73 153.69 27.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.632 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.25 104.91 25.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.68 -28.49 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.399 2.066 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.81 62.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.093 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' CB ' ' HB1' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -100.67 32.36 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.803 . . . . 0.0 109.494 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 9.2 t-20 69.56 44.13 0.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 61.55 22.37 61.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 166' ' ' LYS . . . -66.47 137.16 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -1.083 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -69.15 161.7 28.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.3 t -144.44 97.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.268 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.574 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 3.3 t-105 -79.55 105.82 11.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.622 -179.858 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -59.33 -60.39 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.64 153.98 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -69.3 156.7 38.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.399 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 59.2 m-85 -134.24 -162.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 -179.766 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 178' ' ' THR . 0.0 OUTLIER -111.09 -25.55 9.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.799 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.52 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 2.9 p -145.78 -177.32 5.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.925 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.515 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -79.92 -27.76 39.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 109.29 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.17 -37.66 75.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.413 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -72.87 -57.3 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 -179.809 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -59.27 -31.61 69.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.869 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.644 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -68.87 -42.96 76.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.333 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 1.8 tm? -61.67 -44.44 96.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.857 . . . . 0.0 108.792 179.556 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.573 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.06 -28.16 69.28 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 27.6 t80 -68.8 -35.39 76.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.552 -0.718 . . . . 0.0 109.138 179.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -60.52 -48.18 82.89 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.323 -0.86 . . . . 0.0 109.594 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -55.14 -42.72 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.529 ' CB ' HD13 ' A' ' 173' ' ' LEU . . . -74.55 -20.65 59.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.496 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.36 2.43 56.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.0 t80 -109.77 -29.28 8.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 108.636 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -84.07 -39.36 19.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 0.0 OUTLIER -75.23 -32.47 61.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.646 -0.659 . . . . 0.0 109.86 179.861 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 4.3 mtt85 -92.44 -12.58 31.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 88.52 -145.94 19.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.448 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 2.1 m -54.85 -96.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -1.101 . . . . 0.0 109.613 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -56.36 164.55 1.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.063 -1.023 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . 179.04 176.35 0.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.425 ' C ' HD22 ' A' ' 200' ' ' LEU . 2.4 mt -113.4 106.1 14.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.899 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -115.1 158.04 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.7 OUTLIER -64.41 -28.93 70.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.321 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.0 m-85 -126.22 72.84 71.92 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.571 -0.706 . . . . 0.0 109.19 -179.685 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 200' ' ' LEU . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.723 2.282 . . . . 0.0 110.444 -179.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.646 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 21.4 m-85 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.257 0.551 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -75.05 82.8 2.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.24 179.666 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.03 9.65 1.44 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.617 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 54.1 t -121.09 111.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.747 -1.443 . . . . 0.0 109.892 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.43 101.26 5.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 108.917 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 1.1 pt20 -97.38 134.49 40.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.375 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.585 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 5.3 mtt180 -89.35 -176.19 0.64 Allowed Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.03 87.09 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.087 1.858 . . . . 0.0 110.281 -179.642 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 43.7 m95 55.43 73.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.393 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.59 -93.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.659 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.546 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.1 mtpp -115.77 -168.78 1.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -1.12 . . . . 0.0 110.431 -178.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 156' ' ' LYS . 45.0 m-85 -150.61 -175.96 5.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.05 155.58 34.36 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.544 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -129.5 115.77 17.96 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.84 159.86 41.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.392 -179.526 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.504 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 9.9 tt -134.91 136.21 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.33 126.78 34.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -115.51 91.16 28.12 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 109.487 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.31 -25.08 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.534 2.156 . . . . 0.0 110.454 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -92.55 23.36 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 38.19 8.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.928 . . . . 0.0 109.555 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.04 122.5 2.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.86 80.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.19 148.31 4.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 51.4 t -129.89 93.07 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.58 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 7.5 t-105 -81.29 95.35 6.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.667 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.516 HD23 ' CB ' ' A' ' 189' ' ' ALA . 21.1 mt -53.57 -50.55 65.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.77 . . . . 0.0 109.306 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.96 14.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 4.2 p -81.68 145.77 30.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.1 m-85 -120.01 -169.93 1.87 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 -179.841 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.59 -29.29 12.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.51 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.8 p -138.22 167.66 21.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.5 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -70.75 -24.68 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.271 -0.893 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 39.6 tt0 -73.49 -30.4 63.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.668 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -81.71 -41.43 21.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 -179.868 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.15 -39.15 78.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.13 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -67.18 -42.06 84.86 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.395 -0.815 . . . . 0.0 108.828 179.589 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.431 ' HG ' ' CD2' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -59.35 -46.29 89.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.027 179.592 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.61 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.2 -23.05 67.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.1 t80 -71.55 -34.4 69.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.422 -0.799 . . . . 0.0 109.144 179.711 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.455 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 15.2 m-20 -63.37 -41.73 98.81 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -50.31 74.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 -179.757 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.516 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -74.37 -18.51 60.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.783 -179.507 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.488 ' HB1' ' CE1' ' A' ' 186' ' ' TYR . . . -91.3 -4.77 55.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -106.19 -32.14 8.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.259 -0.901 . . . . 0.0 108.841 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -41.3 30.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 47.0 ttm -70.82 -33.78 71.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 179.648 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.513 ' CD ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -84.93 -17.19 38.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.411 -0.806 . . . . 0.0 109.08 179.713 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 63.09 -88.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 195' ' ' GLY . 3.9 p -54.65 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 196' ' ' SER . 4.1 mpt_? -53.85 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' CD ' ' A' ' 194' ' ' ARG . . . 177.44 160.29 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 113.93 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.551 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.455 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -114.84 179.91 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.295 179.919 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -72.31 -31.87 66.07 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.03 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.1 m-85 -125.94 71.51 68.68 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo . . . . . 0 C--N 1.309 -1.539 0 C-N-CA 122.646 2.231 . . . . 0.0 110.619 -179.468 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 26.9 m-85 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.59 96.08 6.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.29 -9.82 11.86 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 78.4 t -104.31 114.5 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.252 . . . . 0.0 109.739 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -87.26 141.55 28.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 108.733 179.436 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.462 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -113.16 141.39 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.0 -1.062 . . . . 0.0 109.872 -179.583 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.4 mmt-85 -116.75 162.18 28.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.888 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.61 -25.34 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.439 2.093 . . . . 0.0 110.279 179.839 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.47 82.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 156' ' ' LYS . . . 133.53 37.29 0.24 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 155' ' ' GLY . 22.2 mttt -135.12 170.83 15.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -1.106 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 64.1 m-85 -140.79 -170.35 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -159.29 113.64 2.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 109.934 179.686 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -86.18 123.63 31.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.473 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.554 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 9.3 mt-10 -141.58 169.16 18.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.66 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 19.1 tt -152.54 131.41 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.976 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 18.3 ptt180 -94.8 118.35 31.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 109.978 -179.374 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.422 ' HB2' ' HE2' ' A' ' 193' ' ' MET . 11.8 t0 -108.68 107.02 59.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.43 -0.794 . . . . 0.0 109.008 179.557 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.84 -28.77 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.389 2.059 . . . . 0.0 110.477 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.18 40.73 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.219 -0.925 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . 29.3 mttm -94.91 33.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.05 37.91 20.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.85 83.68 0.43 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 166' ' ' LYS . . . -137.78 118.83 14.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.15 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -78.68 151.19 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.744 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 17.9 t -131.04 100.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.013 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 5.1 t-105 -87.12 99.9 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.683 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -55.4 -51.2 67.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.852 . . . . 0.0 109.562 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 153.7 153.77 6.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 3.1 p -72.24 148.22 45.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -1.115 . . . . 0.0 109.671 -179.869 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.0 m-85 -122.41 -169.14 1.85 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.464 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 2.3 pt-20 -101.47 -25.91 13.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.0 p -138.7 174.35 10.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.293 179.537 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -78.12 -26.76 48.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.213 -0.929 . . . . 0.0 109.761 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.23 -37.76 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.076 -1.015 . . . . 0.0 109.805 -179.754 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -72.7 -39.19 67.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.34 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -72.41 -31.16 65.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.24 -36.0 66.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.329 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.99 -49.18 73.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.214 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.47 -30.95 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.32 -0.862 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -67.23 -32.41 73.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.37 -0.831 . . . . 0.0 109.32 179.706 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 9.6 m-20 -65.56 -35.15 80.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -50.21 30.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.812 . . . . 0.0 110.476 -179.401 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.426 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -67.62 -25.87 65.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 110.072 -179.294 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -81.87 -29.0 32.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.632 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.483 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.4 t80 -78.32 -22.41 48.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.968 . . . . 0.0 108.995 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -73.98 -50.52 19.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 108.978 179.574 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.516 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -71.25 -36.41 71.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.779 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.8 OUTLIER -104.08 36.81 2.23 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 179.917 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . -31.42 -68.54 0.12 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 197' ' ' ARG . 29.8 m -61.42 89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -1.193 . . . . 0.0 109.125 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.7 OUTLIER 62.84 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 109.25 -179.66 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.427 ' HB1' ' CB ' ' A' ' 194' ' ' ARG . . . -154.57 154.95 33.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.633 -179.882 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 tm? -99.89 123.87 44.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.447 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -131.98 175.61 9.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.744 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.415 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.12 -34.29 66.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.818 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.0 m-85 -119.81 82.71 27.89 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.372 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.311 -1.416 0 C-N-CA 122.89 2.393 . . . . 0.0 111.051 -179.095 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 201' ' ' ASN . 50.5 m-85 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.26 90.21 3.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 -17.82 5.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 92.9 t -96.92 110.32 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -1.137 . . . . 0.0 110.125 -179.573 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 29.5 mtt180 -85.55 141.07 30.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.534 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -107.47 152.76 23.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.976 -1.077 . . . . 0.0 110.41 -178.954 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.538 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -126.04 147.02 57.71 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.003 179.841 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.18 -6.63 16.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -98.85 7.52 45.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.774 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.27 81.43 1.21 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER 175.31 163.12 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.153 . . . . 0.0 109.552 -179.998 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 156' ' ' LYS . 36.2 m-85 -146.51 -176.25 5.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.594 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.08 110.24 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -82.34 118.39 23.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 1.5 mt-10 -138.78 153.14 48.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.803 . . . . 0.0 109.16 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -134.93 130.71 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.066 -1.021 . . . . 0.0 109.734 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -70.11 126.37 29.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.186 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -121.62 94.84 48.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.56 -21.08 11.74 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.616 2.211 . . . . 0.0 110.414 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.43 70.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 4.0 mmtm -79.99 -69.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 109.417 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.4 p30 166.81 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.42 34.25 68.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.31 96.97 7.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -1.143 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -50.2 156.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.661 -179.762 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 171' ' ' VAL . 44.0 t -123.04 91.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -0.826 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.594 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 10.2 t-105 -75.77 91.51 2.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' A' ' 189' ' ' ALA . 12.4 mt -53.86 -38.16 64.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.38 160.37 8.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.35 171.47 12.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 59.3 m-85 -145.94 -173.39 4.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.423 ' O ' HG21 ' A' ' 178' ' ' THR . 0.4 OUTLIER -95.86 -28.17 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 -179.906 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.3 p -145.95 170.42 16.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.553 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -69.65 -26.33 64.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.885 . . . . 0.0 109.31 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -70.58 -36.22 73.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -73.37 -47.87 38.68 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.61 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -63.55 -36.01 82.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.0 109.422 -179.806 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -67.0 -40.66 87.39 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 109.045 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.83 -48.75 79.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.416 -0.803 . . . . 0.0 109.127 179.797 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.08 -28.68 70.25 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 4.6 t80 -67.42 -28.47 67.93 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.529 -0.732 . . . . 0.0 109.038 179.252 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 191' ' ' PHE . 9.6 m-20 -70.26 -45.62 66.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -33.95 76.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.243 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.468 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -75.23 -54.45 7.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.747 -179.586 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -62.47 -14.95 46.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.862 -179.685 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.508 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 9.1 t80 -85.41 -34.93 21.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.007 -1.058 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -65.31 -43.13 92.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -82.35 -40.12 21.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 109.249 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 7.6 mtp85 -104.24 34.49 3.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.009 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . -41.54 165.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 0.3 OUTLIER 72.31 93.54 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -1.162 . . . . 0.0 109.306 -179.967 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 65.89 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.848 . . . . 0.0 109.677 179.929 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 63.59 147.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.83 121.03 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.355 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.6 -178.81 4.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.107 -179.871 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.545 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -72.2 -35.51 68.94 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.881 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 7.5 m-85 -120.09 76.4 23.1 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.63 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.63 2.22 . . . . 0.0 110.553 -179.525 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.594 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 14.4 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.397 0.617 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -77.4 85.3 3.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.574 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.98 -20.43 4.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.519 HG11 ' CB ' ' A' ' 182' ' ' ALA . 16.2 t -96.39 127.42 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -1.197 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.2 ttt85 -94.13 153.12 18.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.15 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -127.31 134.33 50.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.949 -1.094 . . . . 0.0 109.683 -179.679 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -114.77 167.01 10.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 109.502 -179.75 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.35 5.85 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.597 2.198 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -102.22 -18.96 15.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.631 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 15.88 11.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.817 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.407 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.4 mtpp -112.5 171.36 7.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 53.8 m-85 -142.84 -172.84 3.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.333 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.57 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.41 105.6 2.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.997 179.842 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.589 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.88 118.59 21.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.545 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.552 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 9.0 mt-10 -136.53 155.08 50.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.344 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 12.2 tt -140.38 143.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.705 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -87.6 126.62 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 109.025 179.659 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -112.95 95.67 35.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.634 -179.768 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.3 Cg_endo -77.26 -26.0 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.488 2.125 . . . . 0.0 110.248 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.79 -15.11 62.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 0.0 109.606 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.506 ' HA ' ' CE ' ' A' ' 166' ' ' LYS . 2.4 mmpt? -106.39 41.32 1.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.336 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER 48.26 72.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.956 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' ASN . . . 48.74 96.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 166' ' ' LYS . . . -148.48 101.32 3.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.173 . . . . 0.0 109.633 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 152.55 23.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.195 179.885 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.455 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 53.4 t -133.58 91.94 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.57 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 9.6 t-105 -79.05 92.6 5.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.066 179.492 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.499 ' CD2' ' CB ' ' A' ' 189' ' ' ALA . 7.7 mt -53.8 -38.72 64.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.29 -179.827 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.517 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 141.67 175.44 15.17 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -91.88 161.73 14.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -1.132 . . . . 0.0 109.191 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.589 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 60.7 m-85 -134.63 169.32 17.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.558 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.445 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 1.3 pt-20 -75.6 -25.41 56.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.868 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 181' ' ' ASP . 0.9 OUTLIER -147.58 -178.24 6.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 109.45 -179.937 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.523 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -82.6 -24.63 33.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.2 tt0 -71.09 -34.18 70.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 109.613 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.459 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -76.58 -50.78 13.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.288 -0.883 . . . . 0.0 109.671 -179.891 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -59.3 -45.94 89.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 109.186 179.921 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.594 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -59.31 -46.04 89.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.7 OUTLIER -59.51 -31.16 69.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.634 -0.666 . . . . 0.0 109.219 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.485 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -79.81 -23.74 41.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.488 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.6 t80 -74.77 -30.3 61.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.41 -0.806 . . . . 0.0 108.879 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 21.6 m-20 -71.12 -50.76 30.12 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.519 0.676 . . . . 0.0 109.31 179.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -36.33 82.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.633 -0.667 . . . . 0.0 109.688 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -80.84 -22.13 40.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.05 179.863 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 195' ' ' GLY . 1.7 t80 -85.31 -33.36 22.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 109.166 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -76.54 -40.72 49.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.868 . . . . 0.0 109.371 179.874 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -80.68 -27.7 36.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 110.284 -179.481 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 190' ' ' ALA . 2.8 mmt180 -92.61 8.93 36.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.897 -1.127 . . . . 0.0 109.676 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 71.48 -136.71 25.1 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.2 m -97.34 151.29 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.529 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 57.75 113.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.67 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.606 -179.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 113.17 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.377 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.66 176.07 8.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.403 -179.933 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -68.83 -37.27 79.06 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.368 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.1 m-85 -124.52 78.94 62.28 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.501 -0.749 . . . . 0.0 109.196 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.597 2.198 . . . . 0.0 110.447 -179.909 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.603 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 21.3 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 85.33 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.08 -15.28 4.54 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 183' ' ' ALA . 39.9 t -99.65 120.23 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.125 -1.221 . . . . 0.0 109.657 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 mmm180 -93.95 114.65 26.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.131 179.714 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.7 pt20 -89.68 139.32 30.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.829 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.492 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -110.54 160.72 27.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 179.96 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.7 Cg_endo -77.88 3.12 7.24 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.511 2.141 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.572 ' HA ' ' CE3' ' A' ' 154' ' ' TRP . 0.0 OUTLIER -105.06 -21.23 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.063 -1.023 . . . . 0.0 109.387 179.828 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 115.59 22.32 4.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.43 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 75.8 mttt -117.07 152.35 34.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.263 179.823 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 15.9 m-85 -132.6 170.53 15.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.982 . . . . 0.0 109.675 -179.615 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.581 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.84 114.9 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.921 179.814 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.56 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -84.95 121.95 28.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 108.764 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.53 152.7 40.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.562 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.542 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.2 tt -144.36 133.52 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 179.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.84 136.67 57.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 179.675 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.452 ' HB2' HG22 ' A' ' 171' ' ' VAL . 29.4 t0 -116.69 109.36 43.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.21 -27.39 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.375 2.05 . . . . 0.0 110.205 179.71 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.07 -16.72 61.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.402 -0.811 . . . . 0.0 109.732 -179.944 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 83.5 mttt -102.48 37.64 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 22.9 m-80 60.32 40.38 17.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.578 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.7 65.05 3.36 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.84 133.8 55.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.37 141.76 58.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 163' ' ' ASP . 26.0 t -117.31 88.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.581 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 9.4 t-105 -73.99 92.82 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.343 179.841 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 189' ' ' ALA . 2.2 mt -54.44 -40.81 68.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 144.84 157.33 7.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -72.06 169.09 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 64.6 m-85 -143.78 -178.99 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.69 -30.06 21.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.3 p -142.51 -179.62 6.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.551 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -79.28 -24.11 43.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -72.12 -35.59 69.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -76.14 -39.27 55.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.298 179.878 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.37 -32.44 70.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 108.97 179.837 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.603 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.09 -40.76 64.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.547 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 -44.27 97.28 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.18 -31.0 70.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.256 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CE2' ' HB ' ' A' ' 161' ' ' ILE . 8.2 t80 -63.03 -29.77 71.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.557 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.531 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.4 m-20 -68.98 -48.73 62.41 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 109.223 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -52.9 -36.01 58.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 110.578 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -81.79 -39.14 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.914 -1.116 . . . . 0.0 109.905 -179.491 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -80.74 4.66 18.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.314 179.835 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 195' ' ' GLY . 6.0 t80 -113.89 -42.69 3.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.416 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -38.8 66.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.116 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.445 ' HE3' ' OD2' ' A' ' 163' ' ' ASP . 15.3 ttm -81.59 -35.4 30.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.653 -0.654 . . . . 0.0 110.292 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.513 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -81.69 -13.88 57.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.041 . . . . 0.0 109.654 -179.418 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 99.21 -125.1 8.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.493 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -66.65 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -1.198 . . . . 0.0 109.922 -179.523 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.47 152.91 37.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.722 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . 172.52 153.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.852 . . . . 0.0 109.162 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.6 116.94 29.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.11 -0.994 . . . . 0.0 109.772 -179.698 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.531 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.03 146.91 50.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.526 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.24 -32.7 11.18 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.58 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.14 85.22 41.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 109.196 179.855 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 C--N 1.307 -1.616 0 C-N-CA 122.598 2.199 . . . . 0.0 110.138 179.952 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.649 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 25.3 m-85 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -81.4 91.4 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.68 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.68 3.37 11.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.904 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.7 t -112.8 109.37 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -1.181 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.416 ' HB2' ' HB1' ' A' ' 158' ' ' ALA . 39.3 mtm180 -84.96 113.99 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.17 -0.956 . . . . 0.0 108.789 179.544 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -91.92 131.29 37.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.322 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.547 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -79.32 -177.27 0.84 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.897 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.547 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 32.9 Cg_endo -76.57 76.37 4.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.84 1.693 . . . . 0.0 109.908 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 61.45 69.57 0.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 109.154 -179.617 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.6 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.503 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.526 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.2 mttp -113.18 -171.43 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -1.175 . . . . 0.0 110.627 -178.812 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.591 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 28.5 m-85 -144.33 -179.0 6.26 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.03 111.33 4.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.836 -1.165 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.22 117.99 27.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.141 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 3.9 mt-10 -134.33 -165.87 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.213 -179.864 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 160' ' ' GLU . 2.5 tt 174.68 138.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.667 179.868 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -75.52 131.14 39.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.246 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 171' ' ' VAL . 27.6 t0 -105.83 111.86 64.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.859 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.3 -28.55 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.498 2.132 . . . . 0.0 110.304 179.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.65 58.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.863 . . . . 0.0 109.594 -179.867 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 3.9 mmpt? -104.75 25.48 10.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.814 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 76.49 33.72 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 179.791 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.2 86.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.8 -168.89 2.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.4 179.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -112.41 144.9 41.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.785 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 163' ' ' ASP . 38.3 t -128.67 116.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.101 179.603 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 6.3 t-105 -102.11 100.67 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.437 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -57.75 -47.32 82.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.741 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.74 157.24 7.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.875 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.2 p -73.58 152.95 40.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.4 -1.059 . . . . 0.0 109.607 -179.846 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 70.7 m-85 -126.44 -177.2 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.165 179.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.468 ' C ' HG21 ' A' ' 178' ' ' THR . 1.0 OUTLIER -91.19 -32.47 15.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.928 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.468 HG21 ' C ' ' A' ' 177' ' ' GLU . 8.5 p -134.32 168.81 18.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.591 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.462 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -75.0 -38.13 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.374 -0.828 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -75.72 -34.89 60.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.097 -1.002 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.54 -35.71 65.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.08 179.664 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.649 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.428 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.405 ' HG ' ' CD2' ' A' ' 202' ' ' PHE . 0.6 OUTLIER -61.95 -46.19 90.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.464 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.39 -29.7 69.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.052 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.5 t80 -61.39 -42.97 99.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.501 -0.75 . . . . 0.0 109.106 179.426 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 191' ' ' PHE . 8.8 m-20 -58.25 -45.03 88.51 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.498 -0.751 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.847 -179.7 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -89.15 -25.61 21.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 110.199 -179.461 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.94 5.12 52.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.456 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -113.6 -31.66 6.43 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.328 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -83.79 -40.5 18.67 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.803 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 3.7 tpp -74.91 -29.56 61.02 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.618 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 70.2 mtt-85 -109.86 -3.37 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.706 -179.836 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 75.47 -146.37 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 197' ' ' ARG . 73.8 m -78.11 158.09 29.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -1.105 . . . . 0.0 109.7 -179.716 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 196' ' ' SER . 16.7 ttp180 55.3 103.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.654 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -159.52 31.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 179.723 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 198' ' ' ALA . 55.5 mt 36.57 98.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.372 0.606 . . . . 0.0 110.715 179.354 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.405 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -119.34 177.19 5.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.012 . . . . 0.0 108.88 179.019 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.519 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -71.27 -34.43 70.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.191 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.5 m-85 -121.86 74.83 36.99 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.852 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.5 0 C-N-CA 122.513 2.142 . . . . 0.0 110.38 -179.811 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.2 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.239 0.542 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.72 107.22 2.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 108.918 179.347 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.92 -34.0 4.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.544 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 42.0 t -81.24 119.75 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 109.233 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -101.4 101.67 12.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.807 -179.609 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.3 pt20 -62.91 144.02 57.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 109.118 179.534 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.476 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 1.5 mmt-85 -120.58 162.36 34.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.435 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.8 Cg_endo -76.7 73.49 5.24 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.611 2.207 . . . . 0.0 110.28 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.6 -179.681 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.66 14.12 3.59 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 18.8 mmtt -108.5 -176.92 3.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.236 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 156' ' ' LYS . 86.7 m-85 -156.4 159.09 38.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -127.69 111.7 13.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.99 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.533 ' HB1' ' CE2' ' A' ' 176' ' ' PHE . . . -79.17 124.43 28.33 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -148.17 140.64 24.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.992 . . . . 0.0 110.042 -179.337 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.534 HD12 ' CE ' ' A' ' 193' ' ' MET . 6.7 tt -128.41 137.41 57.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.424 -0.797 . . . . 0.0 109.121 179.735 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' O ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -80.28 142.99 34.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 -179.803 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 30.4 t0 -137.37 97.03 10.75 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.241 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.64 -24.37 10.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.322 2.014 . . . . 0.0 110.337 -179.917 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -11.75 58.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.859 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HG3' ' CG ' ' A' ' 163' ' ' ASP . 1.6 mtpt -105.84 40.57 1.55 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.63 45.97 3.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.434 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.77 84.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.78 120.77 13.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -1.088 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -63.82 157.26 25.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.148 -0.97 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 34.0 t -128.85 89.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.847 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.505 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 8.9 t-105 -72.1 93.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.185 179.712 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -52.07 -41.4 62.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.965 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.08 162.78 9.45 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 -179.648 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 1.2 p -76.14 -179.73 5.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.265 . . . . 0.0 109.393 -179.939 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 182' ' ' ALA . 78.4 m-85 -157.57 179.95 8.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.61 -25.47 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.453 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -142.98 165.43 27.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 109.562 -179.988 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.485 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -67.75 -22.64 65.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.45 -0.782 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -72.07 -39.48 68.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.841 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -73.18 -39.69 65.4 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.653 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -71.54 -32.71 68.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 -179.909 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.636 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -74.49 -37.02 63.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.205 -0.934 . . . . 0.0 108.852 179.71 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.7 tp -66.03 -43.47 87.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.701 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.7 -30.96 72.0 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.241 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 9.3 t80 -66.36 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.548 -0.72 . . . . 0.0 109.144 179.545 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 62.7 m-20 -60.0 -48.99 79.42 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.352 -0.842 . . . . 0.0 109.87 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -43.9 76.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 109.771 -179.753 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -75.26 -18.42 60.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.822 . . . . 0.0 109.454 -179.941 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.08 -8.66 48.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.561 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 4.5 t80 -105.8 -29.48 10.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -81.01 -40.3 24.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.508 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.534 ' CE ' HD12 ' A' ' 161' ' ' ILE . 27.0 mtp -75.11 -27.94 60.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.56 -0.713 . . . . 0.0 109.693 179.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -98.16 10.06 41.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.519 -179.806 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 73.15 -97.52 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.782 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.561 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 2.5 m -142.87 164.78 29.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -1.111 . . . . 0.0 109.482 -179.859 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 58.86 63.35 1.67 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 -179.808 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.19 171.52 8.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.397 -0.814 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.52 125.67 50.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.24 178.04 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 -179.789 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.448 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.2 OUTLIER -70.95 -31.96 68.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.061 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.4 m-85 -121.61 74.14 33.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.45 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 19.1 m-85 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 97.39 4.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.771 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.87 -21.39 7.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.725 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.3 t -89.55 126.06 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.252 . . . . 0.0 109.999 -179.66 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 tpp180 -97.65 147.07 24.7 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.951 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.3 pt20 -119.4 139.75 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 -179.392 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -105.3 155.91 37.09 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.145 179.672 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.47 6.17 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.577 2.185 . . . . 0.0 110.803 -179.742 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -106.11 -52.17 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.628 -179.986 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 152.79 56.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mtmt -155.26 -177.75 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.336 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 179' ' ' ALA . 62.8 m-85 -153.65 -171.77 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.93 110.92 2.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.457 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.56 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.36 114.41 18.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.261 -0.9 . . . . 0.0 109.078 179.734 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.516 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 1.6 mt-10 -130.83 151.35 51.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.312 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.446 HG21 ' HB ' ' A' ' 171' ' ' VAL . 2.6 tt -140.11 120.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.543 -179.82 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -61.12 140.77 57.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.304 179.867 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.414 ' CG ' ' CG ' ' A' ' 166' ' ' LYS . 30.9 t0 -118.99 100.94 50.53 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 -179.875 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -30.0 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.43 2.087 . . . . 0.0 110.463 179.842 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -10.13 59.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 16.1 mmtt -106.14 44.78 1.02 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 50.45 49.61 20.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.277 -179.797 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.19 99.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.954 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -159.56 111.16 2.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -1.099 . . . . 0.0 109.25 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -63.02 149.43 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.582 -179.716 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 161' ' ' ILE . 21.7 t -122.13 104.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 11.3 t-105 -77.47 95.88 4.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.2 mt -55.77 -54.9 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 162.46 158.69 9.77 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.937 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.9 p -72.75 154.39 40.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.568 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 53.7 m-85 -131.25 168.93 16.67 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -80.14 -24.75 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.669 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 181' ' ' ASP . 3.4 p -145.1 175.96 9.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -79.88 -24.75 40.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.76 -33.57 64.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.1 OUTLIER -79.72 -39.03 32.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.899 . . . . 0.0 109.288 179.945 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.32 -31.64 67.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 109.208 179.851 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -73.49 -39.72 64.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.235 -0.915 . . . . 0.0 108.959 179.721 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 22.8 tp -61.97 -42.62 99.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.824 . . . . 0.0 108.866 179.487 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.58 -31.35 72.0 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.8 t80 -62.33 -29.78 70.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 200' ' ' LEU . 13.1 m-20 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.1 -31.7 70.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 -179.841 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.474 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -83.15 -28.13 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -4.07 58.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.485 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -108.54 -34.34 6.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.296 179.859 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -81.96 -38.77 24.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.343 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.3 ttm -78.03 -31.13 50.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.639 -0.663 . . . . 0.0 109.798 179.91 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 195' ' ' GLY . 34.7 mtp85 -98.65 -16.3 19.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.116 -0.99 . . . . 0.0 109.165 -179.911 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 47.68 -176.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.795 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 195' ' ' GLY . 93.3 p 42.82 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -1.168 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.25 149.61 40.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' C ' HD22 ' A' ' 200' ' ' LEU . . . -149.09 157.11 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.54 118.01 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.972 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.87 -172.71 2.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.647 -179.675 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.483 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -80.22 -32.04 38.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 108.967 179.703 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.7 m-85 -125.61 68.37 60.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.531 -0.731 . . . . 0.0 109.602 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.8 Cg_endo . . . . . 0 C--N 1.311 -1.422 0 C-N-CA 122.808 2.338 . . . . 0.0 110.694 -179.845 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.502 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.9 m-85 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.19 85.14 2.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.66 -20.74 2.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.79 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 29.2 t -92.15 112.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.349 -1.089 . . . . 0.0 109.645 -179.847 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -93.12 79.49 4.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.765 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 6.7 pt20 -70.84 134.97 47.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.355 -0.841 . . . . 0.0 109.357 -179.871 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.551 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -89.08 -179.75 1.36 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.969 -1.082 . . . . 0.0 108.344 179.407 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -73.93 83.97 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.973 1.782 . . . . 0.0 110.18 -179.612 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.426 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 66.77 64.78 0.47 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.469 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.544 ' HA3' ' NE ' ' A' ' 152' ' ' ARG . . . -157.86 -111.83 0.33 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.75 -179.404 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.1 mtmm -110.52 -172.58 2.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.14 . . . . 0.0 110.976 -178.515 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.634 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 17.0 m-85 -140.59 131.07 25.35 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -104.33 112.84 26.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.885 -1.135 . . . . 0.0 110.752 -178.948 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -81.79 117.25 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.549 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.579 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 2.6 mt-10 -138.88 154.5 48.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.003 . . . . 0.0 109.68 -179.193 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 8.3 tt -133.07 164.47 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.742 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.487 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 2.5 tpp180 -101.01 119.65 39.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.963 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -120.83 93.04 48.6 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.33 -22.99 10.54 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.623 2.215 . . . . 0.0 110.342 179.984 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.58 60.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -90.38 33.24 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.91 25.57 15.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.557 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.38 97.96 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -161.81 97.9 1.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.4 mtt180 -45.56 155.63 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.949 . . . . 0.0 109.263 179.853 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.439 HG23 ' HE2' ' A' ' 193' ' ' MET . 54.9 t -128.15 100.75 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 10.1 t-105 -86.16 97.33 10.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 189' ' ' ALA . 15.1 mt -57.13 -46.59 82.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.508 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.25 155.93 7.17 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.3 p -68.93 178.8 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.164 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 175' ' ' THR . 67.1 m-85 -155.1 -171.51 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.924 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.43 ' O ' HG21 ' A' ' 178' ' ' THR . 5.8 mt-10 -97.32 -29.38 13.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.68 -179.846 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 13.3 p -142.53 -179.61 6.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 109.587 -179.797 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.558 ' CA ' ' CD2' ' A' ' 157' ' ' PHE . . . -78.96 -21.76 46.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.322 -0.862 . . . . 0.0 109.04 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -75.68 -36.79 59.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.91 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -73.27 -40.75 64.35 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.234 -0.916 . . . . 0.0 109.412 179.94 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 159' ' ' ALA . . . -67.78 -47.2 69.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' ND2' ' A' ' 201' ' ' ASN . . . -59.41 -40.13 85.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -49.74 76.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.525 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.66 -21.88 64.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.402 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -76.95 -28.44 55.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.801 . . . . 0.0 109.171 179.562 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.8 m-20 -69.12 -38.59 78.97 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 -179.573 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -69.31 -44.7 71.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.522 -179.088 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.517 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -70.16 -44.14 69.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.129 -179.25 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.538 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -64.82 -29.95 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.958 -179.412 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.41 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.4 t80 -75.56 -24.67 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.97 -1.081 . . . . 0.0 109.889 -179.623 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -82.27 -40.99 20.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.439 ' HE2' HG23 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -78.7 -27.65 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 110.497 -179.302 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -97.46 7.78 45.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.943 -1.098 . . . . 0.0 109.603 -179.751 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 68.06 -132.33 28.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.764 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -80.77 -177.22 6.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 -179.984 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.497 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 17.0 ttm180 52.77 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.497 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 59.05 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 199' ' ' LEU . 3.8 mp -106.76 122.08 45.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.24 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.5 161.63 26.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 1.2 m-80 -60.82 -31.49 70.9 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.246 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.0 m-85 -123.73 88.52 52.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.31 -1.455 0 C-N-CA 122.632 2.221 . . . . 0.0 110.742 -179.275 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 27.5 m-85 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.55 96.27 4.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.18 -18.43 6.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.865 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 65.6 t -99.62 127.62 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -1.171 . . . . 0.0 109.62 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 1.1 mtt85 -100.51 141.19 33.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.181 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -110.92 147.37 34.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 -179.314 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.469 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mtt180 -112.02 165.76 12.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.442 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.49 -29.56 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.546 2.164 . . . . 0.0 110.646 -179.898 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -73.14 -57.1 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.562 -179.957 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 53.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.459 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 12.6 mttm -144.86 171.52 14.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -1.176 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.557 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 50.3 m-85 -144.93 -173.75 4.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.628 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.17 112.85 2.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.696 179.88 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.34 126.76 34.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.09 150.33 36.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.625 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 189' ' ' ALA . 1.6 tt -142.46 139.2 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.879 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -72.4 135.76 45.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.415 ' HB2' HG22 ' A' ' 171' ' ' VAL . 37.3 t0 -130.08 96.54 25.21 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.593 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.87 -26.49 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.505 2.136 . . . . 0.0 110.287 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.78 -20.95 62.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.334 -0.853 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 16.6 mmtp -95.25 33.51 1.55 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.494 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 12.6 m120 66.5 49.3 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.313 -179.843 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.89 105.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.972 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -175.54 112.88 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -1.189 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -53.53 166.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 163' ' ' ASP . 43.2 t -137.33 94.57 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.628 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 5.4 t-105 -78.47 97.81 5.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.1 -46.82 78.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.538 -179.822 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.66 162.87 11.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.931 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -79.65 151.53 30.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.288 -179.853 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 85.9 m-85 -127.25 -175.85 3.56 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.14 -33.06 19.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.298 -179.418 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.524 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.5 p -137.31 179.51 6.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.035 -1.041 . . . . 0.0 110.028 -179.579 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.557 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -74.76 -27.39 60.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.152 179.744 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 11.1 tt0 -68.54 -70.82 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.471 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -37.85 -54.45 1.26 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.804 -0.56 . . . . 0.0 110.217 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -60.3 -41.34 93.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.037 -179.472 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 202' ' ' PHE . . . -61.98 -31.38 71.73 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -45.86 63.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.167 -0.958 . . . . 0.0 108.455 179.595 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.62 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -59.04 -25.58 63.83 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.722 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 21.2 t80 -74.21 -36.38 63.96 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 71.1 m-20 -64.54 -45.64 86.26 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.472 -0.767 . . . . 0.0 109.146 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -42.18 84.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 161' ' ' ILE . . . -77.37 -16.73 58.72 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.805 179.498 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.66 1.17 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.377 -0.827 . . . . 0.0 109.048 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -114.91 -37.6 4.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.71 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 42.5 mmt-85 -81.16 -39.44 25.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.078 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 193' ' ' MET . . . . . 0.416 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 40.8 ttm -75.05 -30.54 61.04 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.463 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.4 mtt180 -99.54 -10.28 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.27 -169.65 54.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.938 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' ARG . 1.4 t -54.6 150.69 9.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -1.085 . . . . 0.0 109.635 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 62.76 125.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.957 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 179.92 145.7 0.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 179.953 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.41 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -90.34 120.2 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.631 -179.773 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.21 -173.54 3.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.007 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.431 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -74.96 -35.89 62.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.087 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.4 m-85 -122.33 87.42 48.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.201 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.61 2.206 . . . . 0.0 110.755 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -134.99 78.02 1.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.922 . . . . 0.0 109.492 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.617 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 19.6 m-85 -48.38 150.6 1.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.84 82.24 5.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.561 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.56 -13.48 3.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 33.3 t -102.16 120.87 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 109.395 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -103.9 89.44 3.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.54 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -46.97 149.98 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.426 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 13.1 mmt180 -113.42 161.81 25.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.937 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.29 6.09 4.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.662 2.241 . . . . 0.0 110.584 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -114.18 -15.05 12.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 30.96 2.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 28.6 mmmt -120.35 -175.31 2.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.638 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 156' ' ' LYS . 88.2 m-85 -157.64 117.71 3.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.104 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -89.94 122.46 32.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -98.53 111.95 24.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.58 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 4.4 mt-10 -135.21 150.88 50.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.403 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -127.9 148.29 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 133.0 36.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.746 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 171' ' ' VAL . 43.2 t0 -126.65 94.5 40.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.436 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.83 -24.99 8.09 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.656 2.237 . . . . 0.0 110.575 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.37 -11.91 61.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -100.12 55.61 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 56.3 31.04 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.955 . . . . 0.0 109.592 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.22 67.96 1.85 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -124.69 -180.0 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -1.154 . . . . 0.0 109.375 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -111.32 156.13 22.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.53 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 163' ' ' ASP . 29.5 t -129.15 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 3.2 t-105 -79.58 102.23 8.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.482 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 7.9 mt -56.78 -55.51 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 109.331 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 159.53 153.32 6.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.0 p -65.99 166.68 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 69.2 m-85 -141.39 -177.33 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.466 ' C ' HG21 ' A' ' 178' ' ' THR . 22.9 tt0 -95.84 -30.25 13.77 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.307 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.553 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.6 p -136.68 167.07 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.268 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.512 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -71.45 -26.34 62.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.307 -0.871 . . . . 0.0 108.916 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.93 -35.27 69.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.285 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' CG ' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.12 -43.56 57.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.075 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.36 -23.78 61.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 108.916 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -76.59 -42.75 41.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.02 -38.81 92.68 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.82 -38.58 83.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 108.982 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.2 t80 -60.61 -39.24 87.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.456 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 1.2 m-20 -56.96 -44.1 82.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -0.815 . . . . 0.0 109.577 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -48.84 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.482 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -72.82 -15.45 61.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 0.0 109.847 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.527 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -91.45 -17.49 25.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.152 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 2.8 t80 -94.34 -31.29 14.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -46.72 26.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.6 ttm -65.54 -33.52 76.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.687 -0.633 . . . . 0.0 109.83 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.473 ' HG2' ' NH1' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -100.14 18.21 19.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 109.646 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 57.43 -99.43 0.1 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.51 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 0.5 OUTLIER -126.13 158.08 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -1.154 . . . . 0.0 109.717 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.57 91.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . -140.19 174.12 10.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.415 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.99 113.58 26.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.16 179.48 5.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.88 -35.16 64.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 4.9 m-85 -120.03 83.35 30.67 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.29 71.79 6.21 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.626 2.217 . . . . 0.0 110.465 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.51 -73.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -74.96 102.63 4.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.349 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.408 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.3 -165.0 0.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.524 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 27.8 m-85 -74.82 146.14 42.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.0 109.328 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.52 31.01 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.034 -1.041 . . . . 0.0 109.774 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.09 20.16 0.35 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' A' ' 182' ' ' ALA . 61.6 t -140.62 107.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -1.061 . . . . 0.0 109.37 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -85.06 110.6 19.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 108.678 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -75.95 156.01 34.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.567 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.425 ' HG3' ' C ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -109.56 158.54 34.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.83 . . . . 0.0 109.19 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.82 13.79 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.514 2.143 . . . . 0.0 111.024 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -120.33 -25.43 5.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.071 -1.018 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.53 33.84 0.59 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.425 ' C ' ' HG3' ' A' ' 152' ' ' ARG . 42.5 mttt -126.44 -169.24 1.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 178' ' ' THR . 58.6 m-85 -156.42 172.19 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.379 -0.825 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.591 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.08 116.99 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.063 -1.023 . . . . 0.0 110.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -87.17 119.77 27.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 108.605 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -144.3 147.01 32.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.515 HD13 ' NH1' ' A' ' 194' ' ' ARG . 8.8 tt -135.94 143.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 108.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -80.81 134.47 35.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.036 -1.04 . . . . 0.0 109.811 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -122.94 103.6 36.62 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.391 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 -29.95 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.448 2.099 . . . . 0.0 110.594 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.66 -26.69 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.641 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -91.4 37.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.24 50.23 18.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.64 80.09 0.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -132.37 95.51 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.3 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -44.28 133.0 5.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 43.7 t -109.92 103.18 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.439 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.591 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.0 t-105 -93.68 97.31 10.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -54.3 -49.0 70.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.061 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.54 159.53 8.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -76.99 144.08 38.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.647 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 61.4 m-85 -118.01 178.26 4.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.456 -0.778 . . . . 0.0 109.21 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.6 mm-40 -88.24 -25.55 22.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 110.012 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.566 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.8 p -141.17 178.17 7.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.514 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -80.38 -23.17 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.385 -0.822 . . . . 0.0 109.19 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 13.6 tt0 -74.93 -36.81 62.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.455 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.84 -43.91 43.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.609 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -67.25 -37.88 84.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.346 -0.846 . . . . 0.0 109.045 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.532 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -61.25 -44.88 96.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.426 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.7 -18.72 62.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 108.894 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 11.6 t80 -76.22 -31.58 58.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.002 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 200' ' ' LEU . 15.2 m-20 -68.38 -51.09 47.95 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.545 -0.722 . . . . 0.0 109.798 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -27.52 69.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.438 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -86.15 -23.03 26.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.302 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.49 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.18 -15.63 35.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.37 -0.831 . . . . 0.0 109.124 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.4 OUTLIER -92.81 -32.13 14.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -78.8 -40.58 32.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.02 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.1 tpp -70.34 -30.93 68.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 0.0 109.581 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.515 ' NH1' HD13 ' A' ' 161' ' ' ILE . 1.5 mpt_? -91.62 -12.67 33.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 196' ' ' SER . . . 62.57 81.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.574 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 3.3 m 61.01 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -1.161 . . . . 0.0 109.69 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 61.76 120.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.922 . . . . 0.0 109.632 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 173.31 153.59 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.04 118.6 35.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.02 -177.41 4.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.499 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -72.8 -34.36 66.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.532 ' CD2' HD21 ' A' ' 184' ' ' LEU . 2.2 m-85 -128.66 76.52 78.62 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' LEU . 35.1 Cg_endo -76.54 72.11 5.7 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.722 2.281 . . . . 0.0 110.66 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 205' ' ' ARG . 0.7 OUTLIER 42.3 30.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 206' ' ' VAL . 0.0 OUTLIER 166.09 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 109.222 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.518 ' N ' ' HG2' ' A' ' 205' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.8 mttt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER 62.18 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.362 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 18.6 m-85 -105.85 140.28 39.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.09 88.19 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 124.77 26.29 1.43 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.7 t -140.35 109.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -1.106 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -95.46 93.77 7.41 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.224 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 157' ' ' PHE . 44.0 tt0 -52.05 167.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.418 ' N ' ' CG ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -129.69 158.91 72.15 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.335 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.57 4.32 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.625 2.216 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CD1' ' O ' ' A' ' 154' ' ' TRP . 50.0 t-105 -113.25 -7.77 13.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.52 22.6 8.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -115.09 174.08 6.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.596 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 151' ' ' GLN . 79.6 m-85 -146.91 152.98 39.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.032 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -121.85 117.45 26.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.873 -1.142 . . . . 0.0 109.653 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE2' ' A' ' 176' ' ' PHE . . . -91.89 111.07 22.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.435 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -130.22 145.87 51.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.063 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.51 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 14.9 tt -124.15 154.7 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.61 136.32 34.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.418 ' HB2' HG22 ' A' ' 171' ' ' VAL . 44.0 t0 -146.16 93.05 5.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.669 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.16 -23.42 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.635 2.223 . . . . 0.0 110.281 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.48 -11.52 24.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.821 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 13.2 mtpt -100.87 35.67 2.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 1.6 t-20 70.39 47.22 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.66 89.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -163.71 136.1 5.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -71.82 178.68 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.497 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 23.2 t -138.51 81.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.581 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 9.2 t-105 -61.87 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.506 ' CD2' ' CB ' ' A' ' 189' ' ' ALA . 26.6 mt -51.7 -34.87 40.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.127 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 137.33 155.22 6.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 5.8 p -68.24 -177.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.323 -1.104 . . . . 0.0 109.383 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 175' ' ' THR . 74.2 m-85 -157.54 177.94 10.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -88.84 -26.91 21.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.655 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.7 p -140.83 175.59 9.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.545 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -80.44 -21.07 42.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.284 -0.885 . . . . 0.0 109.2 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -76.31 -37.55 57.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.35 -36.06 63.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.167 -0.958 . . . . 0.0 109.027 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . . . -72.72 -39.76 66.67 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.038 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.619 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -66.3 -39.53 89.39 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.0 108.734 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.0 tp -64.56 -42.7 95.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.53 -24.15 67.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.2 t80 -76.04 -28.79 57.81 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.482 -0.761 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.3 m-20 -74.48 -47.55 32.66 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -62.43 -31.61 72.34 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.506 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -88.54 -20.59 24.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.024 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.1 -1.96 58.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -107.97 -35.42 6.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.906 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -76.81 -39.77 50.27 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 27.7 ttm -76.6 -36.94 57.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.64 -0.662 . . . . 0.0 109.978 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -77.73 -18.36 56.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.965 . . . . 0.0 109.18 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.16 -127.79 9.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 197' ' ' ARG . 13.8 m -63.96 -148.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 110.053 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 196' ' ' SER . 1.8 ttm180 -39.99 139.72 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 110.033 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.78 -175.88 4.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.143 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.23 121.36 43.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.497 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -131.69 152.42 50.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -33.04 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.3 m-85 -117.44 94.19 44.85 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.59 78.54 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.432 2.088 . . . . 0.0 110.374 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.15 125.83 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.406 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.413 ' C ' HG22 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -139.92 57.74 1.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.409 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.413 HG22 ' C ' ' A' ' 205' ' ' ARG . 2.5 t . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.39 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.307 0.575 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.1 133.76 0.53 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.628 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.577 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 12.7 m-85 -103.81 157.49 17.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.43 81.84 3.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 108.917 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.67 19.79 2.0 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 44.4 t -133.21 129.51 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.259 . . . . 0.0 109.198 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 112.36 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.579 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.1 pt20 -80.17 157.18 26.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -125.75 159.13 62.63 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 109.698 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 3.4 7.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.571 2.181 . . . . 0.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -101.22 -19.21 15.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.51 39.79 1.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 35.1 mttt -145.56 166.1 26.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.427 -1.043 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.611 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 23.8 m-85 -133.65 178.54 6.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.36 112.74 6.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.704 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -88.49 108.17 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -129.4 158.42 39.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.356 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.8 tt -139.72 139.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -80.72 128.72 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.902 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -114.78 95.74 42.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -23.27 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.613 2.208 . . . . 0.0 110.617 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.65 -7.1 30.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.185 -0.947 . . . . 0.0 109.687 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -119.09 57.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.1 m120 49.49 26.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.91 99.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -142.62 105.34 4.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 109.248 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.01 141.94 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 38.2 t -122.81 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.574 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 5.6 t-105 -73.7 96.49 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.786 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 189' ' ' ALA . 30.3 mt -56.04 -46.99 78.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.33 154.53 6.59 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.9 p -70.33 161.25 30.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -1.107 . . . . 0.0 109.356 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 65.2 m-85 -136.16 178.72 6.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.414 ' C ' HG21 ' A' ' 178' ' ' THR . 23.7 mp0 -84.15 -31.25 25.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.459 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.8 p -142.06 170.33 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -70.23 -22.42 62.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.106 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.88 -42.59 63.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -68.29 -43.45 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.862 . . . . 0.0 109.606 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.67 -45.76 85.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . . . -58.8 -38.93 79.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.63 -51.52 68.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 109.125 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.532 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.49 -20.25 65.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 108.815 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -79.27 -28.47 42.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.445 -0.785 . . . . 0.0 109.41 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.485 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 9.4 m-20 -72.34 -35.47 68.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.701 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -76.19 -40.04 53.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.502 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -73.89 -30.02 62.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.467 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.87 -23.62 33.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.837 . . . . 0.0 109.4 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.51 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 28.7 t80 -83.74 -22.34 31.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 108.974 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -78.86 -38.49 37.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.638 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.1 ttm -80.15 -43.12 22.17 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 0.0 110.173 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.519 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 12.2 mtt180 -92.57 -38.34 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.828 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 63.11 161.43 0.28 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 197' ' ' ARG . 22.5 p 50.53 -176.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -1.097 . . . . 0.0 109.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.5 mtm180 -43.7 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.519 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . -119.27 35.99 4.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 198' ' ' ALA . 5.0 mt 39.35 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.485 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -118.18 149.77 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.972 . . . . 0.0 109.353 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -49.18 -37.31 22.17 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.9 m-85 -120.81 83.22 36.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 200' ' ' LEU . 36.2 Cg_endo -79.96 57.91 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.905 2.403 . . . . 0.0 110.594 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 203' ' ' PRO . 16.7 mt -151.73 172.29 16.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.114 -0.991 . . . . 0.0 109.294 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.532 ' O ' ' CG1' ' A' ' 206' ' ' VAL . 0.7 OUTLIER -59.57 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 205' ' ' ARG . 9.5 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -127.49 156.95 41.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.82 . . . . 0.0 109.159 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 68.6 m-85 -71.18 159.57 34.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.59 35.02 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.184 -0.948 . . . . 0.0 110.15 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.431 ' O ' HG21 ' A' ' 149' ' ' VAL . . . -171.78 26.24 0.09 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 183' ' ' ALA . 96.7 t -150.27 117.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.417 -1.049 . . . . 0.0 109.185 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.541 ' CG ' ' HB1' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -99.09 137.13 38.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.104 -0.997 . . . . 0.0 109.09 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.6 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -103.11 155.62 18.27 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.265 -0.897 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.69 161.02 55.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.815 . . . . 0.0 109.38 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.85 -8.41 16.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.513 2.142 . . . . 0.0 109.964 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.59 -1.41 57.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.5 56.27 2.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.4 mttt -159.27 171.27 20.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.788 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.6 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 36.2 m-85 -142.17 -177.68 5.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -152.49 116.92 4.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.779 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -89.23 118.35 28.85 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 109.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 5.6 mt-10 -137.82 177.57 7.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.1 tt -164.72 142.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.909 -1.119 . . . . 0.0 109.939 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -69.5 134.17 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.045 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 171' ' ' VAL . 11.2 t0 -113.14 98.07 44.7 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 0.0 109.62 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.12 -22.07 10.17 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.535 2.157 . . . . 0.0 110.28 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.25 67.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.296 -0.878 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -104.98 32.5 4.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.72 58.52 4.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 82.09 -127.56 8.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 67.18 87.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -53.5 134.83 40.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 163' ' ' ASP . 70.3 t -102.01 105.8 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 108.962 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.578 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 9.4 t-105 -87.49 93.9 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.031 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 189' ' ' ALA . 3.7 mt -53.55 -48.69 68.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.0 108.998 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 153.62 162.23 10.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.29 160.84 30.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -1.141 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -134.75 -176.5 4.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 0.0 109.608 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -90.58 -28.2 18.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.638 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.542 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p -146.5 172.18 13.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -70.61 -24.36 62.72 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.127 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -73.81 -36.37 64.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.2 OUTLIER -72.03 -47.05 54.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -65.65 -32.15 73.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.589 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -70.2 -37.62 75.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.135 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.97 -47.56 77.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 108.86 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.571 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.25 -22.11 66.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 183' ' ' ALA . 28.9 t80 -69.79 -36.28 75.57 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 9.7 m-20 -63.57 -54.33 37.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.395 -0.815 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -55.68 -29.68 59.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.26 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.528 ' HB3' ' CD2' ' A' ' 173' ' ' LEU . . . -85.11 -24.64 27.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.084 . . . . 0.0 110.06 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.94 -14.91 37.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.995 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.548 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.4 t80 -96.25 -25.33 15.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.17 -0.956 . . . . 0.0 108.853 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.34 -38.79 34.31 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.2 tpp -79.59 -42.13 25.63 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.383 0.611 . . . . 0.0 109.749 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 9.7 mtp180 -97.73 -41.27 8.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 109.629 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 43.24 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 197' ' ' ARG . 0.6 OUTLIER 45.87 50.62 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -1.12 . . . . 0.0 109.828 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 70.46 118.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -138.96 174.21 10.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.335 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 108.07 19.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.522 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -122.0 -175.91 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.562 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -84.6 -33.52 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 6.2 m-85 -121.02 77.49 31.5 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HA ' HD13 ' A' ' 200' ' ' LEU . 34.6 Cg_endo -77.41 179.94 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.686 2.257 . . . . 0.0 110.507 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.34 142.8 37.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -56.35 -30.49 62.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.511 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -55.2 176.48 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 30.4 m-85 -130.69 154.27 48.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.303 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.89 83.6 2.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.57 -22.2 3.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.7 t -90.48 116.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -1.15 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -105.48 120.21 41.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.575 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 pp0? -85.54 163.8 18.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.881 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -131.66 165.73 33.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.452 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.0 Cg_endo -78.39 -4.09 13.92 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.683 2.255 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -91.96 -18.03 24.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.007 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.86 35.84 2.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -137.16 -175.59 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 0.0 109.634 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 36.2 m-85 -144.83 -173.37 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.59 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -154.01 108.32 3.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.213 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -82.73 119.41 24.29 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.563 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 10.6 mt-10 -134.89 179.65 6.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.084 -1.01 . . . . 0.0 109.365 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -174.76 141.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.43 136.76 39.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' CA ' ' A' ' 168' ' ' GLY . 10.5 t0 -111.47 101.02 49.8 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -24.02 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 110.308 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.85 -37.0 75.99 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 14.2 mttt -98.33 59.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 8.6 p30 41.36 48.02 3.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.438 -0.789 . . . . 0.0 109.797 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 163' ' ' ASP . . . 75.48 -114.68 4.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 168' ' ' GLY . . . 63.27 95.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 169' ' ' ALA . 7.7 ptt180 -45.28 157.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.675 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 41.1 t -129.29 93.02 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.59 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 13.5 t-105 -79.59 93.19 5.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.12 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -53.47 -40.18 65.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.485 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 148.25 -171.93 28.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -103.39 154.94 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -1.162 . . . . 0.0 109.028 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 67.0 m-85 -130.1 165.28 22.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.464 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.7 OUTLIER -77.71 -17.87 57.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.096 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.517 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.9 p -153.56 162.36 41.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.545 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -66.63 -23.28 66.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.309 -0.869 . . . . 0.0 109.405 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.0 -39.72 65.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.501 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.453 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.8 OUTLIER -72.04 -40.49 68.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.572 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -70.83 -32.13 69.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.592 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -71.47 -41.15 69.73 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.75 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.32 -46.91 88.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.34 -22.88 63.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 108.845 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.0 t80 -72.48 -30.74 64.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 38.5 m-20 -69.34 -50.48 45.97 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.36 -0.837 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -54.95 -38.02 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.918 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.02 -30.15 49.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -82.64 -2.8 55.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.383 -0.823 . . . . 0.0 109.385 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' GLY . 37.3 t80 -99.45 -40.67 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.149 -0.97 . . . . 0.0 108.918 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -64.34 -49.12 72.94 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -40.38 95.22 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 195' ' ' GLY . 60.3 mtt180 -105.31 36.52 2.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 108.962 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -34.69 147.72 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.2 t 80.91 102.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.56 -0.965 . . . . 0.0 109.402 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.496 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 49.8 ttm-85 64.71 -96.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.407 -0.808 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.496 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 63.08 145.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.005 -1.06 . . . . 0.0 109.401 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 122.46 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.23 152.53 38.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -0.919 . . . . 0.0 109.24 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -48.5 -37.16 16.78 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.9 m-85 -120.19 92.31 47.0 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.66 160.91 34.36 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.631 2.221 . . . . 0.0 110.916 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mt -149.28 -161.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.9 162.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.343 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 145' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 32.9 t-80 176.39 125.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.599 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.635 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.8 m-85 -107.64 158.41 17.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.412 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 86.41 3.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.832 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.41 -19.78 5.62 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.494 ' CG2' ' HB2' ' A' ' 146' ' ' TYR . 44.1 t -90.0 114.58 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.667 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -100.08 113.92 26.88 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.459 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 12.0 pt20 -78.62 154.57 30.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.311 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.493 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -118.42 174.43 2.67 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -77.68 -48.07 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.632 2.221 . . . . 0.0 110.507 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -62.51 1.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.65 52.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -141.48 173.44 11.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.674 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.459 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 74.8 m-85 -139.15 175.37 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.64 110.27 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.558 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.56 124.2 28.76 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -146.03 160.29 42.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.788 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.45 HD11 ' HE1' ' A' ' 193' ' ' MET . 3.4 tt -149.47 147.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.859 . . . . 0.0 109.181 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.441 ' NH2' ' HG2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -96.94 137.15 36.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.99 . . . . 0.0 109.614 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.444 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 44.5 t0 -122.23 114.45 30.59 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.361 -0.837 . . . . 0.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.71 -35.05 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.324 2.016 . . . . 0.0 110.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.61 64.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.105 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -93.89 39.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.42 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.36 30.98 13.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.76 62.59 5.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.44 33.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.491 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -84.64 161.93 19.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.632 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.6 t -137.3 94.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.432 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 7.3 t-105 -79.3 100.36 7.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 2.2 mt -59.47 -43.12 93.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 146.26 157.02 7.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -76.26 151.06 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.169 . . . . 0.0 109.432 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.608 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 58.9 m-85 -123.38 -176.25 3.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -87.59 -31.98 19.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.5 p -139.29 176.27 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.193 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.457 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -76.26 -26.06 55.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.3 -37.37 71.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -72.97 -39.57 66.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.552 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -72.97 -26.52 61.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.327 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.635 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -77.21 -39.28 49.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.136 -0.978 . . . . 0.0 109.013 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 1.1 tm? -63.75 -43.07 97.54 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 108.838 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.608 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.72 -29.45 69.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -66.31 -32.18 73.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 0.0 109.14 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 3.6 m-20 -65.93 -49.6 67.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.09 -29.71 67.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.005 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.449 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -85.48 -24.28 27.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.821 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.69 -6.53 58.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.613 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 196' ' ' SER . 2.1 t80 -104.01 -37.47 7.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.44 -40.99 56.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.273 -0.892 . . . . 0.0 109.163 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.45 ' HE1' HD11 ' A' ' 161' ' ' ILE . 2.0 mtm -71.94 -30.79 65.69 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.563 -0.711 . . . . 0.0 110.067 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -92.75 -6.4 49.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.84 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.0 -104.23 3.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.581 ' O ' ' CZ ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -108.02 -78.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.981 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.83 122.79 15.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.881 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -156.54 162.4 39.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.158 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.55 124.77 52.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -123.61 173.19 8.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.222 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.463 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.5 OUTLIER -74.66 -28.73 60.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 4.0 m-85 -125.24 67.25 54.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.545 -0.722 . . . . 0.0 109.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.463 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.8 Cg_endo -77.25 73.25 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.553 2.169 . . . . 0.0 109.876 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 -73.68 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.948 . . . . 0.0 110.242 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.73 -165.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.14 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.386 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.527 ' CE1' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -150.66 -175.71 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.559 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 17.8 m-85 -67.29 127.53 33.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 109.586 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 87.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 125.8 28.29 1.07 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.8 t -142.41 123.05 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.094 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 85.62 2.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.585 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 1.3 pp0? -59.49 144.39 47.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.511 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 159.79 34.71 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.23 18.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.742 2.295 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.35 -39.99 2.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.44 46.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HD2' ' HB ' ' A' ' 175' ' ' THR . 34.9 ttpt -147.18 147.93 31.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -1.165 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.585 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 16.4 m-85 -133.79 130.46 38.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.581 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -99.32 108.93 21.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.082 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.543 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.11 109.21 18.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.224 -0.923 . . . . 0.0 108.585 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.496 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 1.8 mp0 -132.53 141.54 48.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.12 -0.987 . . . . 0.0 109.668 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.7 131.89 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.798 . . . . 0.0 109.269 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.73 122.98 24.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.683 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -113.87 108.39 51.22 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.858 . . . . 0.0 109.313 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 -27.62 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.387 2.058 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.31 75.29 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -95.9 40.56 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.463 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 4.9 m-20 69.56 46.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.506 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.35 29.79 1.82 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.96 123.05 20.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -1.122 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.04 130.16 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.489 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.75 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.581 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 9.3 t-105 -74.65 94.17 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.372 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 39.4 mt -54.24 -41.63 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 145.15 155.01 6.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 2.3 p -68.04 179.77 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 75.1 m-85 -154.62 -174.23 4.89 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.396 -0.815 . . . . 0.0 109.343 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.38 -25.37 13.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.578 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.8 p -142.7 170.85 14.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.551 ' CA ' ' CD2' ' A' ' 157' ' ' PHE . . . -74.68 -23.9 58.7 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.157 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -34.03 61.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.2 OUTLIER -74.79 -39.97 61.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 109.019 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.468 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -70.48 -35.63 73.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -70.54 -40.64 73.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.996 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.1 -43.66 97.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.48 -24.0 63.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.539 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 7.2 t80 -69.37 -30.08 67.99 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -49.11 50.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.491 -0.756 . . . . 0.0 109.046 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -54.11 -39.27 66.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.687 . . . . 0.0 109.608 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.539 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -79.61 -27.62 41.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.7 -4.1 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.19 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 10.0 t80 -103.79 -23.82 13.37 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -81.55 -36.41 29.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.6 tpp -81.05 -44.07 18.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.785 -0.572 . . . . 0.0 109.91 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.7 mtt180 -85.3 -33.35 22.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.175 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 62.47 127.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 195' ' ' GLY . 69.6 m 61.56 142.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -1.104 . . . . 0.0 110.34 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 2.4 tpp180 43.06 -96.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.49 -0.756 . . . . 0.0 110.376 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 65.29 168.7 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.152 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 200' ' ' LEU . 0.1 OUTLIER -106.0 109.85 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.599 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.439 ' N ' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.75 159.41 32.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.464 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -68.66 -30.55 69.26 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.0 m-85 -122.49 86.36 48.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.22 -177.07 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.707 2.271 . . . . 0.0 110.669 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.71 38.39 3.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.474 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -147.44 96.77 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.534 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 145' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.241 0.544 . . . . 0.0 109.573 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.484 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.8 m170 73.24 102.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.64 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 28.1 m-85 -85.67 146.6 26.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 99.85 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.09 -33.25 4.28 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 146' ' ' TYR . 52.1 t -75.3 134.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -1.19 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.18 106.69 11.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.061 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -77.12 163.21 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -120.8 175.99 2.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.412 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.39 -23.43 8.67 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.744 2.296 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -84.25 -56.03 3.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.62 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.02 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.2 157.88 41.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -1.125 . . . . 0.0 109.138 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 13.7 m-85 -126.1 -178.43 4.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 109.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.615 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.97 108.19 4.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 110.345 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.69 107.57 13.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.42 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -130.29 146.05 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 189' ' ' ALA . 14.5 tt -135.12 156.44 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.291 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.05 132.78 33.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -132.17 102.55 14.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.303 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 -26.67 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.442 2.094 . . . . 0.0 109.961 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.52 64.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 35.9 mttm -90.03 26.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 3.7 t-20 75.11 43.99 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.38 48.48 80.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.02 147.32 42.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -1.153 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -76.81 154.95 33.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 171' ' ' VAL . 9.0 t -122.12 85.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.615 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 6.5 t-105 -73.86 96.46 2.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 108.882 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 189' ' ' ALA . 7.6 mt -52.94 -48.59 67.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.132 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 150.43 152.29 5.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.5 p -65.55 171.14 4.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.173 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 61.6 m-85 -144.95 -176.49 5.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -89.42 -29.58 18.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.5 p -143.06 171.18 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.572 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -71.62 -28.11 63.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -69.46 -33.75 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -76.36 -41.11 49.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 109.031 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.58 -23.12 61.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.852 . . . . 0.0 109.081 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.64 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -80.24 -42.52 23.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 108.86 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -36.22 83.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.14 -29.78 65.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 17.7 t80 -64.83 -37.43 87.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.504 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 14.2 m-20 -63.39 -47.09 83.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.512 -0.742 . . . . 0.0 109.336 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -53.04 -42.37 65.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.52 ' HB3' ' CD2' ' A' ' 173' ' ' LEU . . . -82.02 -17.92 45.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.7 -5.09 56.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.189 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 5.6 t80 -102.8 -33.73 9.26 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -77.23 -41.36 41.47 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.39 -29.27 63.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 109.343 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.6 mtt-85 -104.66 9.79 35.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.67 -162.79 14.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 59.0 p -61.49 161.56 9.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -1.101 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 54.94 104.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.551 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -151.58 172.98 15.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 109.163 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.415 ' C ' ' CD1' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -107.43 112.89 25.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.72 179.44 4.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 109.31 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.464 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -74.53 -30.59 61.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 108.422 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.3 m-85 -126.1 67.0 61.52 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.589 -0.694 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.46 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo -76.53 159.11 35.99 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.609 2.206 . . . . 0.0 110.304 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.59 89.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.65 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -160.31 129.94 5.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 -179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -118.92 105.87 11.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.646 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.0 m-85 -101.11 159.11 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -80.71 99.08 8.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.668 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 160' ' ' GLU . . . 115.92 -9.72 18.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 89.7 t -100.88 112.61 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.034 -1.274 . . . . 0.0 109.79 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.1 ttm-85 -91.83 94.12 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.108 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.564 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -71.57 134.94 46.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.85 160.65 34.31 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.85 -2.55 12.53 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.71 2.273 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -109.73 19.95 18.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.661 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.16 68.03 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.527 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -162.01 133.47 5.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 108.797 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 5.3 m-85 -132.51 137.27 47.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -0.945 . . . . 0.0 109.115 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.637 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -107.26 116.76 32.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.002 -1.061 . . . . 0.0 110.357 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -89.39 114.12 25.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 148' ' ' GLY . 2.5 mp0 -130.61 155.57 46.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.403 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.475 ' CG2' ' HE3' ' A' ' 193' ' ' MET . 8.9 tt -139.06 125.77 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -82.03 117.55 22.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.52 108.94 58.31 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.23 -33.08 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.381 2.054 . . . . 0.0 110.288 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.28 65.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -89.46 39.54 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.428 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.4 m120 46.57 50.17 13.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.594 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.15 88.69 0.03 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -146.85 89.04 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -1.157 . . . . 0.0 109.741 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -49.18 145.23 4.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.326 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.55 86.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.691 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.637 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 5.6 t-105 -67.21 97.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 108.91 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.498 HD13 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -53.98 -42.42 68.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.859 . . . . 0.0 109.606 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.48 155.53 6.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.7 p -67.77 -176.59 0.67 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -1.141 . . . . 0.0 109.302 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 71.0 m-85 -156.75 -168.52 2.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 109.397 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.57 -25.88 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.456 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.57 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.1 p -141.49 174.54 10.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.476 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -79.85 -24.42 41.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -35.08 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.455 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.1 OUTLIER -77.79 -39.32 44.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.91 -41.93 61.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 108.853 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.59 -40.58 95.3 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.67 -25.83 64.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.454 ' HA ' HD12 ' A' ' 173' ' ' LEU . 15.2 t80 -68.15 -41.09 82.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 25.5 m-20 -61.1 -50.1 74.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.224 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -48.27 -39.5 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.557 -0.714 . . . . 0.0 110.128 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 173' ' ' LEU . . . -81.9 -26.16 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.966 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.15 7.36 32.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.041 -1.037 . . . . 0.0 109.143 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 10.0 t80 -111.94 -33.8 6.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -43.06 32.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.475 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -75.62 -29.73 59.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.319 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -95.51 5.41 51.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.907 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 85.37 -89.51 1.61 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 45.0 t -138.76 -80.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -1.208 . . . . 0.0 109.879 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 111.79 1.01 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.408 ' C ' HD22 ' A' ' 200' ' ' LEU . . . -150.49 170.01 20.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.83 107.99 20.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.453 ' HB3' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -115.42 157.87 23.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.189 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.441 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -61.19 -31.72 71.48 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 4.8 m-85 -121.97 83.92 44.42 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 145.14 24.59 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.301 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 78.2 mt -68.85 -92.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 205' ' ' ARG . 17.4 mmm180 52.65 -154.33 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.532 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.447 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.95 155.24 38.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.535 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 19.2 m-85 -59.19 169.43 1.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -82.45 83.32 7.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.878 . . . . 0.0 109.199 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.96 6.15 5.51 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 95.8 t -119.69 118.14 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -1.233 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.2 ttp180 -88.24 115.0 25.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -83.38 152.3 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.751 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.516 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.3 mtm105 -137.5 175.42 3.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -0.819 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 34.9 Cg_endo -77.44 159.13 32.67 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.5 2.134 . . . . 0.0 110.019 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.568 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 8.2 t-105 83.77 -60.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.41 54.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -132.88 154.11 50.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -1.185 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.551 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 74.4 m-85 -142.43 179.17 7.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.45 113.94 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.061 -1.024 . . . . 0.0 110.017 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.536 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -88.31 121.74 31.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.377 -0.827 . . . . 0.0 108.974 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -146.17 151.34 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.148 -0.97 . . . . 0.0 109.313 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.9 tt -129.83 124.3 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 124.28 22.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.43 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.19 96.92 50.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.72 -22.67 10.26 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.611 2.207 . . . . 0.0 110.223 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.29 -3.85 19.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.349 -0.844 . . . . 0.0 109.703 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 1.0 OUTLIER -122.38 27.59 7.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 75.19 58.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.095 -1.003 . . . . 0.0 109.626 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.9 39.69 6.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -84.44 93.32 8.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -1.209 . . . . 0.0 109.285 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -50.01 142.47 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.452 ' HB ' HG21 ' A' ' 161' ' ' ILE . 31.4 t -116.3 86.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 109.194 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.7 t-105 -75.62 96.12 3.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.539 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 4.3 mp -54.45 -42.88 71.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.62 152.42 5.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.6 p -68.35 164.44 20.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.443 -1.033 . . . . 0.0 109.44 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.4 m-85 -138.41 -169.88 2.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.491 ' HG2' ' OD2' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -96.93 -30.87 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p -136.59 -179.62 5.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.85 -1.157 . . . . 0.0 110.247 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -76.49 -32.38 58.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 8.0 tt0 -66.23 -70.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.497 ' OD1' ' OG1' ' A' ' 178' ' ' THR . 0.0 OUTLIER -38.79 -59.97 0.89 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.623 . . . . 0.0 110.166 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -55.6 -38.44 69.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 202' ' ' PHE . . . -64.08 -34.63 78.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.136 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -38.42 80.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.915 -1.115 . . . . 0.0 109.44 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.551 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.06 -32.39 73.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.84 . . . . 0.0 108.911 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.0 t80 -67.17 -33.85 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 109.523 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.465 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 29.4 m-20 -64.25 -44.91 90.33 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -62.66 -32.88 74.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.79 . . . . 0.0 110.408 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.539 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -83.47 -24.65 31.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.101 -1.0 . . . . 0.0 109.853 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.65 -12.64 53.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.8 t80 -99.56 -40.47 7.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.016 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.14 -39.9 96.01 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.9 tpp -74.92 -55.32 5.91 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.558 0.694 . . . . 0.0 109.569 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.7 mtt180 -88.95 -55.74 3.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 0.0 109.685 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 57.28 170.15 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER 56.25 81.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.522 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.42 100.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.896 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 200' ' ' LEU . . . -133.56 176.7 8.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 200' ' ' LEU . 8.1 mp -95.85 109.3 21.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -130.49 143.17 50.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.117 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.413 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -51.89 -32.11 31.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 4.9 m-85 -124.13 89.53 51.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.447 ' HA ' ' CD1' ' A' ' 200' ' ' LEU . 34.0 Cg_endo -75.93 99.21 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.462 2.108 . . . . 0.0 110.435 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mp 47.86 -167.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.283 -0.886 . . . . 0.0 109.208 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 -75.64 0.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.333 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.343 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 145' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 11.4 t-160 63.97 113.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.589 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 36.8 m-85 -104.81 152.43 22.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 89.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.66 -28.19 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 50.6 t -85.86 118.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -1.177 . . . . 0.0 109.61 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.53 116.81 33.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 108.994 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.51 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 4.4 pt20 -81.58 157.25 24.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.931 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.489 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.3 mtt-85 -122.46 160.36 48.61 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -76.84 -8.54 17.97 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.514 2.143 . . . . 0.0 110.162 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.89 -27.14 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.3 34.46 0.95 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 11.8 mtpp -132.06 176.97 7.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -1.157 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.58 ' CE2' ' HB1' ' A' ' 179' ' ' ALA . 64.3 m-85 -145.45 177.24 8.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.29 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.13 108.35 3.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.866 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.55 107.21 13.16 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -129.6 151.98 49.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.304 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 162' ' ' ARG . 3.0 tt -141.61 149.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 161' ' ' ILE . 5.6 ttp85 -86.51 144.76 27.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -137.6 99.35 9.52 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.11 -25.63 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.015 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.83 -13.38 32.98 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -104.83 43.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.74 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 23.0 m120 59.38 59.28 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.13 79.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.08 148.91 42.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.384 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.5 mtt-85 -86.15 167.04 15.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.53 100.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.102 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.0 t-105 -85.95 106.3 17.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.4 mt -64.56 -49.61 70.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 153.75 158.13 8.45 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -78.03 155.59 30.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -1.145 . . . . 0.0 109.076 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 66.6 m-85 -130.5 173.8 10.5 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.42 -31.77 42.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.935 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.436 HG22 ' OD2' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -141.03 172.55 12.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.58 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -72.48 -22.54 61.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.474 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -72.76 -38.55 67.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -74.3 -44.92 50.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.589 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -62.72 -44.76 95.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.394 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.589 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -58.43 -43.29 88.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.089 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.36 -51.66 68.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.865 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.95 -23.15 66.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.4 t80 -72.96 -31.88 64.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 109.503 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 26.8 m-20 -70.93 -50.28 36.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -37.45 47.66 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.676 -0.64 . . . . 0.0 109.985 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.1 -23.49 23.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.83 7.69 45.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -118.83 -37.61 3.22 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -81.5 -38.87 25.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -79.07 -32.86 44.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.718 -0.614 . . . . 0.0 109.727 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -91.74 -17.88 24.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.219 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 41.98 -156.94 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.0 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.173 . . . . 0.0 109.545 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -56.05 -58.3 8.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.606 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.29 177.81 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.169 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.403 ' C ' HD21 ' A' ' 200' ' ' LEU . 11.0 mt -140.89 122.5 15.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.541 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -123.32 154.37 38.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 109.377 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.3 OUTLIER -56.06 -33.68 65.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.39 80.27 37.44 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.76 96.32 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -108.21 -148.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.48 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 3.0 mtp180 -100.98 -179.64 4.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 5.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.351 0.596 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 146' ' ' TYR . 27.9 p-80 -99.83 168.67 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.561 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 17.4 m-85 -89.09 161.57 16.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 83.68 7.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.27 -3.52 5.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 146' ' ' TYR . 41.9 t -107.62 114.71 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.775 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -94.89 115.93 28.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.852 . . . . 0.0 109.219 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -88.39 155.04 19.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.23 162.28 22.87 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 -7.59 16.59 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.526 2.151 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -99.21 -64.53 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.47 50.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -146.05 156.43 43.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -1.176 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.55 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 28.4 m-85 -130.24 179.99 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.597 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.63 111.8 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.85 125.75 33.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.676 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -147.81 158.63 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 171' ' ' VAL . 7.7 tt -143.54 134.61 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.98 131.18 41.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -111.33 106.32 57.12 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.06 -31.4 4.95 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.279 1.986 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.4 -16.67 64.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.339 -0.85 . . . . 0.0 108.948 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -107.42 53.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.477 -0.764 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.23 21.68 2.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.11 62.41 3.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.87 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -1.182 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.69 155.85 14.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.887 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' A' ' 161' ' ' ILE . 23.7 t -140.98 83.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.597 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 3.9 t-105 -71.49 98.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 108.98 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 186' ' ' TYR . 0.8 OUTLIER -56.32 -51.42 68.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 157.28 157.85 8.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.6 p -72.81 153.12 41.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -1.129 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 72.0 m-85 -129.01 -172.63 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.511 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.32 -28.84 13.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.7 p -140.91 166.06 25.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.487 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -68.03 -21.22 65.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -75.32 -44.25 46.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 109.756 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.408 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -69.81 -38.69 76.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.16 -43.27 74.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -64.16 -35.43 80.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 108.97 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.474 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.5 -48.4 77.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.026 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.13 -25.45 67.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.469 -0.77 . . . . 0.0 109.064 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.9 t80 -68.91 -34.3 75.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 40.1 m-20 -64.05 -48.01 77.93 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.379 -0.825 . . . . 0.0 108.917 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -52.16 -44.58 64.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.711 -0.618 . . . . 0.0 110.295 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -75.42 -27.64 59.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -88.2 6.82 34.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.472 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.0 t80 -115.61 -26.4 7.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 108.938 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -83.32 -37.5 23.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mtp -80.9 -39.27 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.525 ' CB ' ' HB1' ' A' ' 198' ' ' ALA . 73.1 mtt180 -94.0 -34.24 13.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 48.92 -168.72 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.9 m 57.96 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.361 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -124.87 -54.92 1.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.083 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 194' ' ' ARG . . . 61.85 154.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.751 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 108.44 19.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.64 -174.34 2.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.58 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.439 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -80.72 -37.79 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.1 m-85 -116.4 80.58 10.11 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.288 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.4 Cg_endo -77.23 -168.89 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.688 2.259 . . . . 0.0 110.086 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.2 mt -118.44 -176.79 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 24.53 7.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.399 179.932 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.193 0.521 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 65.29 116.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 109.286 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 40.4 m-85 -114.0 152.53 30.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.5 88.31 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.96 -29.85 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 179' ' ' ALA . 48.1 t -86.15 113.25 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.698 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -93.34 105.86 17.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 108.583 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.632 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 13.7 pt20 -103.47 133.85 47.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 110.097 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.553 ' HG3' ' N ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -88.23 -179.26 1.26 Allowed Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.553 ' N ' ' HG3' ' A' ' 152' ' ' ARG . 33.3 Cg_endo -75.22 77.98 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.826 1.684 . . . . 0.0 109.825 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER 70.47 75.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.775 . . . . 0.0 109.272 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.61 -86.35 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -137.87 178.35 7.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.147 -1.208 . . . . 0.0 110.252 -178.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.632 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 9.5 m-85 -135.93 174.53 10.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.12 104.73 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.504 ' HB1' ' CA ' ' A' ' 182' ' ' ALA . . . -79.93 102.6 9.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.195 -0.941 . . . . 0.0 109.201 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 5.8 tm-20 -125.79 154.27 42.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.792 . . . . 0.0 109.197 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.1 tt -132.71 149.24 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.963 . . . . 0.0 109.694 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.449 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.2 ttm180 -103.46 108.33 19.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.314 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -100.23 118.36 61.48 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.96 -26.46 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.284 1.989 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -14.4 22.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.255 -0.903 . . . . 0.0 109.378 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -102.1 39.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.354 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.67 33.41 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.82 53.66 9.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -108.72 121.97 46.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.53 159.21 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.605 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 26.1 t -138.25 87.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.264 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.577 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 3.1 t-105 -69.71 114.55 8.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 109.394 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.523 HD23 ' CB ' ' A' ' 189' ' ' ALA . 20.2 mt -75.39 -53.9 7.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.85 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.69 156.46 8.75 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -73.67 152.93 40.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.15 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 58.3 m-85 -131.05 173.99 10.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.74 -30.68 32.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.623 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -138.2 -172.77 3.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.593 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 183' ' ' ALA . . . -88.42 -22.24 23.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.955 . . . . 0.0 108.833 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -72.21 -37.43 69.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.011 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -74.2 -46.72 40.19 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.416 -0.802 . . . . 0.0 108.948 179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -70.27 -21.23 62.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.6 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -78.68 -39.11 37.68 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 3.1 tm? -68.24 -45.33 73.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.24 -26.73 68.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -67.84 -33.51 74.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 11.3 m-20 -68.19 -42.36 80.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 188' ' ' ARG . 17.4 tpp180 -61.59 -40.41 94.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.995 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -79.65 -23.96 42.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 109.701 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.92 -3.5 57.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.581 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 187' ' ' ASP . 1.7 t80 -105.53 -27.84 11.15 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.204 -0.935 . . . . 0.0 108.763 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -81.59 -40.97 22.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.77 -33.55 60.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -0.777 . . . . 0.0 109.304 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 8.0 mmm180 -92.63 -16.41 25.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.827 . . . . 0.0 108.929 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . 42.29 -108.72 0.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 197' ' ' ARG . 56.1 p -50.53 111.81 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -1.136 . . . . 0.0 110.097 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.35 160.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 0.0 110.344 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 177.32 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.2 mt -95.54 116.21 28.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.64 -176.69 4.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.411 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.479 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -80.36 -35.5 35.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 2.3 m-85 -120.03 79.25 25.45 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.14 93.89 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.614 2.209 . . . . 0.0 110.713 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.31 173.59 7.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 109.299 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 mtm-85 -90.03 154.34 19.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.4 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 62.14 -174.56 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.556 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.643 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 23.2 m-85 -96.65 143.83 27.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.873 . . . . 0.0 109.685 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.58 74.91 7.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.381 -0.825 . . . . 0.0 108.898 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 155.3 -16.41 0.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 179' ' ' ALA . 9.2 t -105.26 111.11 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.979 -1.306 . . . . 0.0 109.785 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.94 131.68 54.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.586 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . 2.8 pm0 -122.8 131.76 53.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.991 . . . . 0.0 110.473 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.583 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -71.86 -172.87 0.23 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.13 90.57 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.645 1.563 . . . . 0.0 109.977 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.8 m95 64.49 50.14 2.27 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.02 -123.61 2.04 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.459 -1.353 . . . . 0.0 111.09 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -106.68 151.78 24.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.972 . . . . 0.0 110.434 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 151' ' ' GLN . 2.9 m-30 -100.2 -171.7 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.591 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.79 121.28 2.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.611 -1.306 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -100.11 121.24 41.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 2.0 mt-10 -136.19 158.47 44.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.809 . . . . 0.0 109.672 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.6 tt -141.54 123.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.57 139.2 58.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.417 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 43.7 t0 -128.2 97.8 28.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.284 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.52 -28.18 7.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.307 2.005 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.2 -14.06 52.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -108.8 42.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.736 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.47 30.02 9.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.074 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.47 66.94 1.56 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -116.33 85.92 2.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -1.147 . . . . 0.0 109.338 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.3 ptt85 -42.2 144.95 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.406 -0.808 . . . . 0.0 109.481 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.437 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 45.7 t -120.19 88.58 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.145 -0.972 . . . . 0.0 109.811 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.591 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.0 t-105 -73.66 93.75 2.11 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.137 -0.977 . . . . 0.0 109.025 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 2.2 mt -51.43 -47.38 63.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.763 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.51 165.11 12.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -77.54 148.02 35.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 48.3 m-85 -123.44 -166.4 1.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.35 -0.844 . . . . 0.0 109.397 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -105.01 -26.75 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.541 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.9 p -144.61 -172.27 3.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 109.548 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 183' ' ' ALA . . . -87.11 -22.63 25.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.03 -36.61 56.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.59 -52.2 11.12 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.217 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.574 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -62.43 -34.73 77.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.164 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.643 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -68.64 -44.16 74.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -38.21 77.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.397 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.73 -28.24 63.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.006 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -70.67 -30.16 66.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 96.7 m-20 -71.84 -41.9 67.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.411 -0.806 . . . . 0.0 109.942 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.7 -34.12 73.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 110.082 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.472 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -80.65 -29.08 36.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.764 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.02 -24.93 35.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.377 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -81.33 -26.84 35.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -45.56 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.43 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -71.71 -35.22 70.14 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.585 -0.697 . . . . 0.0 109.965 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 198' ' ' ALA . 3.3 mpt_? -94.66 -7.89 39.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.24 -87.25 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 197' ' ' ARG . 4.4 t -85.25 -146.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.702 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' A' ' 196' ' ' SER . 28.1 mtm180 -38.46 140.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.598 -0.689 . . . . 0.0 110.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 194' ' ' ARG . . . -157.14 32.69 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 198' ' ' ALA . 7.2 mt 41.68 92.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.66 -0.65 . . . . 0.0 109.651 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.536 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -120.51 143.66 48.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.2 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -45.89 -33.96 3.56 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 1.4 m-85 -134.04 88.01 32.92 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 200' ' ' LEU . 34.2 Cg_endo -76.57 75.69 4.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.572 2.181 . . . . 0.0 110.545 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 203' ' ' PRO . 10.9 mp 48.0 -175.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 22.0 3.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.384 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.498 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.363 0.602 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -143.3 111.56 6.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 15.5 m-85 -82.79 134.71 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 0.0 109.492 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 98.46 3.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.192 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.0 -31.94 3.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 157' ' ' PHE . 41.0 t -79.55 136.53 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -1.1 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.4 89.91 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 109.228 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.557 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 3.9 pt20 -59.42 131.21 50.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.978 . . . . 0.0 109.462 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -110.66 159.5 32.1 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.75 -1.68 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.708 2.272 . . . . 0.0 110.543 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -25.71 14.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.05 39.87 0.62 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 157' ' ' PHE . 21.6 mttt -130.05 179.96 5.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 151' ' ' GLN . 86.5 m-85 -159.12 109.0 1.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 108.679 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -85.8 127.12 34.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.09 -1.006 . . . . 0.0 111.263 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -99.9 116.92 33.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.45 166.16 25.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.041 -1.037 . . . . 0.0 110.316 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 8.8 tt -152.18 158.63 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.451 -0.78 . . . . 0.0 108.952 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.54 139.7 48.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.95 -1.094 . . . . 0.0 109.858 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.404 ' HB2' ' HE3' ' A' ' 193' ' ' MET . 64.7 t0 -138.11 93.63 11.62 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.36 -22.99 10.51 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.587 2.191 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.89 -13.99 19.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -107.38 51.03 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 167' ' ' ASN . 28.7 t-20 57.03 38.32 29.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.341 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.94 97.91 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.6 100.89 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.127 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -51.99 166.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 67.2 t -147.83 90.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.575 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.1 t-105 -87.06 101.83 13.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 1.2 mt -56.12 -50.79 70.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.42 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 148.63 148.68 4.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -68.32 158.41 33.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.08 -1.247 . . . . 0.0 108.967 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.577 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 85.5 m-85 -131.86 -176.89 4.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.622 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -27.69 14.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.553 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.7 p -133.03 170.41 15.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.515 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.536 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -78.42 -22.61 47.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.377 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -73.09 -33.11 65.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.428 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.454 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -80.54 -34.95 35.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.235 -0.915 . . . . 0.0 109.173 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.577 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -76.48 -27.83 56.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -77.14 -40.56 45.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.203 -0.936 . . . . 0.0 108.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.9 tp -63.89 -41.75 97.64 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.513 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.58 -37.76 85.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -62.73 -40.44 97.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.45 -0.781 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.506 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 14.4 m-20 -60.7 -52.2 66.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.498 -0.751 . . . . 0.0 109.833 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -54.16 -31.19 51.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -84.4 -26.95 27.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.25 2.99 54.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.542 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.5 t80 -117.16 -31.24 5.4 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -74.92 -38.49 61.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.404 ' HE3' ' HB2' ' A' ' 163' ' ' ASP . 26.2 ttm -81.53 -46.26 14.74 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.418 0.627 . . . . 0.0 109.735 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.7 mtt85 -93.94 -41.89 9.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.039 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 48.12 -149.79 3.39 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m 50.26 -107.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -1.188 . . . . 0.0 109.601 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.01 56.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.222 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -66.18 169.65 6.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.332 -0.855 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -113.67 116.44 29.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.098 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -125.25 179.28 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.555 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.4 OUTLIER -70.33 -38.25 74.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 7.8 m-85 -112.16 96.11 33.26 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.67 148.62 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.578 2.185 . . . . 0.0 110.708 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.33 106.43 14.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.5 -27.24 11.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.95 . . . . 0.0 109.529 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.499 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 128.58 48.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.596 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 18.8 m-85 -67.23 143.27 56.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -77.79 96.98 5.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.637 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.66 -16.72 7.39 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 27.3 t -97.48 117.61 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.811 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 3.4 mmp_? -96.53 117.89 31.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -85.38 160.07 19.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 0.0 110.016 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.536 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 16.4 mtt180 -126.7 158.26 68.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.681 -0.637 . . . . 0.0 109.337 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.2 3.49 7.05 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.577 2.185 . . . . 0.0 110.298 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -9.9 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.485 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.01 33.24 4.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.2 mtmt -127.81 173.09 10.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 59.6 m-85 -144.33 -178.29 5.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.366 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.69 104.1 2.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 109.94 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.513 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.04 123.22 27.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.235 -0.916 . . . . 0.0 108.974 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 1.1 mt-10 -139.12 164.51 29.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.266 -0.896 . . . . 0.0 109.267 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.457 HG21 ' HB ' ' A' ' 171' ' ' VAL . 6.2 tt -146.02 141.84 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -86.8 108.72 18.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.68 113.14 64.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.321 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.36 -27.31 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -9.14 56.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 4.4 mmpt? -117.87 39.35 3.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 1.2 m-20 68.74 29.38 5.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.41 27.1 68.89 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.81 116.53 8.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -1.209 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -59.04 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.457 ' HB ' HG21 ' A' ' 161' ' ' ILE . 37.8 t -68.31 104.99 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 10.4 t-105 -80.51 99.01 7.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 19.7 mt -56.63 -37.67 71.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.027 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 136.3 158.27 8.04 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -78.52 148.87 33.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -1.13 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 69.4 m-85 -120.25 -168.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.695 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.466 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 9.9 pt-20 -99.23 -32.59 11.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.579 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.1 p -133.85 170.1 16.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -77.32 -23.65 50.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.96 . . . . 0.0 109.556 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -73.13 -36.61 66.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -75.32 -45.38 39.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -61.76 -47.2 86.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -58.32 -42.39 86.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.103 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 184' ' ' LEU . 21.3 tp -60.79 -39.83 90.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.564 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.19 -24.34 66.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -0.813 . . . . 0.0 109.046 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -72.35 -29.95 64.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 187' ' ' ASP . 2.0 m-20 -72.18 -50.32 28.58 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -60.91 -28.7 69.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.48 -19.57 23.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.927 . . . . 0.0 109.274 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.72 -8.14 41.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -105.79 -33.67 7.92 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -80.15 -39.77 28.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -30.57 64.12 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.673 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 12.8 mtt180 -96.2 -0.95 49.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.36 -87.17 1.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 197' ' ' ARG . 3.0 m -135.8 164.4 27.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -1.188 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.82 109.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' ' HD3' ' A' ' 194' ' ' ARG . . . -163.31 150.1 12.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.957 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.432 ' C ' HD21 ' A' ' 200' ' ' LEU . 1.1 mp -92.37 118.23 30.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.432 HD21 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -127.51 174.74 8.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 109.413 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.484 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -70.42 -34.59 72.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 108.613 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.8 m-85 -121.34 84.58 41.34 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.06 117.65 4.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.48 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 205' ' ' ARG . 0.3 OUTLIER 51.64 -173.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.5 ' CB ' ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER 75.99 -169.73 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.471 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.458 -179.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.373 0.606 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -129.96 -173.33 3.01 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.424 -0.798 . . . . 0.0 109.415 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 46.0 m-85 -122.62 152.46 40.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -82.03 36.18 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.154 -0.966 . . . . 0.0 109.753 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.04 26.59 0.09 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 57.6 t -143.6 113.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -1.154 . . . . 0.0 109.424 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.05 94.79 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.32 134.29 56.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.454 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 7.5 mmt180 -99.17 161.25 25.37 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.668 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.454 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.32 -34.81 1.41 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.678 2.252 . . . . 0.0 110.263 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -47.69 83.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.08 43.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 2.6 mttm -131.94 -168.65 2.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.587 ' CD2' ' HA ' ' A' ' 178' ' ' THR . 63.3 m-85 -159.47 108.29 1.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.096 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.618 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -82.38 139.34 34.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -111.11 113.58 26.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -134.79 164.75 26.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 0.0 109.899 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.3 tt -141.52 143.3 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 108.914 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.405 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 1.2 tmm_? -82.62 119.71 24.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.825 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.407 ' CG ' ' SD ' ' A' ' 193' ' ' MET . 41.5 t0 -111.06 97.74 35.99 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.072 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.426 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 34.7 Cg_endo -76.39 -26.39 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.475 2.117 . . . . 0.0 110.673 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.81 -22.76 67.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 109.578 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -100.4 64.33 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.587 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 48.16 44.22 19.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.602 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 50.92 59.64 7.87 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -107.18 136.71 46.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -1.165 . . . . 0.0 109.44 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 163.24 28.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.87 99.7 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 158' ' ' ALA . 16.0 t-105 -84.09 91.67 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.982 . . . . 0.0 109.599 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 57.6 mt -51.38 -48.45 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.246 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 152.39 158.52 8.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.8 p -73.61 162.71 28.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -1.175 . . . . 0.0 109.477 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 67.0 m-85 -138.83 179.57 6.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -28.46 19.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.587 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 p -142.72 168.51 19.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.5 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -72.09 -24.6 61.52 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.83 -39.79 76.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -74.63 -45.69 43.18 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -64.14 -31.15 72.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -72.69 -47.83 44.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.255 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -35.68 72.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 108.834 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.43 -28.98 65.47 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.278 -0.888 . . . . 0.0 108.696 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -65.88 -28.03 68.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.62 -47.88 51.67 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.303 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -34.74 68.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.501 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -84.2 -39.11 19.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.929 -1.107 . . . . 0.0 109.981 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -69.22 -18.91 63.95 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.572 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.6 t80 -85.55 -40.6 16.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.139 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -40.28 86.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.759 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.407 ' SD ' ' CG ' ' A' ' 163' ' ' ASP . 28.9 ttm -77.86 -43.16 31.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.666 -0.646 . . . . 0.0 109.591 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.506 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 70.4 mtt180 -102.25 34.2 2.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.955 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -41.12 164.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 84.53 -47.71 0.1 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.834 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -171.73 128.81 0.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.208 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.506 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . -159.66 148.77 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.436 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -89.77 122.62 33.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.436 HD22 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.83 157.26 31.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.164 -0.96 . . . . 0.0 109.303 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -53.93 -35.59 61.86 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 4.2 m-85 -124.16 83.53 56.18 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.1 123.64 6.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.515 2.143 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mp 51.78 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 10.8 mtp85 -69.45 173.35 6.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 2.4 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.361 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -53.56 177.44 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.371 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.579 ' CG ' ' HB3' ' A' ' 183' ' ' ALA . 21.5 m-85 -45.66 133.35 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.494 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -72.11 96.75 1.81 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.54 -8.33 7.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 38.5 t -105.01 112.32 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -1.172 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -96.19 117.61 31.11 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.574 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.38 153.76 24.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.84 . . . . 0.0 109.433 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -116.58 155.94 48.18 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.25 -10.52 16.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.661 2.241 . . . . 0.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -36.59 17.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.136 -0.977 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 156' ' ' LYS . . . 133.61 61.81 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 155' ' ' GLY . 19.4 mttp -166.83 -171.64 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 109.514 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 53.8 m-85 -148.88 -175.12 4.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 109.102 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.578 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.31 108.53 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 0.0 110.017 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.562 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.8 134.17 36.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.154 -0.966 . . . . 0.0 108.984 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.24 148.96 29.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.095 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 3.8 tt -141.79 127.71 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.023 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.427 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -69.46 143.63 53.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 109.204 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 168' ' ' GLY . 43.5 t0 -110.52 97.65 33.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.573 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.6 Cg_endo -76.57 -26.9 8.04 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.355 2.037 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.51 68.33 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 3.0 mmmm -101.55 25.31 8.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 67.46 66.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 69.32 -106.64 1.85 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 51.33 80.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.255 . . . . 0.0 109.578 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.9 153.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 171' ' ' VAL . 11.7 t -128.07 81.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.578 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 7.5 t-105 -61.4 97.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 109.168 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 185' ' ' ALA . 0.3 OUTLIER -52.68 -49.14 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.43 154.26 6.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -68.54 153.86 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -1.196 . . . . 0.0 109.214 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 56.7 m-85 -129.4 172.91 11.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.754 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -77.02 -30.11 55.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 109.854 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.519 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.5 p -145.65 -174.07 4.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.501 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -81.81 -28.62 33.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.673 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -70.61 -34.46 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 109.624 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -73.32 -44.42 58.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.133 -0.979 . . . . 0.0 109.452 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -68.96 -30.2 68.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.579 ' HB3' ' CG ' ' A' ' 146' ' ' TYR . . . -71.98 -41.49 67.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.301 -0.875 . . . . 0.0 109.105 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.75 94.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.302 -0.873 . . . . 0.0 109.16 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.18 -22.9 66.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -0.809 . . . . 0.0 108.935 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.3 t80 -69.79 -33.9 73.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 109.081 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.489 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 18.9 m-20 -67.68 -43.85 79.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.429 -0.795 . . . . 0.0 109.472 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -58.9 -40.53 84.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.773 . . . . 0.0 109.84 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 173' ' ' LEU . . . -81.89 -20.75 38.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.89 -8.9 48.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.3 t80 -101.96 -33.95 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.284 -0.885 . . . . 0.0 108.924 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -76.4 -40.95 49.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 108.782 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.01 -31.61 64.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.576 -0.702 . . . . 0.0 109.484 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.7 mtt85 -105.81 1.82 27.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 49.3 -99.07 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER -48.2 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 109.737 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -42.77 160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.778 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -157.72 37.0 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 109.273 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 199' ' ' LEU . 7.8 mp 39.89 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.718 -0.614 . . . . 0.0 109.869 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.489 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -111.91 173.93 6.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.972 . . . . 0.0 109.401 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.419 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -72.0 -34.54 68.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 5.7 m-85 -122.67 80.42 48.16 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 -169.45 0.72 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.58 2.186 . . . . 0.0 110.65 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 60.32 1.66 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.17 132.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.391 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 pttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -141.33 115.69 9.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.593 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.642 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 17.4 m-85 -104.28 149.42 25.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 99.9 4.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.2 -25.21 7.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 52.0 t -86.79 126.14 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -1.191 . . . . 0.0 110.046 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -104.4 110.98 23.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 pm0 -75.88 144.63 41.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 156.62 53.32 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.158 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.03 3.51 6.96 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.552 2.168 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -96.19 -13.84 23.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.79 26.41 6.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.493 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -133.76 -173.78 3.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -1.155 . . . . 0.0 109.527 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.551 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 65.7 m-85 -149.0 -177.59 5.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.351 -0.843 . . . . 0.0 109.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.63 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.77 108.24 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.842 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.94 108.82 13.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 108.993 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER -126.47 155.16 42.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -0.947 . . . . 0.0 109.966 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 193' ' ' MET . 7.5 tt -141.55 117.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.387 -0.82 . . . . 0.0 109.015 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -89.99 126.05 35.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -111.11 103.9 55.48 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 0.0 109.395 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.98 -25.12 9.19 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.307 2.005 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.92 -18.71 64.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 39.16 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.93 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.2 m120 55.53 46.05 23.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.42 121.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.61 128.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -1.137 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -95.26 148.62 22.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 171' ' ' VAL . 41.6 t -133.48 89.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.63 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 3.5 t-105 -75.36 102.9 5.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.063 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.529 HD22 ' CB ' ' A' ' 189' ' ' ALA . 3.6 mt -57.67 -57.8 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.665 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 161.88 157.01 8.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.47 153.21 41.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -1.128 . . . . 0.0 109.227 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 61.8 m-85 -127.06 178.11 6.21 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.913 . . . . 0.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.416 ' C ' HG21 ' A' ' 178' ' ' THR . 4.0 mt-10 -84.51 -30.86 24.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -138.64 176.81 8.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.273 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.542 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -79.86 -23.09 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.439 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -74.45 -35.05 63.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.14 -37.83 53.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -72.57 -32.85 66.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.226 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.642 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -75.84 -37.28 59.15 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -66.34 -39.58 89.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.086 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.88 -23.34 62.28 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -73.14 -29.81 63.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.505 -0.747 . . . . 0.0 109.0 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 39.5 m-20 -69.74 -50.15 46.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.266 -0.897 . . . . 0.0 109.55 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -60.09 -35.84 76.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 109.946 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -80.96 -24.67 37.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.159 -0.963 . . . . 0.0 109.521 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.8 -1.85 57.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -106.51 -27.89 10.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.606 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -40.32 23.72 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.459 ' HE1' HD12 ' A' ' 161' ' ' ILE . 4.6 ttp -74.24 -33.77 63.44 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.5 mtt180 -86.74 -13.02 46.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 53.97 -92.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 195' ' ' GLY . 9.3 p -54.17 -167.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.3 mtm105 -42.77 156.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.454 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 194' ' ' ARG . . . -156.31 155.23 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 118.25 36.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.459 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -129.17 179.94 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -76.53 -31.45 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.14 75.26 30.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo -77.34 -169.14 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.661 2.24 . . . . 0.0 110.638 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -149.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 109.482 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 52.57 60.04 4.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.196 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.8 160.54 31.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.485 -0.759 . . . . 0.0 109.38 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.595 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 18.7 m-85 -107.41 128.28 54.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.604 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.458 ' CG ' ' O ' ' A' ' 147' ' ' ARG . 1.7 ptt180 -67.83 125.06 25.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.126 -0.984 . . . . 0.0 108.718 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.04 20.9 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -88.94 106.44 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.772 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -80.16 108.45 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.604 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -72.0 160.17 32.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 110.51 -178.798 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.628 ' HG2' ' CA ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.58 169.15 18.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.851 -0.531 . . . . 0.0 112.334 -178.046 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 152' ' ' ARG . 37.3 Cg_endo -85.17 -16.24 5.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.567 2.178 . . . . 0.0 106.986 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -145.64 -67.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.628 ' CA ' ' HG2' ' A' ' 152' ' ' ARG . . . -147.68 113.22 0.63 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 147.79 148.31 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 117.856 0.828 . . . . 0.0 110.1 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 51.4 m-85 -139.84 170.44 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.449 -1.407 . . . . 0.0 108.645 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.577 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -141.99 113.36 7.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.478 ' HB1' ' CE2' ' A' ' 176' ' ' PHE . . . -81.96 118.46 22.98 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' A' ' 170' ' ' ARG . 1.5 tt0 -141.18 158.36 44.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 109.864 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.446 HG21 ' HB ' ' A' ' 171' ' ' VAL . 6.5 tt -151.85 125.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -88.71 118.94 28.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -99.33 117.38 64.06 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.62 -26.42 7.08 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.355 2.037 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -14.98 62.64 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -103.21 32.62 3.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.679 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.43 54.98 1.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 45.83 65.98 1.8 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.98 98.31 6.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.457 ' HB3' ' OE2' ' A' ' 160' ' ' GLU . 7.5 mtt180 -48.69 166.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 170' ' ' ARG . 7.2 t -143.96 86.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.161 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.577 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.3 t-105 -70.77 96.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.25 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 185' ' ' ALA . 0.8 OUTLIER -56.01 -42.74 76.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 176' ' ' PHE . . . 146.06 152.06 5.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 4.4 p -66.68 179.36 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.223 -1.163 . . . . 0.0 109.464 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 70.4 m-85 -155.56 -173.93 4.75 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 0.0 109.141 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' C ' ' CG2' ' A' ' 178' ' ' THR . 32.9 tt0 -97.37 -17.94 19.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.617 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 7.3 p -152.32 169.45 22.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.786 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.6 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -71.33 -22.79 61.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -73.09 -41.95 63.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -34.79 67.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.431 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -74.66 -31.27 61.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.266 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.595 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -72.8 -40.17 66.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.47 -48.46 81.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.28 -28.56 70.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.552 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.0 t80 -68.34 -28.1 66.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.535 ' CB ' HD11 ' A' ' 200' ' ' LEU . 5.0 m-20 -72.64 -37.02 68.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -64.67 -36.21 83.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 110.196 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -80.25 -41.86 24.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.826 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -71.96 -5.95 38.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.734 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.1 t80 -104.81 -44.03 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.048 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -40.11 94.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.0 mtm -80.44 -43.3 21.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.569 -0.707 . . . . 0.0 109.54 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 196' ' ' SER . 14.1 mtt180 -102.78 33.19 3.31 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.449 -0.782 . . . . 0.0 109.415 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -41.98 94.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 194' ' ' ARG . 12.2 p 170.28 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.268 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 35.5 11.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.449 ' O ' HD22 ' A' ' 200' ' ' LEU . . . -60.19 145.55 46.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.35 135.65 35.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.535 HD11 ' CB ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -138.59 -174.56 3.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.853 . . . . 0.0 109.127 -179.982 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.446 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -68.94 -36.39 77.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 8.3 m-85 -119.15 76.32 15.85 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.3 Cg_endo -75.57 162.96 34.91 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.631 2.221 . . . . 0.0 110.801 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.42 79.72 9.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -137.85 17.69 2.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.442 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 39.5 mttm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 144' ' ' LYS . 3.2 m170 -167.74 157.64 10.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.579 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 12.9 m-85 -78.48 124.25 27.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.15 84.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.9 -32.62 1.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.3 t -77.21 144.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 158' ' ' ALA . 8.7 ttm-85 -123.83 97.34 5.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.063 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.552 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 5.4 pt20 -87.57 135.62 33.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.329 -0.857 . . . . 0.0 109.345 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.568 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -89.36 -173.99 0.43 Allowed Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -74.37 81.05 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.411 1.408 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.2 m0 63.17 74.85 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.63 -0.669 . . . . 0.0 109.309 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 152' ' ' ARG . . . -170.5 -99.99 0.13 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.156 -1.497 . . . . 0.0 111.003 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.41 -178.23 3.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -1.134 . . . . 0.0 110.755 -178.334 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 8.3 m-85 -132.47 179.76 5.93 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.28 112.61 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.881 -1.137 . . . . 0.0 110.446 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -88.38 119.29 28.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 6.6 mt-10 -137.91 170.42 16.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.872 -179.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.444 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.3 tt -159.22 156.38 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.444 ' N ' HG12 ' A' ' 161' ' ' ILE . 42.0 ttp180 -96.38 129.67 43.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.738 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.471 ' HB2' HG22 ' A' ' 171' ' ' VAL . 10.6 t0 -113.31 106.17 54.74 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.236 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.83 -23.59 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.413 2.075 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.23 -19.61 62.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.282 -0.886 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -100.84 46.97 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.74 38.9 21.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 58.88 53.79 43.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.15 138.5 39.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -1.144 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -67.39 163.24 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 163' ' ' ASP . 40.5 t -139.06 94.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.578 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 9.3 t-105 -82.69 94.13 7.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 109.028 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 189' ' ' ALA . 13.6 mt -51.25 -41.73 60.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 109.134 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.546 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 142.58 152.76 5.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.6 p -67.28 152.61 45.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -1.107 . . . . 0.0 109.444 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 52.3 m-85 -127.06 179.11 5.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.167 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 -25.43 28.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.819 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.581 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.7 p -147.5 -174.15 4.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.486 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -84.51 -23.99 29.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.781 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -34.29 65.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 109.615 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.64 -43.92 36.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.03 -47.1 81.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 109.17 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.579 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -58.53 -38.39 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -52.31 65.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 108.915 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -62.65 -18.55 62.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.559 ' CE1' ' HB3' ' A' ' 190' ' ' ALA . 10.5 t80 -75.65 -34.6 60.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.878 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.448 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 26.7 m-20 -61.67 -47.64 84.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.567 -0.708 . . . . 0.0 109.597 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.37 85.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.532 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -73.25 -17.01 61.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.559 ' HB3' ' CE1' ' A' ' 186' ' ' TYR . . . -87.41 -19.65 27.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.238 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.532 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 5.5 t80 -93.59 -31.49 14.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -38.91 67.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.432 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -74.12 -52.13 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -86.41 -50.23 7.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.463 -0.773 . . . . 0.0 109.241 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 50.79 176.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 197' ' ' ARG . 33.9 t 58.81 71.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.634 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER 50.12 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.967 . . . . 0.0 109.535 179.839 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -125.39 163.36 22.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -92.83 127.54 38.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.448 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -133.23 152.74 51.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.29 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -48.89 -38.99 24.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.145 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.0 m-85 -120.85 89.47 45.56 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 204' ' ' LEU . 35.3 Cg_endo -77.02 83.37 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' PRO . 0.3 OUTLIER 41.83 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.697 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 59.36 -148.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.457 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.387 -179.989 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.347 0.594 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -78.38 171.1 15.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.64 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 30.8 m-85 -143.18 159.55 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -76.86 85.28 3.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.865 . . . . 0.0 109.352 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.56 -23.27 3.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 94.7 t -88.13 137.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.398 -1.06 . . . . 0.0 109.301 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.456 ' HB3' ' HB1' ' A' ' 158' ' ' ALA . 14.6 tpp180 -124.82 103.64 8.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.84 . . . . 0.0 109.244 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.564 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 60.1 tt0 -61.89 169.27 2.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.44 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -128.57 163.36 45.33 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.341 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 35.1 Cg_endo -76.63 76.08 4.16 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.577 2.185 . . . . 0.0 110.319 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER 168.86 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.535 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 156' ' ' LYS . . . 159.86 41.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.6 mmtt -137.49 179.8 6.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.513 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 151' ' ' GLN . 62.1 m-85 -149.83 -179.99 7.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.63 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.32 113.25 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.574 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.79 119.08 25.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 108.936 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -140.5 152.24 45.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.44 HD12 ' HE3' ' A' ' 193' ' ' MET . 3.5 tt -137.26 132.33 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 99.2 12.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.64 116.13 65.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.619 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.98 -23.6 9.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.39 2.06 . . . . 0.0 110.295 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.24 -22.33 62.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.453 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -96.98 44.79 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.576 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.11 20.53 5.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.3 43.21 7.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.79 109.86 21.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -54.9 150.13 10.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.064 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.9 t -131.19 86.63 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.63 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 4.1 t-105 -74.15 99.7 3.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 2.1 mt -53.54 -54.48 36.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.458 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 156.13 153.09 6.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.8 p -66.72 152.85 44.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -1.069 . . . . 0.0 109.357 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.574 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 63.9 m-85 -126.53 -173.1 2.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.885 . . . . 0.0 109.541 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.51 -28.75 15.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.455 HG21 ' OD2' ' A' ' 181' ' ' ASP . 2.7 p -140.75 171.91 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 109.423 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.56 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -75.97 -25.04 55.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -74.05 -35.94 64.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.455 ' OD2' HG21 ' A' ' 178' ' ' THR . 0.0 OUTLIER -75.13 -40.15 59.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 108.994 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.98 -31.02 67.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.316 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.64 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.89 -38.08 64.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.338 -0.851 . . . . 0.0 108.817 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.406 ' HA ' ' OD2' ' A' ' 187' ' ' ASP . 43.8 tp -64.14 -45.2 89.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.448 -0.783 . . . . 0.0 109.102 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.55 -27.85 68.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 108.888 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -66.86 -30.79 71.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.212 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 184' ' ' LEU . 11.7 m-20 -67.89 -55.0 14.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.296 -0.877 . . . . 0.0 109.423 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -31.59 37.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.531 -0.73 . . . . 0.0 109.919 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.466 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -82.58 -29.47 30.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.834 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -86.75 -1.32 57.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -103.33 -31.14 10.2 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 108.89 179.613 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -77.75 -40.59 40.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.327 -0.858 . . . . 0.0 108.961 179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.44 ' HE3' HD12 ' A' ' 161' ' ' ILE . 1.6 mtp -81.16 -32.07 33.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.606 -0.684 . . . . 0.0 110.378 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -91.18 -1.62 57.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 83.13 -150.05 27.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.57 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 p -63.01 -97.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 109.833 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -48.99 153.14 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.814 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 178.8 160.91 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.38 111.53 23.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.59 172.1 9.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 108.987 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.428 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -72.55 -33.28 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.237 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 6.8 m-85 -121.46 75.36 33.49 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -76.47 103.74 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.611 2.207 . . . . 0.0 110.417 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 100.83 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -158.97 44.38 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 206' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.458 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.1 pttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -48.56 173.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.234 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 23.2 m-85 -79.86 148.89 31.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -78.23 83.02 4.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.202 -0.936 . . . . 0.0 109.284 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 144.21 -23.36 2.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 182' ' ' ALA . 6.1 t -102.12 122.93 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.259 . . . . 0.0 109.735 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 9.3 mtt180 -122.03 171.61 8.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 151' ' ' GLN . 9.4 pm0 -138.2 143.54 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 109.597 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.7 mtt85 -104.41 169.59 7.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.726 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.4 Cg_endo -78.18 8.02 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.764 2.31 . . . . 0.0 110.93 -179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -35.28 7.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.456 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 128.31 45.77 0.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 21.7 mttt -149.59 134.86 18.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.165 . . . . 0.0 109.618 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD2' ' C ' ' A' ' 178' ' ' THR . 5.4 m-30 -98.38 -168.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 108.671 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.618 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.91 126.31 2.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 173' ' ' LEU . . . -106.57 113.78 27.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.489 ' OE2' ' HB3' ' A' ' 158' ' ' ALA . 2.7 mp0 -131.04 174.77 9.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.425 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.3 tt -168.6 140.62 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -0.797 . . . . 0.0 109.148 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -73.67 152.76 40.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.0 109.66 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' CG ' ' A' ' 166' ' ' LYS . 58.1 t0 -123.08 95.49 45.91 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.93 -27.86 6.64 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.527 2.151 . . . . 0.0 110.056 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.49 -28.44 69.83 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.446 -0.784 . . . . 0.0 109.099 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' CG ' ' OD2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -95.25 27.37 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 0.0 109.534 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.88 72.54 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.65 106.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -169.07 102.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.9 148.36 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 32.0 t -133.03 94.92 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 109.449 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.4 t-105 -82.77 100.33 10.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.432 HD23 ' HB1' ' A' ' 189' ' ' ALA . 7.5 mt -55.51 -55.37 32.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.15 161.08 10.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -74.59 153.18 39.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.218 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 182' ' ' ALA . 54.2 m-85 -127.11 -167.59 1.76 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.68 -28.45 11.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.002 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.4 p -147.0 -179.81 7.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 183' ' ' ALA . . . -76.94 -33.41 57.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.79 -37.9 88.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.064 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -70.66 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.483 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.569 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -46.36 -27.59 1.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.256 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.642 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -71.37 -45.65 62.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.44 -39.05 93.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.684 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.36 -28.2 64.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.8 t80 -71.33 -30.84 66.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.447 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 13.0 m-20 -67.85 -45.21 75.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.964 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -37.8 83.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.687 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.432 ' HB1' HD23 ' A' ' 173' ' ' LEU . . . -82.83 -20.35 35.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.52 -0.6 56.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -109.78 -31.38 7.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.145 -0.972 . . . . 0.0 108.599 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.54 -40.39 21.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.2 ttm -75.26 -31.59 60.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.753 -0.592 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.3 mtt180 -95.5 -17.45 21.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' SER . . . 47.68 -106.28 0.16 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 197' ' ' ARG . 83.8 p -40.34 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -1.046 . . . . 0.0 110.165 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER 46.17 -173.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.833 . . . . 0.0 109.649 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 190' ' ' ALA . . . 170.73 152.59 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.8 mt -101.75 108.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.453 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -123.17 -175.64 3.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -78.59 -37.86 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 108.875 179.7 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.615 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 4.5 m-85 -115.6 82.26 9.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.491 -0.756 . . . . 0.0 109.173 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -77.28 123.44 6.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.753 2.302 . . . . 0.0 110.563 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 206' ' ' VAL . 2.3 mp -89.24 -58.21 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 54.52 -91.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.438 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' LEU . 5.8 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 tttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -159.22 -172.95 3.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.649 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 27.2 m-85 -128.81 152.34 48.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.81 131.19 45.08 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.287 -0.883 . . . . 0.0 108.963 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.63 -35.93 3.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 182' ' ' ALA . 52.9 t -81.19 113.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.272 . . . . 0.0 109.996 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -95.88 114.44 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 19.8 pt20 -97.43 128.74 44.47 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.866 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.627 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mtp180 -75.62 169.59 19.85 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 29.4 Cg_endo -69.85 83.79 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.18 1.253 . . . . 0.0 109.605 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.448 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 61.6 m95 63.27 63.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -155.06 -106.45 0.26 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.589 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.55 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 5.4 mttp -111.19 -169.67 1.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.335 -1.097 . . . . 0.0 110.514 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.615 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 27.4 m-85 -143.59 173.56 11.54 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.45 109.06 3.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.851 -1.156 . . . . 0.0 110.305 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.87 124.96 29.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.166 -0.959 . . . . 0.0 108.882 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 136.45 31.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.952 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.432 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 2.7 tt -128.78 120.53 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.17 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.29 144.74 29.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 0.0 109.585 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.437 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 32.1 t0 -124.34 116.52 26.92 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.925 . . . . 0.0 109.317 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 36.2 Cg_endo -77.04 -31.03 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.528 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -25.42 67.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -89.03 44.76 1.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.18 53.7 10.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.36 94.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -147.86 111.16 4.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 144.48 54.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.303 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 53.3 t -122.93 94.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.669 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 4.6 t-105 -72.75 98.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.483 ' CD2' ' CB ' ' A' ' 189' ' ' ALA . 1.1 mt -57.91 -45.48 86.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.797 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 149.8 162.96 10.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -79.51 158.14 27.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.23 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 75.1 m-85 -133.84 175.39 9.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.0 tp10 -82.37 -30.7 30.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.683 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -143.31 167.6 21.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.561 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -67.77 -22.47 65.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -38.68 69.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.92 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -75.47 -37.12 60.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.91 -34.74 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.188 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.649 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -72.43 -39.65 67.71 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -42.86 98.12 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.467 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.41 -32.79 73.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.556 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.6 t80 -62.98 -30.49 71.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.148 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 16.0 m-20 -69.7 -41.79 74.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.378 -0.826 . . . . 0.0 109.657 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -63.72 -40.19 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 110.594 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -82.08 -25.95 34.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.987 -1.071 . . . . 0.0 109.94 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.29 -18.19 39.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.437 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.7 t80 -85.39 -36.24 20.84 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.083 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -66.64 -42.18 87.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.437 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 7.2 tpp -80.52 -41.78 23.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.792 . . . . 0.0 109.445 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 18.6 mtt180 -100.71 33.37 2.79 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 108.959 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -39.52 161.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 76.94 85.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 108.983 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 71.83 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 108.999 -179.492 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 67.02 162.47 0.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 110.061 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.434 ' C ' HD22 ' A' ' 200' ' ' LEU . 5.7 mt -116.52 113.25 22.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.442 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.0 159.78 27.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -32.87 70.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 8.3 m-85 -117.35 88.75 29.27 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 204' ' ' LEU . 35.0 Cg_endo -76.73 -176.61 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.698 2.266 . . . . 0.0 110.637 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 203' ' ' PRO . 39.8 mt -43.77 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -127.1 110.95 13.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.545 179.991 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.1 pttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.25 109.19 2.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.5 m-85 -83.27 148.78 27.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.247 -0.908 . . . . 0.0 109.563 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -79.53 85.84 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.945 . . . . 0.0 109.935 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.35 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.415 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 179' ' ' ALA . 96.8 t -109.18 116.95 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.38 . . . . 0.0 110.325 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.82 146.02 28.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.2 pt20 -142.01 132.58 25.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.554 ' CD ' ' N ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -84.1 178.7 2.25 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.5 Cg_endo -77.09 79.27 3.18 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.179 1.92 . . . . 0.0 109.549 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 23.7 t-105 72.6 60.83 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -153.31 -108.8 0.36 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.704 -179.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.544 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 14.6 mmtt -113.24 -171.7 1.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -1.137 . . . . 0.0 110.694 -178.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 23.5 m-85 -141.81 -170.9 3.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.561 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -161.22 110.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.951 -1.093 . . . . 0.0 110.446 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.552 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -83.68 107.16 15.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.523 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 27.9 mt-10 -132.32 152.11 51.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.13 -0.981 . . . . 0.0 109.739 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.448 HD12 ' CE ' ' A' ' 193' ' ' MET . 1.5 tt -140.41 133.06 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.214 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.62 139.61 33.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.404 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 28.7 t0 -123.87 107.24 31.14 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.169 -0.957 . . . . 0.0 109.291 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.63 -28.28 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.268 1.978 . . . . 0.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -25.91 67.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.404 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 10.4 mmtt -90.86 43.45 1.15 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.88 27.17 15.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.54 58.43 3.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.24 95.35 6.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -1.129 . . . . 0.0 109.545 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.442 ' O ' HG21 ' A' ' 171' ' ' VAL . 1.0 OUTLIER -55.06 162.12 1.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.822 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 170' ' ' ARG . 59.9 t -149.84 95.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.04 -1.038 . . . . 0.0 110.153 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.561 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 2.8 t-105 -79.99 106.54 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 29.0 mt -64.16 -47.01 81.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 109.715 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.62 157.09 7.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -76.49 156.65 32.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 -179.8 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.6 m-85 -133.01 177.36 7.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.466 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 3.2 pt-20 -82.55 -31.63 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.162 -0.961 . . . . 0.0 109.786 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 p -141.26 175.36 9.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 109.777 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.578 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -74.1 -22.53 59.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.656 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.55 -49.13 51.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 1.4 m-20 -64.2 -50.39 68.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -56.19 -52.4 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.615 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -52.39 -42.12 63.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.57 -41.78 90.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.77 -22.29 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.8 . . . . 0.0 109.185 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 21.2 t80 -71.51 -36.59 71.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.476 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 6.3 m-20 -65.52 -50.85 63.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.11 -34.74 58.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.49 -0.756 . . . . 0.0 110.101 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -87.79 -19.85 26.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.054 -1.028 . . . . 0.0 109.679 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 194' ' ' ARG . . . -92.14 -5.43 52.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.444 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.6 t80 -102.76 -34.13 9.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.221 -0.924 . . . . 0.0 108.611 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -79.34 -40.69 29.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.448 ' CE ' HD12 ' A' ' 161' ' ' ILE . 6.2 ttp -83.12 -30.05 28.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.609 -0.682 . . . . 0.0 109.656 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -99.77 -9.23 23.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 -179.727 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 42.19 -163.63 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.6 OUTLIER 48.39 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -1.14 . . . . 0.0 109.562 179.874 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 198' ' ' ALA . 0.7 OUTLIER -57.28 -47.02 82.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 197' ' ' ARG . . . 59.39 149.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.438 -0.789 . . . . 0.0 109.722 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.75 124.04 41.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.62 169.23 14.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.93 . . . . 0.0 109.387 -179.906 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.476 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -63.29 -36.07 82.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.039 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 2.8 m-85 -127.18 81.66 69.56 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 204' ' ' LEU . 34.6 Cg_endo -76.6 162.13 33.32 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.635 2.223 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 205' ' ' ARG . 0.3 OUTLIER 71.27 167.5 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.353 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 204' ' ' LEU . 1.5 mmt-85 -54.11 -169.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.337 179.928 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 145' ' ' HIS . 4.8 p80 -100.59 124.72 46.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.248 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 19.5 m-85 -106.4 141.13 38.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.28 110.62 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.73 -20.7 14.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.8 t -92.59 110.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -1.12 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 112.39 24.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 108.954 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.567 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -75.63 153.74 37.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 110.02 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.551 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.1 mtp180 -132.52 174.87 4.2 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.3 Cg_endo -77.66 167.53 23.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.11 1.873 . . . . 0.0 110.069 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.489 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 74.92 -80.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.191 -179.47 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 156' ' ' LYS . . . 174.99 67.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 mmtt -146.35 164.05 33.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.051 -1.264 . . . . 0.0 110.069 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.567 ' CD2' ' HA ' ' A' ' 151' ' ' GLN . 62.7 m-85 -148.31 179.61 7.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.574 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.51 107.78 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.028 -1.045 . . . . 0.0 109.991 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -80.85 117.13 21.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.032 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.46 ' OE2' ' HD2' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -141.76 140.45 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.53 -179.771 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.519 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.2 tt -125.38 159.42 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.519 ' N ' HG12 ' A' ' 161' ' ' ILE . 8.7 ttt180 -97.78 115.05 27.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 193' ' ' MET . 19.1 t0 -99.25 110.12 57.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.1 Cg_endo -77.63 -27.72 5.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.3 2.0 . . . . 0.0 110.168 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.71 -21.68 64.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.348 -0.845 . . . . 0.0 109.555 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 2.7 mttt -90.66 23.15 3.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.448 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 76.51 40.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.626 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.42 86.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.35 177.82 8.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -1.081 . . . . 0.0 109.417 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 0.9 OUTLIER -100.99 163.87 12.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.678 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.39 85.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.0 109.045 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.574 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.9 t-105 -73.2 97.12 2.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.395 -0.816 . . . . 0.0 109.883 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' A' ' 189' ' ' ALA . 1.1 mt -59.6 -41.06 89.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.88 . . . . 0.0 109.257 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.428 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 147.52 166.6 12.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -83.72 153.68 24.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -1.194 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 59.2 m-85 -126.72 -177.5 4.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.659 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 -30.97 16.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 181' ' ' ASP . 1.7 p -138.72 167.45 21.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.25 -41.21 67.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.293 -0.879 . . . . 0.0 109.79 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.7 OUTLIER -71.22 -40.74 70.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.56 -30.34 67.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.3 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.593 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -75.15 -34.04 61.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.143 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -66.72 -42.09 86.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 109.044 179.635 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.03 -22.72 64.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.2 t80 -77.32 -32.2 55.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.238 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 97.6 m-20 -67.55 -41.44 84.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -70.05 -35.91 74.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.867 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.487 ' HB3' ' CD2' ' A' ' 173' ' ' LEU . . . -77.51 -24.22 50.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.656 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.95 -26.74 27.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 195' ' ' GLY . 5.7 t80 -83.11 -23.55 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -43.74 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.515 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -75.01 -32.36 61.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.02 -179.658 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.9 mtt-85 -96.69 -13.28 22.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.283 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 191' ' ' PHE . . . 74.86 -125.2 8.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.68 172.37 9.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -1.094 . . . . 0.0 109.97 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.403 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 0.0 OUTLIER 54.04 -117.64 1.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.408 -0.807 . . . . 0.0 109.608 179.743 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 194' ' ' ARG . . . 65.35 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.692 -1.255 . . . . 0.0 109.317 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 200' ' ' LEU . 5.8 mt -85.04 130.13 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.705 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.527 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.66 166.16 18.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.806 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.427 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.3 OUTLIER -63.0 -31.91 73.16 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.327 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 7.2 m-85 -120.06 77.17 23.64 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo -78.24 86.06 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.699 2.266 . . . . 0.0 110.562 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.23 11.71 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.273 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -122.91 117.89 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.47 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.4 mtpt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 144' ' ' LYS . 30.9 m170 61.07 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.902 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.612 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 20.4 m-85 -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.242 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -82.35 92.46 6.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 186' ' ' TYR . . . 123.39 -5.58 9.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -108.96 120.72 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -1.159 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -97.07 118.65 33.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.493 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -89.36 149.45 23.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.606 -179.805 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.439 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mmt180 -120.51 158.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.52 8.81 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.616 2.21 . . . . 0.0 110.876 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.29 -13.33 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 105.4 49.21 0.99 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 8.8 mtmm -150.07 -174.74 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -1.165 . . . . 0.0 109.54 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 178' ' ' THR . 76.8 m-85 -153.99 178.35 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.271 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.619 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.12 111.15 4.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.683 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -84.91 118.43 24.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.345 -0.847 . . . . 0.0 108.96 179.46 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 19.2 mt-10 -137.42 179.55 6.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 109.28 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.2 tt -169.63 130.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -63.36 153.05 36.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.857 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.93 103.71 3.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.45 -25.33 9.79 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.42 2.08 . . . . 0.0 110.321 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.6 66.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 109.168 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 44.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 0.0 109.473 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t30 51.08 57.16 6.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.417 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 51.24 79.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -141.31 131.15 24.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -1.203 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -73.28 143.53 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.42 ' HB ' HG21 ' A' ' 161' ' ' ILE . 54.1 t -111.77 105.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.619 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 6.7 t-105 -89.69 95.57 10.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.53 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -53.58 -42.87 68.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.451 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 146.64 158.17 7.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.36 159.36 32.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -1.045 . . . . 0.0 109.516 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.557 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 70.9 m-85 -133.45 174.91 9.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.43 -30.42 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.6 p -137.54 -176.98 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.493 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -84.52 -30.15 25.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -68.05 -32.21 72.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.958 . . . . 0.0 109.584 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.469 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.1 OUTLIER -75.67 -48.59 21.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.306 -0.871 . . . . 0.0 109.025 179.862 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -66.61 -21.69 66.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 108.912 179.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.612 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -77.59 -45.77 24.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 17.9 tp -62.56 -40.75 97.86 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.17 -24.71 63.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 108.919 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 160' ' ' GLU . 14.6 t80 -70.77 -32.17 69.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -69.04 -45.61 69.97 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -58.29 -35.22 71.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.509 -0.744 . . . . 0.0 110.176 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.53 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -80.83 -33.63 34.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.516 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -86.95 -2.41 58.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.202 -0.937 . . . . 0.0 109.217 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.489 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 25.4 t80 -103.25 -24.47 13.54 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.295 -0.878 . . . . 0.0 109.113 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -84.48 -40.9 17.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 108.785 179.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -31.33 57.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.621 -0.674 . . . . 0.0 109.868 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 43.8 mtt180 -100.86 -18.82 16.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 47.57 -176.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.41 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.311 -1.111 . . . . 0.0 109.732 179.952 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.3 140.04 48.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.61 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 200' ' ' LEU . . . -144.83 163.58 33.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.412 ' C ' HD21 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -82.45 105.61 13.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.682 -179.773 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -122.86 164.97 17.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 108.998 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -66.4 -33.0 74.73 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.128 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.4 m-85 -124.54 76.06 63.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.97 142.58 22.25 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.683 2.255 . . . . 0.0 110.558 -179.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.0 65.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 109.561 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.423 ' C ' ' CG2' ' A' ' 206' ' ' VAL . 22.9 mmt180 -118.38 100.9 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.423 ' CG2' ' C ' ' A' ' 205' ' ' ARG . 1.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.408 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 145' ' ' HIS . 23.9 mttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.433 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER 70.88 113.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 22.8 m-85 -78.32 136.99 37.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.438 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.4 92.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.15 -32.06 3.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.465 HG22 ' CB ' ' A' ' 146' ' ' TYR . 29.5 t -77.8 133.64 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -1.216 . . . . 0.0 109.801 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.502 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -121.41 107.01 11.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.324 179.898 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.575 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.3 pt20 -75.09 164.61 26.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.46 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.9 mtt-85 -127.81 172.11 7.33 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.678 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.02 -30.22 3.72 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.822 2.348 . . . . 0.0 110.704 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -35.36 60.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.657 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.46 34.93 0.43 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -127.23 159.42 34.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -1.165 . . . . 0.0 109.264 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 27.5 m-85 -125.19 -179.12 4.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.566 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.41 108.29 3.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.31 114.8 19.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.718 179.185 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -131.18 157.88 42.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.567 -179.727 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.6 tt -149.8 128.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.551 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.15 8.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.454 ' HB2' HG22 ' A' ' 171' ' ' VAL . 48.3 t0 -92.8 117.22 67.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 109.557 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 35.6 Cg_endo -78.19 -26.24 6.5 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.286 1.991 . . . . 0.0 109.899 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.73 -14.63 62.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 6.2 mmtp -101.26 30.16 4.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 41.3 t-20 67.51 28.4 7.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.53 62.5 2.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.8 129.26 55.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -1.128 . . . . 0.0 109.469 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.42 122.52 16.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.504 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 21.6 t -101.73 94.69 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.566 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 5.8 t-105 -69.65 100.73 1.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -59.77 -48.99 79.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.656 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 153.67 152.56 6.09 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.1 p -69.51 163.71 24.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -1.206 . . . . 0.0 109.131 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 60.7 m-85 -140.0 -177.84 5.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -86.85 -30.01 21.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.626 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.579 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -146.71 171.41 15.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.589 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.558 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -69.82 -22.51 63.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.05 -40.54 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.1 m-20 -71.52 -41.84 68.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.27 -30.38 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -74.42 -40.7 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -38.85 89.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.497 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.32 -24.15 63.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.6 t80 -73.93 -29.07 61.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.534 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 43.4 m-20 -70.26 -49.04 53.89 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.218 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -60.97 -38.49 86.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 109.874 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.434 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -80.5 -21.83 41.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.646 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.92 -14.31 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.76 -27.14 14.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 109.101 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -82.56 -40.36 21.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 2.7 tpp -70.9 -30.56 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.666 -0.647 . . . . 0.0 109.357 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 196' ' ' SER . 2.7 mtt180 -101.13 -12.82 18.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.33 -0.856 . . . . 0.0 109.242 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 52.61 -88.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 194' ' ' ARG . 0.3 OUTLIER -46.3 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -1.093 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' SER . 13.4 mtt180 -40.44 157.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 200' ' ' LEU . . . -164.25 156.25 16.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 109.307 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.13 127.85 37.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.534 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.96 162.67 29.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.141 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 0.2 OUTLIER -58.23 -34.69 70.7 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.117 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 8.5 m-85 -116.58 80.95 10.86 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 33.8 Cg_endo -76.13 111.1 3.2 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.561 2.174 . . . . 0.0 110.311 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 62.79 151.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.008 -179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.442 ' HG3' HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -153.05 -172.86 4.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 -179.907 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 205' ' ' ARG . 1.3 t . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.3 mttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -178.46 167.41 1.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.858 . . . . 0.0 109.6 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.634 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 9.2 m-85 -114.15 148.09 37.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.61 87.76 3.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 108.824 179.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.97 2.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 182' ' ' ALA . 45.8 t -137.87 108.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.288 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.81 127.62 33.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.426 -0.796 . . . . 0.0 109.009 179.713 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.1 pp0? -104.48 146.64 28.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.944 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.5 164.03 15.89 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.61 37.0 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.836 2.358 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -146.05 -62.28 0.32 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.02 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.99 36.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.63 168.92 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -1.202 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 178' ' ' THR . 59.3 m-85 -148.36 177.23 9.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.374 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.15 111.84 4.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -82.29 110.4 17.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -131.33 149.52 52.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.281 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 17.4 tt -128.21 146.68 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.094 -1.004 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -87.38 130.59 34.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 109.55 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -119.96 94.39 48.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.468 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 35.9 Cg_endo -78.26 -22.78 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.578 2.186 . . . . 0.0 110.44 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.46 75.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 166' ' ' LYS . 8.4 mmtt -86.25 63.03 7.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.847 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 168' ' ' GLY . 1.8 m-80 52.67 48.55 22.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 43.41 52.63 6.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.52 130.08 35.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 109.319 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 143.94 46.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.416 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 77.1 t -123.19 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.835 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 4.8 t-105 -117.01 97.33 5.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.525 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 2.3 mp -54.83 -50.51 68.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.266 -0.896 . . . . 0.0 109.149 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 155.31 153.56 6.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.4 p -65.36 166.93 9.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -1.046 . . . . 0.0 109.332 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.565 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 65.0 m-85 -144.02 174.51 10.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -25.3 30.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.731 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 2.3 p -149.56 171.06 17.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.47 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -70.56 -25.46 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.46 -42.1 75.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.28 -48.59 56.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.202 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.552 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -65.91 -22.82 66.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.922 . . . . 0.0 109.029 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.634 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -78.22 -36.89 46.55 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 108.873 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -68.05 -45.22 74.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.581 -0.699 . . . . 0.0 109.175 179.491 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.565 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.01 -23.69 65.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.459 -0.775 . . . . 0.0 109.012 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.476 ' O ' ' HB1' ' A' ' 190' ' ' ALA . 12.2 t80 -71.52 -35.38 70.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -0.783 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.6 m-20 -65.64 -41.85 92.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.321 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -41.05 84.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -82.75 -19.65 37.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.33 -9.63 52.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -99.12 -31.22 11.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.821 . . . . 0.0 109.271 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -77.98 -42.78 31.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.896 . . . . 0.0 109.116 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 48.0 ttm -69.65 -31.53 69.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.315 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 22.2 mtt-85 -100.86 11.91 38.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 48.57 -154.54 1.76 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 29.6 m -53.45 143.27 19.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -1.119 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 196' ' ' SER . 6.5 mtp85 68.53 138.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.466 ' O ' HD22 ' A' ' 200' ' ' LEU . . . 176.47 140.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.417 ' C ' HD22 ' A' ' 200' ' ' LEU . 2.2 mt -81.37 109.3 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -116.0 -178.09 3.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.408 179.755 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.458 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -81.38 -28.81 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.155 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 6.6 m-85 -122.68 70.15 36.33 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -76.29 110.37 3.05 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.467 2.112 . . . . 0.0 110.165 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.18 -73.94 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.985 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.15 -165.67 2.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.02 -179.555 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.208 179.967 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.348 0.594 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -113.66 166.33 11.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.555 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 12.4 m-85 -130.66 141.72 50.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.878 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.36 89.67 3.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 108.848 179.364 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.48 11.0 3.47 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 146' ' ' TYR . 47.3 t -126.3 109.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.289 . . . . 0.0 109.359 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -93.0 111.34 22.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.443 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.5 pt20 -80.87 151.08 28.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 108.975 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.49 163.89 37.72 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.442 -179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.13 -5.56 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.615 2.21 . . . . 0.0 110.121 -179.88 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -98.23 27.89 4.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 109.273 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.53 60.99 7.98 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -156.44 170.52 22.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 179' ' ' ALA . 73.4 m-85 -142.64 172.84 12.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.008 179.917 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.87 105.28 4.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.57 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -81.5 123.09 28.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.051 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.465 ' CD ' ' CE3' ' A' ' 172' ' ' TRP . 4.3 mt-10 -145.28 153.3 41.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 0.0 109.334 -179.543 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.5 tt -141.04 149.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -84.33 117.1 23.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 109.734 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.523 ' HB2' ' CE ' ' A' ' 193' ' ' MET . 67.8 t0 -114.58 102.12 54.66 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -25.53 9.78 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.326 2.017 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.47 -16.12 63.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.863 . . . . 0.0 109.217 179.67 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -93.38 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.7 54.13 9.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.421 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.95 71.26 0.67 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.23 118.55 12.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.494 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.4 ' O ' HG21 ' A' ' 171' ' ' VAL . 13.1 ptp180 -54.21 170.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 163' ' ' ASP . 38.4 t -139.84 90.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.656 -179.694 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 6.0 t-105 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 109.178 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.466 HD12 ' HB1' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -52.62 -43.96 65.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 -179.72 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.38 150.39 5.23 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.8 p -63.18 168.78 3.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -1.157 . . . . 0.0 109.327 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.57 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 63.9 m-85 -141.55 -174.14 3.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.515 -179.767 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.74 -24.97 14.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.698 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.46 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.6 p -140.82 174.49 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -77.29 -24.83 50.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.328 -0.857 . . . . 0.0 109.363 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -77.02 -30.27 55.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.631 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -76.08 -40.68 52.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 109.279 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.96 -36.48 69.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.195 -0.941 . . . . 0.0 109.028 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.605 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -69.58 -39.78 77.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.799 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.97 -46.32 88.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 109.004 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.76 -26.87 67.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.475 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 29.8 t80 -68.7 -36.28 78.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.132 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 7.0 m-20 -64.07 -52.15 60.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 109.838 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -56.88 -37.16 70.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.422 -0.799 . . . . 0.0 109.527 -179.76 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 173' ' ' LEU . . . -78.38 -20.65 50.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.212 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.68 -11.88 43.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.3 t80 -101.88 -26.67 13.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.119 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -40.63 29.85 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.315 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 163' ' ' ASP . 13.9 mtp -77.93 -44.49 26.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.242 0.544 . . . . 0.0 110.165 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.0 mtt180 -83.51 -37.74 22.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 108.943 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 58.52 145.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ALA . 2.8 m 63.12 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -1.138 . . . . 0.0 109.987 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 44.26 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.999 179.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 196' ' ' SER . . . 66.95 144.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.988 . . . . 0.0 109.328 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.434 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.12 117.27 34.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.913 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.1 156.06 35.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 179.944 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -32.32 73.5 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.05 97.51 47.95 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.094 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.459 ' HA ' HD13 ' A' ' 200' ' ' LEU . 33.4 Cg_endo -74.62 106.72 2.31 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.331 2.02 . . . . 0.0 110.6 -179.188 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 93.36 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.392 -179.874 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 58.17 100.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 179.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.432 -179.927 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -52.18 179.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 28.4 m-85 -80.19 142.54 34.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 -179.845 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.87 37.64 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.129 179.738 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . -169.95 26.77 0.11 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 182' ' ' ALA . 60.9 t -142.67 117.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -1.091 . . . . 0.0 109.681 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 93.08 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.162 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.47 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 9.9 pt20 -60.65 144.67 51.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.75 -179.748 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.482 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -103.88 171.7 4.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.308 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.2 Cg_endo -77.12 -31.81 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -82.6 -74.98 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.73 71.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 56.3 mttt -153.85 168.04 27.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.577 179.925 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 64.0 m-85 -150.68 120.67 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 108.737 179.694 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.608 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -93.76 118.87 31.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.748 -178.823 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.509 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -86.15 122.73 30.57 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.308 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.437 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 11.2 tt0 -137.69 150.6 47.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.02 . . . . 0.0 110.421 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 4.3 tt -136.23 137.33 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -86.57 127.46 34.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.834 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.418 ' HB2' ' HE3' ' A' ' 193' ' ' MET . 63.3 t0 -125.05 105.55 28.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.413 -0.805 . . . . 0.0 108.984 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.91 -26.08 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.455 2.103 . . . . 0.0 110.58 -179.737 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.88 -12.0 57.83 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 51.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 56.24 25.05 8.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 -179.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.18 40.92 40.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -100.1 142.87 30.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -84.43 155.7 22.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.3 100.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.608 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.4 t-105 -80.16 95.29 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.322 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.486 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -50.55 -49.46 55.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.039 -179.641 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.466 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 151.23 155.25 6.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.6 p -68.18 169.97 9.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -1.095 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.509 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 67.2 m-85 -148.2 -170.46 3.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -23.84 13.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.578 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.574 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.6 p -144.34 160.05 41.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.302 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.56 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -66.26 -24.7 66.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.065 -1.022 . . . . 0.0 109.216 179.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.66 -33.22 68.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -76.78 -47.88 20.32 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.021 179.78 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -66.46 -25.62 66.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.17 -0.956 . . . . 0.0 108.954 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.616 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -74.12 -49.94 21.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.112 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -34.09 74.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.438 -0.789 . . . . 0.0 109.032 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.74 -30.63 68.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.5 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -67.77 -27.89 67.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.712 . . . . 0.0 109.109 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 58.5 m-20 -71.19 -45.27 63.78 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.596 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -65.15 -29.03 69.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 110.368 -179.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.486 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -85.7 -32.65 21.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 110.026 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -80.99 -18.81 45.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.41 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.3 t80 -91.02 -38.73 12.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.326 -0.859 . . . . 0.0 109.353 179.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -41.85 97.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.09 -1.007 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 163' ' ' ASP . 3.6 ttm -79.95 -43.1 22.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 109.271 179.608 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 21.4 mtt180 -101.96 32.96 3.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.515 -0.74 . . . . 0.0 109.162 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -37.94 -32.47 0.12 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -75.74 81.93 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -1.15 . . . . 0.0 109.263 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 61.19 139.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.358 -179.806 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -170.57 144.51 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -98.1 108.99 21.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.454 ' HB3' ' OD1' ' A' ' 187' ' ' ASP . 0.2 OUTLIER -111.1 159.42 17.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.435 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -53.0 -37.81 61.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.094 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.9 m-85 -123.08 86.12 51.15 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.321 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.75 131.4 13.4 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.644 2.229 . . . . 0.0 110.722 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.91 123.94 19.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 0.0 109.436 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 58.23 104.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.461 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.439 179.968 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -110.71 96.45 6.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 14.8 m-85 -67.66 147.08 53.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -77.82 94.44 4.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.25 -3.4 11.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 49.0 t -108.69 112.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.27 . . . . 0.0 110.057 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.541 ' HG3' ' CB ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -87.43 111.61 21.31 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.752 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.563 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 8.0 pt20 -90.06 138.62 31.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -178.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.631 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 14.0 mmm-85 -74.86 -166.76 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.1 Cg_endo -76.88 -15.23 16.83 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.313 1.342 . . . . 0.0 110.629 -179.256 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.54 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 158.79 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.496 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.58 -68.93 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.347 179.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mttt -116.7 -168.53 1.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.852 -1.381 . . . . 0.0 111.282 -178.16 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.615 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 50.9 m-85 -154.8 179.46 9.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.2 110.33 4.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 109.993 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 182' ' ' ALA . . . -81.5 134.86 35.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.71 134.68 14.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.8 tt -120.11 141.4 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.411 ' HD2' ' HD3' ' A' ' 164' ' ' PRO . 1.6 tmm_? -85.07 129.54 34.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -116.12 92.47 35.62 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD3' ' HD2' ' A' ' 162' ' ' ARG . 34.8 Cg_endo -76.97 -22.35 11.56 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.676 2.251 . . . . 0.0 110.719 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.12 69.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.407 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 35.4 mmtt -85.38 -55.78 3.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 109.473 179.907 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 12.6 p30 169.14 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.97 4.5 67.5 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.824 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.09 108.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.119 . . . . 0.0 109.446 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 142.86 29.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.265 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 161' ' ' ILE . 47.1 t -115.65 83.18 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 3.5 t-105 -65.32 100.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 109.164 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 189' ' ' ALA . 4.8 mt -61.61 -41.48 97.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.687 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 144.29 174.0 16.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.846 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -92.06 157.36 16.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.252 . . . . 0.0 109.148 179.753 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 78.7 m-85 -130.53 -176.51 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.815 -179.53 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.408 ' O ' HG21 ' A' ' 178' ' ' THR . 8.8 mm-40 -89.14 -20.12 24.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 4.0 p -147.97 175.41 11.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.95 . . . . 0.0 109.87 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -78.7 -22.21 47.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.45 -0.781 . . . . 0.0 109.45 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.6 tm-20 -76.83 -32.43 57.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -77.78 -36.12 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.927 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.27 -43.92 60.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 108.895 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -63.34 -37.15 86.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.361 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -64.98 -46.71 80.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.521 -0.737 . . . . 0.0 109.11 179.495 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.98 -18.8 64.64 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.5 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -74.14 -38.12 63.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.041 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 25.2 m-20 -62.16 -49.87 74.12 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.449 -0.782 . . . . 0.0 109.37 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -52.11 -44.84 64.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.618 -0.676 . . . . 0.0 109.925 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.449 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -78.32 -19.15 54.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 109.702 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -92.27 -4.55 53.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.883 . . . . 0.0 109.586 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.441 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.1 t80 -108.38 -29.8 8.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -85.04 -37.75 19.98 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.016 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.7 ttm -77.88 -35.61 50.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.737 -0.602 . . . . 0.0 109.562 179.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.5 mtp180 -94.26 -23.57 17.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.139 -0.976 . . . . 0.0 108.886 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 53.2 170.29 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.986 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 43.61 -159.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -1.211 . . . . 0.0 109.664 179.898 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.25 153.84 3.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.579 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -160.86 168.18 25.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.43 104.83 14.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.519 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -122.75 162.96 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.983 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.471 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -65.7 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.606 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 7.2 m-85 -119.1 80.29 19.04 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 204' ' ' LEU . 34.7 Cg_endo -77.18 140.26 19.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.566 2.178 . . . . 0.0 110.285 -179.557 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 203' ' ' PRO . 0.3 OUTLIER 54.05 172.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.33 -179.93 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.431 ' CZ ' ' CB ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -89.1 112.04 22.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.313 179.89 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.587 -179.85 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.598 ' CG ' ' O ' ' A' ' 145' ' ' HIS . 0.5 OUTLIER -152.7 71.48 0.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.84 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 65.9 m-85 -51.06 168.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.388 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -81.01 36.07 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.616 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.415 ' HA3' ' CD2' ' A' ' 186' ' ' TYR . . . -176.8 27.3 0.07 OUTLIER Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.664 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 182' ' ' ALA . 78.6 t -150.67 139.8 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -1.204 . . . . 0.0 109.648 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -110.55 160.1 16.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 108.991 179.489 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.576 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.0 pt20 -131.37 146.15 52.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.043 -1.036 . . . . 0.0 110.115 -179.48 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.8 OUTLIER -121.63 160.55 45.93 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.759 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -77.78 -4.43 14.5 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 110.776 -179.848 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -98.08 -7.35 29.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.504 179.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.28 47.46 1.85 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 9.2 mtpp -146.74 140.72 26.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.161 . . . . 0.0 109.513 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' A' ' 151' ' ' GLN . 7.0 m-85 -119.98 -170.28 1.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.917 . . . . 0.0 109.376 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.579 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -156.43 110.51 2.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 179.892 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -81.11 119.78 24.0 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.435 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 12.3 mt-10 -136.94 153.89 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.827 . . . . 0.0 109.603 -179.67 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.457 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 5.8 tt -141.61 138.91 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 108.979 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.47 131.39 35.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.756 -179.664 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -124.73 90.81 50.41 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.51 -23.33 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.549 2.166 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.46 -9.89 29.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 15.0 mmtp -104.37 23.7 12.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 26.8 t-20 64.34 45.14 3.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.06 110.74 0.12 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 170' ' ' ARG . . . -177.11 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -1.179 . . . . 0.0 109.466 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -43.2 163.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.457 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 92.7 t -135.15 91.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.955 . . . . 0.0 109.864 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 10.8 t-105 -75.31 92.38 2.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 108.882 179.464 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -52.31 -46.11 65.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.224 -179.741 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.25 156.37 7.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.678 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 5.6 p -73.21 153.27 40.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -1.082 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.584 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 61.2 m-85 -128.99 -170.97 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 -32.38 14.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.277 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.555 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -141.41 173.89 11.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.226 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.508 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -72.27 -24.58 61.37 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -70.63 -37.7 73.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.867 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.97 -43.81 51.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.072 -1.018 . . . . 0.0 109.205 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.27 -24.81 63.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 108.997 179.717 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.609 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -75.59 -44.9 40.72 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -61.68 -43.52 98.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.573 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.83 -32.23 73.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 108.827 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -64.46 -29.62 70.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.325 -0.859 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 191' ' ' PHE . 38.1 m-20 -72.92 -43.56 62.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.382 -0.824 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.03 -23.94 67.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.772 . . . . 0.0 110.127 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.52 ' HB1' ' CD2' ' A' ' 173' ' ' LEU . . . -92.72 -31.9 14.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.011 -1.056 . . . . 0.0 109.761 -179.708 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.93 -10.83 57.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.235 -0.915 . . . . 0.0 109.099 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -100.38 -41.15 7.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 179.542 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -41.24 94.34 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.32 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 ttp -75.73 -42.75 49.81 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 109.177 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 37.4 mtt180 -104.0 33.95 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.48 -0.763 . . . . 0.0 109.095 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -38.29 109.3 0.09 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 1.4 t 162.87 -71.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -1.071 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 62.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.785 . . . . 0.0 109.214 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.472 ' O ' HD22 ' A' ' 200' ' ' LEU . . . -83.27 160.92 21.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.859 . . . . 0.0 109.627 -179.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.88 124.18 35.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 108.988 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.472 HD22 ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -123.97 177.03 5.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.482 -179.59 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.533 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.5 OUTLIER -63.92 -34.88 78.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.327 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.1 m-85 -122.66 79.66 48.03 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.32 67.03 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.817 2.344 . . . . 0.0 110.742 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.59 155.6 45.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.749 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -171.95 132.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.689 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.479 179.898 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.313 0.578 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -150.54 105.42 3.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.656 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 19.1 m-85 -95.07 141.81 28.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 179.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' ARG . 3.2 ptt180 -75.13 127.85 34.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.181 179.623 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.28 -21.02 47.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 183' ' ' ALA . 89.3 t -94.3 108.02 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -79.21 147.71 32.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.058 -1.026 . . . . 0.0 108.769 179.339 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.454 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.6 pp0? -120.07 140.36 51.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.897 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.463 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mpp_? -115.87 171.43 4.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -78.04 -35.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.63 2.22 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.63 -21.81 66.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.522 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.24 17.62 8.16 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -102.37 174.33 5.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -1.154 . . . . 0.0 109.449 179.905 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.455 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 55.4 m-85 -147.55 -172.86 4.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.006 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.584 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.05 110.34 2.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.75 121.83 25.84 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.204 -0.935 . . . . 0.0 108.915 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -142.92 151.49 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 -179.552 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 5.4 tt -137.33 128.35 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.854 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 5.2 ptt180 -73.48 117.95 15.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -98.73 109.26 52.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 109.602 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.43 -25.13 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.353 2.036 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.16 -17.54 60.9 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.356 -0.84 . . . . 0.0 109.343 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -94.75 26.93 3.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 63.56 48.2 3.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.503 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.87 69.2 1.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -127.78 103.97 7.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -1.135 . . . . 0.0 109.389 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 149.13 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 29.9 t -127.55 93.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.095 179.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 10.2 t-105 -73.8 97.43 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.817 -179.614 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -58.38 -38.13 76.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.48 157.04 7.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.81 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 4.9 p -73.73 155.63 38.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -1.047 . . . . 0.0 109.784 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 59.8 m-85 -131.24 173.95 10.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' O ' HG21 ' A' ' 178' ' ' THR . 0.5 OUTLIER -85.58 -18.16 34.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 0.0 109.7 -179.854 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 177' ' ' GLU . 3.7 p -151.53 173.31 14.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.953 . . . . 0.0 109.592 -179.758 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.486 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -74.95 -24.98 58.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.54 -34.68 65.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.46 -34.11 54.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.377 -0.827 . . . . 0.0 109.269 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -78.73 -26.98 44.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -0.908 . . . . 0.0 109.319 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -76.7 -37.58 55.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.134 -0.979 . . . . 0.0 108.688 179.382 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -62.65 -44.12 97.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.191 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.35 -33.95 77.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.457 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 190' ' ' ALA . 11.7 t80 -62.73 -35.11 78.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.14 179.624 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 62.7 m-20 -60.41 -53.26 59.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.503 -0.748 . . . . 0.0 109.901 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -26.78 66.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.484 ' HB2' HG23 ' A' ' 161' ' ' ILE . . . -88.57 -16.91 31.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.448 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 186' ' ' TYR . . . -93.48 -11.73 31.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -99.84 -33.85 10.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 108.865 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -79.54 -42.29 25.43 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.425 ' HE2' HG22 ' A' ' 171' ' ' VAL . 3.5 tpp -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.644 -0.66 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.6 mmp_? -102.17 12.59 36.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.03 -156.31 11.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 5.4 p -65.41 154.72 37.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 196' ' ' SER . 10.8 mtt180 62.86 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -161.65 173.66 14.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.46 125.91 51.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.603 -179.8 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.45 -179.76 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.815 -179.63 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.437 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -75.88 -34.6 59.99 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.128 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.3 m-85 -123.84 83.61 54.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.86 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.82 143.31 23.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.511 2.141 . . . . 0.0 110.508 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.47 -161.33 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.426 179.963 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' CG ' ' N ' ' A' ' 206' ' ' VAL . 0.3 OUTLIER -140.55 -41.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.734 -179.919 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.424 ' N ' ' CG ' ' A' ' 205' ' ' ARG . 9.6 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -164.41 123.7 1.91 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.644 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 26.9 m-85 -99.57 144.71 28.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 -179.885 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -79.15 76.39 5.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.228 179.647 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.98 -21.33 0.44 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.511 HG12 ' CB ' ' A' ' 182' ' ' ALA . 16.8 t -101.11 109.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.283 . . . . 0.0 109.455 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.77 174.7 5.77 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.608 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.584 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -142.53 133.35 25.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 110.282 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.568 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.0 ttm-85 -68.67 -174.95 0.23 Allowed Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.918 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 29.3 Cg_endo -70.75 82.78 0.92 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.17 1.246 . . . . 0.0 110.021 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 7.2 m95 63.7 65.41 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.524 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.62 -132.49 1.35 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.537 -1.315 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -79.23 159.17 27.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.549 -0.971 . . . . 0.0 110.47 -178.756 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 151' ' ' GLN . 8.5 m-30 -101.71 -163.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -158.35 112.3 2.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.896 -1.127 . . . . 0.0 110.779 -179.906 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -84.94 128.01 34.43 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.381 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -143.76 166.85 23.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.108 -178.942 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.424 HG12 ' N ' ' A' ' 162' ' ' ARG . 1.9 tt -161.74 149.05 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 161' ' ' ILE . 12.6 ptm180 -80.73 153.69 27.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.632 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.25 104.91 25.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.68 -28.49 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.399 2.066 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.81 62.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.093 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' CB ' ' HB1' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -100.67 32.36 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.803 . . . . 0.0 109.494 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 9.2 t-20 69.56 44.13 0.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 61.55 22.37 61.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 166' ' ' LYS . . . -66.47 137.16 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -1.083 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -69.15 161.7 28.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.3 t -144.44 97.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.268 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.574 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 3.3 t-105 -79.55 105.82 11.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.622 -179.858 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -59.33 -60.39 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.64 153.98 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -69.3 156.7 38.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.399 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.575 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 59.2 m-85 -134.24 -162.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 -179.766 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 178' ' ' THR . 0.0 OUTLIER -111.09 -25.55 9.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.799 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.52 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 2.9 p -145.78 -177.32 5.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.925 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.515 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -79.92 -27.76 39.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 109.29 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.17 -37.66 75.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.413 ' OD2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -72.87 -57.3 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 -179.809 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 176' ' ' PHE . . . -59.27 -31.61 69.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.869 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.644 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -68.87 -42.96 76.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.333 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 1.8 tm? -61.67 -44.44 96.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.857 . . . . 0.0 108.792 179.556 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.573 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.06 -28.16 69.28 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 27.6 t80 -68.8 -35.39 76.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.552 -0.718 . . . . 0.0 109.138 179.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -60.52 -48.18 82.89 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.323 -0.86 . . . . 0.0 109.594 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -55.14 -42.72 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.529 ' CB ' HD13 ' A' ' 173' ' ' LEU . . . -74.55 -20.65 59.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.496 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.36 2.43 56.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.0 t80 -109.77 -29.28 8.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 108.636 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -84.07 -39.36 19.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 0.0 OUTLIER -75.23 -32.47 61.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.646 -0.659 . . . . 0.0 109.86 179.861 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 4.3 mtt85 -92.44 -12.58 31.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 88.52 -145.94 19.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.448 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 2.1 m -54.85 -96.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -1.101 . . . . 0.0 109.613 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 6.8 ttm105 -56.36 164.55 1.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.063 -1.023 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . 179.04 176.35 0.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.425 ' C ' HD22 ' A' ' 200' ' ' LEU . 2.4 mt -113.4 106.1 14.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.899 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -115.1 158.04 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.7 OUTLIER -64.41 -28.93 70.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.321 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.0 m-85 -126.22 72.84 71.92 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.571 -0.706 . . . . 0.0 109.19 -179.685 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 200' ' ' LEU . 35.1 Cg_endo -77.37 148.47 26.72 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.723 2.282 . . . . 0.0 110.444 -179.591 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.83 86.65 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 33.05 4.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.439 179.731 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.396 179.933 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 mptt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.428 ' CD2' ' NE2' ' A' ' 151' ' ' GLN . 35.9 m170 -76.42 106.28 7.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.646 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 21.4 m-85 -102.98 145.21 30.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.61 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -75.05 82.8 2.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.24 179.666 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.03 9.65 1.44 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.617 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 54.1 t -121.09 111.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.747 -1.443 . . . . 0.0 109.892 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.43 101.26 5.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 108.917 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 1.1 pt20 -97.38 134.49 40.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.375 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.585 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 5.3 mtt180 -89.35 -176.19 0.64 Allowed Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.03 87.09 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.087 1.858 . . . . 0.0 110.281 -179.642 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 43.7 m95 55.43 73.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.393 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.59 -93.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.659 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.546 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.1 mtpp -115.77 -168.78 1.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -1.12 . . . . 0.0 110.431 -178.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 156' ' ' LYS . 45.0 m-85 -150.61 -175.96 5.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.05 155.58 34.36 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.544 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -129.5 115.77 17.96 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.84 159.86 41.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.392 -179.526 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.504 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 9.9 tt -134.91 136.21 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.33 126.78 34.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -115.51 91.16 28.12 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 109.487 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.31 -25.08 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.534 2.156 . . . . 0.0 110.454 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -92.55 23.36 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 38.19 8.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.928 . . . . 0.0 109.555 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.04 122.5 2.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.86 80.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.19 148.31 4.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 51.4 t -129.89 93.07 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.58 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 7.5 t-105 -81.29 95.35 6.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.667 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.516 HD23 ' CB ' ' A' ' 189' ' ' ALA . 21.1 mt -53.57 -50.55 65.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.77 . . . . 0.0 109.306 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.96 14.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 4.2 p -81.68 145.77 30.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.1 m-85 -120.01 -169.93 1.87 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 -179.841 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.59 -29.29 12.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.51 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.8 p -138.22 167.66 21.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.5 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -70.75 -24.68 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.271 -0.893 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 39.6 tt0 -73.49 -30.4 63.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.668 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -81.71 -41.43 21.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 -179.868 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.15 -39.15 78.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.13 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -67.18 -42.06 84.86 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.395 -0.815 . . . . 0.0 108.828 179.589 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.431 ' HG ' ' CD2' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -59.35 -46.29 89.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.027 179.592 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.61 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.2 -23.05 67.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.1 t80 -71.55 -34.4 69.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.422 -0.799 . . . . 0.0 109.144 179.711 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.455 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 15.2 m-20 -63.37 -41.73 98.81 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -50.31 74.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 -179.757 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.516 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -74.37 -18.51 60.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.783 -179.507 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.488 ' HB1' ' CE1' ' A' ' 186' ' ' TYR . . . -91.3 -4.77 55.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -106.19 -32.14 8.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.259 -0.901 . . . . 0.0 108.841 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -41.3 30.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 47.0 ttm -70.82 -33.78 71.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 179.648 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.513 ' CD ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -84.93 -17.19 38.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.411 -0.806 . . . . 0.0 109.08 179.713 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 63.09 -88.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 195' ' ' GLY . 3.9 p -54.65 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 196' ' ' SER . 4.1 mpt_? -53.85 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' CD ' ' A' ' 194' ' ' ARG . . . 177.44 160.29 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 113.93 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.551 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.455 ' CB ' ' CG ' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -114.84 179.91 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.295 179.919 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -72.31 -31.87 66.07 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.03 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.1 m-85 -125.94 71.51 68.68 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo -76.82 149.26 29.32 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.646 2.231 . . . . 0.0 110.619 -179.468 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 205' ' ' ARG . 1.2 mt 173.94 175.64 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER 61.1 114.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.144 -0.972 . . . . 0.0 109.53 -179.985 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.468 -179.989 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.35 161.27 20.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 26.9 m-85 -84.4 163.26 19.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.59 96.08 6.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.29 -9.82 11.86 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 78.4 t -104.31 114.5 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.252 . . . . 0.0 109.739 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -87.26 141.55 28.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 108.733 179.436 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.462 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -113.16 141.39 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.0 -1.062 . . . . 0.0 109.872 -179.583 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.4 mmt-85 -116.75 162.18 28.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.888 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.61 -25.34 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.439 2.093 . . . . 0.0 110.279 179.839 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.47 82.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 156' ' ' LYS . . . 133.53 37.29 0.24 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 155' ' ' GLY . 22.2 mttt -135.12 170.83 15.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -1.106 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 64.1 m-85 -140.79 -170.35 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -159.29 113.64 2.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 109.934 179.686 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -86.18 123.63 31.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.473 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.554 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 9.3 mt-10 -141.58 169.16 18.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.66 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 19.1 tt -152.54 131.41 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.976 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 18.3 ptt180 -94.8 118.35 31.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 109.978 -179.374 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.422 ' HB2' ' HE2' ' A' ' 193' ' ' MET . 11.8 t0 -108.68 107.02 59.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.43 -0.794 . . . . 0.0 109.008 179.557 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.84 -28.77 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.389 2.059 . . . . 0.0 110.477 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.18 40.73 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.219 -0.925 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . 29.3 mttm -94.91 33.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.05 37.91 20.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.85 83.68 0.43 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 166' ' ' LYS . . . -137.78 118.83 14.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.15 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -78.68 151.19 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.744 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 17.9 t -131.04 100.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.013 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 5.1 t-105 -87.12 99.9 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.683 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -55.4 -51.2 67.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.852 . . . . 0.0 109.562 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 153.7 153.77 6.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 3.1 p -72.24 148.22 45.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -1.115 . . . . 0.0 109.671 -179.869 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.0 m-85 -122.41 -169.14 1.85 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.464 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 2.3 pt-20 -101.47 -25.91 13.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.0 p -138.7 174.35 10.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.293 179.537 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -78.12 -26.76 48.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.213 -0.929 . . . . 0.0 109.761 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.23 -37.76 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.076 -1.015 . . . . 0.0 109.805 -179.754 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -72.7 -39.19 67.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.34 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -72.41 -31.16 65.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.24 -36.0 66.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.329 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.99 -49.18 73.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.214 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.47 -30.95 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.32 -0.862 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -67.23 -32.41 73.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.37 -0.831 . . . . 0.0 109.32 179.706 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 9.6 m-20 -65.56 -35.15 80.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -50.21 30.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.812 . . . . 0.0 110.476 -179.401 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.426 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -67.62 -25.87 65.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 110.072 -179.294 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -81.87 -29.0 32.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.632 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.483 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.4 t80 -78.32 -22.41 48.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.968 . . . . 0.0 108.995 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -73.98 -50.52 19.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 108.978 179.574 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.516 ' HE3' ' CG2' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -71.25 -36.41 71.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.779 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.8 OUTLIER -104.08 36.81 2.23 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 179.917 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . -31.42 -68.54 0.12 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 197' ' ' ARG . 29.8 m -61.42 89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -1.193 . . . . 0.0 109.125 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.7 OUTLIER 62.84 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 109.25 -179.66 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.427 ' HB1' ' CB ' ' A' ' 194' ' ' ARG . . . -154.57 154.95 33.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.633 -179.882 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 tm? -99.89 123.87 44.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -131.98 175.61 9.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.744 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.415 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.12 -34.29 66.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.818 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.0 m-85 -119.81 82.71 27.89 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.372 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.98 49.23 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.89 2.393 . . . . 0.0 111.051 -179.095 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.3 tt -140.24 113.04 8.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.969 . . . . 0.0 109.304 179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.24 121.32 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.764 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.542 179.938 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.94 90.81 2.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.216 -0.927 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 201' ' ' ASN . 50.5 m-85 -86.5 154.28 21.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.896 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.26 90.21 3.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 -17.82 5.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 92.9 t -96.92 110.32 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -1.137 . . . . 0.0 110.125 -179.573 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 29.5 mtt180 -85.55 141.07 30.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.534 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -107.47 152.76 23.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.976 -1.077 . . . . 0.0 110.41 -178.954 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.538 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -126.04 147.02 57.71 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.003 179.841 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.18 -6.63 16.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -98.85 7.52 45.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.774 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.27 81.43 1.21 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER 175.31 163.12 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.153 . . . . 0.0 109.552 -179.998 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 156' ' ' LYS . 36.2 m-85 -146.51 -176.25 5.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.594 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.08 110.24 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -82.34 118.39 23.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 1.5 mt-10 -138.78 153.14 48.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.803 . . . . 0.0 109.16 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -134.93 130.71 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.066 -1.021 . . . . 0.0 109.734 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -70.11 126.37 29.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.186 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -121.62 94.84 48.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.56 -21.08 11.74 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.616 2.211 . . . . 0.0 110.414 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.43 70.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 4.0 mmtm -79.99 -69.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 109.417 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.4 p30 166.81 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.42 34.25 68.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.31 96.97 7.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -1.143 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -50.2 156.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.661 -179.762 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 171' ' ' VAL . 44.0 t -123.04 91.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -0.826 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.594 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 10.2 t-105 -75.77 91.51 2.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' A' ' 189' ' ' ALA . 12.4 mt -53.86 -38.16 64.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.38 160.37 8.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.35 171.47 12.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.564 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 59.3 m-85 -145.94 -173.39 4.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.423 ' O ' HG21 ' A' ' 178' ' ' THR . 0.4 OUTLIER -95.86 -28.17 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 -179.906 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.3 p -145.95 170.42 16.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.553 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -69.65 -26.33 64.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.885 . . . . 0.0 109.31 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -70.58 -36.22 73.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -73.37 -47.87 38.68 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.61 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -63.55 -36.01 82.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.0 109.422 -179.806 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -67.0 -40.66 87.39 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 109.045 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.83 -48.75 79.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.416 -0.803 . . . . 0.0 109.127 179.797 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.08 -28.68 70.25 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 4.6 t80 -67.42 -28.47 67.93 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.529 -0.732 . . . . 0.0 109.038 179.252 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 191' ' ' PHE . 9.6 m-20 -70.26 -45.62 66.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -33.95 76.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.243 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.468 ' HB3' HD22 ' A' ' 173' ' ' LEU . . . -75.23 -54.45 7.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.747 -179.586 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -62.47 -14.95 46.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.862 -179.685 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.508 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 9.1 t80 -85.41 -34.93 21.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.007 -1.058 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -65.31 -43.13 92.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -82.35 -40.12 21.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 109.249 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 7.6 mtp85 -104.24 34.49 3.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.009 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . -41.54 165.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 0.3 OUTLIER 72.31 93.54 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -1.162 . . . . 0.0 109.306 -179.967 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 65.89 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.848 . . . . 0.0 109.677 179.929 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 194' ' ' ARG . . . 63.59 147.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.83 121.03 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.355 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.6 -178.81 4.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.107 -179.871 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.545 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -72.2 -35.51 68.94 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.881 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 7.5 m-85 -120.09 76.4 23.1 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.63 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -77.4 111.49 3.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.63 2.22 . . . . 0.0 110.553 -179.525 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 -168.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.345 179.851 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -98.86 80.71 2.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.915 . . . . 0.0 109.554 -179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.489 -179.979 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.405 0.621 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -98.96 151.55 20.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 -179.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.594 ' CD2' ' HB1' ' A' ' 183' ' ' ALA . 14.4 m-85 -130.36 151.37 50.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.703 -179.81 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -77.4 85.3 3.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.574 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.98 -20.43 4.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.519 HG11 ' CB ' ' A' ' 182' ' ' ALA . 16.2 t -96.39 127.42 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -1.197 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.2 ttt85 -94.13 153.12 18.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.15 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -127.31 134.33 50.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.949 -1.094 . . . . 0.0 109.683 -179.679 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -114.77 167.01 10.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 109.502 -179.75 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.35 5.85 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.597 2.198 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -102.22 -18.96 15.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.631 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 15.88 11.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.817 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.407 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.4 mtpp -112.5 171.36 7.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 53.8 m-85 -142.84 -172.84 3.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.333 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.57 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.41 105.6 2.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.997 179.842 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.589 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.88 118.59 21.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.545 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.552 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 9.0 mt-10 -136.53 155.08 50.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.344 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 12.2 tt -140.38 143.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.705 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -87.6 126.62 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 109.025 179.659 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -112.95 95.67 35.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.634 -179.768 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.3 Cg_endo -77.26 -26.0 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.488 2.125 . . . . 0.0 110.248 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.79 -15.11 62.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 0.0 109.606 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.506 ' HA ' ' CE ' ' A' ' 166' ' ' LYS . 2.4 mmpt? -106.39 41.32 1.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.336 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER 48.26 72.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.956 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' ASN . . . 48.74 96.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 166' ' ' LYS . . . -148.48 101.32 3.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.173 . . . . 0.0 109.633 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 152.55 23.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.195 179.885 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.455 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 53.4 t -133.58 91.94 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.57 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 9.6 t-105 -79.05 92.6 5.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.066 179.492 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.499 ' CD2' ' CB ' ' A' ' 189' ' ' ALA . 7.7 mt -53.8 -38.72 64.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.29 -179.827 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.517 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 141.67 175.44 15.17 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -91.88 161.73 14.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -1.132 . . . . 0.0 109.191 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.589 ' CE1' ' HB1' ' A' ' 159' ' ' ALA . 60.7 m-85 -134.63 169.32 17.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.558 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.445 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 1.3 pt-20 -75.6 -25.41 56.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.868 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 181' ' ' ASP . 0.9 OUTLIER -147.58 -178.24 6.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 109.45 -179.937 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.523 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -82.6 -24.63 33.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.2 tt0 -71.09 -34.18 70.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 109.613 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.459 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -76.58 -50.78 13.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.288 -0.883 . . . . 0.0 109.671 -179.891 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -59.3 -45.94 89.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 109.186 179.921 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.594 ' HB1' ' CD2' ' A' ' 146' ' ' TYR . . . -59.31 -46.04 89.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.7 OUTLIER -59.51 -31.16 69.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.634 -0.666 . . . . 0.0 109.219 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.485 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -79.81 -23.74 41.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.488 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.6 t80 -74.77 -30.3 61.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.41 -0.806 . . . . 0.0 108.879 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . 21.6 m-20 -71.12 -50.76 30.12 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.519 0.676 . . . . 0.0 109.31 179.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -36.33 82.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.633 -0.667 . . . . 0.0 109.688 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' A' ' 173' ' ' LEU . . . -80.84 -22.13 40.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.05 179.863 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 195' ' ' GLY . 1.7 t80 -85.31 -33.36 22.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 109.166 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -76.54 -40.72 49.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.868 . . . . 0.0 109.371 179.874 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -80.68 -27.7 36.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 110.284 -179.481 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 190' ' ' ALA . 2.8 mmt180 -92.61 8.93 36.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.897 -1.127 . . . . 0.0 109.676 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 71.48 -136.71 25.1 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.2 m -97.34 151.29 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.529 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 57.75 113.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.67 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.606 -179.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 113.17 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.377 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.66 176.07 8.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.403 -179.933 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -68.83 -37.27 79.06 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.368 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 183' ' ' ALA . 3.1 m-85 -124.52 78.94 62.28 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.501 -0.749 . . . . 0.0 109.196 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 69.74 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.597 2.198 . . . . 0.0 110.447 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.85 56.03 4.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' O ' HG11 ' A' ' 206' ' ' VAL . 0.0 OUTLIER 56.01 -175.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 109.787 179.842 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 205' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.335 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.288 0.566 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.25 173.31 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.896 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.603 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 21.3 m-85 -80.18 152.96 28.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 85.33 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.08 -15.28 4.54 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 183' ' ' ALA . 39.9 t -99.65 120.23 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.125 -1.221 . . . . 0.0 109.657 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 mmm180 -93.95 114.65 26.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.131 179.714 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.7 pt20 -89.68 139.32 30.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.829 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.492 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -110.54 160.72 27.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 179.96 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.7 Cg_endo -77.88 3.12 7.24 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.511 2.141 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.572 ' HA ' ' CE3' ' A' ' 154' ' ' TRP . 0.0 OUTLIER -105.06 -21.23 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.063 -1.023 . . . . 0.0 109.387 179.828 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 115.59 22.32 4.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.43 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 75.8 mttt -117.07 152.35 34.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.263 179.823 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 15.9 m-85 -132.6 170.53 15.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.982 . . . . 0.0 109.675 -179.615 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.581 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.84 114.9 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.921 179.814 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.56 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -84.95 121.95 28.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 108.764 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.53 152.7 40.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.562 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.542 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.2 tt -144.36 133.52 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 179.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.84 136.67 57.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 179.675 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.452 ' HB2' HG22 ' A' ' 171' ' ' VAL . 29.4 t0 -116.69 109.36 43.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.21 -27.39 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.375 2.05 . . . . 0.0 110.205 179.71 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.07 -16.72 61.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.402 -0.811 . . . . 0.0 109.732 -179.944 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 83.5 mttt -102.48 37.64 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 22.9 m-80 60.32 40.38 17.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.578 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.7 65.05 3.36 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.84 133.8 55.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.37 141.76 58.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 163' ' ' ASP . 26.0 t -117.31 88.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.581 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 9.4 t-105 -73.99 92.82 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.343 179.841 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 189' ' ' ALA . 2.2 mt -54.44 -40.81 68.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 144.84 157.33 7.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -72.06 169.09 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 64.6 m-85 -143.78 -178.99 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.69 -30.06 21.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.3 p -142.51 -179.62 6.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.551 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -79.28 -24.11 43.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -72.12 -35.59 69.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -76.14 -39.27 55.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.298 179.878 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -70.37 -32.44 70.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 108.97 179.837 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.603 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -73.09 -40.76 64.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.547 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 -44.27 97.28 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.18 -31.0 70.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.256 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CE2' ' HB ' ' A' ' 161' ' ' ILE . 8.2 t80 -63.03 -29.77 71.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.557 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.531 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.4 m-20 -68.98 -48.73 62.41 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 109.223 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -52.9 -36.01 58.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 110.578 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 173' ' ' LEU . . . -81.79 -39.14 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.914 -1.116 . . . . 0.0 109.905 -179.491 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -80.74 4.66 18.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.314 179.835 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 195' ' ' GLY . 6.0 t80 -113.89 -42.69 3.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.416 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -38.8 66.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.116 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.445 ' HE3' ' OD2' ' A' ' 163' ' ' ASP . 15.3 ttm -81.59 -35.4 30.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.653 -0.654 . . . . 0.0 110.292 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.513 ' CB ' ' HB3' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -81.69 -13.88 57.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.041 . . . . 0.0 109.654 -179.418 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 99.21 -125.1 8.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.493 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -66.65 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -1.198 . . . . 0.0 109.922 -179.523 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.47 152.91 37.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.722 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.513 ' HB3' ' CB ' ' A' ' 194' ' ' ARG . . . 172.52 153.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.852 . . . . 0.0 109.162 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.6 116.94 29.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.11 -0.994 . . . . 0.0 109.772 -179.698 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.531 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.03 146.91 50.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.526 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.24 -32.7 11.18 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.58 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.14 85.22 41.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 109.196 179.855 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.21 111.27 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.598 2.199 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.91 143.89 49.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.073 -1.017 . . . . 0.0 109.666 -179.726 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -115.7 53.83 0.83 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 179.849 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.584 -179.809 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 65.61 55.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.649 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 25.3 m-85 -55.77 159.83 2.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.283 -0.885 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -81.4 91.4 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.68 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.68 3.37 11.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.904 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.7 t -112.8 109.37 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -1.181 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.416 ' HB2' ' HB1' ' A' ' 158' ' ' ALA . 39.3 mtm180 -84.96 113.99 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.17 -0.956 . . . . 0.0 108.789 179.544 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -91.92 131.29 37.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.322 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.547 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -79.32 -177.27 0.84 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.897 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.547 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 32.9 Cg_endo -76.57 76.37 4.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.84 1.693 . . . . 0.0 109.908 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 61.45 69.57 0.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 109.154 -179.617 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.6 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.503 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.526 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.2 mttp -113.18 -171.43 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -1.175 . . . . 0.0 110.627 -178.812 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.591 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 28.5 m-85 -144.33 -179.0 6.26 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.62 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.03 111.33 4.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.836 -1.165 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.22 117.99 27.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.141 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 3.9 mt-10 -134.33 -165.87 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.213 -179.864 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 160' ' ' GLU . 2.5 tt 174.68 138.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.667 179.868 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -75.52 131.14 39.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.246 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 171' ' ' VAL . 27.6 t0 -105.83 111.86 64.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.859 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.3 -28.55 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.498 2.132 . . . . 0.0 110.304 179.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.65 58.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.863 . . . . 0.0 109.594 -179.867 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 3.9 mmpt? -104.75 25.48 10.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.814 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 76.49 33.72 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 179.791 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.2 86.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.8 -168.89 2.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.4 179.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -112.41 144.9 41.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.785 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 163' ' ' ASP . 38.3 t -128.67 116.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.101 179.603 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.62 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 6.3 t-105 -102.11 100.67 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.437 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -57.75 -47.32 82.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.741 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.74 157.24 7.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.875 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.2 p -73.58 152.95 40.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.4 -1.059 . . . . 0.0 109.607 -179.846 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 70.7 m-85 -126.44 -177.2 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.165 179.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.468 ' C ' HG21 ' A' ' 178' ' ' THR . 1.0 OUTLIER -91.19 -32.47 15.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.928 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.468 HG21 ' C ' ' A' ' 177' ' ' GLU . 8.5 p -134.32 168.81 18.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.591 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.462 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -75.0 -38.13 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.374 -0.828 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -75.72 -34.89 60.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.097 -1.002 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.54 -35.71 65.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.08 179.664 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.649 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.428 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.405 ' HG ' ' CD2' ' A' ' 202' ' ' PHE . 0.6 OUTLIER -61.95 -46.19 90.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.464 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.39 -29.7 69.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.052 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.5 t80 -61.39 -42.97 99.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.501 -0.75 . . . . 0.0 109.106 179.426 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 191' ' ' PHE . 8.8 m-20 -58.25 -45.03 88.51 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.498 -0.751 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.847 -179.7 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -89.15 -25.61 21.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 110.199 -179.461 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.94 5.12 52.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.456 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -113.6 -31.66 6.43 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.328 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -83.79 -40.5 18.67 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.803 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 3.7 tpp -74.91 -29.56 61.02 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.618 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 70.2 mtt-85 -109.86 -3.37 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.706 -179.836 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 75.47 -146.37 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 197' ' ' ARG . 73.8 m -78.11 158.09 29.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -1.105 . . . . 0.0 109.7 -179.716 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 196' ' ' SER . 16.7 ttp180 55.3 103.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.654 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -159.52 31.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 179.723 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 198' ' ' ALA . 55.5 mt 36.57 98.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.372 0.606 . . . . 0.0 110.715 179.354 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.405 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -119.34 177.19 5.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.012 . . . . 0.0 108.88 179.019 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.519 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -71.27 -34.43 70.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.191 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.5 m-85 -121.86 74.83 36.99 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.852 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.504 ' O ' ' HG ' ' A' ' 204' ' ' LEU . 34.4 Cg_endo -76.18 172.88 15.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.513 2.142 . . . . 0.0 110.38 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 203' ' ' PRO . 0.4 OUTLIER 33.8 41.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.2 0.524 . . . . 0.0 110.501 -179.83 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.42 87.77 2.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.384 0.611 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -56.51 160.86 2.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.2 m-85 -93.05 126.59 38.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.619 179.997 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.72 107.22 2.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 108.918 179.347 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.92 -34.0 4.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.544 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 42.0 t -81.24 119.75 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 109.233 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -101.4 101.67 12.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.807 -179.609 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.3 pt20 -62.91 144.02 57.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 109.118 179.534 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.476 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 1.5 mmt-85 -120.58 162.36 34.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.435 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.8 Cg_endo -76.7 73.49 5.24 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.611 2.207 . . . . 0.0 110.28 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.6 -179.681 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.66 14.12 3.59 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 18.8 mmtt -108.5 -176.92 3.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.236 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 156' ' ' LYS . 86.7 m-85 -156.4 159.09 38.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -127.69 111.7 13.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.99 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.533 ' HB1' ' CE2' ' A' ' 176' ' ' PHE . . . -79.17 124.43 28.33 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -148.17 140.64 24.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.992 . . . . 0.0 110.042 -179.337 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.534 HD12 ' CE ' ' A' ' 193' ' ' MET . 6.7 tt -128.41 137.41 57.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.424 -0.797 . . . . 0.0 109.121 179.735 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' O ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -80.28 142.99 34.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 -179.803 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 30.4 t0 -137.37 97.03 10.75 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.241 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.64 -24.37 10.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.322 2.014 . . . . 0.0 110.337 -179.917 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -11.75 58.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.859 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HG3' ' CG ' ' A' ' 163' ' ' ASP . 1.6 mtpt -105.84 40.57 1.55 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.63 45.97 3.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.434 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.77 84.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.78 120.77 13.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -1.088 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -63.82 157.26 25.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.148 -0.97 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 34.0 t -128.85 89.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.847 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.505 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 8.9 t-105 -72.1 93.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.185 179.712 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -52.07 -41.4 62.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.965 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.08 162.78 9.45 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 -179.648 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 1.2 p -76.14 -179.73 5.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.265 . . . . 0.0 109.393 -179.939 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 182' ' ' ALA . 78.4 m-85 -157.57 179.95 8.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.61 -25.47 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.453 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -142.98 165.43 27.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 109.562 -179.988 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.485 ' O ' ' HB1' ' A' ' 183' ' ' ALA . . . -67.75 -22.64 65.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.45 -0.782 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -72.07 -39.48 68.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.841 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -73.18 -39.69 65.4 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.653 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -71.54 -32.71 68.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 -179.909 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.636 ' CB ' ' CD2' ' A' ' 146' ' ' TYR . . . -74.49 -37.02 63.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.205 -0.934 . . . . 0.0 108.852 179.71 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.7 tp -66.03 -43.47 87.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.701 179.301 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.7 -30.96 72.0 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.241 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 9.3 t80 -66.36 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.548 -0.72 . . . . 0.0 109.144 179.545 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 62.7 m-20 -60.0 -48.99 79.42 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.352 -0.842 . . . . 0.0 109.87 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -43.9 76.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 109.771 -179.753 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -75.26 -18.42 60.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.822 . . . . 0.0 109.454 -179.941 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.08 -8.66 48.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.561 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 4.5 t80 -105.8 -29.48 10.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -81.01 -40.3 24.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.508 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.534 ' CE ' HD12 ' A' ' 161' ' ' ILE . 27.0 mtp -75.11 -27.94 60.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.56 -0.713 . . . . 0.0 109.693 179.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -98.16 10.06 41.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.519 -179.806 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 73.15 -97.52 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.782 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.561 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 2.5 m -142.87 164.78 29.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -1.111 . . . . 0.0 109.482 -179.859 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 58.86 63.35 1.67 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 -179.808 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.19 171.52 8.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.397 -0.814 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.52 125.67 50.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.85 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.24 178.04 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 -179.789 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.448 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.2 OUTLIER -70.95 -31.96 68.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.061 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 5.4 m-85 -121.61 74.14 33.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.45 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -76.87 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.354 -179.62 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.5 tp 46.6 78.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 -179.912 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -82.39 115.16 21.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.559 -179.833 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -139.92 157.56 45.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 19.1 m-85 -112.17 149.75 31.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.26 179.841 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 97.39 4.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.771 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.87 -21.39 7.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.725 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.3 t -89.55 126.06 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.252 . . . . 0.0 109.999 -179.66 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 tpp180 -97.65 147.07 24.7 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.951 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.3 pt20 -119.4 139.75 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 -179.392 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -105.3 155.91 37.09 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.145 179.672 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.47 6.17 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.577 2.185 . . . . 0.0 110.803 -179.742 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -106.11 -52.17 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.628 -179.986 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 152.79 56.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mtmt -155.26 -177.75 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.336 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 179' ' ' ALA . 62.8 m-85 -153.65 -171.77 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.93 110.92 2.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.457 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.56 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -79.36 114.41 18.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.261 -0.9 . . . . 0.0 109.078 179.734 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.516 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 1.6 mt-10 -130.83 151.35 51.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.312 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.446 HG21 ' HB ' ' A' ' 171' ' ' VAL . 2.6 tt -140.11 120.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.543 -179.82 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -61.12 140.77 57.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.304 179.867 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.414 ' CG ' ' CG ' ' A' ' 166' ' ' LYS . 30.9 t0 -118.99 100.94 50.53 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 -179.875 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -30.0 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.43 2.087 . . . . 0.0 110.463 179.842 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -10.13 59.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 16.1 mmtt -106.14 44.78 1.02 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 50.45 49.61 20.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.277 -179.797 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.19 99.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.954 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -159.56 111.16 2.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -1.099 . . . . 0.0 109.25 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -63.02 149.43 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.582 -179.716 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 161' ' ' ILE . 21.7 t -122.13 104.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 158' ' ' ALA . 11.3 t-105 -77.47 95.88 4.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.2 mt -55.77 -54.9 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 162.46 158.69 9.77 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.937 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 2.9 p -72.75 154.39 40.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.568 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 53.7 m-85 -131.25 168.93 16.67 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -80.14 -24.75 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.669 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 181' ' ' ASP . 3.4 p -145.1 175.96 9.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . . . -79.88 -24.75 40.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.76 -33.57 64.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.1 OUTLIER -79.72 -39.03 32.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.899 . . . . 0.0 109.288 179.945 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.32 -31.64 67.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 109.208 179.851 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -73.49 -39.72 64.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.235 -0.915 . . . . 0.0 108.959 179.721 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 22.8 tp -61.97 -42.62 99.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.824 . . . . 0.0 108.866 179.487 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.58 -31.35 72.0 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.8 t80 -62.33 -29.78 70.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.467 ' HB3' HD12 ' A' ' 200' ' ' LEU . 13.1 m-20 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.1 -31.7 70.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 -179.841 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.474 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -83.15 -28.13 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -4.07 58.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.485 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -108.54 -34.34 6.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.296 179.859 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -81.96 -38.77 24.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.343 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.3 ttm -78.03 -31.13 50.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.639 -0.663 . . . . 0.0 109.798 179.91 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 195' ' ' GLY . 34.7 mtp85 -98.65 -16.3 19.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.116 -0.99 . . . . 0.0 109.165 -179.911 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 47.68 -176.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.795 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 195' ' ' GLY . 93.3 p 42.82 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -1.168 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.25 149.61 40.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' C ' HD22 ' A' ' 200' ' ' LEU . . . -149.09 157.11 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.54 118.01 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.972 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.87 -172.71 2.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.647 -179.675 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.483 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -80.22 -32.04 38.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 108.967 179.703 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.7 m-85 -125.61 68.37 60.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.531 -0.731 . . . . 0.0 109.602 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.8 Cg_endo -78.41 71.18 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.808 2.338 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.1 tp -161.68 -106.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.998 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -81.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.805 -1.185 . . . . 0.0 109.422 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.445 179.898 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.433 0.635 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -103.27 121.05 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.339 -0.85 . . . . 0.0 109.592 -179.848 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.502 ' CD2' ' CB ' ' A' ' 183' ' ' ALA . 22.9 m-85 -123.88 133.64 53.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -179.97 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.19 85.14 2.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.66 -20.74 2.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.79 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 29.2 t -92.15 112.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.349 -1.089 . . . . 0.0 109.645 -179.847 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -93.12 79.49 4.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.765 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 6.7 pt20 -70.84 134.97 47.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.355 -0.841 . . . . 0.0 109.357 -179.871 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.551 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -89.08 -179.75 1.36 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.969 -1.082 . . . . 0.0 108.344 179.407 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -73.93 83.97 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.973 1.782 . . . . 0.0 110.18 -179.612 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.426 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 66.77 64.78 0.47 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.469 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.544 ' HA3' ' NE ' ' A' ' 152' ' ' ARG . . . -157.86 -111.83 0.33 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.75 -179.404 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.1 mtmm -110.52 -172.58 2.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.14 . . . . 0.0 110.976 -178.515 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.634 ' CE2' ' CB ' ' A' ' 151' ' ' GLN . 17.0 m-85 -140.59 131.07 25.35 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -104.33 112.84 26.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.885 -1.135 . . . . 0.0 110.752 -178.948 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -81.79 117.25 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.549 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.579 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 2.6 mt-10 -138.88 154.5 48.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.003 . . . . 0.0 109.68 -179.193 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 8.3 tt -133.07 164.47 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.742 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.487 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 2.5 tpp180 -101.01 119.65 39.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.963 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -120.83 93.04 48.6 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.33 -22.99 10.54 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.623 2.215 . . . . 0.0 110.342 179.984 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.58 60.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -90.38 33.24 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.91 25.57 15.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.557 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.38 97.96 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -161.81 97.9 1.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.4 mtt180 -45.56 155.63 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.949 . . . . 0.0 109.263 179.853 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.439 HG23 ' HE2' ' A' ' 193' ' ' MET . 54.9 t -128.15 100.75 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 10.1 t-105 -86.16 97.33 10.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 189' ' ' ALA . 15.1 mt -57.13 -46.59 82.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.508 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.25 155.93 7.17 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.3 p -68.93 178.8 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.164 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 175' ' ' THR . 67.1 m-85 -155.1 -171.51 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.924 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.43 ' O ' HG21 ' A' ' 178' ' ' THR . 5.8 mt-10 -97.32 -29.38 13.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.68 -179.846 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 13.3 p -142.53 -179.61 6.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 109.587 -179.797 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.558 ' CA ' ' CD2' ' A' ' 157' ' ' PHE . . . -78.96 -21.76 46.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.322 -0.862 . . . . 0.0 109.04 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -75.68 -36.79 59.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.91 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -73.27 -40.75 64.35 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.234 -0.916 . . . . 0.0 109.412 179.94 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 159' ' ' ALA . . . -67.78 -47.2 69.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' ND2' ' A' ' 201' ' ' ASN . . . -59.41 -40.13 85.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -49.74 76.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.525 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.66 -21.88 64.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.402 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -76.95 -28.44 55.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.801 . . . . 0.0 109.171 179.562 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.8 m-20 -69.12 -38.59 78.97 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 -179.573 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -69.31 -44.7 71.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.522 -179.088 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.517 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -70.16 -44.14 69.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.129 -179.25 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.538 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -64.82 -29.95 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.958 -179.412 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.41 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.4 t80 -75.56 -24.67 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.97 -1.081 . . . . 0.0 109.889 -179.623 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -82.27 -40.99 20.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.439 ' HE2' HG23 ' A' ' 171' ' ' VAL . 0.0 OUTLIER -78.7 -27.65 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 110.497 -179.302 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -97.46 7.78 45.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.943 -1.098 . . . . 0.0 109.603 -179.751 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 68.06 -132.33 28.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.764 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -80.77 -177.22 6.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 -179.984 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.497 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 17.0 ttm180 52.77 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.497 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 59.05 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 199' ' ' LEU . 3.8 mp -106.76 122.08 45.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.24 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.5 161.63 26.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 183' ' ' ALA . 1.2 m-80 -60.82 -31.49 70.9 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.246 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.0 m-85 -123.73 88.52 52.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.84 -177.5 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.632 2.221 . . . . 0.0 110.742 -179.275 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.8 -10.22 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 -179.978 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.94 121.56 8.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.875 . . . . 0.0 109.376 -179.885 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.547 -179.997 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.3 mttt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.352 0.596 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -74.12 113.8 11.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.329 179.785 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 27.5 m-85 -75.41 148.77 38.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.191 -0.943 . . . . 0.0 109.297 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.55 96.27 4.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.18 -18.43 6.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.865 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 65.6 t -99.62 127.62 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -1.171 . . . . 0.0 109.62 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 1.1 mtt85 -100.51 141.19 33.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.181 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -110.92 147.37 34.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 -179.314 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.469 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mtt180 -112.02 165.76 12.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.442 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.49 -29.56 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.546 2.164 . . . . 0.0 110.646 -179.898 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -73.14 -57.1 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.562 -179.957 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 53.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.459 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 12.6 mttm -144.86 171.52 14.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -1.176 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.557 ' CE2' ' CB ' ' A' ' 179' ' ' ALA . 50.3 m-85 -144.93 -173.75 4.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.628 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.17 112.85 2.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.696 179.88 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -85.34 126.76 34.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.09 150.33 36.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.625 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 189' ' ' ALA . 1.6 tt -142.46 139.2 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.879 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -72.4 135.76 45.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.415 ' HB2' HG22 ' A' ' 171' ' ' VAL . 37.3 t0 -130.08 96.54 25.21 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.593 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.87 -26.49 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.505 2.136 . . . . 0.0 110.287 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.78 -20.95 62.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.334 -0.853 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 16.6 mmtp -95.25 33.51 1.55 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.494 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 12.6 m120 66.5 49.3 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.313 -179.843 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.89 105.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.972 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -175.54 112.88 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -1.189 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -53.53 166.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 163' ' ' ASP . 43.2 t -137.33 94.57 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.628 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 5.4 t-105 -78.47 97.81 5.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.1 -46.82 78.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.538 -179.822 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.66 162.87 11.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.931 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -79.65 151.53 30.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.288 -179.853 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 85.9 m-85 -127.25 -175.85 3.56 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.14 -33.06 19.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.298 -179.418 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.524 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.5 p -137.31 179.51 6.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.035 -1.041 . . . . 0.0 110.028 -179.579 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.557 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . . . -74.76 -27.39 60.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.152 179.744 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 11.1 tt0 -68.54 -70.82 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.471 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -37.85 -54.45 1.26 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.804 -0.56 . . . . 0.0 110.217 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -60.3 -41.34 93.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.037 -179.472 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 202' ' ' PHE . . . -61.98 -31.38 71.73 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -45.86 63.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.167 -0.958 . . . . 0.0 108.455 179.595 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.62 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -59.04 -25.58 63.83 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.722 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 21.2 t80 -74.21 -36.38 63.96 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 200' ' ' LEU . 71.1 m-20 -64.54 -45.64 86.26 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.472 -0.767 . . . . 0.0 109.146 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -42.18 84.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 161' ' ' ILE . . . -77.37 -16.73 58.72 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.805 179.498 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.66 1.17 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.377 -0.827 . . . . 0.0 109.048 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -114.91 -37.6 4.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.71 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 42.5 mmt-85 -81.16 -39.44 25.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.078 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.416 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 40.8 ttm -75.05 -30.54 61.04 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.463 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.4 mtt180 -99.54 -10.28 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.27 -169.65 54.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.938 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' ARG . 1.4 t -54.6 150.69 9.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -1.085 . . . . 0.0 109.635 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 62.76 125.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.957 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 179.92 145.7 0.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 179.953 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.41 ' C ' HD22 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -90.34 120.2 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.631 -179.773 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.21 -173.54 3.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.007 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.431 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -74.96 -35.89 62.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.087 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 3.4 m-85 -122.33 87.42 48.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.201 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.7 171.01 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.61 2.206 . . . . 0.0 110.755 -179.386 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.8 mt -50.06 111.99 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.466 ' O ' HG11 ' A' ' 206' ' ' VAL . 8.1 mtt180 -47.03 -65.36 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.886 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 205' ' ' ARG . 16.7 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.6 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.264 0.554 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.84 82.24 5.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.561 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.56 -13.48 3.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 33.3 t -102.16 120.87 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 109.395 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -103.9 89.44 3.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.55 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -46.97 149.98 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 13.1 mmt180 -113.42 161.81 25.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.937 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.29 6.09 4.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.662 2.241 . . . . 0.0 110.584 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -114.18 -15.05 12.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 30.96 2.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 28.6 mmmt -120.35 -175.31 2.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.638 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.805 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 88.2 m-85 -157.64 117.71 3.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.104 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -89.94 122.46 32.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -98.53 111.95 24.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.58 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 4.4 mt-10 -135.21 150.88 50.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.403 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -127.9 148.29 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 133.0 36.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.746 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -126.65 94.5 40.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.436 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.83 -24.99 8.09 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.656 2.237 . . . . 0.0 110.575 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.37 -11.91 61.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -100.12 55.61 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.2 m120 56.3 31.04 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.955 . . . . 0.0 109.592 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.22 67.96 1.85 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -124.69 -180.0 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -1.154 . . . . 0.0 109.375 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -111.32 156.13 22.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.53 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 171' ' ' VAL . 29.5 t -129.15 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.2 t-105 -79.58 102.23 8.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.043 HD21 ' HB2' ' A' ' 189' ' ' ALA . 7.9 mt -56.78 -55.51 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 109.331 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 159.53 153.32 6.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.512 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.0 p -65.99 166.68 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.707 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.2 m-85 -141.39 -177.33 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -95.84 -30.25 13.77 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.307 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.548 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -136.68 167.07 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.268 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.805 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.45 -26.34 62.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.307 -0.871 . . . . 0.0 108.916 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.93 -35.27 69.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.285 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.12 -43.56 57.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.075 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.36 -23.78 61.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 108.916 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.59 -42.75 41.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.02 -38.81 92.68 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.82 -38.58 83.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 108.982 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.2 t80 -60.61 -39.24 87.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 1.2 m-20 -56.96 -44.1 82.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -0.815 . . . . 0.0 109.577 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -48.84 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.043 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -72.82 -15.45 61.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 0.0 109.847 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.45 -17.49 25.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.152 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 2.8 t80 -94.34 -31.29 14.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -46.72 26.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.6 ttm -65.54 -33.52 76.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.687 -0.633 . . . . 0.0 109.83 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.481 ' HG2' ' NH1' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -100.14 18.21 19.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 109.646 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 57.43 -99.43 0.1 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 0.5 OUTLIER -126.13 158.08 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -1.154 . . . . 0.0 109.717 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.57 91.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.19 174.12 10.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.99 113.58 26.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.16 179.48 5.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -35.16 64.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.437 ' HD2' HD22 ' A' ' 184' ' ' LEU . 4.9 m-85 -120.03 83.35 30.67 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 122.626 2.217 . . . . 0.0 110.465 -179.649 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.754 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.543 ' HE ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.52 31.01 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.034 -1.041 . . . . 0.0 109.774 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.09 20.16 0.35 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 183' ' ' ALA . 61.6 t -140.62 107.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -1.061 . . . . 0.0 109.37 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -85.06 110.6 19.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 108.678 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -75.95 156.01 34.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.567 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -109.56 158.54 34.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.83 . . . . 0.0 109.19 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.82 13.79 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.514 2.143 . . . . 0.0 111.024 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -120.33 -25.43 5.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.071 -1.018 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.53 33.84 0.59 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.441 ' C ' ' HG3' ' A' ' 152' ' ' ARG . 42.5 mttt -126.44 -169.24 1.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 58.6 m-85 -156.42 172.19 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.379 -0.825 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.08 116.99 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.063 -1.023 . . . . 0.0 110.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -87.17 119.77 27.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 108.605 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -144.3 147.01 32.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.605 HD11 ' NH1' ' A' ' 194' ' ' ARG . 8.8 tt -135.94 143.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 108.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -80.81 134.47 35.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.036 -1.04 . . . . 0.0 109.811 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -122.94 103.6 36.62 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.391 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 -29.95 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.448 2.099 . . . . 0.0 110.594 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.66 -26.69 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.641 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -91.4 37.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.24 50.23 18.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.64 80.09 0.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -132.37 95.51 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.3 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -44.28 133.0 5.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 43.7 t -109.92 103.18 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.439 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.493 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 5.0 t-105 -93.68 97.31 10.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -54.3 -49.0 70.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.061 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.54 159.53 8.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -76.99 144.08 38.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.647 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.814 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.4 m-85 -118.01 178.26 4.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.456 -0.778 . . . . 0.0 109.21 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.6 mm-40 -88.24 -25.55 22.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 110.012 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.573 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.8 p -141.17 178.17 7.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.651 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -80.38 -23.17 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.385 -0.822 . . . . 0.0 109.19 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 13.6 tt0 -74.93 -36.81 62.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.84 -43.91 43.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.754 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.25 -37.88 84.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.346 -0.846 . . . . 0.0 109.045 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.854 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -61.25 -44.88 96.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.426 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.7 -18.72 62.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 108.894 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 11.6 t80 -76.22 -31.58 58.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.002 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.549 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -68.38 -51.09 47.95 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.545 -0.722 . . . . 0.0 109.798 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -27.52 69.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -86.15 -23.03 26.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.302 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -88.18 -15.63 35.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.37 -0.831 . . . . 0.0 109.124 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.4 OUTLIER -92.81 -32.13 14.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -78.8 -40.58 32.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.02 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.1 tpp -70.34 -30.93 68.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 0.0 109.581 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.605 ' NH1' HD11 ' A' ' 161' ' ' ILE . 1.5 mpt_? -91.62 -12.67 33.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 196' ' ' SER . . . 62.57 81.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 3.3 m 61.01 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -1.161 . . . . 0.0 109.69 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER 61.76 120.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.922 . . . . 0.0 109.632 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 173.31 153.59 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.543 HD23 ' HE ' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -98.04 118.6 35.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.02 -177.41 4.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.549 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -72.8 -34.36 66.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.854 ' HD2' HD22 ' A' ' 184' ' ' LEU . 2.2 m-85 -128.66 76.52 78.62 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.722 2.281 . . . . 0.0 110.66 -179.382 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 1.004 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.6 m-85 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.168 0.508 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.09 88.19 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 124.77 26.29 1.43 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.7 t -140.35 109.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -1.106 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -95.46 93.77 7.41 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.224 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 44.0 tt0 -52.05 167.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.418 ' N ' ' CG ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -129.69 158.91 72.15 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.335 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.57 4.32 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.625 2.216 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CD1' ' O ' ' A' ' 154' ' ' TRP . 50.0 t-105 -113.25 -7.77 13.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.52 22.6 8.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -115.09 174.08 6.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.596 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.066 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 79.6 m-85 -146.91 152.98 39.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.032 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.643 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -121.85 117.45 26.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.873 -1.142 . . . . 0.0 109.653 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.606 ' HB3' ' HE2' ' A' ' 176' ' ' PHE . . . -91.89 111.07 22.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -130.22 145.87 51.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.063 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 14.9 tt -124.15 154.7 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.61 136.32 34.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.412 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 44.0 t0 -146.16 93.05 5.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.669 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.16 -23.42 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.635 2.223 . . . . 0.0 110.281 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.48 -11.52 24.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.821 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 13.2 mtpt -100.87 35.67 2.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 1.6 t-20 70.39 47.22 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.66 89.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -163.71 136.1 5.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -71.82 178.68 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.2 t -138.51 81.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.715 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.2 t-105 -61.87 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.548 HD21 ' CB ' ' A' ' 189' ' ' ALA . 26.6 mt -51.7 -34.87 40.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.127 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 137.33 155.22 6.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.715 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.8 p -68.24 -177.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.323 -1.104 . . . . 0.0 109.383 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' HE2' ' HB3' ' A' ' 159' ' ' ALA . 74.2 m-85 -157.54 177.94 10.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -88.84 -26.91 21.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.655 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.7 p -140.83 175.59 9.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.066 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -80.44 -21.07 42.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.284 -0.885 . . . . 0.0 109.2 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -76.31 -37.55 57.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -36.06 63.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.167 -0.958 . . . . 0.0 109.027 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.72 -39.76 66.67 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.038 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.004 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -66.3 -39.53 89.39 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.0 108.734 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.0 tp -64.56 -42.7 95.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.53 -24.15 67.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.2 t80 -76.04 -28.79 57.81 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.482 -0.761 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 72.3 m-20 -74.48 -47.55 32.66 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -62.43 -31.61 72.34 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.548 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -88.54 -20.59 24.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.024 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.1 -1.96 58.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -107.97 -35.42 6.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.906 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -76.81 -39.77 50.27 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 27.7 ttm -76.6 -36.94 57.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.64 -0.662 . . . . 0.0 109.978 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -77.73 -18.36 56.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.965 . . . . 0.0 109.18 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.16 -127.79 9.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 197' ' ' ARG . 13.8 m -63.96 -148.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 110.053 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 196' ' ' SER . 1.8 ttm180 -39.99 139.72 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 110.033 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.78 -175.88 4.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.143 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -104.23 121.36 43.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.843 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.69 152.42 50.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.426 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -54.96 -33.04 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.3 m-85 -117.44 94.19 44.85 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.308 -1.558 0 C-N-CA 122.432 2.088 . . . . 0.0 110.374 -179.695 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.7 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.43 81.84 3.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 108.917 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.67 19.79 2.0 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 44.4 t -133.21 129.51 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.259 . . . . 0.0 109.198 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 112.36 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.601 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.1 pt20 -80.17 157.18 26.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -125.75 159.13 62.63 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 109.698 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 3.4 7.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.571 2.181 . . . . 0.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -101.22 -19.21 15.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.51 39.79 1.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 35.1 mttt -145.56 166.1 26.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.427 -1.043 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.083 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.8 m-85 -133.65 178.54 6.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.58 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.36 112.74 6.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.704 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.49 108.17 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -129.4 158.42 39.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.356 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.8 tt -139.72 139.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -80.72 128.72 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.902 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -114.78 95.74 42.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -23.27 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.613 2.208 . . . . 0.0 110.617 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.65 -7.1 30.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.185 -0.947 . . . . 0.0 109.687 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -119.09 57.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 49.49 26.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.91 99.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -142.62 105.34 4.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 109.248 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.01 141.94 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.2 t -122.81 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.68 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.6 t-105 -73.7 96.49 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.786 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.458 HD21 ' CB ' ' A' ' 189' ' ' ALA . 30.3 mt -56.04 -46.99 78.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.33 154.53 6.59 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.68 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -70.33 161.25 30.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -1.107 . . . . 0.0 109.356 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 65.2 m-85 -136.16 178.72 6.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -84.15 -31.25 25.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.8 p -142.06 170.33 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.083 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.23 -22.42 62.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.106 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.88 -42.59 63.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -68.29 -43.45 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.862 . . . . 0.0 109.606 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.67 -45.76 85.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.8 -38.93 79.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.63 -51.52 68.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 109.125 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.532 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.49 -20.25 65.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 108.815 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -79.27 -28.47 42.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.445 -0.785 . . . . 0.0 109.41 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.4 m-20 -72.34 -35.47 68.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.701 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -76.19 -40.04 53.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.458 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -73.89 -30.02 62.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.467 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.87 -23.62 33.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.837 . . . . 0.0 109.4 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.513 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 28.7 t80 -83.74 -22.34 31.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 108.974 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -78.86 -38.49 37.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.638 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.1 ttm -80.15 -43.12 22.17 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 0.0 110.173 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.718 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 12.2 mtt180 -92.57 -38.34 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.828 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 63.11 161.43 0.28 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 197' ' ' ARG . 22.5 p 50.53 -176.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -1.097 . . . . 0.0 109.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.5 mtm180 -43.7 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -119.27 35.99 4.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 198' ' ' ALA . 5.0 mt 39.35 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -118.18 149.77 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.972 . . . . 0.0 109.353 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.18 -37.31 22.17 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.9 m-85 -120.81 83.22 36.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 200' ' ' LEU . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.905 2.403 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.867 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 68.6 m-85 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.59 35.02 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.184 -0.948 . . . . 0.0 110.15 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.78 26.24 0.09 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 182' ' ' ALA . 96.7 t -150.27 117.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.417 -1.049 . . . . 0.0 109.185 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.552 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -99.09 137.13 38.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.104 -0.997 . . . . 0.0 109.09 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -103.11 155.62 18.27 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.265 -0.897 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.69 161.02 55.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.815 . . . . 0.0 109.38 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.85 -8.41 16.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.513 2.142 . . . . 0.0 109.964 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.59 -1.41 57.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.5 56.27 2.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.4 mttt -159.27 171.27 20.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.788 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -142.17 -177.68 5.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -152.49 116.92 4.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.779 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -89.23 118.35 28.85 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 109.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 5.6 mt-10 -137.82 177.57 7.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 171' ' ' VAL . 1.1 tt -164.72 142.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.909 -1.119 . . . . 0.0 109.939 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -69.5 134.17 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.045 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 168' ' ' GLY . 11.2 t0 -113.14 98.07 44.7 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 0.0 109.62 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.12 -22.07 10.17 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.535 2.157 . . . . 0.0 110.28 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.25 67.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.296 -0.878 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -104.98 32.5 4.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.72 58.52 4.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 169' ' ' ALA . . . 82.09 -127.56 8.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 67.18 87.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -53.5 134.83 40.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 163' ' ' ASP . 70.3 t -102.01 105.8 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 108.962 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -87.49 93.9 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.031 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.7 mt -53.55 -48.69 68.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.0 108.998 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 153.62 162.23 10.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.29 160.84 30.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -1.141 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -134.75 -176.5 4.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 0.0 109.608 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -90.58 -28.2 18.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.638 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p -146.5 172.18 13.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.61 -24.36 62.72 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.127 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -73.81 -36.37 64.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.539 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -72.03 -47.05 54.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.65 -32.15 73.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.2 -37.62 75.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.135 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.97 -47.56 77.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 108.86 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.571 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.25 -22.11 66.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' ALA . 28.9 t80 -69.79 -36.28 75.57 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.792 ' HB3' HD13 ' A' ' 200' ' ' LEU . 9.7 m-20 -63.57 -54.33 37.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.395 -0.815 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -55.68 -29.68 59.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.26 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.11 -24.64 27.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.084 . . . . 0.0 110.06 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.94 -14.91 37.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.995 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.548 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.4 t80 -96.25 -25.33 15.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.17 -0.956 . . . . 0.0 108.853 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.34 -38.79 34.31 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.2 tpp -79.59 -42.13 25.63 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.383 0.611 . . . . 0.0 109.749 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 9.7 mtp180 -97.73 -41.27 8.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 109.629 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 43.24 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 197' ' ' ARG . 0.6 OUTLIER 45.87 50.62 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -1.12 . . . . 0.0 109.828 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 70.46 118.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -138.96 174.21 10.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.335 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 108.07 19.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -122.0 -175.91 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.562 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.516 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -84.6 -33.52 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.416 ' HZ ' ' CZ ' ' A' ' 146' ' ' TYR . 6.2 m-85 -121.02 77.49 31.5 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.6 Cg_endo . . . . . 0 C--N 1.31 -1.498 0 C-N-CA 122.686 2.257 . . . . 0.0 110.507 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.4 m-85 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -75.89 83.6 2.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.634 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.57 -22.2 3.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.7 t -90.48 116.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -1.15 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -105.48 120.21 41.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 pp0? -85.54 163.8 18.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.881 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.426 ' CD ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -131.66 165.73 33.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.452 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 152' ' ' ARG . 35.0 Cg_endo -78.39 -4.09 13.92 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.683 2.255 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -91.96 -18.03 24.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.007 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.86 35.84 2.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -137.16 -175.59 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 0.0 109.634 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.828 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -144.83 -173.37 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.636 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -154.01 108.32 3.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.213 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.73 119.41 24.29 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.563 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 10.6 mt-10 -134.89 179.65 6.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.084 -1.01 . . . . 0.0 109.365 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -174.76 141.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.43 136.76 39.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' CA ' ' A' ' 168' ' ' GLY . 10.5 t0 -111.47 101.02 49.8 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -24.02 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 110.308 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.85 -37.0 75.99 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 167' ' ' ASN . 14.2 mttt -98.33 59.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 167' ' ' ASN . 3.6 p-10 41.36 48.02 3.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.438 -0.789 . . . . 0.0 109.797 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 163' ' ' ASP . . . 75.48 -114.68 4.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 63.27 95.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 169' ' ' ALA . 7.7 ptt180 -45.28 157.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.675 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 41.1 t -129.29 93.02 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.636 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 13.5 t-105 -79.59 93.19 5.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.12 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -53.47 -40.18 65.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.485 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 148.25 -171.93 28.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -103.39 154.94 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -1.162 . . . . 0.0 109.028 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -130.1 165.28 22.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.464 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.7 OUTLIER -77.71 -17.87 57.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.096 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.9 p -153.56 162.36 41.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.545 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.828 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.63 -23.28 66.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.309 -0.869 . . . . 0.0 109.405 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.0 -39.72 65.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.501 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -72.04 -40.49 68.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.763 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.83 -32.13 69.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.47 -41.15 69.73 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.75 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.32 -46.91 88.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.34 -22.88 63.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 108.845 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.0 t80 -72.48 -30.74 64.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.495 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.5 m-20 -69.34 -50.48 45.97 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.36 -0.837 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -54.95 -38.02 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.918 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.424 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -78.02 -30.15 49.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 109.453 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -82.64 -2.8 55.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.383 -0.823 . . . . 0.0 109.385 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' GLY . 37.3 t80 -99.45 -40.67 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.149 -0.97 . . . . 0.0 108.918 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -64.34 -49.12 72.94 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -40.38 95.22 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 60.3 mtt180 -105.31 36.52 2.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 108.962 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -34.69 147.72 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.2 t 80.91 102.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.56 -0.965 . . . . 0.0 109.402 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.494 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 49.8 ttm-85 64.71 -96.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.407 -0.808 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.08 145.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.005 -1.06 . . . . 0.0 109.401 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -104.85 122.46 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.544 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -121.23 152.53 38.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -0.919 . . . . 0.0 109.24 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.405 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -48.5 -37.16 16.78 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.9 m-85 -120.19 92.31 47.0 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.631 2.221 . . . . 0.0 110.916 -179.202 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 1.011 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 86.41 3.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.832 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.41 -19.78 5.62 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 182' ' ' ALA . 44.1 t -90.0 114.58 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.667 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -100.08 113.92 26.88 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.459 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 12.0 pt20 -78.62 154.57 30.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.311 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -118.42 174.43 2.67 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -77.68 -48.07 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.632 2.221 . . . . 0.0 110.507 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -62.51 1.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.65 52.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -141.48 173.44 11.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.674 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.951 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.8 m-85 -139.15 175.37 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.628 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.64 110.27 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.53 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.56 124.2 28.76 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -146.03 160.29 42.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.788 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.529 HD13 ' HE2' ' A' ' 193' ' ' MET . 3.4 tt -149.47 147.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.859 . . . . 0.0 109.181 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.436 ' NH2' ' HG2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -96.94 137.15 36.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.99 . . . . 0.0 109.614 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.444 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 44.5 t0 -122.23 114.45 30.59 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.361 -0.837 . . . . 0.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.71 -35.05 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.324 2.016 . . . . 0.0 110.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.61 64.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.105 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -93.89 39.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.42 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.36 30.98 13.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.76 62.59 5.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.44 33.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.491 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -84.64 161.93 19.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.632 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.6 t -137.3 94.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.432 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.628 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.3 t-105 -79.3 100.36 7.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.049 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -59.47 -43.12 93.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 146.26 157.02 7.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.582 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -76.26 151.06 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.169 . . . . 0.0 109.432 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.9 m-85 -123.38 -176.25 3.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -87.59 -31.98 19.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.5 p -139.29 176.27 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.193 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.26 -26.06 55.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.3 -37.37 71.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -72.97 -39.57 66.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.97 -26.52 61.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.327 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.011 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.21 -39.28 49.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.136 -0.978 . . . . 0.0 109.013 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 184' ' ' LEU . 1.1 tm? -63.75 -43.07 97.54 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 108.838 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.608 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.72 -29.45 69.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -66.31 -32.18 73.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 0.0 109.14 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.661 ' HB3' HD13 ' A' ' 200' ' ' LEU . 3.6 m-20 -65.93 -49.6 67.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.09 -29.71 67.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.005 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.049 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.48 -24.28 27.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.821 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.522 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -87.69 -6.53 58.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.613 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 196' ' ' SER . 2.1 t80 -104.01 -37.47 7.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.44 -40.99 56.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.273 -0.892 . . . . 0.0 109.163 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.529 ' HE2' HD13 ' A' ' 161' ' ' ILE . 2.0 mtm -71.94 -30.79 65.69 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.563 -0.711 . . . . 0.0 110.067 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -92.75 -6.4 49.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.84 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.0 -104.23 3.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.581 ' O ' ' CZ ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -108.02 -78.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.981 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.83 122.79 15.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.881 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . -156.54 162.4 39.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.158 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.727 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -110.55 124.77 52.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.61 173.19 8.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.222 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.494 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.3 OUTLIER -74.66 -28.73 60.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.0 m-85 -125.24 67.25 54.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.545 -0.722 . . . . 0.0 109.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.8 Cg_endo . . . . . 0 C--N 1.31 -1.471 0 C-N-CA 122.553 2.169 . . . . 0.0 109.876 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.915 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.8 m-85 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 87.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 125.8 28.29 1.07 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.8 t -142.41 123.05 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.094 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 85.62 2.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.585 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 1.3 pp0? -59.49 144.39 47.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.511 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 159.79 34.71 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.23 18.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.742 2.295 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.35 -39.99 2.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.44 46.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HD2' ' HB ' ' A' ' 175' ' ' THR . 34.9 ttpt -147.18 147.93 31.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -1.165 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.903 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 16.4 m-85 -133.79 130.46 38.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.563 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -99.32 108.93 21.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.082 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.65 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.11 109.21 18.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.224 -0.923 . . . . 0.0 108.585 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.496 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 1.8 mp0 -132.53 141.54 48.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.12 -0.987 . . . . 0.0 109.668 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 5.4 tt -120.7 131.89 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.798 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.73 122.98 24.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.683 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -113.87 108.39 51.22 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.858 . . . . 0.0 109.313 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 -27.62 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.387 2.058 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.31 75.29 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -95.9 40.56 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.463 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 4.9 m-20 69.56 46.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.506 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.35 29.79 1.82 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.96 123.05 20.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -1.122 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.04 130.16 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.489 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.9 t -106.75 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.668 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.566 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -74.65 94.17 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.372 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.612 HD22 ' HB2' ' A' ' 189' ' ' ALA . 39.4 mt -54.24 -41.63 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 145.15 155.01 6.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.566 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.3 p -68.04 179.77 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 75.1 m-85 -154.62 -174.23 4.89 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.396 -0.815 . . . . 0.0 109.343 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.38 -25.37 13.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.8 p -142.7 170.85 14.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.903 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.68 -23.9 58.7 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.157 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -34.03 61.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.413 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -74.79 -39.97 61.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 109.019 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.48 -35.63 73.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.915 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.54 -40.64 73.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.996 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 184' ' ' LEU . 28.2 tp -63.1 -43.66 97.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.48 -24.0 63.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 7.2 t80 -69.37 -30.08 67.99 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -49.11 50.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.491 -0.756 . . . . 0.0 109.046 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -54.11 -39.27 66.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.687 . . . . 0.0 109.608 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.612 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.61 -27.62 41.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.7 -4.1 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.19 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.453 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 10.0 t80 -103.79 -23.82 13.37 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -81.55 -36.41 29.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.6 tpp -81.05 -44.07 18.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.785 -0.572 . . . . 0.0 109.91 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.7 mtt180 -85.3 -33.35 22.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.175 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 62.47 127.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' ALA . 69.6 m 61.56 142.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -1.104 . . . . 0.0 110.34 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 2.4 tpp180 43.06 -96.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.49 -0.756 . . . . 0.0 110.376 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.29 168.7 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.152 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -106.0 109.85 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.599 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.75 159.41 32.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.565 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -68.66 -30.55 69.26 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.0 m-85 -122.49 86.36 48.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HA ' HD12 ' A' ' 200' ' ' LEU . 35.2 Cg_endo . . . . . 0 C--N 1.309 -1.51 0 C-N-CA 122.707 2.271 . . . . 0.0 110.669 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.1 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.259 0.552 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 99.85 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.09 -33.25 4.28 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.1 t -75.3 134.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -1.19 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -121.18 106.69 11.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.061 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -77.12 163.21 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.541 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -120.8 175.99 2.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.412 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.39 -23.43 8.67 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.744 2.296 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -84.25 -56.03 3.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.62 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.02 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.2 157.88 41.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -1.125 . . . . 0.0 109.138 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 13.7 m-85 -126.1 -178.43 4.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 109.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.68 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.97 108.19 4.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 110.345 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.69 107.57 13.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.423 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -130.29 146.05 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.5 tt -135.12 156.44 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.291 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.05 132.78 33.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -132.17 102.55 14.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.303 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 -26.67 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.442 2.094 . . . . 0.0 109.961 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.52 64.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 35.9 mttm -90.03 26.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 3.7 t-20 75.11 43.99 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.38 48.48 80.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.02 147.32 42.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -1.153 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -76.81 154.95 33.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 171' ' ' VAL . 9.0 t -122.12 85.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.68 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.5 t-105 -73.86 96.46 2.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 108.882 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.6 mt -52.94 -48.59 67.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.132 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 150.43 152.29 5.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.564 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.5 p -65.55 171.14 4.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.173 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.529 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 61.6 m-85 -144.95 -176.49 5.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -89.42 -29.58 18.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.584 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.5 p -143.06 171.18 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.05 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.62 -28.11 63.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -69.46 -33.75 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -76.36 -41.11 49.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 109.031 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -71.58 -23.12 61.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.852 . . . . 0.0 109.081 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -80.24 -42.52 23.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 108.86 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -36.22 83.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.14 -29.78 65.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 17.7 t80 -64.83 -37.43 87.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.904 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.2 m-20 -63.39 -47.09 83.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.512 -0.742 . . . . 0.0 109.336 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -53.04 -42.37 65.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.02 -17.92 45.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.7 -5.09 56.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.189 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 5.6 t80 -102.8 -33.73 9.26 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -77.23 -41.36 41.47 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.39 -29.27 63.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 109.343 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.6 mtt-85 -104.66 9.79 35.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.67 -162.79 14.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 59.0 p -61.49 161.56 9.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -1.101 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 54.94 104.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.551 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -151.58 172.98 15.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 109.163 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.627 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -107.43 112.89 25.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.72 179.44 4.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 109.31 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.498 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -74.53 -30.59 61.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 108.422 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.3 m-85 -126.1 67.0 61.52 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.589 -0.694 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 122.609 2.206 . . . . 0.0 110.304 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.364 0.602 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -80.71 99.08 8.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.668 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 160' ' ' GLU . . . 115.92 -9.72 18.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 179' ' ' ALA . 89.7 t -100.88 112.61 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.034 -1.274 . . . . 0.0 109.79 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.1 ttm-85 -91.83 94.12 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.108 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.564 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -71.57 134.94 46.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.85 160.65 34.31 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.85 -2.55 12.53 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.71 2.273 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -109.73 19.95 18.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.661 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.16 68.03 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -162.01 133.47 5.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 108.797 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 5.3 m-85 -132.51 137.27 47.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -0.945 . . . . 0.0 109.115 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.693 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -107.26 116.76 32.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.002 -1.061 . . . . 0.0 110.357 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -89.39 114.12 25.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 148' ' ' GLY . 2.5 mp0 -130.61 155.57 46.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.403 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 8.9 tt -139.06 125.77 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -82.03 117.55 22.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.52 108.94 58.31 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.23 -33.08 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.381 2.054 . . . . 0.0 110.288 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.28 65.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -89.46 39.54 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.428 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.4 m120 46.57 50.17 13.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.594 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.15 88.69 0.03 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -146.85 89.04 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -1.157 . . . . 0.0 109.741 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -49.18 145.23 4.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.326 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.5 t -127.55 86.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.691 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.693 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.6 t-105 -67.21 97.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 108.91 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.831 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -53.98 -42.42 68.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.859 . . . . 0.0 109.606 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.48 155.53 6.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.7 p -67.77 -176.59 0.67 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -1.141 . . . . 0.0 109.302 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 71.0 m-85 -156.75 -168.52 2.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 109.397 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.57 -25.88 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.456 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.1 p -141.49 174.54 10.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.719 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.85 -24.42 41.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -35.08 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -39.32 44.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.91 -41.93 61.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 108.853 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.59 -40.58 95.3 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.67 -25.83 64.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 15.2 t80 -68.15 -41.09 82.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.562 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.5 m-20 -61.1 -50.1 74.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.224 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -48.27 -39.5 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.557 -0.714 . . . . 0.0 110.128 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.831 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.9 -26.16 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.966 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.15 7.36 32.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.041 -1.037 . . . . 0.0 109.143 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 10.0 t80 -111.94 -33.8 6.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -43.06 32.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -75.62 -29.73 59.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.319 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.636 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -95.51 5.41 51.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.907 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 85.37 -89.51 1.61 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.587 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 45.0 t -138.76 -80.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -1.208 . . . . 0.0 109.879 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 111.79 1.01 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -150.49 170.01 20.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.523 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -97.83 107.99 20.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.562 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -115.42 157.87 23.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.189 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.519 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -61.19 -31.72 71.48 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.8 m-85 -121.97 83.92 44.42 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.301 -179.71 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.872 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.2 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.345 0.593 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -82.45 83.32 7.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.878 . . . . 0.0 109.199 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.96 6.15 5.51 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 95.8 t -119.69 118.14 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -1.233 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.2 ttp180 -88.24 115.0 25.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.555 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -83.38 152.3 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.751 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.531 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.3 mtm105 -137.5 175.42 3.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -0.819 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 34.9 Cg_endo -77.44 159.13 32.67 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.5 2.134 . . . . 0.0 110.019 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.568 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 8.2 t-105 83.77 -60.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.41 54.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -132.88 154.11 50.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -1.185 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.811 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.4 m-85 -142.43 179.17 7.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.56 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.45 113.94 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.061 -1.024 . . . . 0.0 110.017 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.31 121.74 31.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.377 -0.827 . . . . 0.0 108.974 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -146.17 151.34 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.148 -0.97 . . . . 0.0 109.313 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 161' ' ' ILE . 7.9 tt -129.83 124.3 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 124.28 22.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.43 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.19 96.92 50.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.72 -22.67 10.26 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.611 2.207 . . . . 0.0 110.223 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.29 -3.85 19.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.349 -0.844 . . . . 0.0 109.703 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 1.0 OUTLIER -122.38 27.59 7.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.8 t-20 75.19 58.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.095 -1.003 . . . . 0.0 109.626 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.9 39.69 6.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -84.44 93.32 8.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -1.209 . . . . 0.0 109.285 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -50.01 142.47 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.4 t -116.3 86.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 109.194 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.7 t-105 -75.62 96.12 3.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.3 mp -54.45 -42.88 71.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.62 152.42 5.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.6 p -68.35 164.44 20.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.443 -1.033 . . . . 0.0 109.44 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.887 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.4 m-85 -138.41 -169.88 2.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.515 ' HG2' ' OD2' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -96.93 -30.87 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p -136.59 -179.62 5.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.85 -1.157 . . . . 0.0 110.247 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.811 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.49 -32.38 58.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 8.0 tt0 -66.23 -70.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -38.79 -59.97 0.89 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.623 . . . . 0.0 110.166 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -55.6 -38.44 69.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.872 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.08 -34.63 78.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.136 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -38.42 80.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.915 -1.115 . . . . 0.0 109.44 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.551 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.06 -32.39 73.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.84 . . . . 0.0 108.911 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.0 t80 -67.17 -33.85 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 109.523 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.47 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 29.4 m-20 -64.25 -44.91 90.33 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -62.66 -32.88 74.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.79 . . . . 0.0 110.408 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.774 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -83.47 -24.65 31.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.101 -1.0 . . . . 0.0 109.853 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.65 -12.64 53.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.8 t80 -99.56 -40.47 7.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.016 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.14 -39.9 96.01 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.9 tpp -74.92 -55.32 5.91 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.558 0.694 . . . . 0.0 109.569 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.7 mtt180 -88.95 -55.74 3.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 0.0 109.685 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 57.28 170.15 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER 56.25 81.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.522 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.42 100.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.896 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -133.56 176.7 8.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 200' ' ' LEU . 8.1 mp -95.85 109.3 21.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.726 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -130.49 143.17 50.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.117 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.417 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -51.89 -32.11 31.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 m-85 -124.13 89.53 51.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.726 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.0 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 C-N-CA 122.462 2.108 . . . . 0.0 110.435 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 1.013 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 36.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 89.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.66 -28.19 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 50.6 t -85.86 118.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -1.177 . . . . 0.0 109.61 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -101.53 116.81 33.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 108.994 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.512 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.4 pt20 -81.58 157.25 24.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.931 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.3 mtt-85 -122.46 160.36 48.61 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -76.84 -8.54 17.97 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.514 2.143 . . . . 0.0 110.162 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.89 -27.14 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.3 34.46 0.95 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 11.8 mtpp -132.06 176.97 7.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -1.157 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.3 m-85 -145.45 177.24 8.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.29 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -149.13 108.35 3.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.866 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.55 107.21 13.16 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -129.6 151.98 49.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.304 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.442 HG12 ' N ' ' A' ' 162' ' ' ARG . 3.0 tt -141.61 149.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.442 ' N ' HG12 ' A' ' 161' ' ' ILE . 5.6 ttp85 -86.51 144.76 27.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -137.6 99.35 9.52 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.11 -25.63 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.015 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.83 -13.38 32.98 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -104.83 43.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.74 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 23.0 m120 59.38 59.28 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.13 79.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.08 148.91 42.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.384 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.5 mtt-85 -86.15 167.04 15.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.53 100.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.102 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.482 ' C ' ' CD1' ' A' ' 172' ' ' TRP . 3.0 t-105 -85.95 106.3 17.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.4 mt -64.56 -49.61 70.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 153.75 158.13 8.45 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -78.03 155.59 30.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -1.145 . . . . 0.0 109.076 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 66.6 m-85 -130.5 173.8 10.5 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.42 -31.77 42.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.935 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -141.03 172.55 12.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.48 -22.54 61.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.474 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -72.76 -38.55 67.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.3 -44.92 50.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.72 -44.76 95.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.394 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.013 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.43 -43.29 88.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.089 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.36 -51.66 68.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.865 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.95 -23.15 66.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.4 t80 -72.96 -31.88 64.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 109.503 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.678 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.8 m-20 -70.93 -50.28 36.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -37.45 47.66 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.676 -0.64 . . . . 0.0 109.985 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.1 -23.49 23.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.83 7.69 45.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.802 ' CD2' HD11 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -118.83 -37.61 3.22 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -81.5 -38.87 25.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -79.07 -32.86 44.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.718 -0.614 . . . . 0.0 109.727 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -91.74 -17.88 24.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.219 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 41.98 -156.94 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.0 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.173 . . . . 0.0 109.545 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.4 mtm180 -56.05 -58.3 8.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.606 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 60.29 177.81 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.169 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 200' ' ' LEU . 11.0 mt -140.89 122.5 15.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.541 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -123.32 154.37 38.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 109.377 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.529 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -56.06 -33.68 65.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.39 80.27 37.44 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.499 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.921 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 83.68 7.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.27 -3.52 5.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 179' ' ' ALA . 41.9 t -107.62 114.71 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.775 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -94.89 115.93 28.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.852 . . . . 0.0 109.219 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.509 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -88.39 155.04 19.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.23 162.28 22.87 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 -7.59 16.59 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.526 2.151 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -99.21 -64.53 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.47 50.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -146.05 156.43 43.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -1.176 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.4 m-85 -130.24 179.99 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.711 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.63 111.8 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.546 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.85 125.75 33.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.676 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -147.81 158.63 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.7 tt -143.54 134.61 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.98 131.18 41.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -111.33 106.32 57.12 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.06 -31.4 4.95 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.279 1.986 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.4 -16.67 64.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.339 -0.85 . . . . 0.0 108.948 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -107.42 53.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.477 -0.764 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.23 21.68 2.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.11 62.41 3.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.87 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -1.182 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.69 155.85 14.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.887 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.7 t -140.98 83.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.711 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.9 t-105 -71.49 98.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 108.98 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.942 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.32 -51.42 68.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 157.28 157.85 8.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.565 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -72.81 153.12 41.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -1.129 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 72.0 m-85 -129.01 -172.63 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.511 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.32 -28.84 13.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.56 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.7 p -140.91 166.06 25.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -68.03 -21.22 65.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -75.32 -44.25 46.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 109.756 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.435 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -69.81 -38.69 76.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -69.16 -43.27 74.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.921 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.16 -35.43 80.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 108.97 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.766 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -63.5 -48.4 77.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.026 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.13 -25.45 67.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.469 -0.77 . . . . 0.0 109.064 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.9 t80 -68.91 -34.3 75.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.665 ' HB3' HD13 ' A' ' 200' ' ' LEU . 40.1 m-20 -64.05 -48.01 77.93 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.379 -0.825 . . . . 0.0 108.917 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -52.16 -44.58 64.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.711 -0.618 . . . . 0.0 110.295 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.942 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.42 -27.64 59.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -88.2 6.82 34.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.471 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.0 t80 -115.61 -26.4 7.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 108.938 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -83.32 -37.5 23.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mtp -80.9 -39.27 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.636 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 73.1 mtt180 -94.0 -34.24 13.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 48.92 -168.72 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.9 m 57.96 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.361 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 52.1 ttt180 -124.87 -54.92 1.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.083 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . 61.85 154.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.751 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 108.44 19.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.64 -174.34 2.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.58 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.556 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -80.72 -37.79 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.766 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.1 m-85 -116.4 80.58 10.11 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.288 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.513 0 C-N-CA 122.688 2.259 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 40.4 m-85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.281 0.562 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.5 88.31 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.96 -29.85 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.1 t -86.15 113.25 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.698 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -93.34 105.86 17.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 108.583 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.632 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 13.7 pt20 -103.47 133.85 47.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 110.097 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.571 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -88.23 -179.26 1.26 Allowed Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.3 Cg_endo -75.22 77.98 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.826 1.684 . . . . 0.0 109.825 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER 70.47 75.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.775 . . . . 0.0 109.272 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.61 -86.35 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.553 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -137.87 178.35 7.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.147 -1.208 . . . . 0.0 110.252 -178.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.634 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 9.5 m-85 -135.93 174.53 10.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.584 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.12 104.73 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.61 ' HB2' ' CA ' ' A' ' 182' ' ' ALA . . . -79.93 102.6 9.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.195 -0.941 . . . . 0.0 109.201 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 5.8 tm-20 -125.79 154.27 42.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.792 . . . . 0.0 109.197 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.865 HD13 ' HE2' ' A' ' 193' ' ' MET . 2.1 tt -132.71 149.24 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.963 . . . . 0.0 109.694 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.2 ttm180 -103.46 108.33 19.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.314 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -100.23 118.36 61.48 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.96 -26.46 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.284 1.989 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -14.4 22.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.255 -0.903 . . . . 0.0 109.378 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -102.1 39.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.354 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.67 33.41 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.82 53.66 9.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -108.72 121.97 46.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.53 159.21 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.605 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.1 t -138.25 87.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.264 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.1 t-105 -69.71 114.55 8.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 109.394 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 20.2 mt -75.39 -53.9 7.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.85 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.69 156.46 8.75 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -73.67 152.93 40.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.15 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.792 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.3 m-85 -131.05 173.99 10.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.74 -30.68 32.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.634 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -138.2 -172.77 3.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.593 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -88.42 -22.24 23.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.955 . . . . 0.0 108.833 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -72.21 -37.43 69.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.011 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -74.2 -46.72 40.19 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.416 -0.802 . . . . 0.0 108.948 179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -21.23 62.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.68 -39.11 37.68 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 184' ' ' LEU . 3.1 tm? -68.24 -45.33 73.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.24 -26.73 68.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -67.84 -33.51 74.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.492 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.3 m-20 -68.19 -42.36 80.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 188' ' ' ARG . 17.4 tpp180 -61.59 -40.41 94.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.995 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.65 -23.96 42.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 109.701 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.92 -3.5 57.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.581 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 187' ' ' ASP . 1.7 t80 -105.53 -27.84 11.15 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.204 -0.935 . . . . 0.0 108.763 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -81.59 -40.97 22.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.865 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.77 -33.55 60.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -0.777 . . . . 0.0 109.304 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 8.0 mmm180 -92.63 -16.41 25.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.827 . . . . 0.0 108.929 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . 42.29 -108.72 0.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 197' ' ' ARG . 56.1 p -50.53 111.81 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -1.136 . . . . 0.0 110.097 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.2 OUTLIER 56.35 160.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 0.0 110.344 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . 177.32 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.2 mt -95.54 116.21 28.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.64 -176.69 4.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.411 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.479 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -80.36 -35.5 35.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 2.3 m-85 -120.03 79.25 25.45 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 122.614 2.209 . . . . 0.0 110.713 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.185 0.517 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.58 74.91 7.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.381 -0.825 . . . . 0.0 108.898 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 155.3 -16.41 0.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 1.003 HG11 ' HA ' ' A' ' 179' ' ' ALA . 9.2 t -105.26 111.11 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.979 -1.306 . . . . 0.0 109.785 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.94 131.68 54.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.612 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . 2.8 pm0 -122.8 131.76 53.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.991 . . . . 0.0 110.473 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.585 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -71.86 -172.87 0.23 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.13 90.57 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.645 1.563 . . . . 0.0 109.977 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.8 m95 64.49 50.14 2.27 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.02 -123.61 2.04 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.459 -1.353 . . . . 0.0 111.09 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -106.68 151.78 24.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.972 . . . . 0.0 110.434 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE1' ' HB2' ' A' ' 151' ' ' GLN . 2.9 m-30 -100.2 -171.7 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.626 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.79 121.28 2.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.611 -1.306 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -100.11 121.24 41.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 2.0 mt-10 -136.19 158.47 44.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.809 . . . . 0.0 109.672 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.508 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.6 tt -141.54 123.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 170' ' ' ARG . 1.0 OUTLIER -63.57 139.2 58.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.417 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 43.7 t0 -128.2 97.8 28.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.284 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.52 -28.18 7.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.307 2.005 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.2 -14.06 52.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -108.8 42.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.736 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.47 30.02 9.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.074 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.47 66.94 1.56 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -116.33 85.92 2.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -1.147 . . . . 0.0 109.338 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.3 ptt85 -42.2 144.95 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.406 -0.808 . . . . 0.0 109.481 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 161' ' ' ILE . 45.7 t -120.19 88.58 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.145 -0.972 . . . . 0.0 109.811 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.626 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.0 t-105 -73.66 93.75 2.11 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.137 -0.977 . . . . 0.0 109.025 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -51.43 -47.38 63.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.763 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.51 165.11 12.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -77.54 148.02 35.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.933 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 48.3 m-85 -123.44 -166.4 1.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.35 -0.844 . . . . 0.0 109.397 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -105.01 -26.75 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . 1.9 p -144.61 -172.27 3.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 109.548 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.003 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -87.11 -22.63 25.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.03 -36.61 56.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.59 -52.2 11.12 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.217 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.933 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.43 -34.73 77.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.164 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.64 -44.16 74.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.732 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -58.65 -38.21 77.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.397 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.73 -28.24 63.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.006 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -70.67 -30.16 66.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 96.7 m-20 -71.84 -41.9 67.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.411 -0.806 . . . . 0.0 109.942 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.7 -34.12 73.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 110.082 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.994 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.65 -29.08 36.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.764 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.02 -24.93 35.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.377 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -81.33 -26.84 35.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -45.56 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.43 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -71.71 -35.22 70.14 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.585 -0.697 . . . . 0.0 109.965 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.716 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 3.3 mpt_? -94.66 -7.89 39.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.24 -87.25 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 197' ' ' ARG . 4.4 t -85.25 -146.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.702 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' A' ' 196' ' ' SER . 28.1 mtm180 -38.46 140.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.598 -0.689 . . . . 0.0 110.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.716 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . -157.14 32.69 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 199' ' ' LEU . 7.2 mt 41.68 92.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.66 -0.65 . . . . 0.0 109.651 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -120.51 143.66 48.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.2 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -45.89 -33.96 3.56 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.526 ' HD2' HD22 ' A' ' 184' ' ' LEU . 1.4 m-85 -134.04 88.01 32.92 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.2 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.572 2.181 . . . . 0.0 110.545 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.927 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 15.5 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 98.46 3.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.192 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.0 -31.94 3.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 157' ' ' PHE . 41.0 t -79.55 136.53 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -1.1 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -108.4 89.91 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 109.228 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 14.0 pt20 -59.42 131.21 50.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.978 . . . . 0.0 109.462 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -110.66 159.5 32.1 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.75 -1.68 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.708 2.272 . . . . 0.0 110.543 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.423 ' HB3' ' HE3' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -98.73 -25.71 14.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.05 39.87 0.62 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 157' ' ' PHE . 21.6 mttt -130.05 179.96 5.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 86.5 m-85 -159.12 109.0 1.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 108.679 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -85.8 127.12 34.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.09 -1.006 . . . . 0.0 111.263 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -99.9 116.92 33.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.45 166.16 25.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.041 -1.037 . . . . 0.0 110.316 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 8.8 tt -152.18 158.63 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.451 -0.78 . . . . 0.0 108.952 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.54 139.7 48.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.95 -1.094 . . . . 0.0 109.858 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -138.11 93.63 11.62 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.36 -22.99 10.51 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.587 2.191 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.89 -13.99 19.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -107.38 51.03 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 167' ' ' ASN . 28.7 t-20 57.03 38.32 29.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.341 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.94 97.91 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.6 100.89 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.127 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -51.99 166.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.441 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 67.2 t -147.83 90.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.612 ' HZ2' HG22 ' A' ' 175' ' ' THR . 3.1 t-105 -87.06 101.83 13.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.099 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.2 mt -56.12 -50.79 70.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.42 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 148.63 148.68 4.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.612 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.1 p -68.32 158.41 33.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.08 -1.247 . . . . 0.0 108.967 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 85.5 m-85 -131.86 -176.89 4.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.622 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -27.69 14.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.553 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.7 p -133.03 170.41 15.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.515 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -22.61 47.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.377 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -73.09 -33.11 65.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.428 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.0 OUTLIER -80.54 -34.95 35.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.235 -0.915 . . . . 0.0 109.173 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -76.48 -27.83 56.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.927 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.14 -40.56 45.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.203 -0.936 . . . . 0.0 108.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 202' ' ' PHE . 6.9 tp -63.89 -41.75 97.64 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.513 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.58 -37.76 85.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -62.73 -40.44 97.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.45 -0.781 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.4 m-20 -60.7 -52.2 66.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.498 -0.751 . . . . 0.0 109.833 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -54.16 -31.19 51.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.099 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -84.4 -26.95 27.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.25 2.99 54.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.542 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.5 t80 -117.16 -31.24 5.4 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -74.92 -38.49 61.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 ttm -81.53 -46.26 14.74 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.418 0.627 . . . . 0.0 109.735 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.7 mtt85 -93.94 -41.89 9.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.039 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 48.12 -149.79 3.39 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m 50.26 -107.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -1.188 . . . . 0.0 109.601 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.01 56.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.222 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -66.18 169.65 6.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.332 -0.855 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -113.67 116.44 29.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.098 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -125.25 179.28 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.555 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.574 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -70.33 -38.25 74.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 200' ' ' LEU . 7.8 m-85 -112.16 96.11 33.26 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.457 0 C-N-CA 122.578 2.185 . . . . 0.0 110.708 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.8 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -77.79 96.98 5.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.637 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.66 -16.72 7.39 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 183' ' ' ALA . 27.3 t -97.48 117.61 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.811 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 3.4 mmp_? -96.53 117.89 31.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.588 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -85.38 160.07 19.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 0.0 110.016 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.528 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 16.4 mtt180 -126.7 158.26 68.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.681 -0.637 . . . . 0.0 109.337 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.2 3.49 7.05 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.577 2.185 . . . . 0.0 110.298 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -9.9 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.485 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.01 33.24 4.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.2 mtmt -127.81 173.09 10.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.127 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.6 m-85 -144.33 -178.29 5.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.366 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.621 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.69 104.1 2.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 109.94 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.59 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.04 123.22 27.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.235 -0.916 . . . . 0.0 108.974 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 1.1 mt-10 -139.12 164.51 29.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.266 -0.896 . . . . 0.0 109.267 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 171' ' ' VAL . 6.2 tt -146.02 141.84 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -86.8 108.72 18.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 166' ' ' LYS . 11.8 t70 -99.68 113.14 64.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.36 -27.31 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -9.14 56.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 4.4 mmpt? -117.87 39.35 3.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 1.2 m-20 68.74 29.38 5.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.41 27.1 68.89 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.81 116.53 8.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -1.209 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -59.04 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HG23 ' A' ' 161' ' ' ILE . 37.8 t -68.31 104.99 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.621 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.4 t-105 -80.51 99.01 7.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 19.7 mt -56.63 -37.67 71.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.027 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.555 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 136.3 158.27 8.04 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -78.52 148.87 33.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -1.13 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.4 m-85 -120.25 -168.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.695 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.938 ' HG3' HG23 ' A' ' 178' ' ' THR . 9.9 pt-20 -99.23 -32.59 11.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.938 HG23 ' HG3' ' A' ' 177' ' ' GLU . 2.1 p -133.85 170.1 16.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.127 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.32 -23.65 50.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.96 . . . . 0.0 109.556 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -73.13 -36.61 66.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.491 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.3 OUTLIER -75.32 -45.38 39.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -61.76 -47.2 86.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.32 -42.39 86.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.103 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 184' ' ' LEU . 21.3 tp -60.79 -39.83 90.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.564 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.19 -24.34 66.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -0.813 . . . . 0.0 109.046 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -72.35 -29.95 64.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.714 ' HB3' HD13 ' A' ' 200' ' ' LEU . 2.0 m-20 -72.18 -50.32 28.58 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -60.91 -28.7 69.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.48 -19.57 23.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.927 . . . . 0.0 109.274 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.72 -8.14 41.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -105.79 -33.67 7.92 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -80.15 -39.77 28.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -30.57 64.12 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.673 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 12.8 mtt180 -96.2 -0.95 49.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.36 -87.17 1.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 197' ' ' ARG . 3.0 m -135.8 164.4 27.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -1.188 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.82 109.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -163.31 150.1 12.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.957 . . . . 0.0 109.492 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mp -92.37 118.23 30.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.51 174.74 8.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 109.413 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.616 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -70.42 -34.59 72.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 108.613 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.8 m-85 -121.34 84.58 41.34 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.48 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.76 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 46.0 m-85 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -82.03 36.18 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.154 -0.966 . . . . 0.0 109.753 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.04 26.59 0.09 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 57.6 t -143.6 113.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -1.154 . . . . 0.0 109.424 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.05 94.79 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.32 134.29 56.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.494 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 7.5 mmt180 -99.17 161.25 25.37 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.668 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.494 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.32 -34.81 1.41 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.678 2.252 . . . . 0.0 110.263 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -47.69 83.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.08 43.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 2.6 mttm -131.94 -168.65 2.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 63.3 m-85 -159.47 108.29 1.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.096 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.618 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -82.38 139.34 34.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -111.11 113.58 26.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -134.79 164.75 26.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 0.0 109.899 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -141.52 143.3 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 108.914 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 1.2 tmm_? -82.62 119.71 24.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.825 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.407 ' CG ' ' SD ' ' A' ' 193' ' ' MET . 41.5 t0 -111.06 97.74 35.99 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.072 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 34.7 Cg_endo -76.39 -26.39 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.475 2.117 . . . . 0.0 110.673 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.81 -22.76 67.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 109.578 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -100.4 64.33 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.587 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 48.16 44.22 19.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.602 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 50.92 59.64 7.87 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -107.18 136.71 46.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -1.165 . . . . 0.0 109.44 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 163.24 28.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' A' ' 161' ' ' ILE . 55.7 t -134.87 99.7 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 158' ' ' ALA . 16.0 t-105 -84.09 91.67 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.982 . . . . 0.0 109.599 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 57.6 mt -51.38 -48.45 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.246 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 152.39 158.52 8.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.615 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.8 p -73.61 162.71 28.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -1.175 . . . . 0.0 109.477 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -138.83 179.57 6.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -28.46 19.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 p -142.72 168.51 19.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -72.09 -24.6 61.52 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.83 -39.79 76.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -74.63 -45.69 43.18 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.14 -31.15 72.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.69 -47.83 44.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.255 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.433 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -58.39 -35.68 72.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 108.834 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.43 -28.98 65.47 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.278 -0.888 . . . . 0.0 108.696 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -65.88 -28.03 68.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.723 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.9 m-20 -71.62 -47.88 51.67 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.303 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -34.74 68.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -84.2 -39.11 19.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.929 -1.107 . . . . 0.0 109.981 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -69.22 -18.91 63.95 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.572 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.6 t80 -85.55 -40.6 16.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.139 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -40.28 86.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.759 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.407 ' SD ' ' CG ' ' A' ' 163' ' ' ASP . 28.9 ttm -77.86 -43.16 31.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.666 -0.646 . . . . 0.0 109.591 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 70.4 mtt180 -102.25 34.2 2.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.955 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -41.12 164.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 84.53 -47.71 0.1 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.834 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -171.73 128.81 0.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.208 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 194' ' ' ARG . . . -159.66 148.77 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -89.77 122.62 33.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -121.83 157.26 31.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.164 -0.96 . . . . 0.0 109.303 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -53.93 -35.59 61.86 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.2 m-85 -124.16 83.53 56.18 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.515 2.143 . . . . 0.0 110.529 -179.78 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.958 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.5 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -72.11 96.75 1.81 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.54 -8.33 7.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' A' ' 182' ' ' ALA . 38.5 t -105.01 112.32 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -1.172 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -96.19 117.61 31.11 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.596 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.38 153.76 24.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.84 . . . . 0.0 109.433 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -116.58 155.94 48.18 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.25 -10.52 16.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.661 2.241 . . . . 0.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -36.59 17.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.136 -0.977 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 156' ' ' LYS . . . 133.61 61.81 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 155' ' ' GLY . 19.4 mttp -166.83 -171.64 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 109.514 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.015 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -148.88 -175.12 4.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 109.102 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.705 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.31 108.53 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 0.0 110.017 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.8 134.17 36.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.154 -0.966 . . . . 0.0 108.984 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.24 148.96 29.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.095 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.435 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 3.8 tt -141.79 127.71 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.023 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -69.46 143.63 53.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 109.204 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 168' ' ' GLY . 43.5 t0 -110.52 97.65 33.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.573 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.6 Cg_endo -76.57 -26.9 8.04 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.355 2.037 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.51 68.33 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 3.0 mmmm -101.55 25.31 8.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 67.46 66.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 69.32 -106.64 1.85 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 51.33 80.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.255 . . . . 0.0 109.578 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.9 153.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 171' ' ' VAL . 11.7 t -128.07 81.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.705 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.5 t-105 -61.4 97.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 109.168 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -52.68 -49.14 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 176' ' ' PHE . . . 149.43 154.26 6.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -68.54 153.86 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -1.196 . . . . 0.0 109.214 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 56.7 m-85 -129.4 172.91 11.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.754 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -77.02 -30.11 55.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 109.854 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.519 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.5 p -145.65 -174.07 4.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.015 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -81.81 -28.62 33.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.673 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -70.61 -34.46 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 109.624 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -73.32 -44.42 58.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.133 -0.979 . . . . 0.0 109.452 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.96 -30.2 68.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.958 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.98 -41.49 67.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.301 -0.875 . . . . 0.0 109.105 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.75 94.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.302 -0.873 . . . . 0.0 109.16 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.18 -22.9 66.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -0.809 . . . . 0.0 108.935 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.3 t80 -69.79 -33.9 73.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 109.081 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.489 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 18.9 m-20 -67.68 -43.85 79.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.429 -0.795 . . . . 0.0 109.472 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -58.9 -40.53 84.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.773 . . . . 0.0 109.84 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.89 -20.75 38.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.89 -8.9 48.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.3 t80 -101.96 -33.95 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.284 -0.885 . . . . 0.0 108.924 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -76.4 -40.95 49.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 108.782 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.01 -31.61 64.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.576 -0.702 . . . . 0.0 109.484 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.7 mtt85 -105.81 1.82 27.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 49.3 -99.07 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER -48.2 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 109.737 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -42.77 160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.778 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -157.72 37.0 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 109.273 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.472 ' C ' HD23 ' A' ' 200' ' ' LEU . 7.8 mp 39.89 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.718 -0.614 . . . . 0.0 109.869 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -111.91 173.93 6.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.972 . . . . 0.0 109.401 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.419 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -72.0 -34.54 68.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.7 m-85 -122.67 80.42 48.16 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.58 2.186 . . . . 0.0 110.65 -179.421 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.914 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 99.9 4.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.2 -25.21 7.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 183' ' ' ALA . 52.0 t -86.79 126.14 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -1.191 . . . . 0.0 110.046 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -104.4 110.98 23.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.558 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 pm0 -75.88 144.63 41.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 156.62 53.32 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.158 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.03 3.51 6.96 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.552 2.168 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -96.19 -13.84 23.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.79 26.41 6.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.493 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -133.76 -173.78 3.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -1.155 . . . . 0.0 109.527 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 65.7 m-85 -149.0 -177.59 5.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.351 -0.843 . . . . 0.0 109.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.754 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.77 108.24 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.842 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.706 ' C ' HD12 ' A' ' 173' ' ' LEU . . . -79.94 108.82 13.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 108.993 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER -126.47 155.16 42.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -0.947 . . . . 0.0 109.966 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 171' ' ' VAL . 7.5 tt -141.55 117.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.387 -0.82 . . . . 0.0 109.015 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -89.99 126.05 35.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -111.11 103.9 55.48 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 0.0 109.395 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.98 -25.12 9.19 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.307 2.005 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.92 -18.71 64.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 39.16 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.93 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.2 m120 55.53 46.05 23.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.42 121.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.61 128.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -1.137 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -95.26 148.62 22.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 161' ' ' ILE . 41.6 t -133.48 89.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.754 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.5 t-105 -75.36 102.9 5.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.063 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 159' ' ' ALA . 3.6 mt -57.67 -57.8 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.665 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 161.88 157.01 8.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.47 153.21 41.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -1.128 . . . . 0.0 109.227 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.759 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.8 m-85 -127.06 178.11 6.21 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.913 . . . . 0.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.51 -30.86 24.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -138.64 176.81 8.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.273 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.86 -23.09 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.439 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -74.45 -35.05 63.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.14 -37.83 53.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.57 -32.85 66.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.226 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.914 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.84 -37.28 59.15 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -66.34 -39.58 89.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.086 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.88 -23.34 62.28 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -73.14 -29.81 63.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.505 -0.747 . . . . 0.0 109.0 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.653 ' HB3' HD13 ' A' ' 200' ' ' LEU . 39.5 m-20 -69.74 -50.15 46.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.266 -0.897 . . . . 0.0 109.55 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -60.09 -35.84 76.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 109.946 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -80.96 -24.67 37.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.159 -0.963 . . . . 0.0 109.521 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.8 -1.85 57.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -106.51 -27.89 10.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.606 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -40.32 23.72 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -74.24 -33.77 63.44 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.588 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 5.5 mtt180 -86.74 -13.02 46.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 53.97 -92.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 195' ' ' GLY . 9.3 p -54.17 -167.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.3 mtm105 -42.77 156.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.454 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.588 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -156.31 155.23 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -100.39 118.25 36.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -129.17 179.94 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.469 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -76.53 -31.45 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.14 75.26 30.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.311 -1.434 0 C-N-CA 122.661 2.24 . . . . 0.0 110.638 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.986 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.7 m-85 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.458 ' CG ' ' O ' ' A' ' 147' ' ' ARG . 1.7 ptt180 -67.83 125.06 25.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.126 -0.984 . . . . 0.0 108.718 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.04 20.9 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -88.94 106.44 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.772 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -80.16 108.45 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.613 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -72.0 160.17 32.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 110.51 -178.798 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HG2' ' CA ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.58 169.15 18.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.851 -0.531 . . . . 0.0 112.334 -178.046 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 152' ' ' ARG . 37.3 Cg_endo -85.17 -16.24 5.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.567 2.178 . . . . 0.0 106.986 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -145.64 -67.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.647 ' CA ' ' HG2' ' A' ' 152' ' ' ARG . . . -147.68 113.22 0.63 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 147.79 148.31 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 117.856 0.828 . . . . 0.0 110.1 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.103 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 51.4 m-85 -139.84 170.44 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.449 -1.407 . . . . 0.0 108.645 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -141.99 113.36 7.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -81.96 118.46 22.98 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 1.5 tt0 -141.18 158.36 44.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 109.864 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.5 tt -151.85 125.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -88.71 118.94 28.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -99.33 117.38 64.06 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.62 -26.42 7.08 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.355 2.037 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -14.98 62.64 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -103.21 32.62 3.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.679 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.43 54.98 1.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 45.83 65.98 1.8 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.98 98.31 6.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 160' ' ' GLU . 7.5 mtt180 -48.69 166.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 171' ' ' VAL . 7.2 t -143.96 86.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.161 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.727 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.3 t-105 -70.77 96.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.25 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.01 -42.74 76.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 176' ' ' PHE . . . 146.06 152.06 5.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.727 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.4 p -66.68 179.36 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.223 -1.163 . . . . 0.0 109.464 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 70.4 m-85 -155.56 -173.93 4.75 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 0.0 109.141 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' C ' ' CG2' ' A' ' 178' ' ' THR . 32.9 tt0 -97.37 -17.94 19.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.617 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 7.3 p -152.32 169.45 22.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.786 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.103 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.33 -22.79 61.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -73.09 -41.95 63.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -34.79 67.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.431 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -74.66 -31.27 61.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.266 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.986 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.8 -40.17 66.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.47 -48.46 81.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.67 ' O ' HD22 ' A' ' 173' ' ' LEU . . . -63.28 -28.56 70.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.552 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.0 t80 -68.34 -28.1 66.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.514 ' CB ' HD13 ' A' ' 200' ' ' LEU . 5.0 m-20 -72.64 -37.02 68.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -64.67 -36.21 83.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 110.196 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.25 -41.86 24.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.826 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.659 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -71.96 -5.95 38.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.734 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.1 t80 -104.81 -44.03 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.048 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -40.11 94.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.0 mtm -80.44 -43.3 21.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.569 -0.707 . . . . 0.0 109.54 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 196' ' ' SER . 14.1 mtt180 -102.78 33.19 3.31 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.449 -0.782 . . . . 0.0 109.415 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -41.98 94.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 194' ' ' ARG . 12.2 p 170.28 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.268 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 35.5 11.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.19 145.55 46.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -82.35 135.65 35.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.716 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -138.59 -174.56 3.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.853 . . . . 0.0 109.127 -179.982 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.506 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -68.94 -36.39 77.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.3 m-85 -119.15 76.32 15.85 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.3 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 122.631 2.221 . . . . 0.0 110.801 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.816 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.9 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.15 84.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.9 -32.62 1.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 183' ' ' ALA . 48.3 t -77.21 144.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 8.7 ttm-85 -123.83 97.34 5.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.063 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.552 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 5.4 pt20 -87.57 135.62 33.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.329 -0.857 . . . . 0.0 109.345 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -89.36 -173.99 0.43 Allowed Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -74.37 81.05 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.411 1.408 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.2 m0 63.17 74.85 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.63 -0.669 . . . . 0.0 109.309 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 152' ' ' ARG . . . -170.5 -99.99 0.13 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.156 -1.497 . . . . 0.0 111.003 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.41 -178.23 3.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -1.134 . . . . 0.0 110.755 -178.334 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.696 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 8.3 m-85 -132.47 179.76 5.93 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.55 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.28 112.61 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.881 -1.137 . . . . 0.0 110.446 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.38 119.29 28.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 6.6 mt-10 -137.91 170.42 16.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.872 -179.204 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.456 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.3 tt -159.22 156.38 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.456 ' N ' HG12 ' A' ' 161' ' ' ILE . 42.0 ttp180 -96.38 129.67 43.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.738 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.432 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 10.6 t0 -113.31 106.17 54.74 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.236 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.83 -23.59 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.413 2.075 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.23 -19.61 62.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.282 -0.886 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -100.84 46.97 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.74 38.9 21.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 58.88 53.79 43.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.15 138.5 39.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -1.144 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -67.39 163.24 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 171' ' ' VAL . 40.5 t -139.06 94.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.605 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -82.69 94.13 7.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 109.028 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.88 HD21 ' HB2' ' A' ' 189' ' ' ALA . 13.6 mt -51.25 -41.73 60.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 109.134 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 142.58 152.76 5.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.605 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -67.28 152.61 45.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -1.107 . . . . 0.0 109.444 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -127.06 179.11 5.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.167 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 -25.43 28.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.819 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.7 p -147.5 -174.15 4.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.51 -23.99 29.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.781 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -34.29 65.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 109.615 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.64 -43.92 36.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.03 -47.1 81.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 109.17 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.816 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.53 -38.39 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.38 -52.31 65.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 108.915 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -62.65 -18.55 62.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.5 t80 -75.65 -34.6 60.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.878 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 26.7 m-20 -61.67 -47.64 84.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.567 -0.708 . . . . 0.0 109.597 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.37 85.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -73.25 -17.01 61.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.535 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -87.41 -19.65 27.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.238 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.532 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 5.5 t80 -93.59 -31.49 14.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -38.91 67.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.432 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -74.12 -52.13 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -86.41 -50.23 7.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.463 -0.773 . . . . 0.0 109.241 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 50.79 176.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 197' ' ' ARG . 33.9 t 58.81 71.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.634 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER 50.12 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.967 . . . . 0.0 109.535 179.839 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -125.39 163.36 22.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 pp -92.83 127.54 38.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -133.23 152.74 51.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.29 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.574 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -48.89 -38.99 24.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.145 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.0 m-85 -120.85 89.47 45.56 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 110.88 -179.289 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.8 m-85 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -76.86 85.28 3.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.865 . . . . 0.0 109.352 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.56 -23.27 3.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 94.7 t -88.13 137.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.398 -1.06 . . . . 0.0 109.301 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 14.6 tpp180 -124.82 103.64 8.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.84 . . . . 0.0 109.244 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 60.1 tt0 -61.89 169.27 2.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -128.57 163.36 45.33 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.341 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 35.1 Cg_endo -76.63 76.08 4.16 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.577 2.185 . . . . 0.0 110.319 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER 168.86 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.535 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 156' ' ' LYS . . . 159.86 41.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.6 mmtt -137.49 179.8 6.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.513 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.09 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.1 m-85 -149.83 -179.99 7.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.74 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.32 113.25 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.637 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.79 119.08 25.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 108.936 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -140.5 152.24 45.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 3.5 tt -137.26 132.33 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 99.2 12.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.64 116.13 65.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.619 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.98 -23.6 9.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.39 2.06 . . . . 0.0 110.295 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.24 -22.33 62.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.453 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -96.98 44.79 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.576 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.11 20.53 5.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.3 43.21 7.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.79 109.86 21.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -54.9 150.13 10.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.064 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.9 t -131.19 86.63 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.74 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.1 t-105 -74.15 99.7 3.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.1 mt -53.54 -54.48 36.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.458 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 156.13 153.09 6.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -66.72 152.85 44.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -1.069 . . . . 0.0 109.357 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.705 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 63.9 m-85 -126.53 -173.1 2.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.885 . . . . 0.0 109.541 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.51 -28.75 15.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.7 p -140.75 171.91 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 109.423 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.09 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -75.97 -25.04 55.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -74.05 -35.94 64.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -75.13 -40.15 59.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 108.994 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.98 -31.02 67.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.316 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.964 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.89 -38.08 64.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.338 -0.851 . . . . 0.0 108.817 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 187' ' ' ASP . 43.8 tp -64.14 -45.2 89.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.448 -0.783 . . . . 0.0 109.102 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.55 -27.85 68.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 108.888 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -66.86 -30.79 71.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.212 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.498 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.7 m-20 -67.89 -55.0 14.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.296 -0.877 . . . . 0.0 109.423 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -31.59 37.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.531 -0.73 . . . . 0.0 109.919 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.58 -29.47 30.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.834 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -86.75 -1.32 57.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -103.33 -31.14 10.2 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 108.89 179.613 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -77.75 -40.59 40.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.327 -0.858 . . . . 0.0 108.961 179.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.6 mtp -81.16 -32.07 33.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.606 -0.684 . . . . 0.0 110.378 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -91.18 -1.62 57.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 83.13 -150.05 27.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.57 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 p -63.01 -97.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 109.833 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 11.6 mtm180 -48.99 153.14 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.814 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 178.8 160.91 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.1 mp -98.38 111.53 23.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.59 172.1 9.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 108.987 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.451 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -72.55 -33.28 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.237 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 6.8 m-85 -121.46 75.36 33.49 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 122.611 2.207 . . . . 0.0 110.417 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -78.23 83.02 4.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.202 -0.936 . . . . 0.0 109.284 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 144.21 -23.36 2.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.884 HG11 ' HA ' ' A' ' 179' ' ' ALA . 6.1 t -102.12 122.93 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.259 . . . . 0.0 109.735 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 9.3 mtt180 -122.03 171.61 8.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 151' ' ' GLN . 9.4 pm0 -138.2 143.54 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 109.597 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.7 mtt85 -104.41 169.59 7.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.726 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.4 Cg_endo -78.18 8.02 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.764 2.31 . . . . 0.0 110.93 -179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -35.28 7.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.456 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 128.31 45.77 0.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 21.7 mttt -149.59 134.86 18.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.165 . . . . 0.0 109.618 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD2' ' C ' ' A' ' 178' ' ' THR . 5.4 m-30 -98.38 -168.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 108.671 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.727 ' HB1' ' OE2' ' A' ' 160' ' ' GLU . . . -162.91 126.31 2.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -106.57 113.78 27.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.727 ' OE2' ' HB1' ' A' ' 158' ' ' ALA . 2.7 mp0 -131.04 174.77 9.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.436 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.3 tt -168.6 140.62 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -0.797 . . . . 0.0 109.148 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -73.67 152.76 40.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.0 109.66 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.446 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 58.1 t0 -123.08 95.49 45.91 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.93 -27.86 6.64 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.527 2.151 . . . . 0.0 110.056 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.49 -28.44 69.83 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.446 -0.784 . . . . 0.0 109.099 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.446 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -95.25 27.37 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 0.0 109.534 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.88 72.54 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.65 106.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 163' ' ' ASP . . . -169.07 102.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.9 148.36 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 171' ' ' VAL . 32.0 t -133.03 94.92 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 160' ' ' GLU . 3.4 t-105 -82.77 100.33 10.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.609 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.5 mt -55.51 -55.37 32.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.15 161.08 10.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -74.59 153.18 39.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.218 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.761 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 54.2 m-85 -127.11 -167.59 1.76 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.68 -28.45 11.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.002 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.4 p -147.0 -179.81 7.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.884 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -76.94 -33.41 57.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.79 -37.9 88.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.064 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -70.66 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.483 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -46.36 -27.59 1.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.256 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.37 -45.65 62.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.44 -39.05 93.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.684 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.36 -28.2 64.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.8 t80 -71.33 -30.84 66.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.447 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.0 m-20 -67.85 -45.21 75.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.964 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -37.8 83.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.687 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.609 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.83 -20.35 35.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.52 -0.6 56.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -109.78 -31.38 7.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.145 -0.972 . . . . 0.0 108.599 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.54 -40.39 21.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.2 ttm -75.26 -31.59 60.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.753 -0.592 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.3 mtt180 -95.5 -17.45 21.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' SER . . . 47.68 -106.28 0.16 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 197' ' ' ARG . 83.8 p -40.34 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -1.046 . . . . 0.0 110.165 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.6 OUTLIER 46.17 -173.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.833 . . . . 0.0 109.649 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 170.73 152.59 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.8 mt -101.75 108.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.526 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -123.17 -175.64 3.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -78.59 -37.86 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 108.875 179.7 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.615 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 4.5 m-85 -115.6 82.26 9.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.491 -0.756 . . . . 0.0 109.173 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.753 2.302 . . . . 0.0 110.563 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.961 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.2 m-85 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.26 0.552 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.81 131.19 45.08 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.287 -0.883 . . . . 0.0 108.963 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.63 -35.93 3.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.9 t -81.19 113.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.272 . . . . 0.0 109.996 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -95.88 114.44 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 19.8 pt20 -97.43 128.74 44.47 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.866 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mtp180 -75.62 169.59 19.85 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.379 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 29.4 Cg_endo -69.85 83.79 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.18 1.253 . . . . 0.0 109.605 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 61.6 m95 63.27 63.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -155.06 -106.45 0.26 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.589 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.55 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 5.4 mttp -111.19 -169.67 1.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.335 -1.097 . . . . 0.0 110.514 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.933 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.4 m-85 -143.59 173.56 11.54 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.45 109.06 3.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.851 -1.156 . . . . 0.0 110.305 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.87 124.96 29.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.166 -0.959 . . . . 0.0 108.882 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 136.45 31.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.952 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 161' ' ' ILE . 2.7 tt -128.78 120.53 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.17 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.29 144.74 29.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 0.0 109.585 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.437 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 32.1 t0 -124.34 116.52 26.92 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.925 . . . . 0.0 109.317 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 36.2 Cg_endo -77.04 -31.03 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.528 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -25.42 67.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -89.03 44.76 1.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.18 53.7 10.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.36 94.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -147.86 111.16 4.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 144.48 54.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.303 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 53.3 t -122.93 94.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.669 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.6 t-105 -72.75 98.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' CB ' ' A' ' 189' ' ' ALA . 1.1 mt -57.91 -45.48 86.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.797 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 149.8 162.96 10.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -79.51 158.14 27.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.23 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 75.1 m-85 -133.84 175.39 9.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.0 tp10 -82.37 -30.7 30.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.683 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -143.31 167.6 21.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.933 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.77 -22.47 65.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -38.68 69.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.92 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -75.47 -37.12 60.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.91 -34.74 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.188 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.961 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.43 -39.65 67.71 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -63.63 -42.86 98.12 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.574 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.467 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.41 -32.79 73.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.556 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.6 t80 -62.98 -30.49 71.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.148 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 16.0 m-20 -69.7 -41.79 74.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.378 -0.826 . . . . 0.0 109.657 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -63.72 -40.19 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 110.594 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.994 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.08 -25.95 34.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.987 -1.071 . . . . 0.0 109.94 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.29 -18.19 39.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.439 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.7 t80 -85.39 -36.24 20.84 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.083 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -66.64 -42.18 87.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.437 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 7.2 tpp -80.52 -41.78 23.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.792 . . . . 0.0 109.445 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 18.6 mtt180 -100.71 33.37 2.79 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 108.959 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -39.52 161.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 76.94 85.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 108.983 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.565 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 71.83 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 108.999 -179.492 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 67.02 162.47 0.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 110.061 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.492 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.7 mt -116.52 113.25 22.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.0 159.78 27.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.464 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -59.03 -32.87 70.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.427 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.35 88.75 29.27 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.698 2.266 . . . . 0.0 110.637 -179.358 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.5 m-85 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.363 0.601 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -79.53 85.84 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.945 . . . . 0.0 109.935 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.35 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.415 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 179' ' ' ALA . 96.8 t -109.18 116.95 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.38 . . . . 0.0 110.325 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -83.82 146.02 28.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.481 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.2 pt20 -142.01 132.58 25.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.557 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -84.1 178.7 2.25 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.5 Cg_endo -77.09 79.27 3.18 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.179 1.92 . . . . 0.0 109.549 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 23.7 t-105 72.6 60.83 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -153.31 -108.8 0.36 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.704 -179.396 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.544 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 14.6 mmtt -113.24 -171.7 1.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -1.137 . . . . 0.0 110.694 -178.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.896 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.5 m-85 -141.81 -170.9 3.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -161.22 110.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.951 -1.093 . . . . 0.0 110.446 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -83.68 107.16 15.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.523 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 27.9 mt-10 -132.32 152.11 51.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.13 -0.981 . . . . 0.0 109.739 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.41 133.06 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.214 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.62 139.61 33.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 28.7 t0 -123.87 107.24 31.14 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.169 -0.957 . . . . 0.0 109.291 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.63 -28.28 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.268 1.978 . . . . 0.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -25.91 67.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.429 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 10.4 mmtt -90.86 43.45 1.15 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.88 27.17 15.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.54 58.43 3.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.24 95.35 6.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -1.129 . . . . 0.0 109.545 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.06 162.12 1.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.84 95.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.04 -1.038 . . . . 0.0 110.153 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.523 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 2.8 t-105 -79.99 106.54 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.213 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 29.0 mt -64.16 -47.01 81.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 109.715 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.62 157.09 7.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -76.49 156.65 32.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 -179.8 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.604 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.6 m-85 -133.01 177.36 7.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 3.2 pt-20 -82.55 -31.63 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.162 -0.961 . . . . 0.0 109.786 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 p -141.26 175.36 9.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 109.777 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.896 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.1 -22.53 59.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.656 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.55 -49.13 51.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 1.4 m-20 -64.2 -50.39 68.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -56.19 -52.4 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -52.39 -42.12 63.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.57 -41.78 90.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.77 -22.29 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.8 . . . . 0.0 109.185 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 21.2 t80 -71.51 -36.59 71.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.87 ' HB3' HD13 ' A' ' 200' ' ' LEU . 6.3 m-20 -65.52 -50.85 63.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.11 -34.74 58.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.49 -0.756 . . . . 0.0 110.101 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.79 -19.85 26.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.054 -1.028 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 194' ' ' ARG . . . -92.14 -5.43 52.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.431 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.6 t80 -102.76 -34.13 9.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.221 -0.924 . . . . 0.0 108.611 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -79.34 -40.69 29.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.407 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.2 ttp -83.12 -30.05 28.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.609 -0.682 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -99.77 -9.23 23.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 -179.727 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 42.19 -163.63 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.6 OUTLIER 48.39 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -1.14 . . . . 0.0 109.562 179.874 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 198' ' ' ALA . 0.7 OUTLIER -57.28 -47.02 82.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 197' ' ' ARG . . . 59.39 149.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.438 -0.789 . . . . 0.0 109.722 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 17.3 mt -97.75 124.04 41.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.87 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.62 169.23 14.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.93 . . . . 0.0 109.387 -179.906 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.592 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -63.29 -36.07 82.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.039 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 2.8 m-85 -127.18 81.66 69.56 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.635 2.223 . . . . 0.0 110.775 -179.436 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.5 m-85 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.406 0.622 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.28 110.62 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.73 -20.7 14.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.8 t -92.59 110.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -1.12 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 112.39 24.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 108.954 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -75.63 153.74 37.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 110.02 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.1 mtp180 -132.52 174.87 4.2 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.3 Cg_endo -77.66 167.53 23.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.11 1.873 . . . . 0.0 110.069 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 74.92 -80.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.191 -179.47 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 156' ' ' LYS . . . 174.99 67.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 mmtt -146.35 164.05 33.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.051 -1.264 . . . . 0.0 110.069 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.813 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.7 m-85 -148.31 179.61 7.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.526 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.51 107.78 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.028 -1.045 . . . . 0.0 109.991 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.85 117.13 21.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.032 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.455 ' OE2' ' HD2' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -141.76 140.45 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.53 -179.771 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.533 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.2 tt -125.38 159.42 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.533 ' N ' HG12 ' A' ' 161' ' ' ILE . 8.7 ttt180 -97.78 115.05 27.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 193' ' ' MET . 19.1 t0 -99.25 110.12 57.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.1 Cg_endo -77.63 -27.72 5.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.3 2.0 . . . . 0.0 110.168 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.71 -21.68 64.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.348 -0.845 . . . . 0.0 109.555 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 2.7 mttt -90.66 23.15 3.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.448 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 76.51 40.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.626 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.42 86.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.35 177.82 8.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -1.081 . . . . 0.0 109.417 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.455 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 0.9 OUTLIER -100.99 163.87 12.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.678 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.8 t -140.39 85.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.0 109.045 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.526 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.9 t-105 -73.2 97.12 2.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.395 -0.816 . . . . 0.0 109.883 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.1 mt -59.6 -41.06 89.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.88 . . . . 0.0 109.257 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.428 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 147.52 166.6 12.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -83.72 153.68 24.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -1.194 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.774 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -126.72 -177.5 4.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.659 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 -30.97 16.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 1.7 p -138.72 167.45 21.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.813 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.25 -41.21 67.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.293 -0.879 . . . . 0.0 109.79 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.7 OUTLIER -71.22 -40.74 70.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.56 -30.34 67.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.3 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.923 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.15 -34.04 61.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.143 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -66.72 -42.09 86.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 109.044 179.635 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.03 -22.72 64.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.2 t80 -77.32 -32.2 55.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.238 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 97.6 m-20 -67.55 -41.44 84.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -70.05 -35.91 74.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.867 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.894 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.51 -24.22 50.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.656 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.95 -26.74 27.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 195' ' ' GLY . 5.7 t80 -83.11 -23.55 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -43.74 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.43 ' HE1' ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -75.01 -32.36 61.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.02 -179.658 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 4.9 mtt-85 -96.69 -13.28 22.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.283 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 191' ' ' PHE . . . 74.86 -125.2 8.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 191' ' ' PHE . 0.8 OUTLIER -71.68 172.37 9.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -1.094 . . . . 0.0 109.97 -179.559 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 54.04 -117.64 1.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.408 -0.807 . . . . 0.0 109.608 179.743 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.35 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.692 -1.255 . . . . 0.0 109.317 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 199' ' ' LEU . 5.8 mt -85.04 130.13 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.705 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.527 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.66 166.16 18.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.806 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.46 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -63.0 -31.91 73.16 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.327 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.453 ' HD2' HD22 ' A' ' 184' ' ' LEU . 7.2 m-85 -120.06 77.17 23.64 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 122.699 2.266 . . . . 0.0 110.562 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 20.4 m-85 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -82.35 92.46 6.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 186' ' ' TYR . . . 123.39 -5.58 9.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -108.96 120.72 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -1.159 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -97.07 118.65 33.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.699 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.493 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -89.36 149.45 23.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.606 -179.805 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mmt180 -120.51 158.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.52 8.81 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.616 2.21 . . . . 0.0 110.876 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.29 -13.33 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 105.4 49.21 0.99 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 8.8 mtmm -150.07 -174.74 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -1.165 . . . . 0.0 109.54 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 76.8 m-85 -153.99 178.35 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.271 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.723 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.12 111.15 4.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.683 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.91 118.43 24.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.345 -0.847 . . . . 0.0 108.96 179.46 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 19.2 mt-10 -137.42 179.55 6.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 109.28 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.2 tt -169.63 130.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -63.36 153.05 36.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.857 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.93 103.71 3.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.45 -25.33 9.79 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.42 2.08 . . . . 0.0 110.321 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.6 66.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 109.168 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 44.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 0.0 109.473 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t30 51.08 57.16 6.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.417 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 51.24 79.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -141.31 131.15 24.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -1.203 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -73.28 143.53 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.1 t -111.77 105.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.723 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.7 t-105 -89.69 95.57 10.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -53.58 -42.87 68.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 146.64 158.17 7.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.488 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.2 p -74.36 159.36 32.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -1.045 . . . . 0.0 109.516 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.9 m-85 -133.45 174.91 9.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.43 -30.42 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.6 p -137.54 -176.98 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.907 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.52 -30.15 25.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -68.05 -32.21 72.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.958 . . . . 0.0 109.584 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.415 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -75.67 -48.59 21.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.306 -0.871 . . . . 0.0 109.025 179.862 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -66.61 -21.69 66.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 108.912 179.547 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.59 -45.77 24.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' LEU . 17.9 tp -62.56 -40.75 97.86 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.17 -24.71 63.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 108.919 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 160' ' ' GLU . 14.6 t80 -70.77 -32.17 69.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -69.04 -45.61 69.97 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -58.29 -35.22 71.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.509 -0.744 . . . . 0.0 110.176 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.016 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.83 -33.63 34.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.541 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -86.95 -2.41 58.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.202 -0.937 . . . . 0.0 109.217 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.485 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 25.4 t80 -103.25 -24.47 13.54 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.295 -0.878 . . . . 0.0 109.113 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -84.48 -40.9 17.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 108.785 179.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -31.33 57.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.621 -0.674 . . . . 0.0 109.868 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 43.8 mtt180 -100.86 -18.82 16.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 47.57 -176.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.41 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.311 -1.111 . . . . 0.0 109.732 179.952 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.3 140.04 48.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.61 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.491 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -144.83 163.58 33.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.506 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -82.45 105.61 13.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.682 -179.773 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.86 164.97 17.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 108.998 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.494 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.3 OUTLIER -66.4 -33.0 74.73 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.128 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.4 m-85 -124.54 76.06 63.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.683 2.255 . . . . 0.0 110.558 -179.471 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.944 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.4 92.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.15 -32.06 3.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.5 t -77.8 133.64 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -1.216 . . . . 0.0 109.801 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.5 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -121.41 107.01 11.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.324 179.898 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.597 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.3 pt20 -75.09 164.61 26.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.471 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.9 mtt-85 -127.81 172.11 7.33 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.678 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.02 -30.22 3.72 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.822 2.348 . . . . 0.0 110.704 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -35.36 60.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.657 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.46 34.93 0.43 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -127.23 159.42 34.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -1.165 . . . . 0.0 109.264 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.888 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.5 m-85 -125.19 -179.12 4.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.41 108.29 3.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.31 114.8 19.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.718 179.185 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -131.18 157.88 42.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.567 -179.727 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 161' ' ' ILE . 1.6 tt -149.8 128.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.551 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.15 8.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 164' ' ' PRO . 48.3 t0 -92.8 117.22 67.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 109.557 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 35.6 Cg_endo -78.19 -26.24 6.5 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.286 1.991 . . . . 0.0 109.899 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.73 -14.63 62.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 6.2 mmtp -101.26 30.16 4.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 41.3 t-20 67.51 28.4 7.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.53 62.5 2.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.8 129.26 55.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -1.128 . . . . 0.0 109.469 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.42 122.52 16.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.504 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 171' ' ' VAL . 21.6 t -101.73 94.69 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.627 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.8 t-105 -69.65 100.73 1.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -59.77 -48.99 79.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.656 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 153.67 152.56 6.09 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.627 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.1 p -69.51 163.71 24.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -1.206 . . . . 0.0 109.131 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 60.7 m-85 -140.0 -177.84 5.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -86.85 -30.01 21.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.626 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -146.71 171.41 15.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.589 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.888 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.82 -22.51 63.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.05 -40.54 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.1 m-20 -71.52 -41.84 68.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.691 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -69.27 -30.38 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.944 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.42 -40.7 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -38.85 89.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.497 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.32 -24.15 63.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.6 t80 -73.93 -29.07 61.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 200' ' ' LEU . 43.4 m-20 -70.26 -49.04 53.89 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.218 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -60.97 -38.49 86.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 109.874 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.44 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -80.5 -21.83 41.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.646 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.92 -14.31 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.76 -27.14 14.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 109.101 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -82.56 -40.36 21.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 2.7 tpp -70.9 -30.56 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.666 -0.647 . . . . 0.0 109.357 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 196' ' ' SER . 2.7 mtt180 -101.13 -12.82 18.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.33 -0.856 . . . . 0.0 109.242 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 52.61 -88.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 194' ' ' ARG . 0.3 OUTLIER -46.3 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -1.093 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' SER . 13.4 mtt180 -40.44 157.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -164.25 156.25 16.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 109.307 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.7 mm? -92.13 127.85 37.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.96 162.67 29.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.141 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.442 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -58.23 -34.69 70.7 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.117 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.5 m-85 -116.58 80.95 10.86 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 33.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.561 2.174 . . . . 0.0 110.311 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 9.2 m-85 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.311 0.577 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.61 87.76 3.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 108.824 179.105 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.97 2.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 179' ' ' ALA . 45.8 t -137.87 108.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.288 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.81 127.62 33.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.426 -0.796 . . . . 0.0 109.009 179.713 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.1 pp0? -104.48 146.64 28.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.944 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.5 164.03 15.89 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.61 37.0 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.836 2.358 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -146.05 -62.28 0.32 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.02 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.99 36.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.63 168.92 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -1.202 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.857 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.3 m-85 -148.36 177.23 9.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.374 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.647 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.15 111.84 4.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.29 110.4 17.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -131.33 149.52 52.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.281 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 17.4 tt -128.21 146.68 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.094 -1.004 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -87.38 130.59 34.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 109.55 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -119.96 94.39 48.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 35.9 Cg_endo -78.26 -22.78 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.578 2.186 . . . . 0.0 110.44 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.46 75.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' LYS . 8.4 mmtt -86.25 63.03 7.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.847 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 168' ' ' GLY . 1.8 m-80 52.67 48.55 22.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 43.41 52.63 6.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.751 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.52 130.08 35.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 109.319 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 143.94 46.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 77.1 t -123.19 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.835 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.647 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.8 t-105 -117.01 97.33 5.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.3 mp -54.83 -50.51 68.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.266 -0.896 . . . . 0.0 109.149 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 155.31 153.56 6.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.52 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.4 p -65.36 166.93 9.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -1.046 . . . . 0.0 109.332 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.757 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 65.0 m-85 -144.02 174.51 10.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -25.3 30.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.731 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 2.3 p -149.56 171.06 17.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.56 -25.46 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.46 -42.1 75.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -70.28 -48.59 56.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.202 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.91 -22.82 66.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.922 . . . . 0.0 109.029 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.22 -36.89 46.55 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 108.873 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.859 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -68.05 -45.22 74.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.581 -0.699 . . . . 0.0 109.175 179.491 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.565 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.01 -23.69 65.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.459 -0.775 . . . . 0.0 109.012 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.2 t80 -71.52 -35.38 70.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -0.783 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.6 m-20 -65.64 -41.85 92.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.321 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -41.05 84.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.75 -19.65 37.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.527 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.33 -9.63 52.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -99.12 -31.22 11.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.821 . . . . 0.0 109.271 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -77.98 -42.78 31.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.896 . . . . 0.0 109.116 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 48.0 ttm -69.65 -31.53 69.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.315 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 22.2 mtt-85 -100.86 11.91 38.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 48.57 -154.54 1.76 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 29.6 m -53.45 143.27 19.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -1.119 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.5 mtp85 68.53 138.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 176.47 140.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 199' ' ' LEU . 2.2 mt -81.37 109.3 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -116.0 -178.09 3.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.408 179.755 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.49 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -81.38 -28.81 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.155 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.859 ' HD2' HD22 ' A' ' 184' ' ' LEU . 6.6 m-85 -122.68 70.15 36.33 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.483 0 C-N-CA 122.467 2.112 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.928 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.4 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.36 89.67 3.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 108.848 179.364 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.48 11.0 3.47 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 182' ' ' ALA . 47.3 t -126.3 109.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.289 . . . . 0.0 109.359 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -93.0 111.34 22.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.443 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.5 pt20 -80.87 151.08 28.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 108.975 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.49 163.89 37.72 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.442 -179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.13 -5.56 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.615 2.21 . . . . 0.0 110.121 -179.88 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -98.23 27.89 4.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 109.273 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.53 60.99 7.98 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -156.44 170.52 22.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 73.4 m-85 -142.64 172.84 12.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.008 179.917 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.649 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.87 105.28 4.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 123.09 28.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.051 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.465 ' CD ' ' CE3' ' A' ' 172' ' ' TRP . 4.3 mt-10 -145.28 153.3 41.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 0.0 109.334 -179.543 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.486 HD11 ' HE ' ' A' ' 194' ' ' ARG . 6.5 tt -141.04 149.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -84.33 117.1 23.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 109.734 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.512 ' HB2' ' CE ' ' A' ' 193' ' ' MET . 67.8 t0 -114.58 102.12 54.66 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -25.53 9.78 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.326 2.017 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.47 -16.12 63.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.863 . . . . 0.0 109.217 179.67 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -93.38 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.7 54.13 9.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.421 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.95 71.26 0.67 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.23 118.55 12.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.494 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -54.21 170.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.4 t -139.84 90.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.656 -179.694 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.649 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.0 t-105 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 109.178 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -52.62 -43.96 65.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 -179.72 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.38 150.39 5.23 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.517 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -63.18 168.78 3.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -1.157 . . . . 0.0 109.327 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.655 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 63.9 m-85 -141.55 -174.14 3.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.515 -179.767 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.74 -24.97 14.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.698 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.598 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.6 p -140.82 174.49 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.68 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.29 -24.83 50.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.328 -0.857 . . . . 0.0 109.363 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -77.02 -30.27 55.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.631 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.598 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -76.08 -40.68 52.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 109.279 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.96 -36.48 69.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.195 -0.941 . . . . 0.0 109.028 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.928 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -69.58 -39.78 77.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.799 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.97 -46.32 88.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 109.004 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.76 -26.87 67.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.475 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 29.8 t80 -68.7 -36.28 78.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.132 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 7.0 m-20 -64.07 -52.15 60.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 109.838 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -56.88 -37.16 70.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.422 -0.799 . . . . 0.0 109.527 -179.76 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.921 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.38 -20.65 50.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.212 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.68 -11.88 43.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.464 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.3 t80 -101.88 -26.67 13.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.119 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -40.63 29.85 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.315 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.512 ' CE ' ' HB2' ' A' ' 163' ' ' ASP . 13.9 mtp -77.93 -44.49 26.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.242 0.544 . . . . 0.0 110.165 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HE ' HD11 ' A' ' 161' ' ' ILE . 24.0 mtt180 -83.51 -37.74 22.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 108.943 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 58.52 145.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ALA . 2.8 m 63.12 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -1.138 . . . . 0.0 109.987 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.3 mmt180 44.26 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.999 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 66.95 144.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.988 . . . . 0.0 109.328 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.12 117.27 34.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.913 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.1 156.06 35.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 179.944 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.416 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -62.82 -32.32 73.5 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.769 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.43 ' O ' HD12 ' A' ' 200' ' ' LEU . 5.8 m-85 -121.05 97.51 47.95 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.094 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.331 2.02 . . . . 0.0 110.6 -179.188 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.703 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.4 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.158 0.504 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.87 37.64 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.129 179.738 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . -169.95 26.77 0.11 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 179' ' ' ALA . 60.9 t -142.67 117.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -1.091 . . . . 0.0 109.681 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 93.08 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.162 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.47 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 9.9 pt20 -60.65 144.67 51.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.75 -179.748 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -103.88 171.7 4.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.308 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.2 Cg_endo -77.12 -31.81 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -82.6 -74.98 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.73 71.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 56.3 mttt -153.85 168.04 27.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.577 179.925 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.753 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.0 m-85 -150.68 120.67 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 108.737 179.694 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.608 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -93.76 118.87 31.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.748 -178.823 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.15 122.73 30.57 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.308 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 11.2 tt0 -137.69 150.6 47.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.02 . . . . 0.0 110.421 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.3 tt -136.23 137.33 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -86.57 127.46 34.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.834 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -125.05 105.55 28.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.413 -0.805 . . . . 0.0 108.984 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.91 -26.08 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.455 2.103 . . . . 0.0 110.58 -179.737 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.88 -12.0 57.83 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 51.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 56.24 25.05 8.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 -179.894 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.18 40.92 40.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -100.1 142.87 30.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -84.43 155.7 22.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 161' ' ' ILE . 40.5 t -124.3 100.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.608 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.4 t-105 -80.16 95.29 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.322 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.157 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -50.55 -49.46 55.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.039 -179.641 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.23 155.25 6.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.502 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -68.18 169.97 9.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -1.095 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.2 m-85 -148.2 -170.46 3.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -23.84 13.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.578 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.6 p -144.34 160.05 41.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.302 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.753 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.26 -24.7 66.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.065 -1.022 . . . . 0.0 109.216 179.83 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.66 -33.22 68.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -76.78 -47.88 20.32 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.021 179.78 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -66.46 -25.62 66.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.17 -0.956 . . . . 0.0 108.954 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.12 -49.94 21.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.112 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -34.09 74.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.438 -0.789 . . . . 0.0 109.032 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.74 -30.63 68.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.5 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -67.77 -27.89 67.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.712 . . . . 0.0 109.109 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 58.5 m-20 -71.19 -45.27 63.78 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.596 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -65.15 -29.03 69.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 110.368 -179.212 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.157 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.7 -32.65 21.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 110.026 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.99 -18.81 45.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.41 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.3 t80 -91.02 -38.73 12.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.326 -0.859 . . . . 0.0 109.353 179.911 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -41.85 97.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.09 -1.007 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 3.6 ttm -79.95 -43.1 22.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 109.271 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.46 ' O ' ' C ' ' A' ' 195' ' ' GLY . 21.4 mtt180 -101.96 32.96 3.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.515 -0.74 . . . . 0.0 109.162 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -37.94 -32.47 0.12 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -75.74 81.93 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -1.15 . . . . 0.0 109.263 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 61.19 139.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.358 -179.806 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -170.57 144.51 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.6 mm? -98.1 108.99 21.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.671 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -111.1 159.42 17.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.435 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -53.0 -37.81 61.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.094 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.9 m-85 -123.08 86.12 51.15 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.321 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.644 2.229 . . . . 0.0 110.722 -179.02 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.939 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.8 m-85 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -77.82 94.44 4.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.25 -3.4 11.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.592 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 49.0 t -108.69 112.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.27 . . . . 0.0 110.057 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.998 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -87.43 111.61 21.31 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.752 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.563 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 8.0 pt20 -90.06 138.62 31.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -178.442 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.631 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 14.0 mmm-85 -74.86 -166.76 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.713 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.1 Cg_endo -76.88 -15.23 16.83 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.313 1.342 . . . . 0.0 110.629 -179.256 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.54 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 158.79 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.496 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.58 -68.93 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.347 179.69 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mttt -116.7 -168.53 1.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.852 -1.381 . . . . 0.0 111.282 -178.16 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.149 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.9 m-85 -154.8 179.46 9.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.998 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . . . -149.2 110.33 4.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 109.993 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.506 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 134.86 35.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.71 134.68 14.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.8 tt -120.11 141.4 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -85.07 129.54 34.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -116.12 92.47 35.62 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.97 -22.35 11.56 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.676 2.251 . . . . 0.0 110.719 -179.726 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.12 69.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.407 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 35.4 mmtt -85.38 -55.78 3.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 109.473 179.907 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 169' ' ' ALA . 12.6 p30 169.14 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.97 4.5 67.5 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.824 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HB2' ' OD1' ' A' ' 167' ' ' ASN . . . -57.09 108.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.119 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 142.86 29.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.265 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.1 t -115.65 83.18 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.78 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 174' ' ' GLY . 3.5 t-105 -65.32 100.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 109.164 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.8 mt -61.61 -41.48 97.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.687 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 144.29 174.0 16.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.846 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -92.06 157.36 16.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.252 . . . . 0.0 109.148 179.753 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 78.7 m-85 -130.53 -176.51 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.815 -179.53 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -89.14 -20.12 24.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 4.0 p -147.97 175.41 11.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.95 . . . . 0.0 109.87 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.149 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.7 -22.21 47.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.45 -0.781 . . . . 0.0 109.45 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.6 tm-20 -76.83 -32.43 57.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.78 -36.12 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.927 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.27 -43.92 60.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 108.895 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.939 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -63.34 -37.15 86.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.361 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -64.98 -46.71 80.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.521 -0.737 . . . . 0.0 109.11 179.495 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.98 -18.8 64.64 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.5 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -74.14 -38.12 63.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.041 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.55 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.2 m-20 -62.16 -49.87 74.12 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.449 -0.782 . . . . 0.0 109.37 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -52.11 -44.84 64.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.618 -0.676 . . . . 0.0 109.925 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.855 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.32 -19.15 54.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 109.702 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -92.27 -4.55 53.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.883 . . . . 0.0 109.586 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.434 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.1 t80 -108.38 -29.8 8.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -85.04 -37.75 19.98 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.016 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.7 ttm -77.88 -35.61 50.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.737 -0.602 . . . . 0.0 109.562 179.704 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.646 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 4.5 mtp180 -94.26 -23.57 17.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.139 -0.976 . . . . 0.0 108.886 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 53.2 170.29 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.986 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 43.61 -159.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -1.211 . . . . 0.0 109.664 179.898 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.25 153.84 3.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.579 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.646 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -160.86 168.18 25.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.4 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.598 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -105.43 104.83 14.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.998 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.75 162.96 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.983 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.578 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -65.7 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.606 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 184' ' ' LEU . 7.2 m-85 -119.1 80.29 19.04 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.7 Cg_endo . . . . . 0 C--N 1.309 -1.524 0 C-N-CA 122.566 2.178 . . . . 0.0 110.285 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.687 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 65.9 m-85 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -81.01 36.07 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.616 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.431 ' HA3' ' CD2' ' A' ' 186' ' ' TYR . . . -176.8 27.3 0.07 OUTLIER Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.664 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 179' ' ' ALA . 78.6 t -150.67 139.8 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -1.204 . . . . 0.0 109.648 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -110.55 160.1 16.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 108.991 179.489 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.0 pt20 -131.37 146.15 52.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.043 -1.036 . . . . 0.0 110.115 -179.48 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.478 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.8 OUTLIER -121.63 160.55 45.93 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.759 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -77.78 -4.43 14.5 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 110.776 -179.848 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -98.08 -7.35 29.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.504 179.898 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.28 47.46 1.85 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 9.2 mtpp -146.74 140.72 26.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.161 . . . . 0.0 109.513 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.703 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 7.0 m-85 -119.98 -170.28 1.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.917 . . . . 0.0 109.376 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.62 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -156.43 110.51 2.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 179.892 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -81.11 119.78 24.0 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.44 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 12.3 mt-10 -136.94 153.89 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.827 . . . . 0.0 109.603 -179.67 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 190' ' ' ALA . 5.8 tt -141.61 138.91 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 108.979 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.47 131.39 35.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.756 -179.664 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -124.73 90.81 50.41 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.51 -23.33 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.549 2.166 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.46 -9.89 29.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 15.0 mmtp -104.37 23.7 12.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.891 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 26.8 t-20 64.34 45.14 3.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.06 110.74 0.12 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 170' ' ' ARG . . . -177.11 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -1.179 . . . . 0.0 109.466 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -43.2 163.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 161' ' ' ILE . 92.7 t -135.15 91.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.955 . . . . 0.0 109.864 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.789 ' HZ2' HG22 ' A' ' 175' ' ' THR . 10.8 t-105 -75.31 92.38 2.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 108.882 179.464 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.027 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -52.31 -46.11 65.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.224 -179.741 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.25 156.37 7.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.678 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.789 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.6 p -73.21 153.27 40.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -1.082 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.2 m-85 -128.99 -170.97 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 -32.38 14.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.277 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.562 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -141.41 173.89 11.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.226 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.703 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.27 -24.58 61.37 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -70.63 -37.7 73.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.867 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.97 -43.81 51.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.072 -1.018 . . . . 0.0 109.205 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -24.81 63.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 108.997 179.717 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.687 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.59 -44.9 40.72 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.409 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.874 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -61.68 -43.52 98.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.573 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.83 -32.23 73.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 108.827 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -64.46 -29.62 70.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.325 -0.859 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.61 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.1 m-20 -72.92 -43.56 62.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.382 -0.824 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.03 -23.94 67.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.772 . . . . 0.0 110.127 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.027 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -92.72 -31.9 14.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.011 -1.056 . . . . 0.0 109.761 -179.708 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.601 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -83.93 -10.83 57.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.235 -0.915 . . . . 0.0 109.099 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -100.38 -41.15 7.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 179.542 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -41.24 94.34 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.32 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 ttp -75.73 -42.75 49.81 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 109.177 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 37.4 mtt180 -104.0 33.95 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.48 -0.763 . . . . 0.0 109.095 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -38.29 109.3 0.09 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 1.4 t 162.87 -71.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -1.071 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 62.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.785 . . . . 0.0 109.214 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.27 160.92 21.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.859 . . . . 0.0 109.627 -179.783 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -91.88 124.18 35.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 108.988 179.437 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.97 177.03 5.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.482 -179.59 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.577 ' ND2' ' HB3' ' A' ' 146' ' ' TYR . 0.4 OUTLIER -63.92 -34.88 78.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.327 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.874 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.1 m-85 -122.66 79.66 48.03 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.311 -1.406 0 C-N-CA 122.817 2.344 . . . . 0.0 110.742 -179.364 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' ARG . 3.2 ptt180 -75.13 127.85 34.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.181 179.623 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.28 -21.02 47.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 182' ' ' ALA . 89.3 t -94.3 108.02 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -79.21 147.71 32.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.058 -1.026 . . . . 0.0 108.769 179.339 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.6 pp0? -120.07 140.36 51.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.897 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.441 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mpp_? -115.87 171.43 4.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -78.04 -35.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.63 2.22 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.63 -21.81 66.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.522 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.24 17.62 8.16 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -102.37 174.33 5.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -1.154 . . . . 0.0 109.449 179.905 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.983 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 55.4 m-85 -147.55 -172.86 4.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.006 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.709 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.05 110.34 2.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.75 121.83 25.84 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.204 -0.935 . . . . 0.0 108.915 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -142.92 151.49 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 -179.552 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 5.4 tt -137.33 128.35 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.854 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 5.2 ptt180 -73.48 117.95 15.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -98.73 109.26 52.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 109.602 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.43 -25.13 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.353 2.036 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.16 -17.54 60.9 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.356 -0.84 . . . . 0.0 109.343 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -94.75 26.93 3.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 63.56 48.2 3.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.503 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.87 69.2 1.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -127.78 103.97 7.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -1.135 . . . . 0.0 109.389 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 149.13 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.55 HG11 ' HE1' ' A' ' 193' ' ' MET . 29.9 t -127.55 93.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.095 179.735 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.709 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -73.8 97.43 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.817 -179.614 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.0 OUTLIER -58.38 -38.13 76.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.48 157.04 7.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.81 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.597 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.9 p -73.73 155.63 38.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -1.047 . . . . 0.0 109.784 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.692 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.8 m-85 -131.24 173.95 10.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.5 OUTLIER -85.58 -18.16 34.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 0.0 109.7 -179.854 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.424 ' CG2' ' C ' ' A' ' 177' ' ' GLU . 3.7 p -151.53 173.31 14.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.953 . . . . 0.0 109.592 -179.758 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.95 -24.98 58.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.54 -34.68 65.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.46 -34.11 54.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.377 -0.827 . . . . 0.0 109.269 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.692 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -78.73 -26.98 44.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -0.908 . . . . 0.0 109.319 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.7 -37.58 55.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.134 -0.979 . . . . 0.0 108.688 179.382 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.917 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -62.65 -44.12 97.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.191 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.35 -33.95 77.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.457 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 11.7 t80 -62.73 -35.11 78.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.14 179.624 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.41 -53.26 59.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.503 -0.748 . . . . 0.0 109.901 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -26.78 66.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -88.57 -16.91 31.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.448 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.617 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -93.48 -11.73 31.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -99.84 -33.85 10.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 108.865 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -79.54 -42.29 25.43 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.55 ' HE1' HG11 ' A' ' 171' ' ' VAL . 3.5 tpp -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.644 -0.66 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 194' ' ' ARG . 4.6 mmp_? -102.17 12.59 36.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.03 -156.31 11.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 5.4 p -65.41 154.72 37.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 196' ' ' SER . 10.8 mtt180 62.86 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -161.65 173.66 14.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.3 mt -117.46 125.91 51.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.603 -179.8 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.45 -179.76 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.815 -179.63 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.568 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -75.88 -34.6 59.99 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.128 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.917 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.3 m-85 -123.84 83.61 54.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.86 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.511 2.141 . . . . 0.0 110.508 -179.452 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.297 0.57 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -79.15 76.39 5.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.228 179.647 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.98 -21.33 0.44 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.906 HG11 ' HA ' ' A' ' 179' ' ' ALA . 16.8 t -101.11 109.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.283 . . . . 0.0 109.455 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.77 174.7 5.77 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.608 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.609 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -142.53 133.35 25.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 110.282 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.0 ttm-85 -68.67 -174.95 0.23 Allowed Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.918 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 29.3 Cg_endo -70.75 82.78 0.92 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.17 1.246 . . . . 0.0 110.021 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 7.2 m95 63.7 65.41 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.524 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.62 -132.49 1.35 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.537 -1.315 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -79.23 159.17 27.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.549 -0.971 . . . . 0.0 110.47 -178.756 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 151' ' ' GLN . 8.5 m-30 -101.71 -163.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.586 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -158.35 112.3 2.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.896 -1.127 . . . . 0.0 110.779 -179.906 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -84.94 128.01 34.43 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.381 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -143.76 166.85 23.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.108 -178.942 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.438 HG12 ' N ' ' A' ' 162' ' ' ARG . 1.9 tt -161.74 149.05 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 161' ' ' ILE . 12.6 ptm180 -80.73 153.69 27.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.632 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.25 104.91 25.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.68 -28.49 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.399 2.066 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.81 62.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.093 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -100.67 32.36 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.803 . . . . 0.0 109.494 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 9.2 t-20 69.56 44.13 0.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 61.55 22.37 61.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.47 137.16 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -1.083 . . . . 0.0 109.594 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -69.15 161.7 28.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.3 t -144.44 97.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.268 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.586 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.3 t-105 -79.55 105.82 11.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.622 -179.858 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -59.33 -60.39 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.64 153.98 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -69.3 156.7 38.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.399 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -134.24 -162.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 -179.766 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -25.55 9.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.52 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 2.9 p -145.78 -177.32 5.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.925 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.906 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -79.92 -27.76 39.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 109.29 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.17 -37.66 75.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 -57.3 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 -179.809 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.822 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -59.27 -31.61 69.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.869 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.87 -42.96 76.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.333 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 184' ' ' LEU . 1.8 tm? -61.67 -44.44 96.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.857 . . . . 0.0 108.792 179.556 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.573 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.06 -28.16 69.28 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 27.6 t80 -68.8 -35.39 76.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.552 -0.718 . . . . 0.0 109.138 179.663 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -60.52 -48.18 82.89 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.323 -0.86 . . . . 0.0 109.594 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -55.14 -42.72 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.644 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -74.55 -20.65 59.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.496 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.547 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -91.36 2.43 56.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.0 t80 -109.77 -29.28 8.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 108.636 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -84.07 -39.36 19.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 0.0 OUTLIER -75.23 -32.47 61.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.646 -0.659 . . . . 0.0 109.86 179.861 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.3 mtt85 -92.44 -12.58 31.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 88.52 -145.94 19.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.448 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 2.1 m -54.85 -96.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -1.101 . . . . 0.0 109.613 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.8 ttm105 -56.36 164.55 1.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.063 -1.023 . . . . 0.0 109.33 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . 179.04 176.35 0.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.543 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.4 mt -113.4 106.1 14.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.899 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -115.1 158.04 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -64.41 -28.93 70.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.321 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.0 m-85 -126.22 72.84 71.92 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.571 -0.706 . . . . 0.0 109.19 -179.685 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.723 2.282 . . . . 0.0 110.444 -179.591 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.4 m-85 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.257 0.551 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -75.05 82.8 2.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.24 179.666 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.03 9.65 1.44 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.617 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 54.1 t -121.09 111.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.747 -1.443 . . . . 0.0 109.892 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' CB ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -76.43 101.26 5.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 108.917 179.508 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 1.1 pt20 -97.38 134.49 40.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.375 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.598 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 5.3 mtt180 -89.35 -176.19 0.64 Allowed Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.03 87.09 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.087 1.858 . . . . 0.0 110.281 -179.642 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 43.7 m95 55.43 73.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.393 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.59 -93.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.659 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.546 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.1 mtpp -115.77 -168.78 1.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -1.12 . . . . 0.0 110.431 -178.842 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 45.0 m-85 -150.61 -175.96 5.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 149' ' ' VAL . . . -155.05 155.58 34.36 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.527 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -129.5 115.77 17.96 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.84 159.86 41.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.392 -179.526 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 171' ' ' VAL . 9.9 tt -134.91 136.21 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -85.33 126.78 34.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 179.891 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -115.51 91.16 28.12 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 109.487 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.31 -25.08 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.534 2.156 . . . . 0.0 110.454 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -92.55 23.36 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 38.19 8.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.928 . . . . 0.0 109.555 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 169' ' ' ALA . . . 89.04 122.5 2.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 168' ' ' GLY . . . -179.86 80.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.19 148.31 4.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 161' ' ' ILE . 51.4 t -129.89 93.07 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 7.5 t-105 -81.29 95.35 6.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.667 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.664 HD21 ' CB ' ' A' ' 189' ' ' ALA . 21.1 mt -53.57 -50.55 65.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.77 . . . . 0.0 109.306 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.96 14.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.801 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.2 p -81.68 145.77 30.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.1 m-85 -120.01 -169.93 1.87 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 -179.841 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.59 -29.29 12.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.8 p -138.22 167.66 21.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.812 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.75 -24.68 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.271 -0.893 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 39.6 tt0 -73.49 -30.4 63.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.668 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -81.71 -41.43 21.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 -179.868 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.15 -39.15 78.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.13 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.18 -42.06 84.86 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.395 -0.815 . . . . 0.0 108.828 179.589 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -59.35 -46.29 89.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.027 179.592 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.61 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.2 -23.05 67.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.1 t80 -71.55 -34.4 69.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.422 -0.799 . . . . 0.0 109.144 179.711 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -63.37 -41.73 98.81 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -50.31 74.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 -179.757 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.664 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -74.37 -18.51 60.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.783 -179.507 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.3 -4.77 55.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -106.19 -32.14 8.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.259 -0.901 . . . . 0.0 108.841 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -41.3 30.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 47.0 ttm -70.82 -33.78 71.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 179.648 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.55 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -84.93 -17.19 38.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.411 -0.806 . . . . 0.0 109.08 179.713 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 63.09 -88.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 195' ' ' GLY . 3.9 p -54.65 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 4.1 mpt_? -53.85 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . 177.44 160.29 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 199' ' ' LEU . 4.7 mp -95.47 113.93 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.551 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -114.84 179.91 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.295 179.919 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.529 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -72.31 -31.87 66.07 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.03 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.1 m-85 -125.94 71.51 68.68 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo . . . . . 0 C--N 1.309 -1.539 0 C-N-CA 122.646 2.231 . . . . 0.0 110.619 -179.468 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.957 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.59 96.08 6.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.29 -9.82 11.86 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 78.4 t -104.31 114.5 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.252 . . . . 0.0 109.739 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -87.26 141.55 28.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 108.733 179.436 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.462 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -113.16 141.39 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.0 -1.062 . . . . 0.0 109.872 -179.583 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.497 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 3.4 mmt-85 -116.75 162.18 28.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.888 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.497 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.61 -25.34 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.439 2.093 . . . . 0.0 110.279 179.839 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.47 82.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 156' ' ' LYS . . . 133.53 37.29 0.24 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 155' ' ' GLY . 22.2 mttt -135.12 170.83 15.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -1.106 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.1 m-85 -140.79 -170.35 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.653 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -159.29 113.64 2.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 109.934 179.686 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.18 123.63 31.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.473 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.554 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 9.3 mt-10 -141.58 169.16 18.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.66 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.562 HD13 ' HE1' ' A' ' 193' ' ' MET . 19.1 tt -152.54 131.41 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.976 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 18.3 ptt180 -94.8 118.35 31.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 109.978 -179.374 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -108.68 107.02 59.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.43 -0.794 . . . . 0.0 109.008 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.84 -28.77 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.389 2.059 . . . . 0.0 110.477 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.18 40.73 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.219 -0.925 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -94.91 33.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.05 37.91 20.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.85 83.68 0.43 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -137.78 118.83 14.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.15 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -78.68 151.19 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.744 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 17.9 t -131.04 100.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.013 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.678 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.1 t-105 -87.12 99.9 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.683 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.135 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -55.4 -51.2 67.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.852 . . . . 0.0 109.562 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 153.7 153.77 6.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.678 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 3.1 p -72.24 148.22 45.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -1.115 . . . . 0.0 109.671 -179.869 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.0 m-85 -122.41 -169.14 1.85 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 2.3 pt-20 -101.47 -25.91 13.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.0 p -138.7 174.35 10.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.293 179.537 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.12 -26.76 48.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.213 -0.929 . . . . 0.0 109.761 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.23 -37.76 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.076 -1.015 . . . . 0.0 109.805 -179.754 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -72.7 -39.19 67.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.34 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.41 -31.16 65.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.957 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.24 -36.0 66.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.329 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.99 -49.18 73.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.214 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.47 -30.95 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.32 -0.862 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -67.23 -32.41 73.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.37 -0.831 . . . . 0.0 109.32 179.706 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 9.6 m-20 -65.56 -35.15 80.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -50.21 30.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.812 . . . . 0.0 110.476 -179.401 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.135 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -67.62 -25.87 65.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 110.072 -179.294 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -81.87 -29.0 32.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.632 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.487 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.4 t80 -78.32 -22.41 48.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.968 . . . . 0.0 108.995 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -73.98 -50.52 19.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 108.978 179.574 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.562 ' HE1' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -71.25 -36.41 71.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.779 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.515 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -104.08 36.81 2.23 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 179.917 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . -31.42 -68.54 0.12 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 197' ' ' ARG . 29.8 m -61.42 89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -1.193 . . . . 0.0 109.125 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.7 OUTLIER 62.84 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 109.25 -179.66 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . -154.57 154.95 33.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.633 -179.882 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 200' ' ' LEU . 1.4 tm? -99.89 123.87 44.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.98 175.61 9.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.744 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -73.12 -34.29 66.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.818 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.561 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.0 m-85 -119.81 82.71 27.89 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.372 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.311 -1.416 0 C-N-CA 122.89 2.393 . . . . 0.0 111.051 -179.095 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.933 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 50.5 m-85 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.26 90.21 3.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 -17.82 5.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 182' ' ' ALA . 92.9 t -96.92 110.32 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -1.137 . . . . 0.0 110.125 -179.573 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 29.5 mtt180 -85.55 141.07 30.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -107.47 152.76 23.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.976 -1.077 . . . . 0.0 110.41 -178.954 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.559 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -126.04 147.02 57.71 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.003 179.841 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.18 -6.63 16.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -98.85 7.52 45.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.774 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.27 81.43 1.21 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER 175.31 163.12 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.153 . . . . 0.0 109.552 -179.998 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -146.51 -176.25 5.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.677 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.08 110.24 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.528 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.34 118.39 23.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 1.5 mt-10 -138.78 153.14 48.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.803 . . . . 0.0 109.16 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.8 tt -134.93 130.71 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.066 -1.021 . . . . 0.0 109.734 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -70.11 126.37 29.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.186 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -121.62 94.84 48.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.56 -21.08 11.74 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.616 2.211 . . . . 0.0 110.414 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.43 70.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 4.0 mmtm -79.99 -69.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 109.417 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.4 p30 166.81 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.42 34.25 68.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.31 96.97 7.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -1.143 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -50.2 156.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.661 -179.762 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 161' ' ' ILE . 44.0 t -123.04 91.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -0.826 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.677 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -75.77 91.51 2.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 189' ' ' ALA . 12.4 mt -53.86 -38.16 64.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.38 160.37 8.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.35 171.47 12.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 59.3 m-85 -145.94 -173.39 4.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -28.17 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.3 p -145.95 170.42 16.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.65 -26.33 64.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.885 . . . . 0.0 109.31 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -70.58 -36.22 73.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -73.37 -47.87 38.68 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.61 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.578 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -63.55 -36.01 82.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.0 109.422 -179.806 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.0 -40.66 87.39 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 109.045 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 184' ' ' LEU . 42.6 tp -61.83 -48.75 79.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.416 -0.803 . . . . 0.0 109.127 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.08 -28.68 70.25 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 4.6 t80 -67.42 -28.47 67.93 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.529 -0.732 . . . . 0.0 109.038 179.252 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -70.26 -45.62 66.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -33.95 76.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.243 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.806 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.23 -54.45 7.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.747 -179.586 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -62.47 -14.95 46.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.862 -179.685 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.508 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 9.1 t80 -85.41 -34.93 21.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.007 -1.058 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -65.31 -43.13 92.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -82.35 -40.12 21.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 109.249 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.892 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 7.6 mtp85 -104.24 34.49 3.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.009 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . -41.54 165.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 72.31 93.54 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -1.162 . . . . 0.0 109.306 -179.967 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 65.89 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.848 . . . . 0.0 109.677 179.929 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.59 147.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.83 121.03 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.355 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.6 -178.81 4.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.107 -179.871 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.563 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -72.2 -35.51 68.94 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.881 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ ' ' A' ' 146' ' ' TYR . 7.5 m-85 -120.09 76.4 23.1 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.63 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.63 2.22 . . . . 0.0 110.553 -179.525 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.4 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.397 0.617 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -77.4 85.3 3.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.574 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.98 -20.43 4.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 16.2 t -96.39 127.42 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -1.197 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.2 ttt85 -94.13 153.12 18.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.15 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.498 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -127.31 134.33 50.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.949 -1.094 . . . . 0.0 109.683 -179.679 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.499 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -114.77 167.01 10.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 109.502 -179.75 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.35 5.85 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.597 2.198 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -102.22 -18.96 15.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.631 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 15.88 11.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.817 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.407 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.4 mtpp -112.5 171.36 7.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.973 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -142.84 -172.84 3.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.333 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -153.41 105.6 2.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.997 179.842 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.88 118.59 21.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.545 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.552 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 9.0 mt-10 -136.53 155.08 50.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.344 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 ' HE2' ' A' ' 193' ' ' MET . 12.2 tt -140.38 143.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.705 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -87.6 126.62 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 109.025 179.659 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -112.95 95.67 35.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.634 -179.768 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.3 Cg_endo -77.26 -26.0 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.488 2.125 . . . . 0.0 110.248 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.79 -15.11 62.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 0.0 109.606 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.514 ' HA ' ' CE ' ' A' ' 166' ' ' LYS . 2.4 mmpt? -106.39 41.32 1.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.336 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER 48.26 72.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.956 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' ASN . . . 48.74 96.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -148.48 101.32 3.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.173 . . . . 0.0 109.633 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 152.55 23.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.195 179.885 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.46 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 53.4 t -133.58 91.94 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.552 ' CE3' ' OE2' ' A' ' 160' ' ' GLU . 9.6 t-105 -79.05 92.6 5.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.066 179.492 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 189' ' ' ALA . 7.7 mt -53.8 -38.72 64.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.29 -179.827 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 141.67 175.44 15.17 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -91.88 161.73 14.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -1.132 . . . . 0.0 109.191 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 60.7 m-85 -134.63 169.32 17.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.558 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.454 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 1.3 pt-20 -75.6 -25.41 56.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.868 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.453 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -147.58 -178.24 6.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 109.45 -179.937 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -82.6 -24.63 33.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.2 tt0 -71.09 -34.18 70.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 109.613 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.454 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -76.58 -50.78 13.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.288 -0.883 . . . . 0.0 109.671 -179.891 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.7 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -59.3 -45.94 89.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 109.186 179.921 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.31 -46.04 89.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -59.51 -31.16 69.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.634 -0.666 . . . . 0.0 109.219 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.485 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -79.81 -23.74 41.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.488 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.6 t80 -74.77 -30.3 61.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.41 -0.806 . . . . 0.0 108.879 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 200' ' ' LEU . 21.6 m-20 -71.12 -50.76 30.12 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.519 0.676 . . . . 0.0 109.31 179.91 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -36.33 82.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.633 -0.667 . . . . 0.0 109.688 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 173' ' ' LEU . . . -80.84 -22.13 40.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.05 179.863 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 195' ' ' GLY . 1.7 t80 -85.31 -33.36 22.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 109.166 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -76.54 -40.72 49.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.868 . . . . 0.0 109.371 179.874 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.661 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -80.68 -27.7 36.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 110.284 -179.481 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 190' ' ' ALA . 2.8 mmt180 -92.61 8.93 36.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.897 -1.127 . . . . 0.0 109.676 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 71.48 -136.71 25.1 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.2 m -97.34 151.29 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.529 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 57.75 113.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.67 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.606 -179.906 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 113.17 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.377 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.66 176.07 8.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.403 -179.933 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.487 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -68.83 -37.27 79.06 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.368 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.1 m-85 -124.52 78.94 62.28 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.501 -0.749 . . . . 0.0 109.196 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.597 2.198 . . . . 0.0 110.447 -179.909 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.3 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 85.33 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.08 -15.28 4.54 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 182' ' ' ALA . 39.9 t -99.65 120.23 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.125 -1.221 . . . . 0.0 109.657 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 mmm180 -93.95 114.65 26.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.131 179.714 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.7 pt20 -89.68 139.32 30.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.829 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.507 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -110.54 160.72 27.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 179.96 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.7 Cg_endo -77.88 3.12 7.24 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.511 2.141 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.58 ' HA ' ' CE3' ' A' ' 154' ' ' TRP . 0.0 OUTLIER -105.06 -21.23 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.063 -1.023 . . . . 0.0 109.387 179.828 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 115.59 22.32 4.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.43 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 75.8 mttt -117.07 152.35 34.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.263 179.823 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.975 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 m-85 -132.6 170.53 15.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.982 . . . . 0.0 109.675 -179.615 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.606 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.84 114.9 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.921 179.814 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.95 121.95 28.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 108.764 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.53 152.7 40.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.562 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 190' ' ' ALA . 1.2 tt -144.36 133.52 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 179.961 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.84 136.67 57.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 179.675 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.42 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 29.4 t0 -116.69 109.36 43.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.21 -27.39 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.375 2.05 . . . . 0.0 110.205 179.71 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.07 -16.72 61.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.402 -0.811 . . . . 0.0 109.732 -179.944 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 83.5 mttt -102.48 37.64 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 22.9 m-80 60.32 40.38 17.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.578 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.7 65.05 3.36 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.84 133.8 55.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.37 141.76 58.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.54 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.0 t -117.31 88.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.606 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -73.99 92.82 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.343 179.841 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.083 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -54.44 -40.81 68.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 144.84 157.33 7.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.515 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -72.06 169.09 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 64.6 m-85 -143.78 -178.99 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.69 -30.06 21.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.3 p -142.51 -179.62 6.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.975 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.28 -24.11 43.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -72.12 -35.59 69.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -76.14 -39.27 55.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.298 179.878 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.37 -32.44 70.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 108.97 179.837 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.09 -40.76 64.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.547 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -61.65 -44.27 97.28 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.576 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.18 -31.0 70.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.256 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 161' ' ' ILE . 8.2 t80 -63.03 -29.77 71.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.557 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.531 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.4 m-20 -68.98 -48.73 62.41 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 109.223 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -52.9 -36.01 58.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 110.578 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 1.083 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.79 -39.14 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.914 -1.116 . . . . 0.0 109.905 -179.491 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.74 4.66 18.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.314 179.835 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 195' ' ' GLY . 6.0 t80 -113.89 -42.69 3.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.416 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -38.8 66.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.116 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 15.3 ttm -81.59 -35.4 30.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.653 -0.654 . . . . 0.0 110.292 -179.507 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -81.69 -13.88 57.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.041 . . . . 0.0 109.654 -179.418 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 99.21 -125.1 8.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.493 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -66.65 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -1.198 . . . . 0.0 109.922 -179.523 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -75.47 152.91 37.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 172.52 153.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.852 . . . . 0.0 109.162 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -92.6 116.94 29.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.11 -0.994 . . . . 0.0 109.772 -179.698 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.531 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.03 146.91 50.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.606 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.24 -32.7 11.18 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.58 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.14 85.22 41.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 109.196 179.855 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 C--N 1.307 -1.616 0 C-N-CA 122.598 2.199 . . . . 0.0 110.138 179.952 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.962 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 25.3 m-85 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -81.4 91.4 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.68 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.68 3.37 11.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.904 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.7 t -112.8 109.37 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -1.181 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -84.96 113.99 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.17 -0.956 . . . . 0.0 108.789 179.544 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -91.92 131.29 37.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.322 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -79.32 -177.27 0.84 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.897 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 32.9 Cg_endo -76.57 76.37 4.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.84 1.693 . . . . 0.0 109.908 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 61.45 69.57 0.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 109.154 -179.617 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.6 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.503 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.526 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.2 mttp -113.18 -171.43 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -1.175 . . . . 0.0 110.627 -178.812 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.053 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.5 m-85 -144.33 -179.0 6.26 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.03 111.33 4.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.836 -1.165 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.22 117.99 27.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.141 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt-10 -134.33 -165.87 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.213 -179.864 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 160' ' ' GLU . 2.5 tt 174.68 138.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.667 179.868 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -75.52 131.14 39.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.246 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -105.83 111.86 64.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.859 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.3 -28.55 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.498 2.132 . . . . 0.0 110.304 179.923 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.65 58.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.863 . . . . 0.0 109.594 -179.867 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 3.9 mmpt? -104.75 25.48 10.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.814 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 76.49 33.72 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 179.791 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.2 86.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.8 -168.89 2.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.4 179.851 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -112.41 144.9 41.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.785 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 38.3 t -128.67 116.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.101 179.603 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.3 t-105 -102.11 100.67 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.437 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.9 OUTLIER -57.75 -47.32 82.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.741 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.74 157.24 7.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.875 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -73.58 152.95 40.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.4 -1.059 . . . . 0.0 109.607 -179.846 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.661 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.7 m-85 -126.44 -177.2 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.165 179.659 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 -32.47 15.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.456 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -134.32 168.81 18.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.053 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.462 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -75.0 -38.13 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.374 -0.828 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -75.72 -34.89 60.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.097 -1.002 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -73.54 -35.71 65.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.08 179.664 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.962 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.428 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -61.95 -46.19 90.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.464 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.39 -29.7 69.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.052 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.5 t80 -61.39 -42.97 99.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.501 -0.75 . . . . 0.0 109.106 179.426 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 200' ' ' LEU . 8.8 m-20 -58.25 -45.03 88.51 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.498 -0.751 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.847 -179.7 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -89.15 -25.61 21.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 110.199 -179.461 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.94 5.12 52.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.456 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -113.6 -31.66 6.43 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.328 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -83.79 -40.5 18.67 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.803 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 3.7 tpp -74.91 -29.56 61.02 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.618 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 70.2 mtt-85 -109.86 -3.37 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.706 -179.836 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 75.47 -146.37 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 73.8 m -78.11 158.09 29.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -1.105 . . . . 0.0 109.7 -179.716 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 196' ' ' SER . 16.7 ttp180 55.3 103.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.654 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -159.52 31.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 179.723 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 198' ' ' ALA . 55.5 mt 36.57 98.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.372 0.606 . . . . 0.0 110.715 179.354 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -119.34 177.19 5.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.012 . . . . 0.0 108.88 179.019 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.576 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -71.27 -34.43 70.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.191 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.5 m-85 -121.86 74.83 36.99 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.852 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.5 0 C-N-CA 122.513 2.142 . . . . 0.0 110.38 -179.811 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.2 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.239 0.542 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.72 107.22 2.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 108.918 179.347 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.92 -34.0 4.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.544 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 182' ' ' ALA . 42.0 t -81.24 119.75 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 109.233 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 22.3 mtt85 -101.4 101.67 12.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.807 -179.609 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.3 pt20 -62.91 144.02 57.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 109.118 179.534 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.484 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 1.5 mmt-85 -120.58 162.36 34.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.435 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.8 Cg_endo -76.7 73.49 5.24 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.611 2.207 . . . . 0.0 110.28 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.6 -179.681 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.66 14.12 3.59 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 18.8 mmtt -108.5 -176.92 3.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.236 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 86.7 m-85 -156.4 159.09 38.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -127.69 111.7 13.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.99 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.17 124.43 28.33 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -148.17 140.64 24.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.992 . . . . 0.0 110.042 -179.337 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 6.7 tt -128.41 137.41 57.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.424 -0.797 . . . . 0.0 109.121 179.735 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -80.28 142.99 34.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 -179.803 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 30.4 t0 -137.37 97.03 10.75 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.241 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.64 -24.37 10.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.322 2.014 . . . . 0.0 110.337 -179.917 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -11.75 58.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.859 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 163' ' ' ASP . 1.6 mtpt -105.84 40.57 1.55 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.63 45.97 3.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.434 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.77 84.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.78 120.77 13.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -1.088 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -63.82 157.26 25.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.148 -0.97 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 171' ' ' VAL . 34.0 t -128.85 89.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.847 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.491 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 8.9 t-105 -72.1 93.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.185 179.712 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.953 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.1 OUTLIER -52.07 -41.4 62.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.965 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.08 162.78 9.45 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 -179.648 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 1.2 p -76.14 -179.73 5.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.265 . . . . 0.0 109.393 -179.939 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 182' ' ' ALA . 78.4 m-85 -157.57 179.95 8.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.61 -25.47 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.457 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -142.98 165.43 27.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 109.562 -179.988 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.75 -22.64 65.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.45 -0.782 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -72.07 -39.48 68.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.841 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -73.18 -39.69 65.4 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.653 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.591 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -71.54 -32.71 68.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 -179.909 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.49 -37.02 63.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.205 -0.934 . . . . 0.0 108.852 179.71 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 184' ' ' LEU . 41.7 tp -66.03 -43.47 87.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.701 179.301 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.7 -30.96 72.0 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.241 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 9.3 t80 -66.36 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.548 -0.72 . . . . 0.0 109.144 179.545 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.648 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.0 -48.99 79.42 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.352 -0.842 . . . . 0.0 109.87 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -43.9 76.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 109.771 -179.753 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.953 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -75.26 -18.42 60.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.822 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.08 -8.66 48.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 4.5 t80 -105.8 -29.48 10.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -81.01 -40.3 24.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.508 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 27.0 mtp -75.11 -27.94 60.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.56 -0.713 . . . . 0.0 109.693 179.951 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -98.16 10.06 41.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.519 -179.806 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 73.15 -97.52 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.782 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.571 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 2.5 m -142.87 164.78 29.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -1.111 . . . . 0.0 109.482 -179.859 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 58.86 63.35 1.67 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 -179.808 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.19 171.52 8.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.397 -0.814 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -104.52 125.67 50.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.85 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.24 178.04 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 -179.789 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -70.95 -31.96 68.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.061 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.4 m-85 -121.61 74.14 33.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.45 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.896 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 97.39 4.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.771 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.87 -21.39 7.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.725 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.3 t -89.55 126.06 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.252 . . . . 0.0 109.999 -179.66 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 tpp180 -97.65 147.07 24.7 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.951 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.516 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.3 pt20 -119.4 139.75 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 -179.392 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -105.3 155.91 37.09 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.145 179.672 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.47 6.17 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.577 2.185 . . . . 0.0 110.803 -179.742 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -106.11 -52.17 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.628 -179.986 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 152.79 56.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mtmt -155.26 -177.75 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.336 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.8 m-85 -153.65 -171.77 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.93 110.92 2.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.457 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -79.36 114.41 18.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.261 -0.9 . . . . 0.0 109.078 179.734 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.516 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 1.6 mt-10 -130.83 151.35 51.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.312 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 171' ' ' VAL . 2.6 tt -140.11 120.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.543 -179.82 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -61.12 140.77 57.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.304 179.867 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.414 ' CG ' ' CG ' ' A' ' 166' ' ' LYS . 30.9 t0 -118.99 100.94 50.53 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 -179.875 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -30.0 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.43 2.087 . . . . 0.0 110.463 179.842 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -10.13 59.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.414 ' CG ' ' CG ' ' A' ' 163' ' ' ASP . 16.1 mmtt -106.14 44.78 1.02 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.45 49.61 20.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.277 -179.797 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.19 99.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.954 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -159.56 111.16 2.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -1.099 . . . . 0.0 109.25 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -63.02 149.43 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.582 -179.716 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 161' ' ' ILE . 21.7 t -122.13 104.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 11.3 t-105 -77.47 95.88 4.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 189' ' ' ALA . 31.2 mt -55.77 -54.9 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 162.46 158.69 9.77 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.937 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.575 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -72.75 154.39 40.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.568 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 53.7 m-85 -131.25 168.93 16.67 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -80.14 -24.75 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.669 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.587 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 3.4 p -145.1 175.96 9.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.88 -24.75 40.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.76 -33.57 64.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.587 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.1 OUTLIER -79.72 -39.03 32.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.899 . . . . 0.0 109.288 179.945 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.32 -31.64 67.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 109.208 179.851 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.896 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.49 -39.72 64.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.235 -0.915 . . . . 0.0 108.959 179.721 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 184' ' ' LEU . 22.8 tp -61.97 -42.62 99.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.824 . . . . 0.0 108.866 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.58 -31.35 72.0 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.8 t80 -62.33 -29.78 70.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.772 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.1 m-20 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.1 -31.7 70.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 -179.841 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.514 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -83.15 -28.13 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -4.07 58.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.485 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -108.54 -34.34 6.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.296 179.859 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -81.96 -38.77 24.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.343 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.3 ttm -78.03 -31.13 50.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.639 -0.663 . . . . 0.0 109.798 179.91 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 195' ' ' GLY . 34.7 mtp85 -98.65 -16.3 19.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.116 -0.99 . . . . 0.0 109.165 -179.911 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 47.68 -176.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.795 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 195' ' ' GLY . 93.3 p 42.82 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -1.168 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.25 149.61 40.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -149.09 157.11 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -100.54 118.01 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.772 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.87 -172.71 2.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.647 -179.675 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.624 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -80.22 -32.04 38.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 108.967 179.703 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.7 m-85 -125.61 68.37 60.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.531 -0.731 . . . . 0.0 109.602 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 203' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.8 Cg_endo . . . . . 0 C--N 1.311 -1.422 0 C-N-CA 122.808 2.338 . . . . 0.0 110.694 -179.845 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.883 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.9 m-85 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.19 85.14 2.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.66 -20.74 2.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.79 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.2 t -92.15 112.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.349 -1.089 . . . . 0.0 109.645 -179.847 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -93.12 79.49 4.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.765 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 29.7 pt20 -70.84 134.97 47.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.355 -0.841 . . . . 0.0 109.357 -179.871 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.579 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -89.08 -179.75 1.36 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.969 -1.082 . . . . 0.0 108.344 179.407 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -73.93 83.97 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.973 1.782 . . . . 0.0 110.18 -179.612 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 66.77 64.78 0.47 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.469 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.56 ' HA3' ' NE ' ' A' ' 152' ' ' ARG . . . -157.86 -111.83 0.33 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.75 -179.404 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.1 mtmm -110.52 -172.58 2.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.14 . . . . 0.0 110.976 -178.515 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.764 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 17.0 m-85 -140.59 131.07 25.35 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.576 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -104.33 112.84 26.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.885 -1.135 . . . . 0.0 110.752 -178.948 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.472 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.79 117.25 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.549 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.579 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 2.6 mt-10 -138.88 154.5 48.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.003 . . . . 0.0 109.68 -179.193 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 8.3 tt -133.07 164.47 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.742 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.489 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.5 tpp180 -101.01 119.65 39.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.963 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -120.83 93.04 48.6 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.33 -22.99 10.54 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.623 2.215 . . . . 0.0 110.342 179.984 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.58 60.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -90.38 33.24 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.91 25.57 15.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.557 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.38 97.96 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -161.81 97.9 1.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.4 mtt180 -45.56 155.63 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.949 . . . . 0.0 109.263 179.853 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.45 ' HB ' HG23 ' A' ' 161' ' ' ILE . 54.9 t -128.15 100.75 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ3' ' OE2' ' A' ' 160' ' ' GLU . 10.1 t-105 -86.16 97.33 10.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.75 HD21 ' CB ' ' A' ' 189' ' ' ALA . 15.1 mt -57.13 -46.59 82.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.508 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.25 155.93 7.17 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.3 p -68.93 178.8 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.164 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 175' ' ' THR . 67.1 m-85 -155.1 -171.51 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.924 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -97.32 -29.38 13.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.68 -179.846 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.591 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 13.3 p -142.53 -179.61 6.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 109.587 -179.797 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.96 -21.76 46.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.322 -0.862 . . . . 0.0 109.04 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -75.68 -36.79 59.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.91 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -73.27 -40.75 64.35 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.234 -0.916 . . . . 0.0 109.412 179.94 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.563 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -67.78 -47.2 69.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.883 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.41 -40.13 85.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.812 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -59.9 -49.74 76.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.525 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.66 -21.88 64.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.402 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -76.95 -28.44 55.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.801 . . . . 0.0 109.171 179.562 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.8 m-20 -69.12 -38.59 78.97 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 -179.573 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -69.31 -44.7 71.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.522 -179.088 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.75 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -70.16 -44.14 69.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.129 -179.25 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -64.82 -29.95 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.958 -179.412 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.41 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.4 t80 -75.56 -24.67 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.97 -1.081 . . . . 0.0 109.889 -179.623 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -82.27 -40.99 20.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -27.65 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 110.497 -179.302 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -97.46 7.78 45.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.943 -1.098 . . . . 0.0 109.603 -179.751 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 68.06 -132.33 28.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.764 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -80.77 -177.22 6.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 -179.984 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.493 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 17.0 ttm180 52.77 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.493 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 59.05 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 199' ' ' LEU . 3.8 mp -106.76 122.08 45.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.24 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.5 161.63 26.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.69 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -60.82 -31.49 70.9 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.246 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.812 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.0 m-85 -123.73 88.52 52.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.31 -1.455 0 C-N-CA 122.632 2.221 . . . . 0.0 110.742 -179.275 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.5 m-85 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.55 96.27 4.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.18 -18.43 6.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.865 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 65.6 t -99.62 127.62 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -1.171 . . . . 0.0 109.62 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 1.1 mtt85 -100.51 141.19 33.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.181 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.527 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -110.92 147.37 34.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 -179.314 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mtt180 -112.02 165.76 12.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.442 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.49 -29.56 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.546 2.164 . . . . 0.0 110.646 -179.898 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -73.14 -57.1 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.562 -179.957 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 53.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.459 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 12.6 mttm -144.86 171.52 14.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -1.176 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.002 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.3 m-85 -144.93 -173.75 4.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.772 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.17 112.85 2.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.696 179.88 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.34 126.76 34.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.09 150.33 36.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.625 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 161' ' ' ILE . 1.6 tt -142.46 139.2 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.879 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -72.4 135.76 45.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 163' ' ' ASP . 37.3 t0 -130.08 96.54 25.21 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.593 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.87 -26.49 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.505 2.136 . . . . 0.0 110.287 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.78 -20.95 62.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.334 -0.853 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 16.6 mmtp -95.25 33.51 1.55 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.494 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 12.6 m120 66.5 49.3 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.313 -179.843 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.89 105.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.972 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -175.54 112.88 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -1.189 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -53.53 166.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 171' ' ' VAL . 43.2 t -137.33 94.57 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.772 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.4 t-105 -78.47 97.81 5.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.967 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.1 mt -56.1 -46.82 78.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.538 -179.822 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.66 162.87 11.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.931 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -79.65 151.53 30.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.288 -179.853 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 85.9 m-85 -127.25 -175.85 3.56 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.14 -33.06 19.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.298 -179.418 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.5 p -137.31 179.51 6.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.035 -1.041 . . . . 0.0 110.028 -179.579 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.76 -27.39 60.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.152 179.744 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 11.1 tt0 -68.54 -70.82 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.471 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -37.85 -54.45 1.26 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.804 -0.56 . . . . 0.0 110.217 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -60.3 -41.34 93.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.037 -179.472 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -61.98 -31.38 71.73 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.669 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -70.9 -45.86 63.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.167 -0.958 . . . . 0.0 108.455 179.595 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.62 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -59.04 -25.58 63.83 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.722 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 21.2 t80 -74.21 -36.38 63.96 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.559 ' HB3' HD13 ' A' ' 200' ' ' LEU . 71.1 m-20 -64.54 -45.64 86.26 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.472 -0.767 . . . . 0.0 109.146 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -42.18 84.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.967 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.37 -16.73 58.72 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.805 179.498 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.66 1.17 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.377 -0.827 . . . . 0.0 109.048 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -114.91 -37.6 4.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.71 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 42.5 mmt-85 -81.16 -39.44 25.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.078 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 40.8 ttm -75.05 -30.54 61.04 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.463 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.4 mtt180 -99.54 -10.28 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.27 -169.65 54.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.938 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' ARG . 1.4 t -54.6 150.69 9.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -1.085 . . . . 0.0 109.635 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 62.76 125.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.957 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 179.92 145.7 0.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 179.953 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -90.34 120.2 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.631 -179.773 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.21 -173.54 3.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.007 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.431 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -74.96 -35.89 62.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.087 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.4 m-85 -122.33 87.42 48.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.201 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.61 2.206 . . . . 0.0 110.755 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -134.99 78.02 1.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.922 . . . . 0.0 109.492 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.6 m-85 -48.38 150.6 1.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.84 82.24 5.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.561 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.56 -13.48 3.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 33.3 t -102.16 120.87 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 109.395 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -103.9 89.44 3.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.55 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -46.97 149.98 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 13.1 mmt180 -113.42 161.81 25.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.937 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.29 6.09 4.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.662 2.241 . . . . 0.0 110.584 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -114.18 -15.05 12.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 30.96 2.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 28.6 mmmt -120.35 -175.31 2.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.638 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.805 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 88.2 m-85 -157.64 117.71 3.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.104 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -89.94 122.46 32.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -98.53 111.95 24.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.58 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 4.4 mt-10 -135.21 150.88 50.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.403 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -127.9 148.29 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 133.0 36.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.746 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -126.65 94.5 40.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.436 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.83 -24.99 8.09 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.656 2.237 . . . . 0.0 110.575 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.37 -11.91 61.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -100.12 55.61 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.2 m120 56.3 31.04 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.955 . . . . 0.0 109.592 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.22 67.96 1.85 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -124.69 -180.0 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -1.154 . . . . 0.0 109.375 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -111.32 156.13 22.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.53 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 171' ' ' VAL . 29.5 t -129.15 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.2 t-105 -79.58 102.23 8.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.043 HD21 ' HB2' ' A' ' 189' ' ' ALA . 7.9 mt -56.78 -55.51 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 109.331 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 159.53 153.32 6.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.512 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.0 p -65.99 166.68 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.707 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.2 m-85 -141.39 -177.33 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -95.84 -30.25 13.77 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.307 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.548 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -136.68 167.07 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.268 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.805 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.45 -26.34 62.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.307 -0.871 . . . . 0.0 108.916 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.93 -35.27 69.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.285 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.12 -43.56 57.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.075 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.36 -23.78 61.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 108.916 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.59 -42.75 41.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.02 -38.81 92.68 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.82 -38.58 83.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 108.982 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.2 t80 -60.61 -39.24 87.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 1.2 m-20 -56.96 -44.1 82.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -0.815 . . . . 0.0 109.577 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -48.84 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.043 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -72.82 -15.45 61.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 0.0 109.847 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.45 -17.49 25.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.152 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 2.8 t80 -94.34 -31.29 14.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -46.72 26.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.6 ttm -65.54 -33.52 76.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.687 -0.633 . . . . 0.0 109.83 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.481 ' HG2' ' NH1' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -100.14 18.21 19.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 109.646 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 57.43 -99.43 0.1 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 0.5 OUTLIER -126.13 158.08 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -1.154 . . . . 0.0 109.717 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.57 91.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.19 174.12 10.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.99 113.58 26.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.16 179.48 5.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -35.16 64.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.437 ' HD2' HD22 ' A' ' 184' ' ' LEU . 4.9 m-85 -120.03 83.35 30.67 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.29 71.79 6.21 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.626 2.217 . . . . 0.0 110.465 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.51 -73.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -74.96 102.63 4.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.349 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.408 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.3 -165.0 0.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.524 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.754 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.8 m-85 -74.82 146.14 42.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.0 109.328 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.543 ' HE ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.52 31.01 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.034 -1.041 . . . . 0.0 109.774 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.09 20.16 0.35 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 183' ' ' ALA . 61.6 t -140.62 107.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -1.061 . . . . 0.0 109.37 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -85.06 110.6 19.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 108.678 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -75.95 156.01 34.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.567 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -109.56 158.54 34.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.83 . . . . 0.0 109.19 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.82 13.79 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.514 2.143 . . . . 0.0 111.024 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -120.33 -25.43 5.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.071 -1.018 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.53 33.84 0.59 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.441 ' C ' ' HG3' ' A' ' 152' ' ' ARG . 42.5 mttt -126.44 -169.24 1.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 58.6 m-85 -156.42 172.19 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.379 -0.825 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.08 116.99 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.063 -1.023 . . . . 0.0 110.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -87.17 119.77 27.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 108.605 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -144.3 147.01 32.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.605 HD11 ' NH1' ' A' ' 194' ' ' ARG . 8.8 tt -135.94 143.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 108.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -80.81 134.47 35.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.036 -1.04 . . . . 0.0 109.811 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -122.94 103.6 36.62 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.391 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 -29.95 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.448 2.099 . . . . 0.0 110.594 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.66 -26.69 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.641 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -91.4 37.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.24 50.23 18.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.64 80.09 0.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -132.37 95.51 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.3 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -44.28 133.0 5.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 43.7 t -109.92 103.18 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.439 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.493 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 5.0 t-105 -93.68 97.31 10.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -54.3 -49.0 70.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.061 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.54 159.53 8.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -76.99 144.08 38.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.647 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.814 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.4 m-85 -118.01 178.26 4.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.456 -0.778 . . . . 0.0 109.21 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.6 mm-40 -88.24 -25.55 22.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 110.012 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.573 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.8 p -141.17 178.17 7.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.651 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -80.38 -23.17 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.385 -0.822 . . . . 0.0 109.19 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 13.6 tt0 -74.93 -36.81 62.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.84 -43.91 43.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.754 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.25 -37.88 84.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.346 -0.846 . . . . 0.0 109.045 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.854 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -61.25 -44.88 96.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.426 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.7 -18.72 62.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 108.894 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 11.6 t80 -76.22 -31.58 58.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.002 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.549 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -68.38 -51.09 47.95 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.545 -0.722 . . . . 0.0 109.798 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -27.52 69.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -86.15 -23.03 26.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.302 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -88.18 -15.63 35.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.37 -0.831 . . . . 0.0 109.124 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.4 OUTLIER -92.81 -32.13 14.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -78.8 -40.58 32.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.02 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.1 tpp -70.34 -30.93 68.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 0.0 109.581 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.605 ' NH1' HD11 ' A' ' 161' ' ' ILE . 1.5 mpt_? -91.62 -12.67 33.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 196' ' ' SER . . . 62.57 81.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 3.3 m 61.01 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -1.161 . . . . 0.0 109.69 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER 61.76 120.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.922 . . . . 0.0 109.632 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 173.31 153.59 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.543 HD23 ' HE ' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -98.04 118.6 35.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.02 -177.41 4.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.549 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -72.8 -34.36 66.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.854 ' HD2' HD22 ' A' ' 184' ' ' LEU . 2.2 m-85 -128.66 76.52 78.62 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' LEU . 35.1 Cg_endo -76.54 72.11 5.7 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.722 2.281 . . . . 0.0 110.66 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 205' ' ' ARG . 0.7 OUTLIER 42.3 30.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER 166.09 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 109.222 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.506 ' N ' ' HG2' ' A' ' 205' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.8 mttt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER 62.18 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.362 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 1.004 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.6 m-85 -105.85 140.28 39.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.09 88.19 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 124.77 26.29 1.43 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.7 t -140.35 109.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -1.106 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -95.46 93.77 7.41 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.224 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 44.0 tt0 -52.05 167.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.418 ' N ' ' CG ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -129.69 158.91 72.15 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.335 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.57 4.32 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.625 2.216 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CD1' ' O ' ' A' ' 154' ' ' TRP . 50.0 t-105 -113.25 -7.77 13.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.52 22.6 8.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -115.09 174.08 6.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.596 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.066 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 79.6 m-85 -146.91 152.98 39.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.032 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.643 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -121.85 117.45 26.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.873 -1.142 . . . . 0.0 109.653 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.606 ' HB3' ' HE2' ' A' ' 176' ' ' PHE . . . -91.89 111.07 22.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -130.22 145.87 51.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.063 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 14.9 tt -124.15 154.7 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.61 136.32 34.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.412 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 44.0 t0 -146.16 93.05 5.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.669 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.16 -23.42 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.635 2.223 . . . . 0.0 110.281 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.48 -11.52 24.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.821 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 13.2 mtpt -100.87 35.67 2.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 1.6 t-20 70.39 47.22 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.66 89.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -163.71 136.1 5.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -71.82 178.68 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.2 t -138.51 81.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.715 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.2 t-105 -61.87 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.548 HD21 ' CB ' ' A' ' 189' ' ' ALA . 26.6 mt -51.7 -34.87 40.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.127 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 137.33 155.22 6.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.715 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.8 p -68.24 -177.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.323 -1.104 . . . . 0.0 109.383 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.606 ' HE2' ' HB3' ' A' ' 159' ' ' ALA . 74.2 m-85 -157.54 177.94 10.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -88.84 -26.91 21.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.655 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.7 p -140.83 175.59 9.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.066 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -80.44 -21.07 42.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.284 -0.885 . . . . 0.0 109.2 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -76.31 -37.55 57.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -36.06 63.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.167 -0.958 . . . . 0.0 109.027 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.72 -39.76 66.67 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.038 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.004 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -66.3 -39.53 89.39 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.0 108.734 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.0 tp -64.56 -42.7 95.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.53 -24.15 67.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.2 t80 -76.04 -28.79 57.81 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.482 -0.761 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 72.3 m-20 -74.48 -47.55 32.66 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -62.43 -31.61 72.34 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.548 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -88.54 -20.59 24.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.024 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.1 -1.96 58.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -107.97 -35.42 6.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.906 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -76.81 -39.77 50.27 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 27.7 ttm -76.6 -36.94 57.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.64 -0.662 . . . . 0.0 109.978 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -77.73 -18.36 56.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.965 . . . . 0.0 109.18 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.16 -127.79 9.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 197' ' ' ARG . 13.8 m -63.96 -148.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 110.053 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 196' ' ' SER . 1.8 ttm180 -39.99 139.72 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 110.033 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.78 -175.88 4.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.143 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -104.23 121.36 43.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.843 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.69 152.42 50.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.426 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -54.96 -33.04 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.3 m-85 -117.44 94.19 44.85 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.59 78.54 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.432 2.088 . . . . 0.0 110.374 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.15 125.83 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.406 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -139.92 57.74 1.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.409 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 205' ' ' ARG . 2.5 t . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.39 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.307 0.575 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.1 133.76 0.53 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.628 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.7 m-85 -103.81 157.49 17.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.43 81.84 3.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 108.917 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.67 19.79 2.0 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 44.4 t -133.21 129.51 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.259 . . . . 0.0 109.198 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 112.36 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.601 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.1 pt20 -80.17 157.18 26.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -125.75 159.13 62.63 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 109.698 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 3.4 7.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.571 2.181 . . . . 0.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -101.22 -19.21 15.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.51 39.79 1.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 35.1 mttt -145.56 166.1 26.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.427 -1.043 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.083 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.8 m-85 -133.65 178.54 6.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.58 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.36 112.74 6.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.704 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.49 108.17 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -129.4 158.42 39.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.356 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.8 tt -139.72 139.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -80.72 128.72 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.902 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -114.78 95.74 42.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -23.27 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.613 2.208 . . . . 0.0 110.617 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.65 -7.1 30.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.185 -0.947 . . . . 0.0 109.687 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -119.09 57.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 49.49 26.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.91 99.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -142.62 105.34 4.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 109.248 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.01 141.94 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.2 t -122.81 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.68 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.6 t-105 -73.7 96.49 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.786 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.458 HD21 ' CB ' ' A' ' 189' ' ' ALA . 30.3 mt -56.04 -46.99 78.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.33 154.53 6.59 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.68 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -70.33 161.25 30.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -1.107 . . . . 0.0 109.356 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 65.2 m-85 -136.16 178.72 6.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -84.15 -31.25 25.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.8 p -142.06 170.33 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.083 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.23 -22.42 62.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.106 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.88 -42.59 63.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -68.29 -43.45 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.862 . . . . 0.0 109.606 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.67 -45.76 85.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.8 -38.93 79.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.63 -51.52 68.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 109.125 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.532 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.49 -20.25 65.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 108.815 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -79.27 -28.47 42.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.445 -0.785 . . . . 0.0 109.41 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.4 m-20 -72.34 -35.47 68.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.701 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -76.19 -40.04 53.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.458 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -73.89 -30.02 62.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.467 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.87 -23.62 33.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.837 . . . . 0.0 109.4 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.513 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 28.7 t80 -83.74 -22.34 31.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 108.974 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -78.86 -38.49 37.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.638 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.1 ttm -80.15 -43.12 22.17 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 0.0 110.173 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.718 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 12.2 mtt180 -92.57 -38.34 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.828 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 63.11 161.43 0.28 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 197' ' ' ARG . 22.5 p 50.53 -176.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -1.097 . . . . 0.0 109.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.5 mtm180 -43.7 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -119.27 35.99 4.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 198' ' ' ALA . 5.0 mt 39.35 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -118.18 149.77 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.972 . . . . 0.0 109.353 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.18 -37.31 22.17 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.9 m-85 -120.81 83.22 36.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.473 ' O ' ' HG ' ' A' ' 204' ' ' LEU . 36.2 Cg_endo -79.96 57.91 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.905 2.403 . . . . 0.0 110.594 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 203' ' ' PRO . 16.7 mt -151.73 172.29 16.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.114 -0.991 . . . . 0.0 109.294 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.639 ' O ' HG12 ' A' ' 206' ' ' VAL . 0.7 OUTLIER -59.57 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 205' ' ' ARG . 9.5 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -127.49 156.95 41.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.82 . . . . 0.0 109.159 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.867 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 68.6 m-85 -71.18 159.57 34.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.59 35.02 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.184 -0.948 . . . . 0.0 110.15 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.78 26.24 0.09 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 182' ' ' ALA . 96.7 t -150.27 117.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.417 -1.049 . . . . 0.0 109.185 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.552 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -99.09 137.13 38.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.104 -0.997 . . . . 0.0 109.09 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -103.11 155.62 18.27 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.265 -0.897 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.69 161.02 55.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.815 . . . . 0.0 109.38 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.85 -8.41 16.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.513 2.142 . . . . 0.0 109.964 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.59 -1.41 57.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.5 56.27 2.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.4 mttt -159.27 171.27 20.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.788 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -142.17 -177.68 5.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -152.49 116.92 4.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.779 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -89.23 118.35 28.85 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 109.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 5.6 mt-10 -137.82 177.57 7.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 171' ' ' VAL . 1.1 tt -164.72 142.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.909 -1.119 . . . . 0.0 109.939 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -69.5 134.17 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.045 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 168' ' ' GLY . 11.2 t0 -113.14 98.07 44.7 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 0.0 109.62 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.12 -22.07 10.17 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.535 2.157 . . . . 0.0 110.28 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.25 67.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.296 -0.878 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -104.98 32.5 4.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.72 58.52 4.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 169' ' ' ALA . . . 82.09 -127.56 8.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 67.18 87.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -53.5 134.83 40.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 163' ' ' ASP . 70.3 t -102.01 105.8 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 108.962 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -87.49 93.9 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.031 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.7 mt -53.55 -48.69 68.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.0 108.998 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 153.62 162.23 10.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.29 160.84 30.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -1.141 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -134.75 -176.5 4.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 0.0 109.608 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -90.58 -28.2 18.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.638 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p -146.5 172.18 13.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.61 -24.36 62.72 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.127 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -73.81 -36.37 64.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.539 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -72.03 -47.05 54.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.65 -32.15 73.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.2 -37.62 75.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.135 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.97 -47.56 77.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 108.86 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.571 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.25 -22.11 66.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' ALA . 28.9 t80 -69.79 -36.28 75.57 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.792 ' HB3' HD13 ' A' ' 200' ' ' LEU . 9.7 m-20 -63.57 -54.33 37.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.395 -0.815 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -55.68 -29.68 59.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.26 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.11 -24.64 27.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.084 . . . . 0.0 110.06 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.94 -14.91 37.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.995 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.548 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.4 t80 -96.25 -25.33 15.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.17 -0.956 . . . . 0.0 108.853 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.34 -38.79 34.31 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.2 tpp -79.59 -42.13 25.63 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.383 0.611 . . . . 0.0 109.749 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 9.7 mtp180 -97.73 -41.27 8.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 109.629 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 43.24 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 197' ' ' ARG . 0.6 OUTLIER 45.87 50.62 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -1.12 . . . . 0.0 109.828 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 70.46 118.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -138.96 174.21 10.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.335 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 108.07 19.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -122.0 -175.91 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.562 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.516 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -84.6 -33.52 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.416 ' HZ ' ' CZ ' ' A' ' 146' ' ' TYR . 6.2 m-85 -121.02 77.49 31.5 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.6 Cg_endo -77.41 179.94 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.686 2.257 . . . . 0.0 110.507 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.34 142.8 37.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -56.35 -30.49 62.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.511 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -55.2 176.48 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.4 m-85 -130.69 154.27 48.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.303 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -75.89 83.6 2.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.634 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.57 -22.2 3.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.7 t -90.48 116.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -1.15 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -105.48 120.21 41.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 pp0? -85.54 163.8 18.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.881 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.426 ' CD ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -131.66 165.73 33.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.452 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 152' ' ' ARG . 35.0 Cg_endo -78.39 -4.09 13.92 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.683 2.255 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -91.96 -18.03 24.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.007 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.86 35.84 2.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -137.16 -175.59 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 0.0 109.634 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.828 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -144.83 -173.37 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.636 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -154.01 108.32 3.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.213 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.73 119.41 24.29 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.563 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 10.6 mt-10 -134.89 179.65 6.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.084 -1.01 . . . . 0.0 109.365 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -174.76 141.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.43 136.76 39.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' CA ' ' A' ' 168' ' ' GLY . 10.5 t0 -111.47 101.02 49.8 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -24.02 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 110.308 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.85 -37.0 75.99 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 167' ' ' ASN . 14.2 mttt -98.33 59.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 167' ' ' ASN . 3.6 p-10 41.36 48.02 3.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.438 -0.789 . . . . 0.0 109.797 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 163' ' ' ASP . . . 75.48 -114.68 4.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 63.27 95.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 169' ' ' ALA . 7.7 ptt180 -45.28 157.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.675 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 41.1 t -129.29 93.02 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.636 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 13.5 t-105 -79.59 93.19 5.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.12 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -53.47 -40.18 65.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.485 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 148.25 -171.93 28.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -103.39 154.94 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -1.162 . . . . 0.0 109.028 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -130.1 165.28 22.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.464 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.7 OUTLIER -77.71 -17.87 57.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.096 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.9 p -153.56 162.36 41.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.545 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.828 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.63 -23.28 66.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.309 -0.869 . . . . 0.0 109.405 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.0 -39.72 65.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.501 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -72.04 -40.49 68.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.763 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.83 -32.13 69.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.47 -41.15 69.73 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.75 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.32 -46.91 88.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.34 -22.88 63.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 108.845 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.0 t80 -72.48 -30.74 64.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.495 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.5 m-20 -69.34 -50.48 45.97 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.36 -0.837 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -54.95 -38.02 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.918 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.424 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -78.02 -30.15 49.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 109.453 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -82.64 -2.8 55.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.383 -0.823 . . . . 0.0 109.385 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' GLY . 37.3 t80 -99.45 -40.67 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.149 -0.97 . . . . 0.0 108.918 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -64.34 -49.12 72.94 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -40.38 95.22 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 60.3 mtt180 -105.31 36.52 2.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 108.962 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -34.69 147.72 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.2 t 80.91 102.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.56 -0.965 . . . . 0.0 109.402 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.494 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 49.8 ttm-85 64.71 -96.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.407 -0.808 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.08 145.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.005 -1.06 . . . . 0.0 109.401 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -104.85 122.46 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.544 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -121.23 152.53 38.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -0.919 . . . . 0.0 109.24 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.405 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -48.5 -37.16 16.78 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.9 m-85 -120.19 92.31 47.0 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.66 160.91 34.36 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.631 2.221 . . . . 0.0 110.916 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mt -149.28 -161.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.9 162.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.343 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 145' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 32.9 t-80 176.39 125.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.599 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 1.011 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 -107.64 158.41 17.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.412 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 86.41 3.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.832 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.41 -19.78 5.62 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 182' ' ' ALA . 44.1 t -90.0 114.58 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.667 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -100.08 113.92 26.88 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.459 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 12.0 pt20 -78.62 154.57 30.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.311 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -118.42 174.43 2.67 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -77.68 -48.07 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.632 2.221 . . . . 0.0 110.507 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -62.51 1.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.65 52.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -141.48 173.44 11.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.674 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.951 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.8 m-85 -139.15 175.37 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.628 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.64 110.27 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.53 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.56 124.2 28.76 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -146.03 160.29 42.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.788 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.529 HD13 ' HE2' ' A' ' 193' ' ' MET . 3.4 tt -149.47 147.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.859 . . . . 0.0 109.181 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.436 ' NH2' ' HG2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -96.94 137.15 36.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.99 . . . . 0.0 109.614 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.444 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 44.5 t0 -122.23 114.45 30.59 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.361 -0.837 . . . . 0.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.71 -35.05 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.324 2.016 . . . . 0.0 110.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.61 64.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.105 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -93.89 39.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.42 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.36 30.98 13.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.76 62.59 5.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.44 33.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.491 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -84.64 161.93 19.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.632 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.6 t -137.3 94.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.432 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.628 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.3 t-105 -79.3 100.36 7.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.049 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -59.47 -43.12 93.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 146.26 157.02 7.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.582 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -76.26 151.06 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.169 . . . . 0.0 109.432 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.9 m-85 -123.38 -176.25 3.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -87.59 -31.98 19.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.5 p -139.29 176.27 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.193 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.26 -26.06 55.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.3 -37.37 71.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -72.97 -39.57 66.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.97 -26.52 61.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.327 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.011 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.21 -39.28 49.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.136 -0.978 . . . . 0.0 109.013 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 184' ' ' LEU . 1.1 tm? -63.75 -43.07 97.54 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 108.838 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.608 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.72 -29.45 69.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -66.31 -32.18 73.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 0.0 109.14 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.661 ' HB3' HD13 ' A' ' 200' ' ' LEU . 3.6 m-20 -65.93 -49.6 67.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.09 -29.71 67.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.005 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.049 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.48 -24.28 27.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.821 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.522 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -87.69 -6.53 58.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.613 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 196' ' ' SER . 2.1 t80 -104.01 -37.47 7.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.44 -40.99 56.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.273 -0.892 . . . . 0.0 109.163 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.529 ' HE2' HD13 ' A' ' 161' ' ' ILE . 2.0 mtm -71.94 -30.79 65.69 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.563 -0.711 . . . . 0.0 110.067 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -92.75 -6.4 49.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.84 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.0 -104.23 3.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.581 ' O ' ' CZ ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -108.02 -78.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.981 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.83 122.79 15.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.881 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . -156.54 162.4 39.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.158 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.727 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -110.55 124.77 52.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.61 173.19 8.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.222 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.494 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.3 OUTLIER -74.66 -28.73 60.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.0 m-85 -125.24 67.25 54.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.545 -0.722 . . . . 0.0 109.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.8 Cg_endo -77.25 73.25 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.553 2.169 . . . . 0.0 109.876 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 -73.68 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.948 . . . . 0.0 110.242 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.73 -165.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.14 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.386 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -175.71 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.915 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.8 m-85 -67.29 127.53 33.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 109.586 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 87.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 125.8 28.29 1.07 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.8 t -142.41 123.05 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.094 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 85.62 2.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.585 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 1.3 pp0? -59.49 144.39 47.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.511 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 159.79 34.71 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.23 18.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.742 2.295 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.35 -39.99 2.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.44 46.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HD2' ' HB ' ' A' ' 175' ' ' THR . 34.9 ttpt -147.18 147.93 31.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -1.165 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.903 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 16.4 m-85 -133.79 130.46 38.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.563 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -99.32 108.93 21.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.082 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.65 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.11 109.21 18.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.224 -0.923 . . . . 0.0 108.585 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.496 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 1.8 mp0 -132.53 141.54 48.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.12 -0.987 . . . . 0.0 109.668 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 5.4 tt -120.7 131.89 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.798 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.73 122.98 24.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.683 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -113.87 108.39 51.22 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.858 . . . . 0.0 109.313 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 -27.62 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.387 2.058 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.31 75.29 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -95.9 40.56 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.463 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 4.9 m-20 69.56 46.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.506 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.35 29.79 1.82 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.96 123.05 20.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -1.122 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.04 130.16 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.489 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.9 t -106.75 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.668 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.566 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -74.65 94.17 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.372 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.612 HD22 ' HB2' ' A' ' 189' ' ' ALA . 39.4 mt -54.24 -41.63 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 145.15 155.01 6.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.566 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.3 p -68.04 179.77 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 75.1 m-85 -154.62 -174.23 4.89 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.396 -0.815 . . . . 0.0 109.343 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.38 -25.37 13.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.8 p -142.7 170.85 14.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.903 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.68 -23.9 58.7 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.157 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -34.03 61.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.413 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -74.79 -39.97 61.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 109.019 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.48 -35.63 73.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.915 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.54 -40.64 73.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.996 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 184' ' ' LEU . 28.2 tp -63.1 -43.66 97.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.48 -24.0 63.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 7.2 t80 -69.37 -30.08 67.99 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -49.11 50.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.491 -0.756 . . . . 0.0 109.046 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -54.11 -39.27 66.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.687 . . . . 0.0 109.608 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.612 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.61 -27.62 41.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.7 -4.1 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.19 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.453 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 10.0 t80 -103.79 -23.82 13.37 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -81.55 -36.41 29.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.6 tpp -81.05 -44.07 18.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.785 -0.572 . . . . 0.0 109.91 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.7 mtt180 -85.3 -33.35 22.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.175 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 62.47 127.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' ALA . 69.6 m 61.56 142.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -1.104 . . . . 0.0 110.34 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 2.4 tpp180 43.06 -96.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.49 -0.756 . . . . 0.0 110.376 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.29 168.7 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.152 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -106.0 109.85 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.599 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.75 159.41 32.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.565 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -68.66 -30.55 69.26 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.0 m-85 -122.49 86.36 48.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HA ' HD12 ' A' ' 200' ' ' LEU . 35.2 Cg_endo -77.22 -177.07 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.707 2.271 . . . . 0.0 110.669 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.71 38.39 3.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.474 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -147.44 96.77 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.534 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 145' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.241 0.544 . . . . 0.0 109.573 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.484 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.8 m170 73.24 102.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.1 m-85 -85.67 146.6 26.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 99.85 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.09 -33.25 4.28 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.1 t -75.3 134.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -1.19 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -121.18 106.69 11.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.061 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -77.12 163.21 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.541 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -120.8 175.99 2.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.412 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.39 -23.43 8.67 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.744 2.296 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -84.25 -56.03 3.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.62 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.02 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.2 157.88 41.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -1.125 . . . . 0.0 109.138 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 13.7 m-85 -126.1 -178.43 4.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 109.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.68 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.97 108.19 4.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 110.345 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.69 107.57 13.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.423 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -130.29 146.05 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.5 tt -135.12 156.44 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.291 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.05 132.78 33.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -132.17 102.55 14.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.303 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 -26.67 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.442 2.094 . . . . 0.0 109.961 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.52 64.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 35.9 mttm -90.03 26.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 3.7 t-20 75.11 43.99 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.38 48.48 80.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.02 147.32 42.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -1.153 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -76.81 154.95 33.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 171' ' ' VAL . 9.0 t -122.12 85.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.68 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.5 t-105 -73.86 96.46 2.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 108.882 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.6 mt -52.94 -48.59 67.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.132 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 150.43 152.29 5.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.564 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.5 p -65.55 171.14 4.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.173 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.529 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 61.6 m-85 -144.95 -176.49 5.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -89.42 -29.58 18.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.584 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.5 p -143.06 171.18 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.05 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.62 -28.11 63.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -69.46 -33.75 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -76.36 -41.11 49.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 109.031 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -71.58 -23.12 61.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.852 . . . . 0.0 109.081 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -80.24 -42.52 23.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 108.86 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -36.22 83.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.14 -29.78 65.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 17.7 t80 -64.83 -37.43 87.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.904 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.2 m-20 -63.39 -47.09 83.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.512 -0.742 . . . . 0.0 109.336 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -53.04 -42.37 65.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.02 -17.92 45.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.7 -5.09 56.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.189 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 5.6 t80 -102.8 -33.73 9.26 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -77.23 -41.36 41.47 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.39 -29.27 63.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 109.343 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.6 mtt-85 -104.66 9.79 35.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.67 -162.79 14.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 59.0 p -61.49 161.56 9.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -1.101 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 54.94 104.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.551 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -151.58 172.98 15.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 109.163 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.627 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -107.43 112.89 25.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.72 179.44 4.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 109.31 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.498 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -74.53 -30.59 61.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 108.422 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.3 m-85 -126.1 67.0 61.52 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.589 -0.694 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo -76.53 159.11 35.99 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.609 2.206 . . . . 0.0 110.304 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.59 89.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.65 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.445 ' CG ' HG23 ' A' ' 206' ' ' VAL . 3.6 ttt-85 -160.31 129.94 5.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.445 HG23 ' CG ' ' A' ' 205' ' ' ARG . 3.5 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -118.92 105.87 11.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.0 m-85 -101.11 159.11 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -80.71 99.08 8.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.668 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 160' ' ' GLU . . . 115.92 -9.72 18.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 179' ' ' ALA . 89.7 t -100.88 112.61 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.034 -1.274 . . . . 0.0 109.79 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.1 ttm-85 -91.83 94.12 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.108 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.564 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -71.57 134.94 46.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.85 160.65 34.31 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.85 -2.55 12.53 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.71 2.273 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -109.73 19.95 18.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.661 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.16 68.03 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -162.01 133.47 5.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 108.797 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 5.3 m-85 -132.51 137.27 47.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -0.945 . . . . 0.0 109.115 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.693 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -107.26 116.76 32.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.002 -1.061 . . . . 0.0 110.357 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -89.39 114.12 25.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 148' ' ' GLY . 2.5 mp0 -130.61 155.57 46.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.403 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 8.9 tt -139.06 125.77 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -82.03 117.55 22.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.52 108.94 58.31 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.23 -33.08 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.381 2.054 . . . . 0.0 110.288 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.28 65.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -89.46 39.54 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.428 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.4 m120 46.57 50.17 13.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.594 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.15 88.69 0.03 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -146.85 89.04 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -1.157 . . . . 0.0 109.741 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -49.18 145.23 4.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.326 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.5 t -127.55 86.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.691 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.693 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.6 t-105 -67.21 97.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 108.91 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.831 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -53.98 -42.42 68.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.859 . . . . 0.0 109.606 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.48 155.53 6.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.7 p -67.77 -176.59 0.67 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -1.141 . . . . 0.0 109.302 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 71.0 m-85 -156.75 -168.52 2.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 109.397 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.57 -25.88 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.456 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.1 p -141.49 174.54 10.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.719 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.85 -24.42 41.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -35.08 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -39.32 44.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.91 -41.93 61.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 108.853 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.59 -40.58 95.3 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.67 -25.83 64.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 15.2 t80 -68.15 -41.09 82.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.562 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.5 m-20 -61.1 -50.1 74.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.224 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -48.27 -39.5 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.557 -0.714 . . . . 0.0 110.128 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.831 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.9 -26.16 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.966 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.15 7.36 32.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.041 -1.037 . . . . 0.0 109.143 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 10.0 t80 -111.94 -33.8 6.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -43.06 32.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -75.62 -29.73 59.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.319 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.636 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -95.51 5.41 51.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.907 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 85.37 -89.51 1.61 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.587 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 45.0 t -138.76 -80.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -1.208 . . . . 0.0 109.879 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 111.79 1.01 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -150.49 170.01 20.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.523 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -97.83 107.99 20.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.562 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -115.42 157.87 23.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.189 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.519 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -61.19 -31.72 71.48 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.8 m-85 -121.97 83.92 44.42 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 145.14 24.59 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.301 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 78.2 mt -68.85 -92.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 52.65 -154.33 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.532 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 206' ' ' VAL . 4.5 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.447 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.95 155.24 38.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.535 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.872 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.2 m-85 -59.19 169.43 1.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -82.45 83.32 7.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.878 . . . . 0.0 109.199 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.96 6.15 5.51 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 95.8 t -119.69 118.14 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -1.233 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.2 ttp180 -88.24 115.0 25.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.555 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -83.38 152.3 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.751 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.531 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.3 mtm105 -137.5 175.42 3.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -0.819 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 34.9 Cg_endo -77.44 159.13 32.67 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.5 2.134 . . . . 0.0 110.019 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.568 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 8.2 t-105 83.77 -60.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.41 54.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -132.88 154.11 50.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -1.185 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.811 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.4 m-85 -142.43 179.17 7.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.56 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.45 113.94 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.061 -1.024 . . . . 0.0 110.017 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.31 121.74 31.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.377 -0.827 . . . . 0.0 108.974 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -146.17 151.34 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.148 -0.97 . . . . 0.0 109.313 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 161' ' ' ILE . 7.9 tt -129.83 124.3 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 124.28 22.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.43 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.19 96.92 50.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.72 -22.67 10.26 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.611 2.207 . . . . 0.0 110.223 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.29 -3.85 19.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.349 -0.844 . . . . 0.0 109.703 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 1.0 OUTLIER -122.38 27.59 7.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.8 t-20 75.19 58.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.095 -1.003 . . . . 0.0 109.626 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.9 39.69 6.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -84.44 93.32 8.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -1.209 . . . . 0.0 109.285 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -50.01 142.47 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.4 t -116.3 86.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 109.194 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.7 t-105 -75.62 96.12 3.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.3 mp -54.45 -42.88 71.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.62 152.42 5.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.6 p -68.35 164.44 20.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.443 -1.033 . . . . 0.0 109.44 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.887 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.4 m-85 -138.41 -169.88 2.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.515 ' HG2' ' OD2' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -96.93 -30.87 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p -136.59 -179.62 5.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.85 -1.157 . . . . 0.0 110.247 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.811 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.49 -32.38 58.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 8.0 tt0 -66.23 -70.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -38.79 -59.97 0.89 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.623 . . . . 0.0 110.166 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -55.6 -38.44 69.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.872 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.08 -34.63 78.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.136 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -38.42 80.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.915 -1.115 . . . . 0.0 109.44 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.551 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.06 -32.39 73.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.84 . . . . 0.0 108.911 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.0 t80 -67.17 -33.85 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 109.523 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.47 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 29.4 m-20 -64.25 -44.91 90.33 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -62.66 -32.88 74.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.79 . . . . 0.0 110.408 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.774 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -83.47 -24.65 31.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.101 -1.0 . . . . 0.0 109.853 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.65 -12.64 53.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.8 t80 -99.56 -40.47 7.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.016 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.14 -39.9 96.01 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.9 tpp -74.92 -55.32 5.91 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.558 0.694 . . . . 0.0 109.569 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.7 mtt180 -88.95 -55.74 3.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 0.0 109.685 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 57.28 170.15 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER 56.25 81.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.522 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.42 100.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.896 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -133.56 176.7 8.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 200' ' ' LEU . 8.1 mp -95.85 109.3 21.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.726 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -130.49 143.17 50.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.117 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.417 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -51.89 -32.11 31.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 m-85 -124.13 89.53 51.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.726 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.0 Cg_endo -75.93 99.21 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.462 2.108 . . . . 0.0 110.435 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mp 47.86 -167.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.283 -0.886 . . . . 0.0 109.208 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 -75.64 0.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.333 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 206' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.343 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 145' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 0.6 OUTLIER 63.97 113.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 1.013 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 36.8 m-85 -104.81 152.43 22.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 89.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.66 -28.19 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 50.6 t -85.86 118.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -1.177 . . . . 0.0 109.61 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -101.53 116.81 33.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 108.994 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.512 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.4 pt20 -81.58 157.25 24.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.931 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.3 mtt-85 -122.46 160.36 48.61 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -76.84 -8.54 17.97 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.514 2.143 . . . . 0.0 110.162 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.89 -27.14 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.3 34.46 0.95 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 11.8 mtpp -132.06 176.97 7.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -1.157 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.3 m-85 -145.45 177.24 8.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.29 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -149.13 108.35 3.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.866 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.55 107.21 13.16 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -129.6 151.98 49.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.304 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.442 HG12 ' N ' ' A' ' 162' ' ' ARG . 3.0 tt -141.61 149.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.442 ' N ' HG12 ' A' ' 161' ' ' ILE . 5.6 ttp85 -86.51 144.76 27.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -137.6 99.35 9.52 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.11 -25.63 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.015 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.83 -13.38 32.98 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -104.83 43.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.74 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 23.0 m120 59.38 59.28 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.13 79.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.08 148.91 42.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.384 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.5 mtt-85 -86.15 167.04 15.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.53 100.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.102 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.482 ' C ' ' CD1' ' A' ' 172' ' ' TRP . 3.0 t-105 -85.95 106.3 17.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.4 mt -64.56 -49.61 70.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 153.75 158.13 8.45 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -78.03 155.59 30.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -1.145 . . . . 0.0 109.076 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 66.6 m-85 -130.5 173.8 10.5 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.42 -31.77 42.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.935 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -141.03 172.55 12.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.48 -22.54 61.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.474 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -72.76 -38.55 67.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.3 -44.92 50.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.72 -44.76 95.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.394 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.013 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.43 -43.29 88.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.089 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.36 -51.66 68.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.865 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.95 -23.15 66.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.4 t80 -72.96 -31.88 64.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 109.503 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.678 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.8 m-20 -70.93 -50.28 36.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -37.45 47.66 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.676 -0.64 . . . . 0.0 109.985 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.1 -23.49 23.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.83 7.69 45.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.802 ' CD2' HD11 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -118.83 -37.61 3.22 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -81.5 -38.87 25.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -79.07 -32.86 44.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.718 -0.614 . . . . 0.0 109.727 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -91.74 -17.88 24.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.219 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 41.98 -156.94 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.0 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.173 . . . . 0.0 109.545 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.4 mtm180 -56.05 -58.3 8.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.606 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 60.29 177.81 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.169 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 200' ' ' LEU . 11.0 mt -140.89 122.5 15.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.541 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -123.32 154.37 38.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 109.377 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.529 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -56.06 -33.68 65.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.39 80.27 37.44 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.76 96.32 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -148.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 3.0 mtp180 -100.98 -179.64 4.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 5.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.351 0.596 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 146' ' ' TYR . 27.9 p-80 -99.83 168.67 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.561 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.921 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 -89.09 161.57 16.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 83.68 7.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.27 -3.52 5.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 179' ' ' ALA . 41.9 t -107.62 114.71 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.775 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -94.89 115.93 28.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.852 . . . . 0.0 109.219 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.509 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -88.39 155.04 19.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.23 162.28 22.87 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 -7.59 16.59 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.526 2.151 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -99.21 -64.53 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.47 50.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -146.05 156.43 43.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -1.176 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.4 m-85 -130.24 179.99 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.711 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.63 111.8 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.546 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.85 125.75 33.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.676 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -147.81 158.63 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.7 tt -143.54 134.61 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.98 131.18 41.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -111.33 106.32 57.12 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.06 -31.4 4.95 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.279 1.986 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.4 -16.67 64.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.339 -0.85 . . . . 0.0 108.948 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -107.42 53.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.477 -0.764 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.23 21.68 2.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.11 62.41 3.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.87 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -1.182 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.69 155.85 14.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.887 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.7 t -140.98 83.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.711 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.9 t-105 -71.49 98.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 108.98 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.942 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.32 -51.42 68.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 157.28 157.85 8.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.565 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -72.81 153.12 41.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -1.129 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 72.0 m-85 -129.01 -172.63 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.511 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.32 -28.84 13.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.56 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.7 p -140.91 166.06 25.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -68.03 -21.22 65.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -75.32 -44.25 46.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 109.756 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.435 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -69.81 -38.69 76.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -69.16 -43.27 74.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.921 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.16 -35.43 80.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 108.97 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.766 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -63.5 -48.4 77.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.026 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.13 -25.45 67.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.469 -0.77 . . . . 0.0 109.064 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.9 t80 -68.91 -34.3 75.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.665 ' HB3' HD13 ' A' ' 200' ' ' LEU . 40.1 m-20 -64.05 -48.01 77.93 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.379 -0.825 . . . . 0.0 108.917 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -52.16 -44.58 64.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.711 -0.618 . . . . 0.0 110.295 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.942 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.42 -27.64 59.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -88.2 6.82 34.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.471 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.0 t80 -115.61 -26.4 7.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 108.938 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -83.32 -37.5 23.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mtp -80.9 -39.27 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.636 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 73.1 mtt180 -94.0 -34.24 13.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 48.92 -168.72 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.9 m 57.96 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.361 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 52.1 ttt180 -124.87 -54.92 1.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.083 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . 61.85 154.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.751 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 108.44 19.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.64 -174.34 2.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.58 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.556 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -80.72 -37.79 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.766 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.1 m-85 -116.4 80.58 10.11 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.288 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 35.4 Cg_endo -77.23 -168.89 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.688 2.259 . . . . 0.0 110.086 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.2 mt -118.44 -176.79 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 24.53 7.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.399 179.932 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.193 0.521 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 65.29 116.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 109.286 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 40.4 m-85 -114.0 152.53 30.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.5 88.31 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.96 -29.85 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.1 t -86.15 113.25 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.698 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -93.34 105.86 17.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 108.583 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.632 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 13.7 pt20 -103.47 133.85 47.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 110.097 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.571 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -88.23 -179.26 1.26 Allowed Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.3 Cg_endo -75.22 77.98 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.826 1.684 . . . . 0.0 109.825 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER 70.47 75.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.775 . . . . 0.0 109.272 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.61 -86.35 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -137.87 178.35 7.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.147 -1.208 . . . . 0.0 110.252 -178.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.634 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 9.5 m-85 -135.93 174.53 10.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.584 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.12 104.73 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.61 ' HB2' ' CA ' ' A' ' 182' ' ' ALA . . . -79.93 102.6 9.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.195 -0.941 . . . . 0.0 109.201 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 5.8 tm-20 -125.79 154.27 42.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.792 . . . . 0.0 109.197 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.865 HD13 ' HE2' ' A' ' 193' ' ' MET . 2.1 tt -132.71 149.24 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.963 . . . . 0.0 109.694 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.2 ttm180 -103.46 108.33 19.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.314 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -100.23 118.36 61.48 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.96 -26.46 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.284 1.989 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -14.4 22.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.255 -0.903 . . . . 0.0 109.378 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -102.1 39.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.354 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.67 33.41 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.82 53.66 9.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -108.72 121.97 46.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.53 159.21 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.605 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.1 t -138.25 87.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.264 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.1 t-105 -69.71 114.55 8.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 109.394 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 20.2 mt -75.39 -53.9 7.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.85 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.69 156.46 8.75 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -73.67 152.93 40.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.15 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.792 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.3 m-85 -131.05 173.99 10.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.74 -30.68 32.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.634 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -138.2 -172.77 3.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.593 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -88.42 -22.24 23.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.955 . . . . 0.0 108.833 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -72.21 -37.43 69.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.011 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -74.2 -46.72 40.19 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.416 -0.802 . . . . 0.0 108.948 179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -21.23 62.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.68 -39.11 37.68 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 184' ' ' LEU . 3.1 tm? -68.24 -45.33 73.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.24 -26.73 68.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -67.84 -33.51 74.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.492 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.3 m-20 -68.19 -42.36 80.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 188' ' ' ARG . 17.4 tpp180 -61.59 -40.41 94.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.995 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.65 -23.96 42.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 109.701 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.92 -3.5 57.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.581 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 187' ' ' ASP . 1.7 t80 -105.53 -27.84 11.15 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.204 -0.935 . . . . 0.0 108.763 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -81.59 -40.97 22.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.865 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.77 -33.55 60.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -0.777 . . . . 0.0 109.304 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 8.0 mmm180 -92.63 -16.41 25.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.827 . . . . 0.0 108.929 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . 42.29 -108.72 0.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 197' ' ' ARG . 56.1 p -50.53 111.81 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -1.136 . . . . 0.0 110.097 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.2 OUTLIER 56.35 160.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 0.0 110.344 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . 177.32 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.2 mt -95.54 116.21 28.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.64 -176.69 4.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.411 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.479 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -80.36 -35.5 35.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 2.3 m-85 -120.03 79.25 25.45 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -77.14 93.89 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.614 2.209 . . . . 0.0 110.713 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.31 173.59 7.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 109.299 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 mtm-85 -90.03 154.34 19.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 206' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 16.2 m80 62.14 -174.56 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.556 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 -96.65 143.83 27.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.873 . . . . 0.0 109.685 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.58 74.91 7.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.381 -0.825 . . . . 0.0 108.898 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 155.3 -16.41 0.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 1.003 HG11 ' HA ' ' A' ' 179' ' ' ALA . 9.2 t -105.26 111.11 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.979 -1.306 . . . . 0.0 109.785 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.94 131.68 54.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.612 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . 2.8 pm0 -122.8 131.76 53.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.991 . . . . 0.0 110.473 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.585 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -71.86 -172.87 0.23 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.13 90.57 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.645 1.563 . . . . 0.0 109.977 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.8 m95 64.49 50.14 2.27 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.02 -123.61 2.04 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.459 -1.353 . . . . 0.0 111.09 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -106.68 151.78 24.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.972 . . . . 0.0 110.434 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE1' ' HB2' ' A' ' 151' ' ' GLN . 2.9 m-30 -100.2 -171.7 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.626 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.79 121.28 2.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.611 -1.306 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -100.11 121.24 41.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 2.0 mt-10 -136.19 158.47 44.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.809 . . . . 0.0 109.672 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.508 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.6 tt -141.54 123.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 170' ' ' ARG . 1.0 OUTLIER -63.57 139.2 58.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.417 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 43.7 t0 -128.2 97.8 28.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.284 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.52 -28.18 7.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.307 2.005 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.2 -14.06 52.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -108.8 42.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.736 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.47 30.02 9.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.074 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.47 66.94 1.56 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -116.33 85.92 2.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -1.147 . . . . 0.0 109.338 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.3 ptt85 -42.2 144.95 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.406 -0.808 . . . . 0.0 109.481 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 161' ' ' ILE . 45.7 t -120.19 88.58 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.145 -0.972 . . . . 0.0 109.811 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.626 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.0 t-105 -73.66 93.75 2.11 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.137 -0.977 . . . . 0.0 109.025 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -51.43 -47.38 63.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.763 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.51 165.11 12.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -77.54 148.02 35.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.933 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 48.3 m-85 -123.44 -166.4 1.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.35 -0.844 . . . . 0.0 109.397 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -105.01 -26.75 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . 1.9 p -144.61 -172.27 3.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 109.548 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.003 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -87.11 -22.63 25.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.03 -36.61 56.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.59 -52.2 11.12 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.217 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.933 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.43 -34.73 77.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.164 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.64 -44.16 74.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.732 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -58.65 -38.21 77.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.397 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.73 -28.24 63.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.006 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -70.67 -30.16 66.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 96.7 m-20 -71.84 -41.9 67.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.411 -0.806 . . . . 0.0 109.942 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.7 -34.12 73.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 110.082 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.994 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.65 -29.08 36.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.764 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.02 -24.93 35.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.377 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -81.33 -26.84 35.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -45.56 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.43 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -71.71 -35.22 70.14 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.585 -0.697 . . . . 0.0 109.965 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.716 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 3.3 mpt_? -94.66 -7.89 39.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.24 -87.25 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 197' ' ' ARG . 4.4 t -85.25 -146.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.702 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' A' ' 196' ' ' SER . 28.1 mtm180 -38.46 140.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.598 -0.689 . . . . 0.0 110.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.716 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . -157.14 32.69 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 199' ' ' LEU . 7.2 mt 41.68 92.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.66 -0.65 . . . . 0.0 109.651 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -120.51 143.66 48.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.2 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -45.89 -33.96 3.56 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.526 ' HD2' HD22 ' A' ' 184' ' ' LEU . 1.4 m-85 -134.04 88.01 32.92 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.2 Cg_endo -76.57 75.69 4.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.572 2.181 . . . . 0.0 110.545 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 203' ' ' PRO . 10.9 mp 48.0 -175.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 22.0 3.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.384 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.498 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.363 0.602 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -143.3 111.56 6.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.927 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 15.5 m-85 -82.79 134.71 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 0.0 109.492 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 98.46 3.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.192 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.0 -31.94 3.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 157' ' ' PHE . 41.0 t -79.55 136.53 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -1.1 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -108.4 89.91 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 109.228 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 14.0 pt20 -59.42 131.21 50.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.978 . . . . 0.0 109.462 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -110.66 159.5 32.1 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.75 -1.68 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.708 2.272 . . . . 0.0 110.543 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.423 ' HB3' ' HE3' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -98.73 -25.71 14.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.05 39.87 0.62 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 157' ' ' PHE . 21.6 mttt -130.05 179.96 5.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 86.5 m-85 -159.12 109.0 1.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 108.679 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -85.8 127.12 34.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.09 -1.006 . . . . 0.0 111.263 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -99.9 116.92 33.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.45 166.16 25.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.041 -1.037 . . . . 0.0 110.316 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 8.8 tt -152.18 158.63 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.451 -0.78 . . . . 0.0 108.952 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.54 139.7 48.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.95 -1.094 . . . . 0.0 109.858 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -138.11 93.63 11.62 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.36 -22.99 10.51 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.587 2.191 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.89 -13.99 19.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -107.38 51.03 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 167' ' ' ASN . 28.7 t-20 57.03 38.32 29.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.341 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.94 97.91 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.6 100.89 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.127 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -51.99 166.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.441 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 67.2 t -147.83 90.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.612 ' HZ2' HG22 ' A' ' 175' ' ' THR . 3.1 t-105 -87.06 101.83 13.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.099 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.2 mt -56.12 -50.79 70.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.42 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 148.63 148.68 4.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.612 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.1 p -68.32 158.41 33.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.08 -1.247 . . . . 0.0 108.967 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 85.5 m-85 -131.86 -176.89 4.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.622 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -27.69 14.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.553 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.7 p -133.03 170.41 15.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.515 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -22.61 47.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.377 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -73.09 -33.11 65.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.428 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.0 OUTLIER -80.54 -34.95 35.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.235 -0.915 . . . . 0.0 109.173 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -76.48 -27.83 56.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.927 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.14 -40.56 45.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.203 -0.936 . . . . 0.0 108.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 202' ' ' PHE . 6.9 tp -63.89 -41.75 97.64 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.513 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.58 -37.76 85.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -62.73 -40.44 97.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.45 -0.781 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.4 m-20 -60.7 -52.2 66.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.498 -0.751 . . . . 0.0 109.833 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -54.16 -31.19 51.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.099 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -84.4 -26.95 27.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.25 2.99 54.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.542 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.5 t80 -117.16 -31.24 5.4 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -74.92 -38.49 61.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 ttm -81.53 -46.26 14.74 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.418 0.627 . . . . 0.0 109.735 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.7 mtt85 -93.94 -41.89 9.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.039 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 48.12 -149.79 3.39 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m 50.26 -107.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -1.188 . . . . 0.0 109.601 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.01 56.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.222 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -66.18 169.65 6.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.332 -0.855 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -113.67 116.44 29.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.098 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -125.25 179.28 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.555 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.574 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -70.33 -38.25 74.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 200' ' ' LEU . 7.8 m-85 -112.16 96.11 33.26 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -75.67 148.62 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.578 2.185 . . . . 0.0 110.708 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.33 106.43 14.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.5 -27.24 11.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.95 . . . . 0.0 109.529 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.499 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 128.58 48.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.8 m-85 -67.23 143.27 56.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -77.79 96.98 5.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.637 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.66 -16.72 7.39 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 183' ' ' ALA . 27.3 t -97.48 117.61 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.811 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 3.4 mmp_? -96.53 117.89 31.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.588 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -85.38 160.07 19.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 0.0 110.016 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.528 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 16.4 mtt180 -126.7 158.26 68.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.681 -0.637 . . . . 0.0 109.337 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.2 3.49 7.05 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.577 2.185 . . . . 0.0 110.298 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -9.9 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.485 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.01 33.24 4.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.2 mtmt -127.81 173.09 10.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.127 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.6 m-85 -144.33 -178.29 5.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.366 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.621 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.69 104.1 2.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 109.94 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.59 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.04 123.22 27.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.235 -0.916 . . . . 0.0 108.974 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 1.1 mt-10 -139.12 164.51 29.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.266 -0.896 . . . . 0.0 109.267 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 171' ' ' VAL . 6.2 tt -146.02 141.84 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -86.8 108.72 18.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 166' ' ' LYS . 11.8 t70 -99.68 113.14 64.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.36 -27.31 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -9.14 56.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 4.4 mmpt? -117.87 39.35 3.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 1.2 m-20 68.74 29.38 5.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.41 27.1 68.89 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.81 116.53 8.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -1.209 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -59.04 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HG23 ' A' ' 161' ' ' ILE . 37.8 t -68.31 104.99 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.621 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.4 t-105 -80.51 99.01 7.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 19.7 mt -56.63 -37.67 71.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.027 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.555 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 136.3 158.27 8.04 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -78.52 148.87 33.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -1.13 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.4 m-85 -120.25 -168.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.695 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.938 ' HG3' HG23 ' A' ' 178' ' ' THR . 9.9 pt-20 -99.23 -32.59 11.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.938 HG23 ' HG3' ' A' ' 177' ' ' GLU . 2.1 p -133.85 170.1 16.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.127 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.32 -23.65 50.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.96 . . . . 0.0 109.556 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -73.13 -36.61 66.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.491 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.3 OUTLIER -75.32 -45.38 39.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -61.76 -47.2 86.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.32 -42.39 86.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.103 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 184' ' ' LEU . 21.3 tp -60.79 -39.83 90.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.564 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.19 -24.34 66.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -0.813 . . . . 0.0 109.046 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -72.35 -29.95 64.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.714 ' HB3' HD13 ' A' ' 200' ' ' LEU . 2.0 m-20 -72.18 -50.32 28.58 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -60.91 -28.7 69.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.48 -19.57 23.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.927 . . . . 0.0 109.274 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.72 -8.14 41.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -105.79 -33.67 7.92 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -80.15 -39.77 28.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -30.57 64.12 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.673 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 12.8 mtt180 -96.2 -0.95 49.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.36 -87.17 1.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 197' ' ' ARG . 3.0 m -135.8 164.4 27.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -1.188 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.82 109.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -163.31 150.1 12.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.957 . . . . 0.0 109.492 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mp -92.37 118.23 30.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.51 174.74 8.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 109.413 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.616 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -70.42 -34.59 72.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 108.613 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.8 m-85 -121.34 84.58 41.34 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.06 117.65 4.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.48 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 205' ' ' ARG . 0.3 OUTLIER 51.64 -173.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.5 ' CB ' ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER 75.99 -169.73 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.471 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.458 -179.973 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.373 0.606 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -129.96 -173.33 3.01 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.424 -0.798 . . . . 0.0 109.415 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.76 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 46.0 m-85 -122.62 152.46 40.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -82.03 36.18 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.154 -0.966 . . . . 0.0 109.753 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.04 26.59 0.09 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 57.6 t -143.6 113.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -1.154 . . . . 0.0 109.424 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.05 94.79 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.32 134.29 56.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.494 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 7.5 mmt180 -99.17 161.25 25.37 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.668 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.494 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.32 -34.81 1.41 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.678 2.252 . . . . 0.0 110.263 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -47.69 83.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.08 43.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 2.6 mttm -131.94 -168.65 2.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 63.3 m-85 -159.47 108.29 1.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.096 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.618 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -82.38 139.34 34.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -111.11 113.58 26.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -134.79 164.75 26.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 0.0 109.899 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -141.52 143.3 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 108.914 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 1.2 tmm_? -82.62 119.71 24.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.825 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.407 ' CG ' ' SD ' ' A' ' 193' ' ' MET . 41.5 t0 -111.06 97.74 35.99 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.072 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 34.7 Cg_endo -76.39 -26.39 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.475 2.117 . . . . 0.0 110.673 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.81 -22.76 67.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 109.578 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -100.4 64.33 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.587 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 48.16 44.22 19.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.602 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 50.92 59.64 7.87 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -107.18 136.71 46.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -1.165 . . . . 0.0 109.44 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 163.24 28.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' A' ' 161' ' ' ILE . 55.7 t -134.87 99.7 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 158' ' ' ALA . 16.0 t-105 -84.09 91.67 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.982 . . . . 0.0 109.599 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 57.6 mt -51.38 -48.45 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.246 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 152.39 158.52 8.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.615 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.8 p -73.61 162.71 28.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -1.175 . . . . 0.0 109.477 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -138.83 179.57 6.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -28.46 19.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 p -142.72 168.51 19.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -72.09 -24.6 61.52 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.83 -39.79 76.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -74.63 -45.69 43.18 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.14 -31.15 72.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.69 -47.83 44.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.255 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.433 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -58.39 -35.68 72.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 108.834 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.43 -28.98 65.47 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.278 -0.888 . . . . 0.0 108.696 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -65.88 -28.03 68.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.723 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.9 m-20 -71.62 -47.88 51.67 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.303 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -34.74 68.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -84.2 -39.11 19.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.929 -1.107 . . . . 0.0 109.981 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -69.22 -18.91 63.95 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.572 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.6 t80 -85.55 -40.6 16.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.139 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -40.28 86.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.759 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.407 ' SD ' ' CG ' ' A' ' 163' ' ' ASP . 28.9 ttm -77.86 -43.16 31.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.666 -0.646 . . . . 0.0 109.591 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 70.4 mtt180 -102.25 34.2 2.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.955 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -41.12 164.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 84.53 -47.71 0.1 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.834 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -171.73 128.81 0.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.208 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 194' ' ' ARG . . . -159.66 148.77 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -89.77 122.62 33.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -121.83 157.26 31.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.164 -0.96 . . . . 0.0 109.303 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -53.93 -35.59 61.86 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.2 m-85 -124.16 83.53 56.18 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.1 123.64 6.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.515 2.143 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mp 51.78 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 10.8 mtp85 -69.45 173.35 6.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 2.4 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.361 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -53.56 177.44 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.371 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.958 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.5 m-85 -45.66 133.35 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.494 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -72.11 96.75 1.81 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.54 -8.33 7.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' A' ' 182' ' ' ALA . 38.5 t -105.01 112.32 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -1.172 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -96.19 117.61 31.11 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.596 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.38 153.76 24.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.84 . . . . 0.0 109.433 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -116.58 155.94 48.18 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.25 -10.52 16.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.661 2.241 . . . . 0.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -36.59 17.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.136 -0.977 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 156' ' ' LYS . . . 133.61 61.81 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 155' ' ' GLY . 19.4 mttp -166.83 -171.64 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 109.514 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.015 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -148.88 -175.12 4.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 109.102 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.705 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.31 108.53 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 0.0 110.017 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.8 134.17 36.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.154 -0.966 . . . . 0.0 108.984 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.24 148.96 29.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.095 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.435 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 3.8 tt -141.79 127.71 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.023 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -69.46 143.63 53.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 109.204 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 168' ' ' GLY . 43.5 t0 -110.52 97.65 33.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.573 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.6 Cg_endo -76.57 -26.9 8.04 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.355 2.037 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.51 68.33 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 3.0 mmmm -101.55 25.31 8.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 67.46 66.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 69.32 -106.64 1.85 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 51.33 80.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.255 . . . . 0.0 109.578 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.9 153.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 171' ' ' VAL . 11.7 t -128.07 81.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.705 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.5 t-105 -61.4 97.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 109.168 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -52.68 -49.14 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 176' ' ' PHE . . . 149.43 154.26 6.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -68.54 153.86 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -1.196 . . . . 0.0 109.214 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 56.7 m-85 -129.4 172.91 11.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.754 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -77.02 -30.11 55.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 109.854 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.519 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.5 p -145.65 -174.07 4.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.015 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -81.81 -28.62 33.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.673 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -70.61 -34.46 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 109.624 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -73.32 -44.42 58.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.133 -0.979 . . . . 0.0 109.452 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.96 -30.2 68.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.958 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.98 -41.49 67.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.301 -0.875 . . . . 0.0 109.105 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.75 94.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.302 -0.873 . . . . 0.0 109.16 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.18 -22.9 66.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -0.809 . . . . 0.0 108.935 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.3 t80 -69.79 -33.9 73.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 109.081 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.489 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 18.9 m-20 -67.68 -43.85 79.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.429 -0.795 . . . . 0.0 109.472 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -58.9 -40.53 84.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.773 . . . . 0.0 109.84 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.89 -20.75 38.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.89 -8.9 48.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.3 t80 -101.96 -33.95 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.284 -0.885 . . . . 0.0 108.924 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -76.4 -40.95 49.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 108.782 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.01 -31.61 64.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.576 -0.702 . . . . 0.0 109.484 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.7 mtt85 -105.81 1.82 27.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 49.3 -99.07 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER -48.2 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 109.737 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -42.77 160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.778 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -157.72 37.0 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 109.273 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.472 ' C ' HD23 ' A' ' 200' ' ' LEU . 7.8 mp 39.89 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.718 -0.614 . . . . 0.0 109.869 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -111.91 173.93 6.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.972 . . . . 0.0 109.401 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.419 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -72.0 -34.54 68.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.7 m-85 -122.67 80.42 48.16 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 -169.45 0.72 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.58 2.186 . . . . 0.0 110.65 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 60.32 1.66 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.17 132.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.391 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 pttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -141.33 115.69 9.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.593 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.914 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 -104.28 149.42 25.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 99.9 4.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.2 -25.21 7.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 183' ' ' ALA . 52.0 t -86.79 126.14 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -1.191 . . . . 0.0 110.046 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -104.4 110.98 23.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.558 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 pm0 -75.88 144.63 41.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 156.62 53.32 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.158 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.03 3.51 6.96 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.552 2.168 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -96.19 -13.84 23.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.79 26.41 6.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.493 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -133.76 -173.78 3.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -1.155 . . . . 0.0 109.527 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 65.7 m-85 -149.0 -177.59 5.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.351 -0.843 . . . . 0.0 109.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.754 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.77 108.24 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.842 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.706 ' C ' HD12 ' A' ' 173' ' ' LEU . . . -79.94 108.82 13.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 108.993 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER -126.47 155.16 42.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -0.947 . . . . 0.0 109.966 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 171' ' ' VAL . 7.5 tt -141.55 117.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.387 -0.82 . . . . 0.0 109.015 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -89.99 126.05 35.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -111.11 103.9 55.48 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 0.0 109.395 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.98 -25.12 9.19 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.307 2.005 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.92 -18.71 64.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 39.16 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.93 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.2 m120 55.53 46.05 23.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.42 121.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.61 128.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -1.137 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -95.26 148.62 22.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 161' ' ' ILE . 41.6 t -133.48 89.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.754 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.5 t-105 -75.36 102.9 5.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.063 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 159' ' ' ALA . 3.6 mt -57.67 -57.8 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.665 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 161.88 157.01 8.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.47 153.21 41.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -1.128 . . . . 0.0 109.227 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.759 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.8 m-85 -127.06 178.11 6.21 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.913 . . . . 0.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.51 -30.86 24.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -138.64 176.81 8.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.273 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.86 -23.09 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.439 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -74.45 -35.05 63.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.14 -37.83 53.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.57 -32.85 66.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.226 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.914 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.84 -37.28 59.15 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -66.34 -39.58 89.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.086 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.88 -23.34 62.28 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -73.14 -29.81 63.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.505 -0.747 . . . . 0.0 109.0 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.653 ' HB3' HD13 ' A' ' 200' ' ' LEU . 39.5 m-20 -69.74 -50.15 46.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.266 -0.897 . . . . 0.0 109.55 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -60.09 -35.84 76.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 109.946 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -80.96 -24.67 37.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.159 -0.963 . . . . 0.0 109.521 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.8 -1.85 57.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -106.51 -27.89 10.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.606 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -40.32 23.72 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -74.24 -33.77 63.44 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.588 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 5.5 mtt180 -86.74 -13.02 46.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 53.97 -92.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 195' ' ' GLY . 9.3 p -54.17 -167.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.3 mtm105 -42.77 156.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.454 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.588 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -156.31 155.23 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -100.39 118.25 36.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -129.17 179.94 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.469 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -76.53 -31.45 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.14 75.26 30.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo -77.34 -169.14 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.661 2.24 . . . . 0.0 110.638 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -149.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 109.482 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 52.57 60.04 4.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.196 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.8 160.54 31.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.485 -0.759 . . . . 0.0 109.38 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.986 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.7 m-85 -107.41 128.28 54.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.604 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.458 ' CG ' ' O ' ' A' ' 147' ' ' ARG . 1.7 ptt180 -67.83 125.06 25.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.126 -0.984 . . . . 0.0 108.718 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.04 20.9 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -88.94 106.44 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.772 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -80.16 108.45 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.613 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -72.0 160.17 32.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 110.51 -178.798 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HG2' ' CA ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.58 169.15 18.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.851 -0.531 . . . . 0.0 112.334 -178.046 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 152' ' ' ARG . 37.3 Cg_endo -85.17 -16.24 5.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.567 2.178 . . . . 0.0 106.986 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -145.64 -67.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.647 ' CA ' ' HG2' ' A' ' 152' ' ' ARG . . . -147.68 113.22 0.63 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 147.79 148.31 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 117.856 0.828 . . . . 0.0 110.1 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.103 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 51.4 m-85 -139.84 170.44 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.449 -1.407 . . . . 0.0 108.645 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -141.99 113.36 7.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -81.96 118.46 22.98 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 1.5 tt0 -141.18 158.36 44.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 109.864 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.5 tt -151.85 125.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -88.71 118.94 28.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -99.33 117.38 64.06 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.62 -26.42 7.08 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.355 2.037 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -14.98 62.64 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -103.21 32.62 3.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.679 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.43 54.98 1.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 45.83 65.98 1.8 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.98 98.31 6.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 160' ' ' GLU . 7.5 mtt180 -48.69 166.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 171' ' ' VAL . 7.2 t -143.96 86.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.161 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.727 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.3 t-105 -70.77 96.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.25 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.01 -42.74 76.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 176' ' ' PHE . . . 146.06 152.06 5.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.727 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.4 p -66.68 179.36 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.223 -1.163 . . . . 0.0 109.464 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 70.4 m-85 -155.56 -173.93 4.75 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 0.0 109.141 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' C ' ' CG2' ' A' ' 178' ' ' THR . 32.9 tt0 -97.37 -17.94 19.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.617 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 7.3 p -152.32 169.45 22.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.786 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.103 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.33 -22.79 61.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -73.09 -41.95 63.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -34.79 67.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.431 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -74.66 -31.27 61.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.266 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.986 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.8 -40.17 66.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.47 -48.46 81.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.67 ' O ' HD22 ' A' ' 173' ' ' LEU . . . -63.28 -28.56 70.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.552 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.0 t80 -68.34 -28.1 66.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.514 ' CB ' HD13 ' A' ' 200' ' ' LEU . 5.0 m-20 -72.64 -37.02 68.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -64.67 -36.21 83.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 110.196 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.25 -41.86 24.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.826 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.659 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -71.96 -5.95 38.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.734 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.1 t80 -104.81 -44.03 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.048 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -40.11 94.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.0 mtm -80.44 -43.3 21.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.569 -0.707 . . . . 0.0 109.54 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 196' ' ' SER . 14.1 mtt180 -102.78 33.19 3.31 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.449 -0.782 . . . . 0.0 109.415 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -41.98 94.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 194' ' ' ARG . 12.2 p 170.28 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.268 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 35.5 11.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.19 145.55 46.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -82.35 135.65 35.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.716 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -138.59 -174.56 3.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.853 . . . . 0.0 109.127 -179.982 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.506 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -68.94 -36.39 77.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.3 m-85 -119.15 76.32 15.85 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.3 Cg_endo -75.57 162.96 34.91 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.631 2.221 . . . . 0.0 110.801 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.42 79.72 9.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -137.85 17.69 2.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.442 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 39.5 mttm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 144' ' ' LYS . 3.2 m170 -167.74 157.64 10.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.816 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.9 m-85 -78.48 124.25 27.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.15 84.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.9 -32.62 1.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 183' ' ' ALA . 48.3 t -77.21 144.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 8.7 ttm-85 -123.83 97.34 5.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.063 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.552 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 5.4 pt20 -87.57 135.62 33.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.329 -0.857 . . . . 0.0 109.345 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -89.36 -173.99 0.43 Allowed Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -74.37 81.05 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.411 1.408 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.2 m0 63.17 74.85 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.63 -0.669 . . . . 0.0 109.309 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 152' ' ' ARG . . . -170.5 -99.99 0.13 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.156 -1.497 . . . . 0.0 111.003 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.41 -178.23 3.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -1.134 . . . . 0.0 110.755 -178.334 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.696 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 8.3 m-85 -132.47 179.76 5.93 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.55 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.28 112.61 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.881 -1.137 . . . . 0.0 110.446 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.38 119.29 28.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 6.6 mt-10 -137.91 170.42 16.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.872 -179.204 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.456 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.3 tt -159.22 156.38 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.456 ' N ' HG12 ' A' ' 161' ' ' ILE . 42.0 ttp180 -96.38 129.67 43.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.738 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.432 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 10.6 t0 -113.31 106.17 54.74 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.236 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.83 -23.59 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.413 2.075 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.23 -19.61 62.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.282 -0.886 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -100.84 46.97 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.74 38.9 21.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 58.88 53.79 43.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.15 138.5 39.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -1.144 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -67.39 163.24 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 171' ' ' VAL . 40.5 t -139.06 94.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.605 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -82.69 94.13 7.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 109.028 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.88 HD21 ' HB2' ' A' ' 189' ' ' ALA . 13.6 mt -51.25 -41.73 60.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 109.134 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 142.58 152.76 5.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.605 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -67.28 152.61 45.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -1.107 . . . . 0.0 109.444 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -127.06 179.11 5.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.167 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 -25.43 28.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.819 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.7 p -147.5 -174.15 4.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.51 -23.99 29.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.781 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -34.29 65.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 109.615 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.64 -43.92 36.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.03 -47.1 81.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 109.17 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.816 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.53 -38.39 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.38 -52.31 65.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 108.915 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -62.65 -18.55 62.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.5 t80 -75.65 -34.6 60.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.878 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 26.7 m-20 -61.67 -47.64 84.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.567 -0.708 . . . . 0.0 109.597 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.37 85.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -73.25 -17.01 61.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.535 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -87.41 -19.65 27.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.238 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.532 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 5.5 t80 -93.59 -31.49 14.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -38.91 67.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.432 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -74.12 -52.13 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -86.41 -50.23 7.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.463 -0.773 . . . . 0.0 109.241 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 50.79 176.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 197' ' ' ARG . 33.9 t 58.81 71.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.634 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER 50.12 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.967 . . . . 0.0 109.535 179.839 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -125.39 163.36 22.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 pp -92.83 127.54 38.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -133.23 152.74 51.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.29 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.574 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -48.89 -38.99 24.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.145 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.0 m-85 -120.85 89.47 45.56 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 204' ' ' LEU . 35.3 Cg_endo -77.02 83.37 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' PRO . 0.3 OUTLIER 41.83 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.697 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 59.36 -148.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.457 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 206' ' ' VAL . 16.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.387 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.347 0.594 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -78.38 171.1 15.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.8 m-85 -143.18 159.55 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -76.86 85.28 3.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.865 . . . . 0.0 109.352 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.56 -23.27 3.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 94.7 t -88.13 137.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.398 -1.06 . . . . 0.0 109.301 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 14.6 tpp180 -124.82 103.64 8.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.84 . . . . 0.0 109.244 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 60.1 tt0 -61.89 169.27 2.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -128.57 163.36 45.33 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.341 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 35.1 Cg_endo -76.63 76.08 4.16 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.577 2.185 . . . . 0.0 110.319 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER 168.86 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.535 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 156' ' ' LYS . . . 159.86 41.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.6 mmtt -137.49 179.8 6.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.513 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.09 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.1 m-85 -149.83 -179.99 7.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.74 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.32 113.25 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.637 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.79 119.08 25.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 108.936 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -140.5 152.24 45.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 3.5 tt -137.26 132.33 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 99.2 12.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.64 116.13 65.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.619 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.98 -23.6 9.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.39 2.06 . . . . 0.0 110.295 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.24 -22.33 62.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.453 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -96.98 44.79 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.576 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.11 20.53 5.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.3 43.21 7.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.79 109.86 21.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -54.9 150.13 10.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.064 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.9 t -131.19 86.63 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.74 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.1 t-105 -74.15 99.7 3.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.1 mt -53.54 -54.48 36.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.458 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 156.13 153.09 6.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -66.72 152.85 44.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -1.069 . . . . 0.0 109.357 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.705 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 63.9 m-85 -126.53 -173.1 2.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.885 . . . . 0.0 109.541 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.51 -28.75 15.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.7 p -140.75 171.91 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 109.423 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.09 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -75.97 -25.04 55.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -74.05 -35.94 64.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -75.13 -40.15 59.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 108.994 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.98 -31.02 67.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.316 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.964 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.89 -38.08 64.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.338 -0.851 . . . . 0.0 108.817 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 187' ' ' ASP . 43.8 tp -64.14 -45.2 89.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.448 -0.783 . . . . 0.0 109.102 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.55 -27.85 68.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 108.888 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -66.86 -30.79 71.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.212 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.498 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.7 m-20 -67.89 -55.0 14.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.296 -0.877 . . . . 0.0 109.423 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -31.59 37.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.531 -0.73 . . . . 0.0 109.919 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.58 -29.47 30.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.834 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -86.75 -1.32 57.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -103.33 -31.14 10.2 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 108.89 179.613 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -77.75 -40.59 40.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.327 -0.858 . . . . 0.0 108.961 179.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.6 mtp -81.16 -32.07 33.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.606 -0.684 . . . . 0.0 110.378 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -91.18 -1.62 57.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 83.13 -150.05 27.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.57 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 p -63.01 -97.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 109.833 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 11.6 mtm180 -48.99 153.14 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.814 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 178.8 160.91 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.1 mp -98.38 111.53 23.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.59 172.1 9.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 108.987 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.451 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -72.55 -33.28 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.237 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 6.8 m-85 -121.46 75.36 33.49 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -76.47 103.74 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.611 2.207 . . . . 0.0 110.417 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 100.83 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -158.97 44.38 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 206' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.458 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.1 pttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -48.56 173.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.234 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 -79.86 148.89 31.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -78.23 83.02 4.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.202 -0.936 . . . . 0.0 109.284 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 144.21 -23.36 2.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.884 HG11 ' HA ' ' A' ' 179' ' ' ALA . 6.1 t -102.12 122.93 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.259 . . . . 0.0 109.735 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 9.3 mtt180 -122.03 171.61 8.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 151' ' ' GLN . 9.4 pm0 -138.2 143.54 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 109.597 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.7 mtt85 -104.41 169.59 7.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.726 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.4 Cg_endo -78.18 8.02 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.764 2.31 . . . . 0.0 110.93 -179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -35.28 7.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.456 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 128.31 45.77 0.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 21.7 mttt -149.59 134.86 18.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.165 . . . . 0.0 109.618 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD2' ' C ' ' A' ' 178' ' ' THR . 5.4 m-30 -98.38 -168.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 108.671 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.727 ' HB1' ' OE2' ' A' ' 160' ' ' GLU . . . -162.91 126.31 2.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -106.57 113.78 27.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.727 ' OE2' ' HB1' ' A' ' 158' ' ' ALA . 2.7 mp0 -131.04 174.77 9.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.436 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.3 tt -168.6 140.62 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -0.797 . . . . 0.0 109.148 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -73.67 152.76 40.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.0 109.66 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.446 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 58.1 t0 -123.08 95.49 45.91 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.93 -27.86 6.64 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.527 2.151 . . . . 0.0 110.056 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.49 -28.44 69.83 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.446 -0.784 . . . . 0.0 109.099 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.446 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -95.25 27.37 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 0.0 109.534 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.88 72.54 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.65 106.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 163' ' ' ASP . . . -169.07 102.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.9 148.36 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 171' ' ' VAL . 32.0 t -133.03 94.92 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 160' ' ' GLU . 3.4 t-105 -82.77 100.33 10.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.609 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.5 mt -55.51 -55.37 32.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.15 161.08 10.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -74.59 153.18 39.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.218 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.761 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 54.2 m-85 -127.11 -167.59 1.76 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.68 -28.45 11.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.002 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.4 p -147.0 -179.81 7.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.884 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -76.94 -33.41 57.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.79 -37.9 88.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.064 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -70.66 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.483 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -46.36 -27.59 1.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.256 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.37 -45.65 62.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.44 -39.05 93.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.684 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.36 -28.2 64.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.8 t80 -71.33 -30.84 66.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.447 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.0 m-20 -67.85 -45.21 75.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.964 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -37.8 83.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.687 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.609 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.83 -20.35 35.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.52 -0.6 56.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -109.78 -31.38 7.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.145 -0.972 . . . . 0.0 108.599 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.54 -40.39 21.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.2 ttm -75.26 -31.59 60.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.753 -0.592 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.3 mtt180 -95.5 -17.45 21.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' SER . . . 47.68 -106.28 0.16 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 197' ' ' ARG . 83.8 p -40.34 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -1.046 . . . . 0.0 110.165 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.6 OUTLIER 46.17 -173.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.833 . . . . 0.0 109.649 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 170.73 152.59 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.8 mt -101.75 108.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.526 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -123.17 -175.64 3.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -78.59 -37.86 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 108.875 179.7 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.615 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 4.5 m-85 -115.6 82.26 9.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.491 -0.756 . . . . 0.0 109.173 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -77.28 123.44 6.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.753 2.302 . . . . 0.0 110.563 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 206' ' ' VAL . 2.3 mp -89.24 -58.21 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 54.52 -91.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.438 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' LEU . 5.8 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 tttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -159.22 -172.95 3.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.961 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.2 m-85 -128.81 152.34 48.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.81 131.19 45.08 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.287 -0.883 . . . . 0.0 108.963 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.63 -35.93 3.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.9 t -81.19 113.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.272 . . . . 0.0 109.996 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -95.88 114.44 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 19.8 pt20 -97.43 128.74 44.47 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.866 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mtp180 -75.62 169.59 19.85 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 29.4 Cg_endo -69.85 83.79 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.18 1.253 . . . . 0.0 109.605 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 61.6 m95 63.27 63.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -155.06 -106.45 0.26 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.589 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.55 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 5.4 mttp -111.19 -169.67 1.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.335 -1.097 . . . . 0.0 110.514 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.933 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.4 m-85 -143.59 173.56 11.54 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.45 109.06 3.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.851 -1.156 . . . . 0.0 110.305 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.87 124.96 29.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.166 -0.959 . . . . 0.0 108.882 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 136.45 31.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.952 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 161' ' ' ILE . 2.7 tt -128.78 120.53 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.17 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.29 144.74 29.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 0.0 109.585 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.437 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 32.1 t0 -124.34 116.52 26.92 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.925 . . . . 0.0 109.317 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 36.2 Cg_endo -77.04 -31.03 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.528 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -25.42 67.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -89.03 44.76 1.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.18 53.7 10.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.36 94.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -147.86 111.16 4.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 144.48 54.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.303 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 53.3 t -122.93 94.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.669 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.6 t-105 -72.75 98.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' CB ' ' A' ' 189' ' ' ALA . 1.1 mt -57.91 -45.48 86.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.797 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 149.8 162.96 10.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -79.51 158.14 27.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.23 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 75.1 m-85 -133.84 175.39 9.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.0 tp10 -82.37 -30.7 30.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.683 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -143.31 167.6 21.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.933 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.77 -22.47 65.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -38.68 69.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.92 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -75.47 -37.12 60.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.91 -34.74 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.188 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.961 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.43 -39.65 67.71 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -63.63 -42.86 98.12 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.574 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.467 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.41 -32.79 73.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.556 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.6 t80 -62.98 -30.49 71.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.148 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 16.0 m-20 -69.7 -41.79 74.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.378 -0.826 . . . . 0.0 109.657 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -63.72 -40.19 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 110.594 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.994 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.08 -25.95 34.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.987 -1.071 . . . . 0.0 109.94 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.29 -18.19 39.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.439 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.7 t80 -85.39 -36.24 20.84 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.083 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -66.64 -42.18 87.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.437 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 7.2 tpp -80.52 -41.78 23.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.792 . . . . 0.0 109.445 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 18.6 mtt180 -100.71 33.37 2.79 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 108.959 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -39.52 161.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 76.94 85.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 108.983 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.565 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 71.83 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 108.999 -179.492 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 67.02 162.47 0.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 110.061 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.492 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.7 mt -116.52 113.25 22.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.0 159.78 27.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.464 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -59.03 -32.87 70.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.427 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.35 88.75 29.27 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 204' ' ' LEU . 35.0 Cg_endo -76.73 -176.61 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.698 2.266 . . . . 0.0 110.637 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 203' ' ' PRO . 39.8 mt -43.77 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -127.1 110.95 13.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.545 179.991 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.1 pttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -65.25 109.19 2.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.5 m-85 -83.27 148.78 27.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.247 -0.908 . . . . 0.0 109.563 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -79.53 85.84 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.945 . . . . 0.0 109.935 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.35 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.415 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 179' ' ' ALA . 96.8 t -109.18 116.95 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.38 . . . . 0.0 110.325 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -83.82 146.02 28.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.481 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.2 pt20 -142.01 132.58 25.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.557 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -84.1 178.7 2.25 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.5 Cg_endo -77.09 79.27 3.18 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.179 1.92 . . . . 0.0 109.549 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 23.7 t-105 72.6 60.83 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -153.31 -108.8 0.36 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.704 -179.396 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.544 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 14.6 mmtt -113.24 -171.7 1.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -1.137 . . . . 0.0 110.694 -178.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.896 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.5 m-85 -141.81 -170.9 3.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -161.22 110.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.951 -1.093 . . . . 0.0 110.446 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -83.68 107.16 15.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.523 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 27.9 mt-10 -132.32 152.11 51.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.13 -0.981 . . . . 0.0 109.739 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.41 133.06 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.214 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.62 139.61 33.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 28.7 t0 -123.87 107.24 31.14 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.169 -0.957 . . . . 0.0 109.291 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.63 -28.28 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.268 1.978 . . . . 0.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -25.91 67.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.429 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 10.4 mmtt -90.86 43.45 1.15 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.88 27.17 15.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.54 58.43 3.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.24 95.35 6.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -1.129 . . . . 0.0 109.545 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.06 162.12 1.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.84 95.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.04 -1.038 . . . . 0.0 110.153 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.523 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 2.8 t-105 -79.99 106.54 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.213 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 29.0 mt -64.16 -47.01 81.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 109.715 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.62 157.09 7.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -76.49 156.65 32.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 -179.8 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.604 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.6 m-85 -133.01 177.36 7.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 3.2 pt-20 -82.55 -31.63 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.162 -0.961 . . . . 0.0 109.786 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 p -141.26 175.36 9.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 109.777 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.896 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.1 -22.53 59.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.656 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.55 -49.13 51.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 1.4 m-20 -64.2 -50.39 68.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -56.19 -52.4 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -52.39 -42.12 63.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.57 -41.78 90.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.77 -22.29 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.8 . . . . 0.0 109.185 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 21.2 t80 -71.51 -36.59 71.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.87 ' HB3' HD13 ' A' ' 200' ' ' LEU . 6.3 m-20 -65.52 -50.85 63.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.11 -34.74 58.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.49 -0.756 . . . . 0.0 110.101 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.79 -19.85 26.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.054 -1.028 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 194' ' ' ARG . . . -92.14 -5.43 52.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.431 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.6 t80 -102.76 -34.13 9.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.221 -0.924 . . . . 0.0 108.611 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -79.34 -40.69 29.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.2 ttp -83.12 -30.05 28.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.609 -0.682 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -99.77 -9.23 23.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 -179.727 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 42.19 -163.63 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.6 OUTLIER 48.39 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -1.14 . . . . 0.0 109.562 179.874 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 198' ' ' ALA . 0.7 OUTLIER -57.28 -47.02 82.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 197' ' ' ARG . . . 59.39 149.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.438 -0.789 . . . . 0.0 109.722 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 17.3 mt -97.75 124.04 41.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.87 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.62 169.23 14.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.93 . . . . 0.0 109.387 -179.906 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.592 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -63.29 -36.07 82.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.039 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 2.8 m-85 -127.18 81.66 69.56 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 204' ' ' LEU . 34.6 Cg_endo -76.6 162.13 33.32 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.635 2.223 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 205' ' ' ARG . 0.3 OUTLIER 71.27 167.5 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.353 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 204' ' ' LEU . 1.5 mmt-85 -54.11 -169.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.337 179.928 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 145' ' ' HIS . 21.0 p-80 -100.59 124.72 46.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.248 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.5 m-85 -106.4 141.13 38.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.28 110.62 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.73 -20.7 14.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.8 t -92.59 110.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -1.12 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 112.39 24.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 108.954 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -75.63 153.74 37.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 110.02 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.1 mtp180 -132.52 174.87 4.2 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.3 Cg_endo -77.66 167.53 23.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.11 1.873 . . . . 0.0 110.069 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 74.92 -80.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.191 -179.47 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 156' ' ' LYS . . . 174.99 67.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 mmtt -146.35 164.05 33.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.051 -1.264 . . . . 0.0 110.069 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.813 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.7 m-85 -148.31 179.61 7.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.526 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.51 107.78 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.028 -1.045 . . . . 0.0 109.991 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.85 117.13 21.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.032 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' OE2' ' HD2' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -141.76 140.45 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.53 -179.771 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.533 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.2 tt -125.38 159.42 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.533 ' N ' HG12 ' A' ' 161' ' ' ILE . 8.7 ttt180 -97.78 115.05 27.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 193' ' ' MET . 19.1 t0 -99.25 110.12 57.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.1 Cg_endo -77.63 -27.72 5.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.3 2.0 . . . . 0.0 110.168 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.71 -21.68 64.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.348 -0.845 . . . . 0.0 109.555 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 2.7 mttt -90.66 23.15 3.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.448 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 76.51 40.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.626 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.42 86.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.35 177.82 8.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -1.081 . . . . 0.0 109.417 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.455 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 0.9 OUTLIER -100.99 163.87 12.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.678 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.8 t -140.39 85.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.0 109.045 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.526 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.9 t-105 -73.2 97.12 2.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.395 -0.816 . . . . 0.0 109.883 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.1 mt -59.6 -41.06 89.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.88 . . . . 0.0 109.257 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.428 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 147.52 166.6 12.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -83.72 153.68 24.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -1.194 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.774 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -126.72 -177.5 4.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.659 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 -30.97 16.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 1.7 p -138.72 167.45 21.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.813 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.25 -41.21 67.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.293 -0.879 . . . . 0.0 109.79 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.7 OUTLIER -71.22 -40.74 70.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.56 -30.34 67.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.3 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.923 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.15 -34.04 61.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.143 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -66.72 -42.09 86.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 109.044 179.635 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.03 -22.72 64.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.2 t80 -77.32 -32.2 55.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.238 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 97.6 m-20 -67.55 -41.44 84.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -70.05 -35.91 74.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.867 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.894 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.51 -24.22 50.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.656 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.95 -26.74 27.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 195' ' ' GLY . 5.7 t80 -83.11 -23.55 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -43.74 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.43 ' HE1' ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -75.01 -32.36 61.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.02 -179.658 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 4.9 mtt-85 -96.69 -13.28 22.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.283 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 191' ' ' PHE . . . 74.86 -125.2 8.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 191' ' ' PHE . 0.8 OUTLIER -71.68 172.37 9.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -1.094 . . . . 0.0 109.97 -179.559 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 54.04 -117.64 1.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.408 -0.807 . . . . 0.0 109.608 179.743 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.35 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.692 -1.255 . . . . 0.0 109.317 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 199' ' ' LEU . 5.8 mt -85.04 130.13 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.705 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.527 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.66 166.16 18.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.806 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.46 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -63.0 -31.91 73.16 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.327 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.453 ' HD2' HD22 ' A' ' 184' ' ' LEU . 7.2 m-85 -120.06 77.17 23.64 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.58 ' O ' HD12 ' A' ' 204' ' ' LEU . 36.0 Cg_endo -78.24 86.06 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.699 2.266 . . . . 0.0 110.562 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 203' ' ' PRO . 2.0 mp -132.23 11.71 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.273 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -122.91 117.89 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.47 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.4 mtpt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 144' ' ' LYS . 30.9 m170 61.07 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.902 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 20.4 m-85 -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.242 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -82.35 92.46 6.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 186' ' ' TYR . . . 123.39 -5.58 9.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -108.96 120.72 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -1.159 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -97.07 118.65 33.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.699 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.493 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -89.36 149.45 23.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.606 -179.805 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mmt180 -120.51 158.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.52 8.81 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.616 2.21 . . . . 0.0 110.876 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.29 -13.33 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 105.4 49.21 0.99 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 8.8 mtmm -150.07 -174.74 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -1.165 . . . . 0.0 109.54 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 76.8 m-85 -153.99 178.35 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.271 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.723 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.12 111.15 4.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.683 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.91 118.43 24.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.345 -0.847 . . . . 0.0 108.96 179.46 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 19.2 mt-10 -137.42 179.55 6.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 109.28 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.2 tt -169.63 130.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -63.36 153.05 36.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.857 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.93 103.71 3.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.45 -25.33 9.79 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.42 2.08 . . . . 0.0 110.321 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.6 66.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 109.168 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 44.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 0.0 109.473 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t30 51.08 57.16 6.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.417 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 51.24 79.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -141.31 131.15 24.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -1.203 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -73.28 143.53 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.1 t -111.77 105.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.723 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.7 t-105 -89.69 95.57 10.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -53.58 -42.87 68.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 146.64 158.17 7.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.488 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.2 p -74.36 159.36 32.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -1.045 . . . . 0.0 109.516 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.9 m-85 -133.45 174.91 9.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.43 -30.42 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.6 p -137.54 -176.98 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.907 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.52 -30.15 25.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -68.05 -32.21 72.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.958 . . . . 0.0 109.584 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.415 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -75.67 -48.59 21.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.306 -0.871 . . . . 0.0 109.025 179.862 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -66.61 -21.69 66.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 108.912 179.547 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.59 -45.77 24.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' LEU . 17.9 tp -62.56 -40.75 97.86 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.17 -24.71 63.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 108.919 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 160' ' ' GLU . 14.6 t80 -70.77 -32.17 69.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -69.04 -45.61 69.97 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -58.29 -35.22 71.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.509 -0.744 . . . . 0.0 110.176 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.016 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.83 -33.63 34.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.541 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -86.95 -2.41 58.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.202 -0.937 . . . . 0.0 109.217 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.485 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 25.4 t80 -103.25 -24.47 13.54 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.295 -0.878 . . . . 0.0 109.113 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -84.48 -40.9 17.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 108.785 179.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -31.33 57.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.621 -0.674 . . . . 0.0 109.868 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 43.8 mtt180 -100.86 -18.82 16.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 47.57 -176.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.41 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.311 -1.111 . . . . 0.0 109.732 179.952 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.3 140.04 48.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.61 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.491 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -144.83 163.58 33.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.506 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -82.45 105.61 13.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.682 -179.773 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.86 164.97 17.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 108.998 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.494 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.3 OUTLIER -66.4 -33.0 74.73 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.128 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.4 m-85 -124.54 76.06 63.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.97 142.58 22.25 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.683 2.255 . . . . 0.0 110.558 -179.471 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 204' ' ' LEU . 0.8 OUTLIER 65.0 65.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 109.561 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.65 ' C ' HG23 ' A' ' 206' ' ' VAL . 22.9 mmt180 -118.38 100.9 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 205' ' ' ARG . 1.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.408 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 145' ' ' HIS . 23.9 mttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.433 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER 70.88 113.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.944 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 -78.32 136.99 37.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.438 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.4 92.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.15 -32.06 3.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.5 t -77.8 133.64 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -1.216 . . . . 0.0 109.801 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.5 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -121.41 107.01 11.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.324 179.898 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.597 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.3 pt20 -75.09 164.61 26.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.471 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.9 mtt-85 -127.81 172.11 7.33 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.678 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.02 -30.22 3.72 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.822 2.348 . . . . 0.0 110.704 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -35.36 60.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.657 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.46 34.93 0.43 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -127.23 159.42 34.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -1.165 . . . . 0.0 109.264 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.888 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.5 m-85 -125.19 -179.12 4.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.41 108.29 3.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.31 114.8 19.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.718 179.185 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -131.18 157.88 42.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.567 -179.727 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 161' ' ' ILE . 1.6 tt -149.8 128.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.551 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.15 8.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 164' ' ' PRO . 48.3 t0 -92.8 117.22 67.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 109.557 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 35.6 Cg_endo -78.19 -26.24 6.5 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.286 1.991 . . . . 0.0 109.899 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.73 -14.63 62.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 6.2 mmtp -101.26 30.16 4.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 41.3 t-20 67.51 28.4 7.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.53 62.5 2.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.8 129.26 55.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -1.128 . . . . 0.0 109.469 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.42 122.52 16.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.504 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 171' ' ' VAL . 21.6 t -101.73 94.69 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.627 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.8 t-105 -69.65 100.73 1.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -59.77 -48.99 79.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.656 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 153.67 152.56 6.09 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.627 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.1 p -69.51 163.71 24.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -1.206 . . . . 0.0 109.131 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 60.7 m-85 -140.0 -177.84 5.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -86.85 -30.01 21.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.626 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -146.71 171.41 15.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.589 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.888 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.82 -22.51 63.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.05 -40.54 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.1 m-20 -71.52 -41.84 68.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.691 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -69.27 -30.38 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.944 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.42 -40.7 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -38.85 89.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.497 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.32 -24.15 63.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.6 t80 -73.93 -29.07 61.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 200' ' ' LEU . 43.4 m-20 -70.26 -49.04 53.89 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.218 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -60.97 -38.49 86.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 109.874 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.44 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -80.5 -21.83 41.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.646 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.92 -14.31 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.76 -27.14 14.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 109.101 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -82.56 -40.36 21.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 2.7 tpp -70.9 -30.56 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.666 -0.647 . . . . 0.0 109.357 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 196' ' ' SER . 2.7 mtt180 -101.13 -12.82 18.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.33 -0.856 . . . . 0.0 109.242 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 52.61 -88.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 194' ' ' ARG . 0.3 OUTLIER -46.3 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -1.093 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' SER . 13.4 mtt180 -40.44 157.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -164.25 156.25 16.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 109.307 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.7 mm? -92.13 127.85 37.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.96 162.67 29.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.141 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.442 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -58.23 -34.69 70.7 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.117 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.5 m-85 -116.58 80.95 10.86 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 33.8 Cg_endo -76.13 111.1 3.2 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.561 2.174 . . . . 0.0 110.311 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.441 ' HA ' HD22 ' A' ' 204' ' ' LEU . 0.8 OUTLIER 62.79 151.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.008 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.46 ' HG3' HG23 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -153.05 -172.86 4.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 -179.907 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.46 HG23 ' HG3' ' A' ' 205' ' ' ARG . 1.3 t . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.3 mttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -178.46 167.41 1.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.858 . . . . 0.0 109.6 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 9.2 m-85 -114.15 148.09 37.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.61 87.76 3.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 108.824 179.105 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.97 2.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 179' ' ' ALA . 45.8 t -137.87 108.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.288 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.81 127.62 33.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.426 -0.796 . . . . 0.0 109.009 179.713 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.1 pp0? -104.48 146.64 28.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.944 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.5 164.03 15.89 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.61 37.0 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.836 2.358 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -146.05 -62.28 0.32 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.02 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.99 36.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.63 168.92 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -1.202 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.857 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.3 m-85 -148.36 177.23 9.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.374 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.647 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.15 111.84 4.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.29 110.4 17.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -131.33 149.52 52.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.281 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 17.4 tt -128.21 146.68 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.094 -1.004 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -87.38 130.59 34.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 109.55 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -119.96 94.39 48.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 35.9 Cg_endo -78.26 -22.78 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.578 2.186 . . . . 0.0 110.44 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.46 75.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' LYS . 8.4 mmtt -86.25 63.03 7.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.847 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 168' ' ' GLY . 1.8 m-80 52.67 48.55 22.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 43.41 52.63 6.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.751 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.52 130.08 35.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 109.319 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 143.94 46.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 77.1 t -123.19 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.835 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.647 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.8 t-105 -117.01 97.33 5.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.3 mp -54.83 -50.51 68.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.266 -0.896 . . . . 0.0 109.149 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 155.31 153.56 6.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.52 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.4 p -65.36 166.93 9.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -1.046 . . . . 0.0 109.332 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.757 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 65.0 m-85 -144.02 174.51 10.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -25.3 30.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.731 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 2.3 p -149.56 171.06 17.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.56 -25.46 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.46 -42.1 75.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -70.28 -48.59 56.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.202 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.91 -22.82 66.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.922 . . . . 0.0 109.029 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.22 -36.89 46.55 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 108.873 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.859 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -68.05 -45.22 74.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.581 -0.699 . . . . 0.0 109.175 179.491 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.565 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.01 -23.69 65.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.459 -0.775 . . . . 0.0 109.012 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.2 t80 -71.52 -35.38 70.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -0.783 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.6 m-20 -65.64 -41.85 92.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.321 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -41.05 84.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.75 -19.65 37.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.527 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.33 -9.63 52.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -99.12 -31.22 11.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.821 . . . . 0.0 109.271 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -77.98 -42.78 31.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.896 . . . . 0.0 109.116 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 48.0 ttm -69.65 -31.53 69.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.315 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 22.2 mtt-85 -100.86 11.91 38.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 48.57 -154.54 1.76 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 29.6 m -53.45 143.27 19.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -1.119 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.5 mtp85 68.53 138.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 176.47 140.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 199' ' ' LEU . 2.2 mt -81.37 109.3 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -116.0 -178.09 3.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.408 179.755 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.49 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -81.38 -28.81 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.155 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.859 ' HD2' HD22 ' A' ' 184' ' ' LEU . 6.6 m-85 -122.68 70.15 36.33 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -76.29 110.37 3.05 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.467 2.112 . . . . 0.0 110.165 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 204' ' ' LEU . 0.2 OUTLIER -109.18 -73.94 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.985 -179.66 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.15 -165.67 2.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.02 -179.555 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.208 179.967 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.348 0.594 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -113.66 166.33 11.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.555 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.928 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.4 m-85 -130.66 141.72 50.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.878 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.36 89.67 3.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 108.848 179.364 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.48 11.0 3.47 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 182' ' ' ALA . 47.3 t -126.3 109.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.289 . . . . 0.0 109.359 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -93.0 111.34 22.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.443 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.5 pt20 -80.87 151.08 28.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 108.975 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.49 163.89 37.72 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.442 -179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.13 -5.56 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.615 2.21 . . . . 0.0 110.121 -179.88 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -98.23 27.89 4.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 109.273 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.53 60.99 7.98 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -156.44 170.52 22.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 73.4 m-85 -142.64 172.84 12.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.008 179.917 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.649 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.87 105.28 4.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 123.09 28.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.051 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.465 ' CD ' ' CE3' ' A' ' 172' ' ' TRP . 4.3 mt-10 -145.28 153.3 41.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 0.0 109.334 -179.543 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.486 HD11 ' HE ' ' A' ' 194' ' ' ARG . 6.5 tt -141.04 149.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -84.33 117.1 23.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 109.734 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.512 ' HB2' ' CE ' ' A' ' 193' ' ' MET . 67.8 t0 -114.58 102.12 54.66 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -25.53 9.78 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.326 2.017 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.47 -16.12 63.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.863 . . . . 0.0 109.217 179.67 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -93.38 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.7 54.13 9.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.421 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.95 71.26 0.67 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.23 118.55 12.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.494 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -54.21 170.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.4 t -139.84 90.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.656 -179.694 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.649 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.0 t-105 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 109.178 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -52.62 -43.96 65.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 -179.72 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.38 150.39 5.23 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.517 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -63.18 168.78 3.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -1.157 . . . . 0.0 109.327 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.655 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 63.9 m-85 -141.55 -174.14 3.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.515 -179.767 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.74 -24.97 14.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.698 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.598 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.6 p -140.82 174.49 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.68 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.29 -24.83 50.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.328 -0.857 . . . . 0.0 109.363 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -77.02 -30.27 55.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.631 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.598 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -76.08 -40.68 52.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 109.279 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.96 -36.48 69.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.195 -0.941 . . . . 0.0 109.028 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.928 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -69.58 -39.78 77.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.799 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.97 -46.32 88.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 109.004 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.76 -26.87 67.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.475 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 29.8 t80 -68.7 -36.28 78.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.132 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 7.0 m-20 -64.07 -52.15 60.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 109.838 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -56.88 -37.16 70.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.422 -0.799 . . . . 0.0 109.527 -179.76 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.921 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.38 -20.65 50.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.212 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.68 -11.88 43.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.464 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.3 t80 -101.88 -26.67 13.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.119 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -40.63 29.85 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.315 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.512 ' CE ' ' HB2' ' A' ' 163' ' ' ASP . 13.9 mtp -77.93 -44.49 26.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.242 0.544 . . . . 0.0 110.165 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HE ' HD11 ' A' ' 161' ' ' ILE . 24.0 mtt180 -83.51 -37.74 22.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 108.943 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 58.52 145.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ALA . 2.8 m 63.12 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -1.138 . . . . 0.0 109.987 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.3 mmt180 44.26 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.999 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 66.95 144.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.988 . . . . 0.0 109.328 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.12 117.27 34.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.913 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.1 156.06 35.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 179.944 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.416 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -62.82 -32.32 73.5 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.769 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.43 ' O ' HD12 ' A' ' 200' ' ' LEU . 5.8 m-85 -121.05 97.51 47.95 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.094 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.62 106.72 2.31 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.331 2.02 . . . . 0.0 110.6 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER -98.03 93.36 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.392 -179.874 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 58.17 100.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 179.91 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.432 -179.927 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -52.18 179.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.703 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.4 m-85 -80.19 142.54 34.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 -179.845 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.87 37.64 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.129 179.738 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . -169.95 26.77 0.11 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 179' ' ' ALA . 60.9 t -142.67 117.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -1.091 . . . . 0.0 109.681 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 93.08 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.162 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.47 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 9.9 pt20 -60.65 144.67 51.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.75 -179.748 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -103.88 171.7 4.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.308 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.2 Cg_endo -77.12 -31.81 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -82.6 -74.98 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.73 71.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 56.3 mttt -153.85 168.04 27.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.577 179.925 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.753 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.0 m-85 -150.68 120.67 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 108.737 179.694 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.608 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -93.76 118.87 31.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.748 -178.823 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.15 122.73 30.57 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.308 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 11.2 tt0 -137.69 150.6 47.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.02 . . . . 0.0 110.421 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.3 tt -136.23 137.33 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -86.57 127.46 34.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.834 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -125.05 105.55 28.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.413 -0.805 . . . . 0.0 108.984 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.91 -26.08 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.455 2.103 . . . . 0.0 110.58 -179.737 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.88 -12.0 57.83 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 51.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 56.24 25.05 8.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 -179.894 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.18 40.92 40.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -100.1 142.87 30.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -84.43 155.7 22.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 161' ' ' ILE . 40.5 t -124.3 100.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.608 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.4 t-105 -80.16 95.29 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.322 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.157 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -50.55 -49.46 55.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.039 -179.641 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.23 155.25 6.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.502 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -68.18 169.97 9.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -1.095 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.2 m-85 -148.2 -170.46 3.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -23.84 13.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.578 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.6 p -144.34 160.05 41.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.302 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.753 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.26 -24.7 66.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.065 -1.022 . . . . 0.0 109.216 179.83 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.66 -33.22 68.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -76.78 -47.88 20.32 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.021 179.78 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -66.46 -25.62 66.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.17 -0.956 . . . . 0.0 108.954 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.12 -49.94 21.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.112 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -34.09 74.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.438 -0.789 . . . . 0.0 109.032 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.74 -30.63 68.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.5 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -67.77 -27.89 67.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.712 . . . . 0.0 109.109 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 58.5 m-20 -71.19 -45.27 63.78 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.596 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -65.15 -29.03 69.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 110.368 -179.212 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.157 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.7 -32.65 21.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 110.026 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.99 -18.81 45.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.41 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.3 t80 -91.02 -38.73 12.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.326 -0.859 . . . . 0.0 109.353 179.911 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -41.85 97.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.09 -1.007 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 3.6 ttm -79.95 -43.1 22.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 109.271 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.46 ' O ' ' C ' ' A' ' 195' ' ' GLY . 21.4 mtt180 -101.96 32.96 3.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.515 -0.74 . . . . 0.0 109.162 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -37.94 -32.47 0.12 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -75.74 81.93 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -1.15 . . . . 0.0 109.263 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 61.19 139.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.358 -179.806 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -170.57 144.51 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.6 mm? -98.1 108.99 21.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.671 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -111.1 159.42 17.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.435 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -53.0 -37.81 61.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.094 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.9 m-85 -123.08 86.12 51.15 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.321 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.75 131.4 13.4 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.644 2.229 . . . . 0.0 110.722 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 204' ' ' LEU . 0.4 OUTLIER -60.91 123.94 19.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 0.0 109.436 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 58.23 104.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.461 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.439 179.968 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -110.71 96.45 6.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.939 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.8 m-85 -67.66 147.08 53.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -77.82 94.44 4.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.25 -3.4 11.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.592 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 49.0 t -108.69 112.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.27 . . . . 0.0 110.057 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.998 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -87.43 111.61 21.31 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.752 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.563 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 8.0 pt20 -90.06 138.62 31.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -178.442 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.631 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 14.0 mmm-85 -74.86 -166.76 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.713 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.1 Cg_endo -76.88 -15.23 16.83 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.313 1.342 . . . . 0.0 110.629 -179.256 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.54 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 158.79 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.496 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.58 -68.93 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.347 179.69 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mttt -116.7 -168.53 1.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.852 -1.381 . . . . 0.0 111.282 -178.16 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.149 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.9 m-85 -154.8 179.46 9.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.998 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . . . -149.2 110.33 4.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 109.993 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.506 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 134.86 35.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.71 134.68 14.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.8 tt -120.11 141.4 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -85.07 129.54 34.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -116.12 92.47 35.62 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.97 -22.35 11.56 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.676 2.251 . . . . 0.0 110.719 -179.726 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.12 69.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.407 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 35.4 mmtt -85.38 -55.78 3.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 109.473 179.907 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 169' ' ' ALA . 12.6 p30 169.14 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.97 4.5 67.5 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.824 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HB2' ' OD1' ' A' ' 167' ' ' ASN . . . -57.09 108.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.119 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 142.86 29.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.265 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.1 t -115.65 83.18 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.78 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 174' ' ' GLY . 3.5 t-105 -65.32 100.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 109.164 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.8 mt -61.61 -41.48 97.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.687 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 144.29 174.0 16.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.846 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -92.06 157.36 16.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.252 . . . . 0.0 109.148 179.753 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 78.7 m-85 -130.53 -176.51 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.815 -179.53 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -89.14 -20.12 24.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 4.0 p -147.97 175.41 11.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.95 . . . . 0.0 109.87 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.149 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.7 -22.21 47.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.45 -0.781 . . . . 0.0 109.45 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.6 tm-20 -76.83 -32.43 57.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.78 -36.12 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.927 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.27 -43.92 60.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 108.895 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.939 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -63.34 -37.15 86.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.361 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -64.98 -46.71 80.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.521 -0.737 . . . . 0.0 109.11 179.495 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.98 -18.8 64.64 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.5 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -74.14 -38.12 63.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.041 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.55 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.2 m-20 -62.16 -49.87 74.12 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.449 -0.782 . . . . 0.0 109.37 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -52.11 -44.84 64.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.618 -0.676 . . . . 0.0 109.925 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.855 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.32 -19.15 54.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 109.702 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -92.27 -4.55 53.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.883 . . . . 0.0 109.586 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.434 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.1 t80 -108.38 -29.8 8.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -85.04 -37.75 19.98 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.016 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.7 ttm -77.88 -35.61 50.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.737 -0.602 . . . . 0.0 109.562 179.704 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.646 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 4.5 mtp180 -94.26 -23.57 17.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.139 -0.976 . . . . 0.0 108.886 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 53.2 170.29 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.986 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 43.61 -159.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -1.211 . . . . 0.0 109.664 179.898 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.25 153.84 3.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.579 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.646 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -160.86 168.18 25.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.4 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.598 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -105.43 104.83 14.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.998 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.75 162.96 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.983 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.578 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -65.7 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.606 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 184' ' ' LEU . 7.2 m-85 -119.1 80.29 19.04 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 204' ' ' LEU . 34.7 Cg_endo -77.18 140.26 19.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.566 2.178 . . . . 0.0 110.285 -179.557 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 203' ' ' PRO . 0.3 OUTLIER 54.05 172.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.33 -179.93 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.431 ' CZ ' ' CB ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -89.1 112.04 22.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.313 179.89 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.587 -179.85 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.598 ' CG ' ' O ' ' A' ' 145' ' ' HIS . 0.0 OUTLIER -152.7 71.48 0.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.84 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.687 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 65.9 m-85 -51.06 168.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.388 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -81.01 36.07 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.616 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.431 ' HA3' ' CD2' ' A' ' 186' ' ' TYR . . . -176.8 27.3 0.07 OUTLIER Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.664 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 179' ' ' ALA . 78.6 t -150.67 139.8 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -1.204 . . . . 0.0 109.648 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -110.55 160.1 16.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 108.991 179.489 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.0 pt20 -131.37 146.15 52.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.043 -1.036 . . . . 0.0 110.115 -179.48 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.478 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.8 OUTLIER -121.63 160.55 45.93 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.759 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -77.78 -4.43 14.5 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 110.776 -179.848 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -98.08 -7.35 29.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.504 179.898 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.28 47.46 1.85 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 9.2 mtpp -146.74 140.72 26.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.161 . . . . 0.0 109.513 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.703 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 7.0 m-85 -119.98 -170.28 1.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.917 . . . . 0.0 109.376 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.62 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -156.43 110.51 2.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 179.892 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -81.11 119.78 24.0 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.44 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 12.3 mt-10 -136.94 153.89 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.827 . . . . 0.0 109.603 -179.67 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 190' ' ' ALA . 5.8 tt -141.61 138.91 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 108.979 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.47 131.39 35.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.756 -179.664 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -124.73 90.81 50.41 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.51 -23.33 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.549 2.166 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.46 -9.89 29.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 15.0 mmtp -104.37 23.7 12.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.891 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 26.8 t-20 64.34 45.14 3.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.06 110.74 0.12 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 170' ' ' ARG . . . -177.11 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -1.179 . . . . 0.0 109.466 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -43.2 163.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 161' ' ' ILE . 92.7 t -135.15 91.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.955 . . . . 0.0 109.864 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.789 ' HZ2' HG22 ' A' ' 175' ' ' THR . 10.8 t-105 -75.31 92.38 2.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 108.882 179.464 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.027 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -52.31 -46.11 65.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.224 -179.741 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.25 156.37 7.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.678 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.789 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.6 p -73.21 153.27 40.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -1.082 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.2 m-85 -128.99 -170.97 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 -32.38 14.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.277 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.562 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -141.41 173.89 11.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.226 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.703 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.27 -24.58 61.37 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -70.63 -37.7 73.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.867 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.97 -43.81 51.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.072 -1.018 . . . . 0.0 109.205 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -24.81 63.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 108.997 179.717 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.687 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.59 -44.9 40.72 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.409 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.874 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -61.68 -43.52 98.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.573 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.83 -32.23 73.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 108.827 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -64.46 -29.62 70.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.325 -0.859 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.61 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.1 m-20 -72.92 -43.56 62.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.382 -0.824 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.03 -23.94 67.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.772 . . . . 0.0 110.127 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.027 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -92.72 -31.9 14.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.011 -1.056 . . . . 0.0 109.761 -179.708 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.601 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -83.93 -10.83 57.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.235 -0.915 . . . . 0.0 109.099 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -100.38 -41.15 7.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 179.542 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -41.24 94.34 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.32 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 ttp -75.73 -42.75 49.81 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 109.177 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 37.4 mtt180 -104.0 33.95 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.48 -0.763 . . . . 0.0 109.095 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -38.29 109.3 0.09 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 1.4 t 162.87 -71.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -1.071 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 62.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.785 . . . . 0.0 109.214 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.27 160.92 21.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.859 . . . . 0.0 109.627 -179.783 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -91.88 124.18 35.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 108.988 179.437 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.97 177.03 5.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.482 -179.59 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.577 ' ND2' ' HB3' ' A' ' 146' ' ' TYR . 0.4 OUTLIER -63.92 -34.88 78.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.327 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.874 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.1 m-85 -122.66 79.66 48.03 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.32 67.03 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.817 2.344 . . . . 0.0 110.742 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.59 155.6 45.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.749 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -171.95 132.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.689 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.479 179.898 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.313 0.578 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -150.54 105.42 3.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 -95.07 141.81 28.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 179.998 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' ARG . 3.2 ptt180 -75.13 127.85 34.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.181 179.623 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.28 -21.02 47.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 182' ' ' ALA . 89.3 t -94.3 108.02 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -79.21 147.71 32.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.058 -1.026 . . . . 0.0 108.769 179.339 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.6 pp0? -120.07 140.36 51.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.897 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.441 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mpp_? -115.87 171.43 4.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -78.04 -35.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.63 2.22 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.63 -21.81 66.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.522 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.24 17.62 8.16 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -102.37 174.33 5.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -1.154 . . . . 0.0 109.449 179.905 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.983 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 55.4 m-85 -147.55 -172.86 4.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.006 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.709 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.05 110.34 2.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.75 121.83 25.84 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.204 -0.935 . . . . 0.0 108.915 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -142.92 151.49 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 -179.552 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 5.4 tt -137.33 128.35 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.854 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 5.2 ptt180 -73.48 117.95 15.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -98.73 109.26 52.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 109.602 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.43 -25.13 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.353 2.036 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.16 -17.54 60.9 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.356 -0.84 . . . . 0.0 109.343 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -94.75 26.93 3.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 63.56 48.2 3.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.503 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.87 69.2 1.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -127.78 103.97 7.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -1.135 . . . . 0.0 109.389 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 149.13 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.55 HG11 ' HE1' ' A' ' 193' ' ' MET . 29.9 t -127.55 93.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.095 179.735 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.709 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -73.8 97.43 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.817 -179.614 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.0 OUTLIER -58.38 -38.13 76.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.48 157.04 7.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.81 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.597 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.9 p -73.73 155.63 38.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -1.047 . . . . 0.0 109.784 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.692 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.8 m-85 -131.24 173.95 10.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.5 OUTLIER -85.58 -18.16 34.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 0.0 109.7 -179.854 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.424 ' CG2' ' C ' ' A' ' 177' ' ' GLU . 3.7 p -151.53 173.31 14.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.953 . . . . 0.0 109.592 -179.758 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.95 -24.98 58.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.54 -34.68 65.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.46 -34.11 54.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.377 -0.827 . . . . 0.0 109.269 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.692 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -78.73 -26.98 44.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -0.908 . . . . 0.0 109.319 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.7 -37.58 55.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.134 -0.979 . . . . 0.0 108.688 179.382 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.917 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -62.65 -44.12 97.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.191 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.35 -33.95 77.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.457 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 11.7 t80 -62.73 -35.11 78.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.14 179.624 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.41 -53.26 59.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.503 -0.748 . . . . 0.0 109.901 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -26.78 66.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -88.57 -16.91 31.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.448 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.617 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -93.48 -11.73 31.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -99.84 -33.85 10.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 108.865 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -79.54 -42.29 25.43 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.55 ' HE1' HG11 ' A' ' 171' ' ' VAL . 3.5 tpp -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.644 -0.66 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 194' ' ' ARG . 4.6 mmp_? -102.17 12.59 36.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.03 -156.31 11.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 5.4 p -65.41 154.72 37.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 196' ' ' SER . 10.8 mtt180 62.86 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -161.65 173.66 14.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.3 mt -117.46 125.91 51.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.603 -179.8 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.45 -179.76 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.815 -179.63 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.568 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -75.88 -34.6 59.99 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.128 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.917 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.3 m-85 -123.84 83.61 54.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.86 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.82 143.31 23.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.511 2.141 . . . . 0.0 110.508 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.893 HD23 HG12 ' A' ' 206' ' ' VAL . 0.4 OUTLIER -150.47 -161.33 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.426 179.963 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' CG ' ' N ' ' A' ' 206' ' ' VAL . 0.3 OUTLIER -140.55 -41.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.734 -179.919 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.893 HG12 HD23 ' A' ' 204' ' ' LEU . 9.6 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -164.41 123.7 1.91 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 -99.57 144.71 28.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 -179.885 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -79.15 76.39 5.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.228 179.647 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.98 -21.33 0.44 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.906 HG11 ' HA ' ' A' ' 179' ' ' ALA . 16.8 t -101.11 109.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.283 . . . . 0.0 109.455 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.77 174.7 5.77 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.608 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.609 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -142.53 133.35 25.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 110.282 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.0 ttm-85 -68.67 -174.95 0.23 Allowed Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.918 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 29.3 Cg_endo -70.75 82.78 0.92 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.17 1.246 . . . . 0.0 110.021 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 7.2 m95 63.7 65.41 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.524 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.62 -132.49 1.35 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.537 -1.315 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -79.23 159.17 27.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.549 -0.971 . . . . 0.0 110.47 -178.756 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 151' ' ' GLN . 8.5 m-30 -101.71 -163.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.586 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -158.35 112.3 2.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.896 -1.127 . . . . 0.0 110.779 -179.906 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -84.94 128.01 34.43 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.381 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -143.76 166.85 23.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.108 -178.942 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.438 HG12 ' N ' ' A' ' 162' ' ' ARG . 1.9 tt -161.74 149.05 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 161' ' ' ILE . 12.6 ptm180 -80.73 153.69 27.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.632 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.25 104.91 25.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.68 -28.49 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.399 2.066 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.81 62.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.093 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -100.67 32.36 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.803 . . . . 0.0 109.494 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 9.2 t-20 69.56 44.13 0.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 61.55 22.37 61.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.47 137.16 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -1.083 . . . . 0.0 109.594 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -69.15 161.7 28.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.3 t -144.44 97.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.268 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.586 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.3 t-105 -79.55 105.82 11.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.622 -179.858 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -59.33 -60.39 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.64 153.98 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -69.3 156.7 38.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.399 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -134.24 -162.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 -179.766 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -25.55 9.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.52 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 2.9 p -145.78 -177.32 5.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.925 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.906 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -79.92 -27.76 39.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 109.29 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.17 -37.66 75.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 -57.3 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 -179.809 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.822 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -59.27 -31.61 69.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.869 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.87 -42.96 76.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.333 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 184' ' ' LEU . 1.8 tm? -61.67 -44.44 96.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.857 . . . . 0.0 108.792 179.556 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.573 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.06 -28.16 69.28 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 27.6 t80 -68.8 -35.39 76.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.552 -0.718 . . . . 0.0 109.138 179.663 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -60.52 -48.18 82.89 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.323 -0.86 . . . . 0.0 109.594 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -55.14 -42.72 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.644 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -74.55 -20.65 59.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.496 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.547 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -91.36 2.43 56.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.0 t80 -109.77 -29.28 8.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 108.636 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -84.07 -39.36 19.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 0.0 OUTLIER -75.23 -32.47 61.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.646 -0.659 . . . . 0.0 109.86 179.861 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.3 mtt85 -92.44 -12.58 31.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 88.52 -145.94 19.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.448 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 2.1 m -54.85 -96.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -1.101 . . . . 0.0 109.613 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.8 ttm105 -56.36 164.55 1.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.063 -1.023 . . . . 0.0 109.33 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . 179.04 176.35 0.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.543 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.4 mt -113.4 106.1 14.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.899 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -115.1 158.04 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -64.41 -28.93 70.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.321 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.0 m-85 -126.22 72.84 71.92 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.571 -0.706 . . . . 0.0 109.19 -179.685 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -77.37 148.47 26.72 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.723 2.282 . . . . 0.0 110.444 -179.591 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.83 86.65 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 33.05 4.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.439 179.731 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.396 179.933 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 mptt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.428 ' CD2' ' NE2' ' A' ' 151' ' ' GLN . 35.9 m170 -76.42 106.28 7.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.4 m-85 -102.98 145.21 30.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.61 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -75.05 82.8 2.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.24 179.666 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.03 9.65 1.44 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.617 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 54.1 t -121.09 111.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.747 -1.443 . . . . 0.0 109.892 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' CB ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -76.43 101.26 5.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 108.917 179.508 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 1.1 pt20 -97.38 134.49 40.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.375 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.598 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 5.3 mtt180 -89.35 -176.19 0.64 Allowed Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.03 87.09 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.087 1.858 . . . . 0.0 110.281 -179.642 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 43.7 m95 55.43 73.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.393 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.59 -93.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.659 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.546 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.1 mtpp -115.77 -168.78 1.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -1.12 . . . . 0.0 110.431 -178.842 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 45.0 m-85 -150.61 -175.96 5.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 149' ' ' VAL . . . -155.05 155.58 34.36 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.527 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -129.5 115.77 17.96 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.84 159.86 41.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.392 -179.526 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 171' ' ' VAL . 9.9 tt -134.91 136.21 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -85.33 126.78 34.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 179.891 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -115.51 91.16 28.12 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 109.487 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.31 -25.08 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.534 2.156 . . . . 0.0 110.454 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -92.55 23.36 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 38.19 8.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.928 . . . . 0.0 109.555 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 169' ' ' ALA . . . 89.04 122.5 2.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 168' ' ' GLY . . . -179.86 80.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.19 148.31 4.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 161' ' ' ILE . 51.4 t -129.89 93.07 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 7.5 t-105 -81.29 95.35 6.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.667 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.664 HD21 ' CB ' ' A' ' 189' ' ' ALA . 21.1 mt -53.57 -50.55 65.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.77 . . . . 0.0 109.306 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.96 14.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.801 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.2 p -81.68 145.77 30.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.1 m-85 -120.01 -169.93 1.87 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 -179.841 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.59 -29.29 12.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.8 p -138.22 167.66 21.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.812 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.75 -24.68 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.271 -0.893 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 39.6 tt0 -73.49 -30.4 63.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.668 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -81.71 -41.43 21.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 -179.868 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.15 -39.15 78.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.13 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.18 -42.06 84.86 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.395 -0.815 . . . . 0.0 108.828 179.589 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -59.35 -46.29 89.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.027 179.592 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.61 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.2 -23.05 67.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.1 t80 -71.55 -34.4 69.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.422 -0.799 . . . . 0.0 109.144 179.711 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -63.37 -41.73 98.81 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -50.31 74.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 -179.757 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.664 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -74.37 -18.51 60.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.783 -179.507 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.3 -4.77 55.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -106.19 -32.14 8.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.259 -0.901 . . . . 0.0 108.841 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -41.3 30.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 47.0 ttm -70.82 -33.78 71.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 179.648 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.55 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -84.93 -17.19 38.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.411 -0.806 . . . . 0.0 109.08 179.713 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 63.09 -88.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 195' ' ' GLY . 3.9 p -54.65 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 4.1 mpt_? -53.85 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . 177.44 160.29 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 199' ' ' LEU . 4.7 mp -95.47 113.93 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.551 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -114.84 179.91 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.295 179.919 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.529 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -72.31 -31.87 66.07 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.03 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.1 m-85 -125.94 71.51 68.68 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo -76.82 149.26 29.32 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.646 2.231 . . . . 0.0 110.619 -179.468 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 205' ' ' ARG . 1.2 mt 173.94 175.64 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER 61.1 114.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.144 -0.972 . . . . 0.0 109.53 -179.985 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.468 -179.989 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.35 161.27 20.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.957 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 -84.4 163.26 19.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.59 96.08 6.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.29 -9.82 11.86 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 78.4 t -104.31 114.5 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.252 . . . . 0.0 109.739 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -87.26 141.55 28.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 108.733 179.436 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.462 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -113.16 141.39 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.0 -1.062 . . . . 0.0 109.872 -179.583 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.497 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 3.4 mmt-85 -116.75 162.18 28.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.888 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.497 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.61 -25.34 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.439 2.093 . . . . 0.0 110.279 179.839 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.47 82.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 156' ' ' LYS . . . 133.53 37.29 0.24 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 155' ' ' GLY . 22.2 mttt -135.12 170.83 15.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -1.106 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.1 m-85 -140.79 -170.35 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.653 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -159.29 113.64 2.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 109.934 179.686 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.18 123.63 31.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.473 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.554 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 9.3 mt-10 -141.58 169.16 18.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.66 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.562 HD13 ' HE1' ' A' ' 193' ' ' MET . 19.1 tt -152.54 131.41 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.976 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 162' ' ' ARG . 18.3 ptt180 -94.8 118.35 31.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 109.978 -179.374 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -108.68 107.02 59.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.43 -0.794 . . . . 0.0 109.008 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.84 -28.77 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.389 2.059 . . . . 0.0 110.477 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.18 40.73 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.219 -0.925 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -94.91 33.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.05 37.91 20.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.85 83.68 0.43 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -137.78 118.83 14.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.15 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -78.68 151.19 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.744 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 17.9 t -131.04 100.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.013 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.678 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.1 t-105 -87.12 99.9 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.683 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.135 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -55.4 -51.2 67.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.852 . . . . 0.0 109.562 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 153.7 153.77 6.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.678 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 3.1 p -72.24 148.22 45.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -1.115 . . . . 0.0 109.671 -179.869 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.0 m-85 -122.41 -169.14 1.85 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 2.3 pt-20 -101.47 -25.91 13.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.0 p -138.7 174.35 10.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.293 179.537 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.12 -26.76 48.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.213 -0.929 . . . . 0.0 109.761 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.23 -37.76 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.076 -1.015 . . . . 0.0 109.805 -179.754 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -72.7 -39.19 67.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.34 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.41 -31.16 65.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.957 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.24 -36.0 66.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.329 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.99 -49.18 73.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.214 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.47 -30.95 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.32 -0.862 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -67.23 -32.41 73.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.37 -0.831 . . . . 0.0 109.32 179.706 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 9.6 m-20 -65.56 -35.15 80.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -50.21 30.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.812 . . . . 0.0 110.476 -179.401 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.135 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -67.62 -25.87 65.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 110.072 -179.294 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -81.87 -29.0 32.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.632 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.487 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.4 t80 -78.32 -22.41 48.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.968 . . . . 0.0 108.995 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -73.98 -50.52 19.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 108.978 179.574 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.562 ' HE1' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -71.25 -36.41 71.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.779 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.515 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -104.08 36.81 2.23 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 179.917 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . -31.42 -68.54 0.12 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 197' ' ' ARG . 29.8 m -61.42 89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -1.193 . . . . 0.0 109.125 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.7 OUTLIER 62.84 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 109.25 -179.66 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . -154.57 154.95 33.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.633 -179.882 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 200' ' ' LEU . 1.4 tm? -99.89 123.87 44.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.98 175.61 9.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.744 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -73.12 -34.29 66.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.818 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.561 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.0 m-85 -119.81 82.71 27.89 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.372 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.98 49.23 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.89 2.393 . . . . 0.0 111.051 -179.095 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.3 tt -140.24 113.04 8.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.969 . . . . 0.0 109.304 179.794 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.24 121.32 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.764 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.542 179.938 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.94 90.81 2.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.216 -0.927 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.933 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 50.5 m-85 -86.5 154.28 21.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.896 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.26 90.21 3.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 -17.82 5.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 182' ' ' ALA . 92.9 t -96.92 110.32 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -1.137 . . . . 0.0 110.125 -179.573 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 29.5 mtt180 -85.55 141.07 30.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -107.47 152.76 23.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.976 -1.077 . . . . 0.0 110.41 -178.954 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.559 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -126.04 147.02 57.71 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.003 179.841 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.18 -6.63 16.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -98.85 7.52 45.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.774 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.27 81.43 1.21 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER 175.31 163.12 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.153 . . . . 0.0 109.552 -179.998 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -146.51 -176.25 5.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.677 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.08 110.24 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.528 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.34 118.39 23.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 1.5 mt-10 -138.78 153.14 48.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.803 . . . . 0.0 109.16 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.8 tt -134.93 130.71 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.066 -1.021 . . . . 0.0 109.734 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -70.11 126.37 29.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.186 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -121.62 94.84 48.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.56 -21.08 11.74 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.616 2.211 . . . . 0.0 110.414 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.43 70.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 4.0 mmtm -79.99 -69.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 109.417 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.4 p30 166.81 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.42 34.25 68.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.31 96.97 7.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -1.143 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -50.2 156.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.661 -179.762 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 161' ' ' ILE . 44.0 t -123.04 91.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -0.826 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.677 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -75.77 91.51 2.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 189' ' ' ALA . 12.4 mt -53.86 -38.16 64.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.38 160.37 8.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.35 171.47 12.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 59.3 m-85 -145.94 -173.39 4.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -28.17 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.3 p -145.95 170.42 16.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.65 -26.33 64.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.885 . . . . 0.0 109.31 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -70.58 -36.22 73.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -73.37 -47.87 38.68 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.61 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.578 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -63.55 -36.01 82.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.0 109.422 -179.806 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.0 -40.66 87.39 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 109.045 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 184' ' ' LEU . 42.6 tp -61.83 -48.75 79.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.416 -0.803 . . . . 0.0 109.127 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.08 -28.68 70.25 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 4.6 t80 -67.42 -28.47 67.93 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.529 -0.732 . . . . 0.0 109.038 179.252 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -70.26 -45.62 66.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -33.95 76.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.243 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.806 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.23 -54.45 7.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.747 -179.586 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -62.47 -14.95 46.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.862 -179.685 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.508 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 9.1 t80 -85.41 -34.93 21.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.007 -1.058 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -65.31 -43.13 92.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -82.35 -40.12 21.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 109.249 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.892 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 7.6 mtp85 -104.24 34.49 3.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.009 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . -41.54 165.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 72.31 93.54 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -1.162 . . . . 0.0 109.306 -179.967 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 65.89 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.848 . . . . 0.0 109.677 179.929 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.59 147.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.83 121.03 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.355 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.6 -178.81 4.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.107 -179.871 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.563 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -72.2 -35.51 68.94 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.881 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ ' ' A' ' 146' ' ' TYR . 7.5 m-85 -120.09 76.4 23.1 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.63 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -77.4 111.49 3.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.63 2.22 . . . . 0.0 110.553 -179.525 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 -168.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.345 179.851 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 206' ' ' VAL . 3.5 mtm180 -98.86 80.71 2.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.915 . . . . 0.0 109.554 -179.936 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.489 HG23 ' C ' ' A' ' 205' ' ' ARG . 2.5 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.405 0.621 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -98.96 151.55 20.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 -179.98 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.4 m-85 -130.36 151.37 50.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.703 -179.81 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -77.4 85.3 3.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.574 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.98 -20.43 4.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 16.2 t -96.39 127.42 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -1.197 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.2 ttt85 -94.13 153.12 18.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.15 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.498 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -127.31 134.33 50.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.949 -1.094 . . . . 0.0 109.683 -179.679 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.499 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -114.77 167.01 10.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 109.502 -179.75 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.35 5.85 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.597 2.198 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -102.22 -18.96 15.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.631 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 15.88 11.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.817 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.407 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.4 mtpp -112.5 171.36 7.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.973 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -142.84 -172.84 3.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.333 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -153.41 105.6 2.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.997 179.842 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.88 118.59 21.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.545 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.552 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 9.0 mt-10 -136.53 155.08 50.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.344 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 ' HE2' ' A' ' 193' ' ' MET . 12.2 tt -140.38 143.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.705 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -87.6 126.62 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 109.025 179.659 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -112.95 95.67 35.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.634 -179.768 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.3 Cg_endo -77.26 -26.0 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.488 2.125 . . . . 0.0 110.248 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.79 -15.11 62.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 0.0 109.606 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.514 ' HA ' ' CE ' ' A' ' 166' ' ' LYS . 2.4 mmpt? -106.39 41.32 1.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.336 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER 48.26 72.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.956 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' ASN . . . 48.74 96.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -148.48 101.32 3.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.173 . . . . 0.0 109.633 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 152.55 23.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.195 179.885 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.46 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 53.4 t -133.58 91.94 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.552 ' CE3' ' OE2' ' A' ' 160' ' ' GLU . 9.6 t-105 -79.05 92.6 5.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.066 179.492 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 189' ' ' ALA . 7.7 mt -53.8 -38.72 64.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.29 -179.827 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 141.67 175.44 15.17 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -91.88 161.73 14.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -1.132 . . . . 0.0 109.191 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 60.7 m-85 -134.63 169.32 17.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.558 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.454 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 1.3 pt-20 -75.6 -25.41 56.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.868 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.453 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -147.58 -178.24 6.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 109.45 -179.937 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -82.6 -24.63 33.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.2 tt0 -71.09 -34.18 70.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 109.613 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.454 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -76.58 -50.78 13.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.288 -0.883 . . . . 0.0 109.671 -179.891 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.7 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -59.3 -45.94 89.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 109.186 179.921 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.31 -46.04 89.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -59.51 -31.16 69.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.634 -0.666 . . . . 0.0 109.219 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.485 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -79.81 -23.74 41.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.488 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.6 t80 -74.77 -30.3 61.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.41 -0.806 . . . . 0.0 108.879 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 200' ' ' LEU . 21.6 m-20 -71.12 -50.76 30.12 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.519 0.676 . . . . 0.0 109.31 179.91 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -36.33 82.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.633 -0.667 . . . . 0.0 109.688 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 173' ' ' LEU . . . -80.84 -22.13 40.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.05 179.863 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 195' ' ' GLY . 1.7 t80 -85.31 -33.36 22.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 109.166 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -76.54 -40.72 49.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.868 . . . . 0.0 109.371 179.874 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.661 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -80.68 -27.7 36.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 110.284 -179.481 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 190' ' ' ALA . 2.8 mmt180 -92.61 8.93 36.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.897 -1.127 . . . . 0.0 109.676 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 71.48 -136.71 25.1 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.2 m -97.34 151.29 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.529 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 57.75 113.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.67 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.606 -179.906 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 113.17 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.377 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.66 176.07 8.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.403 -179.933 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.487 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -68.83 -37.27 79.06 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.368 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.1 m-85 -124.52 78.94 62.28 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.501 -0.749 . . . . 0.0 109.196 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 69.74 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.597 2.198 . . . . 0.0 110.447 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.85 56.03 4.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.545 ' O ' HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER 56.01 -175.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 109.787 179.842 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 205' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.335 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.288 0.566 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.25 173.31 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.896 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.3 m-85 -80.18 152.96 28.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 85.33 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.08 -15.28 4.54 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 182' ' ' ALA . 39.9 t -99.65 120.23 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.125 -1.221 . . . . 0.0 109.657 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 mmm180 -93.95 114.65 26.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.131 179.714 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.7 pt20 -89.68 139.32 30.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.829 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.507 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -110.54 160.72 27.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 179.96 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.7 Cg_endo -77.88 3.12 7.24 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.511 2.141 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.58 ' HA ' ' CE3' ' A' ' 154' ' ' TRP . 0.0 OUTLIER -105.06 -21.23 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.063 -1.023 . . . . 0.0 109.387 179.828 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 115.59 22.32 4.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.43 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 75.8 mttt -117.07 152.35 34.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.263 179.823 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.975 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 m-85 -132.6 170.53 15.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.982 . . . . 0.0 109.675 -179.615 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.606 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.84 114.9 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.921 179.814 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.95 121.95 28.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 108.764 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.53 152.7 40.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.562 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 190' ' ' ALA . 1.2 tt -144.36 133.52 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 179.961 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.84 136.67 57.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 179.675 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.42 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 29.4 t0 -116.69 109.36 43.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.21 -27.39 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.375 2.05 . . . . 0.0 110.205 179.71 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.07 -16.72 61.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.402 -0.811 . . . . 0.0 109.732 -179.944 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 83.5 mttt -102.48 37.64 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 22.9 m-80 60.32 40.38 17.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.578 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.7 65.05 3.36 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.84 133.8 55.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.37 141.76 58.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.54 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.0 t -117.31 88.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.606 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -73.99 92.82 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.343 179.841 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.083 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -54.44 -40.81 68.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 144.84 157.33 7.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.515 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -72.06 169.09 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 64.6 m-85 -143.78 -178.99 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.69 -30.06 21.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.3 p -142.51 -179.62 6.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.975 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.28 -24.11 43.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -72.12 -35.59 69.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -76.14 -39.27 55.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.298 179.878 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.37 -32.44 70.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 108.97 179.837 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.09 -40.76 64.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.547 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -61.65 -44.27 97.28 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.576 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.18 -31.0 70.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.256 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 161' ' ' ILE . 8.2 t80 -63.03 -29.77 71.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.557 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.531 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.4 m-20 -68.98 -48.73 62.41 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 109.223 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -52.9 -36.01 58.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 110.578 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 1.083 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.79 -39.14 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.914 -1.116 . . . . 0.0 109.905 -179.491 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.74 4.66 18.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.314 179.835 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 195' ' ' GLY . 6.0 t80 -113.89 -42.69 3.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.416 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -38.8 66.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.116 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 15.3 ttm -81.59 -35.4 30.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.653 -0.654 . . . . 0.0 110.292 -179.507 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -81.69 -13.88 57.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.041 . . . . 0.0 109.654 -179.418 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 99.21 -125.1 8.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.493 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -66.65 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -1.198 . . . . 0.0 109.922 -179.523 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -75.47 152.91 37.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 172.52 153.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.852 . . . . 0.0 109.162 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -92.6 116.94 29.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.11 -0.994 . . . . 0.0 109.772 -179.698 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.531 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.03 146.91 50.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.606 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.24 -32.7 11.18 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.58 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.14 85.22 41.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 109.196 179.855 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.21 111.27 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.598 2.199 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.608 HD12 ' H ' ' A' ' 206' ' ' VAL . 1.6 pp -132.91 143.89 49.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.073 -1.017 . . . . 0.0 109.666 -179.726 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -115.7 53.83 0.83 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 179.849 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.608 ' H ' HD12 ' A' ' 204' ' ' LEU . 54.4 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.584 -179.809 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 65.61 55.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.962 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 25.3 m-85 -55.77 159.83 2.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.283 -0.885 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -81.4 91.4 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.68 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.68 3.37 11.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.904 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.7 t -112.8 109.37 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -1.181 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -84.96 113.99 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.17 -0.956 . . . . 0.0 108.789 179.544 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -91.92 131.29 37.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.322 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -79.32 -177.27 0.84 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.897 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 32.9 Cg_endo -76.57 76.37 4.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.84 1.693 . . . . 0.0 109.908 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 61.45 69.57 0.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 109.154 -179.617 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.6 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.503 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.526 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.2 mttp -113.18 -171.43 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -1.175 . . . . 0.0 110.627 -178.812 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.053 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.5 m-85 -144.33 -179.0 6.26 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.03 111.33 4.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.836 -1.165 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.22 117.99 27.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.141 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt-10 -134.33 -165.87 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.213 -179.864 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 160' ' ' GLU . 2.5 tt 174.68 138.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.667 179.868 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -75.52 131.14 39.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.246 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -105.83 111.86 64.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.859 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.3 -28.55 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.498 2.132 . . . . 0.0 110.304 179.923 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.65 58.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.863 . . . . 0.0 109.594 -179.867 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 3.9 mmpt? -104.75 25.48 10.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.814 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 76.49 33.72 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 179.791 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.2 86.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.8 -168.89 2.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.4 179.851 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -112.41 144.9 41.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.785 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 38.3 t -128.67 116.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.101 179.603 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.3 t-105 -102.11 100.67 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.437 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.9 OUTLIER -57.75 -47.32 82.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.741 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.74 157.24 7.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.875 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -73.58 152.95 40.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.4 -1.059 . . . . 0.0 109.607 -179.846 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.661 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.7 m-85 -126.44 -177.2 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.165 179.659 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 -32.47 15.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.456 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -134.32 168.81 18.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.053 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.462 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -75.0 -38.13 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.374 -0.828 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -75.72 -34.89 60.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.097 -1.002 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -73.54 -35.71 65.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.08 179.664 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.962 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.428 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -61.95 -46.19 90.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.464 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.39 -29.7 69.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.052 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.5 t80 -61.39 -42.97 99.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.501 -0.75 . . . . 0.0 109.106 179.426 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 200' ' ' LEU . 8.8 m-20 -58.25 -45.03 88.51 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.498 -0.751 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.847 -179.7 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -89.15 -25.61 21.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 110.199 -179.461 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.94 5.12 52.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.456 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -113.6 -31.66 6.43 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.328 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -83.79 -40.5 18.67 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.803 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 3.7 tpp -74.91 -29.56 61.02 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.618 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 70.2 mtt-85 -109.86 -3.37 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.706 -179.836 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 75.47 -146.37 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 73.8 m -78.11 158.09 29.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -1.105 . . . . 0.0 109.7 -179.716 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 196' ' ' SER . 16.7 ttp180 55.3 103.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.654 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -159.52 31.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 179.723 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 198' ' ' ALA . 55.5 mt 36.57 98.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.372 0.606 . . . . 0.0 110.715 179.354 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -119.34 177.19 5.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.012 . . . . 0.0 108.88 179.019 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.576 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -71.27 -34.43 70.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.191 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.5 m-85 -121.86 74.83 36.99 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.852 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.516 ' O ' ' HG ' ' A' ' 204' ' ' LEU . 34.4 Cg_endo -76.18 172.88 15.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.513 2.142 . . . . 0.0 110.38 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 203' ' ' PRO . 0.4 OUTLIER 33.8 41.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.2 0.524 . . . . 0.0 110.501 -179.83 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.42 87.77 2.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.384 0.611 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -56.51 160.86 2.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.2 m-85 -93.05 126.59 38.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.619 179.997 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.72 107.22 2.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 108.918 179.347 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.92 -34.0 4.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.544 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 182' ' ' ALA . 42.0 t -81.24 119.75 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 109.233 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 22.3 mtt85 -101.4 101.67 12.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.807 -179.609 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.3 pt20 -62.91 144.02 57.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 109.118 179.534 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.484 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 1.5 mmt-85 -120.58 162.36 34.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.435 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.8 Cg_endo -76.7 73.49 5.24 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.611 2.207 . . . . 0.0 110.28 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.6 -179.681 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.66 14.12 3.59 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 18.8 mmtt -108.5 -176.92 3.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.236 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 86.7 m-85 -156.4 159.09 38.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -127.69 111.7 13.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.99 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.17 124.43 28.33 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -148.17 140.64 24.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.992 . . . . 0.0 110.042 -179.337 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 6.7 tt -128.41 137.41 57.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.424 -0.797 . . . . 0.0 109.121 179.735 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -80.28 142.99 34.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 -179.803 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 30.4 t0 -137.37 97.03 10.75 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.241 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.64 -24.37 10.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.322 2.014 . . . . 0.0 110.337 -179.917 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -11.75 58.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.859 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 163' ' ' ASP . 1.6 mtpt -105.84 40.57 1.55 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.63 45.97 3.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.434 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.77 84.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.78 120.77 13.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -1.088 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -63.82 157.26 25.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.148 -0.97 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 171' ' ' VAL . 34.0 t -128.85 89.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.847 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.491 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 8.9 t-105 -72.1 93.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.185 179.712 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.953 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.1 OUTLIER -52.07 -41.4 62.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.965 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.08 162.78 9.45 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 -179.648 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 1.2 p -76.14 -179.73 5.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.265 . . . . 0.0 109.393 -179.939 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 182' ' ' ALA . 78.4 m-85 -157.57 179.95 8.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.61 -25.47 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.457 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -142.98 165.43 27.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 109.562 -179.988 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.75 -22.64 65.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.45 -0.782 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -72.07 -39.48 68.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.841 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -73.18 -39.69 65.4 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.653 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.591 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -71.54 -32.71 68.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 -179.909 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.49 -37.02 63.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.205 -0.934 . . . . 0.0 108.852 179.71 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 184' ' ' LEU . 41.7 tp -66.03 -43.47 87.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.701 179.301 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.7 -30.96 72.0 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.241 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 9.3 t80 -66.36 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.548 -0.72 . . . . 0.0 109.144 179.545 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.648 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.0 -48.99 79.42 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.352 -0.842 . . . . 0.0 109.87 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -43.9 76.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 109.771 -179.753 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.953 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -75.26 -18.42 60.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.822 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.08 -8.66 48.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 4.5 t80 -105.8 -29.48 10.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -81.01 -40.3 24.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.508 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 27.0 mtp -75.11 -27.94 60.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.56 -0.713 . . . . 0.0 109.693 179.951 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -98.16 10.06 41.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.519 -179.806 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 73.15 -97.52 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.782 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.571 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 2.5 m -142.87 164.78 29.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -1.111 . . . . 0.0 109.482 -179.859 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 58.86 63.35 1.67 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 -179.808 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.19 171.52 8.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.397 -0.814 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -104.52 125.67 50.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.85 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.24 178.04 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 -179.789 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -70.95 -31.96 68.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.061 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.4 m-85 -121.61 74.14 33.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.45 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -76.87 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.354 -179.62 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.5 tp 46.6 78.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 -179.912 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -82.39 115.16 21.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.559 -179.833 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -139.92 157.56 45.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.896 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 -112.17 149.75 31.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.26 179.841 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 97.39 4.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.771 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.87 -21.39 7.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.725 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.3 t -89.55 126.06 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.252 . . . . 0.0 109.999 -179.66 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 tpp180 -97.65 147.07 24.7 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.951 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.516 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.3 pt20 -119.4 139.75 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 -179.392 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -105.3 155.91 37.09 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.145 179.672 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.47 6.17 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.577 2.185 . . . . 0.0 110.803 -179.742 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -106.11 -52.17 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.628 -179.986 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 152.79 56.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mtmt -155.26 -177.75 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.336 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.8 m-85 -153.65 -171.77 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.93 110.92 2.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.457 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -79.36 114.41 18.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.261 -0.9 . . . . 0.0 109.078 179.734 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.516 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 1.6 mt-10 -130.83 151.35 51.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.312 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 171' ' ' VAL . 2.6 tt -140.11 120.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.543 -179.82 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -61.12 140.77 57.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.304 179.867 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.414 ' CG ' ' CG ' ' A' ' 166' ' ' LYS . 30.9 t0 -118.99 100.94 50.53 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 -179.875 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -30.0 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.43 2.087 . . . . 0.0 110.463 179.842 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -10.13 59.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.414 ' CG ' ' CG ' ' A' ' 163' ' ' ASP . 16.1 mmtt -106.14 44.78 1.02 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 50.45 49.61 20.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.277 -179.797 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.19 99.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.954 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -159.56 111.16 2.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -1.099 . . . . 0.0 109.25 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -63.02 149.43 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.582 -179.716 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 161' ' ' ILE . 21.7 t -122.13 104.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 11.3 t-105 -77.47 95.88 4.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 189' ' ' ALA . 31.2 mt -55.77 -54.9 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 162.46 158.69 9.77 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.937 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.575 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -72.75 154.39 40.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.568 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 53.7 m-85 -131.25 168.93 16.67 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -80.14 -24.75 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.669 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.587 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 3.4 p -145.1 175.96 9.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.88 -24.75 40.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.76 -33.57 64.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.587 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.1 OUTLIER -79.72 -39.03 32.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.899 . . . . 0.0 109.288 179.945 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.32 -31.64 67.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 109.208 179.851 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.896 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.49 -39.72 64.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.235 -0.915 . . . . 0.0 108.959 179.721 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 184' ' ' LEU . 22.8 tp -61.97 -42.62 99.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.824 . . . . 0.0 108.866 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.58 -31.35 72.0 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.8 t80 -62.33 -29.78 70.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.772 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.1 m-20 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.1 -31.7 70.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 -179.841 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.514 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -83.15 -28.13 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -4.07 58.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.485 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -108.54 -34.34 6.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.296 179.859 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -81.96 -38.77 24.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.343 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.3 ttm -78.03 -31.13 50.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.639 -0.663 . . . . 0.0 109.798 179.91 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 195' ' ' GLY . 34.7 mtp85 -98.65 -16.3 19.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.116 -0.99 . . . . 0.0 109.165 -179.911 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 47.68 -176.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.795 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 195' ' ' GLY . 93.3 p 42.82 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -1.168 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.25 149.61 40.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -149.09 157.11 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -100.54 118.01 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.772 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.87 -172.71 2.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.647 -179.675 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.624 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -80.22 -32.04 38.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 108.967 179.703 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.7 m-85 -125.61 68.37 60.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.531 -0.731 . . . . 0.0 109.602 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.8 Cg_endo -78.41 71.18 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.808 2.338 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.1 tp -161.68 -106.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.998 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -81.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.805 -1.185 . . . . 0.0 109.422 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.445 179.898 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.433 0.635 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -103.27 121.05 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.339 -0.85 . . . . 0.0 109.592 -179.848 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.883 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.9 m-85 -123.88 133.64 53.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -179.97 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.19 85.14 2.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.66 -20.74 2.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.79 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.2 t -92.15 112.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.349 -1.089 . . . . 0.0 109.645 -179.847 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -93.12 79.49 4.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.765 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 29.7 pt20 -70.84 134.97 47.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.355 -0.841 . . . . 0.0 109.357 -179.871 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.579 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -89.08 -179.75 1.36 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.969 -1.082 . . . . 0.0 108.344 179.407 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -73.93 83.97 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.973 1.782 . . . . 0.0 110.18 -179.612 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 66.77 64.78 0.47 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.469 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.56 ' HA3' ' NE ' ' A' ' 152' ' ' ARG . . . -157.86 -111.83 0.33 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.75 -179.404 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.1 mtmm -110.52 -172.58 2.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.14 . . . . 0.0 110.976 -178.515 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.764 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 17.0 m-85 -140.59 131.07 25.35 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.576 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -104.33 112.84 26.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.885 -1.135 . . . . 0.0 110.752 -178.948 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.79 117.25 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.549 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.579 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 2.6 mt-10 -138.88 154.5 48.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.003 . . . . 0.0 109.68 -179.193 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 8.3 tt -133.07 164.47 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.742 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.489 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.5 tpp180 -101.01 119.65 39.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.963 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -120.83 93.04 48.6 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.33 -22.99 10.54 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.623 2.215 . . . . 0.0 110.342 179.984 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.58 60.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -90.38 33.24 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.91 25.57 15.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.557 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.38 97.96 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -161.81 97.9 1.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.4 mtt180 -45.56 155.63 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.949 . . . . 0.0 109.263 179.853 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.45 ' HB ' HG23 ' A' ' 161' ' ' ILE . 54.9 t -128.15 100.75 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ3' ' OE2' ' A' ' 160' ' ' GLU . 10.1 t-105 -86.16 97.33 10.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.75 HD21 ' CB ' ' A' ' 189' ' ' ALA . 15.1 mt -57.13 -46.59 82.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.508 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.25 155.93 7.17 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.3 p -68.93 178.8 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.164 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 175' ' ' THR . 67.1 m-85 -155.1 -171.51 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.924 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -97.32 -29.38 13.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.68 -179.846 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.591 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 13.3 p -142.53 -179.61 6.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 109.587 -179.797 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.96 -21.76 46.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.322 -0.862 . . . . 0.0 109.04 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -75.68 -36.79 59.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.91 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -73.27 -40.75 64.35 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.234 -0.916 . . . . 0.0 109.412 179.94 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.563 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -67.78 -47.2 69.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.883 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.41 -40.13 85.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.812 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -59.9 -49.74 76.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.525 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.66 -21.88 64.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.402 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -76.95 -28.44 55.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.801 . . . . 0.0 109.171 179.562 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.8 m-20 -69.12 -38.59 78.97 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 -179.573 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -69.31 -44.7 71.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.522 -179.088 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.75 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -70.16 -44.14 69.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.129 -179.25 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -64.82 -29.95 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.958 -179.412 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.41 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.4 t80 -75.56 -24.67 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.97 -1.081 . . . . 0.0 109.889 -179.623 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -82.27 -40.99 20.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -27.65 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 110.497 -179.302 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -97.46 7.78 45.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.943 -1.098 . . . . 0.0 109.603 -179.751 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 68.06 -132.33 28.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.764 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -80.77 -177.22 6.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 -179.984 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.493 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 17.0 ttm180 52.77 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.493 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 59.05 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 199' ' ' LEU . 3.8 mp -106.76 122.08 45.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.24 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.5 161.63 26.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.69 ' OD1' ' HB1' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -60.82 -31.49 70.9 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.246 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.812 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.0 m-85 -123.73 88.52 52.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.84 -177.5 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.632 2.221 . . . . 0.0 110.742 -179.275 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.8 -10.22 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 -179.978 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.94 121.56 8.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.875 . . . . 0.0 109.376 -179.885 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.547 -179.997 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.3 mttt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.352 0.596 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -74.12 113.8 11.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.329 179.785 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.5 m-85 -75.41 148.77 38.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.191 -0.943 . . . . 0.0 109.297 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.55 96.27 4.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.18 -18.43 6.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.865 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 65.6 t -99.62 127.62 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -1.171 . . . . 0.0 109.62 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 1.1 mtt85 -100.51 141.19 33.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.181 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.527 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -110.92 147.37 34.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 -179.314 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mtt180 -112.02 165.76 12.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.442 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.49 -29.56 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.546 2.164 . . . . 0.0 110.646 -179.898 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -73.14 -57.1 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.562 -179.957 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 53.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.459 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 12.6 mttm -144.86 171.52 14.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -1.176 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.002 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.3 m-85 -144.93 -173.75 4.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.772 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.17 112.85 2.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.696 179.88 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.34 126.76 34.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.09 150.33 36.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.625 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 161' ' ' ILE . 1.6 tt -142.46 139.2 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.879 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -72.4 135.76 45.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 163' ' ' ASP . 37.3 t0 -130.08 96.54 25.21 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.593 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.87 -26.49 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.505 2.136 . . . . 0.0 110.287 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.78 -20.95 62.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.334 -0.853 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 16.6 mmtp -95.25 33.51 1.55 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.494 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 12.6 m120 66.5 49.3 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.313 -179.843 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.89 105.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.972 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -175.54 112.88 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -1.189 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -53.53 166.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 171' ' ' VAL . 43.2 t -137.33 94.57 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.772 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.4 t-105 -78.47 97.81 5.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.967 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.1 mt -56.1 -46.82 78.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.538 -179.822 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.66 162.87 11.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.931 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -79.65 151.53 30.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.288 -179.853 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 85.9 m-85 -127.25 -175.85 3.56 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.14 -33.06 19.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.298 -179.418 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.5 p -137.31 179.51 6.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.035 -1.041 . . . . 0.0 110.028 -179.579 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.76 -27.39 60.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.152 179.744 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 11.1 tt0 -68.54 -70.82 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.471 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -37.85 -54.45 1.26 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.804 -0.56 . . . . 0.0 110.217 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -60.3 -41.34 93.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.037 -179.472 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -61.98 -31.38 71.73 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.669 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -70.9 -45.86 63.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.167 -0.958 . . . . 0.0 108.455 179.595 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.62 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -59.04 -25.58 63.83 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.722 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 21.2 t80 -74.21 -36.38 63.96 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.559 ' HB3' HD13 ' A' ' 200' ' ' LEU . 71.1 m-20 -64.54 -45.64 86.26 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.472 -0.767 . . . . 0.0 109.146 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -42.18 84.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.967 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.37 -16.73 58.72 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.805 179.498 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.66 1.17 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.377 -0.827 . . . . 0.0 109.048 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -114.91 -37.6 4.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.71 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 42.5 mmt-85 -81.16 -39.44 25.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.078 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 40.8 ttm -75.05 -30.54 61.04 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.463 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.4 mtt180 -99.54 -10.28 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.27 -169.65 54.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.938 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' ARG . 1.4 t -54.6 150.69 9.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -1.085 . . . . 0.0 109.635 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 62.76 125.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.957 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 179.92 145.7 0.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 179.953 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -90.34 120.2 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.631 -179.773 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.21 -173.54 3.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.007 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.431 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -74.96 -35.89 62.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.087 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.4 m-85 -122.33 87.42 48.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.201 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.7 171.01 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.61 2.206 . . . . 0.0 110.755 -179.386 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.8 mt -50.06 111.99 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' ' 206' ' ' VAL . 8.1 mtt180 -47.03 -65.36 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.886 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.7 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.6 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.264 0.554 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.84 82.24 5.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.561 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.56 -13.48 3.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 33.3 t -102.16 120.87 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 109.395 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -103.9 89.44 3.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.55 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -46.97 149.98 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 13.1 mmt180 -113.42 161.81 25.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.937 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.29 6.09 4.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.662 2.241 . . . . 0.0 110.584 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -114.18 -15.05 12.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 30.96 2.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 28.6 mmmt -120.35 -175.31 2.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.638 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.805 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 88.2 m-85 -157.64 117.71 3.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.104 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -89.94 122.46 32.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -98.53 111.95 24.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.58 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 4.4 mt-10 -135.21 150.88 50.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.403 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -127.9 148.29 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 133.0 36.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.746 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -126.65 94.5 40.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.436 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.83 -24.99 8.09 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.656 2.237 . . . . 0.0 110.575 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.37 -11.91 61.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -100.12 55.61 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 56.3 31.04 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.955 . . . . 0.0 109.592 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.22 67.96 1.85 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -124.69 -180.0 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -1.154 . . . . 0.0 109.375 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -111.32 156.13 22.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.53 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 171' ' ' VAL . 29.5 t -129.15 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.2 t-105 -79.58 102.23 8.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.043 HD21 ' HB2' ' A' ' 189' ' ' ALA . 7.9 mt -56.78 -55.51 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 109.331 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 159.53 153.32 6.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.512 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.0 p -65.99 166.68 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.707 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.2 m-85 -141.39 -177.33 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -95.84 -30.25 13.77 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.307 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.548 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -136.68 167.07 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.268 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.805 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.45 -26.34 62.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.307 -0.871 . . . . 0.0 108.916 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.93 -35.27 69.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.285 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.12 -43.56 57.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.075 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.36 -23.78 61.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 108.916 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.59 -42.75 41.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.713 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.02 -38.81 92.68 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.82 -38.58 83.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 108.982 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.2 t80 -60.61 -39.24 87.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 1.2 m-20 -56.96 -44.1 82.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -0.815 . . . . 0.0 109.577 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -48.84 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.043 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -72.82 -15.45 61.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 0.0 109.847 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.45 -17.49 25.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.152 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 2.8 t80 -94.34 -31.29 14.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -46.72 26.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.6 ttm -65.54 -33.52 76.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.687 -0.633 . . . . 0.0 109.83 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -100.14 18.21 19.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 109.646 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 57.43 -99.43 0.1 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 0.5 OUTLIER -126.13 158.08 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -1.154 . . . . 0.0 109.717 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.57 91.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.19 174.12 10.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.99 113.58 26.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.16 179.48 5.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.402 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.88 -35.16 64.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.437 ' HD2' HD22 ' A' ' 184' ' ' LEU . 4.9 m-85 -120.03 83.35 30.67 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 122.626 2.217 . . . . 0.0 110.465 -179.649 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.754 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.543 ' HE ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.52 31.01 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.034 -1.041 . . . . 0.0 109.774 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.09 20.16 0.35 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 183' ' ' ALA . 61.6 t -140.62 107.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -1.061 . . . . 0.0 109.37 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -85.06 110.6 19.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 108.678 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -75.95 156.01 34.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.567 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -109.56 158.54 34.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.83 . . . . 0.0 109.19 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.82 13.79 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.514 2.143 . . . . 0.0 111.024 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -120.33 -25.43 5.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.071 -1.018 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.53 33.84 0.59 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.441 ' C ' ' HG3' ' A' ' 152' ' ' ARG . 42.5 mttt -126.44 -169.24 1.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 58.6 m-85 -156.42 172.19 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.379 -0.825 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.08 116.99 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.063 -1.023 . . . . 0.0 110.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -87.17 119.77 27.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 108.605 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -144.3 147.01 32.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.605 HD11 ' NH1' ' A' ' 194' ' ' ARG . 8.8 tt -135.94 143.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 108.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -80.81 134.47 35.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.036 -1.04 . . . . 0.0 109.811 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -122.94 103.6 36.62 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.391 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 -29.95 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.448 2.099 . . . . 0.0 110.594 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.66 -26.69 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.641 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -91.4 37.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.24 50.23 18.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.64 80.09 0.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -132.37 95.51 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.3 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -44.28 133.0 5.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 43.7 t -109.92 103.18 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.439 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.493 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 5.0 t-105 -93.68 97.31 10.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -54.3 -49.0 70.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.061 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.54 159.53 8.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -76.99 144.08 38.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.647 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.814 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.4 m-85 -118.01 178.26 4.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.456 -0.778 . . . . 0.0 109.21 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.6 mm-40 -88.24 -25.55 22.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 110.012 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.573 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.8 p -141.17 178.17 7.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.651 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -80.38 -23.17 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.385 -0.822 . . . . 0.0 109.19 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 13.6 tt0 -74.93 -36.81 62.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.84 -43.91 43.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.754 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.25 -37.88 84.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.346 -0.846 . . . . 0.0 109.045 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.854 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -61.25 -44.88 96.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.426 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.7 -18.72 62.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 108.894 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 11.6 t80 -76.22 -31.58 58.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.002 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.549 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -68.38 -51.09 47.95 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.545 -0.722 . . . . 0.0 109.798 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -27.52 69.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -86.15 -23.03 26.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.302 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -88.18 -15.63 35.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.37 -0.831 . . . . 0.0 109.124 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.4 OUTLIER -92.81 -32.13 14.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -78.8 -40.58 32.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.02 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.1 tpp -70.34 -30.93 68.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 0.0 109.581 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.605 ' NH1' HD11 ' A' ' 161' ' ' ILE . 1.5 mpt_? -91.62 -12.67 33.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 196' ' ' SER . . . 62.57 81.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 3.3 m 61.01 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -1.161 . . . . 0.0 109.69 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER 61.76 120.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.922 . . . . 0.0 109.632 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 173.31 153.59 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.543 HD23 ' HE ' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -98.04 118.6 35.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.02 -177.41 4.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.696 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -72.8 -34.36 66.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.854 ' HD2' HD22 ' A' ' 184' ' ' LEU . 2.2 m-85 -128.66 76.52 78.62 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.722 2.281 . . . . 0.0 110.66 -179.382 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 1.004 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.6 m-85 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.168 0.508 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.09 88.19 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 124.77 26.29 1.43 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.7 t -140.35 109.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -1.106 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -95.46 93.77 7.41 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.224 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 44.0 tt0 -52.05 167.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.418 ' N ' ' CG ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -129.69 158.91 72.15 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.335 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.57 4.32 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.625 2.216 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.485 ' O ' ' CD1' ' A' ' 154' ' ' TRP . 50.0 t-105 -113.25 -7.77 13.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.52 22.6 8.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -115.09 174.08 6.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.596 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.066 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 79.6 m-85 -146.91 152.98 39.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.032 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.643 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -121.85 117.45 26.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.873 -1.142 . . . . 0.0 109.653 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.606 ' HB3' ' HE2' ' A' ' 176' ' ' PHE . . . -91.89 111.07 22.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -130.22 145.87 51.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.063 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 14.9 tt -124.15 154.7 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.61 136.32 34.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.412 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 44.0 t0 -146.16 93.05 5.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.669 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.16 -23.42 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.635 2.223 . . . . 0.0 110.281 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.48 -11.52 24.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.821 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 13.2 mtpt -100.87 35.67 2.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 1.6 t-20 70.39 47.22 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.66 89.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -163.71 136.1 5.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -71.82 178.68 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.2 t -138.51 81.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.715 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.2 t-105 -61.87 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.548 HD21 ' CB ' ' A' ' 189' ' ' ALA . 26.6 mt -51.7 -34.87 40.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.127 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 137.33 155.22 6.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.715 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.8 p -68.24 -177.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.323 -1.104 . . . . 0.0 109.383 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' HE2' ' HB3' ' A' ' 159' ' ' ALA . 74.2 m-85 -157.54 177.94 10.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -88.84 -26.91 21.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.655 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.7 p -140.83 175.59 9.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.066 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -80.44 -21.07 42.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.284 -0.885 . . . . 0.0 109.2 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -76.31 -37.55 57.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -36.06 63.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.167 -0.958 . . . . 0.0 109.027 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.72 -39.76 66.67 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.038 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.004 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -66.3 -39.53 89.39 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.0 108.734 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.0 tp -64.56 -42.7 95.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.53 -24.15 67.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.2 t80 -76.04 -28.79 57.81 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.482 -0.761 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 72.3 m-20 -74.48 -47.55 32.66 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -62.43 -31.61 72.34 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.548 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -88.54 -20.59 24.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.024 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.1 -1.96 58.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -107.97 -35.42 6.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.906 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -76.81 -39.77 50.27 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 27.7 ttm -76.6 -36.94 57.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.64 -0.662 . . . . 0.0 109.978 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -77.73 -18.36 56.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.965 . . . . 0.0 109.18 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.16 -127.79 9.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 197' ' ' ARG . 13.8 m -63.96 -148.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 110.053 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 196' ' ' SER . 1.8 ttm180 -39.99 139.72 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 110.033 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.78 -175.88 4.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.143 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -104.23 121.36 43.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.843 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.69 152.42 50.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.576 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -54.96 -33.04 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.3 m-85 -117.44 94.19 44.85 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.308 -1.558 0 C-N-CA 122.432 2.088 . . . . 0.0 110.374 -179.695 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.7 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.43 81.84 3.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 108.917 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.67 19.79 2.0 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 44.4 t -133.21 129.51 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.259 . . . . 0.0 109.198 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 112.36 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.601 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.1 pt20 -80.17 157.18 26.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -125.75 159.13 62.63 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 109.698 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 3.4 7.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.571 2.181 . . . . 0.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -101.22 -19.21 15.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.51 39.79 1.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 35.1 mttt -145.56 166.1 26.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.427 -1.043 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.083 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.8 m-85 -133.65 178.54 6.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.58 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.36 112.74 6.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.704 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.49 108.17 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -129.4 158.42 39.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.356 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.8 tt -139.72 139.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -80.72 128.72 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.902 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -114.78 95.74 42.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -23.27 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.613 2.208 . . . . 0.0 110.617 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.65 -7.1 30.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.185 -0.947 . . . . 0.0 109.687 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -119.09 57.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.1 m120 49.49 26.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.91 99.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -142.62 105.34 4.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 109.248 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.01 141.94 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.2 t -122.81 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.68 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.6 t-105 -73.7 96.49 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.786 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.458 HD21 ' CB ' ' A' ' 189' ' ' ALA . 30.3 mt -56.04 -46.99 78.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.33 154.53 6.59 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.68 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -70.33 161.25 30.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -1.107 . . . . 0.0 109.356 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 65.2 m-85 -136.16 178.72 6.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -84.15 -31.25 25.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.8 p -142.06 170.33 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.083 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.23 -22.42 62.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.106 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.88 -42.59 63.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -68.29 -43.45 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.862 . . . . 0.0 109.606 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.67 -45.76 85.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.8 -38.93 79.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.64 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.63 -51.52 68.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 109.125 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.532 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.49 -20.25 65.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 108.815 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -79.27 -28.47 42.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.445 -0.785 . . . . 0.0 109.41 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.4 m-20 -72.34 -35.47 68.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.701 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -76.19 -40.04 53.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.458 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -73.89 -30.02 62.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.467 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.87 -23.62 33.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.837 . . . . 0.0 109.4 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.513 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 28.7 t80 -83.74 -22.34 31.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 108.974 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -78.86 -38.49 37.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.638 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.1 ttm -80.15 -43.12 22.17 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 0.0 110.173 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.718 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 12.2 mtt180 -92.57 -38.34 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.828 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 63.11 161.43 0.28 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 197' ' ' ARG . 22.5 p 50.53 -176.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -1.097 . . . . 0.0 109.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.5 mtm180 -43.7 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -119.27 35.99 4.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 198' ' ' ALA . 5.0 mt 39.35 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -118.18 149.77 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.972 . . . . 0.0 109.353 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.622 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -49.18 -37.31 22.17 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.9 m-85 -120.81 83.22 36.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 200' ' ' LEU . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.905 2.403 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.867 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 68.6 m-85 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.59 35.02 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.184 -0.948 . . . . 0.0 110.15 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.78 26.24 0.09 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 182' ' ' ALA . 96.7 t -150.27 117.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.417 -1.049 . . . . 0.0 109.185 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.552 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -99.09 137.13 38.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.104 -0.997 . . . . 0.0 109.09 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -103.11 155.62 18.27 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.265 -0.897 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.69 161.02 55.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.815 . . . . 0.0 109.38 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.85 -8.41 16.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.513 2.142 . . . . 0.0 109.964 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.59 -1.41 57.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.5 56.27 2.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.4 mttt -159.27 171.27 20.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.788 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -142.17 -177.68 5.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -152.49 116.92 4.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.779 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -89.23 118.35 28.85 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 109.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 5.6 mt-10 -137.82 177.57 7.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 171' ' ' VAL . 1.1 tt -164.72 142.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.909 -1.119 . . . . 0.0 109.939 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -69.5 134.17 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.045 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 168' ' ' GLY . 11.2 t0 -113.14 98.07 44.7 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 0.0 109.62 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.12 -22.07 10.17 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.535 2.157 . . . . 0.0 110.28 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.25 67.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.296 -0.878 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -104.98 32.5 4.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.72 58.52 4.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 169' ' ' ALA . . . 82.09 -127.56 8.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 67.18 87.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -53.5 134.83 40.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 163' ' ' ASP . 70.3 t -102.01 105.8 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 108.962 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -87.49 93.9 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.031 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.7 mt -53.55 -48.69 68.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.0 108.998 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 153.62 162.23 10.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.29 160.84 30.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -1.141 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -134.75 -176.5 4.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 0.0 109.608 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -90.58 -28.2 18.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.638 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p -146.5 172.18 13.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.61 -24.36 62.72 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.127 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -73.81 -36.37 64.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.539 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -72.03 -47.05 54.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.65 -32.15 73.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.2 -37.62 75.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.135 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.97 -47.56 77.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 108.86 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.571 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.25 -22.11 66.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' ALA . 28.9 t80 -69.79 -36.28 75.57 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.792 ' HB3' HD13 ' A' ' 200' ' ' LEU . 9.7 m-20 -63.57 -54.33 37.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.395 -0.815 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -55.68 -29.68 59.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.26 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.11 -24.64 27.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.084 . . . . 0.0 110.06 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.94 -14.91 37.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.995 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.548 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.4 t80 -96.25 -25.33 15.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.17 -0.956 . . . . 0.0 108.853 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.34 -38.79 34.31 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.2 tpp -79.59 -42.13 25.63 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.383 0.611 . . . . 0.0 109.749 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 9.7 mtp180 -97.73 -41.27 8.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 109.629 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 43.24 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 197' ' ' ARG . 0.6 OUTLIER 45.87 50.62 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -1.12 . . . . 0.0 109.828 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 70.46 118.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -138.96 174.21 10.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.335 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 108.07 19.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -122.0 -175.91 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.562 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.668 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -84.6 -33.52 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.416 ' HZ ' ' CZ ' ' A' ' 146' ' ' TYR . 6.2 m-85 -121.02 77.49 31.5 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.6 Cg_endo . . . . . 0 C--N 1.31 -1.498 0 C-N-CA 122.686 2.257 . . . . 0.0 110.507 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.4 m-85 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -75.89 83.6 2.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.634 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.57 -22.2 3.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.7 t -90.48 116.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -1.15 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -105.48 120.21 41.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 pp0? -85.54 163.8 18.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.881 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.426 ' CD ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -131.66 165.73 33.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.452 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 152' ' ' ARG . 35.0 Cg_endo -78.39 -4.09 13.92 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.683 2.255 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -91.96 -18.03 24.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.007 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.86 35.84 2.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -137.16 -175.59 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 0.0 109.634 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.828 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -144.83 -173.37 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.636 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -154.01 108.32 3.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.213 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.73 119.41 24.29 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.563 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 10.6 mt-10 -134.89 179.65 6.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.084 -1.01 . . . . 0.0 109.365 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -174.76 141.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.43 136.76 39.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' CA ' ' A' ' 168' ' ' GLY . 10.5 t0 -111.47 101.02 49.8 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -24.02 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 110.308 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.85 -37.0 75.99 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 14.2 mttt -98.33 59.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 8.6 p30 41.36 48.02 3.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.438 -0.789 . . . . 0.0 109.797 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 163' ' ' ASP . . . 75.48 -114.68 4.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 63.27 95.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 169' ' ' ALA . 7.7 ptt180 -45.28 157.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.675 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 41.1 t -129.29 93.02 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.636 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 13.5 t-105 -79.59 93.19 5.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.12 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -53.47 -40.18 65.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.485 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 148.25 -171.93 28.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -103.39 154.94 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -1.162 . . . . 0.0 109.028 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -130.1 165.28 22.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.464 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.7 OUTLIER -77.71 -17.87 57.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.096 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.9 p -153.56 162.36 41.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.545 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.828 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.63 -23.28 66.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.309 -0.869 . . . . 0.0 109.405 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.0 -39.72 65.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.501 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -72.04 -40.49 68.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.763 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.83 -32.13 69.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.47 -41.15 69.73 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.75 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.32 -46.91 88.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.34 -22.88 63.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 108.845 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.0 t80 -72.48 -30.74 64.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.495 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.5 m-20 -69.34 -50.48 45.97 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.36 -0.837 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -54.95 -38.02 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.918 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.424 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -78.02 -30.15 49.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 109.453 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -82.64 -2.8 55.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.383 -0.823 . . . . 0.0 109.385 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' GLY . 37.3 t80 -99.45 -40.67 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.149 -0.97 . . . . 0.0 108.918 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -64.34 -49.12 72.94 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -40.38 95.22 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 60.3 mtt180 -105.31 36.52 2.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 108.962 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -34.69 147.72 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.2 t 80.91 102.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.56 -0.965 . . . . 0.0 109.402 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.494 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 49.8 ttm-85 64.71 -96.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.407 -0.808 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.08 145.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.005 -1.06 . . . . 0.0 109.401 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -104.85 122.46 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.544 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -121.23 152.53 38.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -0.919 . . . . 0.0 109.24 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.584 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -48.5 -37.16 16.78 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.9 m-85 -120.19 92.31 47.0 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.631 2.221 . . . . 0.0 110.916 -179.202 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 1.011 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 86.41 3.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.832 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.41 -19.78 5.62 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 182' ' ' ALA . 44.1 t -90.0 114.58 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.667 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -100.08 113.92 26.88 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.459 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 12.0 pt20 -78.62 154.57 30.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.311 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -118.42 174.43 2.67 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -77.68 -48.07 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.632 2.221 . . . . 0.0 110.507 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -62.51 1.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.65 52.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -141.48 173.44 11.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.674 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.951 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.8 m-85 -139.15 175.37 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.628 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.64 110.27 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.53 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.56 124.2 28.76 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -146.03 160.29 42.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.788 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.529 HD13 ' HE2' ' A' ' 193' ' ' MET . 3.4 tt -149.47 147.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.859 . . . . 0.0 109.181 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.436 ' NH2' ' HG2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -96.94 137.15 36.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.99 . . . . 0.0 109.614 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.444 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 44.5 t0 -122.23 114.45 30.59 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.361 -0.837 . . . . 0.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.71 -35.05 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.324 2.016 . . . . 0.0 110.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.61 64.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.105 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -93.89 39.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.42 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.36 30.98 13.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.76 62.59 5.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.44 33.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.491 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -84.64 161.93 19.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.632 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.6 t -137.3 94.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.432 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.628 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.3 t-105 -79.3 100.36 7.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.049 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -59.47 -43.12 93.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 146.26 157.02 7.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.582 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -76.26 151.06 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.169 . . . . 0.0 109.432 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.9 m-85 -123.38 -176.25 3.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -87.59 -31.98 19.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.5 p -139.29 176.27 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.193 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.26 -26.06 55.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.3 -37.37 71.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -72.97 -39.57 66.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.97 -26.52 61.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.327 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.011 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.21 -39.28 49.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.136 -0.978 . . . . 0.0 109.013 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.855 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.1 tm? -63.75 -43.07 97.54 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 108.838 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.608 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.72 -29.45 69.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -66.31 -32.18 73.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 0.0 109.14 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.661 ' HB3' HD13 ' A' ' 200' ' ' LEU . 3.6 m-20 -65.93 -49.6 67.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.09 -29.71 67.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.005 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.049 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.48 -24.28 27.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.821 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.522 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -87.69 -6.53 58.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.613 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 196' ' ' SER . 2.1 t80 -104.01 -37.47 7.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.44 -40.99 56.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.273 -0.892 . . . . 0.0 109.163 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.529 ' HE2' HD13 ' A' ' 161' ' ' ILE . 2.0 mtm -71.94 -30.79 65.69 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.563 -0.711 . . . . 0.0 110.067 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -92.75 -6.4 49.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.84 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.0 -104.23 3.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.581 ' O ' ' CZ ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -108.02 -78.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.981 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.83 122.79 15.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.881 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . -156.54 162.4 39.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.158 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.727 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -110.55 124.77 52.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.61 173.19 8.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.222 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.603 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -74.66 -28.73 60.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.0 m-85 -125.24 67.25 54.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.545 -0.722 . . . . 0.0 109.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.8 Cg_endo . . . . . 0 C--N 1.31 -1.471 0 C-N-CA 122.553 2.169 . . . . 0.0 109.876 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.915 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.8 m-85 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 87.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 125.8 28.29 1.07 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.8 t -142.41 123.05 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.094 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 85.62 2.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.585 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 1.3 pp0? -59.49 144.39 47.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.511 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 159.79 34.71 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.23 18.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.742 2.295 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.35 -39.99 2.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.44 46.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HD2' ' HB ' ' A' ' 175' ' ' THR . 34.9 ttpt -147.18 147.93 31.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -1.165 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.903 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 16.4 m-85 -133.79 130.46 38.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.563 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -99.32 108.93 21.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.082 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.65 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.11 109.21 18.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.224 -0.923 . . . . 0.0 108.585 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.496 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 1.8 mp0 -132.53 141.54 48.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.12 -0.987 . . . . 0.0 109.668 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 5.4 tt -120.7 131.89 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.798 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.73 122.98 24.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.683 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -113.87 108.39 51.22 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.858 . . . . 0.0 109.313 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 -27.62 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.387 2.058 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.31 75.29 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -95.9 40.56 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.463 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 4.9 m-20 69.56 46.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.506 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.35 29.79 1.82 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.96 123.05 20.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -1.122 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.04 130.16 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.489 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.9 t -106.75 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.668 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.566 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -74.65 94.17 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.372 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.612 HD22 ' HB2' ' A' ' 189' ' ' ALA . 39.4 mt -54.24 -41.63 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 145.15 155.01 6.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.566 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.3 p -68.04 179.77 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 75.1 m-85 -154.62 -174.23 4.89 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.396 -0.815 . . . . 0.0 109.343 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.38 -25.37 13.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.8 p -142.7 170.85 14.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.903 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.68 -23.9 58.7 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.157 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -34.03 61.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.413 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -74.79 -39.97 61.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 109.019 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.48 -35.63 73.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.915 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.54 -40.64 73.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.996 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 184' ' ' LEU . 28.2 tp -63.1 -43.66 97.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.48 -24.0 63.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 7.2 t80 -69.37 -30.08 67.99 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -49.11 50.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.491 -0.756 . . . . 0.0 109.046 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -54.11 -39.27 66.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.687 . . . . 0.0 109.608 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.612 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.61 -27.62 41.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.7 -4.1 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.19 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.453 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 10.0 t80 -103.79 -23.82 13.37 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -81.55 -36.41 29.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.6 tpp -81.05 -44.07 18.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.785 -0.572 . . . . 0.0 109.91 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.7 mtt180 -85.3 -33.35 22.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.175 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 62.47 127.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' ALA . 69.6 m 61.56 142.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -1.104 . . . . 0.0 110.34 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 2.4 tpp180 43.06 -96.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.49 -0.756 . . . . 0.0 110.376 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.29 168.7 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.152 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -106.0 109.85 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.599 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.75 159.41 32.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.716 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -68.66 -30.55 69.26 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.0 m-85 -122.49 86.36 48.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HA ' HD12 ' A' ' 200' ' ' LEU . 35.2 Cg_endo . . . . . 0 C--N 1.309 -1.51 0 C-N-CA 122.707 2.271 . . . . 0.0 110.669 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.1 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.259 0.552 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 99.85 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.09 -33.25 4.28 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.1 t -75.3 134.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -1.19 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -121.18 106.69 11.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.061 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -77.12 163.21 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.541 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -120.8 175.99 2.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.412 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.39 -23.43 8.67 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.744 2.296 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -84.25 -56.03 3.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.62 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.02 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.2 157.88 41.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -1.125 . . . . 0.0 109.138 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 13.7 m-85 -126.1 -178.43 4.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 109.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.68 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.97 108.19 4.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 110.345 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.69 107.57 13.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.423 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -130.29 146.05 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.5 tt -135.12 156.44 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.291 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.05 132.78 33.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -132.17 102.55 14.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.303 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 -26.67 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.442 2.094 . . . . 0.0 109.961 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.52 64.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 35.9 mttm -90.03 26.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 3.7 t-20 75.11 43.99 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.38 48.48 80.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.02 147.32 42.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -1.153 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -76.81 154.95 33.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 171' ' ' VAL . 9.0 t -122.12 85.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.68 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.5 t-105 -73.86 96.46 2.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 108.882 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.6 mt -52.94 -48.59 67.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.132 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 150.43 152.29 5.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.564 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.5 p -65.55 171.14 4.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.173 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.529 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 61.6 m-85 -144.95 -176.49 5.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -89.42 -29.58 18.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.584 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.5 p -143.06 171.18 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.05 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.62 -28.11 63.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -69.46 -33.75 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -76.36 -41.11 49.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 109.031 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -71.58 -23.12 61.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.852 . . . . 0.0 109.081 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -80.24 -42.52 23.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 108.86 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -36.22 83.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.14 -29.78 65.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 17.7 t80 -64.83 -37.43 87.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.904 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.2 m-20 -63.39 -47.09 83.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.512 -0.742 . . . . 0.0 109.336 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -53.04 -42.37 65.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.02 -17.92 45.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.7 -5.09 56.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.189 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 5.6 t80 -102.8 -33.73 9.26 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -77.23 -41.36 41.47 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.39 -29.27 63.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 109.343 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.6 mtt-85 -104.66 9.79 35.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.67 -162.79 14.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 59.0 p -61.49 161.56 9.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -1.101 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 54.94 104.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.551 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -151.58 172.98 15.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 109.163 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.627 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -107.43 112.89 25.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.72 179.44 4.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 109.31 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.648 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -74.53 -30.59 61.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 108.422 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.3 m-85 -126.1 67.0 61.52 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.589 -0.694 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 122.609 2.206 . . . . 0.0 110.304 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.364 0.602 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -80.71 99.08 8.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.668 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 160' ' ' GLU . . . 115.92 -9.72 18.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 179' ' ' ALA . 89.7 t -100.88 112.61 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.034 -1.274 . . . . 0.0 109.79 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.1 ttm-85 -91.83 94.12 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.108 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.564 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -71.57 134.94 46.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.85 160.65 34.31 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.85 -2.55 12.53 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.71 2.273 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -109.73 19.95 18.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.661 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.16 68.03 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -162.01 133.47 5.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 108.797 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 5.3 m-85 -132.51 137.27 47.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -0.945 . . . . 0.0 109.115 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.693 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -107.26 116.76 32.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.002 -1.061 . . . . 0.0 110.357 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -89.39 114.12 25.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 148' ' ' GLY . 2.5 mp0 -130.61 155.57 46.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.403 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 8.9 tt -139.06 125.77 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -82.03 117.55 22.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.52 108.94 58.31 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.23 -33.08 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.381 2.054 . . . . 0.0 110.288 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.28 65.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -89.46 39.54 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.428 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.4 m120 46.57 50.17 13.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.594 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.15 88.69 0.03 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -146.85 89.04 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -1.157 . . . . 0.0 109.741 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -49.18 145.23 4.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.326 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.5 t -127.55 86.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.691 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.693 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.6 t-105 -67.21 97.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 108.91 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.831 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -53.98 -42.42 68.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.859 . . . . 0.0 109.606 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.48 155.53 6.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.7 p -67.77 -176.59 0.67 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -1.141 . . . . 0.0 109.302 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 71.0 m-85 -156.75 -168.52 2.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 109.397 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.57 -25.88 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.456 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.1 p -141.49 174.54 10.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.719 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.85 -24.42 41.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -35.08 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -39.32 44.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.91 -41.93 61.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 108.853 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.59 -40.58 95.3 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.67 -25.83 64.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 15.2 t80 -68.15 -41.09 82.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.562 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.5 m-20 -61.1 -50.1 74.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.224 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -48.27 -39.5 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.557 -0.714 . . . . 0.0 110.128 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.831 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.9 -26.16 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.966 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.15 7.36 32.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.041 -1.037 . . . . 0.0 109.143 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 10.0 t80 -111.94 -33.8 6.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -43.06 32.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -75.62 -29.73 59.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.319 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.636 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -95.51 5.41 51.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.907 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 85.37 -89.51 1.61 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.587 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 45.0 t -138.76 -80.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -1.208 . . . . 0.0 109.879 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 111.79 1.01 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -150.49 170.01 20.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.523 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -97.83 107.99 20.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.562 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -115.42 157.87 23.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.189 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.666 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -61.19 -31.72 71.48 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.8 m-85 -121.97 83.92 44.42 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.301 -179.71 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.872 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.2 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.345 0.593 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -82.45 83.32 7.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.878 . . . . 0.0 109.199 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.96 6.15 5.51 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 95.8 t -119.69 118.14 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -1.233 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.2 ttp180 -88.24 115.0 25.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.555 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -83.38 152.3 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.751 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.531 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.3 mtm105 -137.5 175.42 3.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -0.819 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 34.9 Cg_endo -77.44 159.13 32.67 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.5 2.134 . . . . 0.0 110.019 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.568 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 8.2 t-105 83.77 -60.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.41 54.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -132.88 154.11 50.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -1.185 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.811 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.4 m-85 -142.43 179.17 7.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.56 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.45 113.94 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.061 -1.024 . . . . 0.0 110.017 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.31 121.74 31.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.377 -0.827 . . . . 0.0 108.974 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -146.17 151.34 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.148 -0.97 . . . . 0.0 109.313 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 161' ' ' ILE . 7.9 tt -129.83 124.3 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 124.28 22.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.43 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.19 96.92 50.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.72 -22.67 10.26 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.611 2.207 . . . . 0.0 110.223 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.29 -3.85 19.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.349 -0.844 . . . . 0.0 109.703 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 1.0 OUTLIER -122.38 27.59 7.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 75.19 58.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.095 -1.003 . . . . 0.0 109.626 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.9 39.69 6.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -84.44 93.32 8.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -1.209 . . . . 0.0 109.285 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -50.01 142.47 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.4 t -116.3 86.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 109.194 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.7 t-105 -75.62 96.12 3.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.3 mp -54.45 -42.88 71.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.62 152.42 5.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.6 p -68.35 164.44 20.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.443 -1.033 . . . . 0.0 109.44 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.887 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.4 m-85 -138.41 -169.88 2.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.515 ' HG2' ' OD2' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -96.93 -30.87 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p -136.59 -179.62 5.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.85 -1.157 . . . . 0.0 110.247 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.811 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.49 -32.38 58.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 8.0 tt0 -66.23 -70.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -38.79 -59.97 0.89 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.623 . . . . 0.0 110.166 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -55.6 -38.44 69.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.872 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.08 -34.63 78.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.136 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -38.42 80.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.915 -1.115 . . . . 0.0 109.44 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.551 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.06 -32.39 73.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.84 . . . . 0.0 108.911 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.0 t80 -67.17 -33.85 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 109.523 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.47 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 29.4 m-20 -64.25 -44.91 90.33 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -62.66 -32.88 74.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.79 . . . . 0.0 110.408 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.774 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -83.47 -24.65 31.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.101 -1.0 . . . . 0.0 109.853 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.65 -12.64 53.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.8 t80 -99.56 -40.47 7.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.016 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.14 -39.9 96.01 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.9 tpp -74.92 -55.32 5.91 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.558 0.694 . . . . 0.0 109.569 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.7 mtt180 -88.95 -55.74 3.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 0.0 109.685 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 57.28 170.15 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER 56.25 81.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.522 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.42 100.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.896 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -133.56 176.7 8.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 200' ' ' LEU . 8.1 mp -95.85 109.3 21.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.726 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -130.49 143.17 50.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.117 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.628 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -51.89 -32.11 31.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 m-85 -124.13 89.53 51.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.726 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.0 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 C-N-CA 122.462 2.108 . . . . 0.0 110.435 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 1.013 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 36.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 89.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.66 -28.19 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 50.6 t -85.86 118.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -1.177 . . . . 0.0 109.61 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -101.53 116.81 33.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 108.994 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.512 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.4 pt20 -81.58 157.25 24.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.931 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.3 mtt-85 -122.46 160.36 48.61 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -76.84 -8.54 17.97 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.514 2.143 . . . . 0.0 110.162 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.89 -27.14 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.3 34.46 0.95 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 11.8 mtpp -132.06 176.97 7.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -1.157 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.3 m-85 -145.45 177.24 8.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.29 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -149.13 108.35 3.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.866 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.55 107.21 13.16 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -129.6 151.98 49.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.304 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.442 HG12 ' N ' ' A' ' 162' ' ' ARG . 3.0 tt -141.61 149.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.442 ' N ' HG12 ' A' ' 161' ' ' ILE . 5.6 ttp85 -86.51 144.76 27.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -137.6 99.35 9.52 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.11 -25.63 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.015 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.83 -13.38 32.98 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -104.83 43.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.74 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 23.0 m120 59.38 59.28 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.13 79.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.08 148.91 42.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.384 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.5 mtt-85 -86.15 167.04 15.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.53 100.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.102 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.482 ' C ' ' CD1' ' A' ' 172' ' ' TRP . 3.0 t-105 -85.95 106.3 17.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.4 mt -64.56 -49.61 70.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 153.75 158.13 8.45 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -78.03 155.59 30.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -1.145 . . . . 0.0 109.076 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 66.6 m-85 -130.5 173.8 10.5 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.42 -31.77 42.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.935 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -141.03 172.55 12.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.48 -22.54 61.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.474 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -72.76 -38.55 67.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.3 -44.92 50.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.72 -44.76 95.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.394 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.013 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.43 -43.29 88.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.089 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.36 -51.66 68.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.865 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.95 -23.15 66.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.4 t80 -72.96 -31.88 64.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 109.503 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.678 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.8 m-20 -70.93 -50.28 36.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -37.45 47.66 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.676 -0.64 . . . . 0.0 109.985 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.1 -23.49 23.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.83 7.69 45.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.802 ' CD2' HD11 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -118.83 -37.61 3.22 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -81.5 -38.87 25.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -79.07 -32.86 44.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.718 -0.614 . . . . 0.0 109.727 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -91.74 -17.88 24.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.219 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 41.98 -156.94 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.0 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.173 . . . . 0.0 109.545 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.4 mtm180 -56.05 -58.3 8.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.606 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 60.29 177.81 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.169 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 200' ' ' LEU . 11.0 mt -140.89 122.5 15.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.541 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -123.32 154.37 38.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 109.377 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.677 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -56.06 -33.68 65.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.39 80.27 37.44 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.499 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.921 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 83.68 7.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.27 -3.52 5.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 179' ' ' ALA . 41.9 t -107.62 114.71 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.775 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -94.89 115.93 28.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.852 . . . . 0.0 109.219 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.509 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -88.39 155.04 19.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.23 162.28 22.87 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 -7.59 16.59 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.526 2.151 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -99.21 -64.53 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.47 50.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -146.05 156.43 43.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -1.176 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.4 m-85 -130.24 179.99 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.711 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.63 111.8 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.546 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.85 125.75 33.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.676 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -147.81 158.63 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.7 tt -143.54 134.61 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.98 131.18 41.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -111.33 106.32 57.12 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.06 -31.4 4.95 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.279 1.986 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.4 -16.67 64.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.339 -0.85 . . . . 0.0 108.948 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -107.42 53.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.477 -0.764 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.23 21.68 2.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.11 62.41 3.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.87 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -1.182 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.69 155.85 14.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.887 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.7 t -140.98 83.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.711 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.9 t-105 -71.49 98.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 108.98 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.942 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.32 -51.42 68.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 157.28 157.85 8.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.565 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -72.81 153.12 41.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -1.129 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 72.0 m-85 -129.01 -172.63 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.511 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.32 -28.84 13.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.56 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.7 p -140.91 166.06 25.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -68.03 -21.22 65.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -75.32 -44.25 46.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 109.756 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.435 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -69.81 -38.69 76.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -69.16 -43.27 74.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.921 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.16 -35.43 80.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 108.97 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.766 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -63.5 -48.4 77.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.026 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.13 -25.45 67.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.469 -0.77 . . . . 0.0 109.064 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.9 t80 -68.91 -34.3 75.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.665 ' HB3' HD13 ' A' ' 200' ' ' LEU . 40.1 m-20 -64.05 -48.01 77.93 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.379 -0.825 . . . . 0.0 108.917 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -52.16 -44.58 64.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.711 -0.618 . . . . 0.0 110.295 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.942 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.42 -27.64 59.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -88.2 6.82 34.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.471 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.0 t80 -115.61 -26.4 7.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 108.938 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -83.32 -37.5 23.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mtp -80.9 -39.27 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.636 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 73.1 mtt180 -94.0 -34.24 13.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 48.92 -168.72 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.9 m 57.96 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.361 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 52.1 ttt180 -124.87 -54.92 1.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.083 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . 61.85 154.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.751 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 108.44 19.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.64 -174.34 2.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.58 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.701 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -80.72 -37.79 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.766 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.1 m-85 -116.4 80.58 10.11 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.288 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.513 0 C-N-CA 122.688 2.259 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 40.4 m-85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.281 0.562 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.5 88.31 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.96 -29.85 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.1 t -86.15 113.25 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.698 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -93.34 105.86 17.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 108.583 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.632 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 13.7 pt20 -103.47 133.85 47.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 110.097 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.571 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -88.23 -179.26 1.26 Allowed Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.3 Cg_endo -75.22 77.98 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.826 1.684 . . . . 0.0 109.825 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER 70.47 75.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.775 . . . . 0.0 109.272 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.61 -86.35 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.553 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -137.87 178.35 7.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.147 -1.208 . . . . 0.0 110.252 -178.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.634 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 9.5 m-85 -135.93 174.53 10.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.584 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.12 104.73 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.61 ' HB2' ' CA ' ' A' ' 182' ' ' ALA . . . -79.93 102.6 9.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.195 -0.941 . . . . 0.0 109.201 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 5.8 tm-20 -125.79 154.27 42.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.792 . . . . 0.0 109.197 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.865 HD13 ' HE2' ' A' ' 193' ' ' MET . 2.1 tt -132.71 149.24 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.963 . . . . 0.0 109.694 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.2 ttm180 -103.46 108.33 19.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.314 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -100.23 118.36 61.48 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.96 -26.46 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.284 1.989 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -14.4 22.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.255 -0.903 . . . . 0.0 109.378 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -102.1 39.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.354 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.67 33.41 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.82 53.66 9.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -108.72 121.97 46.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.53 159.21 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.605 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.1 t -138.25 87.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.264 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.1 t-105 -69.71 114.55 8.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 109.394 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 20.2 mt -75.39 -53.9 7.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.85 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.69 156.46 8.75 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -73.67 152.93 40.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.15 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.792 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.3 m-85 -131.05 173.99 10.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.74 -30.68 32.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.634 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -138.2 -172.77 3.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.593 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -88.42 -22.24 23.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.955 . . . . 0.0 108.833 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -72.21 -37.43 69.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.011 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -74.2 -46.72 40.19 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.416 -0.802 . . . . 0.0 108.948 179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -21.23 62.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.68 -39.11 37.68 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.772 ' O ' HD13 ' A' ' 184' ' ' LEU . 3.1 tm? -68.24 -45.33 73.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.24 -26.73 68.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -67.84 -33.51 74.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.492 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.3 m-20 -68.19 -42.36 80.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 188' ' ' ARG . 17.4 tpp180 -61.59 -40.41 94.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.995 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.65 -23.96 42.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 109.701 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.92 -3.5 57.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.581 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 187' ' ' ASP . 1.7 t80 -105.53 -27.84 11.15 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.204 -0.935 . . . . 0.0 108.763 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -81.59 -40.97 22.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.865 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.77 -33.55 60.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -0.777 . . . . 0.0 109.304 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 8.0 mmm180 -92.63 -16.41 25.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.827 . . . . 0.0 108.929 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . 42.29 -108.72 0.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 197' ' ' ARG . 56.1 p -50.53 111.81 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -1.136 . . . . 0.0 110.097 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.2 OUTLIER 56.35 160.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 0.0 110.344 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . 177.32 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.2 mt -95.54 116.21 28.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.64 -176.69 4.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.411 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.479 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -80.36 -35.5 35.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 2.3 m-85 -120.03 79.25 25.45 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 122.614 2.209 . . . . 0.0 110.713 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.185 0.517 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.58 74.91 7.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.381 -0.825 . . . . 0.0 108.898 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 155.3 -16.41 0.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 1.003 HG11 ' HA ' ' A' ' 179' ' ' ALA . 9.2 t -105.26 111.11 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.979 -1.306 . . . . 0.0 109.785 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.94 131.68 54.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.612 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . 2.8 pm0 -122.8 131.76 53.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.991 . . . . 0.0 110.473 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.585 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -71.86 -172.87 0.23 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.13 90.57 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.645 1.563 . . . . 0.0 109.977 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.8 m95 64.49 50.14 2.27 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.02 -123.61 2.04 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.459 -1.353 . . . . 0.0 111.09 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -106.68 151.78 24.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.972 . . . . 0.0 110.434 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE1' ' HB2' ' A' ' 151' ' ' GLN . 2.9 m-30 -100.2 -171.7 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.626 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.79 121.28 2.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.611 -1.306 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -100.11 121.24 41.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 2.0 mt-10 -136.19 158.47 44.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.809 . . . . 0.0 109.672 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.508 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.6 tt -141.54 123.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 170' ' ' ARG . 1.0 OUTLIER -63.57 139.2 58.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.417 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 43.7 t0 -128.2 97.8 28.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.284 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.52 -28.18 7.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.307 2.005 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.2 -14.06 52.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -108.8 42.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.736 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.47 30.02 9.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.074 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.47 66.94 1.56 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -116.33 85.92 2.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -1.147 . . . . 0.0 109.338 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.3 ptt85 -42.2 144.95 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.406 -0.808 . . . . 0.0 109.481 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 161' ' ' ILE . 45.7 t -120.19 88.58 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.145 -0.972 . . . . 0.0 109.811 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.626 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.0 t-105 -73.66 93.75 2.11 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.137 -0.977 . . . . 0.0 109.025 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -51.43 -47.38 63.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.763 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.51 165.11 12.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -77.54 148.02 35.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.933 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 48.3 m-85 -123.44 -166.4 1.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.35 -0.844 . . . . 0.0 109.397 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -105.01 -26.75 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . 1.9 p -144.61 -172.27 3.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 109.548 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.003 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -87.11 -22.63 25.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.03 -36.61 56.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.59 -52.2 11.12 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.217 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.933 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.43 -34.73 77.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.164 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.64 -44.16 74.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -58.65 -38.21 77.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.397 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.73 -28.24 63.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.006 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -70.67 -30.16 66.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 96.7 m-20 -71.84 -41.9 67.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.411 -0.806 . . . . 0.0 109.942 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.7 -34.12 73.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 110.082 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.994 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.65 -29.08 36.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.764 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.02 -24.93 35.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.377 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -81.33 -26.84 35.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -45.56 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.43 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -71.71 -35.22 70.14 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.585 -0.697 . . . . 0.0 109.965 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.716 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 3.3 mpt_? -94.66 -7.89 39.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.24 -87.25 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 197' ' ' ARG . 4.4 t -85.25 -146.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.702 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' A' ' 196' ' ' SER . 28.1 mtm180 -38.46 140.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.598 -0.689 . . . . 0.0 110.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.716 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . -157.14 32.69 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 199' ' ' LEU . 7.2 mt 41.68 92.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.66 -0.65 . . . . 0.0 109.651 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -120.51 143.66 48.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.2 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.545 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -45.89 -33.96 3.56 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.526 ' HD2' HD22 ' A' ' 184' ' ' LEU . 1.4 m-85 -134.04 88.01 32.92 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.2 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 C-N-CA 122.572 2.181 . . . . 0.0 110.545 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.927 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 15.5 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 98.46 3.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.192 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.0 -31.94 3.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 157' ' ' PHE . 41.0 t -79.55 136.53 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -1.1 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -108.4 89.91 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 109.228 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 3.9 pt20 -59.42 131.21 50.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.978 . . . . 0.0 109.462 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -110.66 159.5 32.1 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.75 -1.68 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.708 2.272 . . . . 0.0 110.543 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.423 ' HB3' ' HE3' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -98.73 -25.71 14.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.05 39.87 0.62 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 157' ' ' PHE . 21.6 mttt -130.05 179.96 5.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 86.5 m-85 -159.12 109.0 1.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 108.679 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -85.8 127.12 34.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.09 -1.006 . . . . 0.0 111.263 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -99.9 116.92 33.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.45 166.16 25.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.041 -1.037 . . . . 0.0 110.316 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 8.8 tt -152.18 158.63 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.451 -0.78 . . . . 0.0 108.952 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.54 139.7 48.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.95 -1.094 . . . . 0.0 109.858 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -138.11 93.63 11.62 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.36 -22.99 10.51 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.587 2.191 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.89 -13.99 19.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -107.38 51.03 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.467 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 28.7 t-20 57.03 38.32 29.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.341 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.94 97.91 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.6 100.89 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.127 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -51.99 166.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.441 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 67.2 t -147.83 90.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.612 ' HZ2' HG22 ' A' ' 175' ' ' THR . 3.1 t-105 -87.06 101.83 13.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.099 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.2 mt -56.12 -50.79 70.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.42 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 148.63 148.68 4.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.612 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.1 p -68.32 158.41 33.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.08 -1.247 . . . . 0.0 108.967 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 85.5 m-85 -131.86 -176.89 4.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.622 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -27.69 14.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.553 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.7 p -133.03 170.41 15.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.515 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -22.61 47.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.377 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -73.09 -33.11 65.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.428 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.0 OUTLIER -80.54 -34.95 35.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.235 -0.915 . . . . 0.0 109.173 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -76.48 -27.83 56.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.927 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.14 -40.56 45.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.203 -0.936 . . . . 0.0 108.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 202' ' ' PHE . 6.9 tp -63.89 -41.75 97.64 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.513 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.58 -37.76 85.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -62.73 -40.44 97.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.45 -0.781 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.4 m-20 -60.7 -52.2 66.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.498 -0.751 . . . . 0.0 109.833 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -54.16 -31.19 51.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.099 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -84.4 -26.95 27.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.25 2.99 54.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.542 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.5 t80 -117.16 -31.24 5.4 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -74.92 -38.49 61.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 ttm -81.53 -46.26 14.74 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.418 0.627 . . . . 0.0 109.735 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.7 mtt85 -93.94 -41.89 9.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.039 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 48.12 -149.79 3.39 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m 50.26 -107.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -1.188 . . . . 0.0 109.601 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.01 56.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.222 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -66.18 169.65 6.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.332 -0.855 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -113.67 116.44 29.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.098 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -125.25 179.28 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.599 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -70.33 -38.25 74.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 200' ' ' LEU . 7.8 m-85 -112.16 96.11 33.26 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.457 0 C-N-CA 122.578 2.185 . . . . 0.0 110.708 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.8 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -77.79 96.98 5.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.637 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.66 -16.72 7.39 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 183' ' ' ALA . 27.3 t -97.48 117.61 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.811 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 3.4 mmp_? -96.53 117.89 31.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.588 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -85.38 160.07 19.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 0.0 110.016 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.528 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 16.4 mtt180 -126.7 158.26 68.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.681 -0.637 . . . . 0.0 109.337 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.2 3.49 7.05 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.577 2.185 . . . . 0.0 110.298 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -9.9 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.485 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.01 33.24 4.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.2 mtmt -127.81 173.09 10.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.127 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.6 m-85 -144.33 -178.29 5.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.366 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.621 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.69 104.1 2.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 109.94 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.59 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.04 123.22 27.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.235 -0.916 . . . . 0.0 108.974 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 1.1 mt-10 -139.12 164.51 29.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.266 -0.896 . . . . 0.0 109.267 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 171' ' ' VAL . 6.2 tt -146.02 141.84 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -86.8 108.72 18.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 166' ' ' LYS . 11.8 t70 -99.68 113.14 64.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.36 -27.31 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -9.14 56.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 4.4 mmpt? -117.87 39.35 3.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 1.2 m-20 68.74 29.38 5.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.41 27.1 68.89 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.81 116.53 8.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -1.209 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -59.04 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HG23 ' A' ' 161' ' ' ILE . 37.8 t -68.31 104.99 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.621 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.4 t-105 -80.51 99.01 7.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 19.7 mt -56.63 -37.67 71.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.027 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.555 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 136.3 158.27 8.04 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -78.52 148.87 33.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -1.13 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.4 m-85 -120.25 -168.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.695 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.938 ' HG3' HG23 ' A' ' 178' ' ' THR . 9.9 pt-20 -99.23 -32.59 11.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.938 HG23 ' HG3' ' A' ' 177' ' ' GLU . 2.1 p -133.85 170.1 16.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.127 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.32 -23.65 50.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.96 . . . . 0.0 109.556 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -73.13 -36.61 66.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.491 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.3 OUTLIER -75.32 -45.38 39.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -61.76 -47.2 86.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.32 -42.39 86.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.103 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 184' ' ' LEU . 21.3 tp -60.79 -39.83 90.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.564 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.19 -24.34 66.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -0.813 . . . . 0.0 109.046 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -72.35 -29.95 64.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.714 ' HB3' HD13 ' A' ' 200' ' ' LEU . 2.0 m-20 -72.18 -50.32 28.58 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -60.91 -28.7 69.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.48 -19.57 23.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.927 . . . . 0.0 109.274 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.72 -8.14 41.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -105.79 -33.67 7.92 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -80.15 -39.77 28.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -30.57 64.12 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.673 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 12.8 mtt180 -96.2 -0.95 49.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.36 -87.17 1.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 197' ' ' ARG . 3.0 m -135.8 164.4 27.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -1.188 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.82 109.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -163.31 150.1 12.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.957 . . . . 0.0 109.492 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mp -92.37 118.23 30.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.51 174.74 8.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 109.413 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.764 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -70.42 -34.59 72.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 108.613 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.8 m-85 -121.34 84.58 41.34 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.48 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.76 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 46.0 m-85 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -82.03 36.18 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.154 -0.966 . . . . 0.0 109.753 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.04 26.59 0.09 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 57.6 t -143.6 113.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -1.154 . . . . 0.0 109.424 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.05 94.79 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.32 134.29 56.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.494 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 7.5 mmt180 -99.17 161.25 25.37 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.668 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.494 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.32 -34.81 1.41 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.678 2.252 . . . . 0.0 110.263 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -47.69 83.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.08 43.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 2.6 mttm -131.94 -168.65 2.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 63.3 m-85 -159.47 108.29 1.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.096 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.618 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -82.38 139.34 34.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -111.11 113.58 26.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -134.79 164.75 26.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 0.0 109.899 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -141.52 143.3 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 108.914 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 1.2 tmm_? -82.62 119.71 24.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.825 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.407 ' CG ' ' SD ' ' A' ' 193' ' ' MET . 41.5 t0 -111.06 97.74 35.99 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.072 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 34.7 Cg_endo -76.39 -26.39 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.475 2.117 . . . . 0.0 110.673 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.81 -22.76 67.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 109.578 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -100.4 64.33 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.587 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 48.16 44.22 19.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.602 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 50.92 59.64 7.87 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -107.18 136.71 46.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -1.165 . . . . 0.0 109.44 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 163.24 28.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' A' ' 161' ' ' ILE . 55.7 t -134.87 99.7 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 158' ' ' ALA . 16.0 t-105 -84.09 91.67 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.982 . . . . 0.0 109.599 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 57.6 mt -51.38 -48.45 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.246 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 152.39 158.52 8.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.615 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.8 p -73.61 162.71 28.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -1.175 . . . . 0.0 109.477 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -138.83 179.57 6.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -28.46 19.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 p -142.72 168.51 19.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -72.09 -24.6 61.52 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.83 -39.79 76.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -74.63 -45.69 43.18 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.14 -31.15 72.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.69 -47.83 44.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.255 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.433 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -58.39 -35.68 72.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 108.834 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.43 -28.98 65.47 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.278 -0.888 . . . . 0.0 108.696 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -65.88 -28.03 68.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.723 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.9 m-20 -71.62 -47.88 51.67 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.303 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -34.74 68.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -84.2 -39.11 19.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.929 -1.107 . . . . 0.0 109.981 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -69.22 -18.91 63.95 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.572 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.6 t80 -85.55 -40.6 16.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.139 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -40.28 86.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.759 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.407 ' SD ' ' CG ' ' A' ' 163' ' ' ASP . 28.9 ttm -77.86 -43.16 31.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.666 -0.646 . . . . 0.0 109.591 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 70.4 mtt180 -102.25 34.2 2.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.955 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -41.12 164.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 84.53 -47.71 0.1 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.834 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -171.73 128.81 0.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.208 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 194' ' ' ARG . . . -159.66 148.77 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -89.77 122.62 33.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -121.83 157.26 31.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.164 -0.96 . . . . 0.0 109.303 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.494 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -53.93 -35.59 61.86 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.2 m-85 -124.16 83.53 56.18 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.309 -1.551 0 C-N-CA 122.515 2.143 . . . . 0.0 110.529 -179.78 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.958 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.5 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -72.11 96.75 1.81 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.54 -8.33 7.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' A' ' 182' ' ' ALA . 38.5 t -105.01 112.32 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -1.172 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -96.19 117.61 31.11 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.596 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.38 153.76 24.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.84 . . . . 0.0 109.433 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -116.58 155.94 48.18 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.25 -10.52 16.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.661 2.241 . . . . 0.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -36.59 17.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.136 -0.977 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 156' ' ' LYS . . . 133.61 61.81 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 155' ' ' GLY . 19.4 mttp -166.83 -171.64 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 109.514 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.015 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -148.88 -175.12 4.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 109.102 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.705 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.31 108.53 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 0.0 110.017 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.8 134.17 36.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.154 -0.966 . . . . 0.0 108.984 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.24 148.96 29.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.095 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.435 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 3.8 tt -141.79 127.71 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.023 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -69.46 143.63 53.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 109.204 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 168' ' ' GLY . 43.5 t0 -110.52 97.65 33.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.573 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.6 Cg_endo -76.57 -26.9 8.04 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.355 2.037 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.51 68.33 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 3.0 mmmm -101.55 25.31 8.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 67.46 66.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 69.32 -106.64 1.85 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 51.33 80.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.255 . . . . 0.0 109.578 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.9 153.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 171' ' ' VAL . 11.7 t -128.07 81.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.705 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.5 t-105 -61.4 97.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 109.168 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -52.68 -49.14 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 176' ' ' PHE . . . 149.43 154.26 6.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -68.54 153.86 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -1.196 . . . . 0.0 109.214 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 56.7 m-85 -129.4 172.91 11.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.754 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -77.02 -30.11 55.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 109.854 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.519 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.5 p -145.65 -174.07 4.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.015 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -81.81 -28.62 33.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.673 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -70.61 -34.46 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 109.624 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -73.32 -44.42 58.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.133 -0.979 . . . . 0.0 109.452 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.96 -30.2 68.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.958 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.98 -41.49 67.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.301 -0.875 . . . . 0.0 109.105 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.75 94.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.302 -0.873 . . . . 0.0 109.16 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.18 -22.9 66.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -0.809 . . . . 0.0 108.935 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.3 t80 -69.79 -33.9 73.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 109.081 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.489 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 18.9 m-20 -67.68 -43.85 79.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.429 -0.795 . . . . 0.0 109.472 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -58.9 -40.53 84.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.773 . . . . 0.0 109.84 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.89 -20.75 38.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.89 -8.9 48.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.3 t80 -101.96 -33.95 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.284 -0.885 . . . . 0.0 108.924 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -76.4 -40.95 49.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 108.782 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.01 -31.61 64.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.576 -0.702 . . . . 0.0 109.484 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.7 mtt85 -105.81 1.82 27.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 49.3 -99.07 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER -48.2 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 109.737 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -42.77 160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.778 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -157.72 37.0 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 109.273 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.472 ' C ' HD23 ' A' ' 200' ' ' LEU . 7.8 mp 39.89 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.718 -0.614 . . . . 0.0 109.869 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 200' ' ' LEU . 0.1 OUTLIER -111.91 173.93 6.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.972 . . . . 0.0 109.401 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.59 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.0 -34.54 68.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.7 m-85 -122.67 80.42 48.16 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.58 2.186 . . . . 0.0 110.65 -179.421 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.914 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 99.9 4.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.2 -25.21 7.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 183' ' ' ALA . 52.0 t -86.79 126.14 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -1.191 . . . . 0.0 110.046 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -104.4 110.98 23.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.558 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 pm0 -75.88 144.63 41.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 156.62 53.32 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.158 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.03 3.51 6.96 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.552 2.168 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -96.19 -13.84 23.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.79 26.41 6.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.493 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -133.76 -173.78 3.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -1.155 . . . . 0.0 109.527 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 65.7 m-85 -149.0 -177.59 5.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.351 -0.843 . . . . 0.0 109.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.754 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.77 108.24 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.842 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.706 ' C ' HD12 ' A' ' 173' ' ' LEU . . . -79.94 108.82 13.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 108.993 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER -126.47 155.16 42.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -0.947 . . . . 0.0 109.966 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 171' ' ' VAL . 7.5 tt -141.55 117.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.387 -0.82 . . . . 0.0 109.015 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -89.99 126.05 35.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -111.11 103.9 55.48 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 0.0 109.395 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.98 -25.12 9.19 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.307 2.005 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.92 -18.71 64.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 39.16 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.93 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.2 m120 55.53 46.05 23.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.42 121.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.61 128.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -1.137 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -95.26 148.62 22.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 161' ' ' ILE . 41.6 t -133.48 89.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.754 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.5 t-105 -75.36 102.9 5.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.063 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 159' ' ' ALA . 3.6 mt -57.67 -57.8 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.665 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 161.88 157.01 8.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.47 153.21 41.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -1.128 . . . . 0.0 109.227 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.759 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.8 m-85 -127.06 178.11 6.21 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.913 . . . . 0.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.51 -30.86 24.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -138.64 176.81 8.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.273 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.86 -23.09 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.439 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -74.45 -35.05 63.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.14 -37.83 53.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.57 -32.85 66.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.226 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.914 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.84 -37.28 59.15 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -66.34 -39.58 89.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.086 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.88 -23.34 62.28 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -73.14 -29.81 63.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.505 -0.747 . . . . 0.0 109.0 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.653 ' HB3' HD13 ' A' ' 200' ' ' LEU . 39.5 m-20 -69.74 -50.15 46.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.266 -0.897 . . . . 0.0 109.55 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -60.09 -35.84 76.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 109.946 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -80.96 -24.67 37.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.159 -0.963 . . . . 0.0 109.521 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.8 -1.85 57.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -106.51 -27.89 10.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.606 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -40.32 23.72 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -74.24 -33.77 63.44 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.588 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 5.5 mtt180 -86.74 -13.02 46.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 53.97 -92.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 195' ' ' GLY . 9.3 p -54.17 -167.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.3 mtm105 -42.77 156.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.454 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.588 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -156.31 155.23 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -100.39 118.25 36.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -129.17 179.94 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.619 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -76.53 -31.45 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.14 75.26 30.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.311 -1.434 0 C-N-CA 122.661 2.24 . . . . 0.0 110.638 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.986 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.7 m-85 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.458 ' CG ' ' O ' ' A' ' 147' ' ' ARG . 1.7 ptt180 -67.83 125.06 25.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.126 -0.984 . . . . 0.0 108.718 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.04 20.9 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -88.94 106.44 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.772 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -80.16 108.45 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.613 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -72.0 160.17 32.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 110.51 -178.798 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HG2' ' CA ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.58 169.15 18.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.851 -0.531 . . . . 0.0 112.334 -178.046 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 152' ' ' ARG . 37.3 Cg_endo -85.17 -16.24 5.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.567 2.178 . . . . 0.0 106.986 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -145.64 -67.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.647 ' CA ' ' HG2' ' A' ' 152' ' ' ARG . . . -147.68 113.22 0.63 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 147.79 148.31 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 117.856 0.828 . . . . 0.0 110.1 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.103 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 51.4 m-85 -139.84 170.44 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.449 -1.407 . . . . 0.0 108.645 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -141.99 113.36 7.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -81.96 118.46 22.98 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 1.5 tt0 -141.18 158.36 44.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 109.864 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.5 tt -151.85 125.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -88.71 118.94 28.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -99.33 117.38 64.06 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.62 -26.42 7.08 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.355 2.037 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -14.98 62.64 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -103.21 32.62 3.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.679 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.43 54.98 1.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 45.83 65.98 1.8 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.98 98.31 6.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 160' ' ' GLU . 7.5 mtt180 -48.69 166.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 171' ' ' VAL . 7.2 t -143.96 86.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.161 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.727 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.3 t-105 -70.77 96.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.25 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.01 -42.74 76.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 176' ' ' PHE . . . 146.06 152.06 5.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.727 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.4 p -66.68 179.36 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.223 -1.163 . . . . 0.0 109.464 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 70.4 m-85 -155.56 -173.93 4.75 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 0.0 109.141 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' C ' ' CG2' ' A' ' 178' ' ' THR . 32.9 tt0 -97.37 -17.94 19.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.617 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 7.3 p -152.32 169.45 22.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.786 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.103 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.33 -22.79 61.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -73.09 -41.95 63.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -34.79 67.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.431 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -74.66 -31.27 61.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.266 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.986 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.8 -40.17 66.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.47 -48.46 81.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.67 ' O ' HD22 ' A' ' 173' ' ' LEU . . . -63.28 -28.56 70.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.552 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.0 t80 -68.34 -28.1 66.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.514 ' CB ' HD13 ' A' ' 200' ' ' LEU . 5.0 m-20 -72.64 -37.02 68.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -64.67 -36.21 83.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 110.196 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.25 -41.86 24.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.826 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.659 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -71.96 -5.95 38.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.734 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.1 t80 -104.81 -44.03 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.048 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -40.11 94.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.0 mtm -80.44 -43.3 21.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.569 -0.707 . . . . 0.0 109.54 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 196' ' ' SER . 14.1 mtt180 -102.78 33.19 3.31 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.449 -0.782 . . . . 0.0 109.415 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -41.98 94.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 194' ' ' ARG . 12.2 p 170.28 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.268 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 35.5 11.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.19 145.55 46.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -82.35 135.65 35.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.716 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -138.59 -174.56 3.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.853 . . . . 0.0 109.127 -179.982 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.645 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -68.94 -36.39 77.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.3 m-85 -119.15 76.32 15.85 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.3 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 122.631 2.221 . . . . 0.0 110.801 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.816 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.9 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.15 84.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.9 -32.62 1.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 183' ' ' ALA . 48.3 t -77.21 144.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 8.7 ttm-85 -123.83 97.34 5.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.063 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.552 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 5.4 pt20 -87.57 135.62 33.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.329 -0.857 . . . . 0.0 109.345 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -89.36 -173.99 0.43 Allowed Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -74.37 81.05 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.411 1.408 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.2 m0 63.17 74.85 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.63 -0.669 . . . . 0.0 109.309 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 152' ' ' ARG . . . -170.5 -99.99 0.13 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.156 -1.497 . . . . 0.0 111.003 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.41 -178.23 3.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -1.134 . . . . 0.0 110.755 -178.334 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.696 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 8.3 m-85 -132.47 179.76 5.93 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.55 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.28 112.61 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.881 -1.137 . . . . 0.0 110.446 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.38 119.29 28.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 6.6 mt-10 -137.91 170.42 16.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.872 -179.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.456 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.3 tt -159.22 156.38 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.456 ' N ' HG12 ' A' ' 161' ' ' ILE . 42.0 ttp180 -96.38 129.67 43.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.738 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.432 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 10.6 t0 -113.31 106.17 54.74 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.236 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.83 -23.59 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.413 2.075 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.23 -19.61 62.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.282 -0.886 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -100.84 46.97 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.74 38.9 21.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 58.88 53.79 43.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.15 138.5 39.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -1.144 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -67.39 163.24 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 171' ' ' VAL . 40.5 t -139.06 94.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.605 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -82.69 94.13 7.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 109.028 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.88 HD21 ' HB2' ' A' ' 189' ' ' ALA . 13.6 mt -51.25 -41.73 60.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 109.134 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 142.58 152.76 5.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.605 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -67.28 152.61 45.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -1.107 . . . . 0.0 109.444 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -127.06 179.11 5.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.167 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 -25.43 28.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.819 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.7 p -147.5 -174.15 4.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.51 -23.99 29.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.781 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -34.29 65.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 109.615 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.64 -43.92 36.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.03 -47.1 81.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 109.17 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.816 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.53 -38.39 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.38 -52.31 65.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 108.915 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -62.65 -18.55 62.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.5 t80 -75.65 -34.6 60.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.878 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 26.7 m-20 -61.67 -47.64 84.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.567 -0.708 . . . . 0.0 109.597 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.37 85.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -73.25 -17.01 61.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.535 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -87.41 -19.65 27.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.238 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.532 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 5.5 t80 -93.59 -31.49 14.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -38.91 67.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.432 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -74.12 -52.13 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -86.41 -50.23 7.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.463 -0.773 . . . . 0.0 109.241 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 50.79 176.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 197' ' ' ARG . 33.9 t 58.81 71.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.634 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER 50.12 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.967 . . . . 0.0 109.535 179.839 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -125.39 163.36 22.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 pp -92.83 127.54 38.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -133.23 152.74 51.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.29 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.721 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -48.89 -38.99 24.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.145 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.0 m-85 -120.85 89.47 45.56 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 110.88 -179.289 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.8 m-85 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -76.86 85.28 3.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.865 . . . . 0.0 109.352 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.56 -23.27 3.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 94.7 t -88.13 137.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.398 -1.06 . . . . 0.0 109.301 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 14.6 tpp180 -124.82 103.64 8.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.84 . . . . 0.0 109.244 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 60.1 tt0 -61.89 169.27 2.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -128.57 163.36 45.33 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.341 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 35.1 Cg_endo -76.63 76.08 4.16 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.577 2.185 . . . . 0.0 110.319 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER 168.86 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.535 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 156' ' ' LYS . . . 159.86 41.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.6 mmtt -137.49 179.8 6.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.513 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.09 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.1 m-85 -149.83 -179.99 7.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.74 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.32 113.25 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.637 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.79 119.08 25.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 108.936 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -140.5 152.24 45.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 3.5 tt -137.26 132.33 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 99.2 12.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.64 116.13 65.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.619 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.98 -23.6 9.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.39 2.06 . . . . 0.0 110.295 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.24 -22.33 62.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.453 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -96.98 44.79 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.576 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.11 20.53 5.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.3 43.21 7.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.79 109.86 21.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -54.9 150.13 10.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.064 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.9 t -131.19 86.63 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.74 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.1 t-105 -74.15 99.7 3.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.1 mt -53.54 -54.48 36.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.458 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 156.13 153.09 6.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -66.72 152.85 44.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -1.069 . . . . 0.0 109.357 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.705 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 63.9 m-85 -126.53 -173.1 2.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.885 . . . . 0.0 109.541 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.51 -28.75 15.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.7 p -140.75 171.91 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 109.423 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.09 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -75.97 -25.04 55.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -74.05 -35.94 64.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -75.13 -40.15 59.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 108.994 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.98 -31.02 67.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.316 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.964 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.89 -38.08 64.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.338 -0.851 . . . . 0.0 108.817 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 187' ' ' ASP . 43.8 tp -64.14 -45.2 89.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.448 -0.783 . . . . 0.0 109.102 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.55 -27.85 68.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 108.888 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -66.86 -30.79 71.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.212 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.498 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.7 m-20 -67.89 -55.0 14.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.296 -0.877 . . . . 0.0 109.423 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -31.59 37.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.531 -0.73 . . . . 0.0 109.919 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.58 -29.47 30.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.834 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -86.75 -1.32 57.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -103.33 -31.14 10.2 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 108.89 179.613 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -77.75 -40.59 40.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.327 -0.858 . . . . 0.0 108.961 179.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.6 mtp -81.16 -32.07 33.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.606 -0.684 . . . . 0.0 110.378 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -91.18 -1.62 57.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 83.13 -150.05 27.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.57 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 p -63.01 -97.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 109.833 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 11.6 mtm180 -48.99 153.14 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.814 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 178.8 160.91 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.1 mp -98.38 111.53 23.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.59 172.1 9.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 108.987 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.601 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.55 -33.28 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.237 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 6.8 m-85 -121.46 75.36 33.49 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 122.611 2.207 . . . . 0.0 110.417 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -78.23 83.02 4.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.202 -0.936 . . . . 0.0 109.284 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 144.21 -23.36 2.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.884 HG11 ' HA ' ' A' ' 179' ' ' ALA . 6.1 t -102.12 122.93 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.259 . . . . 0.0 109.735 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 9.3 mtt180 -122.03 171.61 8.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 151' ' ' GLN . 9.4 pm0 -138.2 143.54 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 109.597 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.7 mtt85 -104.41 169.59 7.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.726 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.4 Cg_endo -78.18 8.02 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.764 2.31 . . . . 0.0 110.93 -179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -35.28 7.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.456 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 128.31 45.77 0.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 21.7 mttt -149.59 134.86 18.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.165 . . . . 0.0 109.618 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD2' ' C ' ' A' ' 178' ' ' THR . 5.4 m-30 -98.38 -168.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 108.671 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.727 ' HB1' ' OE2' ' A' ' 160' ' ' GLU . . . -162.91 126.31 2.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -106.57 113.78 27.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.727 ' OE2' ' HB1' ' A' ' 158' ' ' ALA . 2.7 mp0 -131.04 174.77 9.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.436 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.3 tt -168.6 140.62 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -0.797 . . . . 0.0 109.148 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -73.67 152.76 40.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.0 109.66 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.446 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 58.1 t0 -123.08 95.49 45.91 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.93 -27.86 6.64 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.527 2.151 . . . . 0.0 110.056 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.49 -28.44 69.83 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.446 -0.784 . . . . 0.0 109.099 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.446 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -95.25 27.37 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 0.0 109.534 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.88 72.54 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.65 106.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 163' ' ' ASP . . . -169.07 102.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.9 148.36 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 171' ' ' VAL . 32.0 t -133.03 94.92 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 160' ' ' GLU . 3.4 t-105 -82.77 100.33 10.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.609 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.5 mt -55.51 -55.37 32.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.15 161.08 10.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -74.59 153.18 39.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.218 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.761 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 54.2 m-85 -127.11 -167.59 1.76 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.68 -28.45 11.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.002 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.4 p -147.0 -179.81 7.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.884 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -76.94 -33.41 57.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.79 -37.9 88.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.064 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -70.66 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.483 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -46.36 -27.59 1.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.256 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.37 -45.65 62.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.44 -39.05 93.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.684 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.36 -28.2 64.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.8 t80 -71.33 -30.84 66.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.447 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.0 m-20 -67.85 -45.21 75.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.964 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -37.8 83.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.687 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.609 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.83 -20.35 35.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.52 -0.6 56.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -109.78 -31.38 7.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.145 -0.972 . . . . 0.0 108.599 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.54 -40.39 21.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.2 ttm -75.26 -31.59 60.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.753 -0.592 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.3 mtt180 -95.5 -17.45 21.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' SER . . . 47.68 -106.28 0.16 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 197' ' ' ARG . 83.8 p -40.34 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -1.046 . . . . 0.0 110.165 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.6 OUTLIER 46.17 -173.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.833 . . . . 0.0 109.649 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 170.73 152.59 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.8 mt -101.75 108.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.526 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -123.17 -175.64 3.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -78.59 -37.86 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 108.875 179.7 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.615 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 4.5 m-85 -115.6 82.26 9.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.491 -0.756 . . . . 0.0 109.173 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.753 2.302 . . . . 0.0 110.563 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.961 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.2 m-85 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.26 0.552 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.81 131.19 45.08 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.287 -0.883 . . . . 0.0 108.963 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.63 -35.93 3.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.9 t -81.19 113.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.272 . . . . 0.0 109.996 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -95.88 114.44 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 19.8 pt20 -97.43 128.74 44.47 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.866 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mtp180 -75.62 169.59 19.85 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 29.4 Cg_endo -69.85 83.79 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.18 1.253 . . . . 0.0 109.605 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 61.6 m95 63.27 63.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -155.06 -106.45 0.26 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.589 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.55 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 5.4 mttp -111.19 -169.67 1.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.335 -1.097 . . . . 0.0 110.514 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.933 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.4 m-85 -143.59 173.56 11.54 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.45 109.06 3.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.851 -1.156 . . . . 0.0 110.305 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.87 124.96 29.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.166 -0.959 . . . . 0.0 108.882 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 136.45 31.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.952 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 161' ' ' ILE . 2.7 tt -128.78 120.53 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.17 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.29 144.74 29.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 0.0 109.585 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.437 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 32.1 t0 -124.34 116.52 26.92 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.925 . . . . 0.0 109.317 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 36.2 Cg_endo -77.04 -31.03 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.528 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -25.42 67.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -89.03 44.76 1.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.18 53.7 10.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.36 94.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -147.86 111.16 4.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 144.48 54.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.303 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 53.3 t -122.93 94.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.669 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.6 t-105 -72.75 98.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' CB ' ' A' ' 189' ' ' ALA . 1.1 mt -57.91 -45.48 86.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.797 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 149.8 162.96 10.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -79.51 158.14 27.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.23 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 75.1 m-85 -133.84 175.39 9.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.0 tp10 -82.37 -30.7 30.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.683 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -143.31 167.6 21.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.933 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.77 -22.47 65.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -38.68 69.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.92 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -75.47 -37.12 60.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.91 -34.74 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.188 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.961 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.43 -39.65 67.71 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -63.63 -42.86 98.12 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.574 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.467 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.41 -32.79 73.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.556 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.6 t80 -62.98 -30.49 71.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.148 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 16.0 m-20 -69.7 -41.79 74.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.378 -0.826 . . . . 0.0 109.657 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -63.72 -40.19 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 110.594 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.994 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.08 -25.95 34.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.987 -1.071 . . . . 0.0 109.94 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.29 -18.19 39.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.439 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.7 t80 -85.39 -36.24 20.84 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.083 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -66.64 -42.18 87.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.437 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 7.2 tpp -80.52 -41.78 23.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.792 . . . . 0.0 109.445 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 18.6 mtt180 -100.71 33.37 2.79 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 108.959 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -39.52 161.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 76.94 85.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 108.983 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.565 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 71.83 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 108.999 -179.492 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 67.02 162.47 0.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 110.061 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.492 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.7 mt -116.52 113.25 22.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.0 159.78 27.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.612 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -59.03 -32.87 70.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.427 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.35 88.75 29.27 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.698 2.266 . . . . 0.0 110.637 -179.358 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.5 m-85 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.363 0.601 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -79.53 85.84 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.945 . . . . 0.0 109.935 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.35 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.415 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 179' ' ' ALA . 96.8 t -109.18 116.95 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.38 . . . . 0.0 110.325 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -83.82 146.02 28.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.2 pt20 -142.01 132.58 25.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.557 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -84.1 178.7 2.25 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.5 Cg_endo -77.09 79.27 3.18 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.179 1.92 . . . . 0.0 109.549 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 23.7 t-105 72.6 60.83 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -153.31 -108.8 0.36 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.704 -179.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.544 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 14.6 mmtt -113.24 -171.7 1.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -1.137 . . . . 0.0 110.694 -178.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.896 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.5 m-85 -141.81 -170.9 3.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -161.22 110.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.951 -1.093 . . . . 0.0 110.446 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -83.68 107.16 15.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.523 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 27.9 mt-10 -132.32 152.11 51.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.13 -0.981 . . . . 0.0 109.739 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.41 133.06 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.214 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.62 139.61 33.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 28.7 t0 -123.87 107.24 31.14 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.169 -0.957 . . . . 0.0 109.291 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.63 -28.28 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.268 1.978 . . . . 0.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -25.91 67.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.429 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 10.4 mmtt -90.86 43.45 1.15 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.88 27.17 15.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.54 58.43 3.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.24 95.35 6.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -1.129 . . . . 0.0 109.545 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.06 162.12 1.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.84 95.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.04 -1.038 . . . . 0.0 110.153 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.523 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 2.8 t-105 -79.99 106.54 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 29.0 mt -64.16 -47.01 81.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 109.715 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.62 157.09 7.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -76.49 156.65 32.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 -179.8 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.604 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.6 m-85 -133.01 177.36 7.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 3.2 pt-20 -82.55 -31.63 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.162 -0.961 . . . . 0.0 109.786 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 p -141.26 175.36 9.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 109.777 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.896 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.1 -22.53 59.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.656 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.55 -49.13 51.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 1.4 m-20 -64.2 -50.39 68.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -56.19 -52.4 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -52.39 -42.12 63.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.57 -41.78 90.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.77 -22.29 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.8 . . . . 0.0 109.185 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 21.2 t80 -71.51 -36.59 71.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.87 ' HB3' HD13 ' A' ' 200' ' ' LEU . 6.3 m-20 -65.52 -50.85 63.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.11 -34.74 58.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.49 -0.756 . . . . 0.0 110.101 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.79 -19.85 26.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.054 -1.028 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 194' ' ' ARG . . . -92.14 -5.43 52.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.431 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.6 t80 -102.76 -34.13 9.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.221 -0.924 . . . . 0.0 108.611 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -79.34 -40.69 29.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.2 ttp -83.12 -30.05 28.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.609 -0.682 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -99.77 -9.23 23.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 -179.727 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 42.19 -163.63 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.6 OUTLIER 48.39 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -1.14 . . . . 0.0 109.562 179.874 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 198' ' ' ALA . 0.7 OUTLIER -57.28 -47.02 82.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 197' ' ' ARG . . . 59.39 149.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.438 -0.789 . . . . 0.0 109.722 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 17.3 mt -97.75 124.04 41.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.87 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.62 169.23 14.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.93 . . . . 0.0 109.387 -179.906 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.734 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -63.29 -36.07 82.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.039 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 2.8 m-85 -127.18 81.66 69.56 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.635 2.223 . . . . 0.0 110.775 -179.436 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.5 m-85 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.406 0.622 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.28 110.62 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.73 -20.7 14.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.8 t -92.59 110.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -1.12 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 112.39 24.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 108.954 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -75.63 153.74 37.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 110.02 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.1 mtp180 -132.52 174.87 4.2 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.3 Cg_endo -77.66 167.53 23.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.11 1.873 . . . . 0.0 110.069 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 74.92 -80.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.191 -179.47 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 156' ' ' LYS . . . 174.99 67.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 mmtt -146.35 164.05 33.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.051 -1.264 . . . . 0.0 110.069 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.813 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.7 m-85 -148.31 179.61 7.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.526 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.51 107.78 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.028 -1.045 . . . . 0.0 109.991 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.85 117.13 21.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.032 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.455 ' OE2' ' HD2' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -141.76 140.45 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.53 -179.771 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.533 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.2 tt -125.38 159.42 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.533 ' N ' HG12 ' A' ' 161' ' ' ILE . 8.7 ttt180 -97.78 115.05 27.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 193' ' ' MET . 19.1 t0 -99.25 110.12 57.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.1 Cg_endo -77.63 -27.72 5.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.3 2.0 . . . . 0.0 110.168 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.71 -21.68 64.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.348 -0.845 . . . . 0.0 109.555 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 2.7 mttt -90.66 23.15 3.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.448 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 76.51 40.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.626 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.42 86.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.35 177.82 8.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -1.081 . . . . 0.0 109.417 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.455 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 0.9 OUTLIER -100.99 163.87 12.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.678 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.8 t -140.39 85.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.0 109.045 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.526 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.9 t-105 -73.2 97.12 2.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.395 -0.816 . . . . 0.0 109.883 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.1 mt -59.6 -41.06 89.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.88 . . . . 0.0 109.257 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.428 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 147.52 166.6 12.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -83.72 153.68 24.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -1.194 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.774 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -126.72 -177.5 4.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.659 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 -30.97 16.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 1.7 p -138.72 167.45 21.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.813 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.25 -41.21 67.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.293 -0.879 . . . . 0.0 109.79 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.7 OUTLIER -71.22 -40.74 70.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.56 -30.34 67.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.3 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.923 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.15 -34.04 61.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.143 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -66.72 -42.09 86.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 109.044 179.635 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.03 -22.72 64.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.2 t80 -77.32 -32.2 55.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.238 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 97.6 m-20 -67.55 -41.44 84.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -70.05 -35.91 74.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.867 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.894 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.51 -24.22 50.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.656 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.95 -26.74 27.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 195' ' ' GLY . 5.7 t80 -83.11 -23.55 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -43.74 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.43 ' HE1' ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -75.01 -32.36 61.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.02 -179.658 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 4.9 mtt-85 -96.69 -13.28 22.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.283 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 191' ' ' PHE . . . 74.86 -125.2 8.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 191' ' ' PHE . 0.8 OUTLIER -71.68 172.37 9.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -1.094 . . . . 0.0 109.97 -179.559 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 54.04 -117.64 1.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.408 -0.807 . . . . 0.0 109.608 179.743 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.35 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.692 -1.255 . . . . 0.0 109.317 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 199' ' ' LEU . 5.8 mt -85.04 130.13 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.705 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.527 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.66 166.16 18.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.806 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.629 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -63.0 -31.91 73.16 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.327 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.453 ' HD2' HD22 ' A' ' 184' ' ' LEU . 7.2 m-85 -120.06 77.17 23.64 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 122.699 2.266 . . . . 0.0 110.562 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 20.4 m-85 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -82.35 92.46 6.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 186' ' ' TYR . . . 123.39 -5.58 9.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -108.96 120.72 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -1.159 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -97.07 118.65 33.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.493 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -89.36 149.45 23.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.606 -179.805 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mmt180 -120.51 158.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.52 8.81 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.616 2.21 . . . . 0.0 110.876 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.29 -13.33 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 105.4 49.21 0.99 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 8.8 mtmm -150.07 -174.74 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -1.165 . . . . 0.0 109.54 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 76.8 m-85 -153.99 178.35 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.271 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.723 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.12 111.15 4.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.683 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.91 118.43 24.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.345 -0.847 . . . . 0.0 108.96 179.46 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 19.2 mt-10 -137.42 179.55 6.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 109.28 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.2 tt -169.63 130.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -63.36 153.05 36.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.857 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.93 103.71 3.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.45 -25.33 9.79 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.42 2.08 . . . . 0.0 110.321 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.6 66.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 109.168 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 44.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 0.0 109.473 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t30 51.08 57.16 6.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.417 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 51.24 79.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -141.31 131.15 24.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -1.203 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -73.28 143.53 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.1 t -111.77 105.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.723 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.7 t-105 -89.69 95.57 10.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -53.58 -42.87 68.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 146.64 158.17 7.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.488 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.2 p -74.36 159.36 32.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -1.045 . . . . 0.0 109.516 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.9 m-85 -133.45 174.91 9.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.43 -30.42 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.6 p -137.54 -176.98 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.907 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.52 -30.15 25.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -68.05 -32.21 72.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.958 . . . . 0.0 109.584 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.415 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -75.67 -48.59 21.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.306 -0.871 . . . . 0.0 109.025 179.862 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -66.61 -21.69 66.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 108.912 179.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.59 -45.77 24.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' LEU . 17.9 tp -62.56 -40.75 97.86 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.17 -24.71 63.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 108.919 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 160' ' ' GLU . 14.6 t80 -70.77 -32.17 69.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -69.04 -45.61 69.97 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -58.29 -35.22 71.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.509 -0.744 . . . . 0.0 110.176 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.016 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.83 -33.63 34.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -86.95 -2.41 58.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.202 -0.937 . . . . 0.0 109.217 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.485 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 25.4 t80 -103.25 -24.47 13.54 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.295 -0.878 . . . . 0.0 109.113 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -84.48 -40.9 17.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 108.785 179.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -31.33 57.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.621 -0.674 . . . . 0.0 109.868 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 43.8 mtt180 -100.86 -18.82 16.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 47.57 -176.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.41 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.311 -1.111 . . . . 0.0 109.732 179.952 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.3 140.04 48.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.61 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.491 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -144.83 163.58 33.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.506 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -82.45 105.61 13.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.682 -179.773 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.86 164.97 17.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 108.998 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.497 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -66.4 -33.0 74.73 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.128 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.4 m-85 -124.54 76.06 63.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.683 2.255 . . . . 0.0 110.558 -179.471 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.944 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.4 92.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.15 -32.06 3.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.5 t -77.8 133.64 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -1.216 . . . . 0.0 109.801 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.5 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -121.41 107.01 11.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.324 179.898 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.597 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.3 pt20 -75.09 164.61 26.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.471 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.9 mtt-85 -127.81 172.11 7.33 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.678 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.02 -30.22 3.72 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.822 2.348 . . . . 0.0 110.704 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -35.36 60.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.657 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.46 34.93 0.43 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -127.23 159.42 34.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -1.165 . . . . 0.0 109.264 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.888 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.5 m-85 -125.19 -179.12 4.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.41 108.29 3.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.31 114.8 19.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.718 179.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -131.18 157.88 42.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.567 -179.727 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 161' ' ' ILE . 1.6 tt -149.8 128.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.551 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.15 8.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 164' ' ' PRO . 48.3 t0 -92.8 117.22 67.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 109.557 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 35.6 Cg_endo -78.19 -26.24 6.5 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.286 1.991 . . . . 0.0 109.899 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.73 -14.63 62.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 6.2 mmtp -101.26 30.16 4.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 41.3 t-20 67.51 28.4 7.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.53 62.5 2.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.8 129.26 55.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -1.128 . . . . 0.0 109.469 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.42 122.52 16.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.504 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 171' ' ' VAL . 21.6 t -101.73 94.69 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.627 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.8 t-105 -69.65 100.73 1.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -59.77 -48.99 79.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.656 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 153.67 152.56 6.09 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.627 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.1 p -69.51 163.71 24.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -1.206 . . . . 0.0 109.131 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 60.7 m-85 -140.0 -177.84 5.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -86.85 -30.01 21.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.626 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -146.71 171.41 15.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.589 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.888 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.82 -22.51 63.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.05 -40.54 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.1 m-20 -71.52 -41.84 68.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.691 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -69.27 -30.38 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.944 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.42 -40.7 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -38.85 89.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.497 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.32 -24.15 63.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.6 t80 -73.93 -29.07 61.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 200' ' ' LEU . 43.4 m-20 -70.26 -49.04 53.89 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.218 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -60.97 -38.49 86.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 109.874 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.44 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -80.5 -21.83 41.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.646 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.92 -14.31 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.76 -27.14 14.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 109.101 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -82.56 -40.36 21.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 2.7 tpp -70.9 -30.56 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.666 -0.647 . . . . 0.0 109.357 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 196' ' ' SER . 2.7 mtt180 -101.13 -12.82 18.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.33 -0.856 . . . . 0.0 109.242 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 52.61 -88.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 194' ' ' ARG . 0.3 OUTLIER -46.3 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -1.093 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' SER . 13.4 mtt180 -40.44 157.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -164.25 156.25 16.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 109.307 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.7 mm? -92.13 127.85 37.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.96 162.67 29.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.141 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.587 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -58.23 -34.69 70.7 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.117 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.5 m-85 -116.58 80.95 10.86 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 33.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.561 2.174 . . . . 0.0 110.311 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 9.2 m-85 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.311 0.577 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.61 87.76 3.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 108.824 179.105 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.97 2.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 179' ' ' ALA . 45.8 t -137.87 108.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.288 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.81 127.62 33.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.426 -0.796 . . . . 0.0 109.009 179.713 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.1 pp0? -104.48 146.64 28.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.944 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.5 164.03 15.89 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.61 37.0 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.836 2.358 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -146.05 -62.28 0.32 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.02 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.99 36.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.63 168.92 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -1.202 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.857 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.3 m-85 -148.36 177.23 9.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.374 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.647 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.15 111.84 4.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.29 110.4 17.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -131.33 149.52 52.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.281 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 17.4 tt -128.21 146.68 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.094 -1.004 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -87.38 130.59 34.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 109.55 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -119.96 94.39 48.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 35.9 Cg_endo -78.26 -22.78 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.578 2.186 . . . . 0.0 110.44 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.46 75.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' LYS . 8.4 mmtt -86.25 63.03 7.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.847 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 168' ' ' GLY . 1.8 m-80 52.67 48.55 22.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 43.41 52.63 6.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.52 130.08 35.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 109.319 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 143.94 46.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 77.1 t -123.19 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.835 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.647 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.8 t-105 -117.01 97.33 5.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.3 mp -54.83 -50.51 68.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.266 -0.896 . . . . 0.0 109.149 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 155.31 153.56 6.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.52 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.4 p -65.36 166.93 9.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -1.046 . . . . 0.0 109.332 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.757 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 65.0 m-85 -144.02 174.51 10.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -25.3 30.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.731 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 2.3 p -149.56 171.06 17.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.56 -25.46 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.46 -42.1 75.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -70.28 -48.59 56.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.202 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.91 -22.82 66.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.922 . . . . 0.0 109.029 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.22 -36.89 46.55 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 108.873 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.859 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -68.05 -45.22 74.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.581 -0.699 . . . . 0.0 109.175 179.491 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.565 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.01 -23.69 65.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.459 -0.775 . . . . 0.0 109.012 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.2 t80 -71.52 -35.38 70.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -0.783 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.6 m-20 -65.64 -41.85 92.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.321 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -41.05 84.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.75 -19.65 37.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.527 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.33 -9.63 52.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -99.12 -31.22 11.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.821 . . . . 0.0 109.271 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -77.98 -42.78 31.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.896 . . . . 0.0 109.116 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 48.0 ttm -69.65 -31.53 69.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.315 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 22.2 mtt-85 -100.86 11.91 38.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 48.57 -154.54 1.76 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 29.6 m -53.45 143.27 19.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -1.119 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.5 mtp85 68.53 138.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 176.47 140.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 199' ' ' LEU . 2.2 mt -81.37 109.3 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -116.0 -178.09 3.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.408 179.755 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.49 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -81.38 -28.81 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.155 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.859 ' HD2' HD22 ' A' ' 184' ' ' LEU . 6.6 m-85 -122.68 70.15 36.33 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.483 0 C-N-CA 122.467 2.112 . . . . 0.0 110.165 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.928 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.4 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.36 89.67 3.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 108.848 179.364 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.48 11.0 3.47 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 182' ' ' ALA . 47.3 t -126.3 109.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.289 . . . . 0.0 109.359 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -93.0 111.34 22.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.443 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.5 pt20 -80.87 151.08 28.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 108.975 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.49 163.89 37.72 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.442 -179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.13 -5.56 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.615 2.21 . . . . 0.0 110.121 -179.88 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -98.23 27.89 4.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 109.273 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.53 60.99 7.98 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -156.44 170.52 22.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 73.4 m-85 -142.64 172.84 12.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.008 179.917 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.649 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.87 105.28 4.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 123.09 28.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.051 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.465 ' CD ' ' CE3' ' A' ' 172' ' ' TRP . 4.3 mt-10 -145.28 153.3 41.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 0.0 109.334 -179.543 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.486 HD11 ' HE ' ' A' ' 194' ' ' ARG . 6.5 tt -141.04 149.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -84.33 117.1 23.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 109.734 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.512 ' HB2' ' CE ' ' A' ' 193' ' ' MET . 67.8 t0 -114.58 102.12 54.66 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -25.53 9.78 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.326 2.017 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.47 -16.12 63.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.863 . . . . 0.0 109.217 179.67 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -93.38 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.7 54.13 9.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.421 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.95 71.26 0.67 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.23 118.55 12.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.494 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -54.21 170.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.4 t -139.84 90.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.656 -179.694 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.649 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.0 t-105 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 109.178 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -52.62 -43.96 65.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 -179.72 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.38 150.39 5.23 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.517 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -63.18 168.78 3.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -1.157 . . . . 0.0 109.327 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.655 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 63.9 m-85 -141.55 -174.14 3.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.515 -179.767 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.74 -24.97 14.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.698 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.598 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.6 p -140.82 174.49 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.68 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.29 -24.83 50.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.328 -0.857 . . . . 0.0 109.363 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -77.02 -30.27 55.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.631 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.598 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -76.08 -40.68 52.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 109.279 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.96 -36.48 69.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.195 -0.941 . . . . 0.0 109.028 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.928 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -69.58 -39.78 77.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.799 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.97 -46.32 88.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 109.004 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.76 -26.87 67.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.475 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 29.8 t80 -68.7 -36.28 78.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.132 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 7.0 m-20 -64.07 -52.15 60.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 109.838 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -56.88 -37.16 70.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.422 -0.799 . . . . 0.0 109.527 -179.76 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.921 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.38 -20.65 50.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.212 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.68 -11.88 43.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.464 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.3 t80 -101.88 -26.67 13.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.119 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -40.63 29.85 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.315 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.512 ' CE ' ' HB2' ' A' ' 163' ' ' ASP . 13.9 mtp -77.93 -44.49 26.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.242 0.544 . . . . 0.0 110.165 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HE ' HD11 ' A' ' 161' ' ' ILE . 24.0 mtt180 -83.51 -37.74 22.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 108.943 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 58.52 145.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ALA . 2.8 m 63.12 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -1.138 . . . . 0.0 109.987 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.3 mmt180 44.26 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.999 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 66.95 144.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.988 . . . . 0.0 109.328 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.12 117.27 34.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.913 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.1 156.06 35.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 179.944 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.582 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -62.82 -32.32 73.5 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.769 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.43 ' O ' HD12 ' A' ' 200' ' ' LEU . 5.8 m-85 -121.05 97.51 47.95 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.094 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.331 2.02 . . . . 0.0 110.6 -179.188 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.703 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.4 m-85 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.158 0.504 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.87 37.64 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.129 179.738 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . -169.95 26.77 0.11 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 179' ' ' ALA . 60.9 t -142.67 117.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -1.091 . . . . 0.0 109.681 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 93.08 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.162 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.47 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 9.9 pt20 -60.65 144.67 51.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.75 -179.748 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -103.88 171.7 4.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.308 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.2 Cg_endo -77.12 -31.81 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -82.6 -74.98 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.73 71.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 56.3 mttt -153.85 168.04 27.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.577 179.925 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.753 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.0 m-85 -150.68 120.67 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 108.737 179.694 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.608 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -93.76 118.87 31.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.748 -178.823 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.15 122.73 30.57 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.308 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 11.2 tt0 -137.69 150.6 47.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.02 . . . . 0.0 110.421 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.3 tt -136.23 137.33 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -86.57 127.46 34.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.834 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -125.05 105.55 28.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.413 -0.805 . . . . 0.0 108.984 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.91 -26.08 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.455 2.103 . . . . 0.0 110.58 -179.737 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.88 -12.0 57.83 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 51.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 56.24 25.05 8.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 -179.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.18 40.92 40.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -100.1 142.87 30.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -84.43 155.7 22.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 161' ' ' ILE . 40.5 t -124.3 100.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.608 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.4 t-105 -80.16 95.29 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.322 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.157 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -50.55 -49.46 55.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.039 -179.641 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.23 155.25 6.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.502 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -68.18 169.97 9.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -1.095 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.2 m-85 -148.2 -170.46 3.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -23.84 13.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.578 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.6 p -144.34 160.05 41.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.302 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.753 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.26 -24.7 66.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.065 -1.022 . . . . 0.0 109.216 179.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.66 -33.22 68.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -76.78 -47.88 20.32 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.021 179.78 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -66.46 -25.62 66.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.17 -0.956 . . . . 0.0 108.954 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.12 -49.94 21.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.112 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -34.09 74.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.438 -0.789 . . . . 0.0 109.032 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.74 -30.63 68.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.5 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -67.77 -27.89 67.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.712 . . . . 0.0 109.109 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 58.5 m-20 -71.19 -45.27 63.78 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.596 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -65.15 -29.03 69.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 110.368 -179.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.157 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.7 -32.65 21.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 110.026 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.99 -18.81 45.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.41 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.3 t80 -91.02 -38.73 12.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.326 -0.859 . . . . 0.0 109.353 179.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -41.85 97.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.09 -1.007 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 3.6 ttm -79.95 -43.1 22.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 109.271 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.46 ' O ' ' C ' ' A' ' 195' ' ' GLY . 21.4 mtt180 -101.96 32.96 3.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.515 -0.74 . . . . 0.0 109.162 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -37.94 -32.47 0.12 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -75.74 81.93 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -1.15 . . . . 0.0 109.263 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 61.19 139.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.358 -179.806 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -170.57 144.51 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.6 mm? -98.1 108.99 21.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.671 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -111.1 159.42 17.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.435 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -53.0 -37.81 61.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.094 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.9 m-85 -123.08 86.12 51.15 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.321 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.644 2.229 . . . . 0.0 110.722 -179.02 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.939 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.8 m-85 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -77.82 94.44 4.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.25 -3.4 11.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 49.0 t -108.69 112.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.27 . . . . 0.0 110.057 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.998 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -87.43 111.61 21.31 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.752 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.563 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 8.0 pt20 -90.06 138.62 31.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -178.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.631 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 14.0 mmm-85 -74.86 -166.76 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.1 Cg_endo -76.88 -15.23 16.83 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.313 1.342 . . . . 0.0 110.629 -179.256 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.54 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 158.79 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.496 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.58 -68.93 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.347 179.69 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mttt -116.7 -168.53 1.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.852 -1.381 . . . . 0.0 111.282 -178.16 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.149 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.9 m-85 -154.8 179.46 9.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.998 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . . . -149.2 110.33 4.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 109.993 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.506 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 134.86 35.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.71 134.68 14.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.8 tt -120.11 141.4 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -85.07 129.54 34.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -116.12 92.47 35.62 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.97 -22.35 11.56 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.676 2.251 . . . . 0.0 110.719 -179.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.12 69.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.407 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 35.4 mmtt -85.38 -55.78 3.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 109.473 179.907 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 169' ' ' ALA . 12.6 p30 169.14 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.97 4.5 67.5 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.824 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HB2' ' OD1' ' A' ' 167' ' ' ASN . . . -57.09 108.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.119 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 142.86 29.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.265 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.1 t -115.65 83.18 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 174' ' ' GLY . 3.5 t-105 -65.32 100.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 109.164 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.8 mt -61.61 -41.48 97.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.687 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 144.29 174.0 16.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.846 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -92.06 157.36 16.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.252 . . . . 0.0 109.148 179.753 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 78.7 m-85 -130.53 -176.51 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.815 -179.53 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -89.14 -20.12 24.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 4.0 p -147.97 175.41 11.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.95 . . . . 0.0 109.87 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.149 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.7 -22.21 47.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.45 -0.781 . . . . 0.0 109.45 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.6 tm-20 -76.83 -32.43 57.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.78 -36.12 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.927 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.27 -43.92 60.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 108.895 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.939 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -63.34 -37.15 86.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.361 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -64.98 -46.71 80.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.521 -0.737 . . . . 0.0 109.11 179.495 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.98 -18.8 64.64 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.5 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -74.14 -38.12 63.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.041 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.55 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.2 m-20 -62.16 -49.87 74.12 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.449 -0.782 . . . . 0.0 109.37 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -52.11 -44.84 64.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.618 -0.676 . . . . 0.0 109.925 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.855 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.32 -19.15 54.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 109.702 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -92.27 -4.55 53.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.883 . . . . 0.0 109.586 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.434 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.1 t80 -108.38 -29.8 8.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -85.04 -37.75 19.98 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.016 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.7 ttm -77.88 -35.61 50.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.737 -0.602 . . . . 0.0 109.562 179.704 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.646 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 4.5 mtp180 -94.26 -23.57 17.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.139 -0.976 . . . . 0.0 108.886 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 53.2 170.29 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.986 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 43.61 -159.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -1.211 . . . . 0.0 109.664 179.898 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.25 153.84 3.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.579 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.646 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -160.86 168.18 25.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.4 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.598 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -105.43 104.83 14.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.998 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.75 162.96 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.983 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.725 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -65.7 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.606 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 184' ' ' LEU . 7.2 m-85 -119.1 80.29 19.04 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.7 Cg_endo . . . . . 0 C--N 1.309 -1.524 0 C-N-CA 122.566 2.178 . . . . 0.0 110.285 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.687 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 65.9 m-85 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -81.01 36.07 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.616 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.431 ' HA3' ' CD2' ' A' ' 186' ' ' TYR . . . -176.8 27.3 0.07 OUTLIER Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.664 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 179' ' ' ALA . 78.6 t -150.67 139.8 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -1.204 . . . . 0.0 109.648 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -110.55 160.1 16.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 108.991 179.489 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.0 pt20 -131.37 146.15 52.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.043 -1.036 . . . . 0.0 110.115 -179.48 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.478 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.8 OUTLIER -121.63 160.55 45.93 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.759 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -77.78 -4.43 14.5 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 110.776 -179.848 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -98.08 -7.35 29.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.504 179.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.28 47.46 1.85 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 9.2 mtpp -146.74 140.72 26.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.161 . . . . 0.0 109.513 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.703 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 7.0 m-85 -119.98 -170.28 1.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.917 . . . . 0.0 109.376 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.62 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -156.43 110.51 2.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 179.892 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -81.11 119.78 24.0 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.44 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 12.3 mt-10 -136.94 153.89 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.827 . . . . 0.0 109.603 -179.67 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 190' ' ' ALA . 5.8 tt -141.61 138.91 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 108.979 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.47 131.39 35.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.756 -179.664 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -124.73 90.81 50.41 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.51 -23.33 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.549 2.166 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.46 -9.89 29.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 15.0 mmtp -104.37 23.7 12.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 26.8 t-20 64.34 45.14 3.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.06 110.74 0.12 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 170' ' ' ARG . . . -177.11 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -1.179 . . . . 0.0 109.466 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -43.2 163.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 161' ' ' ILE . 92.7 t -135.15 91.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.955 . . . . 0.0 109.864 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.789 ' HZ2' HG22 ' A' ' 175' ' ' THR . 10.8 t-105 -75.31 92.38 2.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 108.882 179.464 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.027 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -52.31 -46.11 65.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.224 -179.741 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.25 156.37 7.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.678 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.789 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.6 p -73.21 153.27 40.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -1.082 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.2 m-85 -128.99 -170.97 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 -32.38 14.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.277 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.562 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -141.41 173.89 11.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.226 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.703 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.27 -24.58 61.37 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -70.63 -37.7 73.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.867 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.97 -43.81 51.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.072 -1.018 . . . . 0.0 109.205 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -24.81 63.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 108.997 179.717 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.687 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.59 -44.9 40.72 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.874 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -61.68 -43.52 98.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.573 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.83 -32.23 73.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 108.827 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -64.46 -29.62 70.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.325 -0.859 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.61 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.1 m-20 -72.92 -43.56 62.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.382 -0.824 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.03 -23.94 67.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.772 . . . . 0.0 110.127 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.027 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -92.72 -31.9 14.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.011 -1.056 . . . . 0.0 109.761 -179.708 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.601 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -83.93 -10.83 57.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.235 -0.915 . . . . 0.0 109.099 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -100.38 -41.15 7.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 179.542 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -41.24 94.34 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.32 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 ttp -75.73 -42.75 49.81 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 109.177 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 37.4 mtt180 -104.0 33.95 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.48 -0.763 . . . . 0.0 109.095 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -38.29 109.3 0.09 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 1.4 t 162.87 -71.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -1.071 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 62.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.785 . . . . 0.0 109.214 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.27 160.92 21.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.859 . . . . 0.0 109.627 -179.783 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -91.88 124.18 35.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 108.988 179.437 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.97 177.03 5.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.482 -179.59 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.5 OUTLIER -63.92 -34.88 78.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.327 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.874 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.1 m-85 -122.66 79.66 48.03 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.311 -1.406 0 C-N-CA 122.817 2.344 . . . . 0.0 110.742 -179.364 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' ARG . 3.2 ptt180 -75.13 127.85 34.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.181 179.623 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.28 -21.02 47.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 182' ' ' ALA . 89.3 t -94.3 108.02 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -79.21 147.71 32.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.058 -1.026 . . . . 0.0 108.769 179.339 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.6 pp0? -120.07 140.36 51.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.897 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.441 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mpp_? -115.87 171.43 4.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -78.04 -35.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.63 2.22 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.63 -21.81 66.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.522 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.24 17.62 8.16 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -102.37 174.33 5.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -1.154 . . . . 0.0 109.449 179.905 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.983 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 55.4 m-85 -147.55 -172.86 4.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.006 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.709 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.05 110.34 2.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.75 121.83 25.84 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.204 -0.935 . . . . 0.0 108.915 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -142.92 151.49 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 -179.552 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 5.4 tt -137.33 128.35 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.854 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 5.2 ptt180 -73.48 117.95 15.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -98.73 109.26 52.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 109.602 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.43 -25.13 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.353 2.036 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.16 -17.54 60.9 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.356 -0.84 . . . . 0.0 109.343 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -94.75 26.93 3.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 63.56 48.2 3.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.503 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.87 69.2 1.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -127.78 103.97 7.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -1.135 . . . . 0.0 109.389 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 149.13 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.55 HG11 ' HE1' ' A' ' 193' ' ' MET . 29.9 t -127.55 93.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.095 179.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.709 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -73.8 97.43 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.817 -179.614 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.0 OUTLIER -58.38 -38.13 76.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.48 157.04 7.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.81 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.597 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.9 p -73.73 155.63 38.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -1.047 . . . . 0.0 109.784 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.692 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.8 m-85 -131.24 173.95 10.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.5 OUTLIER -85.58 -18.16 34.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 0.0 109.7 -179.854 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.424 ' CG2' ' C ' ' A' ' 177' ' ' GLU . 3.7 p -151.53 173.31 14.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.953 . . . . 0.0 109.592 -179.758 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.95 -24.98 58.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.54 -34.68 65.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.46 -34.11 54.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.377 -0.827 . . . . 0.0 109.269 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.692 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -78.73 -26.98 44.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -0.908 . . . . 0.0 109.319 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.7 -37.58 55.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.134 -0.979 . . . . 0.0 108.688 179.382 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.917 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -62.65 -44.12 97.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.191 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.35 -33.95 77.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.457 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 11.7 t80 -62.73 -35.11 78.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.14 179.624 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.41 -53.26 59.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.503 -0.748 . . . . 0.0 109.901 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -26.78 66.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -88.57 -16.91 31.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.448 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.617 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -93.48 -11.73 31.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -99.84 -33.85 10.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 108.865 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -79.54 -42.29 25.43 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.55 ' HE1' HG11 ' A' ' 171' ' ' VAL . 3.5 tpp -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.644 -0.66 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 194' ' ' ARG . 4.6 mmp_? -102.17 12.59 36.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.03 -156.31 11.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 5.4 p -65.41 154.72 37.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 196' ' ' SER . 10.8 mtt180 62.86 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -161.65 173.66 14.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.3 mt -117.46 125.91 51.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.603 -179.8 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.45 -179.76 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.815 -179.63 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.722 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -75.88 -34.6 59.99 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.128 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.917 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.3 m-85 -123.84 83.61 54.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.86 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.511 2.141 . . . . 0.0 110.508 -179.452 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.297 0.57 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -79.15 76.39 5.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.228 179.647 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.98 -21.33 0.44 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.906 HG11 ' HA ' ' A' ' 179' ' ' ALA . 16.8 t -101.11 109.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.283 . . . . 0.0 109.455 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.77 174.7 5.77 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.608 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.609 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -142.53 133.35 25.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 110.282 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.0 ttm-85 -68.67 -174.95 0.23 Allowed Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.918 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 29.3 Cg_endo -70.75 82.78 0.92 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.17 1.246 . . . . 0.0 110.021 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 7.2 m95 63.7 65.41 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.524 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.62 -132.49 1.35 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.537 -1.315 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -79.23 159.17 27.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.549 -0.971 . . . . 0.0 110.47 -178.756 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 151' ' ' GLN . 8.5 m-30 -101.71 -163.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.586 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -158.35 112.3 2.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.896 -1.127 . . . . 0.0 110.779 -179.906 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -84.94 128.01 34.43 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.381 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -143.76 166.85 23.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.108 -178.942 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.438 HG12 ' N ' ' A' ' 162' ' ' ARG . 1.9 tt -161.74 149.05 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 161' ' ' ILE . 12.6 ptm180 -80.73 153.69 27.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.632 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.25 104.91 25.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.68 -28.49 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.399 2.066 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.81 62.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.093 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -100.67 32.36 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.803 . . . . 0.0 109.494 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 9.2 t-20 69.56 44.13 0.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 61.55 22.37 61.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.47 137.16 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -1.083 . . . . 0.0 109.594 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -69.15 161.7 28.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.3 t -144.44 97.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.268 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.586 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.3 t-105 -79.55 105.82 11.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.622 -179.858 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -59.33 -60.39 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.64 153.98 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -69.3 156.7 38.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.399 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -134.24 -162.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 -179.766 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -25.55 9.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.52 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 2.9 p -145.78 -177.32 5.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.925 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.906 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -79.92 -27.76 39.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 109.29 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.17 -37.66 75.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 -57.3 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 -179.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.822 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -59.27 -31.61 69.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.869 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.87 -42.96 76.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.333 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.8 tm? -61.67 -44.44 96.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.857 . . . . 0.0 108.792 179.556 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.573 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.06 -28.16 69.28 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 27.6 t80 -68.8 -35.39 76.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.552 -0.718 . . . . 0.0 109.138 179.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -60.52 -48.18 82.89 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.323 -0.86 . . . . 0.0 109.594 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -55.14 -42.72 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.644 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -74.55 -20.65 59.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.496 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.547 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -91.36 2.43 56.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.0 t80 -109.77 -29.28 8.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 108.636 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -84.07 -39.36 19.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 0.0 OUTLIER -75.23 -32.47 61.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.646 -0.659 . . . . 0.0 109.86 179.861 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.3 mtt85 -92.44 -12.58 31.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 88.52 -145.94 19.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.448 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 2.1 m -54.85 -96.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -1.101 . . . . 0.0 109.613 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.8 ttm105 -56.36 164.55 1.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.063 -1.023 . . . . 0.0 109.33 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . 179.04 176.35 0.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.543 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.4 mt -113.4 106.1 14.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.899 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -115.1 158.04 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.7 OUTLIER -64.41 -28.93 70.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.321 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.0 m-85 -126.22 72.84 71.92 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.571 -0.706 . . . . 0.0 109.19 -179.685 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.723 2.282 . . . . 0.0 110.444 -179.591 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.4 m-85 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.257 0.551 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -75.05 82.8 2.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.24 179.666 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.03 9.65 1.44 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.617 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 54.1 t -121.09 111.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.747 -1.443 . . . . 0.0 109.892 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' CB ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -76.43 101.26 5.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 108.917 179.508 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 1.1 pt20 -97.38 134.49 40.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.375 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.598 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 5.3 mtt180 -89.35 -176.19 0.64 Allowed Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.03 87.09 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.087 1.858 . . . . 0.0 110.281 -179.642 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 43.7 m95 55.43 73.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.393 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.59 -93.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.659 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.546 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.1 mtpp -115.77 -168.78 1.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -1.12 . . . . 0.0 110.431 -178.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 45.0 m-85 -150.61 -175.96 5.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 149' ' ' VAL . . . -155.05 155.58 34.36 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.527 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -129.5 115.77 17.96 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.84 159.86 41.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.392 -179.526 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 171' ' ' VAL . 9.9 tt -134.91 136.21 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -85.33 126.78 34.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 179.891 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -115.51 91.16 28.12 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 109.487 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.31 -25.08 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.534 2.156 . . . . 0.0 110.454 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -92.55 23.36 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 38.19 8.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.928 . . . . 0.0 109.555 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 169' ' ' ALA . . . 89.04 122.5 2.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 168' ' ' GLY . . . -179.86 80.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.19 148.31 4.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 161' ' ' ILE . 51.4 t -129.89 93.07 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 7.5 t-105 -81.29 95.35 6.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.667 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.664 HD21 ' CB ' ' A' ' 189' ' ' ALA . 21.1 mt -53.57 -50.55 65.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.77 . . . . 0.0 109.306 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.96 14.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.2 p -81.68 145.77 30.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.1 m-85 -120.01 -169.93 1.87 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 -179.841 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.59 -29.29 12.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.8 p -138.22 167.66 21.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.812 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.75 -24.68 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.271 -0.893 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 39.6 tt0 -73.49 -30.4 63.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.668 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -81.71 -41.43 21.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 -179.868 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.15 -39.15 78.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.13 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.18 -42.06 84.86 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.395 -0.815 . . . . 0.0 108.828 179.589 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -59.35 -46.29 89.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.027 179.592 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.61 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.2 -23.05 67.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.1 t80 -71.55 -34.4 69.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.422 -0.799 . . . . 0.0 109.144 179.711 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -63.37 -41.73 98.81 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -50.31 74.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 -179.757 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.664 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -74.37 -18.51 60.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.783 -179.507 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.3 -4.77 55.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -106.19 -32.14 8.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.259 -0.901 . . . . 0.0 108.841 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -41.3 30.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 47.0 ttm -70.82 -33.78 71.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 179.648 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.55 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -84.93 -17.19 38.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.411 -0.806 . . . . 0.0 109.08 179.713 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 63.09 -88.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 195' ' ' GLY . 3.9 p -54.65 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 4.1 mpt_? -53.85 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . 177.44 160.29 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 199' ' ' LEU . 4.7 mp -95.47 113.93 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.551 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -114.84 179.91 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.295 179.919 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.677 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -72.31 -31.87 66.07 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.03 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.1 m-85 -125.94 71.51 68.68 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo . . . . . 0 C--N 1.309 -1.539 0 C-N-CA 122.646 2.231 . . . . 0.0 110.619 -179.468 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.957 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.59 96.08 6.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.29 -9.82 11.86 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 78.4 t -104.31 114.5 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.252 . . . . 0.0 109.739 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -87.26 141.55 28.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 108.733 179.436 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.462 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -113.16 141.39 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.0 -1.062 . . . . 0.0 109.872 -179.583 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.497 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 3.4 mmt-85 -116.75 162.18 28.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.888 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.497 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.61 -25.34 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.439 2.093 . . . . 0.0 110.279 179.839 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.47 82.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 156' ' ' LYS . . . 133.53 37.29 0.24 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 155' ' ' GLY . 22.2 mttt -135.12 170.83 15.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -1.106 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.1 m-85 -140.79 -170.35 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.653 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -159.29 113.64 2.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 109.934 179.686 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.18 123.63 31.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.473 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.554 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 9.3 mt-10 -141.58 169.16 18.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.66 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.562 HD13 ' HE1' ' A' ' 193' ' ' MET . 19.1 tt -152.54 131.41 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.976 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 18.3 ptt180 -94.8 118.35 31.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 109.978 -179.374 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -108.68 107.02 59.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.43 -0.794 . . . . 0.0 109.008 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.84 -28.77 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.389 2.059 . . . . 0.0 110.477 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.18 40.73 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.219 -0.925 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -94.91 33.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.05 37.91 20.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.85 83.68 0.43 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -137.78 118.83 14.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.15 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -78.68 151.19 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.744 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 17.9 t -131.04 100.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.013 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.678 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.1 t-105 -87.12 99.9 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.683 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.135 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -55.4 -51.2 67.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.852 . . . . 0.0 109.562 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 153.7 153.77 6.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.678 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 3.1 p -72.24 148.22 45.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -1.115 . . . . 0.0 109.671 -179.869 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.0 m-85 -122.41 -169.14 1.85 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 2.3 pt-20 -101.47 -25.91 13.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.0 p -138.7 174.35 10.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.293 179.537 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.12 -26.76 48.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.213 -0.929 . . . . 0.0 109.761 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.23 -37.76 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.076 -1.015 . . . . 0.0 109.805 -179.754 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -72.7 -39.19 67.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.34 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.41 -31.16 65.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.957 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.24 -36.0 66.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.329 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.604 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.99 -49.18 73.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.214 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.47 -30.95 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.32 -0.862 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -67.23 -32.41 73.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.37 -0.831 . . . . 0.0 109.32 179.706 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 9.6 m-20 -65.56 -35.15 80.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -50.21 30.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.812 . . . . 0.0 110.476 -179.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.135 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -67.62 -25.87 65.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 110.072 -179.294 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -81.87 -29.0 32.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.632 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.487 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.4 t80 -78.32 -22.41 48.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.968 . . . . 0.0 108.995 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -73.98 -50.52 19.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 108.978 179.574 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.562 ' HE1' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -71.25 -36.41 71.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.779 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.515 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -104.08 36.81 2.23 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 179.917 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . -31.42 -68.54 0.12 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 197' ' ' ARG . 29.8 m -61.42 89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -1.193 . . . . 0.0 109.125 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.7 OUTLIER 62.84 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 109.25 -179.66 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . -154.57 154.95 33.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.633 -179.882 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 200' ' ' LEU . 1.4 tm? -99.89 123.87 44.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.98 175.61 9.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.744 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.629 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.12 -34.29 66.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.818 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.561 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.0 m-85 -119.81 82.71 27.89 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.372 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.311 -1.416 0 C-N-CA 122.89 2.393 . . . . 0.0 111.051 -179.095 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.933 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 50.5 m-85 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.26 90.21 3.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 -17.82 5.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 182' ' ' ALA . 92.9 t -96.92 110.32 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -1.137 . . . . 0.0 110.125 -179.573 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 29.5 mtt180 -85.55 141.07 30.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -107.47 152.76 23.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.976 -1.077 . . . . 0.0 110.41 -178.954 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.559 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -126.04 147.02 57.71 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.003 179.841 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.18 -6.63 16.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -98.85 7.52 45.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.774 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.27 81.43 1.21 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER 175.31 163.12 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.153 . . . . 0.0 109.552 -179.998 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -146.51 -176.25 5.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.677 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.08 110.24 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.528 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.34 118.39 23.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 1.5 mt-10 -138.78 153.14 48.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.803 . . . . 0.0 109.16 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.8 tt -134.93 130.71 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.066 -1.021 . . . . 0.0 109.734 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -70.11 126.37 29.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.186 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -121.62 94.84 48.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.56 -21.08 11.74 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.616 2.211 . . . . 0.0 110.414 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.43 70.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 4.0 mmtm -79.99 -69.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 109.417 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.4 p30 166.81 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.42 34.25 68.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.31 96.97 7.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -1.143 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -50.2 156.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.661 -179.762 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 161' ' ' ILE . 44.0 t -123.04 91.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -0.826 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.677 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -75.77 91.51 2.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 189' ' ' ALA . 12.4 mt -53.86 -38.16 64.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.38 160.37 8.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.35 171.47 12.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 59.3 m-85 -145.94 -173.39 4.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -28.17 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.3 p -145.95 170.42 16.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.65 -26.33 64.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.885 . . . . 0.0 109.31 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -70.58 -36.22 73.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -73.37 -47.87 38.68 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.61 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.578 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -63.55 -36.01 82.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.0 109.422 -179.806 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.0 -40.66 87.39 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 109.045 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 184' ' ' LEU . 42.6 tp -61.83 -48.75 79.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.416 -0.803 . . . . 0.0 109.127 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.08 -28.68 70.25 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 4.6 t80 -67.42 -28.47 67.93 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.529 -0.732 . . . . 0.0 109.038 179.252 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -70.26 -45.62 66.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -33.95 76.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.243 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.806 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.23 -54.45 7.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.747 -179.586 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -62.47 -14.95 46.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.862 -179.685 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.508 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 9.1 t80 -85.41 -34.93 21.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.007 -1.058 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -65.31 -43.13 92.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -82.35 -40.12 21.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 109.249 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.892 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 7.6 mtp85 -104.24 34.49 3.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.009 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . -41.54 165.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 72.31 93.54 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -1.162 . . . . 0.0 109.306 -179.967 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 65.89 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.848 . . . . 0.0 109.677 179.929 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.59 147.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.83 121.03 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.355 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.6 -178.81 4.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.107 -179.871 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.603 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -72.2 -35.51 68.94 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.881 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ ' ' A' ' 146' ' ' TYR . 7.5 m-85 -120.09 76.4 23.1 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.63 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.63 2.22 . . . . 0.0 110.553 -179.525 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.4 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.397 0.617 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -77.4 85.3 3.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.574 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.98 -20.43 4.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 16.2 t -96.39 127.42 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -1.197 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.2 ttt85 -94.13 153.12 18.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.15 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.498 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -127.31 134.33 50.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.949 -1.094 . . . . 0.0 109.683 -179.679 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.499 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -114.77 167.01 10.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 109.502 -179.75 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.35 5.85 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.597 2.198 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -102.22 -18.96 15.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.631 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 15.88 11.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.817 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.407 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.4 mtpp -112.5 171.36 7.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.973 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -142.84 -172.84 3.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.333 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -153.41 105.6 2.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.997 179.842 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.88 118.59 21.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.545 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.552 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 9.0 mt-10 -136.53 155.08 50.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.344 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 ' HE2' ' A' ' 193' ' ' MET . 12.2 tt -140.38 143.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.705 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -87.6 126.62 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 109.025 179.659 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -112.95 95.67 35.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.634 -179.768 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.3 Cg_endo -77.26 -26.0 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.488 2.125 . . . . 0.0 110.248 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.79 -15.11 62.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 0.0 109.606 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.514 ' CE ' ' HA ' ' A' ' 166' ' ' LYS . 2.4 mmpt? -106.39 41.32 1.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.336 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER 48.26 72.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.956 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' ASN . . . 48.74 96.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -148.48 101.32 3.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.173 . . . . 0.0 109.633 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 152.55 23.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.195 179.885 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.46 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 53.4 t -133.58 91.94 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.552 ' CE3' ' OE2' ' A' ' 160' ' ' GLU . 9.6 t-105 -79.05 92.6 5.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.066 179.492 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 189' ' ' ALA . 7.7 mt -53.8 -38.72 64.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.29 -179.827 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 141.67 175.44 15.17 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -91.88 161.73 14.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -1.132 . . . . 0.0 109.191 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 60.7 m-85 -134.63 169.32 17.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.558 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.454 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 1.3 pt-20 -75.6 -25.41 56.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.868 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.453 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -147.58 -178.24 6.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 109.45 -179.937 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -82.6 -24.63 33.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.2 tt0 -71.09 -34.18 70.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 109.613 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.454 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -76.58 -50.78 13.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.288 -0.883 . . . . 0.0 109.671 -179.891 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.7 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -59.3 -45.94 89.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 109.186 179.921 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.31 -46.04 89.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -59.51 -31.16 69.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.634 -0.666 . . . . 0.0 109.219 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.485 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -79.81 -23.74 41.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.488 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.6 t80 -74.77 -30.3 61.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.41 -0.806 . . . . 0.0 108.879 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 200' ' ' LEU . 21.6 m-20 -71.12 -50.76 30.12 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.519 0.676 . . . . 0.0 109.31 179.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -36.33 82.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.633 -0.667 . . . . 0.0 109.688 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 173' ' ' LEU . . . -80.84 -22.13 40.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.05 179.863 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 195' ' ' GLY . 1.7 t80 -85.31 -33.36 22.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 109.166 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -76.54 -40.72 49.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.868 . . . . 0.0 109.371 179.874 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.661 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -80.68 -27.7 36.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 110.284 -179.481 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 190' ' ' ALA . 2.8 mmt180 -92.61 8.93 36.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.897 -1.127 . . . . 0.0 109.676 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 71.48 -136.71 25.1 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.2 m -97.34 151.29 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.529 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 57.75 113.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.67 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.606 -179.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 113.17 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.377 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.66 176.07 8.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.403 -179.933 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.636 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -68.83 -37.27 79.06 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.368 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.1 m-85 -124.52 78.94 62.28 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.501 -0.749 . . . . 0.0 109.196 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 C--N 1.308 -1.554 0 C-N-CA 122.597 2.198 . . . . 0.0 110.447 -179.909 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.3 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 85.33 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.08 -15.28 4.54 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 182' ' ' ALA . 39.9 t -99.65 120.23 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.125 -1.221 . . . . 0.0 109.657 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 mmm180 -93.95 114.65 26.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.131 179.714 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.7 pt20 -89.68 139.32 30.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.829 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.507 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -110.54 160.72 27.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 179.96 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.7 Cg_endo -77.88 3.12 7.24 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.511 2.141 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.58 ' HA ' ' CE3' ' A' ' 154' ' ' TRP . 0.0 OUTLIER -105.06 -21.23 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.063 -1.023 . . . . 0.0 109.387 179.828 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 115.59 22.32 4.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.43 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 75.8 mttt -117.07 152.35 34.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.263 179.823 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.975 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 m-85 -132.6 170.53 15.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.982 . . . . 0.0 109.675 -179.615 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.606 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.84 114.9 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.921 179.814 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.95 121.95 28.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 108.764 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.53 152.7 40.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.562 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 190' ' ' ALA . 1.2 tt -144.36 133.52 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 179.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.84 136.67 57.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 179.675 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.42 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 29.4 t0 -116.69 109.36 43.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.21 -27.39 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.375 2.05 . . . . 0.0 110.205 179.71 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.07 -16.72 61.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.402 -0.811 . . . . 0.0 109.732 -179.944 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 83.5 mttt -102.48 37.64 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 22.9 m-80 60.32 40.38 17.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.578 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.7 65.05 3.36 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.84 133.8 55.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.37 141.76 58.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.54 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.0 t -117.31 88.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.606 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -73.99 92.82 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.343 179.841 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.083 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -54.44 -40.81 68.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 144.84 157.33 7.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.515 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -72.06 169.09 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 64.6 m-85 -143.78 -178.99 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.69 -30.06 21.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.3 p -142.51 -179.62 6.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.975 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.28 -24.11 43.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -72.12 -35.59 69.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -76.14 -39.27 55.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.298 179.878 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.37 -32.44 70.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 108.97 179.837 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.09 -40.76 64.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.547 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -61.65 -44.27 97.28 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.576 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.18 -31.0 70.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.256 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 161' ' ' ILE . 8.2 t80 -63.03 -29.77 71.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.557 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.531 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.4 m-20 -68.98 -48.73 62.41 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 109.223 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -52.9 -36.01 58.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 110.578 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 1.083 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.79 -39.14 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.914 -1.116 . . . . 0.0 109.905 -179.491 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.74 4.66 18.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.314 179.835 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 195' ' ' GLY . 6.0 t80 -113.89 -42.69 3.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.416 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -38.8 66.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.116 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 15.3 ttm -81.59 -35.4 30.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.653 -0.654 . . . . 0.0 110.292 -179.507 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -81.69 -13.88 57.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.041 . . . . 0.0 109.654 -179.418 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 99.21 -125.1 8.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.493 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -66.65 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -1.198 . . . . 0.0 109.922 -179.523 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -75.47 152.91 37.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 172.52 153.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.852 . . . . 0.0 109.162 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -92.6 116.94 29.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.11 -0.994 . . . . 0.0 109.772 -179.698 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.531 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.03 146.91 50.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.743 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.24 -32.7 11.18 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.58 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.14 85.22 41.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 109.196 179.855 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 C--N 1.307 -1.616 0 C-N-CA 122.598 2.199 . . . . 0.0 110.138 179.952 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.962 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 25.3 m-85 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -81.4 91.4 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.68 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.68 3.37 11.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.904 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.7 t -112.8 109.37 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -1.181 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -84.96 113.99 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.17 -0.956 . . . . 0.0 108.789 179.544 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -91.92 131.29 37.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.322 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -79.32 -177.27 0.84 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.897 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 32.9 Cg_endo -76.57 76.37 4.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.84 1.693 . . . . 0.0 109.908 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 61.45 69.57 0.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 109.154 -179.617 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.6 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.503 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.526 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.2 mttp -113.18 -171.43 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -1.175 . . . . 0.0 110.627 -178.812 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.053 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.5 m-85 -144.33 -179.0 6.26 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.03 111.33 4.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.836 -1.165 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.22 117.99 27.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.141 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt-10 -134.33 -165.87 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.213 -179.864 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 160' ' ' GLU . 2.5 tt 174.68 138.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.667 179.868 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -75.52 131.14 39.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.246 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -105.83 111.86 64.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.859 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.3 -28.55 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.498 2.132 . . . . 0.0 110.304 179.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.65 58.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.863 . . . . 0.0 109.594 -179.867 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 3.9 mmpt? -104.75 25.48 10.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.814 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 76.49 33.72 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 179.791 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.2 86.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.8 -168.89 2.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.4 179.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -112.41 144.9 41.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.785 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 38.3 t -128.67 116.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.101 179.603 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.3 t-105 -102.11 100.67 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.437 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.9 OUTLIER -57.75 -47.32 82.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.741 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.74 157.24 7.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.875 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -73.58 152.95 40.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.4 -1.059 . . . . 0.0 109.607 -179.846 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.661 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.7 m-85 -126.44 -177.2 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.165 179.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 -32.47 15.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.456 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -134.32 168.81 18.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.053 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.462 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -75.0 -38.13 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.374 -0.828 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -75.72 -34.89 60.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.097 -1.002 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -73.54 -35.71 65.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.08 179.664 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.962 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.428 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -61.95 -46.19 90.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.464 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.39 -29.7 69.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.052 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.5 t80 -61.39 -42.97 99.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.501 -0.75 . . . . 0.0 109.106 179.426 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 200' ' ' LEU . 8.8 m-20 -58.25 -45.03 88.51 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.498 -0.751 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.847 -179.7 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -89.15 -25.61 21.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 110.199 -179.461 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.94 5.12 52.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.456 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -113.6 -31.66 6.43 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.328 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -83.79 -40.5 18.67 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.803 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 3.7 tpp -74.91 -29.56 61.02 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.618 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 70.2 mtt-85 -109.86 -3.37 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.706 -179.836 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 75.47 -146.37 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 73.8 m -78.11 158.09 29.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -1.105 . . . . 0.0 109.7 -179.716 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 196' ' ' SER . 16.7 ttp180 55.3 103.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.654 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -159.52 31.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 179.723 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 198' ' ' ALA . 55.5 mt 36.57 98.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.372 0.606 . . . . 0.0 110.715 179.354 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -119.34 177.19 5.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.012 . . . . 0.0 108.88 179.019 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.729 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -71.27 -34.43 70.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.191 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.5 m-85 -121.86 74.83 36.99 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.852 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo . . . . . 0 C--N 1.31 -1.5 0 C-N-CA 122.513 2.142 . . . . 0.0 110.38 -179.811 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.2 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.239 0.542 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.72 107.22 2.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 108.918 179.347 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.92 -34.0 4.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.544 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 182' ' ' ALA . 42.0 t -81.24 119.75 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 109.233 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 22.3 mtt85 -101.4 101.67 12.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.807 -179.609 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.3 pt20 -62.91 144.02 57.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 109.118 179.534 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.484 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 1.5 mmt-85 -120.58 162.36 34.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.435 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.8 Cg_endo -76.7 73.49 5.24 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.611 2.207 . . . . 0.0 110.28 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.6 -179.681 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.66 14.12 3.59 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 18.8 mmtt -108.5 -176.92 3.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.236 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 86.7 m-85 -156.4 159.09 38.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -127.69 111.7 13.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.99 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.17 124.43 28.33 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -148.17 140.64 24.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.992 . . . . 0.0 110.042 -179.337 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 6.7 tt -128.41 137.41 57.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.424 -0.797 . . . . 0.0 109.121 179.735 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -80.28 142.99 34.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 -179.803 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 30.4 t0 -137.37 97.03 10.75 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.241 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.64 -24.37 10.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.322 2.014 . . . . 0.0 110.337 -179.917 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -11.75 58.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.859 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 163' ' ' ASP . 1.6 mtpt -105.84 40.57 1.55 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.63 45.97 3.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.434 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.77 84.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.78 120.77 13.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -1.088 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -63.82 157.26 25.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.148 -0.97 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 171' ' ' VAL . 34.0 t -128.85 89.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.847 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.491 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 8.9 t-105 -72.1 93.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.185 179.712 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.953 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.1 OUTLIER -52.07 -41.4 62.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.965 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.08 162.78 9.45 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 -179.648 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 1.2 p -76.14 -179.73 5.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.265 . . . . 0.0 109.393 -179.939 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 182' ' ' ALA . 78.4 m-85 -157.57 179.95 8.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.61 -25.47 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.457 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -142.98 165.43 27.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 109.562 -179.988 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.75 -22.64 65.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.45 -0.782 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -72.07 -39.48 68.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.841 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -73.18 -39.69 65.4 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.653 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.591 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -71.54 -32.71 68.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 -179.909 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.49 -37.02 63.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.205 -0.934 . . . . 0.0 108.852 179.71 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 184' ' ' LEU . 41.7 tp -66.03 -43.47 87.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.701 179.301 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.7 -30.96 72.0 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.241 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 9.3 t80 -66.36 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.548 -0.72 . . . . 0.0 109.144 179.545 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.648 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.0 -48.99 79.42 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.352 -0.842 . . . . 0.0 109.87 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -43.9 76.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 109.771 -179.753 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.953 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -75.26 -18.42 60.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.822 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.08 -8.66 48.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 4.5 t80 -105.8 -29.48 10.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -81.01 -40.3 24.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.508 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 27.0 mtp -75.11 -27.94 60.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.56 -0.713 . . . . 0.0 109.693 179.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -98.16 10.06 41.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.519 -179.806 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 73.15 -97.52 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.782 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.571 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 2.5 m -142.87 164.78 29.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -1.111 . . . . 0.0 109.482 -179.859 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 58.86 63.35 1.67 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 -179.808 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.19 171.52 8.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.397 -0.814 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -104.52 125.67 50.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.85 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.24 178.04 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 -179.789 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.614 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -70.95 -31.96 68.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.061 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.4 m-85 -121.61 74.14 33.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.45 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.896 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 97.39 4.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.771 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.87 -21.39 7.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.725 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.3 t -89.55 126.06 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.252 . . . . 0.0 109.999 -179.66 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 tpp180 -97.65 147.07 24.7 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.951 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.516 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.3 pt20 -119.4 139.75 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 -179.392 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -105.3 155.91 37.09 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.145 179.672 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.47 6.17 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.577 2.185 . . . . 0.0 110.803 -179.742 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -106.11 -52.17 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.628 -179.986 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 152.79 56.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mtmt -155.26 -177.75 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.336 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.8 m-85 -153.65 -171.77 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.93 110.92 2.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.457 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -79.36 114.41 18.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.261 -0.9 . . . . 0.0 109.078 179.734 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.516 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 1.6 mt-10 -130.83 151.35 51.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.312 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 171' ' ' VAL . 2.6 tt -140.11 120.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.543 -179.82 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -61.12 140.77 57.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.304 179.867 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.414 ' CG ' ' CG ' ' A' ' 166' ' ' LYS . 30.9 t0 -118.99 100.94 50.53 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 -179.875 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -30.0 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.43 2.087 . . . . 0.0 110.463 179.842 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -10.13 59.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 16.1 mmtt -106.14 44.78 1.02 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 50.45 49.61 20.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.277 -179.797 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.19 99.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.954 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -159.56 111.16 2.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -1.099 . . . . 0.0 109.25 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -63.02 149.43 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.582 -179.716 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 161' ' ' ILE . 21.7 t -122.13 104.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 11.3 t-105 -77.47 95.88 4.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 189' ' ' ALA . 31.2 mt -55.77 -54.9 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 162.46 158.69 9.77 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.937 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.575 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -72.75 154.39 40.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.568 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 53.7 m-85 -131.25 168.93 16.67 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -80.14 -24.75 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.669 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.587 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 3.4 p -145.1 175.96 9.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.88 -24.75 40.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.76 -33.57 64.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.587 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.1 OUTLIER -79.72 -39.03 32.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.899 . . . . 0.0 109.288 179.945 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.32 -31.64 67.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 109.208 179.851 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.896 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.49 -39.72 64.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.235 -0.915 . . . . 0.0 108.959 179.721 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 184' ' ' LEU . 22.8 tp -61.97 -42.62 99.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.824 . . . . 0.0 108.866 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.58 -31.35 72.0 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.8 t80 -62.33 -29.78 70.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.772 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.1 m-20 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.1 -31.7 70.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 -179.841 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.514 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -83.15 -28.13 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -4.07 58.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.485 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -108.54 -34.34 6.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.296 179.859 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -81.96 -38.77 24.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.343 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.3 ttm -78.03 -31.13 50.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.639 -0.663 . . . . 0.0 109.798 179.91 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 195' ' ' GLY . 34.7 mtp85 -98.65 -16.3 19.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.116 -0.99 . . . . 0.0 109.165 -179.911 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 47.68 -176.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.795 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 195' ' ' GLY . 93.3 p 42.82 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -1.168 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.25 149.61 40.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -149.09 157.11 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -100.54 118.01 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.772 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.87 -172.71 2.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.647 -179.675 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.776 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -80.22 -32.04 38.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 108.967 179.703 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.7 m-85 -125.61 68.37 60.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.531 -0.731 . . . . 0.0 109.602 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.8 Cg_endo . . . . . 0 C--N 1.311 -1.422 0 C-N-CA 122.808 2.338 . . . . 0.0 110.694 -179.845 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.883 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.9 m-85 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.19 85.14 2.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.66 -20.74 2.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.79 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.2 t -92.15 112.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.349 -1.089 . . . . 0.0 109.645 -179.847 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -93.12 79.49 4.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.765 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 6.7 pt20 -70.84 134.97 47.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.355 -0.841 . . . . 0.0 109.357 -179.871 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.579 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -89.08 -179.75 1.36 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.969 -1.082 . . . . 0.0 108.344 179.407 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -73.93 83.97 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.973 1.782 . . . . 0.0 110.18 -179.612 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 66.77 64.78 0.47 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.469 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.56 ' HA3' ' NE ' ' A' ' 152' ' ' ARG . . . -157.86 -111.83 0.33 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.75 -179.404 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.1 mtmm -110.52 -172.58 2.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.14 . . . . 0.0 110.976 -178.515 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.764 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 17.0 m-85 -140.59 131.07 25.35 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.576 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -104.33 112.84 26.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.885 -1.135 . . . . 0.0 110.752 -178.948 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.472 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.79 117.25 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.549 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.579 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 2.6 mt-10 -138.88 154.5 48.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.003 . . . . 0.0 109.68 -179.193 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 8.3 tt -133.07 164.47 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.742 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.489 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.5 tpp180 -101.01 119.65 39.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.963 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -120.83 93.04 48.6 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.33 -22.99 10.54 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.623 2.215 . . . . 0.0 110.342 179.984 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.58 60.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -90.38 33.24 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.91 25.57 15.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.557 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.38 97.96 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -161.81 97.9 1.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.4 mtt180 -45.56 155.63 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.949 . . . . 0.0 109.263 179.853 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.45 ' HB ' HG23 ' A' ' 161' ' ' ILE . 54.9 t -128.15 100.75 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ3' ' OE2' ' A' ' 160' ' ' GLU . 10.1 t-105 -86.16 97.33 10.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.75 HD21 ' CB ' ' A' ' 189' ' ' ALA . 15.1 mt -57.13 -46.59 82.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.508 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.25 155.93 7.17 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.3 p -68.93 178.8 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.164 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 175' ' ' THR . 67.1 m-85 -155.1 -171.51 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.924 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -97.32 -29.38 13.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.68 -179.846 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.591 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 13.3 p -142.53 -179.61 6.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 109.587 -179.797 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.96 -21.76 46.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.322 -0.862 . . . . 0.0 109.04 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -75.68 -36.79 59.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.91 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -73.27 -40.75 64.35 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.234 -0.916 . . . . 0.0 109.412 179.94 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.563 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -67.78 -47.2 69.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.883 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.41 -40.13 85.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.812 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -59.9 -49.74 76.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.525 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.66 -21.88 64.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.402 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -76.95 -28.44 55.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.801 . . . . 0.0 109.171 179.562 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.8 m-20 -69.12 -38.59 78.97 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 -179.573 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -69.31 -44.7 71.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.522 -179.088 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.75 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -70.16 -44.14 69.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.129 -179.25 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -64.82 -29.95 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.958 -179.412 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.41 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.4 t80 -75.56 -24.67 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.97 -1.081 . . . . 0.0 109.889 -179.623 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -82.27 -40.99 20.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -27.65 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 110.497 -179.302 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -97.46 7.78 45.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.943 -1.098 . . . . 0.0 109.603 -179.751 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 68.06 -132.33 28.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.764 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -80.77 -177.22 6.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 -179.984 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.493 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 17.0 ttm180 52.77 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.493 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 59.05 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 199' ' ' LEU . 3.8 mp -106.76 122.08 45.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.24 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.5 161.63 26.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.844 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 1.2 m-80 -60.82 -31.49 70.9 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.246 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.812 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.0 m-85 -123.73 88.52 52.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.31 -1.455 0 C-N-CA 122.632 2.221 . . . . 0.0 110.742 -179.275 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.5 m-85 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.55 96.27 4.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.18 -18.43 6.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.865 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 65.6 t -99.62 127.62 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -1.171 . . . . 0.0 109.62 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 1.1 mtt85 -100.51 141.19 33.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.181 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.527 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -110.92 147.37 34.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 -179.314 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mtt180 -112.02 165.76 12.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.442 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.49 -29.56 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.546 2.164 . . . . 0.0 110.646 -179.898 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -73.14 -57.1 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.562 -179.957 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 53.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.459 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 12.6 mttm -144.86 171.52 14.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -1.176 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.002 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.3 m-85 -144.93 -173.75 4.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.772 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.17 112.85 2.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.696 179.88 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.34 126.76 34.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.09 150.33 36.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.625 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 161' ' ' ILE . 1.6 tt -142.46 139.2 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.879 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -72.4 135.76 45.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 163' ' ' ASP . 37.3 t0 -130.08 96.54 25.21 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.593 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.87 -26.49 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.505 2.136 . . . . 0.0 110.287 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.78 -20.95 62.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.334 -0.853 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 16.6 mmtp -95.25 33.51 1.55 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.494 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 12.6 m120 66.5 49.3 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.313 -179.843 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.89 105.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.972 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -175.54 112.88 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -1.189 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -53.53 166.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 171' ' ' VAL . 43.2 t -137.33 94.57 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.772 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.4 t-105 -78.47 97.81 5.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.967 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.1 mt -56.1 -46.82 78.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.538 -179.822 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.66 162.87 11.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.931 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -79.65 151.53 30.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.288 -179.853 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 85.9 m-85 -127.25 -175.85 3.56 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.14 -33.06 19.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.298 -179.418 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.5 p -137.31 179.51 6.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.035 -1.041 . . . . 0.0 110.028 -179.579 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.76 -27.39 60.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.152 179.744 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 11.1 tt0 -68.54 -70.82 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.471 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -37.85 -54.45 1.26 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.804 -0.56 . . . . 0.0 110.217 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -60.3 -41.34 93.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.037 -179.472 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -61.98 -31.38 71.73 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -70.9 -45.86 63.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.167 -0.958 . . . . 0.0 108.455 179.595 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.62 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -59.04 -25.58 63.83 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.722 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 21.2 t80 -74.21 -36.38 63.96 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.559 ' HB3' HD13 ' A' ' 200' ' ' LEU . 71.1 m-20 -64.54 -45.64 86.26 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.472 -0.767 . . . . 0.0 109.146 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -42.18 84.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.967 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.37 -16.73 58.72 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.805 179.498 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.66 1.17 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.377 -0.827 . . . . 0.0 109.048 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -114.91 -37.6 4.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.71 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 42.5 mmt-85 -81.16 -39.44 25.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.078 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 40.8 ttm -75.05 -30.54 61.04 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.463 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.4 mtt180 -99.54 -10.28 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.27 -169.65 54.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.938 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' ARG . 1.4 t -54.6 150.69 9.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -1.085 . . . . 0.0 109.635 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 62.76 125.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.957 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 179.92 145.7 0.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 179.953 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -90.34 120.2 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.631 -179.773 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.21 -173.54 3.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.007 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.632 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -74.96 -35.89 62.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.087 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.4 m-85 -122.33 87.42 48.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.201 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.61 2.206 . . . . 0.0 110.755 -179.386 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -134.99 78.02 1.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.922 . . . . 0.0 109.492 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.6 m-85 -48.38 150.6 1.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.84 82.24 5.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.561 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.56 -13.48 3.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 33.3 t -102.16 120.87 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 109.395 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -103.9 89.44 3.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.55 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -46.97 149.98 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 13.1 mmt180 -113.42 161.81 25.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.937 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.29 6.09 4.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.662 2.241 . . . . 0.0 110.584 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -114.18 -15.05 12.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 30.96 2.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 28.6 mmmt -120.35 -175.31 2.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.638 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.805 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 88.2 m-85 -157.64 117.71 3.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.104 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -89.94 122.46 32.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -98.53 111.95 24.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.58 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 4.4 mt-10 -135.21 150.88 50.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.403 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 6.8 tt -127.9 148.29 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.05 133.0 36.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.093 -1.005 . . . . 0.0 109.746 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -126.65 94.5 40.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.436 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.83 -24.99 8.09 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.656 2.237 . . . . 0.0 110.575 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.37 -11.91 61.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -100.12 55.61 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 56.3 31.04 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.955 . . . . 0.0 109.592 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.22 67.96 1.85 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -124.69 -180.0 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -1.154 . . . . 0.0 109.375 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -111.32 156.13 22.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.53 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 171' ' ' VAL . 29.5 t -129.15 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.2 t-105 -79.58 102.23 8.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.043 HD21 ' HB2' ' A' ' 189' ' ' ALA . 7.9 mt -56.78 -55.51 33.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 109.331 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 159.53 153.32 6.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.512 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.0 p -65.99 166.68 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.707 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.2 m-85 -141.39 -177.33 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -95.84 -30.25 13.77 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.307 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.548 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -136.68 167.07 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.268 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.805 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.45 -26.34 62.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.307 -0.871 . . . . 0.0 108.916 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.93 -35.27 69.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.285 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -74.12 -43.56 57.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.075 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.36 -23.78 61.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 108.916 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.59 -42.75 41.38 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.713 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.02 -38.81 92.68 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.82 -38.58 83.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 108.982 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.2 t80 -60.61 -39.24 87.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 1.2 m-20 -56.96 -44.1 82.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -0.815 . . . . 0.0 109.577 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -48.84 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.043 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -72.82 -15.45 61.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.177 -0.952 . . . . 0.0 109.847 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.45 -17.49 25.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.152 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 2.8 t80 -94.34 -31.29 14.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 108.76 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -46.72 26.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.6 ttm -65.54 -33.52 76.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.687 -0.633 . . . . 0.0 109.83 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.481 ' NH1' ' HG2' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -100.14 18.21 19.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 109.646 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 57.43 -99.43 0.1 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 0.5 OUTLIER -126.13 158.08 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -1.154 . . . . 0.0 109.717 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.57 91.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.19 174.12 10.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.99 113.58 26.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -125.16 179.48 5.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.401 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.402 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.88 -35.16 64.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.437 ' HD2' HD22 ' A' ' 184' ' ' LEU . 4.9 m-85 -120.03 83.35 30.67 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.29 71.79 6.21 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.626 2.217 . . . . 0.0 110.465 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.51 -73.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.301 -0.874 . . . . 0.0 109.182 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -74.96 102.63 4.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.349 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.408 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.3 -165.0 0.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.524 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.754 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.8 m-85 -74.82 146.14 42.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.0 109.328 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.543 ' HE ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.52 31.01 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.034 -1.041 . . . . 0.0 109.774 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.09 20.16 0.35 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 183' ' ' ALA . 61.6 t -140.62 107.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -1.061 . . . . 0.0 109.37 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -85.06 110.6 19.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 108.678 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -75.95 156.01 34.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.567 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -109.56 158.54 34.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.83 . . . . 0.0 109.19 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.82 13.79 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.514 2.143 . . . . 0.0 111.024 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -120.33 -25.43 5.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.071 -1.018 . . . . 0.0 109.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.53 33.84 0.59 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.441 ' C ' ' HG3' ' A' ' 152' ' ' ARG . 42.5 mttt -126.44 -169.24 1.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 58.6 m-85 -156.42 172.19 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.379 -0.825 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.08 116.99 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.063 -1.023 . . . . 0.0 110.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -87.17 119.77 27.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 108.605 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -144.3 147.01 32.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.605 HD11 ' NH1' ' A' ' 194' ' ' ARG . 8.8 tt -135.94 143.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 108.916 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -80.81 134.47 35.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.036 -1.04 . . . . 0.0 109.811 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -122.94 103.6 36.62 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.391 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 -29.95 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.448 2.099 . . . . 0.0 110.594 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.66 -26.69 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.641 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -91.4 37.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.798 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.24 50.23 18.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.64 80.09 0.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -132.37 95.51 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.3 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -44.28 133.0 5.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 43.7 t -109.92 103.18 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.439 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.493 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 5.0 t-105 -93.68 97.31 10.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -54.3 -49.0 70.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.061 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.54 159.53 8.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -76.99 144.08 38.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.647 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.814 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.4 m-85 -118.01 178.26 4.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.456 -0.778 . . . . 0.0 109.21 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.6 mm-40 -88.24 -25.55 22.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 110.012 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.573 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.8 p -141.17 178.17 7.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.651 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -80.38 -23.17 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.385 -0.822 . . . . 0.0 109.19 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 13.6 tt0 -74.93 -36.81 62.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.84 -43.91 43.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.05 -40.46 82.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.754 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.25 -37.88 84.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.346 -0.846 . . . . 0.0 109.045 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.854 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -61.25 -44.88 96.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.426 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.7 -18.72 62.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 108.894 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 11.6 t80 -76.22 -31.58 58.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 109.002 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.549 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -68.38 -51.09 47.95 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.545 -0.722 . . . . 0.0 109.798 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -27.52 69.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.433 -0.792 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -86.15 -23.03 26.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.302 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -88.18 -15.63 35.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.37 -0.831 . . . . 0.0 109.124 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.4 OUTLIER -92.81 -32.13 14.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -78.8 -40.58 32.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.02 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.1 tpp -70.34 -30.93 68.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.455 -0.778 . . . . 0.0 109.581 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.605 ' NH1' HD11 ' A' ' 161' ' ' ILE . 1.5 mpt_? -91.62 -12.67 33.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 109.087 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 196' ' ' SER . . . 62.57 81.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 3.3 m 61.01 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -1.161 . . . . 0.0 109.69 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER 61.76 120.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.922 . . . . 0.0 109.632 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 173.31 153.59 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.543 HD23 ' HE ' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -98.04 118.6 35.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.02 -177.41 4.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.696 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -72.8 -34.36 66.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.854 ' HD2' HD22 ' A' ' 184' ' ' LEU . 2.2 m-85 -128.66 76.52 78.62 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 204' ' ' LEU . 35.1 Cg_endo -76.54 72.11 5.7 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.722 2.281 . . . . 0.0 110.66 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 205' ' ' ARG . 0.7 OUTLIER 42.3 30.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER 166.09 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 109.222 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.506 ' N ' ' HG2' ' A' ' 205' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.8 mttt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 144' ' ' LYS . 0.3 OUTLIER 62.18 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.362 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 1.004 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.6 m-85 -105.85 140.28 39.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -72.09 88.19 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 124.77 26.29 1.43 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.7 t -140.35 109.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -1.106 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -95.46 93.77 7.41 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.224 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 44.0 tt0 -52.05 167.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.221 -0.924 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.418 ' N ' ' CG ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -129.69 158.91 72.15 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.335 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.57 4.32 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.625 2.216 . . . . 0.0 110.37 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.485 ' O ' ' CD1' ' A' ' 154' ' ' TRP . 50.0 t-105 -113.25 -7.77 13.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.52 22.6 8.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -115.09 174.08 6.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.596 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.066 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 79.6 m-85 -146.91 152.98 39.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.032 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.643 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -121.85 117.45 26.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.873 -1.142 . . . . 0.0 109.653 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.606 ' HB3' ' HE2' ' A' ' 176' ' ' PHE . . . -91.89 111.07 22.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -130.22 145.87 51.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.063 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 14.9 tt -124.15 154.7 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -82.61 136.32 34.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.412 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 44.0 t0 -146.16 93.05 5.15 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.669 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.16 -23.42 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.635 2.223 . . . . 0.0 110.281 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.48 -11.52 24.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.821 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 13.2 mtpt -100.87 35.67 2.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 1.6 t-20 70.39 47.22 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.66 89.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -163.71 136.1 5.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -71.82 178.68 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.2 t -138.51 81.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.715 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.2 t-105 -61.87 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.548 HD21 ' CB ' ' A' ' 189' ' ' ALA . 26.6 mt -51.7 -34.87 40.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.127 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 137.33 155.22 6.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.715 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.8 p -68.24 -177.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.323 -1.104 . . . . 0.0 109.383 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.606 ' HE2' ' HB3' ' A' ' 159' ' ' ALA . 74.2 m-85 -157.54 177.94 10.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -88.84 -26.91 21.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.655 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.7 p -140.83 175.59 9.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.066 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -80.44 -21.07 42.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.284 -0.885 . . . . 0.0 109.2 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -76.31 -37.55 57.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -36.06 63.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.167 -0.958 . . . . 0.0 109.027 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.72 -39.76 66.67 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.038 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.004 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -66.3 -39.53 89.39 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.0 108.734 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.0 tp -64.56 -42.7 95.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.53 -24.15 67.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.2 t80 -76.04 -28.79 57.81 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.482 -0.761 . . . . 0.0 109.078 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 72.3 m-20 -74.48 -47.55 32.66 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.327 -0.858 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -62.43 -31.61 72.34 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.548 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -88.54 -20.59 24.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.024 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.1 -1.96 58.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -107.97 -35.42 6.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.906 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -76.81 -39.77 50.27 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 27.7 ttm -76.6 -36.94 57.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.64 -0.662 . . . . 0.0 109.978 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -77.73 -18.36 56.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.965 . . . . 0.0 109.18 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.16 -127.79 9.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 197' ' ' ARG . 13.8 m -63.96 -148.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -1.085 . . . . 0.0 110.053 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 196' ' ' SER . 1.8 ttm180 -39.99 139.72 0.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 110.033 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.78 -175.88 4.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.143 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.843 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -104.23 121.36 43.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.843 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.69 152.42 50.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.576 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -54.96 -33.04 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.3 m-85 -117.44 94.19 44.85 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.59 78.54 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.432 2.088 . . . . 0.0 110.374 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.15 125.83 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.406 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.469 ' C ' HG23 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -139.92 57.74 1.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.409 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.469 HG23 ' C ' ' A' ' 205' ' ' ARG . 2.5 t . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.39 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.307 0.575 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.1 133.76 0.53 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.628 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.7 m-85 -103.81 157.49 17.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -76.43 81.84 3.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 108.917 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.67 19.79 2.0 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 44.4 t -133.21 129.51 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.259 . . . . 0.0 109.198 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 112.36 23.84 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.601 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.1 pt20 -80.17 157.18 26.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -125.75 159.13 62.63 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 109.698 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 3.4 7.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.571 2.181 . . . . 0.0 110.232 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -101.22 -19.21 15.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.51 39.79 1.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 35.1 mttt -145.56 166.1 26.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.427 -1.043 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.083 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.8 m-85 -133.65 178.54 6.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.58 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.36 112.74 6.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.704 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.49 108.17 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -129.4 158.42 39.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.356 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 7.8 tt -139.72 139.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -80.72 128.72 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.902 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -114.78 95.74 42.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -23.27 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.613 2.208 . . . . 0.0 110.617 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.65 -7.1 30.14 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.185 -0.947 . . . . 0.0 109.687 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -119.09 57.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.1 m120 49.49 26.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.91 99.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -142.62 105.34 4.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 109.248 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.01 141.94 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.2 t -122.81 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.68 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.6 t-105 -73.7 96.49 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.786 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.458 HD21 ' CB ' ' A' ' 189' ' ' ALA . 30.3 mt -56.04 -46.99 78.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.33 154.53 6.59 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.68 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -70.33 161.25 30.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.318 -1.107 . . . . 0.0 109.356 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 65.2 m-85 -136.16 178.72 6.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.168 -0.958 . . . . 0.0 109.654 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -84.15 -31.25 25.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.8 p -142.06 170.33 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.083 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.23 -22.42 62.9 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.106 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.88 -42.59 63.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -68.29 -43.45 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.862 . . . . 0.0 109.606 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -64.67 -45.76 85.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 109.286 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.8 -38.93 79.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.64 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.63 -51.52 68.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 109.125 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.532 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.49 -20.25 65.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 108.815 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -79.27 -28.47 42.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.445 -0.785 . . . . 0.0 109.41 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.4 m-20 -72.34 -35.47 68.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.701 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -76.19 -40.04 53.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.458 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -73.89 -30.02 62.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.467 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.87 -23.62 33.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.837 . . . . 0.0 109.4 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.513 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 28.7 t80 -83.74 -22.34 31.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 108.974 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -78.86 -38.49 37.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.638 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.1 ttm -80.15 -43.12 22.17 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 0.0 110.173 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.718 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 12.2 mtt180 -92.57 -38.34 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.828 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 63.11 161.43 0.28 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 197' ' ' ARG . 22.5 p 50.53 -176.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -1.097 . . . . 0.0 109.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.5 mtm180 -43.7 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -119.27 35.99 4.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 198' ' ' ALA . 5.0 mt 39.35 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -118.18 149.77 40.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.972 . . . . 0.0 109.353 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.622 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -49.18 -37.31 22.17 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.532 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.9 m-85 -120.81 83.22 36.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.473 ' O ' ' HG ' ' A' ' 204' ' ' LEU . 36.2 Cg_endo -79.96 57.91 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.905 2.403 . . . . 0.0 110.594 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 203' ' ' PRO . 16.7 mt -151.73 172.29 16.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.114 -0.991 . . . . 0.0 109.294 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.639 ' O ' HG12 ' A' ' 206' ' ' VAL . 0.7 OUTLIER -59.57 -63.86 1.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 205' ' ' ARG . 9.5 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -127.49 156.95 41.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.82 . . . . 0.0 109.159 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.867 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 68.6 m-85 -71.18 159.57 34.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.59 35.02 0.39 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.184 -0.948 . . . . 0.0 110.15 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.78 26.24 0.09 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 182' ' ' ALA . 96.7 t -150.27 117.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.417 -1.049 . . . . 0.0 109.185 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.552 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -99.09 137.13 38.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.104 -0.997 . . . . 0.0 109.09 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -103.11 155.62 18.27 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.265 -0.897 . . . . 0.0 109.781 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.69 161.02 55.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.815 . . . . 0.0 109.38 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.85 -8.41 16.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.513 2.142 . . . . 0.0 109.964 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.59 -1.41 57.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.5 56.27 2.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.451 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.4 mttt -159.27 171.27 20.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.788 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -142.17 -177.68 5.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.585 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -152.49 116.92 4.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.779 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -89.23 118.35 28.85 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 109.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 5.6 mt-10 -137.82 177.57 7.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 171' ' ' VAL . 1.1 tt -164.72 142.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.909 -1.119 . . . . 0.0 109.939 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -69.5 134.17 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.045 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 168' ' ' GLY . 11.2 t0 -113.14 98.07 44.7 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.141 -0.974 . . . . 0.0 109.62 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.12 -22.07 10.17 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.535 2.157 . . . . 0.0 110.28 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.25 67.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.296 -0.878 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -104.98 32.5 4.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.72 58.52 4.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 169' ' ' ALA . . . 82.09 -127.56 8.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 67.18 87.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -53.5 134.83 40.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 163' ' ' ASP . 70.3 t -102.01 105.8 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 108.962 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.585 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -87.49 93.9 9.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.031 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.7 mt -53.55 -48.69 68.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.0 108.998 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 153.62 162.23 10.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -74.29 160.84 30.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -1.141 . . . . 0.0 109.238 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -134.75 -176.5 4.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 0.0 109.608 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -90.58 -28.2 18.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.638 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p -146.5 172.18 13.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.61 -24.36 62.72 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.127 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -73.81 -36.37 64.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.539 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -72.03 -47.05 54.59 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.65 -32.15 73.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.2 -37.62 75.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.135 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.97 -47.56 77.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 108.86 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.571 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.25 -22.11 66.31 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' ALA . 28.9 t80 -69.79 -36.28 75.57 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.792 ' HB3' HD13 ' A' ' 200' ' ' LEU . 9.7 m-20 -63.57 -54.33 37.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.395 -0.815 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -55.68 -29.68 59.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.26 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.11 -24.64 27.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.084 . . . . 0.0 110.06 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.94 -14.91 37.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.995 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.548 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.4 t80 -96.25 -25.33 15.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.17 -0.956 . . . . 0.0 108.853 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.34 -38.79 34.31 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.2 tpp -79.59 -42.13 25.63 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.383 0.611 . . . . 0.0 109.749 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 9.7 mtp180 -97.73 -41.27 8.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 109.629 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 43.24 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 197' ' ' ARG . 0.6 OUTLIER 45.87 50.62 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -1.12 . . . . 0.0 109.828 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 70.46 118.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -138.96 174.21 10.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.335 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 108.07 19.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -122.0 -175.91 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.562 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.668 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -84.6 -33.52 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.416 ' HZ ' ' CZ ' ' A' ' 146' ' ' TYR . 6.2 m-85 -121.02 77.49 31.5 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.6 Cg_endo -77.41 179.94 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.686 2.257 . . . . 0.0 110.507 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.34 142.8 37.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -56.35 -30.49 62.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.511 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -55.2 176.48 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.824 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.4 m-85 -130.69 154.27 48.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.303 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -75.89 83.6 2.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.634 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.57 -22.2 3.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.7 t -90.48 116.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -1.15 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -105.48 120.21 41.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 pp0? -85.54 163.8 18.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 109.881 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.426 ' CD ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -131.66 165.73 33.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.452 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 152' ' ' ARG . 35.0 Cg_endo -78.39 -4.09 13.92 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.683 2.255 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -91.96 -18.03 24.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.007 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.86 35.84 2.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -137.16 -175.59 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -1.139 . . . . 0.0 109.634 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.828 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -144.83 -173.37 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.636 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -154.01 108.32 3.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.213 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.73 119.41 24.29 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.563 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 10.6 mt-10 -134.89 179.65 6.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.084 -1.01 . . . . 0.0 109.365 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -174.76 141.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.43 136.76 39.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' CA ' ' A' ' 168' ' ' GLY . 10.5 t0 -111.47 101.02 49.8 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -24.02 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 110.308 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.85 -37.0 75.99 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.49 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 14.2 mttt -98.33 59.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 8.6 p30 41.36 48.02 3.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.438 -0.789 . . . . 0.0 109.797 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 163' ' ' ASP . . . 75.48 -114.68 4.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 168' ' ' GLY . . . 63.27 95.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 169' ' ' ALA . 7.7 ptt180 -45.28 157.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.675 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 41.1 t -129.29 93.02 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.636 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 13.5 t-105 -79.59 93.19 5.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.12 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -53.47 -40.18 65.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.485 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 148.25 -171.93 28.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -103.39 154.94 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -1.162 . . . . 0.0 109.028 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -130.1 165.28 22.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.464 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.7 OUTLIER -77.71 -17.87 57.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.096 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.9 p -153.56 162.36 41.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.04 -1.038 . . . . 0.0 109.545 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.828 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.63 -23.28 66.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.309 -0.869 . . . . 0.0 109.405 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.0 -39.72 65.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.501 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -72.04 -40.49 68.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.763 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.83 -32.13 69.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.824 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.47 -41.15 69.73 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.75 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.32 -46.91 88.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.34 -22.88 63.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 108.845 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.0 t80 -72.48 -30.74 64.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.495 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.5 m-20 -69.34 -50.48 45.97 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.36 -0.837 . . . . 0.0 109.471 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -54.95 -38.02 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.918 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.424 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -78.02 -30.15 49.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 109.453 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -82.64 -2.8 55.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.383 -0.823 . . . . 0.0 109.385 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 195' ' ' GLY . 37.3 t80 -99.45 -40.67 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.149 -0.97 . . . . 0.0 108.918 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -64.34 -49.12 72.94 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -40.38 95.22 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 60.3 mtt180 -105.31 36.52 2.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.481 -0.762 . . . . 0.0 108.962 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -34.69 147.72 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.2 t 80.91 102.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.56 -0.965 . . . . 0.0 109.402 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.494 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 49.8 ttm-85 64.71 -96.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.407 -0.808 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.08 145.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.005 -1.06 . . . . 0.0 109.401 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -104.85 122.46 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.544 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -121.23 152.53 38.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.23 -0.919 . . . . 0.0 109.24 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.584 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -48.5 -37.16 16.78 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.9 m-85 -120.19 92.31 47.0 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.66 160.91 34.36 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.631 2.221 . . . . 0.0 110.916 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mt -149.28 -161.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.9 162.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.343 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 145' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 32.9 t-80 176.39 125.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.599 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 1.011 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 -107.64 158.41 17.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.412 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 86.41 3.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.832 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.41 -19.78 5.62 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 182' ' ' ALA . 44.1 t -90.0 114.58 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.667 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -100.08 113.92 26.88 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.459 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 12.0 pt20 -78.62 154.57 30.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.311 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.508 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -118.42 174.43 2.67 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -77.68 -48.07 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.632 2.221 . . . . 0.0 110.507 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -62.51 1.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.65 52.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -141.48 173.44 11.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.674 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.951 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.8 m-85 -139.15 175.37 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.628 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.64 110.27 4.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.53 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.56 124.2 28.76 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -146.03 160.29 42.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.788 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.529 HD13 ' HE2' ' A' ' 193' ' ' MET . 3.4 tt -149.47 147.29 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.859 . . . . 0.0 109.181 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.436 ' NH2' ' HG2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -96.94 137.15 36.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.99 . . . . 0.0 109.614 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.444 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 44.5 t0 -122.23 114.45 30.59 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.361 -0.837 . . . . 0.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.71 -35.05 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.324 2.016 . . . . 0.0 110.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.61 64.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.105 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -93.89 39.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.42 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.36 30.98 13.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.76 62.59 5.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.44 33.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -1.126 . . . . 0.0 109.491 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -84.64 161.93 19.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.632 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.6 t -137.3 94.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.432 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.628 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.3 t-105 -79.3 100.36 7.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.049 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -59.47 -43.12 93.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 146.26 157.02 7.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.582 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -76.26 151.06 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.169 . . . . 0.0 109.432 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.9 m-85 -123.38 -176.25 3.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -87.59 -31.98 19.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.5 p -139.29 176.27 8.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.193 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.26 -26.06 55.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.3 -37.37 71.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -72.97 -39.57 66.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.97 -26.52 61.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.327 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.011 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.21 -39.28 49.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.136 -0.978 . . . . 0.0 109.013 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.855 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.1 tm? -63.75 -43.07 97.54 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 108.838 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.608 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.72 -29.45 69.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -66.31 -32.18 73.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.441 -0.787 . . . . 0.0 109.14 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.661 ' HB3' HD13 ' A' ' 200' ' ' LEU . 3.6 m-20 -65.93 -49.6 67.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.09 -29.71 67.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.861 . . . . 0.0 110.005 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.049 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.48 -24.28 27.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.821 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.522 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -87.69 -6.53 58.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.613 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 196' ' ' SER . 2.1 t80 -104.01 -37.47 7.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.44 -40.99 56.93 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.273 -0.892 . . . . 0.0 109.163 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.529 ' HE2' HD13 ' A' ' 161' ' ' ILE . 2.0 mtm -71.94 -30.79 65.69 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.563 -0.711 . . . . 0.0 110.067 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -92.75 -6.4 49.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.84 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.0 -104.23 3.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.581 ' O ' ' CZ ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -108.02 -78.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.981 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.83 122.79 15.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.881 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . -156.54 162.4 39.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.158 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.727 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -110.55 124.77 52.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.61 173.19 8.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.222 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.603 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -74.66 -28.73 60.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.0 m-85 -125.24 67.25 54.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.545 -0.722 . . . . 0.0 109.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.8 Cg_endo -77.25 73.25 5.58 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.553 2.169 . . . . 0.0 109.876 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 -73.68 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.948 . . . . 0.0 110.242 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.73 -165.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.14 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.386 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.538 ' CE1' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -150.66 -175.71 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.915 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.8 m-85 -67.29 127.53 33.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 109.586 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 87.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 125.8 28.29 1.07 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 48.8 t -142.41 123.05 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.094 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 85.62 2.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.585 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 1.3 pp0? -59.49 144.39 47.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.511 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 159.79 34.71 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.23 18.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.742 2.295 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.35 -39.99 2.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.44 46.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' HD2' ' HB ' ' A' ' 175' ' ' THR . 34.9 ttpt -147.18 147.93 31.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -1.165 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.903 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 16.4 m-85 -133.79 130.46 38.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.085 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.563 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -99.32 108.93 21.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.082 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.65 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.11 109.21 18.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.224 -0.923 . . . . 0.0 108.585 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.496 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 1.8 mp0 -132.53 141.54 48.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.12 -0.987 . . . . 0.0 109.668 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 5.4 tt -120.7 131.89 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.798 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.73 122.98 24.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.683 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -113.87 108.39 51.22 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.858 . . . . 0.0 109.313 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 -27.62 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.387 2.058 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.31 75.29 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -95.9 40.56 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.463 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 4.9 m-20 69.56 46.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.506 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.35 29.79 1.82 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.96 123.05 20.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -1.122 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.04 130.16 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.489 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.9 t -106.75 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.668 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.566 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -74.65 94.17 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.372 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.612 HD22 ' HB2' ' A' ' 189' ' ' ALA . 39.4 mt -54.24 -41.63 68.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.079 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 145.15 155.01 6.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.566 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.3 p -68.04 179.77 1.43 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.65 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 75.1 m-85 -154.62 -174.23 4.89 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.396 -0.815 . . . . 0.0 109.343 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.38 -25.37 13.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 4.8 p -142.7 170.85 14.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.903 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.68 -23.9 58.7 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.157 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -34.03 61.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.413 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -74.79 -39.97 61.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 109.019 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.48 -35.63 73.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.915 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -70.54 -40.64 73.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.996 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 184' ' ' LEU . 28.2 tp -63.1 -43.66 97.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.48 -24.0 63.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 7.2 t80 -69.37 -30.08 67.99 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -49.11 50.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.491 -0.756 . . . . 0.0 109.046 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -54.11 -39.27 66.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.6 -0.687 . . . . 0.0 109.608 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.612 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.61 -27.62 41.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -87.7 -4.1 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.19 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.453 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 10.0 t80 -103.79 -23.82 13.37 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -81.55 -36.41 29.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 5.6 tpp -81.05 -44.07 18.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.785 -0.572 . . . . 0.0 109.91 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.7 mtt180 -85.3 -33.35 22.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.175 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 62.47 127.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 198' ' ' ALA . 69.6 m 61.56 142.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -1.104 . . . . 0.0 110.34 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 2.4 tpp180 43.06 -96.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.49 -0.756 . . . . 0.0 110.376 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.29 168.7 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.152 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -106.0 109.85 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.599 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.75 159.41 32.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.716 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -68.66 -30.55 69.26 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.0 m-85 -122.49 86.36 48.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.403 ' HA ' HD12 ' A' ' 200' ' ' LEU . 35.2 Cg_endo -77.22 -177.07 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.707 2.271 . . . . 0.0 110.669 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.71 38.39 3.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.474 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -147.44 96.77 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.534 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 145' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.241 0.544 . . . . 0.0 109.573 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.484 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.8 m170 73.24 102.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.1 m-85 -85.67 146.6 26.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 99.85 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.09 -33.25 4.28 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.1 t -75.3 134.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -1.19 . . . . 0.0 109.772 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -121.18 106.69 11.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.061 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.566 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -77.12 163.21 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.629 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.541 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -120.8 175.99 2.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.412 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.39 -23.43 8.67 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.744 2.296 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -84.25 -56.03 3.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 109.62 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.83 38.02 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.2 157.88 41.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -1.125 . . . . 0.0 109.138 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 13.7 m-85 -126.1 -178.43 4.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 109.093 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.68 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.97 108.19 4.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 110.345 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.69 107.57 13.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.423 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -130.29 146.05 51.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.5 tt -135.12 156.44 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.291 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.05 132.78 33.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -132.17 102.55 14.39 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.303 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 -26.67 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.442 2.094 . . . . 0.0 109.961 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.52 64.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 35.9 mttm -90.03 26.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 3.7 t-20 75.11 43.99 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.38 48.48 80.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.02 147.32 42.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -1.153 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -76.81 154.95 33.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 171' ' ' VAL . 9.0 t -122.12 85.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.68 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.5 t-105 -73.86 96.46 2.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 108.882 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.911 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.6 mt -52.94 -48.59 67.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.132 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.523 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 150.43 152.29 5.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.564 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.5 p -65.55 171.14 4.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.173 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.529 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 61.6 m-85 -144.95 -176.49 5.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -89.42 -29.58 18.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.584 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.5 p -143.06 171.18 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.05 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.62 -28.11 63.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -69.46 -33.75 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -76.36 -41.11 49.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 109.031 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -71.58 -23.12 61.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.852 . . . . 0.0 109.081 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -80.24 -42.52 23.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 108.86 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -36.22 83.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.14 -29.78 65.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 17.7 t80 -64.83 -37.43 87.59 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.904 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.2 m-20 -63.39 -47.09 83.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.512 -0.742 . . . . 0.0 109.336 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -53.04 -42.37 65.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.911 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.02 -17.92 45.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.7 -5.09 56.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.189 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 5.6 t80 -102.8 -33.73 9.26 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -77.23 -41.36 41.47 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.39 -29.27 63.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 109.343 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.6 mtt-85 -104.66 9.79 35.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.67 -162.79 14.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 59.0 p -61.49 161.56 9.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -1.101 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.1 OUTLIER 54.94 104.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.551 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -151.58 172.98 15.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 109.163 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.627 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -107.43 112.89 25.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.437 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.72 179.44 4.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 109.31 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.648 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -74.53 -30.59 61.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 108.422 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.3 m-85 -126.1 67.0 61.52 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.589 -0.694 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo -76.53 159.11 35.99 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.609 2.206 . . . . 0.0 110.304 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.59 89.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.65 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.445 ' CG ' HG23 ' A' ' 206' ' ' VAL . 3.6 ttt-85 -160.31 129.94 5.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.445 HG23 ' CG ' ' A' ' 205' ' ' ARG . 3.5 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -118.92 105.87 11.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.951 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.0 m-85 -101.11 159.11 15.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -80.71 99.08 8.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.668 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 160' ' ' GLU . . . 115.92 -9.72 18.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 179' ' ' ALA . 89.7 t -100.88 112.61 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.034 -1.274 . . . . 0.0 109.79 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.1 ttm-85 -91.83 94.12 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.108 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.564 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -71.57 134.94 46.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.85 160.65 34.31 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.85 -2.55 12.53 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.71 2.273 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -109.73 19.95 18.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.661 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.16 68.03 1.7 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -162.01 133.47 5.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 108.797 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 5.3 m-85 -132.51 137.27 47.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -0.945 . . . . 0.0 109.115 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.693 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -107.26 116.76 32.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.002 -1.061 . . . . 0.0 110.357 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -89.39 114.12 25.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 148' ' ' GLY . 2.5 mp0 -130.61 155.57 46.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.403 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 8.9 tt -139.06 125.77 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -0.951 . . . . 0.0 109.607 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -82.03 117.55 22.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.52 108.94 58.31 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.23 -33.08 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.381 2.054 . . . . 0.0 110.288 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.28 65.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -89.46 39.54 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.428 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.4 m120 46.57 50.17 13.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.594 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.15 88.69 0.03 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -146.85 89.04 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -1.157 . . . . 0.0 109.741 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.7 ptp85 -49.18 145.23 4.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.326 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.5 t -127.55 86.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.691 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.693 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.6 t-105 -67.21 97.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 108.91 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.831 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -53.98 -42.42 68.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.859 . . . . 0.0 109.606 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.48 155.53 6.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.7 p -67.77 -176.59 0.67 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.261 -1.141 . . . . 0.0 109.302 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 71.0 m-85 -156.75 -168.52 2.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 109.397 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.57 -25.88 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.456 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.577 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.1 p -141.49 174.54 10.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.719 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.85 -24.42 41.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -35.08 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -39.32 44.33 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.184 -0.948 . . . . 0.0 109.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.951 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.91 -41.93 61.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 108.853 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.59 -40.58 95.3 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.67 -25.83 64.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 15.2 t80 -68.15 -41.09 82.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.562 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.5 m-20 -61.1 -50.1 74.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.27 -0.894 . . . . 0.0 109.224 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -48.27 -39.5 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.557 -0.714 . . . . 0.0 110.128 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.831 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.9 -26.16 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.966 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.15 7.36 32.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.041 -1.037 . . . . 0.0 109.143 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 10.0 t80 -111.94 -33.8 6.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -43.06 32.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -75.62 -29.73 59.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.319 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.636 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -95.51 5.41 51.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.907 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 85.37 -89.51 1.61 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.587 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 45.0 t -138.76 -80.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -1.208 . . . . 0.0 109.879 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 111.79 1.01 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.804 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . -150.49 170.01 20.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.34 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.523 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -97.83 107.99 20.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.562 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -115.42 157.87 23.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.189 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.666 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -61.19 -31.72 71.48 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.8 m-85 -121.97 83.92 44.42 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 145.14 24.59 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.301 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 78.2 mt -68.85 -92.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 52.65 -154.33 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.532 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 206' ' ' VAL . 4.5 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.447 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.95 155.24 38.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.535 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.872 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.2 m-85 -59.19 169.43 1.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -82.45 83.32 7.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.878 . . . . 0.0 109.199 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.96 6.15 5.51 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 95.8 t -119.69 118.14 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -1.233 . . . . 0.0 109.477 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.2 ttp180 -88.24 115.0 25.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.555 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -83.38 152.3 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.751 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.531 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.3 mtm105 -137.5 175.42 3.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -0.819 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 34.9 Cg_endo -77.44 159.13 32.67 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.5 2.134 . . . . 0.0 110.019 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.568 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 8.2 t-105 83.77 -60.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.655 -0.653 . . . . 0.0 109.519 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.41 54.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -132.88 154.11 50.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -1.185 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.811 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 74.4 m-85 -142.43 179.17 7.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.56 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.45 113.94 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.061 -1.024 . . . . 0.0 110.017 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.31 121.74 31.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.377 -0.827 . . . . 0.0 108.974 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -146.17 151.34 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.148 -0.97 . . . . 0.0 109.313 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 161' ' ' ILE . 7.9 tt -129.83 124.3 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 124.28 22.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.43 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.19 96.92 50.36 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.72 -22.67 10.26 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.611 2.207 . . . . 0.0 110.223 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.29 -3.85 19.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.349 -0.844 . . . . 0.0 109.703 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 1.0 OUTLIER -122.38 27.59 7.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 109.731 -179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 75.19 58.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.095 -1.003 . . . . 0.0 109.626 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.9 39.69 6.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -84.44 93.32 8.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -1.209 . . . . 0.0 109.285 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -50.01 142.47 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.4 t -116.3 86.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 109.194 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.7 t-105 -75.62 96.12 3.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.3 mp -54.45 -42.88 71.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.62 152.42 5.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.6 p -68.35 164.44 20.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.443 -1.033 . . . . 0.0 109.44 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.887 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.4 m-85 -138.41 -169.88 2.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.515 ' HG2' ' OD2' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -96.93 -30.87 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p -136.59 -179.62 5.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.85 -1.157 . . . . 0.0 110.247 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.811 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -76.49 -32.38 58.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 8.0 tt0 -66.23 -70.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -38.79 -59.97 0.89 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.623 . . . . 0.0 110.166 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -55.6 -38.44 69.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.872 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.08 -34.63 78.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.136 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -38.42 80.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.915 -1.115 . . . . 0.0 109.44 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.551 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.06 -32.39 73.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -0.84 . . . . 0.0 108.911 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.0 t80 -67.17 -33.85 76.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 109.523 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.47 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 29.4 m-20 -64.25 -44.91 90.33 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.0 110.04 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -62.66 -32.88 74.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.79 . . . . 0.0 110.408 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.774 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -83.47 -24.65 31.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.101 -1.0 . . . . 0.0 109.853 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.65 -12.64 53.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.8 t80 -99.56 -40.47 7.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.016 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.14 -39.9 96.01 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.9 tpp -74.92 -55.32 5.91 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.558 0.694 . . . . 0.0 109.569 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 5.7 mtt180 -88.95 -55.74 3.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 0.0 109.685 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 57.28 170.15 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.435 ' OG ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER 56.25 81.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.522 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.42 100.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.896 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -133.56 176.7 8.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 200' ' ' LEU . 8.1 mp -95.85 109.3 21.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 110.008 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.726 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -130.49 143.17 50.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.117 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.628 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -51.89 -32.11 31.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 m-85 -124.13 89.53 51.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.726 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.0 Cg_endo -75.93 99.21 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.462 2.108 . . . . 0.0 110.435 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mp 47.86 -167.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.283 -0.886 . . . . 0.0 109.208 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 -75.64 0.3 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.333 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 206' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.343 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 145' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 11.4 t-160 63.97 113.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 1.013 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 36.8 m-85 -104.81 152.43 22.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 89.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.66 -28.19 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 50.6 t -85.86 118.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -1.177 . . . . 0.0 109.61 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -101.53 116.81 33.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 108.994 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.512 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.4 pt20 -81.58 157.25 24.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.94 . . . . 0.0 109.931 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.502 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.3 mtt-85 -122.46 160.36 48.61 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -76.84 -8.54 17.97 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.514 2.143 . . . . 0.0 110.162 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.89 -27.14 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.3 34.46 0.95 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 11.8 mtpp -132.06 176.97 7.92 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -1.157 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.3 m-85 -145.45 177.24 8.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.29 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -149.13 108.35 3.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.866 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.55 107.21 13.16 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -129.6 151.98 49.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.304 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.442 HG12 ' N ' ' A' ' 162' ' ' ARG . 3.0 tt -141.61 149.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.442 ' N ' HG12 ' A' ' 161' ' ' ILE . 5.6 ttp85 -86.51 144.76 27.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -137.6 99.35 9.52 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.11 -25.63 8.51 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.015 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.83 -13.38 32.98 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -104.83 43.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.74 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 23.0 m120 59.38 59.28 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 109.644 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 167' ' ' ASN . . . 44.13 79.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.08 148.91 42.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.384 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.5 mtt-85 -86.15 167.04 15.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.53 100.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.102 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.482 ' C ' ' CD1' ' A' ' 172' ' ' TRP . 3.0 t-105 -85.95 106.3 17.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 31.4 mt -64.56 -49.61 70.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 153.75 158.13 8.45 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -78.03 155.59 30.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -1.145 . . . . 0.0 109.076 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 66.6 m-85 -130.5 173.8 10.5 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.42 -31.77 42.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.935 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -141.03 172.55 12.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.48 -22.54 61.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.474 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -72.76 -38.55 67.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.3 -44.92 50.66 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.72 -44.76 95.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.394 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.013 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.43 -43.29 88.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.089 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.36 -51.66 68.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.865 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.95 -23.15 66.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.4 t80 -72.96 -31.88 64.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 109.503 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.678 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.8 m-20 -70.93 -50.28 36.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -37.45 47.66 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.676 -0.64 . . . . 0.0 109.985 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.1 -23.49 23.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.83 7.69 45.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.802 ' CD2' HD11 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -118.83 -37.61 3.22 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -81.5 -38.87 25.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -79.07 -32.86 44.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.718 -0.614 . . . . 0.0 109.727 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -91.74 -17.88 24.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.219 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 41.98 -156.94 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.0 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -1.173 . . . . 0.0 109.545 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.4 mtm180 -56.05 -58.3 8.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.606 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 60.29 177.81 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.169 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 200' ' ' LEU . 11.0 mt -140.89 122.5 15.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.541 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -123.32 154.37 38.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 109.377 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.677 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -56.06 -33.68 65.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.39 80.27 37.44 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.76 96.32 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -148.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.48 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 3.0 mtp180 -100.98 -179.64 4.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 5.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.351 0.596 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 146' ' ' TYR . 27.9 p-80 -99.83 168.67 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.561 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.921 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 -89.09 161.57 16.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 83.68 7.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.27 -3.52 5.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 179' ' ' ALA . 41.9 t -107.62 114.71 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.775 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -94.89 115.93 28.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.852 . . . . 0.0 109.219 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.509 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.6 OUTLIER -88.39 155.04 19.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.23 162.28 22.87 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 -7.59 16.59 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.526 2.151 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -99.21 -64.53 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.47 50.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -146.05 156.43 43.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -1.176 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.4 m-85 -130.24 179.99 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.199 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.711 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.63 111.8 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.546 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.85 125.75 33.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.676 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -147.81 158.63 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.484 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.7 tt -143.54 134.61 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.98 131.18 41.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -111.33 106.32 57.12 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.06 -31.4 4.95 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.279 1.986 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.4 -16.67 64.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.339 -0.85 . . . . 0.0 108.948 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -107.42 53.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.477 -0.764 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.23 21.68 2.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.11 62.41 3.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.87 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -1.182 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.69 155.85 14.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.887 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 171' ' ' VAL . 23.7 t -140.98 83.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.528 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.711 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.9 t-105 -71.49 98.63 1.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 108.98 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.942 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.32 -51.42 68.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 157.28 157.85 8.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.565 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -72.81 153.12 41.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -1.129 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 72.0 m-85 -129.01 -172.63 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.511 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.32 -28.84 13.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.56 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.7 p -140.91 166.06 25.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -68.03 -21.22 65.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.27 -0.894 . . . . 0.0 109.421 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -75.32 -44.25 46.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 109.756 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.435 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -69.81 -38.69 76.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -69.16 -43.27 74.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.921 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -64.16 -35.43 80.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 108.97 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.766 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -63.5 -48.4 77.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.026 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.13 -25.45 67.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.469 -0.77 . . . . 0.0 109.064 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 10.9 t80 -68.91 -34.3 75.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.665 ' HB3' HD13 ' A' ' 200' ' ' LEU . 40.1 m-20 -64.05 -48.01 77.93 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.379 -0.825 . . . . 0.0 108.917 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -52.16 -44.58 64.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.711 -0.618 . . . . 0.0 110.295 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.942 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.42 -27.64 59.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . -88.2 6.82 34.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.471 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.0 t80 -115.61 -26.4 7.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 108.938 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -83.32 -37.5 23.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mtp -80.9 -39.27 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.636 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 73.1 mtt180 -94.0 -34.24 13.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 48.92 -168.72 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.9 m 57.96 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.361 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 52.1 ttt180 -124.87 -54.92 1.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.083 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.636 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . 61.85 154.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.751 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 108.44 19.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -121.64 -174.34 2.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.58 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.701 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -80.72 -37.79 29.97 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.766 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.1 m-85 -116.4 80.58 10.11 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.288 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 35.4 Cg_endo -77.23 -168.89 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.688 2.259 . . . . 0.0 110.086 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.2 mt -118.44 -176.79 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 24.53 7.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.399 179.932 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.193 0.521 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 65.29 116.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 109.286 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 40.4 m-85 -114.0 152.53 30.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.5 88.31 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.96 -29.85 3.03 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 179' ' ' ALA . 48.1 t -86.15 113.25 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.698 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -93.34 105.86 17.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 108.583 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.632 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 13.7 pt20 -103.47 133.85 47.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 110.097 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.571 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -88.23 -179.26 1.26 Allowed Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.3 Cg_endo -75.22 77.98 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.826 1.684 . . . . 0.0 109.825 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER 70.47 75.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.775 . . . . 0.0 109.272 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.61 -86.35 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -137.87 178.35 7.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.147 -1.208 . . . . 0.0 110.252 -178.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.634 ' CE1' ' HA ' ' A' ' 178' ' ' THR . 9.5 m-85 -135.93 174.53 10.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.584 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.12 104.73 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.61 ' HB2' ' CA ' ' A' ' 182' ' ' ALA . . . -79.93 102.6 9.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.195 -0.941 . . . . 0.0 109.201 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 5.8 tm-20 -125.79 154.27 42.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.792 . . . . 0.0 109.197 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.865 HD13 ' HE2' ' A' ' 193' ' ' MET . 2.1 tt -132.71 149.24 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.963 . . . . 0.0 109.694 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.2 ttm180 -103.46 108.33 19.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.314 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -100.23 118.36 61.48 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.143 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.96 -26.46 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.284 1.989 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -14.4 22.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.255 -0.903 . . . . 0.0 109.378 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -102.1 39.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.354 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.67 33.41 23.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.82 53.66 9.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -108.72 121.97 46.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -1.149 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.53 159.21 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.605 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.1 t -138.25 87.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.264 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.584 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.1 t-105 -69.71 114.55 8.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 109.394 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 20.2 mt -75.39 -53.9 7.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.85 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.69 156.46 8.75 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.1 p -73.67 152.93 40.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.15 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.792 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 58.3 m-85 -131.05 173.99 10.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.74 -30.68 32.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.634 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -138.2 -172.77 3.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.593 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -88.42 -22.24 23.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.955 . . . . 0.0 108.833 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -72.21 -37.43 69.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 109.011 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.8 OUTLIER -74.2 -46.72 40.19 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.416 -0.802 . . . . 0.0 108.948 179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -21.23 62.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 108.771 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.68 -39.11 37.68 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.772 ' O ' HD13 ' A' ' 184' ' ' LEU . 3.1 tm? -68.24 -45.33 73.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.24 -26.73 68.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -67.84 -33.51 74.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.492 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.3 m-20 -68.19 -42.36 80.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 188' ' ' ARG . 17.4 tpp180 -61.59 -40.41 94.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 109.995 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 173' ' ' LEU . . . -79.65 -23.96 42.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 109.701 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -90.92 -3.5 57.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.581 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 187' ' ' ASP . 1.7 t80 -105.53 -27.84 11.15 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.204 -0.935 . . . . 0.0 108.763 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -81.59 -40.97 22.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.865 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.77 -33.55 60.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -0.777 . . . . 0.0 109.304 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 8.0 mmm180 -92.63 -16.41 25.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.378 -0.827 . . . . 0.0 108.929 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . 42.29 -108.72 0.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 197' ' ' ARG . 56.1 p -50.53 111.81 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -1.136 . . . . 0.0 110.097 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.2 OUTLIER 56.35 160.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 0.0 110.344 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . 177.32 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.2 mt -95.54 116.21 28.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.64 -176.69 4.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.411 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.479 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -80.36 -35.5 35.35 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 2.3 m-85 -120.03 79.25 25.45 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -77.14 93.89 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.614 2.209 . . . . 0.0 110.713 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.31 173.59 7.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 109.299 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 mtm-85 -90.03 154.34 19.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 206' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 62.14 -174.56 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.556 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 -96.65 143.83 27.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.873 . . . . 0.0 109.685 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.58 74.91 7.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.381 -0.825 . . . . 0.0 108.898 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . 155.3 -16.41 0.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 1.003 HG11 ' HA ' ' A' ' 179' ' ' ALA . 9.2 t -105.26 111.11 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.979 -1.306 . . . . 0.0 109.785 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.94 131.68 54.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.612 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . 2.8 pm0 -122.8 131.76 53.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.991 . . . . 0.0 110.473 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.585 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -71.86 -172.87 0.23 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.13 90.57 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.645 1.563 . . . . 0.0 109.977 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.8 m95 64.49 50.14 2.27 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.02 -123.61 2.04 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.459 -1.353 . . . . 0.0 111.09 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.4 mttt -106.68 151.78 24.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.972 . . . . 0.0 110.434 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE1' ' HB2' ' A' ' 151' ' ' GLN . 2.9 m-30 -100.2 -171.7 2.08 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.626 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -162.79 121.28 2.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.611 -1.306 . . . . 0.0 110.773 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -100.11 121.24 41.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 2.0 mt-10 -136.19 158.47 44.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.809 . . . . 0.0 109.672 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.508 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.6 tt -141.54 123.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.317 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 170' ' ' ARG . 1.0 OUTLIER -63.57 139.2 58.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.417 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 43.7 t0 -128.2 97.8 28.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.284 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.52 -28.18 7.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.307 2.005 . . . . 0.0 110.401 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.2 -14.06 52.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -108.8 42.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.736 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.47 30.02 9.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.074 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.47 66.94 1.56 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -116.33 85.92 2.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -1.147 . . . . 0.0 109.338 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.3 ptt85 -42.2 144.95 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.406 -0.808 . . . . 0.0 109.481 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 161' ' ' ILE . 45.7 t -120.19 88.58 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.145 -0.972 . . . . 0.0 109.811 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.626 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.0 t-105 -73.66 93.75 2.11 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.137 -0.977 . . . . 0.0 109.025 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -51.43 -47.38 63.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.763 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 149.51 165.11 12.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -77.54 148.02 35.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.933 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 48.3 m-85 -123.44 -166.4 1.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.35 -0.844 . . . . 0.0 109.397 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -105.01 -26.75 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.544 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . 1.9 p -144.61 -172.27 3.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 109.548 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.003 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -87.11 -22.63 25.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -77.03 -36.61 56.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 0.0 109.512 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.6 OUTLIER -75.59 -52.2 11.12 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.217 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.933 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -62.43 -34.73 77.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.164 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.64 -44.16 74.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -58.65 -38.21 77.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.397 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -71.73 -28.24 63.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.006 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -70.67 -30.16 66.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 96.7 m-20 -71.84 -41.9 67.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.411 -0.806 . . . . 0.0 109.942 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.7 -34.12 73.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 110.082 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.994 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.65 -29.08 36.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.764 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -82.02 -24.93 35.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.377 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -81.33 -26.84 35.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -45.56 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.43 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -71.71 -35.22 70.14 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.585 -0.697 . . . . 0.0 109.965 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.716 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 3.3 mpt_? -94.66 -7.89 39.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.24 -87.25 0.19 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 197' ' ' ARG . 4.4 t -85.25 -146.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.702 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' A' ' 196' ' ' SER . 28.1 mtm180 -38.46 140.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.598 -0.689 . . . . 0.0 110.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.716 ' HB2' ' HB2' ' A' ' 194' ' ' ARG . . . -157.14 32.69 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 199' ' ' LEU . 7.2 mt 41.68 92.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.66 -0.65 . . . . 0.0 109.651 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 203' ' ' PRO . 0.0 OUTLIER -120.51 143.66 48.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.2 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.545 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -45.89 -33.96 3.56 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.526 ' HD2' HD22 ' A' ' 184' ' ' LEU . 1.4 m-85 -134.04 88.01 32.92 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' A' ' 200' ' ' LEU . 34.2 Cg_endo -76.57 75.69 4.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.572 2.181 . . . . 0.0 110.545 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 203' ' ' PRO . 10.9 mp 48.0 -175.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 22.0 3.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.384 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.498 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.363 0.602 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -143.3 111.56 6.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.927 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 15.5 m-85 -82.79 134.71 35.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.846 . . . . 0.0 109.492 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 98.46 3.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.192 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.0 -31.94 3.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 157' ' ' PHE . 41.0 t -79.55 136.53 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -1.1 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.5 OUTLIER -108.4 89.91 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 109.228 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 3.9 pt20 -59.42 131.21 50.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.978 . . . . 0.0 109.462 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -110.66 159.5 32.1 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.75 -1.68 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.708 2.272 . . . . 0.0 110.543 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.423 ' HB3' ' HE3' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -98.73 -25.71 14.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.05 39.87 0.62 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 157' ' ' PHE . 21.6 mttt -130.05 179.96 5.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.245 -1.15 . . . . 0.0 109.415 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 86.5 m-85 -159.12 109.0 1.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 108.679 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -85.8 127.12 34.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.09 -1.006 . . . . 0.0 111.263 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -99.9 116.92 33.08 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.45 166.16 25.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.041 -1.037 . . . . 0.0 110.316 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 8.8 tt -152.18 158.63 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.451 -0.78 . . . . 0.0 108.952 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.54 139.7 48.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.95 -1.094 . . . . 0.0 109.858 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -138.11 93.63 11.62 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.36 -22.99 10.51 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.587 2.191 . . . . 0.0 110.431 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.89 -13.99 19.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -107.38 51.03 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.467 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 28.7 t-20 57.03 38.32 29.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.341 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 60.94 97.91 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.6 100.89 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.127 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -51.99 166.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.441 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 67.2 t -147.83 90.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.612 ' HZ2' HG22 ' A' ' 175' ' ' THR . 3.1 t-105 -87.06 101.83 13.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.099 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.2 mt -56.12 -50.79 70.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.42 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 148.63 148.68 4.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.612 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.1 p -68.32 158.41 33.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.08 -1.247 . . . . 0.0 108.967 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 85.5 m-85 -131.86 -176.89 4.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.622 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -27.69 14.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.553 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.7 p -133.03 170.41 15.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.515 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -22.61 47.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.377 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -73.09 -33.11 65.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.428 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.0 OUTLIER -80.54 -34.95 35.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.235 -0.915 . . . . 0.0 109.173 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -76.48 -27.83 56.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.927 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.14 -40.56 45.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.203 -0.936 . . . . 0.0 108.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 202' ' ' PHE . 6.9 tp -63.89 -41.75 97.64 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.513 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.58 -37.76 85.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -62.73 -40.44 97.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.45 -0.781 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 200' ' ' LEU . 14.4 m-20 -60.7 -52.2 66.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.498 -0.751 . . . . 0.0 109.833 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -54.16 -31.19 51.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.099 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -84.4 -26.95 27.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.25 2.99 54.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.542 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 1.5 t80 -117.16 -31.24 5.4 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -74.92 -38.49 61.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 ttm -81.53 -46.26 14.74 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.418 0.627 . . . . 0.0 109.735 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.7 mtt85 -93.94 -41.89 9.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.039 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 48.12 -149.79 3.39 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m 50.26 -107.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -1.188 . . . . 0.0 109.601 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.01 56.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.222 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 190' ' ' ALA . . . -66.18 169.65 6.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.332 -0.855 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -113.67 116.44 29.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.098 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -125.25 179.28 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.599 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -70.33 -38.25 74.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.613 ' O ' HD12 ' A' ' 200' ' ' LEU . 7.8 m-85 -112.16 96.11 33.26 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -75.67 148.62 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.578 2.185 . . . . 0.0 110.708 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.33 106.43 14.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.5 -27.24 11.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.95 . . . . 0.0 109.529 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.499 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 128.58 48.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.373 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.8 m-85 -67.23 143.27 56.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -77.79 96.98 5.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.637 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.66 -16.72 7.39 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 183' ' ' ALA . 27.3 t -97.48 117.61 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -1.196 . . . . 0.0 109.811 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 3.4 mmp_? -96.53 117.89 31.89 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.588 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -85.38 160.07 19.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.967 . . . . 0.0 110.016 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.528 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 16.4 mtt180 -126.7 158.26 68.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.681 -0.637 . . . . 0.0 109.337 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.2 3.49 7.05 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.577 2.185 . . . . 0.0 110.298 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.93 -9.9 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.485 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.01 33.24 4.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 2.2 mtmt -127.81 173.09 10.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.127 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.6 m-85 -144.33 -178.29 5.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.366 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.621 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -153.69 104.1 2.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 109.94 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.59 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.04 123.22 27.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.235 -0.916 . . . . 0.0 108.974 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 172' ' ' TRP . 1.1 mt-10 -139.12 164.51 29.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.266 -0.896 . . . . 0.0 109.267 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 171' ' ' VAL . 6.2 tt -146.02 141.84 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -86.8 108.72 18.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 166' ' ' LYS . 11.8 t70 -99.68 113.14 64.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.36 -27.31 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -9.14 56.67 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.56 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 4.4 mmpt? -117.87 39.35 3.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 1.2 m-20 68.74 29.38 5.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.511 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.41 27.1 68.89 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.81 116.53 8.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -1.209 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -59.04 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HG23 ' A' ' 161' ' ' ILE . 37.8 t -68.31 104.99 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.621 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.4 t-105 -80.51 99.01 7.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 19.7 mt -56.63 -37.67 71.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.027 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.555 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 136.3 158.27 8.04 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -78.52 148.87 33.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -1.13 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 69.4 m-85 -120.25 -168.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.695 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.938 ' HG3' HG23 ' A' ' 178' ' ' THR . 9.9 pt-20 -99.23 -32.59 11.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.938 HG23 ' HG3' ' A' ' 177' ' ' GLU . 2.1 p -133.85 170.1 16.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.127 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.32 -23.65 50.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.96 . . . . 0.0 109.556 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -73.13 -36.61 66.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.491 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.3 OUTLIER -75.32 -45.38 39.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 109.462 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -61.76 -47.2 86.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.32 -42.39 86.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.103 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 184' ' ' LEU . 21.3 tp -60.79 -39.83 90.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.564 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.19 -24.34 66.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -0.813 . . . . 0.0 109.046 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.9 t80 -72.35 -29.95 64.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.714 ' HB3' HD13 ' A' ' 200' ' ' LEU . 2.0 m-20 -72.18 -50.32 28.58 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.302 -0.874 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -60.91 -28.7 69.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.48 -19.57 23.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.927 . . . . 0.0 109.274 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.72 -8.14 41.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.252 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -105.79 -33.67 7.92 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -80.15 -39.77 28.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -30.57 64.12 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.673 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 12.8 mtt180 -96.2 -0.95 49.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.36 -87.17 1.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 197' ' ' ARG . 3.0 m -135.8 164.4 27.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -1.188 . . . . 0.0 109.423 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.2 OUTLIER 56.82 109.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.474 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -163.31 150.1 12.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.957 . . . . 0.0 109.492 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mp -92.37 118.23 30.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.51 174.74 8.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 109.413 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.764 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -70.42 -34.59 72.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 108.613 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.8 m-85 -121.34 84.58 41.34 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.06 117.65 4.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.48 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 205' ' ' ARG . 0.3 OUTLIER 51.64 -173.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.5 ' CB ' ' O ' ' A' ' 204' ' ' LEU . 0.8 OUTLIER 75.99 -169.73 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.471 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.458 -179.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.373 0.606 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -129.96 -173.33 3.01 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.424 -0.798 . . . . 0.0 109.415 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.76 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 46.0 m-85 -122.62 152.46 40.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -82.03 36.18 0.45 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.154 -0.966 . . . . 0.0 109.753 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.04 26.59 0.09 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' ALA . 57.6 t -143.6 113.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -1.154 . . . . 0.0 109.424 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.05 94.79 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.32 134.29 56.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.494 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 7.5 mmt180 -99.17 161.25 25.37 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.668 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.494 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 36.1 Cg_endo -78.32 -34.81 1.41 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.678 2.252 . . . . 0.0 110.263 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -47.69 83.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.08 43.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 157' ' ' PHE . 2.6 mttm -131.94 -168.65 2.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 179' ' ' ALA . 63.3 m-85 -159.47 108.29 1.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.096 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.618 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -82.38 139.34 34.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -111.11 113.58 26.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -134.79 164.75 26.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 0.0 109.899 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 171' ' ' VAL . 4.3 tt -141.52 143.3 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 108.914 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 1.2 tmm_? -82.62 119.71 24.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.825 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.407 ' CG ' ' SD ' ' A' ' 193' ' ' MET . 41.5 t0 -111.06 97.74 35.99 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.072 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 34.7 Cg_endo -76.39 -26.39 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.475 2.117 . . . . 0.0 110.673 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.81 -22.76 67.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 0.0 109.578 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -100.4 64.33 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.587 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 48.16 44.22 19.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.602 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 50.92 59.64 7.87 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -107.18 136.71 46.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -1.165 . . . . 0.0 109.44 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 163.24 28.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' A' ' 161' ' ' ILE . 55.7 t -134.87 99.7 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 158' ' ' ALA . 16.0 t-105 -84.09 91.67 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.982 . . . . 0.0 109.599 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 57.6 mt -51.38 -48.45 62.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.246 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 152.39 158.52 8.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.615 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.8 p -73.61 162.71 28.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -1.175 . . . . 0.0 109.477 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.0 m-85 -138.83 179.57 6.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -28.46 19.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 p -142.72 168.51 19.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 157' ' ' PHE . . . -72.09 -24.6 61.52 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.83 -39.79 76.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.6 OUTLIER -74.63 -45.69 43.18 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.14 -31.15 72.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.69 -47.83 44.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.255 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.433 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -58.39 -35.68 72.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 108.834 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.43 -28.98 65.47 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.278 -0.888 . . . . 0.0 108.696 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -65.88 -28.03 68.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.409 -0.807 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.723 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.9 m-20 -71.62 -47.88 51.67 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.303 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -34.74 68.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -84.2 -39.11 19.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.929 -1.107 . . . . 0.0 109.981 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -69.22 -18.91 63.95 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.572 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.6 t80 -85.55 -40.6 16.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.139 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -40.28 86.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.759 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.407 ' SD ' ' CG ' ' A' ' 163' ' ' ASP . 28.9 ttm -77.86 -43.16 31.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.666 -0.646 . . . . 0.0 109.591 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 70.4 mtt180 -102.25 34.2 2.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.955 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -41.12 164.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 84.53 -47.71 0.1 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.834 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -171.73 128.81 0.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.208 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 194' ' ' ARG . . . -159.66 148.77 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -89.77 122.62 33.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -121.83 157.26 31.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.164 -0.96 . . . . 0.0 109.303 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.494 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -53.93 -35.59 61.86 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 4.2 m-85 -124.16 83.53 56.18 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.1 123.64 6.83 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.515 2.143 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mp 51.78 -173.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 10.8 mtp85 -69.45 173.35 6.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 2.4 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.361 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -53.56 177.44 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.371 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.958 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.5 m-85 -45.66 133.35 8.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.494 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -72.11 96.75 1.81 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.54 -8.33 7.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' A' ' 182' ' ' ALA . 38.5 t -105.01 112.32 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -1.172 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -96.19 117.61 31.11 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.374 -0.829 . . . . 0.0 109.095 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.596 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.38 153.76 24.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.84 . . . . 0.0 109.433 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -116.58 155.94 48.18 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.25 -10.52 16.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.661 2.241 . . . . 0.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -36.59 17.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.136 -0.977 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 156' ' ' LYS . . . 133.61 61.81 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 155' ' ' GLY . 19.4 mttp -166.83 -171.64 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 109.514 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.015 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -148.88 -175.12 4.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 109.102 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.705 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -155.31 108.53 2.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 0.0 110.017 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.8 134.17 36.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.154 -0.966 . . . . 0.0 108.984 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.24 148.96 29.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.095 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.435 ' O ' ' HB ' ' A' ' 171' ' ' VAL . 3.8 tt -141.79 127.71 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.023 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -69.46 143.63 53.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 109.204 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 168' ' ' GLY . 43.5 t0 -110.52 97.65 33.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.573 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.6 Cg_endo -76.57 -26.9 8.04 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.355 2.037 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.51 68.33 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 3.0 mmmm -101.55 25.31 8.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 67.46 66.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 163' ' ' ASP . . . 69.32 -106.64 1.85 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . 51.33 80.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.255 . . . . 0.0 109.578 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.9 153.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 171' ' ' VAL . 11.7 t -128.07 81.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.705 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 7.5 t-105 -61.4 97.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 109.168 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -52.68 -49.14 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 176' ' ' PHE . . . 149.43 154.26 6.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.4 p -68.54 153.86 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -1.196 . . . . 0.0 109.214 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 56.7 m-85 -129.4 172.91 11.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.754 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -77.02 -30.11 55.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 109.854 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.519 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.5 p -145.65 -174.07 4.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.015 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -81.81 -28.62 33.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.673 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -70.61 -34.46 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 109.624 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -73.32 -44.42 58.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.133 -0.979 . . . . 0.0 109.452 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.656 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -68.96 -30.2 68.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.958 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.98 -41.49 67.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.301 -0.875 . . . . 0.0 109.105 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.75 94.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.302 -0.873 . . . . 0.0 109.16 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.18 -22.9 66.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -0.809 . . . . 0.0 108.935 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.3 t80 -69.79 -33.9 73.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 109.081 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.489 ' CG ' ' CB ' ' A' ' 200' ' ' LEU . 18.9 m-20 -67.68 -43.85 79.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.429 -0.795 . . . . 0.0 109.472 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -58.9 -40.53 84.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.773 . . . . 0.0 109.84 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.89 -20.75 38.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.89 -8.9 48.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 195' ' ' GLY . 2.3 t80 -101.96 -33.95 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.284 -0.885 . . . . 0.0 108.924 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -76.4 -40.95 49.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 108.782 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 tpp -73.01 -31.61 64.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.576 -0.702 . . . . 0.0 109.484 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.7 mtt85 -105.81 1.82 27.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . 49.3 -99.07 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER -48.2 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 109.737 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -42.77 160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.778 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -157.72 37.0 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 0.0 109.273 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.472 ' C ' HD23 ' A' ' 200' ' ' LEU . 7.8 mp 39.89 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.718 -0.614 . . . . 0.0 109.869 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 200' ' ' LEU . 0.1 OUTLIER -111.91 173.93 6.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.972 . . . . 0.0 109.401 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.59 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.0 -34.54 68.96 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.7 m-85 -122.67 80.42 48.16 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 -169.45 0.72 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.58 2.186 . . . . 0.0 110.65 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 60.32 1.66 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.17 132.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.65 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.391 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 pttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -141.33 115.69 9.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.593 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.914 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 17.4 m-85 -104.28 149.42 25.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 99.9 4.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.2 -25.21 7.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 183' ' ' ALA . 52.0 t -86.79 126.14 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -1.191 . . . . 0.0 110.046 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -104.4 110.98 23.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.558 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 3.4 pm0 -75.88 144.63 41.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 156.62 53.32 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.158 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.03 3.51 6.96 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.552 2.168 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -96.19 -13.84 23.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.79 26.41 6.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.493 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -133.76 -173.78 3.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -1.155 . . . . 0.0 109.527 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 65.7 m-85 -149.0 -177.59 5.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.351 -0.843 . . . . 0.0 109.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.754 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -145.77 108.24 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.842 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.706 ' C ' HD12 ' A' ' 173' ' ' LEU . . . -79.94 108.82 13.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 108.993 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER -126.47 155.16 42.72 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -0.947 . . . . 0.0 109.966 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 171' ' ' VAL . 7.5 tt -141.55 117.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.387 -0.82 . . . . 0.0 109.015 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -89.99 126.05 35.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -111.11 103.9 55.48 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 0.0 109.395 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.98 -25.12 9.19 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.307 2.005 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.92 -18.71 64.49 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 39.16 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.213 -0.93 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.2 m120 55.53 46.05 23.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.42 121.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -179.61 128.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -1.137 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -95.26 148.62 22.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 161' ' ' ILE . 41.6 t -133.48 89.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.754 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.5 t-105 -75.36 102.9 5.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.063 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 159' ' ' ALA . 3.6 mt -57.67 -57.8 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.665 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 161.88 157.01 8.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.47 153.21 41.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -1.128 . . . . 0.0 109.227 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.759 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.8 m-85 -127.06 178.11 6.21 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.913 . . . . 0.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.51 -30.86 24.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 3.6 p -138.64 176.81 8.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.273 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.86 -23.09 42.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.439 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -74.45 -35.05 63.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.14 -37.83 53.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.57 -32.85 66.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.226 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.914 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.84 -37.28 59.15 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -66.34 -39.58 89.3 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.086 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.88 -23.34 62.28 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -73.14 -29.81 63.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.505 -0.747 . . . . 0.0 109.0 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.653 ' HB3' HD13 ' A' ' 200' ' ' LEU . 39.5 m-20 -69.74 -50.15 46.26 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.266 -0.897 . . . . 0.0 109.55 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -60.09 -35.84 76.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.774 . . . . 0.0 109.946 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -80.96 -24.67 37.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.159 -0.963 . . . . 0.0 109.521 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -90.8 -1.85 57.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -106.51 -27.89 10.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.606 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -40.32 23.72 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 4.6 ttp -74.24 -33.77 63.44 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.588 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 5.5 mtt180 -86.74 -13.02 46.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 53.97 -92.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 195' ' ' GLY . 9.3 p -54.17 -167.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 196' ' ' SER . 3.3 mtm105 -42.77 156.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.454 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.588 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -156.31 155.23 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.5 OUTLIER -100.39 118.25 36.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -129.17 179.94 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.619 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -76.53 -31.45 57.64 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.8 m-85 -121.14 75.26 30.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.0 Cg_endo -77.34 -169.14 0.68 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.661 2.24 . . . . 0.0 110.638 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -149.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 109.482 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 52.57 60.04 4.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.196 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.8 160.54 31.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.485 -0.759 . . . . 0.0 109.38 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.986 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 18.7 m-85 -107.41 128.28 54.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.604 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.458 ' CG ' ' O ' ' A' ' 147' ' ' ARG . 1.7 ptt180 -67.83 125.06 25.07 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.126 -0.984 . . . . 0.0 108.718 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.31 -27.04 20.9 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -88.94 106.44 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.772 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -80.16 108.45 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.613 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -72.0 160.17 32.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 110.51 -178.798 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HG2' ' CA ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.58 169.15 18.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.851 -0.531 . . . . 0.0 112.334 -178.046 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 152' ' ' ARG . 37.3 Cg_endo -85.17 -16.24 5.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.567 2.178 . . . . 0.0 106.986 175.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -145.64 -67.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.647 ' CA ' ' HG2' ' A' ' 152' ' ' ARG . . . -147.68 113.22 0.63 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 147.79 148.31 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 117.856 0.828 . . . . 0.0 110.1 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.103 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 51.4 m-85 -139.84 170.44 15.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.449 -1.407 . . . . 0.0 108.645 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -141.99 113.36 7.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -81.96 118.46 22.98 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 1.5 tt0 -141.18 158.36 44.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 109.864 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.5 tt -151.85 125.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -88.71 118.94 28.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -99.33 117.38 64.06 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.62 -26.42 7.08 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.355 2.037 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.75 -14.98 62.64 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -103.21 32.62 3.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.679 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.43 54.98 1.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 45.83 65.98 1.8 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.98 98.31 6.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 160' ' ' GLU . 7.5 mtt180 -48.69 166.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.768 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 171' ' ' VAL . 7.2 t -143.96 86.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.161 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.727 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.3 t-105 -70.77 96.29 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.25 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -56.01 -42.74 76.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.534 ' O ' ' CE2' ' A' ' 176' ' ' PHE . . . 146.06 152.06 5.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.727 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.4 p -66.68 179.36 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.223 -1.163 . . . . 0.0 109.464 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 70.4 m-85 -155.56 -173.93 4.75 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.374 -0.829 . . . . 0.0 109.141 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' C ' ' CG2' ' A' ' 178' ' ' THR . 32.9 tt0 -97.37 -17.94 19.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.617 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 7.3 p -152.32 169.45 22.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.786 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.103 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -71.33 -22.79 61.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -73.09 -41.95 63.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -34.79 67.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.431 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -74.66 -31.27 61.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.266 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.986 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.8 -40.17 66.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.47 -48.46 81.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.67 ' O ' HD22 ' A' ' 173' ' ' LEU . . . -63.28 -28.56 70.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.552 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.0 t80 -68.34 -28.1 66.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.514 ' CB ' HD13 ' A' ' 200' ' ' LEU . 5.0 m-20 -72.64 -37.02 68.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -64.67 -36.21 83.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 110.196 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.25 -41.86 24.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.826 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.659 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -71.96 -5.95 38.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.734 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.1 t80 -104.81 -44.03 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.048 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -40.11 94.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.0 mtm -80.44 -43.3 21.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.569 -0.707 . . . . 0.0 109.54 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 196' ' ' SER . 14.1 mtt180 -102.78 33.19 3.31 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.449 -0.782 . . . . 0.0 109.415 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -41.98 94.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 194' ' ' ARG . 12.2 p 170.28 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.268 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 35.5 11.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.19 145.55 46.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.3 OUTLIER -82.35 135.65 35.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.716 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -138.59 -174.56 3.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.853 . . . . 0.0 109.127 -179.982 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.645 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -68.94 -36.39 77.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.3 m-85 -119.15 76.32 15.85 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.3 Cg_endo -75.57 162.96 34.91 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.631 2.221 . . . . 0.0 110.801 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.42 79.72 9.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -137.85 17.69 2.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.442 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 39.5 mttm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 144' ' ' LYS . 3.2 m170 -167.74 157.64 10.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.816 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.9 m-85 -78.48 124.25 27.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.15 84.3 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.9 -32.62 1.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 183' ' ' ALA . 48.3 t -77.21 144.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 8.7 ttm-85 -123.83 97.34 5.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.063 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.552 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 5.4 pt20 -87.57 135.62 33.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.329 -0.857 . . . . 0.0 109.345 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -89.36 -173.99 0.43 Allowed Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -74.37 81.05 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.411 1.408 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 1.2 m0 63.17 74.85 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.63 -0.669 . . . . 0.0 109.309 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.481 ' HA3' ' HD3' ' A' ' 152' ' ' ARG . . . -170.5 -99.99 0.13 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.156 -1.497 . . . . 0.0 111.003 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.41 -178.23 3.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -1.134 . . . . 0.0 110.755 -178.334 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.696 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 8.3 m-85 -132.47 179.76 5.93 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.55 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.28 112.61 4.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.881 -1.137 . . . . 0.0 110.446 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -88.38 119.29 28.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 6.6 mt-10 -137.91 170.42 16.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.872 -179.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.456 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.3 tt -159.22 156.38 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.456 ' N ' HG12 ' A' ' 161' ' ' ILE . 42.0 ttp180 -96.38 129.67 43.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.738 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.432 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 10.6 t0 -113.31 106.17 54.74 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.236 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.83 -23.59 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.413 2.075 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.23 -19.61 62.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.282 -0.886 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -100.84 46.97 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.74 38.9 21.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 58.88 53.79 43.41 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.15 138.5 39.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -1.144 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -67.39 163.24 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 171' ' ' VAL . 40.5 t -139.06 94.47 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.605 ' HZ2' HG22 ' A' ' 175' ' ' THR . 9.3 t-105 -82.69 94.13 7.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 109.028 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.88 HD21 ' HB2' ' A' ' 189' ' ' ALA . 13.6 mt -51.25 -41.73 60.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 109.134 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 142.58 152.76 5.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.605 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -67.28 152.61 45.42 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -1.107 . . . . 0.0 109.444 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 52.3 m-85 -127.06 179.11 5.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.167 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 -25.43 28.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.107 -0.996 . . . . 0.0 109.819 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.7 p -147.5 -174.15 4.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 109.452 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.51 -23.99 29.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.781 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -34.29 65.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 109.615 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.64 -43.92 36.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -64.03 -47.1 81.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 109.17 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.816 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -58.53 -38.39 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.572 -0.705 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -61.38 -52.31 65.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 108.915 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -62.65 -18.55 62.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.5 t80 -75.65 -34.6 60.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.878 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 26.7 m-20 -61.67 -47.64 84.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.567 -0.708 . . . . 0.0 109.597 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.37 85.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -73.25 -17.01 61.38 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.535 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -87.41 -19.65 27.77 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.238 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.532 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 5.5 t80 -93.59 -31.49 14.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -38.91 67.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.432 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -74.12 -52.13 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.382 0.61 . . . . 0.0 109.72 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -86.41 -50.23 7.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.463 -0.773 . . . . 0.0 109.241 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 50.79 176.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 197' ' ' ARG . 33.9 t 58.81 71.95 0.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.634 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER 50.12 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.967 . . . . 0.0 109.535 179.839 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -125.39 163.36 22.76 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 pp -92.83 127.54 38.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -133.23 152.74 51.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.29 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.721 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -48.89 -38.99 24.25 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.145 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.0 m-85 -120.85 89.47 45.56 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 204' ' ' LEU . 35.3 Cg_endo -77.02 83.37 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 203' ' ' PRO . 0.3 OUTLIER 41.83 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.697 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 59.36 -148.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.457 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 206' ' ' VAL . 16.9 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.387 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.347 0.594 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -78.38 171.1 15.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.571 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 30.8 m-85 -143.18 159.55 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -76.86 85.28 3.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.865 . . . . 0.0 109.352 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.56 -23.27 3.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 94.7 t -88.13 137.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.398 -1.06 . . . . 0.0 109.301 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 14.6 tpp180 -124.82 103.64 8.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.84 . . . . 0.0 109.244 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.551 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 60.1 tt0 -61.89 169.27 2.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -128.57 163.36 45.33 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.341 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 154' ' ' TRP . 35.1 Cg_endo -76.63 76.08 4.16 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.577 2.185 . . . . 0.0 110.319 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER 168.86 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.535 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 156' ' ' LYS . . . 159.86 41.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.541 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.6 mmtt -137.49 179.8 6.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.513 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.09 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.1 m-85 -149.83 -179.99 7.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.442 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.74 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -146.32 113.25 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.637 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.79 119.08 25.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 108.936 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -140.5 152.24 45.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 3.5 tt -137.26 132.33 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 99.2 12.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.64 116.13 65.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.619 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.98 -23.6 9.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.39 2.06 . . . . 0.0 110.295 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.24 -22.33 62.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.453 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -96.98 44.79 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.576 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.11 20.53 5.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.3 43.21 7.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.79 109.86 21.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.626 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -54.9 150.13 10.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.064 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 171' ' ' VAL . 31.9 t -131.19 86.63 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.74 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.1 t-105 -74.15 99.7 3.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.048 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.1 mt -53.54 -54.48 36.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.458 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 156.13 153.09 6.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -66.72 152.85 44.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -1.069 . . . . 0.0 109.357 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.705 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 63.9 m-85 -126.53 -173.1 2.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.285 -0.885 . . . . 0.0 109.541 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.51 -28.75 15.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.239 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.7 p -140.75 171.91 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 109.423 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.09 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -75.97 -25.04 55.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -74.05 -35.94 64.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -75.13 -40.15 59.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 108.994 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.98 -31.02 67.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.316 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.964 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.89 -38.08 64.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.338 -0.851 . . . . 0.0 108.817 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 187' ' ' ASP . 43.8 tp -64.14 -45.2 89.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.448 -0.783 . . . . 0.0 109.102 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.55 -27.85 68.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 108.888 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -66.86 -30.79 71.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.212 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.498 ' HB3' HD13 ' A' ' 200' ' ' LEU . 11.7 m-20 -67.89 -55.0 14.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.296 -0.877 . . . . 0.0 109.423 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -31.59 37.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.531 -0.73 . . . . 0.0 109.919 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.048 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.58 -29.47 30.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.834 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 194' ' ' ARG . . . -86.75 -1.32 57.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 196' ' ' SER . 0.6 OUTLIER -103.33 -31.14 10.2 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 108.89 179.613 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -77.75 -40.59 40.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.327 -0.858 . . . . 0.0 108.961 179.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.6 mtp -81.16 -32.07 33.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.606 -0.684 . . . . 0.0 110.378 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -91.18 -1.62 57.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 83.13 -150.05 27.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.57 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 p -63.01 -97.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 109.833 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 11.6 mtm180 -48.99 153.14 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.814 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 178.8 160.91 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.1 mp -98.38 111.53 23.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -124.59 172.1 9.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 108.987 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.601 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.55 -33.28 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.237 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 6.8 m-85 -121.46 75.36 33.49 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -76.47 103.74 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.611 2.207 . . . . 0.0 110.417 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.88 100.83 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -158.97 44.38 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 206' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.458 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.1 pttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -48.56 173.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.234 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 23.2 m-85 -79.86 148.89 31.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -78.23 83.02 4.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.202 -0.936 . . . . 0.0 109.284 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 144.21 -23.36 2.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.884 HG11 ' HA ' ' A' ' 179' ' ' ALA . 6.1 t -102.12 122.93 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.259 . . . . 0.0 109.735 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 9.3 mtt180 -122.03 171.61 8.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 151' ' ' GLN . 9.4 pm0 -138.2 143.54 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 109.597 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.7 mtt85 -104.41 169.59 7.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.726 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.4 Cg_endo -78.18 8.02 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.764 2.31 . . . . 0.0 110.93 -179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -35.28 7.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.456 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 128.31 45.77 0.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 21.7 mttt -149.59 134.86 18.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -1.165 . . . . 0.0 109.618 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.546 ' CD2' ' C ' ' A' ' 178' ' ' THR . 5.4 m-30 -98.38 -168.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 108.671 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.727 ' HB1' ' OE2' ' A' ' 160' ' ' GLU . . . -162.91 126.31 2.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . -106.57 113.78 27.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.727 ' OE2' ' HB1' ' A' ' 158' ' ' ALA . 2.7 mp0 -131.04 174.77 9.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.771 -179.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.436 ' HB ' ' CE2' ' A' ' 186' ' ' TYR . 1.3 tt -168.6 140.62 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.425 -0.797 . . . . 0.0 109.148 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -73.67 152.76 40.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.0 109.66 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.446 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 58.1 t0 -123.08 95.49 45.91 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.93 -27.86 6.64 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.527 2.151 . . . . 0.0 110.056 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.49 -28.44 69.83 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.446 -0.784 . . . . 0.0 109.099 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.446 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -95.25 27.37 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 0.0 109.534 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.88 72.54 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.65 106.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 163' ' ' ASP . . . -169.07 102.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.9 148.36 43.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 171' ' ' VAL . 32.0 t -133.03 94.92 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 160' ' ' GLU . 3.4 t-105 -82.77 100.33 10.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.176 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.609 HD21 ' CB ' ' A' ' 189' ' ' ALA . 7.5 mt -55.51 -55.37 32.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.15 161.08 10.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -74.59 153.18 39.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.218 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.761 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 54.2 m-85 -127.11 -167.59 1.76 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.68 -28.45 11.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.002 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 1.4 p -147.0 -179.81 7.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.884 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -76.94 -33.41 57.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.79 -37.9 88.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.064 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -70.66 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.483 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -46.36 -27.59 1.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.256 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.37 -45.65 62.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -63.44 -39.05 93.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.684 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.36 -28.2 64.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.509 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 8.8 t80 -71.33 -30.84 66.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.447 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.0 m-20 -67.85 -45.21 75.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.964 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -37.8 83.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.687 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.609 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.83 -20.35 35.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -93.52 -0.6 56.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.502 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -109.78 -31.38 7.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.145 -0.972 . . . . 0.0 108.599 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.54 -40.39 21.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.2 ttm -75.26 -31.59 60.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.753 -0.592 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 24.3 mtt180 -95.5 -17.45 21.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' SER . . . 47.68 -106.28 0.16 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 197' ' ' ARG . 83.8 p -40.34 105.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -1.046 . . . . 0.0 110.165 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.61 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.6 OUTLIER 46.17 -173.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.833 . . . . 0.0 109.649 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 170.73 152.59 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.174 -0.954 . . . . 0.0 109.613 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.8 mt -101.75 108.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.526 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -123.17 -175.64 3.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -78.59 -37.86 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 108.875 179.7 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.615 ' CZ ' ' CB ' ' A' ' 183' ' ' ALA . 4.5 m-85 -115.6 82.26 9.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.491 -0.756 . . . . 0.0 109.173 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 34.4 Cg_endo -77.28 123.44 6.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.753 2.302 . . . . 0.0 110.563 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 206' ' ' VAL . 2.3 mp -89.24 -58.21 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 54.52 -91.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.438 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' LEU . 5.8 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 tttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -159.22 -172.95 3.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.961 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.2 m-85 -128.81 152.34 48.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.81 131.19 45.08 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.287 -0.883 . . . . 0.0 108.963 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.63 -35.93 3.73 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 182' ' ' ALA . 52.9 t -81.19 113.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.272 . . . . 0.0 109.996 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -95.88 114.44 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.615 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 19.8 pt20 -97.43 128.74 44.47 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.866 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.647 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mtp180 -75.62 169.59 19.85 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 29.4 Cg_endo -69.85 83.79 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.18 1.253 . . . . 0.0 109.605 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 61.6 m95 63.27 63.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -155.06 -106.45 0.26 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.589 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.55 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 5.4 mttp -111.19 -169.67 1.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.335 -1.097 . . . . 0.0 110.514 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.933 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.4 m-85 -143.59 173.56 11.54 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.45 109.06 3.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.851 -1.156 . . . . 0.0 110.305 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.87 124.96 29.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.166 -0.959 . . . . 0.0 108.882 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 136.45 31.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.952 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 161' ' ' ILE . 2.7 tt -128.78 120.53 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.17 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.29 144.74 29.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 0.0 109.585 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.437 ' OD2' ' SD ' ' A' ' 193' ' ' MET . 32.1 t0 -124.34 116.52 26.92 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.925 . . . . 0.0 109.317 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 36.2 Cg_endo -77.04 -31.03 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.528 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -25.42 67.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -89.03 44.76 1.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.18 53.7 10.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 55.36 94.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -147.86 111.16 4.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 144.48 54.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.303 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 53.3 t -122.93 94.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.669 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.582 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.6 t-105 -72.75 98.76 2.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.994 HD21 ' CB ' ' A' ' 189' ' ' ALA . 1.1 mt -57.91 -45.48 86.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.797 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 149.8 162.96 10.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -79.51 158.14 27.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.23 -179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 75.1 m-85 -133.84 175.39 9.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 177' ' ' GLU . 7.0 tp10 -82.37 -30.7 30.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.683 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -143.31 167.6 21.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 109.526 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.933 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.77 -22.47 65.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -38.68 69.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.92 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -75.47 -37.12 60.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.91 -34.74 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.188 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.961 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -72.43 -39.65 67.71 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -63.63 -42.86 98.12 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.574 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.467 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -67.41 -32.79 73.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.556 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.6 t80 -62.98 -30.49 71.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.148 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 16.0 m-20 -69.7 -41.79 74.92 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.378 -0.826 . . . . 0.0 109.657 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -63.72 -40.19 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 110.594 -179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.994 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -82.08 -25.95 34.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.987 -1.071 . . . . 0.0 109.94 -179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -83.29 -18.19 39.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.439 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.7 t80 -85.39 -36.24 20.84 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.083 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -66.64 -42.18 87.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.437 ' SD ' ' OD2' ' A' ' 163' ' ' ASP . 7.2 tpp -80.52 -41.78 23.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.432 -0.792 . . . . 0.0 109.445 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 18.6 mtt180 -100.71 33.37 2.79 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 108.959 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . -39.52 161.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 76.94 85.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -1.153 . . . . 0.0 108.983 -179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.565 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 71.83 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 108.999 -179.492 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 67.02 162.47 0.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 110.061 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.492 ' C ' HD23 ' A' ' 200' ' ' LEU . 5.7 mt -116.52 113.25 22.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -123.0 159.78 27.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.612 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -59.03 -32.87 70.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.427 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.35 88.75 29.27 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 204' ' ' LEU . 35.0 Cg_endo -76.73 -176.61 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.698 2.266 . . . . 0.0 110.637 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 203' ' ' PRO . 39.8 mt -43.77 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -127.1 110.95 13.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.545 179.991 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.1 pttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.25 109.19 2.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.5 m-85 -83.27 148.78 27.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.247 -0.908 . . . . 0.0 109.563 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.2 mmt-85 -79.53 85.84 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.945 . . . . 0.0 109.935 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.35 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.415 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 179' ' ' ALA . 96.8 t -109.18 116.95 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.854 -1.38 . . . . 0.0 110.325 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -83.82 146.02 28.35 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.2 pt20 -142.01 132.58 25.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.557 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -84.1 178.7 2.25 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.5 Cg_endo -77.09 79.27 3.18 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.179 1.92 . . . . 0.0 109.549 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 23.7 t-105 72.6 60.83 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -153.31 -108.8 0.36 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.704 -179.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.544 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 14.6 mmtt -113.24 -171.7 1.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -1.137 . . . . 0.0 110.694 -178.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.896 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 23.5 m-85 -141.81 -170.9 3.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -161.22 110.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.951 -1.093 . . . . 0.0 110.446 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -83.68 107.16 15.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.523 ' OE1' ' CE3' ' A' ' 172' ' ' TRP . 27.9 mt-10 -132.32 152.11 51.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.13 -0.981 . . . . 0.0 109.739 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.41 133.06 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.214 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.62 139.61 33.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.134 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 166' ' ' LYS . 28.7 t0 -123.87 107.24 31.14 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.169 -0.957 . . . . 0.0 109.291 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.63 -28.28 6.73 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.268 1.978 . . . . 0.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.56 -25.91 67.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.429 ' HG3' ' OD2' ' A' ' 163' ' ' ASP . 10.4 mmtt -90.86 43.45 1.15 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.88 27.17 15.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.54 58.43 3.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.24 95.35 6.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -1.129 . . . . 0.0 109.545 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.06 162.12 1.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.9 t -149.84 95.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.04 -1.038 . . . . 0.0 110.153 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.523 ' CE3' ' OE1' ' A' ' 160' ' ' GLU . 2.8 t-105 -79.99 106.54 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 29.0 mt -64.16 -47.01 81.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 109.715 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.62 157.09 7.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.7 OUTLIER -76.49 156.65 32.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 -179.8 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.604 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 67.6 m-85 -133.01 177.36 7.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 3.2 pt-20 -82.55 -31.63 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.162 -0.961 . . . . 0.0 109.786 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 p -141.26 175.36 9.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 109.777 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.896 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.1 -22.53 59.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.656 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.55 -49.13 51.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 1.4 m-20 -64.2 -50.39 68.27 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -56.19 -52.4 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -52.39 -42.12 63.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.57 -41.78 90.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.77 -22.29 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.8 . . . . 0.0 109.185 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 173' ' ' LEU . 21.2 t80 -71.51 -36.59 71.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.87 ' HB3' HD13 ' A' ' 200' ' ' LEU . 6.3 m-20 -65.52 -50.85 63.7 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.425 -0.797 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.11 -34.74 58.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.49 -0.756 . . . . 0.0 110.101 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.79 -19.85 26.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.054 -1.028 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 194' ' ' ARG . . . -92.14 -5.43 52.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.431 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.6 t80 -102.76 -34.13 9.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.221 -0.924 . . . . 0.0 108.611 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -79.34 -40.69 29.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.2 ttp -83.12 -30.05 28.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.609 -0.682 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 190' ' ' ALA . 1.0 OUTLIER -99.77 -9.23 23.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 -179.727 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 42.19 -163.63 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 195' ' ' GLY . 0.6 OUTLIER 48.39 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -1.14 . . . . 0.0 109.562 179.874 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 198' ' ' ALA . 0.7 OUTLIER -57.28 -47.02 82.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.448 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 197' ' ' ARG . . . 59.39 149.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.438 -0.789 . . . . 0.0 109.722 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 200' ' ' LEU . 17.3 mt -97.75 124.04 41.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.87 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.62 169.23 14.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.93 . . . . 0.0 109.387 -179.906 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.734 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -63.29 -36.07 82.46 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.039 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 2.8 m-85 -127.18 81.66 69.56 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 204' ' ' LEU . 34.6 Cg_endo -76.6 162.13 33.32 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.635 2.223 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 205' ' ' ARG . 0.3 OUTLIER 71.27 167.5 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.353 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 204' ' ' LEU . 1.5 mmt-85 -54.11 -169.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.337 179.928 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.501 ' O ' ' CG ' ' A' ' 145' ' ' HIS . 4.8 p80 -100.59 124.72 46.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.411 -0.806 . . . . 0.0 109.248 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.5 m-85 -106.4 141.13 38.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.28 110.62 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.73 -20.7 14.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.8 t -92.59 110.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -1.12 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 112.39 24.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 108.954 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.569 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -75.63 153.74 37.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 110.02 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 3.1 mtp180 -132.52 174.87 4.2 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.3 Cg_endo -77.66 167.53 23.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.11 1.873 . . . . 0.0 110.069 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 74.92 -80.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.191 -179.47 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 156' ' ' LYS . . . 174.99 67.28 0.05 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 mmtt -146.35 164.05 33.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.051 -1.264 . . . . 0.0 110.069 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.813 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.7 m-85 -148.31 179.61 7.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.526 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -147.51 107.78 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.028 -1.045 . . . . 0.0 109.991 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -80.85 117.13 21.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.032 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' OE2' ' HD2' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -141.76 140.45 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.53 -179.771 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.533 HG12 ' N ' ' A' ' 162' ' ' ARG . 7.2 tt -125.38 159.42 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.533 ' N ' HG12 ' A' ' 161' ' ' ILE . 8.7 ttt180 -97.78 115.05 27.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 193' ' ' MET . 19.1 t0 -99.25 110.12 57.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.1 Cg_endo -77.63 -27.72 5.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.3 2.0 . . . . 0.0 110.168 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.71 -21.68 64.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.348 -0.845 . . . . 0.0 109.555 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 2.7 mttt -90.66 23.15 3.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.448 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 76.51 40.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.626 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.42 86.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -144.35 177.82 8.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -1.081 . . . . 0.0 109.417 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.455 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 0.9 OUTLIER -100.99 163.87 12.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.678 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 171' ' ' VAL . 39.8 t -140.39 85.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.0 109.045 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.526 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.9 t-105 -73.2 97.12 2.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.395 -0.816 . . . . 0.0 109.883 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.894 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.1 mt -59.6 -41.06 89.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.88 . . . . 0.0 109.257 179.586 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.428 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 147.52 166.6 12.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.0 OUTLIER -83.72 153.68 24.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -1.194 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.774 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -126.72 -177.5 4.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.659 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 -30.97 16.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 1.7 p -138.72 167.45 21.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.813 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.25 -41.21 67.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.293 -0.879 . . . . 0.0 109.79 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.7 OUTLIER -71.22 -40.74 70.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.56 -30.34 67.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.3 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.923 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.15 -34.04 61.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.143 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -66.72 -42.09 86.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 109.044 179.635 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.03 -22.72 64.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 6.2 t80 -77.32 -32.2 55.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.238 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 97.6 m-20 -67.55 -41.44 84.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -70.05 -35.91 74.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.867 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.894 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.51 -24.22 50.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.656 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -84.95 -26.74 27.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 195' ' ' GLY . 5.7 t80 -83.11 -23.55 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -43.74 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.43 ' HE1' ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -75.01 -32.36 61.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.02 -179.658 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 198' ' ' ALA . 4.9 mtt-85 -96.69 -13.28 22.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 109.283 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 191' ' ' PHE . . . 74.86 -125.2 8.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 191' ' ' PHE . 0.8 OUTLIER -71.68 172.37 9.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -1.094 . . . . 0.0 109.97 -179.559 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 0.0 OUTLIER 54.04 -117.64 1.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.408 -0.807 . . . . 0.0 109.608 179.743 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 65.35 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.692 -1.255 . . . . 0.0 109.317 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 199' ' ' LEU . 5.8 mt -85.04 130.13 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.705 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.527 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.66 166.16 18.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.806 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.629 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -63.0 -31.91 73.16 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.327 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.453 ' HD2' HD22 ' A' ' 184' ' ' LEU . 7.2 m-85 -120.06 77.17 23.64 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.58 ' O ' HD12 ' A' ' 204' ' ' LEU . 36.0 Cg_endo -78.24 86.06 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.699 2.266 . . . . 0.0 110.562 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 203' ' ' PRO . 2.0 mp -132.23 11.71 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.273 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -122.91 117.89 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.413 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.47 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 145' ' ' HIS . 1.4 mtpt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 144' ' ' LYS . 30.9 m170 61.07 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.902 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 20.4 m-85 -70.63 159.8 33.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.242 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -82.35 92.46 6.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 186' ' ' TYR . . . 123.39 -5.58 9.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 57.5 t -108.96 120.72 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -1.159 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -97.07 118.65 33.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.338 179.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.493 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -89.36 149.45 23.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.606 -179.805 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mmt180 -120.51 158.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.362 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.52 8.81 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.616 2.21 . . . . 0.0 110.876 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.29 -13.33 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 156' ' ' LYS . . . 105.4 49.21 0.99 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 8.8 mtmm -150.07 -174.74 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -1.165 . . . . 0.0 109.54 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 76.8 m-85 -153.99 178.35 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.271 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.723 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -148.12 111.15 4.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.683 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.91 118.43 24.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.345 -0.847 . . . . 0.0 108.96 179.46 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 19.2 mt-10 -137.42 179.55 6.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 109.28 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.2 tt -169.63 130.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -63.36 153.05 36.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.857 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.93 103.71 3.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.45 -25.33 9.79 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.42 2.08 . . . . 0.0 110.321 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.6 66.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 109.168 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 44.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 0.0 109.473 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t30 51.08 57.16 6.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.417 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 51.24 79.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -141.31 131.15 24.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -1.203 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -73.28 143.53 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.1 t -111.77 105.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.723 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.7 t-105 -89.69 95.57 10.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -53.58 -42.87 68.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 146.64 158.17 7.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.488 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.2 p -74.36 159.36 32.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -1.045 . . . . 0.0 109.516 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.9 m-85 -133.45 174.91 9.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.43 -30.42 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.6 p -137.54 -176.98 4.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.907 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -84.52 -30.15 25.37 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -68.05 -32.21 72.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.958 . . . . 0.0 109.584 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.415 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -75.67 -48.59 21.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.306 -0.871 . . . . 0.0 109.025 179.862 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -66.61 -21.69 66.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 108.912 179.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -77.59 -45.77 24.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' LEU . 17.9 tp -62.56 -40.75 97.86 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -70.17 -24.71 63.19 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 108.919 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 160' ' ' GLU . 14.6 t80 -70.77 -32.17 69.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -0.848 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -69.04 -45.61 69.97 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.26 -0.9 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -58.29 -35.22 71.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.509 -0.744 . . . . 0.0 110.176 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.016 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -80.83 -33.63 34.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -86.95 -2.41 58.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.202 -0.937 . . . . 0.0 109.217 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.485 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 25.4 t80 -103.25 -24.47 13.54 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.295 -0.878 . . . . 0.0 109.113 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -84.48 -40.9 17.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 108.785 179.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -31.33 57.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.621 -0.674 . . . . 0.0 109.868 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 43.8 mtt180 -100.86 -18.82 16.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 191' ' ' PHE . . . 47.57 -176.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.1 OUTLIER 43.41 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.311 -1.111 . . . . 0.0 109.732 179.952 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.3 140.04 48.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.342 -0.849 . . . . 0.0 109.61 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.491 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -144.83 163.58 33.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.506 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -82.45 105.61 13.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.682 -179.773 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.86 164.97 17.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 108.998 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.497 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -66.4 -33.0 74.73 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.128 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.4 m-85 -124.54 76.06 63.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.97 142.58 22.25 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.683 2.255 . . . . 0.0 110.558 -179.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 204' ' ' LEU . 0.8 OUTLIER 65.0 65.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.832 . . . . 0.0 109.561 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.65 ' C ' HG23 ' A' ' 206' ' ' VAL . 22.9 mmt180 -118.38 100.9 7.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 205' ' ' ARG . 1.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.408 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 145' ' ' HIS . 23.9 mttp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.433 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER 70.88 113.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.678 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.944 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.8 m-85 -78.32 136.99 37.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.438 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.4 92.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.15 -32.06 3.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.5 t -77.8 133.64 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -1.216 . . . . 0.0 109.801 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.5 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -121.41 107.01 11.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.324 179.898 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.597 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 4.3 pt20 -75.09 164.61 26.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.471 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 3.9 mtt-85 -127.81 172.11 7.33 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.678 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.8 Cg_endo -78.02 -30.22 3.72 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.822 2.348 . . . . 0.0 110.704 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -35.36 60.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.657 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.46 34.93 0.43 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -127.23 159.42 34.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -1.165 . . . . 0.0 109.264 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.888 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 27.5 m-85 -125.19 -179.12 4.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -150.41 108.29 3.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.017 . . . . 0.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -80.31 114.8 19.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.718 179.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -131.18 157.88 42.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.567 -179.727 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 161' ' ' ILE . 1.6 tt -149.8 128.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.551 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.15 8.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 164' ' ' PRO . 48.3 t0 -92.8 117.22 67.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 109.557 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 163' ' ' ASP . 35.6 Cg_endo -78.19 -26.24 6.5 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.286 1.991 . . . . 0.0 109.899 179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.73 -14.63 62.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 6.2 mmtp -101.26 30.16 4.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 41.3 t-20 67.51 28.4 7.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.53 62.5 2.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.8 129.26 55.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -1.128 . . . . 0.0 109.469 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.42 122.52 16.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.504 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 171' ' ' VAL . 21.6 t -101.73 94.69 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.627 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.8 t-105 -69.65 100.73 1.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mt -59.77 -48.99 79.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.656 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 153.67 152.56 6.09 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.627 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.1 p -69.51 163.71 24.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -1.206 . . . . 0.0 109.131 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.497 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 60.7 m-85 -140.0 -177.84 5.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -86.85 -30.01 21.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.626 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.588 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.2 p -146.71 171.41 15.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.589 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.888 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.82 -22.51 63.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.05 -40.54 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.1 m-20 -71.52 -41.84 68.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.691 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -69.27 -30.38 68.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.944 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.42 -40.7 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -38.85 89.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.497 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.32 -24.15 63.89 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.6 t80 -73.93 -29.07 61.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 200' ' ' LEU . 43.4 m-20 -70.26 -49.04 53.89 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.218 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -60.97 -38.49 86.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 109.874 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.44 ' CB ' HD22 ' A' ' 173' ' ' LEU . . . -80.5 -21.83 41.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.646 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.92 -14.31 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.76 -27.14 14.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 109.101 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -82.56 -40.36 21.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 2.7 tpp -70.9 -30.56 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.666 -0.647 . . . . 0.0 109.357 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 196' ' ' SER . 2.7 mtt180 -101.13 -12.82 18.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.33 -0.856 . . . . 0.0 109.242 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 52.61 -88.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 194' ' ' ARG . 0.3 OUTLIER -46.3 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -1.093 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 196' ' ' SER . 13.4 mtt180 -40.44 157.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -164.25 156.25 16.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 109.307 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.7 mm? -92.13 127.85 37.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.96 162.67 29.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.141 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.587 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -58.23 -34.69 70.7 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.117 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 8.5 m-85 -116.58 80.95 10.86 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 201' ' ' ASN . 33.8 Cg_endo -76.13 111.1 3.2 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.561 2.174 . . . . 0.0 110.311 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.441 ' HA ' HD22 ' A' ' 204' ' ' LEU . 0.8 OUTLIER 62.79 151.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.008 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.46 ' HG3' HG23 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -153.05 -172.86 4.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 -179.907 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.46 HG23 ' HG3' ' A' ' 205' ' ' ARG . 1.3 t . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.3 mttt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -178.46 167.41 1.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.858 . . . . 0.0 109.6 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 9.2 m-85 -114.15 148.09 37.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.673 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.61 87.76 3.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 108.824 179.105 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.97 2.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 179' ' ' ALA . 45.8 t -137.87 108.82 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.288 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -83.81 127.62 33.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.426 -0.796 . . . . 0.0 109.009 179.713 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.1 pp0? -104.48 146.64 28.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 109.944 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.5 164.03 15.89 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.61 37.0 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.836 2.358 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -146.05 -62.28 0.32 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.02 . . . . 0.0 109.412 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 167.99 36.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.63 168.92 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -1.202 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.857 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 59.3 m-85 -148.36 177.23 9.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.374 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.647 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -150.15 111.84 4.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.29 110.4 17.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 6.1 mt-10 -131.33 149.52 52.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.281 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 17.4 tt -128.21 146.68 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.094 -1.004 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -87.38 130.59 34.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 109.55 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -119.96 94.39 48.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HA ' ' HA2' ' A' ' 168' ' ' GLY . 35.9 Cg_endo -78.26 -22.78 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.578 2.186 . . . . 0.0 110.44 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.46 75.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' LYS . 8.4 mmtt -86.25 63.03 7.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.847 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 168' ' ' GLY . 1.8 m-80 52.67 48.55 22.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 164' ' ' PRO . . . 43.41 52.63 6.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.52 130.08 35.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 109.319 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 143.94 46.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 77.1 t -123.19 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.835 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.647 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.8 t-105 -117.01 97.33 5.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.024 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.3 mp -54.83 -50.51 68.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.266 -0.896 . . . . 0.0 109.149 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 155.31 153.56 6.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.52 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.4 p -65.36 166.93 9.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -1.046 . . . . 0.0 109.332 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.757 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 65.0 m-85 -144.02 174.51 10.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -25.3 30.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.731 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CD1' ' A' ' 157' ' ' PHE . 2.3 p -149.56 171.06 17.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.56 -25.46 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.46 -42.1 75.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.376 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 1.0 OUTLIER -70.28 -48.59 56.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.202 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -65.91 -22.82 66.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.922 . . . . 0.0 109.029 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . . . -78.22 -36.89 46.55 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 108.873 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.859 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -68.05 -45.22 74.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.581 -0.699 . . . . 0.0 109.175 179.491 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.565 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.01 -23.69 65.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.459 -0.775 . . . . 0.0 109.012 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 12.2 t80 -71.52 -35.38 70.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -0.783 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 72.6 m-20 -65.64 -41.85 92.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.321 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -41.05 84.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.024 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -82.75 -19.65 37.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.527 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -88.33 -9.63 52.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.181 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -99.12 -31.22 11.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.821 . . . . 0.0 109.271 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -77.98 -42.78 31.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.267 -0.896 . . . . 0.0 109.116 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 48.0 ttm -69.65 -31.53 69.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.315 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 22.2 mtt-85 -100.86 11.91 38.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.328 -0.858 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 48.57 -154.54 1.76 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 29.6 m -53.45 143.27 19.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -1.119 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.5 mtp85 68.53 138.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 176.47 140.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 199' ' ' LEU . 2.2 mt -81.37 109.3 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -116.0 -178.09 3.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.408 179.755 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.49 ' C ' ' HD3' ' A' ' 203' ' ' PRO . 0.1 OUTLIER -81.38 -28.81 34.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.155 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.859 ' HD2' HD22 ' A' ' 184' ' ' LEU . 6.6 m-85 -122.68 70.15 36.33 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -76.29 110.37 3.05 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.467 2.112 . . . . 0.0 110.165 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 204' ' ' LEU . 0.2 OUTLIER -109.18 -73.94 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.985 -179.66 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.15 -165.67 2.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.02 -179.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.208 179.967 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.348 0.594 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -113.66 166.33 11.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.555 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.928 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 12.4 m-85 -130.66 141.72 50.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.878 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.36 89.67 3.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 108.848 179.364 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 127.48 11.0 3.47 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 182' ' ' ALA . 47.3 t -126.3 109.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.009 -1.289 . . . . 0.0 109.359 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -93.0 111.34 22.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.443 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 2.5 pt20 -80.87 151.08 28.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.835 . . . . 0.0 108.975 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.49 163.89 37.72 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.442 -179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.13 -5.56 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.615 2.21 . . . . 0.0 110.121 -179.88 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -98.23 27.89 4.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 109.273 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.53 60.99 7.98 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -156.44 170.52 22.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 73.4 m-85 -142.64 172.84 12.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.008 179.917 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.649 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.87 105.28 4.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 123.09 28.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.051 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.465 ' CD ' ' CE3' ' A' ' 172' ' ' TRP . 4.3 mt-10 -145.28 153.3 41.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 0.0 109.334 -179.543 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.486 HD11 ' HE ' ' A' ' 194' ' ' ARG . 6.5 tt -141.04 149.18 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -84.33 117.1 23.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 109.734 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.512 ' HB2' ' CE ' ' A' ' 193' ' ' MET . 67.8 t0 -114.58 102.12 54.66 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -25.53 9.78 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.326 2.017 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.47 -16.12 63.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.318 -0.863 . . . . 0.0 109.217 179.67 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -93.38 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.7 54.13 9.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.421 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.95 71.26 0.67 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.23 118.55 12.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.494 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -54.21 170.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 171' ' ' VAL . 38.4 t -139.84 90.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.656 -179.694 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.649 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.0 t-105 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 109.178 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -52.62 -43.96 65.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 -179.72 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 144.38 150.39 5.23 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.517 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.8 p -63.18 168.78 3.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.233 -1.157 . . . . 0.0 109.327 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.655 ' HE1' ' HB3' ' A' ' 159' ' ' ALA . 63.9 m-85 -141.55 -174.14 3.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 109.515 -179.767 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.74 -24.97 14.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.698 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.598 HG23 ' OD2' ' A' ' 181' ' ' ASP . 2.6 p -140.82 174.49 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.68 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -77.29 -24.83 50.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.328 -0.857 . . . . 0.0 109.363 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -77.02 -30.27 55.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.631 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.598 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -76.08 -40.68 52.57 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 109.279 -179.985 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -71.96 -36.48 69.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.195 -0.941 . . . . 0.0 109.028 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.928 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -69.58 -39.78 77.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.799 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.97 -46.32 88.28 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 109.004 179.709 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.76 -26.87 67.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.475 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 29.8 t80 -68.7 -36.28 78.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.132 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 7.0 m-20 -64.07 -52.15 60.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 109.838 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -56.88 -37.16 70.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.422 -0.799 . . . . 0.0 109.527 -179.76 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.921 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.38 -20.65 50.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.212 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.68 -11.88 43.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.464 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 13.3 t80 -101.88 -26.67 13.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.119 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -40.63 29.85 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.315 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.512 ' CE ' ' HB2' ' A' ' 163' ' ' ASP . 13.9 mtp -77.93 -44.49 26.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.242 0.544 . . . . 0.0 110.165 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.486 ' HE ' HD11 ' A' ' 161' ' ' ILE . 24.0 mtt180 -83.51 -37.74 22.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 108.943 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 58.52 145.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 198' ' ' ALA . 2.8 m 63.12 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -1.138 . . . . 0.0 109.987 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 198' ' ' ALA . 3.3 mmt180 44.26 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.999 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 197' ' ' ARG . . . 66.95 144.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.988 . . . . 0.0 109.328 -179.72 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.8 OUTLIER -101.12 117.27 34.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.913 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.1 156.06 35.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 179.944 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.582 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -62.82 -32.32 73.5 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.769 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.43 ' O ' HD12 ' A' ' 200' ' ' LEU . 5.8 m-85 -121.05 97.51 47.95 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.094 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.62 106.72 2.31 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.331 2.02 . . . . 0.0 110.6 -179.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 204' ' ' LEU . 0.7 OUTLIER -98.03 93.36 6.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.392 -179.874 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 58.17 100.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 109.51 179.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.432 -179.927 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -52.18 179.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.703 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 28.4 m-85 -80.19 142.54 34.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 -179.845 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.87 37.64 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.129 179.738 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 159' ' ' ALA . . . -169.95 26.77 0.11 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 179' ' ' ALA . 60.9 t -142.67 117.82 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -1.091 . . . . 0.0 109.681 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 93.08 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.162 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.47 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 9.9 pt20 -60.65 144.67 51.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.75 -179.748 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -103.88 171.7 4.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.308 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.2 Cg_endo -77.12 -31.81 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -82.6 -74.98 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.987 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.73 71.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 56.3 mttt -153.85 168.04 27.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.577 179.925 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.753 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.0 m-85 -150.68 120.67 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 108.737 179.694 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.608 ' CB ' ' CZ2' ' A' ' 172' ' ' TRP . . . -93.76 118.87 31.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.974 . . . . 0.0 110.748 -178.823 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.15 122.73 30.57 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.308 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 11.2 tt0 -137.69 150.6 47.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.02 . . . . 0.0 110.421 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 190' ' ' ALA . 4.3 tt -136.23 137.33 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -86.57 127.46 34.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.834 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -125.05 105.55 28.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.413 -0.805 . . . . 0.0 108.984 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.91 -26.08 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.455 2.103 . . . . 0.0 110.58 -179.737 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.88 -12.0 57.83 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 51.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.362 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 56.24 25.05 8.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 -179.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.18 40.92 40.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -100.1 142.87 30.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -84.43 155.7 22.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 161' ' ' ILE . 40.5 t -124.3 100.09 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.608 ' CZ2' ' CB ' ' A' ' 158' ' ' ALA . 9.4 t-105 -80.16 95.29 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.322 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.157 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.3 OUTLIER -50.55 -49.46 55.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.039 -179.641 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.23 155.25 6.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.502 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.6 p -68.18 169.97 9.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -1.095 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 67.2 m-85 -148.2 -170.46 3.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -23.84 13.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.578 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.6 p -144.34 160.05 41.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.302 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.753 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -66.26 -24.7 66.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.065 -1.022 . . . . 0.0 109.216 179.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.66 -33.22 68.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -76.78 -47.88 20.32 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.021 179.78 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -66.46 -25.62 66.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.17 -0.956 . . . . 0.0 108.954 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.12 -49.94 21.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.112 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -34.09 74.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.438 -0.789 . . . . 0.0 109.032 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -69.74 -30.63 68.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.411 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.5 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.0 t80 -67.77 -27.89 67.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.561 -0.712 . . . . 0.0 109.109 179.538 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 200' ' ' LEU . 58.5 m-20 -71.19 -45.27 63.78 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.596 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -65.15 -29.03 69.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.796 . . . . 0.0 110.368 -179.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.157 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -85.7 -32.65 21.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 110.026 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.99 -18.81 45.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.41 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 195' ' ' GLY . 3.3 t80 -91.02 -38.73 12.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.326 -0.859 . . . . 0.0 109.353 179.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -41.85 97.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.09 -1.007 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 3.6 ttm -79.95 -43.1 22.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 109.271 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.46 ' O ' ' C ' ' A' ' 195' ' ' GLY . 21.4 mtt180 -101.96 32.96 3.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.515 -0.74 . . . . 0.0 109.162 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -37.94 -32.47 0.12 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -75.74 81.93 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -1.15 . . . . 0.0 109.263 179.699 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 61.19 139.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.358 -179.806 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -170.57 144.51 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.6 mm? -98.1 108.99 21.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.671 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -111.1 159.42 17.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.435 -179.566 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.442 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.2 OUTLIER -53.0 -37.81 61.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.094 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.9 m-85 -123.08 86.12 51.15 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.321 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.75 131.4 13.4 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.644 2.229 . . . . 0.0 110.722 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 204' ' ' LEU . 0.4 OUTLIER -60.91 123.94 19.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.793 . . . . 0.0 109.436 179.942 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 58.23 104.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.461 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.439 179.968 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -110.71 96.45 6.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.939 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.8 m-85 -67.66 147.08 53.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -77.82 94.44 4.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.25 -3.4 11.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 49.0 t -108.69 112.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.27 . . . . 0.0 110.057 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.998 ' CG ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -87.43 111.61 21.31 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.752 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.563 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 8.0 pt20 -90.06 138.62 31.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -178.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.631 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 14.0 mmm-85 -74.86 -166.76 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 152' ' ' ARG . 33.1 Cg_endo -76.88 -15.23 16.83 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.313 1.342 . . . . 0.0 110.629 -179.256 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.54 ' CB ' ' O ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 158.79 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.496 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 168.58 -68.93 0.17 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.347 179.69 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.603 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mttt -116.7 -168.53 1.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.852 -1.381 . . . . 0.0 111.282 -178.16 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.149 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.9 m-85 -154.8 179.46 9.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.998 ' HB3' ' CG ' ' A' ' 150' ' ' ARG . . . -149.2 110.33 4.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 109.993 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.506 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.5 134.86 35.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.71 134.68 14.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 2.8 tt -120.11 141.4 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -85.07 129.54 34.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -116.12 92.47 35.62 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.97 -22.35 11.56 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.676 2.251 . . . . 0.0 110.719 -179.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.12 69.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.407 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 35.4 mmtt -85.38 -55.78 3.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 109.473 179.907 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 169' ' ' ALA . 12.6 p30 169.14 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.97 4.5 67.5 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.824 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HB2' ' OD1' ' A' ' 167' ' ' ASN . . . -57.09 108.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.119 . . . . 0.0 109.446 -179.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 142.86 29.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 109.265 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 171' ' ' VAL . 47.1 t -115.65 83.18 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 174' ' ' GLY . 3.5 t-105 -65.32 100.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.865 . . . . 0.0 109.164 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 189' ' ' ALA . 4.8 mt -61.61 -41.48 97.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.687 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 144.29 174.0 16.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.846 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -92.06 157.36 16.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.252 . . . . 0.0 109.148 179.753 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 78.7 m-85 -130.53 -176.51 3.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.815 -179.53 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -89.14 -20.12 24.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 4.0 p -147.97 175.41 11.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.95 . . . . 0.0 109.87 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.149 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.7 -22.21 47.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.45 -0.781 . . . . 0.0 109.45 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.6 tm-20 -76.83 -32.43 57.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.78 -36.12 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.927 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -73.27 -43.92 60.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 108.895 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.939 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -63.34 -37.15 86.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.361 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 0.8 OUTLIER -64.98 -46.71 80.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.521 -0.737 . . . . 0.0 109.11 179.495 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.98 -18.8 64.64 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.5 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.5 t80 -74.14 -38.12 63.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.041 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.55 ' HB3' HD13 ' A' ' 200' ' ' LEU . 25.2 m-20 -62.16 -49.87 74.12 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.449 -0.782 . . . . 0.0 109.37 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -52.11 -44.84 64.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.618 -0.676 . . . . 0.0 109.925 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.855 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -78.32 -19.15 54.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 109.702 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -92.27 -4.55 53.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.883 . . . . 0.0 109.586 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.434 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 2.1 t80 -108.38 -29.8 8.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -85.04 -37.75 19.98 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.016 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.7 ttm -77.88 -35.61 50.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.737 -0.602 . . . . 0.0 109.562 179.704 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.646 ' HD3' ' HB1' ' A' ' 198' ' ' ALA . 4.5 mtp180 -94.26 -23.57 17.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.139 -0.976 . . . . 0.0 108.886 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 53.2 170.29 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.986 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 43.61 -159.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -1.211 . . . . 0.0 109.664 179.898 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.25 153.84 3.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.579 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.646 ' HB1' ' HD3' ' A' ' 194' ' ' ARG . . . -160.86 168.18 25.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.4 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.598 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -105.43 104.83 14.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.998 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -122.75 162.96 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.983 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.725 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -65.7 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.606 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 184' ' ' LEU . 7.2 m-85 -119.1 80.29 19.04 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 204' ' ' LEU . 34.7 Cg_endo -77.18 140.26 19.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.566 2.178 . . . . 0.0 110.285 -179.557 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 203' ' ' PRO . 0.3 OUTLIER 54.05 172.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.33 -179.93 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -89.1 112.04 22.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.313 179.89 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.587 -179.85 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.598 ' O ' ' CG ' ' A' ' 145' ' ' HIS . 0.5 OUTLIER -152.7 71.48 0.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.84 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.687 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 65.9 m-85 -51.06 168.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.388 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -81.01 36.07 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 179.616 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.431 ' HA3' ' CD2' ' A' ' 186' ' ' TYR . . . -176.8 27.3 0.07 OUTLIER Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.664 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 179' ' ' ALA . 78.6 t -150.67 139.8 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -1.204 . . . . 0.0 109.648 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -110.55 160.1 16.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 108.991 179.489 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.598 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.0 pt20 -131.37 146.15 52.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.043 -1.036 . . . . 0.0 110.115 -179.48 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.478 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.8 OUTLIER -121.63 160.55 45.93 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.759 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -77.78 -4.43 14.5 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 110.776 -179.848 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -98.08 -7.35 29.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.504 179.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.28 47.46 1.85 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 9.2 mtpp -146.74 140.72 26.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.161 . . . . 0.0 109.513 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.703 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 7.0 m-85 -119.98 -170.28 1.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.917 . . . . 0.0 109.376 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.62 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -156.43 110.51 2.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 179.892 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -81.11 119.78 24.0 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.44 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 12.3 mt-10 -136.94 153.89 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.827 . . . . 0.0 109.603 -179.67 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 190' ' ' ALA . 5.8 tt -141.61 138.91 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 108.979 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.47 131.39 35.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.756 -179.664 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -124.73 90.81 50.41 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.51 -23.33 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.549 2.166 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.46 -9.89 29.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 167' ' ' ASN . 15.0 mmtp -104.37 23.7 12.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.535 -179.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 26.8 t-20 64.34 45.14 3.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.06 110.74 0.12 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 170' ' ' ARG . . . -177.11 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -1.179 . . . . 0.0 109.466 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -43.2 163.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 161' ' ' ILE . 92.7 t -135.15 91.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.955 . . . . 0.0 109.864 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.789 ' HZ2' HG22 ' A' ' 175' ' ' THR . 10.8 t-105 -75.31 92.38 2.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 108.882 179.464 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.027 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -52.31 -46.11 65.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.224 -179.741 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 150.25 156.37 7.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.678 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.789 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 5.6 p -73.21 153.27 40.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -1.082 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 61.2 m-85 -128.99 -170.97 2.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 -32.38 14.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.277 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.562 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.4 p -141.41 173.89 11.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.226 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.703 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.27 -24.58 61.37 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.101 -0.999 . . . . 0.0 109.097 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -70.63 -37.7 73.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.867 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -74.97 -43.81 51.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.072 -1.018 . . . . 0.0 109.205 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -70.27 -24.81 63.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 108.997 179.717 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.687 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -75.59 -44.9 40.72 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.874 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -61.68 -43.52 98.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.573 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.584 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.83 -32.23 73.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 108.827 179.524 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -64.46 -29.62 70.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.325 -0.859 . . . . 0.0 109.088 179.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.61 ' HB3' HD13 ' A' ' 200' ' ' LEU . 38.1 m-20 -72.92 -43.56 62.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.382 -0.824 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.03 -23.94 67.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.772 . . . . 0.0 110.127 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.027 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -92.72 -31.9 14.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.011 -1.056 . . . . 0.0 109.761 -179.708 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.601 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -83.93 -10.83 57.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.235 -0.915 . . . . 0.0 109.099 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -100.38 -41.15 7.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 179.542 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -41.24 94.34 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.32 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 ttp -75.73 -42.75 49.81 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 109.177 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 37.4 mtt180 -104.0 33.95 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.48 -0.763 . . . . 0.0 109.095 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 191' ' ' PHE . . . -38.29 109.3 0.09 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 1.4 t 162.87 -71.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -1.071 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.67 62.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -0.785 . . . . 0.0 109.214 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.27 160.92 21.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.859 . . . . 0.0 109.627 -179.783 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -91.88 124.18 35.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 108.988 179.437 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -123.97 177.03 5.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.482 -179.59 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 146' ' ' TYR . 0.5 OUTLIER -63.92 -34.88 78.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.327 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.874 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.1 m-85 -122.66 79.66 48.03 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.32 67.03 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.817 2.344 . . . . 0.0 110.742 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.59 155.6 45.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.749 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -171.95 132.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.689 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.479 179.898 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.313 0.578 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -150.54 105.42 3.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 1.012 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 -95.07 141.81 28.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 179.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 147' ' ' ARG . 3.2 ptt180 -75.13 127.85 34.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.181 179.623 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.28 -21.02 47.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 182' ' ' ALA . 89.3 t -94.3 108.02 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -79.21 147.71 32.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.058 -1.026 . . . . 0.0 108.769 179.339 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 1.6 pp0? -120.07 140.36 51.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.897 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.441 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.9 mpp_? -115.87 171.43 4.65 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.81 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 35.3 Cg_endo -78.04 -35.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.63 2.22 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.63 -21.81 66.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 109.522 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.24 17.62 8.16 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER -102.37 174.33 5.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -1.154 . . . . 0.0 109.449 179.905 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.983 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 55.4 m-85 -147.55 -172.86 4.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.006 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.709 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.05 110.34 2.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -79.75 121.83 25.84 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.204 -0.935 . . . . 0.0 108.915 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -142.92 151.49 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 -179.552 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 5.4 tt -137.33 128.35 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.854 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 5.2 ptt180 -73.48 117.95 15.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 179.75 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -98.73 109.26 52.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 109.602 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.43 -25.13 8.54 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.353 2.036 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.16 -17.54 60.9 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.356 -0.84 . . . . 0.0 109.343 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -94.75 26.93 3.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 63.56 48.2 3.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.503 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.87 69.2 1.35 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -127.78 103.97 7.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -1.135 . . . . 0.0 109.389 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 149.13 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.55 HG11 ' HE1' ' A' ' 193' ' ' MET . 29.9 t -127.55 93.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.095 179.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.709 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -73.8 97.43 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.817 -179.614 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.0 OUTLIER -58.38 -38.13 76.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 143.48 157.04 7.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.81 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.597 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.9 p -73.73 155.63 38.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -1.047 . . . . 0.0 109.784 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.692 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.8 m-85 -131.24 173.95 10.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.276 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' A' ' 178' ' ' THR . 0.5 OUTLIER -85.58 -18.16 34.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 0.0 109.7 -179.854 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.424 ' CG2' ' C ' ' A' ' 177' ' ' GLU . 3.7 p -151.53 173.31 14.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.953 . . . . 0.0 109.592 -179.758 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.983 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.95 -24.98 58.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.54 -34.68 65.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -77.46 -34.11 54.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.377 -0.827 . . . . 0.0 109.269 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.692 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -78.73 -26.98 44.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -0.908 . . . . 0.0 109.319 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.012 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -76.7 -37.58 55.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.134 -0.979 . . . . 0.0 108.688 179.382 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.917 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -62.65 -44.12 97.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.191 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.35 -33.95 77.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.457 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 11.7 t80 -62.73 -35.11 78.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.14 179.624 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.41 -53.26 59.75 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.503 -0.748 . . . . 0.0 109.901 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -26.78 66.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.054 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -88.57 -16.91 31.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.448 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.617 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -93.48 -11.73 31.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -99.84 -33.85 10.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 108.865 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -79.54 -42.29 25.43 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.55 ' HE1' HG11 ' A' ' 171' ' ' VAL . 3.5 tpp -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.644 -0.66 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 194' ' ' ARG . 4.6 mmp_? -102.17 12.59 36.51 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.03 -156.31 11.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ARG . 5.4 p -65.41 154.72 37.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -1.145 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 196' ' ' SER . 10.8 mtt180 62.86 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 179.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -161.65 173.66 14.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 200' ' ' LEU . 3.3 mt -117.46 125.91 51.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.603 -179.8 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.45 -179.76 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.815 -179.63 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.722 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -75.88 -34.6 59.99 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.128 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.917 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.3 m-85 -123.84 83.61 54.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.86 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.82 143.31 23.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.511 2.141 . . . . 0.0 110.508 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.893 HD23 HG12 ' A' ' 206' ' ' VAL . 0.4 OUTLIER -150.47 -161.33 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.426 179.963 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' CG ' ' N ' ' A' ' 206' ' ' VAL . 0.3 OUTLIER -140.55 -41.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.734 -179.919 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.893 HG12 HD23 ' A' ' 204' ' ' LEU . 9.6 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.581 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -164.41 123.7 1.91 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 -99.57 144.71 28.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 -179.885 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -79.15 76.39 5.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.228 179.647 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.98 -21.33 0.44 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.906 HG11 ' HA ' ' A' ' 179' ' ' ALA . 16.8 t -101.11 109.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.283 . . . . 0.0 109.455 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.77 174.7 5.77 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.608 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.609 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -142.53 133.35 25.55 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 110.282 -179.748 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 2.0 ttm-85 -68.67 -174.95 0.23 Allowed Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.918 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 29.3 Cg_endo -70.75 82.78 0.92 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.17 1.246 . . . . 0.0 110.021 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 7.2 m95 63.7 65.41 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.524 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.62 -132.49 1.35 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.537 -1.315 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -79.23 159.17 27.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.549 -0.971 . . . . 0.0 110.47 -178.756 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 151' ' ' GLN . 8.5 m-30 -101.71 -163.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.586 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -158.35 112.3 2.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.896 -1.127 . . . . 0.0 110.779 -179.906 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -84.94 128.01 34.43 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.381 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 172' ' ' TRP . 0.8 OUTLIER -143.76 166.85 23.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.108 -178.942 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.438 HG12 ' N ' ' A' ' 162' ' ' ARG . 1.9 tt -161.74 149.05 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 161' ' ' ILE . 12.6 ptm180 -80.73 153.69 27.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.632 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.25 104.91 25.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.68 -28.49 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.399 2.066 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.17 -24.81 62.31 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.093 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -100.67 32.36 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.803 . . . . 0.0 109.494 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 9.2 t-20 69.56 44.13 0.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 61.55 22.37 61.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.47 137.16 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -1.083 . . . . 0.0 109.594 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -69.15 161.7 28.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 31.3 t -144.44 97.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.268 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.586 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 3.3 t-105 -79.55 105.82 11.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.622 -179.858 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.644 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -59.33 -60.39 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 163.64 153.98 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -69.3 156.7 38.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.399 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 59.2 m-85 -134.24 -162.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 109.226 -179.766 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -25.55 9.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.52 ' C ' ' CD2' ' A' ' 157' ' ' PHE . 2.9 p -145.78 -177.32 5.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 -179.925 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.906 ' HA ' HG11 ' A' ' 149' ' ' VAL . . . -79.92 -27.76 39.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 109.29 -179.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.17 -37.66 75.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.87 -57.3 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 -179.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.822 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -59.27 -31.61 69.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.869 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -68.87 -42.96 76.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.333 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.8 tm? -61.67 -44.44 96.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.857 . . . . 0.0 108.792 179.556 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.573 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -65.06 -28.16 69.28 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 27.6 t80 -68.8 -35.39 76.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.552 -0.718 . . . . 0.0 109.138 179.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -60.52 -48.18 82.89 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.323 -0.86 . . . . 0.0 109.594 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -55.14 -42.72 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.644 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -74.55 -20.65 59.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.496 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.547 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -91.36 2.43 56.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.0 t80 -109.77 -29.28 8.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 108.636 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -84.07 -39.36 19.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 0.0 OUTLIER -75.23 -32.47 61.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.646 -0.659 . . . . 0.0 109.86 179.861 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 4.3 mtt85 -92.44 -12.58 31.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 88.52 -145.94 19.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.448 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 2.1 m -54.85 -96.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -1.101 . . . . 0.0 109.613 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 6.8 ttm105 -56.36 164.55 1.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.063 -1.023 . . . . 0.0 109.33 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 190' ' ' ALA . . . 179.04 176.35 0.57 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.543 ' C ' HD23 ' A' ' 200' ' ' LEU . 2.4 mt -113.4 106.1 14.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.899 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -115.1 158.04 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.472 ' C ' ' CD1' ' A' ' 202' ' ' PHE . 0.7 OUTLIER -64.41 -28.93 70.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.321 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.0 m-85 -126.22 72.84 71.92 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.571 -0.706 . . . . 0.0 109.19 -179.685 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -77.37 148.47 26.72 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.723 2.282 . . . . 0.0 110.444 -179.591 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.83 86.65 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.728 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 33.05 4.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.439 179.731 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.396 179.933 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 mptt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.428 ' CD2' ' NE2' ' A' ' 151' ' ' GLN . 35.9 m170 -76.42 106.28 7.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.4 m-85 -102.98 145.21 30.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.61 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -75.05 82.8 2.27 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.24 179.666 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.03 9.65 1.44 Allowed Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.617 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 183' ' ' ALA . 54.1 t -121.09 111.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.747 -1.443 . . . . 0.0 109.892 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' CB ' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -76.43 101.26 5.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 108.917 179.508 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 1.1 pt20 -97.38 134.49 40.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.941 -179.375 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.598 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 5.3 mtt180 -89.35 -176.19 0.64 Allowed Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 33.8 Cg_endo -78.03 87.09 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.087 1.858 . . . . 0.0 110.281 -179.642 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 43.7 m95 55.43 73.25 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.393 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -168.59 -93.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.659 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.546 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.1 mtpp -115.77 -168.78 1.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -1.12 . . . . 0.0 110.431 -178.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.812 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 45.0 m-85 -150.61 -175.96 5.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 149' ' ' VAL . . . -155.05 155.58 34.36 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.527 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -129.5 115.77 17.96 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -138.84 159.86 41.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.392 -179.526 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 171' ' ' VAL . 9.9 tt -134.91 136.21 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.5 OUTLIER -85.33 126.78 34.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 179.891 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -115.51 91.16 28.12 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 109.487 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 34.7 Cg_endo -77.31 -25.08 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.534 2.156 . . . . 0.0 110.454 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -92.55 23.36 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 38.19 8.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.928 . . . . 0.0 109.555 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 169' ' ' ALA . . . 89.04 122.5 2.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 168' ' ' GLY . . . -179.86 80.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.19 148.31 4.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 161' ' ' ILE . 51.4 t -129.89 93.07 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.562 ' HZ2' HG22 ' A' ' 175' ' ' THR . 7.5 t-105 -81.29 95.35 6.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.667 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.664 HD21 ' CB ' ' A' ' 189' ' ' ALA . 21.1 mt -53.57 -50.55 65.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.77 . . . . 0.0 109.306 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.96 14.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.562 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 4.2 p -81.68 145.77 30.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.469 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.1 m-85 -120.01 -169.93 1.87 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 -179.841 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.59 -29.29 12.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 2.8 p -138.22 167.66 21.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.812 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -70.75 -24.68 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.271 -0.893 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 39.6 tt0 -73.49 -30.4 63.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.668 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -81.71 -41.43 21.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 -179.868 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -69.15 -39.15 78.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.13 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.18 -42.06 84.86 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.395 -0.815 . . . . 0.0 108.828 179.589 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -59.35 -46.29 89.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.525 -0.734 . . . . 0.0 109.027 179.592 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.61 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -64.2 -23.05 67.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 10.1 t80 -71.55 -34.4 69.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.422 -0.799 . . . . 0.0 109.144 179.711 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 200' ' ' LEU . 15.2 m-20 -63.37 -41.73 98.81 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -50.31 74.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 -179.757 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.664 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -74.37 -18.51 60.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.783 -179.507 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.3 -4.77 55.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -106.19 -32.14 8.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.259 -0.901 . . . . 0.0 108.841 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -41.3 30.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 47.0 ttm -70.82 -33.78 71.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 179.648 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.55 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -84.93 -17.19 38.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.411 -0.806 . . . . 0.0 109.08 179.713 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 196' ' ' SER . . . 63.09 -88.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 195' ' ' GLY . 3.9 p -54.65 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 4.1 mpt_? -53.85 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.324 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.55 ' HB1' ' HD2' ' A' ' 194' ' ' ARG . . . 177.44 160.29 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 199' ' ' LEU . 4.7 mp -95.47 113.93 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.551 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.1 OUTLIER -114.84 179.91 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.295 179.919 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.677 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -72.31 -31.87 66.07 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.03 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.1 m-85 -125.94 71.51 68.68 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 34.8 Cg_endo -76.82 149.26 29.32 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.646 2.231 . . . . 0.0 110.619 -179.468 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 205' ' ' ARG . 1.2 mt 173.94 175.64 0.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER 61.1 114.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.144 -0.972 . . . . 0.0 109.53 -179.985 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.468 -179.989 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.35 161.27 20.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.957 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 m-85 -84.4 163.26 19.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.59 96.08 6.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.29 -9.82 11.86 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 78.4 t -104.31 114.5 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.252 . . . . 0.0 109.739 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -87.26 141.55 28.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 108.733 179.436 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.462 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -113.16 141.39 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.0 -1.062 . . . . 0.0 109.872 -179.583 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.497 ' HD2' ' HD2' ' A' ' 153' ' ' PRO . 3.4 mmt-85 -116.75 162.18 28.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.245 179.888 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.497 ' HD2' ' HD2' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.61 -25.34 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.439 2.093 . . . . 0.0 110.279 179.839 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.61 -42.47 82.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 156' ' ' LYS . . . 133.53 37.29 0.24 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 155' ' ' GLY . 22.2 mttt -135.12 170.83 15.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -1.106 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 64.1 m-85 -140.79 -170.35 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.653 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -159.29 113.64 2.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 109.934 179.686 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -86.18 123.63 31.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.473 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.554 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 9.3 mt-10 -141.58 169.16 18.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.66 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.562 HD13 ' HE1' ' A' ' 193' ' ' MET . 19.1 tt -152.54 131.41 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.976 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 18.3 ptt180 -94.8 118.35 31.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 109.978 -179.374 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -108.68 107.02 59.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.43 -0.794 . . . . 0.0 109.008 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.84 -28.77 5.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.389 2.059 . . . . 0.0 110.477 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.18 40.73 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.219 -0.925 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -94.91 33.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.05 37.91 20.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.85 83.68 0.43 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -137.78 118.83 14.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.15 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -78.68 151.19 32.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.744 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 17.9 t -131.04 100.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.013 179.722 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.678 ' HZ2' HG22 ' A' ' 175' ' ' THR . 5.1 t-105 -87.12 99.9 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.84 . . . . 0.0 109.683 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.135 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -55.4 -51.2 67.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.852 . . . . 0.0 109.562 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 153.7 153.77 6.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.678 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 3.1 p -72.24 148.22 45.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -1.115 . . . . 0.0 109.671 -179.869 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.585 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 63.0 m-85 -122.41 -169.14 1.85 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 2.3 pt-20 -101.47 -25.91 13.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 5.0 p -138.7 174.35 10.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.293 179.537 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.859 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.12 -26.76 48.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.213 -0.929 . . . . 0.0 109.761 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.23 -37.76 69.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.076 -1.015 . . . . 0.0 109.805 -179.754 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -72.7 -39.19 67.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.34 -179.967 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -72.41 -31.16 65.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.957 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.24 -36.0 66.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.329 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.604 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -63.99 -49.18 73.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.214 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.585 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.47 -30.95 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.32 -0.862 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.4 t80 -67.23 -32.41 73.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.37 -0.831 . . . . 0.0 109.32 179.706 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 200' ' ' LEU . 9.6 m-20 -65.56 -35.15 80.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.99 -50.21 30.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.402 -0.812 . . . . 0.0 110.476 -179.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.135 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -67.62 -25.87 65.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 110.072 -179.294 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -81.87 -29.0 32.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.632 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.487 ' O ' ' HA2' ' A' ' 195' ' ' GLY . 4.4 t80 -78.32 -22.41 48.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.968 . . . . 0.0 108.995 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -73.98 -50.52 19.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 108.978 179.574 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.562 ' HE1' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -71.25 -36.41 71.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.779 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.515 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -104.08 36.81 2.23 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 179.917 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 194' ' ' ARG . . . -31.42 -68.54 0.12 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 197' ' ' ARG . 29.8 m -61.42 89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -1.193 . . . . 0.0 109.125 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.7 OUTLIER 62.84 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 109.25 -179.66 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 194' ' ' ARG . . . -154.57 154.95 33.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.633 -179.882 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 200' ' ' LEU . 1.4 tm? -99.89 123.87 44.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.98 175.61 9.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.744 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.629 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -73.12 -34.29 66.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.818 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.561 ' HD2' HD22 ' A' ' 184' ' ' LEU . 5.0 m-85 -119.81 82.71 27.89 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.372 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.98 49.23 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.89 2.393 . . . . 0.0 111.051 -179.095 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.3 tt -140.24 113.04 8.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.969 . . . . 0.0 109.304 179.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.24 121.32 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.764 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.542 179.938 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.94 90.81 2.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.216 -0.927 . . . . 0.0 109.615 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.933 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 50.5 m-85 -86.5 154.28 21.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.896 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.26 90.21 3.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 -17.82 5.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 182' ' ' ALA . 92.9 t -96.92 110.32 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -1.137 . . . . 0.0 110.125 -179.573 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 29.5 mtt180 -85.55 141.07 30.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -107.47 152.76 23.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.976 -1.077 . . . . 0.0 110.41 -178.954 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.559 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -126.04 147.02 57.71 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.003 179.841 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.18 -6.63 16.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -98.85 7.52 45.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.774 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.27 81.43 1.21 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER 175.31 163.12 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.153 . . . . 0.0 109.552 -179.998 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 36.2 m-85 -146.51 -176.25 5.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.677 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.08 110.24 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.528 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -82.34 118.39 23.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 158' ' ' ALA . 1.5 mt-10 -138.78 153.14 48.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.803 . . . . 0.0 109.16 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 190' ' ' ALA . 6.8 tt -134.93 130.71 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.066 -1.021 . . . . 0.0 109.734 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -70.11 126.37 29.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.186 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -121.62 94.84 48.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.775 -179.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.56 -21.08 11.74 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.616 2.211 . . . . 0.0 110.414 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.43 70.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 4.0 mmtm -79.99 -69.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 109.417 179.865 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.4 p30 166.81 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.42 34.25 68.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -102.31 96.97 7.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -1.143 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -50.2 156.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.661 -179.762 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 161' ' ' ILE . 44.0 t -123.04 91.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -0.826 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.677 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t-105 -75.77 91.51 2.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 189' ' ' ALA . 12.4 mt -53.86 -38.16 64.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.93 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.38 160.37 8.38 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.3 p -72.35 171.47 12.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 59.3 m-85 -145.94 -173.39 4.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 -179.949 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -28.17 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 3.3 p -145.95 170.42 16.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -69.65 -26.33 64.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.885 . . . . 0.0 109.31 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -70.58 -36.22 73.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -73.37 -47.87 38.68 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.61 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.578 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -63.55 -36.01 82.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.0 109.422 -179.806 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -67.0 -40.66 87.39 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 109.045 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 184' ' ' LEU . 42.6 tp -61.83 -48.75 79.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.416 -0.803 . . . . 0.0 109.127 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.08 -28.68 70.25 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 4.6 t80 -67.42 -28.47 67.93 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.529 -0.732 . . . . 0.0 109.038 179.252 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 200' ' ' LEU . 9.6 m-20 -70.26 -45.62 66.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -33.95 76.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.809 . . . . 0.0 110.243 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.806 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -75.23 -54.45 7.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 109.747 -179.586 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -62.47 -14.95 46.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.862 -179.685 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.508 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 9.1 t80 -85.41 -34.93 21.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.007 -1.058 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -65.31 -43.13 92.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -82.35 -40.12 21.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 109.249 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.892 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 7.6 mtp85 -104.24 34.49 3.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.436 -0.79 . . . . 0.0 109.009 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . -41.54 165.42 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 72.31 93.54 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -1.162 . . . . 0.0 109.306 -179.967 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 65.89 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.848 . . . . 0.0 109.677 179.929 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 194' ' ' ARG . . . 63.59 147.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.895 . . . . 0.0 109.411 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.83 121.03 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 109.355 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -127.6 -178.81 4.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.107 -179.871 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.603 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -72.2 -35.51 68.94 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.881 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ ' ' A' ' 146' ' ' TYR . 7.5 m-85 -120.09 76.4 23.1 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.63 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -77.4 111.49 3.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.63 2.22 . . . . 0.0 110.553 -179.525 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 -168.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.345 179.851 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 206' ' ' VAL . 3.5 mtm180 -98.86 80.71 2.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.915 . . . . 0.0 109.554 -179.936 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.489 HG23 ' C ' ' A' ' 205' ' ' ARG . 2.5 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.489 -179.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.405 0.621 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -98.96 151.55 20.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 -179.98 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 14.4 m-85 -130.36 151.37 50.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 109.703 -179.81 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -77.4 85.3 3.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.574 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.98 -20.43 4.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 182' ' ' ALA . 16.2 t -96.39 127.42 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -1.197 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.2 ttt85 -94.13 153.12 18.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.15 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.498 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -127.31 134.33 50.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.949 -1.094 . . . . 0.0 109.683 -179.679 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.499 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -114.77 167.01 10.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 109.502 -179.75 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 35.6 Cg_endo -78.35 5.85 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.597 2.198 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -102.22 -18.96 15.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.631 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 15.88 11.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.817 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.407 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.4 mtpp -112.5 171.36 7.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.973 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 53.8 m-85 -142.84 -172.84 3.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.333 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -153.41 105.6 2.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.164 -0.96 . . . . 0.0 109.997 179.842 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.88 118.59 21.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.545 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.552 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 9.0 mt-10 -136.53 155.08 50.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.344 -179.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 ' HE2' ' A' ' 193' ' ' MET . 12.2 tt -140.38 143.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.705 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -87.6 126.62 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 109.025 179.659 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -112.95 95.67 35.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.634 -179.768 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 35.3 Cg_endo -77.26 -26.0 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.488 2.125 . . . . 0.0 110.248 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.79 -15.11 62.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 0.0 109.606 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.514 ' CE ' ' HA ' ' A' ' 166' ' ' LYS . 2.4 mmpt? -106.39 41.32 1.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 109.336 179.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER 48.26 72.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.956 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' ASN . . . 48.74 96.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -148.48 101.32 3.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.173 . . . . 0.0 109.633 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 152.55 23.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.195 179.885 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.46 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 53.4 t -133.58 91.94 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.552 ' CE3' ' OE2' ' A' ' 160' ' ' GLU . 9.6 t-105 -79.05 92.6 5.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.066 179.492 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 189' ' ' ALA . 7.7 mt -53.8 -38.72 64.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.911 . . . . 0.0 109.29 -179.827 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 141.67 175.44 15.17 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -91.88 161.73 14.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -1.132 . . . . 0.0 109.191 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 60.7 m-85 -134.63 169.32 17.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.558 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.454 ' HG3' ' OD2' ' A' ' 181' ' ' ASP . 1.3 pt-20 -75.6 -25.41 56.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.868 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.453 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -147.58 -178.24 6.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 109.45 -179.937 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.973 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -82.6 -24.63 33.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 184' ' ' LEU . 1.2 tt0 -71.09 -34.18 70.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 109.613 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.454 ' OD2' ' HG3' ' A' ' 177' ' ' GLU . 0.4 OUTLIER -76.58 -50.78 13.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.288 -0.883 . . . . 0.0 109.671 -179.891 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.7 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -59.3 -45.94 89.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 109.186 179.921 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.31 -46.04 89.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -59.51 -31.16 69.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.634 -0.666 . . . . 0.0 109.219 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.485 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -79.81 -23.74 41.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.488 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.6 t80 -74.77 -30.3 61.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.41 -0.806 . . . . 0.0 108.879 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 200' ' ' LEU . 21.6 m-20 -71.12 -50.76 30.12 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.519 0.676 . . . . 0.0 109.31 179.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -36.33 82.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.633 -0.667 . . . . 0.0 109.688 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 173' ' ' LEU . . . -80.84 -22.13 40.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.825 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.05 179.863 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 195' ' ' GLY . 1.7 t80 -85.31 -33.36 22.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 109.166 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -76.54 -40.72 49.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.868 . . . . 0.0 109.371 179.874 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.661 ' HE2' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -80.68 -27.7 36.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 110.284 -179.481 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 190' ' ' ALA . 2.8 mmt180 -92.61 8.93 36.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.897 -1.127 . . . . 0.0 109.676 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 71.48 -136.71 25.1 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.2 m -97.34 151.29 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.529 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 57.75 113.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.67 13.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.606 -179.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.69 113.17 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.377 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.66 176.07 8.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.403 -179.933 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.636 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -68.83 -37.27 79.06 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.368 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.1 m-85 -124.52 78.94 62.28 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.501 -0.749 . . . . 0.0 109.196 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 69.74 7.47 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.597 2.198 . . . . 0.0 110.447 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.85 56.03 4.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.408 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.545 ' O ' HG12 ' A' ' 206' ' ' VAL . 0.0 OUTLIER 56.01 -175.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 109.787 179.842 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 205' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.335 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.288 0.566 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.25 173.31 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.896 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.965 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 21.3 m-85 -80.18 152.96 28.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 85.33 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.08 -15.28 4.54 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 182' ' ' ALA . 39.9 t -99.65 120.23 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.125 -1.221 . . . . 0.0 109.657 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 mmm180 -93.95 114.65 26.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.131 179.714 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.7 pt20 -89.68 139.32 30.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.829 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.507 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -110.54 160.72 27.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 179.96 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.7 Cg_endo -77.88 3.12 7.24 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.511 2.141 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.58 ' HA ' ' CE3' ' A' ' 154' ' ' TRP . 0.0 OUTLIER -105.06 -21.23 13.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.063 -1.023 . . . . 0.0 109.387 179.828 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 115.59 22.32 4.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.43 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 75.8 mttt -117.07 152.35 34.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.263 179.823 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.975 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 m-85 -132.6 170.53 15.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.128 -0.982 . . . . 0.0 109.675 -179.615 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.606 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -143.84 114.9 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.921 179.814 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -84.95 121.95 28.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 108.764 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.53 152.7 40.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.562 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 190' ' ' ALA . 1.2 tt -144.36 133.52 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 179.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.84 136.67 57.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 179.675 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.42 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 29.4 t0 -116.69 109.36 43.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.21 -27.39 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.375 2.05 . . . . 0.0 110.205 179.71 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.07 -16.72 61.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.402 -0.811 . . . . 0.0 109.732 -179.944 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 83.5 mttt -102.48 37.64 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 22.9 m-80 60.32 40.38 17.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.578 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 62.7 65.05 3.36 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -117.84 133.8 55.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.37 141.76 58.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.54 ' O ' HG12 ' A' ' 171' ' ' VAL . 26.0 t -117.31 88.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.606 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 9.4 t-105 -73.99 92.82 2.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.343 179.841 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.083 HD21 ' HB2' ' A' ' 189' ' ' ALA . 2.2 mt -54.44 -40.81 68.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 144.84 157.33 7.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.515 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 1.4 p -72.06 169.09 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.963 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 185' ' ' ALA . 64.6 m-85 -143.78 -178.99 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 -179.785 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -86.69 -30.06 21.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.539 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 6.3 p -142.51 -179.62 6.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.975 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.28 -24.11 43.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -72.12 -35.59 69.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.5 OUTLIER -76.14 -39.27 55.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.298 179.878 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -70.37 -32.44 70.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 108.97 179.837 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.965 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.09 -40.76 64.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.547 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -61.65 -44.27 97.28 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.576 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -68.18 -31.0 70.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.256 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 161' ' ' ILE . 8.2 t80 -63.03 -29.77 71.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.557 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.531 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.4 m-20 -68.98 -48.73 62.41 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 109.223 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -52.9 -36.01 58.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 110.578 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 1.083 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.79 -39.14 24.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.914 -1.116 . . . . 0.0 109.905 -179.491 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -80.74 4.66 18.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.314 179.835 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 195' ' ' GLY . 6.0 t80 -113.89 -42.69 3.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.416 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -38.8 66.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.116 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 15.3 ttm -81.59 -35.4 30.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.653 -0.654 . . . . 0.0 110.292 -179.507 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -81.69 -13.88 57.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.041 . . . . 0.0 109.654 -179.418 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 99.21 -125.1 8.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.493 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -66.65 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -1.198 . . . . 0.0 109.922 -179.523 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -75.47 152.91 37.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 172.52 153.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.852 . . . . 0.0 109.162 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.1 OUTLIER -92.6 116.94 29.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.11 -0.994 . . . . 0.0 109.772 -179.698 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.531 ' CB ' ' OD1' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.03 146.91 50.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.31 179.836 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.743 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -49.24 -32.7 11.18 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.58 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 6.6 m-85 -121.14 85.22 41.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 109.196 179.855 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.21 111.27 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.598 2.199 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.608 HD12 ' H ' ' A' ' 206' ' ' VAL . 1.6 pp -132.91 143.89 49.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.073 -1.017 . . . . 0.0 109.666 -179.726 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -115.7 53.83 0.83 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.216 179.849 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.608 ' H ' HD12 ' A' ' 204' ' ' LEU . 54.4 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.584 -179.809 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 65.61 55.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.962 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 25.3 m-85 -55.77 159.83 2.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.283 -0.885 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -81.4 91.4 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.68 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.68 3.37 11.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.904 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.7 t -112.8 109.37 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -1.181 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -84.96 113.99 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.17 -0.956 . . . . 0.0 108.789 179.544 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -91.92 131.29 37.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 110.284 -179.322 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -79.32 -177.27 0.84 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.897 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 152' ' ' ARG . 32.9 Cg_endo -76.57 76.37 4.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.84 1.693 . . . . 0.0 109.908 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 61.45 69.57 0.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 109.154 -179.617 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -166.6 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.503 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.526 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 13.2 mttp -113.18 -171.43 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -1.175 . . . . 0.0 110.627 -178.812 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.053 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 28.5 m-85 -144.33 -179.0 6.26 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -149.03 111.33 4.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.836 -1.165 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -88.22 117.99 27.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.141 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt-10 -134.33 -165.87 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.213 -179.864 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 160' ' ' GLU . 2.5 tt 174.68 138.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.667 179.868 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -75.52 131.14 39.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.246 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -105.83 111.86 64.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.859 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.3 -28.55 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.498 2.132 . . . . 0.0 110.304 179.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.65 58.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.863 . . . . 0.0 109.594 -179.867 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 3.9 mmpt? -104.75 25.48 10.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.814 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 76.49 33.72 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.638 179.791 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.2 86.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -139.8 -168.89 2.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.4 179.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -112.41 144.9 41.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.785 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 161' ' ' ILE . 38.3 t -128.67 116.42 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.101 179.603 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 6.3 t-105 -102.11 100.67 10.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.437 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 189' ' ' ALA . 0.9 OUTLIER -57.75 -47.32 82.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.498 179.741 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 172' ' ' TRP . . . 150.74 157.24 7.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.875 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.2 p -73.58 152.95 40.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.4 -1.059 . . . . 0.0 109.607 -179.846 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.661 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 70.7 m-85 -126.44 -177.2 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.165 179.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 -32.47 15.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.288 -0.882 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.456 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -134.32 168.81 18.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.053 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.462 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -75.0 -38.13 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.374 -0.828 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD2' ' OG1' ' A' ' 178' ' ' THR . 0.4 OUTLIER -75.72 -34.89 60.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.097 -1.002 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -73.54 -35.71 65.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.08 179.664 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.962 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.428 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -61.95 -46.19 90.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.464 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.539 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.39 -29.7 69.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.052 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 7.5 t80 -61.39 -42.97 99.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.501 -0.75 . . . . 0.0 109.106 179.426 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 200' ' ' LEU . 8.8 m-20 -58.25 -45.03 88.51 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.498 -0.751 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.847 -179.7 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -89.15 -25.61 21.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 110.199 -179.461 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -94.94 5.12 52.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.456 ' O ' ' CA ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -113.6 -31.66 6.43 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.328 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -83.79 -40.5 18.67 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.803 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 189' ' ' ALA . 3.7 tpp -74.91 -29.56 61.02 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.618 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 70.2 mtt-85 -109.86 -3.37 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.706 -179.836 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 191' ' ' PHE . . . 75.47 -146.37 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 73.8 m -78.11 158.09 29.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -1.105 . . . . 0.0 109.7 -179.716 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 196' ' ' SER . 16.7 ttp180 55.3 103.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.654 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 199' ' ' LEU . . . -159.52 31.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 179.723 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 198' ' ' ALA . 55.5 mt 36.57 98.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.372 0.606 . . . . 0.0 110.715 179.354 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -119.34 177.19 5.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.012 . . . . 0.0 108.88 179.019 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.729 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -71.27 -34.43 70.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.191 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 5.5 m-85 -121.86 74.83 36.99 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.852 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.516 ' O ' ' HG ' ' A' ' 204' ' ' LEU . 34.4 Cg_endo -76.18 172.88 15.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.513 2.142 . . . . 0.0 110.38 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 203' ' ' PRO . 0.4 OUTLIER 33.8 41.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.2 0.524 . . . . 0.0 110.501 -179.83 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.42 87.77 2.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.544 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.42 179.89 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.384 0.611 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -56.51 160.86 2.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.977 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.2 m-85 -93.05 126.59 38.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.619 179.997 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.72 107.22 2.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 108.918 179.347 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.92 -34.0 4.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.544 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 182' ' ' ALA . 42.0 t -81.24 119.75 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 109.233 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 22.3 mtt85 -101.4 101.67 12.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.807 -179.609 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 2.3 pt20 -62.91 144.02 57.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -0.898 . . . . 0.0 109.118 179.534 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.484 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 1.5 mmt-85 -120.58 162.36 34.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.435 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.8 Cg_endo -76.7 73.49 5.24 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.611 2.207 . . . . 0.0 110.28 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.6 -179.681 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.66 14.12 3.59 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 18.8 mmtt -108.5 -176.92 3.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.236 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 86.7 m-85 -156.4 159.09 38.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -127.69 111.7 13.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.99 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' LEU . . . -79.17 124.43 28.33 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -148.17 140.64 24.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.114 -0.992 . . . . 0.0 110.042 -179.337 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.523 HD13 ' HE2' ' A' ' 193' ' ' MET . 6.7 tt -128.41 137.41 57.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.424 -0.797 . . . . 0.0 109.121 179.735 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -80.28 142.99 34.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 -179.803 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.418 ' CG ' ' HG3' ' A' ' 166' ' ' LYS . 30.4 t0 -137.37 97.03 10.75 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.241 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.64 -24.37 10.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.322 2.014 . . . . 0.0 110.337 -179.917 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -11.75 58.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.859 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 163' ' ' ASP . 1.6 mtpt -105.84 40.57 1.55 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.63 45.97 3.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.434 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 50.77 84.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -140.78 120.77 13.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -1.088 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -63.82 157.26 25.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.148 -0.97 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 171' ' ' VAL . 34.0 t -128.85 89.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.847 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.491 ' CD1' ' HA2' ' A' ' 174' ' ' GLY . 8.9 t-105 -72.1 93.28 1.4 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.185 179.712 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.953 HD11 ' CB ' ' A' ' 189' ' ' ALA . 0.1 OUTLIER -52.07 -41.4 62.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.965 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 172' ' ' TRP . . . 143.08 162.78 9.45 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 -179.648 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' PHE . 1.2 p -76.14 -179.73 5.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.049 -1.265 . . . . 0.0 109.393 -179.939 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 182' ' ' ALA . 78.4 m-85 -157.57 179.95 8.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.61 -25.47 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.457 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -142.98 165.43 27.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 109.562 -179.988 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.683 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -67.75 -22.64 65.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.45 -0.782 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -72.07 -39.48 68.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.204 -0.935 . . . . 0.0 109.617 -179.841 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -73.18 -39.69 65.4 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.653 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.591 ' HA ' ' CD2' ' A' ' 176' ' ' PHE . . . -71.54 -32.71 68.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.618 -179.909 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.977 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -74.49 -37.02 63.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.205 -0.934 . . . . 0.0 108.852 179.71 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 184' ' ' LEU . 41.7 tp -66.03 -43.47 87.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 108.701 179.301 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -63.7 -30.96 72.0 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.241 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 190' ' ' ALA . 9.3 t80 -66.36 -36.05 81.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.548 -0.72 . . . . 0.0 109.144 179.545 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.648 ' HB3' HD13 ' A' ' 200' ' ' LEU . 62.7 m-20 -60.0 -48.99 79.42 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.352 -0.842 . . . . 0.0 109.87 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -43.9 76.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 109.771 -179.753 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.953 ' CB ' HD11 ' A' ' 173' ' ' LEU . . . -75.26 -18.42 60.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.384 -0.822 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 186' ' ' TYR . . . -91.08 -8.66 48.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 196' ' ' SER . 4.5 t80 -105.8 -29.48 10.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -81.01 -40.3 24.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.508 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.523 ' HE2' HD13 ' A' ' 161' ' ' ILE . 27.0 mtp -75.11 -27.94 60.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.56 -0.713 . . . . 0.0 109.693 179.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -98.16 10.06 41.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.519 -179.806 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 73.15 -97.52 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.782 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.571 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 2.5 m -142.87 164.78 29.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -1.111 . . . . 0.0 109.482 -179.859 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 58.86 63.35 1.67 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.315 -179.808 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.19 171.52 8.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.397 -0.814 . . . . 0.0 109.563 -179.716 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -104.52 125.67 50.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.85 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -128.24 178.04 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 -179.789 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.614 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.2 OUTLIER -70.95 -31.96 68.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.061 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 5.4 m-85 -121.61 74.14 33.11 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.45 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 35.1 Cg_endo -76.87 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.354 -179.62 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.5 tp 46.6 78.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 -179.912 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -82.39 115.16 21.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.559 -179.833 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -139.92 157.56 45.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.896 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 19.1 m-85 -112.17 149.75 31.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.26 179.841 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 97.39 4.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.771 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.87 -21.39 7.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.725 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 98.3 t -89.55 126.06 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.252 . . . . 0.0 109.999 -179.66 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 2.0 tpp180 -97.65 147.07 24.7 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.951 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.516 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 2.3 pt20 -119.4 139.75 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 -179.392 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -105.3 155.91 37.09 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.145 179.672 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.47 6.17 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.577 2.185 . . . . 0.0 110.803 -179.742 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -106.11 -52.17 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.628 -179.986 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 152.79 56.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' O ' ' CD1' ' A' ' 157' ' ' PHE . 4.2 mtmt -155.26 -177.75 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -1.168 . . . . 0.0 109.336 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.957 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 62.8 m-85 -153.65 -171.77 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.612 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.93 110.92 2.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.457 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ALA . . . -79.36 114.41 18.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.261 -0.9 . . . . 0.0 109.078 179.734 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.516 ' OE2' ' CE3' ' A' ' 172' ' ' TRP . 1.6 mt-10 -130.83 151.35 51.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.312 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 171' ' ' VAL . 2.6 tt -140.11 120.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.543 -179.82 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -61.12 140.77 57.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.304 179.867 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.414 ' CG ' ' CG ' ' A' ' 166' ' ' LYS . 30.9 t0 -118.99 100.94 50.53 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 -179.875 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.32 -30.0 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.43 2.087 . . . . 0.0 110.463 179.842 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.32 -10.13 59.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 16.1 mmtt -106.14 44.78 1.02 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 50.45 49.61 20.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.277 -179.797 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.19 99.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.954 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -159.56 111.16 2.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -1.099 . . . . 0.0 109.25 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -63.02 149.43 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.582 -179.716 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 161' ' ' ILE . 21.7 t -122.13 104.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.612 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 11.3 t-105 -77.47 95.88 4.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 189' ' ' ALA . 31.2 mt -55.77 -54.9 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.299 179.919 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 162.46 158.69 9.77 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.937 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.575 HG22 ' HZ2' ' A' ' 172' ' ' TRP . 2.9 p -72.75 154.39 40.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.568 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 53.7 m-85 -131.25 168.93 16.67 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -80.14 -24.75 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.669 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.587 ' HG1' ' CG ' ' A' ' 181' ' ' ASP . 3.4 p -145.1 175.96 9.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.957 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -79.88 -24.75 40.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.76 -33.57 64.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.587 ' CG ' ' HG1' ' A' ' 178' ' ' THR . 0.1 OUTLIER -79.72 -39.03 32.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.899 . . . . 0.0 109.288 179.945 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -71.32 -31.64 67.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 109.208 179.851 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.896 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -73.49 -39.72 64.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.235 -0.915 . . . . 0.0 108.959 179.721 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 184' ' ' LEU . 22.8 tp -61.97 -42.62 99.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.824 . . . . 0.0 108.866 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.58 -31.35 72.0 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.8 t80 -62.33 -29.78 70.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.772 ' HB3' HD13 ' A' ' 200' ' ' LEU . 13.1 m-20 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.1 -31.7 70.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 -179.841 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.514 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -83.15 -28.13 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -4.07 58.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.485 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -108.54 -34.34 6.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.296 179.859 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -81.96 -38.77 24.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.343 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.3 ttm -78.03 -31.13 50.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.639 -0.663 . . . . 0.0 109.798 179.91 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 195' ' ' GLY . 34.7 mtp85 -98.65 -16.3 19.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.116 -0.99 . . . . 0.0 109.165 -179.911 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 194' ' ' ARG . . . 47.68 -176.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.795 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 195' ' ' GLY . 93.3 p 42.82 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.215 -1.168 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.25 149.61 40.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -149.09 157.11 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 200' ' ' LEU . 1.1 mt -100.54 118.01 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.772 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -132.87 -172.71 2.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.647 -179.675 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.776 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 0.3 OUTLIER -80.22 -32.04 38.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 108.967 179.703 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 201' ' ' ASN . 3.7 m-85 -125.61 68.37 60.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.531 -0.731 . . . . 0.0 109.602 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 201' ' ' ASN . 36.8 Cg_endo -78.41 71.18 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.808 2.338 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.1 tp -161.68 -106.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.998 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -81.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.805 -1.185 . . . . 0.0 109.422 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.445 179.898 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.433 0.635 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -103.27 121.05 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.339 -0.85 . . . . 0.0 109.592 -179.848 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.883 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 22.9 m-85 -123.88 133.64 53.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -179.97 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.19 85.14 2.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.66 -20.74 2.37 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.79 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 182' ' ' ALA . 29.2 t -92.15 112.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.349 -1.089 . . . . 0.0 109.645 -179.847 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -93.12 79.49 4.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.765 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 157' ' ' PHE . 6.7 pt20 -70.84 134.97 47.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.355 -0.841 . . . . 0.0 109.357 -179.871 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.579 ' CB ' ' HD2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -89.08 -179.75 1.36 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.969 -1.082 . . . . 0.0 108.344 179.407 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 152' ' ' ARG . 31.2 Cg_endo -73.93 83.97 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.973 1.782 . . . . 0.0 110.18 -179.612 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER 66.77 64.78 0.47 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.469 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.56 ' HA3' ' NE ' ' A' ' 152' ' ' ARG . . . -157.86 -111.83 0.33 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.75 -179.404 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 1.1 mtmm -110.52 -172.58 2.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.14 . . . . 0.0 110.976 -178.515 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.764 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 17.0 m-85 -140.59 131.07 25.35 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.576 ' CB ' ' CH2' ' A' ' 172' ' ' TRP . . . -104.33 112.84 26.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.885 -1.135 . . . . 0.0 110.752 -178.948 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -81.79 117.25 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.549 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.579 ' OE2' ' CZ3' ' A' ' 172' ' ' TRP . 2.6 mt-10 -138.88 154.5 48.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.003 . . . . 0.0 109.68 -179.193 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 190' ' ' ALA . 8.3 tt -133.07 164.47 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.742 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.489 ' N ' HG12 ' A' ' 161' ' ' ILE . 2.5 tpp180 -101.01 119.65 39.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.372 179.963 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -120.83 93.04 48.6 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.33 -22.99 10.54 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.623 2.215 . . . . 0.0 110.342 179.984 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.58 60.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -90.38 33.24 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.91 25.57 15.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.557 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.38 97.96 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 170' ' ' ARG . . . -161.81 97.9 1.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 169' ' ' ALA . 4.4 mtt180 -45.56 155.63 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.949 . . . . 0.0 109.263 179.853 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.45 ' HB ' HG23 ' A' ' 161' ' ' ILE . 54.9 t -128.15 100.75 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.579 ' CZ3' ' OE2' ' A' ' 160' ' ' GLU . 10.1 t-105 -86.16 97.33 10.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.75 HD21 ' CB ' ' A' ' 189' ' ' ALA . 15.1 mt -57.13 -46.59 82.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.508 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 176' ' ' PHE . . . 151.25 155.93 7.17 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 1.3 p -68.93 178.8 2.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.164 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 175' ' ' THR . 67.1 m-85 -155.1 -171.51 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.193 -0.942 . . . . 0.0 109.46 -179.924 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -97.32 -29.38 13.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.68 -179.846 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.591 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 13.3 p -142.53 -179.61 6.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 109.587 -179.797 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -78.96 -21.76 46.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.322 -0.862 . . . . 0.0 109.04 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -75.68 -36.79 59.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.91 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -73.27 -40.75 64.35 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.234 -0.916 . . . . 0.0 109.412 179.94 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.563 ' HB3' HG13 ' A' ' 149' ' ' VAL . . . -67.78 -47.2 69.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.883 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -59.41 -40.13 85.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.812 HD22 ' HD2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -59.9 -49.74 76.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.525 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -61.66 -21.88 64.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.402 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 5.9 t80 -76.95 -28.44 55.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.419 -0.801 . . . . 0.0 109.171 179.562 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.509 ' OD1' ' CB ' ' A' ' 200' ' ' LEU . 42.8 m-20 -69.12 -38.59 78.97 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.962 -179.573 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -69.31 -44.7 71.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.522 -179.088 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.75 ' CB ' HD21 ' A' ' 173' ' ' LEU . . . -70.16 -44.14 69.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.129 -179.25 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 161' ' ' ILE . . . -64.82 -29.95 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.958 -179.412 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.41 ' O ' ' O ' ' A' ' 195' ' ' GLY . 4.4 t80 -75.56 -24.67 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.97 -1.081 . . . . 0.0 109.889 -179.623 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -82.27 -40.99 20.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -27.65 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 110.497 -179.302 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -97.46 7.78 45.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.943 -1.098 . . . . 0.0 109.603 -179.751 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 191' ' ' PHE . . . 68.06 -132.33 28.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.764 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -80.77 -177.22 6.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -1.15 . . . . 0.0 109.552 -179.984 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.493 ' HG2' ' N ' ' A' ' 198' ' ' ALA . 17.0 ttm180 52.77 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.493 ' N ' ' HG2' ' A' ' 197' ' ' ARG . . . 59.05 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 199' ' ' LEU . 3.8 mp -106.76 122.08 45.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.24 179.856 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.5 161.63 26.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.844 ' ND2' ' HB1' ' A' ' 183' ' ' ALA . 1.2 m-80 -60.82 -31.49 70.9 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.246 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.812 ' HD2' HD22 ' A' ' 184' ' ' LEU . 3.0 m-85 -123.73 88.52 52.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.84 -177.5 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.632 2.221 . . . . 0.0 110.742 -179.275 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.8 -10.22 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 -179.978 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.94 121.56 8.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.875 . . . . 0.0 109.376 -179.885 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.547 -179.997 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.3 mttt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.352 0.596 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -74.12 113.8 11.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.329 179.785 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.942 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 27.5 m-85 -75.41 148.77 38.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.191 -0.943 . . . . 0.0 109.297 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.55 96.27 4.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.18 -18.43 6.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.865 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 65.6 t -99.62 127.62 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -1.171 . . . . 0.0 109.62 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 1.1 mtt85 -100.51 141.19 33.7 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.181 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.527 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -110.92 147.37 34.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 -179.314 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 5.1 mtt180 -112.02 165.76 12.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.442 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 152' ' ' ARG . 34.9 Cg_endo -77.49 -29.56 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.546 2.164 . . . . 0.0 110.646 -179.898 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -73.14 -57.1 4.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.562 -179.957 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 53.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.459 ' C ' ' CD1' ' A' ' 157' ' ' PHE . 12.6 mttm -144.86 171.52 14.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -1.176 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.002 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 50.3 m-85 -144.93 -173.75 4.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.0 109.702 179.879 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.772 ' HB1' ' CZ2' ' A' ' 172' ' ' TRP . . . -157.17 112.85 2.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.696 179.88 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HB3' ' HE1' ' A' ' 176' ' ' PHE . . . -85.34 126.76 34.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.09 150.33 36.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.625 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 161' ' ' ILE . 1.6 tt -142.46 139.2 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.879 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -72.4 135.76 45.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 163' ' ' ASP . 37.3 t0 -130.08 96.54 25.21 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.704 -179.593 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.87 -26.49 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.505 2.136 . . . . 0.0 110.287 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.78 -20.95 62.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.334 -0.853 . . . . 0.0 109.617 -179.973 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 167' ' ' ASN . 16.6 mmtp -95.25 33.51 1.55 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.494 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 12.6 m120 66.5 49.3 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 109.313 -179.843 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 57.89 105.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.972 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -175.54 112.88 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -1.189 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -53.53 166.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 171' ' ' VAL . 43.2 t -137.33 94.57 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.772 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 5.4 t-105 -78.47 97.81 5.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.967 HD21 ' HB2' ' A' ' 189' ' ' ALA . 3.1 mt -56.1 -46.82 78.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.538 -179.822 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.66 162.87 11.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.931 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 1.5 p -79.65 151.53 30.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.288 -179.853 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 85.9 m-85 -127.25 -175.85 3.56 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.14 -33.06 19.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.298 -179.418 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 1.5 p -137.31 179.51 6.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.035 -1.041 . . . . 0.0 110.028 -179.579 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.002 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.76 -27.39 60.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.152 179.744 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 181' ' ' ASP . 11.1 tt0 -68.54 -70.82 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.471 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -37.85 -54.45 1.26 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.804 -0.56 . . . . 0.0 110.217 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -60.3 -41.34 93.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.037 -179.472 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.942 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -61.98 -31.38 71.73 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -70.9 -45.86 63.56 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.167 -0.958 . . . . 0.0 108.455 179.595 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.62 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -59.04 -25.58 63.83 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.722 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 21.2 t80 -74.21 -36.38 63.96 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.559 ' HB3' HD13 ' A' ' 200' ' ' LEU . 71.1 m-20 -64.54 -45.64 86.26 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.472 -0.767 . . . . 0.0 109.146 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -42.18 84.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.967 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -77.37 -16.73 58.72 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.805 179.498 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -91.66 1.17 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.377 -0.827 . . . . 0.0 109.048 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -114.91 -37.6 4.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.71 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 42.5 mmt-85 -81.16 -39.44 25.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.078 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 40.8 ttm -75.05 -30.54 61.04 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.463 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 1.4 mtt180 -99.54 -10.28 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.354 -0.841 . . . . 0.0 109.117 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.27 -169.65 54.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.938 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' ARG . 1.4 t -54.6 150.69 9.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -1.085 . . . . 0.0 109.635 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 62.76 125.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 -179.957 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' ARG . . . 179.92 145.7 0.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 179.953 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -90.34 120.2 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.631 -179.773 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -130.21 -173.54 3.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.007 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.632 HD22 ' HB1' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -74.96 -35.89 62.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.087 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 183' ' ' ALA . 3.4 m-85 -122.33 87.42 48.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.201 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.7 171.01 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.61 2.206 . . . . 0.0 110.755 -179.386 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.8 mt -50.06 111.99 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' ' 206' ' ' VAL . 8.1 mtt180 -47.03 -65.36 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.886 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 206' ' ' VAL . 16.7 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 stop_ save_